Unnamed: 0,Unnamed: 1,Unnamed: 2,Unnamed: 3,April,May,June,July,August,September,October,November,December,January,February,March,Total
District,,,,,,,,,,,,,,,,
Central,1.1,Total number of pregnant women Registered for ANC,TOTAL,9445.0,10262.0,8673.0,9893.0,10541.0,9960.0,9091.0,11698.0,12638.0,11563.0,9045.0,9949.0,122758.0
Central,1.1.1,Of which Number registered within first trimester (within 12 weeks),TOTAL,2598.0,2907.0,2674.0,2839.0,2699.0,2457.0,1777.0,5007.0,2608.0,2539.0,2852.0,3212.0,34169.0
Central,1.2,Number of Pregnant women registered under JSY,TOTAL,316.0,405.0,433.0,419.0,363.0,393.0,278.0,339.0,366.0,486.0,606.0,656.0,5060.0
Central,1.3,Number of pregnant women received 3 ANC check ups during pregnancy,TOTAL,5139.0,5364.0,6643.0,5897.0,7058.0,6272.0,4184.0,6185.0,6926.0,5562.0,5455.0,5727.0,70412.0
Central,1.4.1,Number of pregnant women given TT1 during current pregnancy,TOTAL,3129.0,3411.0,2667.0,2585.0,3077.0,2868.0,2439.0,2357.0,2348.0,2515.0,2671.0,3289.0,33356.0
Central,1.4.2,Number of pregnant women given TT2 or Booster during current pregnancy,TOTAL,2681.0,3066.0,2848.0,2798.0,2901.0,2836.0,2419.0,2483.0,2564.0,2288.0,2191.0,2779.0,31854.0
Central,1.5,Total number of pregnant women given 100 IFA tablets,TOTAL,4234.0,3955.0,5223.0,4699.0,6808.0,6462.0,2299.0,5071.0,5998.0,3758.0,3703.0,5245.0,57455.0
Central,1.6.1,Number of new cases of Hypertension (BP>140/90) detected in Pregnant women at the institution,TOTAL,105.0,126.0,95.0,81.0,108.0,81.0,79.0,101.0,106.0,115.0,78.0,78.0,1153.0
Central,1.6.2,Number of Eclampsia cases managed during delivery,TOTAL,10.0,11.0,9.0,14.0,10.0,6.0,9.0,19.0,15.0,11.0,8.0,6.0,128.0
Central,1.7.1,Number of Pregnant women with anaemia i.e. Hb level<11 (tested cases),TOTAL,2436.0,2449.0,2758.0,2976.0,2984.0,2922.0,2148.0,2257.0,1695.0,2994.0,2371.0,2281.0,30271.0
Central,1.7.2,Number of Pregnant women having severe anaemia (Hb<7) treated at institution,TOTAL,105.0,97.0,116.0,103.0,140.0,142.0,69.0,117.0,59.0,47.0,63.0,45.0,1103.0
Central,1.8,Number of pregnancy test kits used at SC level,TOTAL,15.0,40.0,13.0,35.0,68.0,85.0,105.0,165.0,247.0,78.0,30.0,100.0,981.0
Central,2.1.1.a,Number of deliveries conducted at Home and attended by trained SBA(i.e. Doctor or Nurse or ANM),TOTAL,7.0,9.0,1.0,3.0,4.0,4.0,5.0,2.0,3.0,8.0,3.0,2.0,51.0
Central,2.1.1.b,Number of deliveries conducted at Home and attended by non trained SBA (i.e. trained TBA or Relatives etc.),TOTAL,57.0,42.0,65.0,72.0,80.0,102.0,71.0,92.0,96.0,97.0,81.0,71.0,926.0
Central,2.1.1.c,Total number of deliveries conducted at Home and attended by trained or non-trained SBA (i.e. sum of 2.1.1.a and 2.1.1.b),TOTAL,64.0,51.0,66.0,75.0,84.0,106.0,76.0,94.0,99.0,105.0,84.0,73.0,977.0
Central,2.1.2,Number of newborns visited within 24 hours of delivery for deliveries conducted at home,TOTAL,46.0,31.0,41.0,58.0,64.0,76.0,58.0,65.0,85.0,89.0,61.0,48.0,722.0
Central,2.1.3,Number of mothers paid JSY incentive for deliveries conducted at home,TOTAL,1.0,1.0,0.0,0.0,0.0,0.0,1.0,0.0,0.0,2.0,2.0,1.0,8.0
Central,2.2,Deliveries conducted at Public Institutions (Including C-Sections),TOTAL,2164.0,2514.0,2553.0,3095.0,3742.0,3667.0,3642.0,3372.0,3238.0,3300.0,2808.0,2565.0,36660.0
Central,2.2.1,"Out of 2.2, Number discharged under 48 hours of delivery",TOTAL,629.0,775.0,665.0,875.0,917.0,979.0,956.0,879.0,889.0,831.0,804.0,711.0,9910.0
Central,2.2.2.a,Number of mothers paid JSY Incentive for deliveries conducted at Public Institutions,TOTAL,131.0,156.0,142.0,135.0,182.0,155.0,123.0,163.0,152.0,134.0,279.0,286.0,2038.0
Central,2.2.2.b,Number of ASHAs paid JSY Incentive for deliveries conducted at Public Institutions,TOTAL,59.0,83.0,39.0,42.0,66.0,56.0,51.0,62.0,57.0,52.0,50.0,65.0,682.0
Central,2.2.2.c,Number of cases of deliveries conducted at Public Institutions where JSY incentive was paid to ANMs or AWWs [only for High Performing States (HPS)],TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Central,2.3,Deliveries conducted at Private Institutions (Including C-Sections),TOTAL,662.0,689.0,696.0,818.0,907.0,899.0,837.0,912.0,809.0,862.0,779.0,782.0,9652.0
Central,2.3.1.a,Number of mothers paid JSY Incentive for deliveries conducted at accredited Private Institutions,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Central,2.3.1.b,Number of ASHAs paid JSY Incentive for deliveries conducted at accredited Private Institutions,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Central,2.3.1.c,Number of cases of deliveries conducted at accredited Private Institutions where JSY incentive was paid to ANMs or AWWs [only for High Performing States (HPS)],TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Central,3.1.1,Number of Caesarean (C-Section) deliveries performed at PHCs (Primary Health Centre),TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Central,3.1.2,Number of Caesarean (C-Section) deliveries performed at CHCs (Community Health Centre),TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Central,3.1.3,Number of Caesarean (C-Section) deliveries performed at SDHs (Sub-divisional Hospital) or DHs (District Hospital),TOTAL,527.0,602.0,478.0,723.0,819.0,672.0,684.0,691.0,684.0,917.0,642.0,647.0,8086.0
Central,3.1.4,Number of Caesarean (C-Section) deliveries performed at other State owned public institutions,TOTAL,,,,,,,,,,,,,
Central,3.1.5,"Total Number of Caesarean (C-Section) deliveries performed at Public facilities i.e. PHC, CHC, SDH, DH and other State owned public institutions (sum of items from 3.1.1 to 3.1.4)",TOTAL,527.0,602.0,478.0,723.0,819.0,672.0,684.0,691.0,684.0,917.0,642.0,647.0,8086.0
Central,3.2,No. of C-section deliveries performed at Private facilities,TOTAL,314.0,336.0,429.0,448.0,516.0,514.0,459.0,496.0,440.0,462.0,477.0,482.0,5373.0
Central,4.1.1.a,Number of male live births,TOTAL,1503.0,1642.0,1748.0,2088.0,2487.0,2470.0,2307.0,2242.0,2145.0,2230.0,1855.0,1781.0,24498.0
Central,4.1.1.b,Number of female live births,TOTAL,1363.0,1585.0,1542.0,1868.0,2205.0,2198.0,2201.0,2084.0,1957.0,1987.0,1754.0,1611.0,22355.0
Central,4.1.1.c,Total number of male and female live births (4.1.1.a and 4.1.1.b),TOTAL,2866.0,3227.0,3290.0,3956.0,4692.0,4668.0,4508.0,4326.0,4102.0,4217.0,3609.0,3392.0,46853.0
Central,4.1.2,Number of still births,TOTAL,51.0,75.0,75.0,94.0,98.0,91.0,94.0,96.0,104.0,104.0,81.0,60.0,1023.0
Central,4.1.3,Number of Abortions (spontaneous or induced),TOTAL,539.0,444.0,455.0,469.0,474.0,440.0,345.0,362.0,325.0,472.0,341.0,377.0,5043.0
Central,4.2.1,Number of Newborns weighed at birth,TOTAL,2767.0,3162.0,3253.0,3956.0,4670.0,4654.0,4505.0,4320.0,4097.0,3390.0,3572.0,3369.0,45715.0
Central,4.2.2,Number of Newborns having weight less than 2.5 kg,TOTAL,579.0,763.0,688.0,933.0,1015.0,995.0,989.0,917.0,894.0,919.0,732.0,674.0,10098.0
Central,4.3,Number of Newborns breast fed within 1 hour of birth,TOTAL,1537.0,1762.0,1853.0,2285.0,2405.0,2526.0,2401.0,2362.0,2348.0,2337.0,2036.0,1739.0,25591.0
Central,5.1.1,Number of cases of pregnant women with Obstetric Complications and attended at PHCs,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Central,5.1.2,Number of cases of pregnant women with Obstetric Complications and attended at CHCs,TOTAL,12.0,,17.0,0.0,,,13.0,15.0,,16.0,11.0,0.0,84.0
Central,5.1.3,Number of cases of pregnant women with Obstetric Complications and attended at SDHs or DHs,TOTAL,898.0,882.0,1200.0,1263.0,1493.0,1394.0,1432.0,1330.0,1186.0,1229.0,1276.0,949.0,14532.0
Central,5.1.4,Number of cases of pregnant women with Obstetric Complications and attended at other State owned public institutions,TOTAL,,,,,,,,,,,,,
Central,5.1.5,"Number of cases of pregnant women with Obstetric Complications and attended at Public facilities i.e. PHC, CHC, SDH, DH and other State owned public institutions (sum of items from 5.1.1 to 5.1.4)",TOTAL,910.0,882.0,1217.0,1263.0,1493.0,1394.0,1445.0,1345.0,1186.0,1245.0,1287.0,949.0,14616.0
Central,5.2,Number of cases of pregnant women with Obstetric Complications and attended at Private facilities,TOTAL,80.0,192.0,145.0,203.0,52.0,221.0,33.0,216.0,160.0,31.0,127.0,235.0,1695.0
Central,5.3.1,Number of cases of complicated pregnancies treated with IV antibiotics,TOTAL,619.0,717.0,821.0,901.0,970.0,939.0,990.0,655.0,684.0,826.0,995.0,558.0,9675.0
Central,5.3.2,Number of cases of complicated pregnancies treated with IV Antihypertensive/Magsulph injection,TOTAL,13.0,13.0,32.0,15.0,10.0,10.0,11.0,20.0,18.0,38.0,35.0,14.0,229.0
Central,5.3.3,Number of cases of complicated pregnancies treated with IV Oxytocis,TOTAL,692.0,959.0,917.0,933.0,1385.0,1280.0,1395.0,1245.0,1285.0,1155.0,1012.0,983.0,13241.0
Central,5.3.4,Number of cases of complicated pregnancies treated with Blood Transfusion,TOTAL,191.0,213.0,47.0,211.0,300.0,199.0,192.0,197.0,107.0,160.0,167.0,118.0,2102.0
Central,6.1,Women getting post partum check-up within 48 hours after delivery,TOTAL,2774.0,2998.0,2999.0,2561.0,4217.0,3167.0,3059.0,2880.0,3865.0,3868.0,3374.0,3115.0,38877.0
Central,6.2,Women getting a post partum check up between 48 hours and 14 days after delivery,TOTAL,1951.0,2013.0,2087.0,2260.0,2712.0,2791.0,2634.0,2713.0,2448.0,2416.0,2096.0,2103.0,28224.0
Central,6.3,PNC maternal complications attended,TOTAL,56.0,61.0,23.0,53.0,80.0,33.0,35.0,27.0,18.0,104.0,43.0,37.0,570.0
Central,7.1.1,Number of MTPs conducted at Public Institutions up to 12 weeks of pregnancy,TOTAL,130.0,88.0,84.0,95.0,97.0,102.0,73.0,120.0,150.0,140.0,136.0,151.0,1366.0
Central,7.1.2,Number of MTPs conducted at Public Institutions for more than 12 weeks of pregnancy,TOTAL,11.0,11.0,4.0,6.0,6.0,10.0,5.0,9.0,4.0,5.0,5.0,12.0,88.0
Central,7.1.3,Total number of MTPs conducted at Public Institutions (sum of items 7.1.1 and 7.1.2),TOTAL,141.0,99.0,88.0,101.0,103.0,112.0,78.0,129.0,154.0,145.0,141.0,163.0,1454.0
Central,7.2,Number of MTPs conducted at Private Facilities,TOTAL,196.0,177.0,179.0,190.0,145.0,142.0,139.0,167.0,82.0,205.0,183.0,181.0,1986.0
Central,8.1.a,Number of new cases of RTI/STI in males for which treatment was initiated,TOTAL,424.0,311.0,295.0,337.0,332.0,348.0,311.0,328.0,400.0,255.0,256.0,247.0,3844.0
Central,8.1.b,Number of new cases of RTI/STI in females for which treatment was initiated,TOTAL,2388.0,2457.0,2187.0,1901.0,2252.0,2307.0,1446.0,2609.0,2039.0,1844.0,1836.0,2005.0,25271.0
Central,8.1.c,Total number of new cases of RTI/STI in males and females for which treatment was initiated (sum of items 8.1.a and 8.1.b),TOTAL,2812.0,2768.0,2482.0,2238.0,2584.0,2655.0,1757.0,2937.0,2439.0,2099.0,2092.0,2252.0,29115.0
Central,8.2,Number of suspected RTI/STI cases for whom wet mount test was conducted,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Central,9.1.1.a,Number of NSV (No Scalpel Vasectomy) or Conventional Vasectomy conducted at PHCs,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Central,9.1.1.b,Number of NSV or Conventional Vasectomy conducted at CHCs,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Central,9.1.1.c,Number of NSV or Conventional Vasectomy conducted at SDHs or DHs,TOTAL,29.0,45.0,30.0,24.0,42.0,12.0,7.0,40.0,22.0,16.0,15.0,15.0,297.0
Central,9.1.1.d,Number of NSV or Conventional Vasectomy conducted at other State owned public institutions,TOTAL,,,,,,,,,,,,,
Central,9.1.1.e,"Total Number of NSV or Conventional Vasectomy conducted at Public facilities i.e. PHC, CHC, SDH, DH and other State owned public institutions (sum of items from 9.1.1.a to 9.1.1.d)",TOTAL,29.0,45.0,30.0,24.0,42.0,12.0,7.0,40.0,22.0,16.0,15.0,15.0,297.0
Central,9.1.2,Number of NSV or Conventional Vasectomy conducted at Private facilities,TOTAL,10.0,2.0,10.0,5.0,3.0,6.0,0.0,37.0,0.0,0.0,0.0,0.0,73.0
Central,9.2.1.a,Number of Laparoscopic sterilizations conducted at PHCs,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Central,9.2.1.b,Number of Laparoscopic sterilizations conducted at CHCs,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Central,9.2.1.c,Number of Laparoscopic sterilizations conducted at SDHs or DHs,TOTAL,177.0,196.0,155.0,192.0,157.0,176.0,122.0,235.0,253.0,224.0,215.0,266.0,2368.0
Central,9.2.1.d,Number of Laparoscopic sterilizations conducted at other State owned public institutions,TOTAL,,,,,,,,,,,,,
Central,9.2.1.e,"Total Number of Laparoscopic sterilizations conducted at Public facilities i.e. PHC, CHC, SDH, DH and other State owned public institutions (sum of items from 9.2.1.a to 9.2.1.d)",TOTAL,177.0,196.0,155.0,192.0,157.0,176.0,122.0,235.0,253.0,224.0,215.0,266.0,2368.0
Central,9.2.2,Number of Laparoscopic sterilizations conducted at Private facilities,TOTAL,8.0,9.0,3.0,13.0,3.0,4.0,15.0,9.0,3.0,9.0,5.0,12.0,93.0
Central,9.3.1.a,Number of Mini-lap sterilizations conducted at PHCs,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Central,9.3.1.b,Number of Mini-lap sterilizations conducted at CHCs,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Central,9.3.1.c,Number of Mini-lap sterilizations conducted at SDHs or DHs,TOTAL,3.0,3.0,38.0,65.0,2.0,4.0,18.0,10.0,19.0,17.0,14.0,3.0,196.0
Central,9.3.1.d,Number of Mini-lap sterilizations conducted at other State owned public institutions,TOTAL,,,,,,,,,,,,,
Central,9.3.1.e,"Total Number of Mini-lap sterilizations conducted at Public facilities i.e. PHC, CHC, SDH, DH and other State owned public institutions (sum of items from 9.3.1.a to 9.3.1.d)",TOTAL,3.0,3.0,38.0,65.0,2.0,4.0,18.0,10.0,19.0,17.0,14.0,3.0,196.0
Central,9.3.2,Number of Mini-lap sterilizations conducted at Private facilities,TOTAL,4.0,11.0,4.0,5.0,8.0,1.0,4.0,6.0,0.0,3.0,11.0,0.0,57.0
Central,9.4.1.a,Number of Post-Partum sterilizations conducted at PHCs,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Central,9.4.1.b,Number of Post-Partum sterilizations conducted at CHCs,TOTAL,0.0,0.0,3.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,3.0
Central,9.4.1.c,Number of Post-Partum sterilizations conducted at SDHs or DHs,TOTAL,25.0,41.0,7.0,36.0,44.0,52.0,45.0,49.0,33.0,48.0,38.0,51.0,469.0
Central,9.4.1.d,Number of Post-Partum sterilizations conducted at other State owned public institutions,TOTAL,,,,,,,,,,,,,
Central,9.4.1.e,"Total Number of Post-Partum sterilizations conducted at Public facilities i.e. PHC, CHC, SDH, DH and other State owned public institutions (sum of items from 9.4.1.a to 9.4.1.d)",TOTAL,25.0,41.0,10.0,36.0,44.0,52.0,45.0,49.0,33.0,48.0,38.0,51.0,472.0
Central,9.4.2,Number of Post-Partum sterilizations conducted at Private facilities,TOTAL,1.0,1.0,1.0,6.0,0.0,3.0,0.0,3.0,8.0,2.0,6.0,8.0,39.0
Central,9.5.1.a,Number of IUCD Insertions conducted at SCs,TOTAL,2.0,2.0,2.0,2.0,2.0,2.0,2.0,2.0,1.0,1.0,2.0,1.0,21.0
Central,9.5.1.b,Number of IUCD Insertions conducted at PHCs,TOTAL,166.0,181.0,156.0,365.0,229.0,214.0,192.0,236.0,229.0,234.0,247.0,273.0,2722.0
Central,9.5.1.c,Number of IUCD Insertions conducted at CHCs,TOTAL,44.0,29.0,33.0,103.0,51.0,54.0,38.0,43.0,40.0,41.0,50.0,49.0,575.0
Central,9.5.1.d,Number of IUCD Insertions conducted at SDHs or DHs,TOTAL,377.0,349.0,352.0,356.0,418.0,458.0,324.0,475.0,395.0,407.0,395.0,488.0,4794.0
Central,9.5.1.e,Number of IUCD Insertions conducted at other State owned public institutions,TOTAL,,,,,,,,,,,,,
Central,9.5.1.f,"Total Number of IUCD Insertions conducted at Public facilities i.e. SC, PHC, CHC, SDH, DH and other State owned public institutions (sum of items from 9.5.1.a to 9.5.1.e)",TOTAL,589.0,561.0,543.0,826.0,700.0,728.0,556.0,756.0,665.0,683.0,694.0,811.0,8112.0
Central,9.5.1A,"Out of above total, Post Partum (within 48 hours of delivery) IUCD insertions",TOTAL,263.0,246.0,222.0,284.0,321.0,357.0,290.0,420.0,301.0,338.0,318.0,417.0,3777.0
Central,9.5.2,Number of IUCD Insertions conducted at Private facilities,TOTAL,43.0,38.0,46.0,32.0,27.0,44.0,28.0,41.0,26.0,42.0,57.0,60.0,484.0
Central,9.06,Number of IUCD removals,TOTAL,126.0,146.0,135.0,127.0,129.0,135.0,88.0,117.0,127.0,118.0,113.0,158.0,1519.0
Central,9.07,Number of Oral Pills cycles distributed,TOTAL,2513.0,2063.0,2137.0,4160.0,2592.0,2524.0,2163.0,2673.0,1853.0,1856.0,1930.0,1788.0,28252.0
Central,9.08,Number of Condom pieces distributed,TOTAL,54765.0,36593.0,32318.0,69857.0,51207.0,42605.0,33431.0,22916.0,21465.0,34962.0,36136.0,31626.0,467881.0
Central,9.09,Number of Centchroman (weekly) pills given,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Central,9.10,Number of Emergency Contraceptive Pills distributed,TOTAL,132.0,43.0,21.0,35.0,29.0,39.0,33.0,94.0,27.0,29.0,46.0,16.0,544.0
Central,9.11.1.a,Number of cases of complications following male sterilization,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Central,9.11.1.b,Number of cases of complications following female sterilization,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Central,9.11.2.a,Number of failures following male sterilization,TOTAL,0.0,0.0,0.0,0.0,1.0,0.0,0.0,0.0,1.0,0.0,0.0,0.0,2.0
Central,9.11.2.b,Number of failures following female sterilization,TOTAL,0.0,0.0,0.0,0.0,1.0,0.0,0.0,0.0,2.0,0.0,0.0,2.0,5.0
Central,9.11.3.a,Number of deaths following male sterilization,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Central,9.11.3.b,Number of deaths following female sterilization,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Central,9.12,Number of Institutions having NSV trained doctors,TOTAL,10.0,7.0,8.0,7.0,7.0,8.0,6.0,6.0,6.0,7.0,7.0,5.0,-1.0
Central,10.1.01,Number of Infants (0 to 11 months old)received BCG immunisation,TOTAL,2757.0,3065.0,3161.0,3657.0,4318.0,4575.0,4164.0,4199.0,3872.0,4034.0,3614.0,3376.0,44792.0
Central,10.1.02,Number of Infants (0 to 11 months old) received DPT1 immunisation,TOTAL,391.0,343.0,290.0,246.0,264.0,257.0,281.0,310.0,291.0,266.0,283.0,254.0,3476.0
Central,10.1.03,Number of Infants (0 to 11 months old) received DPT2 immunisation,TOTAL,351.0,334.0,283.0,250.0,266.0,266.0,277.0,322.0,259.0,257.0,263.0,283.0,3411.0
Central,10.1.04,Number of Infants (0 to 11 months old) received DPT3 immunisation,TOTAL,454.0,396.0,313.0,311.0,299.0,277.0,272.0,320.0,282.0,306.0,278.0,299.0,3807.0
Central,10.1.04A,Number of Infants (0 to 11 months old) received Pentavalent1 immunisation,TOTAL,1950.0,1816.0,1571.0,1790.0,1823.0,1824.0,2368.0,2567.0,2451.0,2286.0,2066.0,2374.0,24886.0
Central,10.1.04B,Number of Infants (0 to 11 months old) received Pentavalent2 immunisation,TOTAL,2045.0,1790.0,1573.0,1784.0,1651.0,1530.0,1618.0,2040.0,2443.0,2113.0,2031.0,2295.0,22913.0
Central,10.1.04C,Number of Infants (0 to 11 months old) received Pentavalent3 immunisation,TOTAL,1959.0,1837.0,1610.0,1700.0,1746.0,1389.0,1387.0,1717.0,1946.0,2048.0,1867.0,2213.0,21419.0
Central,10.1.05,Number of Infants (0 to 11 months old) received OPV 0 (Birth Dose),TOTAL,2471.0,2878.0,2892.0,3377.0,3827.0,3083.0,3566.0,3590.0,3573.0,3579.0,3041.0,2791.0,38668.0
Central,10.1.06,Number of Infants (0 to 11 months old) received OPV1 (First Dose),TOTAL,2544.0,2325.0,1918.0,2179.0,2337.0,3340.0,2915.0,3075.0,3112.0,2791.0,2607.0,2813.0,31956.0
Central,10.1.07,Number of Infants (0 to 11 months old) received OPV2 (Second Dose),TOTAL,2494.0,2157.0,1833.0,2048.0,2004.0,2130.0,1959.0,2399.0,2832.0,2524.0,2402.0,2624.0,27406.0
Central,10.1.08,Number of Infants (0 to 11 months old) received OPV3 (Third Dose),TOTAL,2502.0,2216.0,1894.0,2012.0,2037.0,1738.0,1691.0,2087.0,2353.0,2465.0,2247.0,2542.0,25784.0
Central,10.1.09A,Number of Infants (upto 48 hrs of age) received Hepatitis-B0 immunisation,TOTAL,2217.0,2724.0,2732.0,3135.0,3526.0,2884.0,3509.0,3368.0,3376.0,3404.0,2868.0,2670.0,36413.0
Central,10.1.09,Number of Infants (0 to 11 months old) received Hepatitis-B1 immunisation,TOTAL,515.0,394.0,384.0,342.0,315.0,354.0,394.0,439.0,387.0,386.0,351.0,316.0,4577.0
Central,10.1.10,Number of Infants (0 to 11 months old) received Hepatitis-B2 immunisation,TOTAL,318.0,321.0,285.0,268.0,288.0,249.0,262.0,306.0,272.0,357.0,267.0,233.0,3426.0
Central,10.1.11,Number of Infants (0 to 11 months old) received Hepatitis-B3 immunisation,TOTAL,371.0,400.0,454.0,289.0,312.0,278.0,229.0,327.0,282.0,306.0,303.0,284.0,3835.0
Central,10.1.12,Number of Infants (0 to 11 months old) received Measles immunisation (First Dose),TOTAL,4014.0,3708.0,3903.0,2381.0,2747.0,2460.0,2268.0,2596.0,2296.0,1986.0,1791.0,2214.0,32364.0
Central,10.1.12B,Number of Infants (more than 16 months old) received Measles immunisation (Second Dose),TOTAL,8779.0,3047.0,5024.0,1141.0,403.0,148.0,91.0,124.0,89.0,25.0,16.0,95.0,18982.0
Central,10.1A,No. of Children aged 9 to 12 months who received JE 1st dose,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Central,10.1.13.a,Total number of male children (9 to 11 months old) fully immunised (BCG+DPT123/Pentavalent123+OPV123+Measles) during the month,TOTAL,1832.0,1934.0,1453.0,1176.0,1442.0,1245.0,1162.0,1331.0,1160.0,1033.0,960.0,1107.0,15835.0
Central,10.1.13.b,Total number of female children (9 to 11 months old) fully immunised (BCG+DPT123/Pentavalent123+OPV123+Measles) during the month,TOTAL,2012.0,1703.0,1251.0,1001.0,1245.0,1047.0,1083.0,1227.0,1044.0,849.0,801.0,1016.0,14279.0
Central,10.1.13.c,Total number of children (9 to 11 months old) fully immunised (BCG+DPT123/Pentavalent123+OPV123+Measles) during the month (sum of items 10.1.13.a and 10.1.13.b),TOTAL,3844.0,3637.0,2704.0,2177.0,2687.0,2292.0,2245.0,2558.0,2204.0,1882.0,1761.0,2123.0,30114.0
Central,10.2.1,Number of Infants (more than 16 months old) received DPT Booster dose,TOTAL,2242.0,2723.0,2137.0,2279.0,2302.0,1956.0,1520.0,2026.0,2181.0,1784.0,1925.0,2304.0,25379.0
Central,10.2.2,Number of Infants (more than 16 months old) received OPV Booster dose,TOTAL,2234.0,2719.0,1861.0,2274.0,2289.0,1947.0,1516.0,1980.0,2175.0,1793.0,1937.0,2304.0,25029.0
Central,10.2.3,"Number of Infants (more than 16 months old) received Measles, Mumps, Rubella (MMR) Vaccination",TOTAL,310.0,303.0,322.0,355.0,2282.0,2925.0,2324.0,3211.0,3392.0,2329.0,2614.0,2814.0,23181.0
Central,10.3.1.a,Total number of male children (12 to 23 months old) fully immunised (BCG+DPT123/Pentavalent123+OPV123+Measles) during the month,TOTAL,2271.0,1028.0,1588.0,358.0,381.0,370.0,304.0,347.0,372.0,303.0,323.0,382.0,8027.0
Central,10.3.1.b,Total number of female children (12 to 23 months old) fully immunised (BCG+DPT123/Pentavalent123+OPV123+Measles) during the month,TOTAL,2073.0,867.0,1456.0,322.0,306.0,305.0,279.0,349.0,378.0,240.0,262.0,310.0,7147.0
Central,10.3.1.c,Total number of children (12 to 23 months old) fully immunised (BCG+DPT123+OPV123/Pentavalent123+Measles) during the month (sum of items 10.3.1.a and 10.3.1.b),TOTAL,4344.0,1895.0,3044.0,680.0,687.0,675.0,583.0,696.0,750.0,543.0,585.0,692.0,15174.0
Central,10.3.2,Number of children (more than 5 years old) given DT5,TOTAL,1022.0,1709.0,1081.0,843.0,1013.0,1104.0,1094.0,1254.0,1376.0,1183.0,961.0,1438.0,14078.0
Central,10.3.3,Number of children (more than 10 years old) given TT10,TOTAL,460.0,945.0,613.0,449.0,380.0,414.0,409.0,455.0,486.0,575.0,427.0,575.0,6188.0
Central,10.3.4,Number of children (more than 16 years old) given TT16,TOTAL,428.0,692.0,432.0,397.0,476.0,504.0,344.0,367.0,414.0,399.0,356.0,378.0,5187.0
Central,10.3.5.a,Number of cases of Abscess reported following immunisation [Adverse Event Following Immunisation (AEFI)],TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Central,10.3.5.b,Number of cases of Death reported following immunisation [Adverse Event Following Immunisation (AEFI)],TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Central,10.3.5.c,Number of cases of other complications reported following immunisation [Adverse Event Following Immunisation (AEFI)],TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Central,10.4.1,Number of Immunisation sessions planned to be held during the month,TOTAL,1384.0,1181.0,1356.0,873.0,830.0,818.0,859.0,837.0,1161.0,900.0,819.0,809.0,11827.0
Central,10.4.2,Number of Immunisation sessions held during the month,TOTAL,1305.0,1074.0,1275.0,809.0,780.0,771.0,754.0,798.0,1110.0,848.0,761.0,763.0,11048.0
Central,10.4.3,Number of Immunisation sessions held during the month where ASHAs were present,TOTAL,285.0,246.0,328.0,122.0,133.0,145.0,123.0,132.0,218.0,147.0,140.0,126.0,2145.0
Central,10.5.1,Number of children (more than 16 months old) received Japanese Encephalitis (JE) vaccination,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Central,11.1.1,Number of children (9 months to 5 years old) administered 1st dose of Vitamin A (Dose-1),TOTAL,4266.0,3565.0,2584.0,2277.0,2780.0,2478.0,2447.0,2472.0,2578.0,1860.0,1350.0,2028.0,30685.0
Central,11.1.2,Number of children (9 months to 5 years old) were administered 5th dose of Vitamin A (Dose-5),TOTAL,5452.0,2698.0,6697.0,1365.0,1472.0,1674.0,1623.0,2217.0,1908.0,1991.0,1165.0,1498.0,29760.0
Central,11.1.3,Number of children (9 months to 5 years old) administered 9th dose of Vitamin A (Dose-9),TOTAL,1445.0,626.0,1235.0,528.0,442.0,494.0,564.0,779.0,813.0,777.0,487.0,714.0,8904.0
Central,12.1,Number of cases of Diptheria reported in children below 5 years of age,TOTAL,0.0,0.0,0.0,0.0,0.0,1.0,3.0,3.0,3.0,0.0,0.0,0.0,10.0
Central,12.2,Number of cases of Pertusis reported in children below 5 years of age,TOTAL,0.0,0.0,1.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,1.0
Central,12.3,Number of cases of Tetanus neonatarum reported in children below 5 years of age,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,1.0,0.0,1.0
Central,12.4,Number of cases of Tetanus other than neonatarum reported in children below 5 years of age,TOTAL,0.0,1.0,0.0,0.0,0.0,0.0,0.0,2.0,0.0,0.0,0.0,2.0,5.0
Central,12.5,Number of cases of Polio reported in children below 5 years of age,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Central,12.6,Number of cases of Measles reported in children below 5 years of age,TOTAL,24.0,40.0,21.0,7.0,10.0,7.0,4.0,6.0,9.0,14.0,44.0,28.0,214.0
Central,12.7,Number of cases of Diarrhoea and Dehydration reported in children below 5 years of age,TOTAL,567.0,948.0,996.0,930.0,815.0,679.0,700.0,709.0,624.0,485.0,508.0,582.0,8543.0
Central,12.8,Number of cases of Malaria reported in children below 5 years of age,TOTAL,10.0,11.0,12.0,6.0,5.0,13.0,8.0,6.0,3.0,2.0,2.0,3.0,81.0
Central,12.9,Number of children below 5 years of age admitted with Respiratory Infections,TOTAL,142.0,116.0,107.0,92.0,96.0,218.0,280.0,150.0,119.0,197.0,290.0,229.0,2036.0
Central,13.1,Number of Patients operated for cataract,TOTAL,3533.0,3063.0,1646.0,1234.0,1537.0,1835.0,1598.0,2416.0,3486.0,2424.0,2738.0,3553.0,29063.0
Central,13.2,Number of Intraocular Lens(IOL) implantations,TOTAL,3205.0,3029.0,1629.0,1233.0,1452.0,1827.0,1587.0,2303.0,3465.0,2404.0,2711.0,3534.0,28379.0
Central,13.3,Number of School children detected with Refractive errors,TOTAL,70.0,60.0,35.0,45.0,66.0,76.0,55.0,94.0,56.0,25.0,135.0,76.0,793.0
Central,13.4,Number of children provided free glasses,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Central,13.5,Number of eyes collected through eye donation,TOTAL,51.0,114.0,71.0,148.0,117.0,79.0,81.0,109.0,68.0,107.0,101.0,84.0,1130.0
Central,13.6,Number of eyes utilised for corneal transplant,TOTAL,45.0,73.0,42.0,84.0,66.0,50.0,45.0,57.0,36.0,67.0,52.0,51.0,668.0
Central,14.01,Number of CHC or SDH or DH functioning as First Referral units (FRUs),TOTAL,5.0,5.0,5.0,5.0,5.0,5.0,5.0,5.0,5.0,5.0,5.0,5.0,-1.0
Central,14.02,Number of PHCs functioning 24X7 with atleast 3 Staff Nurses,TOTAL,,,,,,,,,,,,,-1.0
Central,14.03,Number of Anganwadi centres reported to have conducted VHNDs,TOTAL,18.0,28.0,25.0,40.0,73.0,65.0,71.0,69.0,29.0,78.0,82.0,72.0,-1.0
Central,14.04,Number of facilities having a Rogi Kalyan Samiti (RKS),TOTAL,5.0,4.0,2.0,3.0,4.0,3.0,3.0,3.0,3.0,3.0,3.0,3.0,-1.0
Central,14.05,Number of RKS meetings held during the month,TOTAL,0.0,4.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,4.0
Central,14.06,Number of facilities having Ambulance services (Assured Referral Services),TOTAL,13.0,16.0,13.0,14.0,14.0,13.0,13.0,13.0,13.0,13.0,11.0,12.0,-1.0
Central,14.07,Total Number of times the Ambulance was used for transporting patients during the month,TOTAL,373.0,334.0,309.0,301.0,405.0,273.0,289.0,305.0,283.0,328.0,302.0,287.0,3789.0
Central,14.08,Number of Institutions having Operational Sick New Born and Child Care Units (SNCU),TOTAL,9.0,9.0,9.0,10.0,9.0,8.0,9.0,9.0,9.0,9.0,8.0,8.0,-1.0
Central,14.09,Number of functional Laproscopes in CHC/SDH/DH,TOTAL,31.0,31.0,30.0,31.0,30.0,31.0,34.0,32.0,30.0,30.0,30.0,30.0,-1.0
Central,14.10.1.a,Number of male patients admitted (Inpatients) during the month,1. Children,2346.0,3081.0,4217.0,3775.0,4431.0,4559.0,4286.0,4334.0,4171.0,3765.0,3812.0,3626.0,46403.0
Central,14.10.1.a,Number of male patients admitted (Inpatients) during the month,2. Adults,11323.0,12418.0,12177.0,12430.0,12246.0,12544.0,12113.0,11488.0,11948.0,11952.0,11594.0,12033.0,144266.0
Central,14.10.1.b,Number of female patients (Inpatients) admitted during the month,1. Children,1832.0,2394.0,3061.0,2650.0,2994.0,3127.0,2985.0,2855.0,2785.0,2677.0,2503.0,2246.0,32109.0
Central,14.10.1.b,Number of female patients (Inpatients) admitted during the month,2. Adults,11467.0,13151.0,14199.0,14347.0,15729.0,16282.0,14641.0,14768.0,14617.0,14602.0,14376.0,14121.0,172300.0
Central,14.10.1.c,Total number of patients admitted (Inpatients) during the month (sum of items 14.10.1.a and 14.10.1.b),1. Children,4178.0,5475.0,7278.0,6425.0,7425.0,7686.0,7271.0,7189.0,6956.0,6442.0,6315.0,5872.0,78512.0
Central,14.10.1.c,Total number of patients admitted (Inpatients) during the month (sum of items 14.10.1.a and 14.10.1.b),2. Adults,22790.0,25569.0,26376.0,26777.0,27975.0,28826.0,26754.0,26256.0,26565.0,26554.0,25970.0,26154.0,316566.0
Central,14.10.2.a,Number of death cases of Inpatient males,TOTAL,578.0,545.0,595.0,675.0,698.0,650.0,587.0,710.0,673.0,787.0,685.0,656.0,7839.0
Central,14.10.2.b,Number of death cases of Inpatient females,TOTAL,381.0,386.0,373.0,392.0,384.0,383.0,362.0,428.0,428.0,463.0,456.0,426.0,4862.0
Central,14.10.2.c,Number of cases of death of Inpatients (sum of items 14.10.2.a and 14.10.2.b),TOTAL,959.0,931.0,968.0,1067.0,1082.0,1033.0,949.0,1138.0,1101.0,1250.0,1141.0,1082.0,12701.0
Central,14.11,In-Patient Head Count at midnight,TOTAL,65183.0,69025.0,70105.0,73361.0,82178.0,77398.0,70006.0,74362.0,71216.0,65256.0,60790.0,66903.0,845783.0
Central,14.12.1,OPD attendance (All),TOTAL,451055.0,459673.0,500324.0,559107.0,559357.0,633449.0,479521.0,526824.0,522589.0,493813.0,564163.0,582178.0,6332053.0
Central,14.13.1,Number of major operations carried out using general or spinal anaesthesia,TOTAL,5527.0,6329.0,5788.0,5455.0,5711.0,6162.0,5268.0,6153.0,5843.0,6088.0,5775.0,5941.0,70040.0
Central,14.13.1A,"Out of 14.13.1,Gynecology- Hysterectomy surgeries",TOTAL,126.0,111.0,201.0,125.0,126.0,176.0,87.0,143.0,146.0,133.0,117.0,156.0,1647.0
Central,14.13.2,Number of minor operations carried out without anaesthesia or using local anaesthesia,TOTAL,4102.0,4496.0,4413.0,4877.0,5079.0,5339.0,4738.0,4859.0,4292.0,4294.0,4178.0,4472.0,55139.0
Central,14.14.a,Number of patients given AYUSH treatment,TOTAL,25705.0,29889.0,26727.0,24610.0,23068.0,26396.0,24480.0,26647.0,20551.0,23108.0,24383.0,24850.0,300414.0
Central,14.14.b,Number of patients on whom Dental Procedure was conducted,TOTAL,5993.0,6118.0,3994.0,2959.0,4124.0,3477.0,2065.0,2297.0,4157.0,2671.0,2480.0,3118.0,43453.0
Central,14.14.c,Number of Adolescents counselled,TOTAL,1475.0,1729.0,1530.0,1325.0,1427.0,1333.0,1105.0,1405.0,1305.0,1410.0,1187.0,1460.0,16691.0
Central,15.1.1.a,Number of Haemoglobin (Hb) tests conducted,TOTAL,54154.0,56487.0,53847.0,57662.0,56657.0,57386.0,55534.0,57034.0,54724.0,53055.0,55763.0,60087.0,672390.0
Central,15.1.1.b,"Out of the total number of Hb tests conducted, number of cases having Hb less than 7gm/dl",TOTAL,1786.0,3193.0,2553.0,3137.0,2860.0,2558.0,2557.0,2484.0,1302.0,1531.0,2028.0,2474.0,28463.0
Central,15.1.2.a,Number of HIV tests conducted on males,1. Number tested,2751.0,2696.0,1832.0,2343.0,2550.0,3111.0,2401.0,2993.0,3151.0,2919.0,3185.0,3233.0,33165.0
Central,15.1.2.a,Number of HIV tests conducted on males,2. Number Positive,67.0,69.0,48.0,63.0,63.0,71.0,55.0,53.0,37.0,55.0,49.0,67.0,697.0
Central,15.1.2.b,Number of HIV tests conducted on Female-Non ANC (i.e. non pregnant females),1. Number tested,2477.0,2471.0,2268.0,2219.0,2388.0,2962.0,2069.0,2618.0,2443.0,2462.0,2483.0,2838.0,29698.0
Central,15.1.2.b,Number of HIV tests conducted on Female-Non ANC (i.e. non pregnant females),2. Number Positive,23.0,20.0,14.0,21.0,19.0,30.0,26.0,19.0,20.0,14.0,25.0,22.0,253.0
Central,15.1.2.c,Number of HIV tests conducted on Female with ANC (i.e. pregnant females),1. Number tested,3618.0,4506.0,3920.0,3037.0,3709.0,3704.0,2585.0,3440.0,3129.0,3165.0,3276.0,3301.0,41390.0
Central,15.1.2.c,Number of HIV tests conducted on Female with ANC (i.e. pregnant females),2. Number Positive,7.0,5.0,20.0,5.0,3.0,3.0,1.0,5.0,5.0,0.0,4.0,7.0,65.0
Central,15.1.2.d,Total number of HIV tests conducted (sum of items 15.1.2.a to 15.1.2.c),1. Number tested,8846.0,9673.0,8020.0,7599.0,8647.0,9777.0,7055.0,9051.0,8723.0,8546.0,8944.0,9372.0,104253.0
Central,15.1.2.d,Total number of HIV tests conducted (sum of items 15.1.2.a to 15.1.2.c),2. Number Positive,97.0,94.0,82.0,89.0,85.0,104.0,82.0,77.0,62.0,69.0,78.0,96.0,1015.0
Central,15.2,Number of Widal tests conducted,Number tested,2046.0,2105.0,1780.0,2209.0,2280.0,2134.0,2084.0,1649.0,1037.0,818.0,1229.0,1508.0,20879.0
Central,15.3.a,Number of VDRL tests conducted on males,Number tested,390.0,415.0,979.0,396.0,494.0,451.0,306.0,375.0,386.0,386.0,467.0,384.0,5429.0
Central,15.3.b,Number of VDRL tests conducted on Female-Non ANC (i.e. non pregnant females),Number tested,709.0,689.0,1372.0,599.0,607.0,860.0,461.0,752.0,698.0,768.0,775.0,1234.0,9524.0
Central,15.3.c,Number of VDRL tests conducted on Female with ANC (i.e. pregnant females),Number tested,3280.0,3206.0,2106.0,2383.0,2561.0,1348.0,1229.0,1650.0,1993.0,1874.0,2561.0,2756.0,26947.0
Central,15.3.d,Total number of VDRL tests conducted (sum of items 15.3.a to 15.3.c),Number tested,4379.0,4310.0,4457.0,3378.0,3662.0,2659.0,1996.0,2777.0,3077.0,3028.0,3803.0,4374.0,41900.0
Central,15.4.1,Number of blood smears examined for Malaria,TOTAL,1291.0,1737.0,2061.0,2981.0,3186.0,3472.0,3481.0,1580.0,1437.0,1186.0,2509.0,1732.0,26653.0
Central,15.4.2,"Out of blood smears examined for malaria, number of blood smears tested positive for Plasmodium Vivax",TOTAL,2.0,4.0,8.0,17.0,31.0,56.0,38.0,9.0,6.0,0.0,0.0,3.0,174.0
Central,15.4.3,"Out of blood smears examined for malaria, number of blood smears tested positive for Plasmodium Falciparum",TOTAL,0.0,0.0,0.0,0.0,1.0,3.0,0.0,1.0,0.0,0.0,1.0,0.0,6.0
Central,16.1.1,Stock position of DPT vaccines,1. Balance From Previous Month,2770.0,850.0,2290.0,1690.0,170.0,1680.0,850.0,2130.0,1150.0,1330.0,1720.0,2010.0,18640.0
Central,16.1.1,Stock position of DPT vaccines,2. Stocks Received,500.0,3000.0,1500.0,0.0,3000.0,1000.0,2500.0,2000.0,1500.0,2000.0,1500.0,1500.0,20000.0
Central,16.1.1,Stock position of DPT vaccines,3. Unusable Stock,,,,0.0,0.0,850.0,,,,,,,850.0
Central,16.1.1,Stock position of DPT vaccines,4. Stock Distributed,2420.0,2510.0,2100.0,1520.0,1490.0,1830.0,1220.0,2980.0,1320.0,1610.0,1210.0,2140.0,22350.0
Central,16.1.1,Stock position of DPT vaccines,5. Total Stock,850.0,1340.0,1690.0,170.0,1680.0,0.0,2130.0,1150.0,1330.0,1720.0,2010.0,1370.0,15440.0
Central,16.1.1A,Stock Position of Pentavalent,1. Balance From Previous Month,2470.0,2670.0,1990.0,1630.0,900.0,2300.0,990.0,5390.0,3220.0,1060.0,890.0,1920.0,25430.0
Central,16.1.1A,Stock Position of Pentavalent,2. Stocks Received,2000.0,2000.0,2000.0,1000.0,3500.0,,7000.0,2000.0,0.0,2000.0,4000.0,1500.0,27000.0
Central,16.1.1A,Stock Position of Pentavalent,3. Unusable Stock,,,,0.0,,990.0,,,,,,,990.0
Central,16.1.1A,Stock Position of Pentavalent,4. Stock Distributed,1800.0,2680.0,2360.0,1730.0,2100.0,1310.0,2600.0,4170.0,1160.0,2190.0,2970.0,2720.0,27790.0
Central,16.1.1A,Stock Position of Pentavalent,5. Total Stock,2670.0,1990.0,1630.0,900.0,2300.0,0.0,5390.0,3220.0,2060.0,870.0,1920.0,700.0,23650.0
Central,16.1.2,Stock position of OPV vaccines,1. Balance From Previous Month,1730.0,2520.0,3060.0,2760.0,3340.0,4560.0,860.0,1680.0,2480.0,1280.0,2710.0,3460.0,30440.0
Central,16.1.2,Stock position of OPV vaccines,2. Stocks Received,5000.0,5000.0,5000.0,4500.0,8000.0,2000.0,3500.0,6800.0,2000.0,5000.0,4500.0,3000.0,54300.0
Central,16.1.2,Stock position of OPV vaccines,3. Unusable Stock,,,,,,860.0,,,,,,,860.0
Central,16.1.2,Stock position of OPV vaccines,4. Stock Distributed,4210.0,5380.0,5300.0,3920.0,7480.0,5700.0,2680.0,6000.0,3200.0,3570.0,3750.0,4580.0,55770.0
Central,16.1.2,Stock position of OPV vaccines,5. Total Stock,2520.0,2140.0,2760.0,3340.0,3860.0,0.0,1680.0,2480.0,1280.0,2710.0,3460.0,1880.0,28110.0
Central,16.1.3,Stock position of TT vaccines,1. Balance From Previous Month,1330.0,1280.0,2450.0,1150.0,180.0,920.0,190.0,1720.0,1080.0,1590.0,1140.0,1980.0,15010.0
Central,16.1.3,Stock position of TT vaccines,2. Stocks Received,2000.0,3000.0,1500.0,1000.0,3000.0,1500.0,3500.0,2000.0,2000.0,1000.0,2500.0,1000.0,24000.0
Central,16.1.3,Stock position of TT vaccines,3. Unusable Stock,,,,,,190.0,,,,,,,190.0
Central,16.1.3,Stock position of TT vaccines,4. Stock Distributed,2200.0,2780.0,2800.0,1970.0,2260.0,2230.0,1970.0,2640.0,1490.0,1450.0,1660.0,1960.0,25410.0
Central,16.1.3,Stock position of TT vaccines,5. Total Stock,1130.0,1500.0,1150.0,180.0,920.0,0.0,1720.0,1080.0,1590.0,1140.0,1980.0,1020.0,13410.0
Central,16.1.4,Stock position of DT vaccines,1. Balance From Previous Month,0.0,0.0,0.0,0.0,0.0,,0.0,,0.0,,0.0,0.0,0.0
Central,16.1.4,Stock position of DT vaccines,2. Stocks Received,0.0,0.0,0.0,0.0,0.0,,0.0,,0.0,,0.0,0.0,0.0
Central,16.1.4,Stock position of DT vaccines,3. Unusable Stock,0.0,,0.0,0.0,0.0,,,,0.0,,,,0.0
Central,16.1.4,Stock position of DT vaccines,4. Stock Distributed,0.0,0.0,0.0,0.0,0.0,,0.0,,0.0,,0.0,0.0,0.0
Central,16.1.4,Stock position of DT vaccines,5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Central,16.1.5,Stock position of BCG vaccines,1. Balance From Previous Month,1110.0,540.0,780.0,410.0,930.0,440.0,530.0,580.0,430.0,910.0,0.0,1370.0,8030.0
Central,16.1.5,Stock position of BCG vaccines,2. Stocks Received,0.0,1000.0,0.0,500.0,500.0,500.0,500.0,1000.0,1000.0,100.0,0.0,500.0,5600.0
Central,16.1.5,Stock position of BCG vaccines,3. Unusable Stock,,,,,,110.0,,,,,,,110.0
Central,16.1.5,Stock position of BCG vaccines,4. Stock Distributed,540.0,760.0,370.0,480.0,440.0,830.0,450.0,1150.0,520.0,620.0,0.0,800.0,6960.0
Central,16.1.5,Stock position of BCG vaccines,5. Total Stock,570.0,780.0,410.0,430.0,990.0,0.0,580.0,430.0,910.0,390.0,0.0,1070.0,6560.0
Central,16.1.6,Stock position of Measles vaccines,1. Balance From Previous Month,1885.0,5895.0,6250.0,3665.0,1475.0,370.0,70.0,1385.0,1625.0,2015.0,1300.0,1240.0,27175.0
Central,16.1.6,Stock position of Measles vaccines,2. Stocks Received,25000.0,0.0,15000.0,0.0,0.0,750.0,2000.0,2500.0,1500.0,0.0,1000.0,1000.0,48750.0
Central,16.1.6,Stock position of Measles vaccines,3. Unusable Stock,,,,,,70.0,,,,,,,70.0
Central,16.1.6,Stock position of Measles vaccines,4. Stock Distributed,20990.0,2045.0,17555.0,2190.0,1105.0,1050.0,685.0,2310.0,1110.0,715.0,1060.0,1210.0,52025.0
Central,16.1.6,Stock position of Measles vaccines,5. Total Stock,5895.0,3850.0,3695.0,1475.0,370.0,0.0,1385.0,1575.0,2015.0,1300.0,1240.0,1030.0,23830.0
Central,16.1.7,Stock position of JE vaccines,1. Balance From Previous Month,0.0,0.0,0.0,0.0,,,0.0,0.0,0.0,,,0.0,0.0
Central,16.1.7,Stock position of JE vaccines,2. Stocks Received,0.0,0.0,0.0,0.0,,,0.0,0.0,0.0,,,0.0,0.0
Central,16.1.7,Stock position of JE vaccines,3. Unusable Stock,0.0,,0.0,0.0,,,,,,,,,0.0
Central,16.1.7,Stock position of JE vaccines,4. Stock Distributed,0.0,0.0,0.0,0.0,,,0.0,0.0,0.0,,,0.0,0.0
Central,16.1.7,Stock position of JE vaccines,5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Central,16.1.8,Stock position of Hepatitis B vaccines,1. Balance From Previous Month,690.0,260.0,500.0,240.0,420.0,670.0,620.0,480.0,290.0,390.0,230.0,150.0,4940.0
Central,16.1.8,Stock position of Hepatitis B vaccines,2. Stocks Received,0.0,0.0,0.0,500.0,1000.0,300.0,0.0,0.0,300.0,0.0,0.0,0.0,2100.0
Central,16.1.8,Stock position of Hepatitis B vaccines,3. Unusable Stock,,,,,,620.0,,,,,,,620.0
Central,16.1.8,Stock position of Hepatitis B vaccines,4. Stock Distributed,430.0,260.0,320.0,320.0,750.0,350.0,140.0,470.0,200.0,160.0,80.0,150.0,3630.0
Central,16.1.8,Stock position of Hepatitis B vaccines,5. Total Stock,260.0,0.0,180.0,420.0,670.0,0.0,480.0,10.0,390.0,230.0,150.0,0.0,2790.0
Central,16.2.1,Stock Position of IU 380 A (to be used for Family Planning),1. Balance From Previous Month,0.0,570.0,510.0,455.0,135.0,,0.0,540.0,985.0,815.0,700.0,550.0,5260.0
Central,16.2.1,Stock Position of IU 380 A (to be used for Family Planning),2. Stocks Received,0.0,0.0,0.0,0.0,0.0,,600.0,0.0,0.0,0.0,0.0,0.0,600.0
Central,16.2.1,Stock Position of IU 380 A (to be used for Family Planning),3. Unusable Stock,0.0,,,,,,,,,,,,0.0
Central,16.2.1,Stock Position of IU 380 A (to be used for Family Planning),4. Stock Distributed,0.0,60.0,55.0,320.0,70.0,,60.0,165.0,170.0,115.0,150.0,130.0,1295.0
Central,16.2.1,Stock Position of IU 380 A (to be used for Family Planning),5. Total Stock,0.0,510.0,455.0,135.0,65.0,0.0,540.0,375.0,815.0,700.0,550.0,420.0,4565.0
Central,16.2.2,Stock Position of Condoms (to be used for Family Planning),1. Balance From Previous Month,0.0,7500.0,0.0,0.0,1500.0,,0.0,0.0,0.0,0.0,0.0,0.0,9000.0
Central,16.2.2,Stock Position of Condoms (to be used for Family Planning),2. Stocks Received,0.0,0.0,0.0,42000.0,0.0,,0.0,0.0,0.0,0.0,0.0,12000.0,54000.0
Central,16.2.2,Stock Position of Condoms (to be used for Family Planning),3. Unusable Stock,0.0,,0.0,40500.0,,,,,,,,,40500.0
Central,16.2.2,Stock Position of Condoms (to be used for Family Planning),4. Stock Distributed,0.0,7500.0,0.0,,1500.0,,0.0,0.0,0.0,0.0,0.0,4500.0,13500.0
Central,16.2.2,Stock Position of Condoms (to be used for Family Planning),5. Total Stock,0.0,0.0,0.0,1500.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,7500.0,9000.0
Central,16.2.3,Stock Position of Oral Contraceptive (to be used for Family Planning),1. Balance From Previous Month,500.0,0.0,410.0,300.0,0.0,310.0,0.0,855.0,545.0,485.0,280.0,210.0,3895.0
Central,16.2.3,Stock Position of Oral Contraceptive (to be used for Family Planning),2. Stocks Received,0.0,0.0,0.0,0.0,1000.0,,1000.0,0.0,0.0,0.0,0.0,0.0,2000.0
Central,16.2.3,Stock Position of Oral Contraceptive (to be used for Family Planning),3. Unusable Stock,,,,0.0,,,,,,,,,0.0
Central,16.2.3,Stock Position of Oral Contraceptive (to be used for Family Planning),4. Stock Distributed,260.0,0.0,110.0,300.0,640.0,310.0,145.0,310.0,60.0,205.0,70.0,0.0,2410.0
Central,16.2.3,Stock Position of Oral Contraceptive (to be used for Family Planning),5. Total Stock,240.0,0.0,300.0,0.0,360.0,0.0,855.0,545.0,485.0,280.0,210.0,210.0,3485.0
Central,16.2.4,Stock Position of Emergency Contraceptive (to be used for Family Planning),1. Balance From Previous Month,0.0,0.0,0.0,0.0,0.0,,0.0,0.0,0.0,,0.0,0.0,0.0
Central,16.2.4,Stock Position of Emergency Contraceptive (to be used for Family Planning),2. Stocks Received,0.0,0.0,0.0,0.0,0.0,,0.0,0.0,0.0,,0.0,0.0,0.0
Central,16.2.4,Stock Position of Emergency Contraceptive (to be used for Family Planning),3. Unusable Stock,0.0,,0.0,0.0,0.0,,,,,,,,0.0
Central,16.2.4,Stock Position of Emergency Contraceptive (to be used for Family Planning),4. Stock Distributed,0.0,0.0,0.0,0.0,0.0,,0.0,0.0,0.0,,0.0,0.0,0.0
Central,16.2.4,Stock Position of Emergency Contraceptive (to be used for Family Planning),5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Central,16.2.5,Stock Position of Tubal Rings (to be used for Family Planning),1. Balance From Previous Month,0.0,0.0,0.0,0.0,,,0.0,0.0,0.0,,0.0,0.0,0.0
Central,16.2.5,Stock Position of Tubal Rings (to be used for Family Planning),2. Stocks Received,0.0,0.0,0.0,0.0,,,0.0,0.0,0.0,,0.0,0.0,0.0
Central,16.2.5,Stock Position of Tubal Rings (to be used for Family Planning),3. Unusable Stock,0.0,,0.0,0.0,,,,,,,,,0.0
Central,16.2.5,Stock Position of Tubal Rings (to be used for Family Planning),4. Stock Distributed,0.0,0.0,0.0,0.0,,,0.0,0.0,0.0,,0.0,0.0,0.0
Central,16.2.5,Stock Position of Tubal Rings (to be used for Family Planning),5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Central,16.3.01,Stock Position of Oxytocin Injection,1. Balance From Previous Month,0.0,0.0,0.0,0.0,0.0,,0.0,0.0,0.0,,0.0,0.0,0.0
Central,16.3.01,Stock Position of Oxytocin Injection,2. Stocks Received,0.0,0.0,0.0,0.0,0.0,,0.0,0.0,0.0,,0.0,0.0,0.0
Central,16.3.01,Stock Position of Oxytocin Injection,3. Unusable Stock,0.0,,0.0,0.0,0.0,,,,,,,,0.0
Central,16.3.01,Stock Position of Oxytocin Injection,4. Stock Distributed,0.0,0.0,0.0,0.0,0.0,,0.0,0.0,0.0,,0.0,0.0,0.0
Central,16.3.01,Stock Position of Oxytocin Injection,5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Central,16.3.02,Stock Position of Gloves,1. Balance From Previous Month,0.0,0.0,0.0,0.0,0.0,,0.0,0.0,0.0,,0.0,0.0,0.0
Central,16.3.02,Stock Position of Gloves,2. Stocks Received,0.0,0.0,0.0,0.0,0.0,,0.0,0.0,0.0,,0.0,0.0,0.0
Central,16.3.02,Stock Position of Gloves,3. Unusable Stock,0.0,,0.0,0.0,0.0,,,,,,,,0.0
Central,16.3.02,Stock Position of Gloves,4. Stock Distributed,0.0,0.0,0.0,0.0,0.0,,0.0,0.0,0.0,,0.0,0.0,0.0
Central,16.3.02,Stock Position of Gloves,5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Central,16.3.03,Stock Position of MVA Syringes,1. Balance From Previous Month,0.0,0.0,0.0,0.0,0.0,,0.0,0.0,0.0,,0.0,0.0,0.0
Central,16.3.03,Stock Position of MVA Syringes,2. Stocks Received,0.0,0.0,0.0,0.0,0.0,,0.0,0.0,0.0,,0.0,0.0,0.0
Central,16.3.03,Stock Position of MVA Syringes,3. Unusable Stock,0.0,,0.0,0.0,0.0,,,,,,,,0.0
Central,16.3.03,Stock Position of MVA Syringes,4. Stock Distributed,0.0,0.0,0.0,0.0,0.0,,0.0,0.0,0.0,,0.0,0.0,0.0
Central,16.3.03,Stock Position of MVA Syringes,5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Central,16.3.04,Stock Position of Fluconazole Tablets,1. Balance From Previous Month,0.0,0.0,0.0,0.0,0.0,,0.0,0.0,0.0,,0.0,0.0,0.0
Central,16.3.04,Stock Position of Fluconazole Tablets,2. Stocks Received,0.0,0.0,0.0,0.0,0.0,,0.0,0.0,0.0,,0.0,0.0,0.0
Central,16.3.04,Stock Position of Fluconazole Tablets,3. Unusable Stock,0.0,,0.0,0.0,0.0,,,,,,,,0.0
Central,16.3.04,Stock Position of Fluconazole Tablets,4. Stock Distributed,0.0,0.0,0.0,0.0,0.0,,0.0,0.0,0.0,,0.0,0.0,0.0
Central,16.3.04,Stock Position of Fluconazole Tablets,5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Central,16.3.05,Stock Position of Blood Transfusion Sets,1. Balance From Previous Month,0.0,0.0,0.0,0.0,0.0,,0.0,0.0,0.0,,0.0,0.0,0.0
Central,16.3.05,Stock Position of Blood Transfusion Sets,2. Stocks Received,0.0,0.0,0.0,0.0,0.0,,0.0,0.0,0.0,,0.0,0.0,0.0
Central,16.3.05,Stock Position of Blood Transfusion Sets,3. Unusable Stock,0.0,,0.0,0.0,0.0,,,,,,,,0.0
Central,16.3.05,Stock Position of Blood Transfusion Sets,4. Stock Distributed,0.0,0.0,0.0,0.0,0.0,,0.0,0.0,0.0,,0.0,0.0,0.0
Central,16.3.05,Stock Position of Blood Transfusion Sets,5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Central,16.3.06,Stock Position of Gluteraldehyde solution of 2% concentration,1. Balance From Previous Month,0.0,0.0,0.0,0.0,0.0,,0.0,0.0,0.0,,0.0,0.0,0.0
Central,16.3.06,Stock Position of Gluteraldehyde solution of 2% concentration,2. Stocks Received,0.0,0.0,0.0,0.0,0.0,,0.0,0.0,0.0,,0.0,0.0,0.0
Central,16.3.06,Stock Position of Gluteraldehyde solution of 2% concentration,3. Unusable Stock,0.0,,0.0,0.0,0.0,,,,,,,,0.0
Central,16.3.06,Stock Position of Gluteraldehyde solution of 2% concentration,4. Stock Distributed,0.0,0.0,0.0,0.0,0.0,,0.0,0.0,0.0,,0.0,0.0,0.0
Central,16.3.06,Stock Position of Gluteraldehyde solution of 2% concentration,5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Central,16.3.07,Stock Position of IFA Tablets,1. Balance From Previous Month,0.0,0.0,0.0,0.0,0.0,,0.0,0.0,0.0,,0.0,0.0,0.0
Central,16.3.07,Stock Position of IFA Tablets,2. Stocks Received,0.0,0.0,0.0,0.0,0.0,,0.0,0.0,0.0,,0.0,0.0,0.0
Central,16.3.07,Stock Position of IFA Tablets,3. Unusable Stock,0.0,,0.0,0.0,0.0,,,,,,,,0.0
Central,16.3.07,Stock Position of IFA Tablets,4. Stock Distributed,0.0,0.0,0.0,0.0,0.0,,0.0,0.0,0.0,,0.0,0.0,0.0
Central,16.3.07,Stock Position of IFA Tablets,5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Central,16.3.08,Stock Position of IFA Syrup (Paediatric),1. Balance From Previous Month,0.0,0.0,0.0,0.0,0.0,,0.0,0.0,0.0,,0.0,0.0,0.0
Central,16.3.08,Stock Position of IFA Syrup (Paediatric),2. Stocks Received,0.0,0.0,0.0,0.0,0.0,,0.0,0.0,0.0,,0.0,0.0,0.0
Central,16.3.08,Stock Position of IFA Syrup (Paediatric),3. Unusable Stock,0.0,,0.0,0.0,0.0,,,,,,,,0.0
Central,16.3.08,Stock Position of IFA Syrup (Paediatric),4. Stock Distributed,0.0,0.0,0.0,0.0,0.0,,0.0,0.0,0.0,,0.0,0.0,0.0
Central,16.3.08,Stock Position of IFA Syrup (Paediatric),5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Central,16.3.09,Stock Position of Paediatrics Antibiotics (Cotrimaxozole and Injectable Gentamicin),1. Balance From Previous Month,0.0,0.0,0.0,0.0,0.0,,0.0,0.0,0.0,,0.0,0.0,0.0
Central,16.3.09,Stock Position of Paediatrics Antibiotics (Cotrimaxozole and Injectable Gentamicin),2. Stocks Received,0.0,0.0,0.0,0.0,0.0,,0.0,0.0,0.0,,0.0,0.0,0.0
Central,16.3.09,Stock Position of Paediatrics Antibiotics (Cotrimaxozole and Injectable Gentamicin),3. Unusable Stock,0.0,,0.0,0.0,0.0,,,,,,,,0.0
Central,16.3.09,Stock Position of Paediatrics Antibiotics (Cotrimaxozole and Injectable Gentamicin),4. Stock Distributed,0.0,0.0,0.0,0.0,0.0,,0.0,0.0,0.0,,0.0,0.0,0.0
Central,16.3.09,Stock Position of Paediatrics Antibiotics (Cotrimaxozole and Injectable Gentamicin),5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Central,16.3.10,Stock Position of Vitamin A solution,1. Balance From Previous Month,110.0,0.0,167.0,0.0,444.0,283.0,278.0,274.0,230.0,198.0,0.0,14.0,1998.0
Central,16.3.10,Stock Position of Vitamin A solution,2. Stocks Received,200.0,0.0,0.0,0.0,0.0,,0.0,0.0,0.0,,0.0,130.0,330.0
Central,16.3.10,Stock Position of Vitamin A solution,3. Unusable Stock,0.0,,,0.0,,283.0,,,,,,,283.0
Central,16.3.10,Stock Position of Vitamin A solution,4. Stock Distributed,108.0,0.0,143.0,0.0,161.0,,4.0,35.0,32.0,59.0,0.0,36.0,578.0
Central,16.3.10,Stock Position of Vitamin A solution,5. Total Stock,202.0,0.0,24.0,0.0,283.0,0.0,274.0,239.0,198.0,139.0,0.0,108.0,1467.0
Central,16.3.11,Stock of ORS (New WHO formulation),1. Balance From Previous Month,500.0,0.0,0.0,0.0,0.0,,0.0,0.0,0.0,0.0,0.0,0.0,500.0
Central,16.3.11,Stock of ORS (New WHO formulation),2. Stocks Received,0.0,0.0,0.0,0.0,0.0,,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Central,16.3.11,Stock of ORS (New WHO formulation),3. Unusable Stock,0.0,,0.0,0.0,0.0,,,,,,,,0.0
Central,16.3.11,Stock of ORS (New WHO formulation),4. Stock Distributed,400.0,0.0,0.0,0.0,0.0,,0.0,0.0,0.0,0.0,0.0,0.0,400.0
Central,16.3.11,Stock of ORS (New WHO formulation),5. Total Stock,100.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,100.0
Central,16.4.1,Stock Position of 0.1 ml Syringes(AD),1. Balance From Previous Month,3000.0,1200.0,2800.0,2200.0,2000.0,1800.0,1600.0,0.0,0.0,,0.0,1800.0,16400.0
Central,16.4.1,Stock Position of 0.1 ml Syringes(AD),2. Stocks Received,0.0,2000.0,0.0,0.0,0.0,,0.0,0.0,0.0,,2600.0,0.0,4600.0
Central,16.4.1,Stock Position of 0.1 ml Syringes(AD),3. Unusable Stock,0.0,,,0.0,,1600.0,,,,,,,1600.0
Central,16.4.1,Stock Position of 0.1 ml Syringes(AD),4. Stock Distributed,1800.0,400.0,600.0,200.0,200.0,200.0,400.0,0.0,0.0,,800.0,0.0,4600.0
Central,16.4.1,Stock Position of 0.1 ml Syringes(AD),5. Total Stock,1200.0,2800.0,2200.0,2000.0,1800.0,0.0,1200.0,0.0,0.0,0.0,1800.0,1800.0,14800.0
Central,16.4.2,Stock Position of 0.5 ml Syringes(AD),1. Balance From Previous Month,6350.0,0.0,11200.0,7000.0,16600.0,3800.0,13200.0,6600.0,5600.0,4200.0,2800.0,6400.0,83750.0
Central,16.4.2,Stock Position of 0.5 ml Syringes(AD),2. Stocks Received,20000.0,22000.0,20000.0,4000.0,0.0,16000.0,4000.0,6000.0,6000.0,6000.0,10000.0,7200.0,121200.0
Central,16.4.2,Stock Position of 0.5 ml Syringes(AD),3. Unusable Stock,0.0,,,0.0,,13200.0,,,,,,,13200.0
Central,16.4.2,Stock Position of 0.5 ml Syringes(AD),4. Stock Distributed,26350.0,10800.0,24200.0,10400.0,12200.0,6600.0,10600.0,10200.0,7400.0,7400.0,6400.0,9700.0,142250.0
Central,16.4.2,Stock Position of 0.5 ml Syringes(AD),5. Total Stock,0.0,11200.0,7000.0,600.0,4400.0,0.0,6600.0,2400.0,4200.0,2800.0,6400.0,3900.0,49500.0
Central,16.4.3,Stock Position of 5.0 ml Syringes(Disposable),1. Balance From Previous Month,0.0,0.0,0.0,3000.0,5200.0,4800.0,4000.0,,0.0,,0.0,1400.0,18400.0
Central,16.4.3,Stock Position of 5.0 ml Syringes(Disposable),2. Stocks Received,0.0,0.0,0.0,2400.0,0.0,,0.0,,0.0,,3200.0,0.0,5600.0
Central,16.4.3,Stock Position of 5.0 ml Syringes(Disposable),3. Unusable Stock,0.0,,0.0,,,4000.0,,,,,,,4000.0
Central,16.4.3,Stock Position of 5.0 ml Syringes(Disposable),4. Stock Distributed,0.0,0.0,0.0,600.0,0.0,800.0,400.0,,0.0,,1800.0,1000.0,4600.0
Central,16.4.3,Stock Position of 5.0 ml Syringes(Disposable),5. Total Stock,0.0,0.0,0.0,4800.0,5200.0,0.0,3600.0,0.0,0.0,0.0,1400.0,400.0,15400.0
Central,17.1,Number of cases of Infant deaths within 24 hrs of birth,TOTAL,,,,,,1.0,1.0,1.0,,,1.0,2.0,6.0
Central,17.2.1,Number of cases of Infant deaths 24 hours to 4 weeks of birth with the probable cause being Sepsis,1. Up to 1 Weeks of Birth,8.0,10.0,15.0,10.0,11.0,7.0,15.0,11.0,13.0,13.0,10.0,16.0,139.0
Central,17.2.1,Number of cases of Infant deaths 24 hours to 4 weeks of birth with the probable cause being Sepsis,2. Between 1 week & 4 weeks of birth,1.0,1.0,3.0,2.0,2.0,3.0,6.0,2.0,4.0,5.0,3.0,3.0,35.0
Central,17.2.1,Number of cases of Infant deaths 24 hours to 4 weeks of birth with the probable cause being Sepsis,3. Total,9.0,11.0,18.0,12.0,13.0,10.0,21.0,13.0,17.0,18.0,13.0,19.0,174.0
Central,17.2.2,Number of cases of Infant deaths 24 hours to 4 weeks of birth with the probable cause being Asphyxia,1. Up to 1 Weeks of Birth,6.0,6.0,13.0,7.0,9.0,14.0,11.0,10.0,5.0,6.0,8.0,5.0,100.0
Central,17.2.2,Number of cases of Infant deaths 24 hours to 4 weeks of birth with the probable cause being Asphyxia,2. Between 1 week & 4 weeks of birth,,2.0,,1.0,,3.0,1.0,,1.0,,,,8.0
Central,17.2.2,Number of cases of Infant deaths 24 hours to 4 weeks of birth with the probable cause being Asphyxia,3. Total,6.0,8.0,13.0,8.0,9.0,17.0,12.0,10.0,6.0,6.0,8.0,5.0,108.0
Central,17.2.3,Number of cases of Infant deaths 24 hours to 4 weeks of birth with the probable cause being LBW,1. Up to 1 Weeks of Birth,1.0,7.0,6.0,7.0,11.0,9.0,8.0,6.0,7.0,8.0,5.0,4.0,79.0
Central,17.2.3,Number of cases of Infant deaths 24 hours to 4 weeks of birth with the probable cause being LBW,2. Between 1 week & 4 weeks of birth,,,5.0,2.0,1.0,3.0,4.0,4.0,3.0,1.0,,1.0,24.0
Central,17.2.3,Number of cases of Infant deaths 24 hours to 4 weeks of birth with the probable cause being LBW,3. Total,1.0,7.0,11.0,9.0,12.0,12.0,12.0,10.0,10.0,9.0,5.0,5.0,103.0
Central,17.2.4,"Number of cases of Infant deaths 24 hours to 4 weeks of birth with the probable cause being other than Sepsis, Asphyxia and LBW",1. Up to 1 Weeks of Birth,10.0,5.0,14.0,13.0,15.0,17.0,11.0,13.0,8.0,11.0,7.0,7.0,131.0
Central,17.2.4,"Number of cases of Infant deaths 24 hours to 4 weeks of birth with the probable cause being other than Sepsis, Asphyxia and LBW",2. Between 1 week & 4 weeks of birth,2.0,2.0,7.0,1.0,2.0,5.0,3.0,4.0,3.0,2.0,2.0,4.0,37.0
Central,17.2.4,"Number of cases of Infant deaths 24 hours to 4 weeks of birth with the probable cause being other than Sepsis, Asphyxia and LBW",3. Total,12.0,7.0,21.0,14.0,17.0,22.0,14.0,17.0,11.0,13.0,9.0,11.0,168.0
Central,17.3.1,Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being Pneumonia,1. Between 1 month and 11 months,1.0,1.0,,2.0,2.0,2.0,1.0,2.0,3.0,2.0,4.0,7.0,27.0
Central,17.3.1,Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being Pneumonia,2. Between 1 year & 5 years,,1.0,1.0,,1.0,,1.0,,1.0,1.0,2.0,1.0,9.0
Central,17.3.1,Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being Pneumonia,3. Total,1.0,2.0,1.0,2.0,3.0,2.0,2.0,2.0,4.0,3.0,6.0,8.0,36.0
Central,17.3.2,Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being Diarrhoea,1. Between 1 month and 11 months,2.0,,,,,1.0,1.0,1.0,,2.0,,1.0,8.0
Central,17.3.2,Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being Diarrhoea,2. Between 1 year & 5 years,1.0,1.0,,,,,,,1.0,,1.0,1.0,5.0
Central,17.3.2,Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being Diarrhoea,3. Total,3.0,1.0,,,,1.0,1.0,1.0,1.0,2.0,1.0,2.0,13.0
Central,17.3.3,Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being Fever related,1. Between 1 month and 11 months,,,1.0,,,,,,,,,,1.0
Central,17.3.3,Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being Fever related,2. Between 1 year & 5 years,,,,,,,,,,,,,
Central,17.3.3,Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being Fever related,3. Total,,,1.0,,,,,,,,,,1.0
Central,17.3.4,Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being Measles,1. Between 1 month and 11 months,,,,,,,,,,,,,
Central,17.3.4,Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being Measles,2. Between 1 year & 5 years,3.0,,,,,1.0,,,,,,,4.0
Central,17.3.4,Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being Measles,3. Total,3.0,,,,,1.0,,,,,,,4.0
Central,17.3.5,"Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being other than Pneumonia, Diarrhoea, Fever related and Measles",1. Between 1 month and 11 months,14.0,13.0,16.0,12.0,13.0,25.0,16.0,13.0,20.0,16.0,13.0,18.0,189.0
Central,17.3.5,"Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being other than Pneumonia, Diarrhoea, Fever related and Measles",2. Between 1 year & 5 years,13.0,15.0,16.0,19.0,17.0,13.0,24.0,18.0,18.0,13.0,15.0,17.0,198.0
Central,17.3.5,"Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being other than Pneumonia, Diarrhoea, Fever related and Measles",3. Total,27.0,28.0,32.0,31.0,30.0,38.0,40.0,31.0,38.0,29.0,28.0,35.0,387.0
Central,17.4.1,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Diarrhoeal diseases,1. 6-14 yrs,,,,,,1.0,,,,,,,1.0
Central,17.4.1,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Diarrhoeal diseases,2. 15-55 yrs.,,2.0,,2.0,4.0,4.0,5.0,,3.0,6.0,3.0,2.0,31.0
Central,17.4.1,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Diarrhoeal diseases,3. Above 55 yrs.,,2.0,1.0,1.0,2.0,1.0,4.0,,2.0,3.0,4.0,3.0,23.0
Central,17.4.1,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Diarrhoeal diseases,4. Total,,4.0,1.0,3.0,6.0,6.0,9.0,,5.0,9.0,7.0,5.0,55.0
Central,17.4.2,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Tuberculosis,1. 6-14 yrs,2.0,,3.0,3.0,2.0,1.0,,,1.0,,1.0,,13.0
Central,17.4.2,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Tuberculosis,2. 15-55 yrs.,13.0,23.0,13.0,9.0,8.0,15.0,12.0,8.0,10.0,10.0,14.0,10.0,145.0
Central,17.4.2,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Tuberculosis,3. Above 55 yrs.,7.0,9.0,5.0,4.0,2.0,3.0,5.0,5.0,6.0,7.0,5.0,1.0,59.0
Central,17.4.2,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Tuberculosis,4. Total,22.0,32.0,21.0,16.0,12.0,19.0,17.0,13.0,17.0,17.0,20.0,11.0,217.0
Central,17.4.3,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Respiratory diseases including infections,1. 6-14 yrs,1.0,,1.0,1.0,,2.0,,1.0,1.0,,3.0,,10.0
Central,17.4.3,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Respiratory diseases including infections,2. 15-55 yrs.,14.0,17.0,8.0,17.0,10.0,22.0,17.0,6.0,30.0,28.0,37.0,35.0,241.0
Central,17.4.3,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Respiratory diseases including infections,3. Above 55 yrs.,11.0,20.0,11.0,24.0,23.0,27.0,20.0,19.0,40.0,38.0,42.0,35.0,310.0
Central,17.4.3,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Respiratory diseases including infections,4. Total,26.0,37.0,20.0,42.0,33.0,51.0,37.0,26.0,71.0,66.0,82.0,70.0,561.0
Central,17.4.4,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Malaria,1. 6-14 yrs,,,,1.0,1.0,,,,,,,,2.0
Central,17.4.4,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Malaria,2. 15-55 yrs.,,,,,1.0,1.0,,1.0,,1.0,,,4.0
Central,17.4.4,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Malaria,3. Above 55 yrs.,,,,,,,,,,,,,
Central,17.4.4,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Malaria,4. Total,,,,1.0,2.0,1.0,,1.0,,1.0,,,6.0
Central,17.4.5,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being other Fever related,1. 6-14 yrs,,,,,2.0,1.0,1.0,,1.0,,,,5.0
Central,17.4.5,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being other Fever related,2. 15-55 yrs.,4.0,2.0,3.0,3.0,1.0,6.0,4.0,4.0,1.0,1.0,5.0,5.0,39.0
Central,17.4.5,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being other Fever related,3. Above 55 yrs.,3.0,,2.0,1.0,2.0,1.0,1.0,1.0,2.0,1.0,3.0,3.0,20.0
Central,17.4.5,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being other Fever related,4. Total,7.0,2.0,5.0,4.0,5.0,8.0,6.0,5.0,4.0,2.0,8.0,8.0,64.0
Central,17.4.6,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being HIV/AIDS,1. 6-14 yrs,,,,,,,,,,,,,
Central,17.4.6,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being HIV/AIDS,2. 15-55 yrs.,,,,,,,,,1.0,,,,1.0
Central,17.4.6,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being HIV/AIDS,3. Above 55 yrs.,,,,,,,,,,,,,
Central,17.4.6,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being HIV/AIDS,4. Total,,,,,,,,,1.0,,,,1.0
Central,17.4.7,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Heart disease or related to Hypertension,1. 6-14 yrs,2.0,4.0,2.0,,1.0,,1.0,,1.0,2.0,2.0,2.0,17.0
Central,17.4.7,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Heart disease or related to Hypertension,2. 15-55 yrs.,40.0,40.0,36.0,33.0,49.0,33.0,35.0,33.0,45.0,41.0,36.0,49.0,470.0
Central,17.4.7,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Heart disease or related to Hypertension,3. Above 55 yrs.,42.0,45.0,28.0,32.0,43.0,41.0,52.0,42.0,55.0,85.0,71.0,65.0,601.0
Central,17.4.7,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Heart disease or related to Hypertension,4. Total,84.0,89.0,66.0,65.0,93.0,74.0,88.0,75.0,101.0,128.0,109.0,116.0,1088.0
Central,17.4.8,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Neurological disease including strokes,1. 6-14 yrs,,,,,2.0,2.0,,,1.0,,1.0,,6.0
Central,17.4.8,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Neurological disease including strokes,2. 15-55 yrs.,3.0,16.0,6.0,6.0,11.0,15.0,18.0,9.0,9.0,10.0,11.0,10.0,124.0
Central,17.4.8,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Neurological disease including strokes,3. Above 55 yrs.,13.0,16.0,11.0,7.0,7.0,13.0,12.0,11.0,13.0,19.0,12.0,18.0,152.0
Central,17.4.8,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Neurological disease including strokes,4. Total,16.0,32.0,17.0,13.0,20.0,30.0,30.0,20.0,23.0,29.0,24.0,28.0,282.0
Central,17.4.9(a),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Abortion,1. 6-14 yrs,,,,,,,,,,,,,
Central,17.4.9(a),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Abortion,2. 15-49 yrs,,,,,,,,,,,,,
Central,17.4.9(a),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Abortion,3. Above 49 yrs.,,,,,,,,,,,,,
Central,17.4.9(a),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Abortion,4. Total,,,,,,,,,,,,,
Central,17.4.9(b),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Obstructed or prolonged labour,1. 6-14 yrs,,,,,,,,,,,,,
Central,17.4.9(b),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Obstructed or prolonged labour,2. 15-49 yrs,,,,,,1.0,,,,,,,1.0
Central,17.4.9(b),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Obstructed or prolonged labour,3. Above 49 yrs.,,,,,,,,,,,,,
Central,17.4.9(b),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Obstructed or prolonged labour,4. Total,,,,,,1.0,,,,,,,1.0
Central,17.4.9(c),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Severe hypertesnion or fits,1. 6-14 yrs,,,,,,,,,,,,,
Central,17.4.9(c),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Severe hypertesnion or fits,2. 15-49 yrs,,,,,1.0,,1.0,,1.0,,,,3.0
Central,17.4.9(c),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Severe hypertesnion or fits,3. Above 49 yrs.,,,,,,,,,,,,,
Central,17.4.9(c),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Severe hypertesnion or fits,4. Total,,,,,1.0,,1.0,,1.0,,,,3.0
Central,17.4.9(d),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Bleeding,1. 6-14 yrs,,,,,,,,,,,,,
Central,17.4.9(d),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Bleeding,2. 15-49 yrs,,1.0,1.0,2.0,,,,,,3.0,,1.0,8.0
Central,17.4.9(d),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Bleeding,3. Above 49 yrs.,,,,,,,,,,,,,
Central,17.4.9(d),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Bleeding,4. Total,,1.0,1.0,2.0,,,,,,3.0,,1.0,8.0
Central,17.4.9(e),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being High Fever,1. 6-14 yrs,,,,,,,,,,,,,
Central,17.4.9(e),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being High Fever,2. 15-49 yrs,,,,,,1.0,,1.0,1.0,,,,3.0
Central,17.4.9(e),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being High Fever,3. Above 49 yrs.,,,,,,,,,,,,,
Central,17.4.9(e),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being High Fever,4. Total,,,,,,1.0,,1.0,1.0,,,,3.0
Central,17.4.9(f),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being other causes (excluding abortion; obstructed or prolonged labour; severe hypertension or fits;,1. 6-14 yrs,,,,,,,,,,,,,
Central,17.4.9(f),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being other causes (excluding abortion; obstructed or prolonged labour; severe hypertension or fits;,2. 15-49 yrs,1.0,3.0,1.0,1.0,2.0,2.0,3.0,,4.0,3.0,1.0,1.0,22.0
Central,17.4.9(f),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being other causes (excluding abortion; obstructed or prolonged labour; severe hypertension or fits;,3. Above 49 yrs.,,,,,,,,,,,,,
Central,17.4.9(f),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being other causes (excluding abortion; obstructed or prolonged labour; severe hypertension or fits;,4. Total,1.0,3.0,1.0,1.0,2.0,2.0,3.0,,4.0,3.0,1.0,1.0,22.0
Central,17.4.10,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Trauma or Accidents or Burn cases,1. 6-14 yrs,4.0,,2.0,6.0,6.0,5.0,1.0,4.0,1.0,,3.0,7.0,39.0
Central,17.4.10,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Trauma or Accidents or Burn cases,2. 15-55 yrs.,52.0,60.0,50.0,43.0,58.0,52.0,59.0,52.0,49.0,44.0,34.0,54.0,607.0
Central,17.4.10,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Trauma or Accidents or Burn cases,3. Above 55 yrs.,7.0,5.0,8.0,7.0,13.0,11.0,7.0,4.0,7.0,12.0,3.0,6.0,90.0
Central,17.4.10,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Trauma or Accidents or Burn cases,4. Total,63.0,65.0,60.0,56.0,77.0,68.0,67.0,60.0,57.0,56.0,40.0,67.0,736.0
Central,17.4.11,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being suicide,1. 6-14 yrs,,,,,,,,,,,,,
Central,17.4.11,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being suicide,2. 15-55 yrs.,,,1.0,,,,2.0,1.0,1.0,1.0,1.0,1.0,8.0
Central,17.4.11,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being suicide,3. Above 55 yrs.,,1.0,,,,,,,,,,,1.0
Central,17.4.11,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being suicide,4. Total,,1.0,1.0,,,,2.0,1.0,1.0,1.0,1.0,1.0,9.0
Central,17.4.12,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Animal bites and stings,1. 6-14 yrs,,,,,,,,,,,,,
Central,17.4.12,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Animal bites and stings,2. 15-55 yrs.,,,,,,,,,,,,,
Central,17.4.12,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Animal bites and stings,3. Above 55 yrs.,,,,,,,,,,,,,
Central,17.4.12,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Animal bites and stings,4. Total,,,,,,,,,,,,,
Central,17.4.13(a),Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Known Acute disease,1. 6-14 yrs,3.0,5.0,7.0,4.0,10.0,9.0,6.0,4.0,9.0,8.0,6.0,4.0,75.0
Central,17.4.13(a),Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Known Acute disease,2. 15-55 yrs.,93.0,100.0,82.0,75.0,97.0,90.0,79.0,75.0,98.0,89.0,91.0,91.0,1060.0
Central,17.4.13(a),Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Known Acute disease,3. Above 55 yrs.,46.0,58.0,51.0,39.0,61.0,40.0,42.0,40.0,54.0,60.0,70.0,50.0,611.0
Central,17.4.13(a),Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Known Acute disease,4. Total,142.0,163.0,140.0,118.0,168.0,139.0,127.0,119.0,161.0,157.0,167.0,145.0,1746.0
Central,17.4.13(b),Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Known Chronic disease,1. 6-14 yrs,2.0,3.0,2.0,5.0,7.0,4.0,3.0,4.0,12.0,6.0,11.0,4.0,63.0
Central,17.4.13(b),Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Known Chronic disease,2. 15-55 yrs.,113.0,138.0,149.0,150.0,170.0,161.0,139.0,159.0,159.0,162.0,168.0,163.0,1831.0
Central,17.4.13(b),Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Known Chronic disease,3. Above 55 yrs.,85.0,128.0,118.0,134.0,156.0,134.0,116.0,138.0,153.0,157.0,172.0,137.0,1628.0
Central,17.4.13(b),Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Known Chronic disease,4. Total,200.0,269.0,269.0,289.0,333.0,299.0,258.0,301.0,324.0,325.0,351.0,304.0,3522.0
Central,17.4.13(c),Number of cases of Adolescent or Adult deaths (age 6 years & above) where the cause was not known,1. 6-14 yrs,,,,,,,,,,,,,
Central,17.4.13(c),Number of cases of Adolescent or Adult deaths (age 6 years & above) where the cause was not known,2. 15-55 yrs.,2.0,9.0,1.0,4.0,3.0,1.0,1.0,4.0,2.0,4.0,6.0,,37.0
Central,17.4.13(c),Number of cases of Adolescent or Adult deaths (age 6 years & above) where the cause was not known,3. Above 55 yrs.,3.0,2.0,1.0,,2.0,3.0,1.0,1.0,,2.0,,2.0,17.0
Central,17.4.13(c),Number of cases of Adolescent or Adult deaths (age 6 years & above) where the cause was not known,4. Total,5.0,11.0,2.0,4.0,5.0,4.0,2.0,5.0,2.0,6.0,6.0,2.0,54.0
East,1.1,Total number of pregnant women Registered for ANC,TOTAL,4269.0,4631.0,4156.0,4564.0,4437.0,4318.0,3858.0,4050.0,3985.0,3920.0,4589.0,4506.0,51283.0
East,1.1.1,Of which Number registered within first trimester (within 12 weeks),TOTAL,1277.0,1297.0,1180.0,1252.0,1233.0,1195.0,1029.0,1103.0,1208.0,1222.0,1540.0,1503.0,15039.0
East,1.2,Number of Pregnant women registered under JSY,TOTAL,93.0,109.0,68.0,49.0,50.0,119.0,72.0,96.0,68.0,71.0,91.0,85.0,971.0
East,1.3,Number of pregnant women received 3 ANC check ups during pregnancy,TOTAL,1234.0,1431.0,1453.0,1736.0,2149.0,2308.0,2374.0,2446.0,2324.0,2060.0,1907.0,1923.0,23345.0
East,1.4.1,Number of pregnant women given TT1 during current pregnancy,TOTAL,1255.0,1526.0,1339.0,1294.0,1516.0,1597.0,1344.0,1412.0,1075.0,1212.0,1343.0,1571.0,16484.0
East,1.4.2,Number of pregnant women given TT2 or Booster during current pregnancy,TOTAL,1075.0,1412.0,1339.0,1364.0,1215.0,1413.0,1443.0,1383.0,1139.0,1138.0,1179.0,1326.0,15426.0
East,1.5,Total number of pregnant women given 100 IFA tablets,TOTAL,1236.0,1442.0,1361.0,1745.0,1703.0,1780.0,1792.0,1568.0,1879.0,1428.0,1605.0,1730.0,19269.0
East,1.6.1,Number of new cases of Hypertension (BP>140/90) detected in Pregnant women at the institution,TOTAL,77.0,67.0,54.0,47.0,147.0,87.0,84.0,94.0,89.0,77.0,59.0,55.0,937.0
East,1.6.2,Number of Eclampsia cases managed during delivery,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,2.0,2.0,4.0
East,1.7.1,Number of Pregnant women with anaemia i.e. Hb level<11 (tested cases),TOTAL,1063.0,1296.0,1245.0,1522.0,1418.0,1354.0,1361.0,1191.0,1177.0,1395.0,1278.0,1287.0,15587.0
East,1.7.2,Number of Pregnant women having severe anaemia (Hb<7) treated at institution,TOTAL,59.0,40.0,42.0,49.0,42.0,28.0,33.0,27.0,20.0,27.0,21.0,26.0,414.0
East,1.8,Number of pregnancy test kits used at SC level,TOTAL,45.0,49.0,43.0,16.0,22.0,50.0,35.0,117.0,237.0,0.0,2.0,2.0,618.0
East,2.1.1.a,Number of deliveries conducted at Home and attended by trained SBA(i.e. Doctor or Nurse or ANM),TOTAL,18.0,21.0,34.0,29.0,43.0,39.0,70.0,35.0,47.0,44.0,12.0,6.0,398.0
East,2.1.1.b,Number of deliveries conducted at Home and attended by non trained SBA (i.e. trained TBA or Relatives etc.),TOTAL,29.0,42.0,28.0,42.0,55.0,41.0,50.0,47.0,59.0,54.0,63.0,55.0,565.0
East,2.1.1.c,Total number of deliveries conducted at Home and attended by trained or non-trained SBA (i.e. sum of 2.1.1.a and 2.1.1.b),TOTAL,47.0,63.0,62.0,71.0,98.0,80.0,120.0,82.0,106.0,98.0,75.0,61.0,963.0
East,2.1.2,Number of newborns visited within 24 hours of delivery for deliveries conducted at home,TOTAL,36.0,30.0,44.0,48.0,62.0,51.0,92.0,47.0,65.0,70.0,53.0,44.0,642.0
East,2.1.3,Number of mothers paid JSY incentive for deliveries conducted at home,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
East,2.2,Deliveries conducted at Public Institutions (Including C-Sections),TOTAL,402.0,423.0,479.0,579.0,695.0,675.0,595.0,642.0,686.0,648.0,554.0,561.0,6939.0
East,2.2.1,"Out of 2.2, Number discharged under 48 hours of delivery",TOTAL,198.0,273.0,388.0,370.0,494.0,409.0,305.0,336.0,437.0,370.0,342.0,395.0,4317.0
East,2.2.2.a,Number of mothers paid JSY Incentive for deliveries conducted at Public Institutions,TOTAL,47.0,51.0,41.0,24.0,30.0,47.0,31.0,38.0,48.0,53.0,52.0,52.0,514.0
East,2.2.2.b,Number of ASHAs paid JSY Incentive for deliveries conducted at Public Institutions,TOTAL,28.0,32.0,29.0,27.0,14.0,28.0,17.0,48.0,51.0,58.0,56.0,25.0,413.0
East,2.2.2.c,Number of cases of deliveries conducted at Public Institutions where JSY incentive was paid to ANMs or AWWs [only for High Performing States (HPS)],TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
East,2.3,Deliveries conducted at Private Institutions (Including C-Sections),TOTAL,259.0,254.0,204.0,267.0,348.0,360.0,371.0,353.0,344.0,359.0,288.0,297.0,3704.0
East,2.3.1.a,Number of mothers paid JSY Incentive for deliveries conducted at accredited Private Institutions,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
East,2.3.1.b,Number of ASHAs paid JSY Incentive for deliveries conducted at accredited Private Institutions,TOTAL,4.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,4.0
East,2.3.1.c,Number of cases of deliveries conducted at accredited Private Institutions where JSY incentive was paid to ANMs or AWWs [only for High Performing States (HPS)],TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
East,3.1.1,Number of Caesarean (C-Section) deliveries performed at PHCs (Primary Health Centre),TOTAL,,,0.0,0.0,0.0,0.0,0.0,0.0,,0.0,,0.0,0.0
East,3.1.2,Number of Caesarean (C-Section) deliveries performed at CHCs (Community Health Centre),TOTAL,,,,,,,,0.0,,,,,0.0
East,3.1.3,Number of Caesarean (C-Section) deliveries performed at SDHs (Sub-divisional Hospital) or DHs (District Hospital),TOTAL,91.0,91.0,122.0,115.0,132.0,114.0,111.0,116.0,131.0,137.0,103.0,106.0,1369.0
East,3.1.4,Number of Caesarean (C-Section) deliveries performed at other State owned public institutions,TOTAL,,,,,,,,,,,,,
East,3.1.5,"Total Number of Caesarean (C-Section) deliveries performed at Public facilities i.e. PHC, CHC, SDH, DH and other State owned public institutions (sum of items from 3.1.1 to 3.1.4)",TOTAL,91.0,91.0,122.0,115.0,132.0,114.0,111.0,116.0,131.0,137.0,103.0,106.0,1369.0
East,3.2,No. of C-section deliveries performed at Private facilities,TOTAL,180.0,152.0,128.0,165.0,244.0,220.0,243.0,221.0,204.0,233.0,188.0,190.0,2368.0
East,4.1.1.a,Number of male live births,TOTAL,358.0,396.0,403.0,483.0,564.0,589.0,562.0,563.0,613.0,571.0,498.0,511.0,6111.0
East,4.1.1.b,Number of female live births,TOTAL,350.0,335.0,332.0,425.0,573.0,510.0,517.0,508.0,526.0,521.0,421.0,410.0,5428.0
East,4.1.1.c,Total number of male and female live births (4.1.1.a and 4.1.1.b),TOTAL,708.0,731.0,735.0,908.0,1137.0,1099.0,1079.0,1071.0,1139.0,1092.0,919.0,921.0,11539.0
East,4.1.2,Number of still births,TOTAL,3.0,13.0,13.0,12.0,10.0,23.0,12.0,11.0,6.0,13.0,8.0,5.0,129.0
East,4.1.3,Number of Abortions (spontaneous or induced),TOTAL,212.0,240.0,218.0,240.0,255.0,210.0,168.0,185.0,155.0,208.0,520.0,254.0,2865.0
East,4.2.1,Number of Newborns weighed at birth,TOTAL,672.0,695.0,712.0,853.0,1066.0,1053.0,1027.0,1052.0,1036.0,1061.0,883.0,907.0,11017.0
East,4.2.2,Number of Newborns having weight less than 2.5 kg,TOTAL,121.0,120.0,127.0,121.0,205.0,229.0,181.0,207.0,210.0,182.0,149.0,165.0,2017.0
East,4.3,Number of Newborns breast fed within 1 hour of birth,TOTAL,479.0,525.0,563.0,690.0,1000.0,996.0,750.0,995.0,862.0,792.0,673.0,667.0,8992.0
East,5.1.1,Number of cases of pregnant women with Obstetric Complications and attended at PHCs,TOTAL,,,0.0,0.0,0.0,,0.0,0.0,,0.0,,0.0,0.0
East,5.1.2,Number of cases of pregnant women with Obstetric Complications and attended at CHCs,TOTAL,5.0,1.0,12.0,18.0,11.0,14.0,3.0,4.0,7.0,,,,75.0
East,5.1.3,Number of cases of pregnant women with Obstetric Complications and attended at SDHs or DHs,TOTAL,115.0,112.0,110.0,120.0,223.0,190.0,180.0,182.0,183.0,330.0,248.0,123.0,2116.0
East,5.1.4,Number of cases of pregnant women with Obstetric Complications and attended at other State owned public institutions,TOTAL,,,,,,,,,,,,,
East,5.1.5,"Number of cases of pregnant women with Obstetric Complications and attended at Public facilities i.e. PHC, CHC, SDH, DH and other State owned public institutions (sum of items from 5.1.1 to 5.1.4)",TOTAL,120.0,113.0,122.0,138.0,234.0,204.0,183.0,186.0,190.0,330.0,248.0,123.0,2191.0
East,5.2,Number of cases of pregnant women with Obstetric Complications and attended at Private facilities,TOTAL,22.0,11.0,21.0,16.0,28.0,29.0,40.0,26.0,26.0,32.0,30.0,22.0,303.0
East,5.3.1,Number of cases of complicated pregnancies treated with IV antibiotics,TOTAL,137.0,123.0,131.0,134.0,248.0,215.0,209.0,206.0,207.0,354.0,271.0,144.0,2379.0
East,5.3.2,Number of cases of complicated pregnancies treated with IV Antihypertensive/Magsulph injection,TOTAL,5.0,19.0,18.0,24.0,23.0,10.0,14.0,10.0,4.0,7.0,8.0,2.0,144.0
East,5.3.3,Number of cases of complicated pregnancies treated with IV Oxytocis,TOTAL,137.0,117.0,33.0,132.0,235.0,213.0,203.0,203.0,213.0,331.0,272.0,145.0,2234.0
East,5.3.4,Number of cases of complicated pregnancies treated with Blood Transfusion,TOTAL,47.0,61.0,82.0,108.0,111.0,80.0,81.0,156.0,77.0,59.0,50.0,60.0,972.0
East,6.1,Women getting post partum check-up within 48 hours after delivery,TOTAL,517.0,553.0,630.0,774.0,898.0,905.0,777.0,1015.0,891.0,780.0,674.0,710.0,9124.0
East,6.2,Women getting a post partum check up between 48 hours and 14 days after delivery,TOTAL,692.0,574.0,661.0,908.0,1000.0,1054.0,1036.0,1069.0,1276.0,1034.0,900.0,959.0,11163.0
East,6.3,PNC maternal complications attended,TOTAL,29.0,28.0,30.0,39.0,42.0,38.0,30.0,28.0,29.0,21.0,19.0,17.0,350.0
East,7.1.1,Number of MTPs conducted at Public Institutions up to 12 weeks of pregnancy,TOTAL,5.0,5.0,3.0,6.0,5.0,4.0,5.0,6.0,7.0,4.0,6.0,5.0,61.0
East,7.1.2,Number of MTPs conducted at Public Institutions for more than 12 weeks of pregnancy,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
East,7.1.3,Total number of MTPs conducted at Public Institutions (sum of items 7.1.1 and 7.1.2),TOTAL,5.0,5.0,3.0,6.0,5.0,4.0,5.0,6.0,7.0,4.0,6.0,5.0,61.0
East,7.2,Number of MTPs conducted at Private Facilities,TOTAL,158.0,188.0,149.0,156.0,173.0,156.0,134.0,136.0,147.0,124.0,398.0,158.0,2077.0
East,8.1.a,Number of new cases of RTI/STI in males for which treatment was initiated,TOTAL,109.0,116.0,103.0,138.0,140.0,168.0,113.0,148.0,179.0,115.0,168.0,136.0,1633.0
East,8.1.b,Number of new cases of RTI/STI in females for which treatment was initiated,TOTAL,1024.0,1034.0,857.0,973.0,1024.0,981.0,862.0,1083.0,997.0,960.0,1082.0,1138.0,12015.0
East,8.1.c,Total number of new cases of RTI/STI in males and females for which treatment was initiated (sum of items 8.1.a and 8.1.b),TOTAL,1133.0,1150.0,960.0,1111.0,1164.0,1149.0,975.0,1231.0,1176.0,1075.0,1250.0,1274.0,13648.0
East,8.2,Number of suspected RTI/STI cases for whom wet mount test was conducted,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,2.0,0.0,2.0,0.0,1.0,0.0,5.0
East,9.1.1.a,Number of NSV (No Scalpel Vasectomy) or Conventional Vasectomy conducted at PHCs,TOTAL,0.0,0.0,0.0,0.0,,0.0,0.0,0.0,,0.0,,0.0,0.0
East,9.1.1.b,Number of NSV or Conventional Vasectomy conducted at CHCs,TOTAL,,,,,,,,,,,,,
East,9.1.1.c,Number of NSV or Conventional Vasectomy conducted at SDHs or DHs,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
East,9.1.1.d,Number of NSV or Conventional Vasectomy conducted at other State owned public institutions,TOTAL,,,,,,,,,,,,,
East,9.1.1.e,"Total Number of NSV or Conventional Vasectomy conducted at Public facilities i.e. PHC, CHC, SDH, DH and other State owned public institutions (sum of items from 9.1.1.a to 9.1.1.d)",TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
East,9.1.2,Number of NSV or Conventional Vasectomy conducted at Private facilities,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
East,9.2.1.a,Number of Laparoscopic sterilizations conducted at PHCs,TOTAL,0.0,0.0,0.0,0.0,,0.0,0.0,0.0,,0.0,0.0,0.0,0.0
East,9.2.1.b,Number of Laparoscopic sterilizations conducted at CHCs,TOTAL,,,,,,,,,,,,,
East,9.2.1.c,Number of Laparoscopic sterilizations conducted at SDHs or DHs,TOTAL,0.0,0.0,0.0,0.0,0.0,1.0,0.0,0.0,0.0,0.0,0.0,0.0,1.0
East,9.2.1.d,Number of Laparoscopic sterilizations conducted at other State owned public institutions,TOTAL,,,,,,,,,,,,,
East,9.2.1.e,"Total Number of Laparoscopic sterilizations conducted at Public facilities i.e. PHC, CHC, SDH, DH and other State owned public institutions (sum of items from 9.2.1.a to 9.2.1.d)",TOTAL,0.0,0.0,0.0,0.0,0.0,1.0,0.0,0.0,0.0,0.0,0.0,0.0,1.0
East,9.2.2,Number of Laparoscopic sterilizations conducted at Private facilities,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,5.0,1.0,6.0,4.0,16.0
East,9.3.1.a,Number of Mini-lap sterilizations conducted at PHCs,TOTAL,0.0,,,0.0,,0.0,0.0,0.0,,0.0,0.0,0.0,0.0
East,9.3.1.b,Number of Mini-lap sterilizations conducted at CHCs,TOTAL,,,,,,,,,,,,,
East,9.3.1.c,Number of Mini-lap sterilizations conducted at SDHs or DHs,TOTAL,14.0,6.0,7.0,7.0,11.0,8.0,5.0,2.0,4.0,8.0,4.0,9.0,85.0
East,9.3.1.d,Number of Mini-lap sterilizations conducted at other State owned public institutions,TOTAL,,,,,,,,,,,,,
East,9.3.1.e,"Total Number of Mini-lap sterilizations conducted at Public facilities i.e. PHC, CHC, SDH, DH and other State owned public institutions (sum of items from 9.3.1.a to 9.3.1.d)",TOTAL,14.0,6.0,7.0,7.0,11.0,8.0,5.0,2.0,4.0,8.0,4.0,9.0,85.0
East,9.3.2,Number of Mini-lap sterilizations conducted at Private facilities,TOTAL,2.0,0.0,5.0,1.0,4.0,4.0,1.0,3.0,1.0,1.0,2.0,1.0,25.0
East,9.4.1.a,Number of Post-Partum sterilizations conducted at PHCs,TOTAL,0.0,0.0,,0.0,,0.0,0.0,0.0,,0.0,0.0,0.0,0.0
East,9.4.1.b,Number of Post-Partum sterilizations conducted at CHCs,TOTAL,,,,,,,,,,,,,
East,9.4.1.c,Number of Post-Partum sterilizations conducted at SDHs or DHs,TOTAL,0.0,6.0,3.0,19.0,0.0,0.0,5.0,0.0,0.0,0.0,0.0,0.0,33.0
East,9.4.1.d,Number of Post-Partum sterilizations conducted at other State owned public institutions,TOTAL,,,,,,,,,,,,,
East,9.4.1.e,"Total Number of Post-Partum sterilizations conducted at Public facilities i.e. PHC, CHC, SDH, DH and other State owned public institutions (sum of items from 9.4.1.a to 9.4.1.d)",TOTAL,0.0,6.0,3.0,19.0,0.0,0.0,5.0,0.0,0.0,0.0,0.0,0.0,33.0
East,9.4.2,Number of Post-Partum sterilizations conducted at Private facilities,TOTAL,0.0,3.0,0.0,0.0,0.0,0.0,3.0,1.0,3.0,3.0,1.0,4.0,18.0
East,9.5.1.a,Number of IUCD Insertions conducted at SCs,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
East,9.5.1.b,Number of IUCD Insertions conducted at PHCs,TOTAL,116.0,124.0,114.0,559.0,202.0,179.0,99.0,126.0,151.0,154.0,147.0,124.0,2095.0
East,9.5.1.c,Number of IUCD Insertions conducted at CHCs,TOTAL,55.0,37.0,37.0,53.0,56.0,23.0,23.0,44.0,37.0,42.0,36.0,29.0,472.0
East,9.5.1.d,Number of IUCD Insertions conducted at SDHs or DHs,TOTAL,100.0,68.0,131.0,132.0,137.0,143.0,126.0,126.0,349.0,348.0,298.0,227.0,2185.0
East,9.5.1.e,Number of IUCD Insertions conducted at other State owned public institutions,TOTAL,,,,,,,,,,,,,
East,9.5.1.f,"Total Number of IUCD Insertions conducted at Public facilities i.e. SC, PHC, CHC, SDH, DH and other State owned public institutions (sum of items from 9.5.1.a to 9.5.1.e)",TOTAL,271.0,229.0,282.0,744.0,395.0,345.0,248.0,296.0,537.0,544.0,481.0,380.0,4752.0
East,9.5.1A,"Out of above total, Post Partum (within 48 hours of delivery) IUCD insertions",TOTAL,65.0,61.0,129.0,117.0,134.0,134.0,128.0,132.0,338.0,349.0,295.0,213.0,2095.0
East,9.5.2,Number of IUCD Insertions conducted at Private facilities,TOTAL,53.0,49.0,43.0,43.0,41.0,19.0,34.0,41.0,38.0,33.0,42.0,39.0,475.0
East,9.06,Number of IUCD removals,TOTAL,92.0,94.0,94.0,92.0,95.0,78.0,65.0,82.0,151.0,87.0,88.0,82.0,1100.0
East,9.07,Number of Oral Pills cycles distributed,TOTAL,809.0,1134.0,2270.0,1436.0,1286.0,1237.0,936.0,782.0,766.0,1109.0,645.0,711.0,13121.0
East,9.08,Number of Condom pieces distributed,TOTAL,18384.0,19372.0,19396.0,32853.0,24004.0,18787.0,11511.0,12381.0,13176.0,16376.0,15812.0,15059.0,217111.0
East,9.09,Number of Centchroman (weekly) pills given,TOTAL,4.0,504.0,4.0,4.0,4.0,4.0,0.0,0.0,0.0,0.0,0.0,0.0,524.0
East,9.10,Number of Emergency Contraceptive Pills distributed,TOTAL,18.0,26.0,22.0,55.0,24.0,83.0,30.0,54.0,45.0,55.0,34.0,56.0,502.0
East,9.11.1.a,Number of cases of complications following male sterilization,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
East,9.11.1.b,Number of cases of complications following female sterilization,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
East,9.11.2.a,Number of failures following male sterilization,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
East,9.11.2.b,Number of failures following female sterilization,TOTAL,0.0,0.0,0.0,0.0,1.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,1.0
East,9.11.3.a,Number of deaths following male sterilization,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
East,9.11.3.b,Number of deaths following female sterilization,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
East,9.12,Number of Institutions having NSV trained doctors,TOTAL,,6.0,,,,,2.0,4.0,4.0,7.0,4.0,3.0,-1.0
East,10.1.01,Number of Infants (0 to 11 months old)received BCG immunisation,TOTAL,951.0,1058.0,937.0,1184.0,1384.0,1401.0,1268.0,1403.0,1514.0,1315.0,1256.0,1250.0,14921.0
East,10.1.02,Number of Infants (0 to 11 months old) received DPT1 immunisation,TOTAL,143.0,168.0,134.0,119.0,166.0,183.0,110.0,120.0,140.0,126.0,99.0,114.0,1622.0
East,10.1.03,Number of Infants (0 to 11 months old) received DPT2 immunisation,TOTAL,206.0,203.0,200.0,220.0,222.0,224.0,140.0,195.0,207.0,165.0,149.0,126.0,2257.0
East,10.1.04,Number of Infants (0 to 11 months old) received DPT3 immunisation,TOTAL,254.0,222.0,168.0,278.0,205.0,237.0,157.0,164.0,211.0,178.0,151.0,157.0,2382.0
East,10.1.04A,Number of Infants (0 to 11 months old) received Pentavalent1 immunisation,TOTAL,1354.0,1285.0,1079.0,1345.0,1329.0,1398.0,1640.0,1772.0,1815.0,1531.0,1546.0,1565.0,17659.0
East,10.1.04B,Number of Infants (0 to 11 months old) received Pentavalent2 immunisation,TOTAL,1465.0,1302.0,1103.0,1261.0,1173.0,1167.0,1282.0,1414.0,1761.0,1511.0,1480.0,1612.0,16531.0
East,10.1.04C,Number of Infants (0 to 11 months old) received Pentavalent3 immunisation,TOTAL,1465.0,1344.0,1160.0,1215.0,1150.0,1085.0,1061.0,1177.0,1427.0,1384.0,1338.0,1500.0,15306.0
East,10.1.05,Number of Infants (0 to 11 months old) received OPV 0 (Birth Dose),TOTAL,671.0,664.0,716.0,821.0,926.0,1069.0,943.0,1020.0,1023.0,1044.0,887.0,966.0,10750.0
East,10.1.06,Number of Infants (0 to 11 months old) received OPV1 (First Dose),TOTAL,1500.0,1469.0,1247.0,1511.0,1481.0,1565.0,1729.0,1896.0,1951.0,1596.0,1624.0,1655.0,19224.0
East,10.1.07,Number of Infants (0 to 11 months old) received OPV2 (Second Dose),TOTAL,1668.0,1506.0,1315.0,1513.0,1390.0,1374.0,1426.0,1621.0,1960.0,1634.0,1611.0,1726.0,18744.0
East,10.1.08,Number of Infants (0 to 11 months old) received OPV3 (Third Dose),TOTAL,1735.0,1562.0,1357.0,1498.0,1345.0,1302.0,1204.0,1412.0,1638.0,1548.0,1507.0,1630.0,17738.0
East,10.1.09A,Number of Infants (upto 48 hrs of age) received Hepatitis-B0 immunisation,TOTAL,637.0,676.0,675.0,751.0,991.0,997.0,873.0,967.0,1029.0,1050.0,858.0,941.0,10445.0
East,10.1.09,Number of Infants (0 to 11 months old) received Hepatitis-B1 immunisation,TOTAL,141.0,210.0,180.0,207.0,176.0,199.0,157.0,132.0,166.0,164.0,145.0,131.0,2008.0
East,10.1.10,Number of Infants (0 to 11 months old) received Hepatitis-B2 immunisation,TOTAL,208.0,170.0,227.0,266.0,249.0,195.0,156.0,140.0,170.0,154.0,172.0,126.0,2233.0
East,10.1.11,Number of Infants (0 to 11 months old) received Hepatitis-B3 immunisation,TOTAL,224.0,194.0,173.0,262.0,199.0,230.0,197.0,150.0,207.0,218.0,195.0,134.0,2383.0
East,10.1.12,Number of Infants (0 to 11 months old) received Measles immunisation (First Dose),TOTAL,2186.0,1963.0,2522.0,1935.0,2023.0,1754.0,1607.0,1762.0,1565.0,1460.0,1321.0,1410.0,21508.0
East,10.1.12B,Number of Infants (more than 16 months old) received Measles immunisation (Second Dose),TOTAL,4287.0,2678.0,4658.0,1164.0,388.0,63.0,19.0,34.0,16.0,58.0,102.0,361.0,13828.0
East,10.1A,No. of Children aged 9 to 12 months who received JE 1st dose,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
East,10.1.13.a,Total number of male children (9 to 11 months old) fully immunised (BCG+DPT123/Pentavalent123+OPV123+Measles) during the month,TOTAL,1196.0,1037.0,1191.0,997.0,1033.0,909.0,828.0,903.0,825.0,758.0,662.0,729.0,11068.0
East,10.1.13.b,Total number of female children (9 to 11 months old) fully immunised (BCG+DPT123/Pentavalent123+OPV123+Measles) during the month,TOTAL,919.0,859.0,1060.0,876.0,922.0,802.0,715.0,813.0,723.0,691.0,651.0,611.0,9642.0
East,10.1.13.c,Total number of children (9 to 11 months old) fully immunised (BCG+DPT123/Pentavalent123+OPV123+Measles) during the month (sum of items 10.1.13.a and 10.1.13.b),TOTAL,2115.0,1896.0,2251.0,1873.0,1955.0,1711.0,1543.0,1716.0,1548.0,1449.0,1313.0,1340.0,20710.0
East,10.2.1,Number of Infants (more than 16 months old) received DPT Booster dose,TOTAL,1247.0,1964.0,1365.0,1663.0,1635.0,1499.0,1138.0,1323.0,1412.0,1380.0,1577.0,1763.0,17966.0
East,10.2.2,Number of Infants (more than 16 months old) received OPV Booster dose,TOTAL,1238.0,1954.0,1353.0,1655.0,1632.0,1496.0,1112.0,1315.0,1412.0,1399.0,1589.0,1822.0,17977.0
East,10.2.3,"Number of Infants (more than 16 months old) received Measles, Mumps, Rubella (MMR) Vaccination",TOTAL,498.0,34.0,34.0,30.0,1254.0,1833.0,1483.0,1852.0,2328.0,1639.0,1810.0,1471.0,14266.0
East,10.3.1.a,Total number of male children (12 to 23 months old) fully immunised (BCG+DPT123/Pentavalent123+OPV123+Measles) during the month,TOTAL,551.0,776.0,787.0,322.0,242.0,267.0,120.0,169.0,290.0,222.0,164.0,189.0,4099.0
East,10.3.1.b,Total number of female children (12 to 23 months old) fully immunised (BCG+DPT123/Pentavalent123+OPV123+Measles) during the month,TOTAL,449.0,679.0,706.0,276.0,192.0,238.0,110.0,134.0,265.0,173.0,147.0,187.0,3556.0
East,10.3.1.c,Total number of children (12 to 23 months old) fully immunised (BCG+DPT123+OPV123/Pentavalent123+Measles) during the month (sum of items 10.3.1.a and 10.3.1.b),TOTAL,1000.0,1455.0,1493.0,598.0,434.0,505.0,230.0,303.0,555.0,395.0,311.0,376.0,7655.0
East,10.3.2,Number of children (more than 5 years old) given DT5,TOTAL,626.0,1165.0,899.0,724.0,752.0,811.0,544.0,767.0,849.0,1010.0,709.0,975.0,9831.0
East,10.3.3,Number of children (more than 10 years old) given TT10,TOTAL,358.0,568.0,588.0,378.0,387.0,421.0,395.0,255.0,394.0,253.0,254.0,394.0,4645.0
East,10.3.4,Number of children (more than 16 years old) given TT16,TOTAL,216.0,293.0,323.0,297.0,229.0,257.0,198.0,177.0,298.0,150.0,144.0,241.0,2823.0
East,10.3.5.a,Number of cases of Abscess reported following immunisation [Adverse Event Following Immunisation (AEFI)],TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
East,10.3.5.b,Number of cases of Death reported following immunisation [Adverse Event Following Immunisation (AEFI)],TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
East,10.3.5.c,Number of cases of other complications reported following immunisation [Adverse Event Following Immunisation (AEFI)],TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
East,10.4.1,Number of Immunisation sessions planned to be held during the month,TOTAL,712.0,564.0,656.0,441.0,424.0,446.0,458.0,449.0,557.0,462.0,477.0,390.0,6036.0
East,10.4.2,Number of Immunisation sessions held during the month,TOTAL,730.0,542.0,625.0,438.0,406.0,422.0,413.0,416.0,543.0,448.0,470.0,371.0,5824.0
East,10.4.3,Number of Immunisation sessions held during the month where ASHAs were present,TOTAL,457.0,299.0,392.0,229.0,202.0,202.0,223.0,240.0,321.0,250.0,249.0,225.0,3289.0
East,10.5.1,Number of children (more than 16 months old) received Japanese Encephalitis (JE) vaccination,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
East,11.1.1,Number of children (9 months to 5 years old) administered 1st dose of Vitamin A (Dose-1),TOTAL,2137.0,1818.0,1978.0,1664.0,1855.0,1648.0,1423.0,1594.0,1446.0,1420.0,1066.0,1304.0,19353.0
East,11.1.2,Number of children (9 months to 5 years old) were administered 5th dose of Vitamin A (Dose-5),TOTAL,2133.0,1888.0,2176.0,1110.0,809.0,1131.0,9940.0,1362.0,1347.0,1049.0,836.0,932.0,24713.0
East,11.1.3,Number of children (9 months to 5 years old) administered 9th dose of Vitamin A (Dose-9),TOTAL,3325.0,1088.0,1384.0,585.0,388.0,606.0,555.0,653.0,683.0,685.0,425.0,635.0,11012.0
East,12.1,Number of cases of Diptheria reported in children below 5 years of age,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
East,12.2,Number of cases of Pertusis reported in children below 5 years of age,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
East,12.3,Number of cases of Tetanus neonatarum reported in children below 5 years of age,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
East,12.4,Number of cases of Tetanus other than neonatarum reported in children below 5 years of age,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
East,12.5,Number of cases of Polio reported in children below 5 years of age,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
East,12.6,Number of cases of Measles reported in children below 5 years of age,TOTAL,50.0,43.0,14.0,3.0,4.0,7.0,9.0,5.0,13.0,36.0,24.0,16.0,224.0
East,12.7,Number of cases of Diarrhoea and Dehydration reported in children below 5 years of age,TOTAL,912.0,593.0,501.0,489.0,348.0,392.0,413.0,521.0,395.0,415.0,354.0,310.0,5643.0
East,12.8,Number of cases of Malaria reported in children below 5 years of age,TOTAL,0.0,0.0,3.0,6.0,6.0,5.0,0.0,0.0,1.0,1.0,0.0,0.0,22.0
East,12.9,Number of children below 5 years of age admitted with Respiratory Infections,TOTAL,202.0,166.0,189.0,177.0,181.0,216.0,218.0,241.0,317.0,373.0,215.0,254.0,2749.0
East,13.1,Number of Patients operated for cataract,TOTAL,132.0,111.0,81.0,71.0,75.0,102.0,73.0,98.0,129.0,103.0,67.0,137.0,1179.0
East,13.2,Number of Intraocular Lens(IOL) implantations,TOTAL,87.0,67.0,44.0,28.0,58.0,46.0,47.0,60.0,64.0,59.0,12.0,76.0,648.0
East,13.3,Number of School children detected with Refractive errors,TOTAL,0.0,0.0,21.0,36.0,20.0,0.0,22.0,0.0,31.0,21.0,41.0,0.0,192.0
East,13.4,Number of children provided free glasses,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
East,13.5,Number of eyes collected through eye donation,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
East,13.6,Number of eyes utilised for corneal transplant,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
East,14.01,Number of CHC or SDH or DH functioning as First Referral units (FRUs),TOTAL,,1.0,,,,,,2.0,3.0,3.0,1.0,1.0,-1.0
East,14.02,Number of PHCs functioning 24X7 with atleast 3 Staff Nurses,TOTAL,,,,,,,,,,,,,-1.0
East,14.03,Number of Anganwadi centres reported to have conducted VHNDs,TOTAL,5.0,14.0,11.0,19.0,16.0,14.0,21.0,12.0,24.0,11.0,19.0,31.0,-1.0
East,14.04,Number of facilities having a Rogi Kalyan Samiti (RKS),TOTAL,,4.0,,,,,3.0,4.0,4.0,3.0,3.0,4.0,-1.0
East,14.05,Number of RKS meetings held during the month,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
East,14.06,Number of facilities having Ambulance services (Assured Referral Services),TOTAL,14.0,15.0,14.0,15.0,14.0,15.0,22.0,30.0,22.0,19.0,23.0,21.0,-1.0
East,14.07,Total Number of times the Ambulance was used for transporting patients during the month,TOTAL,625.0,629.0,764.0,721.0,756.0,607.0,599.0,653.0,627.0,525.0,596.0,660.0,7762.0
East,14.08,Number of Institutions having Operational Sick New Born and Child Care Units (SNCU),TOTAL,,,9.0,,,,2.0,3.0,5.0,6.0,7.0,7.0,-1.0
East,14.09,Number of functional Laproscopes in CHC/SDH/DH,TOTAL,12.0,7.0,7.0,8.0,9.0,5.0,10.0,6.0,11.0,9.0,5.0,14.0,-1.0
East,14.10.1.a,Number of male patients admitted (Inpatients) during the month,1. Children,1316.0,1361.0,1394.0,1455.0,1500.0,1773.0,1491.0,1395.0,1477.0,1410.0,1465.0,1356.0,17393.0
East,14.10.1.a,Number of male patients admitted (Inpatients) during the month,2. Adults,2534.0,2532.0,2401.0,2919.0,2950.0,3003.0,3779.0,2668.0,2576.0,2521.0,2333.0,2924.0,33140.0
East,14.10.1.b,Number of female patients (Inpatients) admitted during the month,1. Children,904.0,1030.0,949.0,1027.0,1118.0,947.0,962.0,1006.0,955.0,934.0,931.0,909.0,11672.0
East,14.10.1.b,Number of female patients (Inpatients) admitted during the month,2. Adults,3171.0,3194.0,3302.0,3754.0,4061.0,3916.0,3199.0,3585.0,3504.0,3526.0,3386.0,4112.0,42710.0
East,14.10.1.c,Total number of patients admitted (Inpatients) during the month (sum of items 14.10.1.a and 14.10.1.b),1. Children,2220.0,2391.0,2343.0,2482.0,2618.0,2720.0,2453.0,2401.0,2432.0,2344.0,2396.0,2265.0,29065.0
East,14.10.1.c,Total number of patients admitted (Inpatients) during the month (sum of items 14.10.1.a and 14.10.1.b),2. Adults,5705.0,5726.0,5703.0,6673.0,7011.0,6919.0,6978.0,6253.0,6080.0,6047.0,5719.0,7036.0,75850.0
East,14.10.2.a,Number of death cases of Inpatient males,TOTAL,120.0,141.0,139.0,143.0,152.0,146.0,132.0,156.0,131.0,144.0,119.0,142.0,1665.0
East,14.10.2.b,Number of death cases of Inpatient females,TOTAL,86.0,91.0,70.0,79.0,93.0,87.0,99.0,61.0,71.0,67.0,71.0,79.0,954.0
East,14.10.2.c,Number of cases of death of Inpatients (sum of items 14.10.2.a and 14.10.2.b),TOTAL,206.0,232.0,209.0,222.0,245.0,233.0,231.0,217.0,202.0,211.0,190.0,221.0,2619.0
East,14.11,In-Patient Head Count at midnight,TOTAL,10201.0,11199.0,10776.0,11683.0,10927.0,11451.0,10624.0,21423.0,24239.0,25198.0,24666.0,29043.0,201430.0
East,14.12.1,OPD attendance (All),TOTAL,290012.0,282904.0,258892.0,288777.0,303830.0,316333.0,247609.0,280678.0,278639.0,268275.0,299048.0,284312.0,3399309.0
East,14.13.1,Number of major operations carried out using general or spinal anaesthesia,TOTAL,1846.0,1869.0,1859.0,1817.0,1839.0,2017.0,1688.0,1864.0,1926.0,1639.0,1489.0,1897.0,21750.0
East,14.13.1A,"Out of 14.13.1,Gynecology- Hysterectomy surgeries",TOTAL,59.0,77.0,55.0,46.0,49.0,49.0,47.0,36.0,58.0,44.0,46.0,48.0,614.0
East,14.13.2,Number of minor operations carried out without anaesthesia or using local anaesthesia,TOTAL,4410.0,4629.0,4674.0,5312.0,4000.0,5331.0,4778.0,4423.0,4858.0,5084.0,4356.0,4219.0,56074.0
East,14.14.a,Number of patients given AYUSH treatment,TOTAL,3913.0,4163.0,3886.0,4081.0,4131.0,4120.0,3870.0,4190.0,3789.0,5280.0,5679.0,4853.0,51955.0
East,14.14.b,Number of patients on whom Dental Procedure was conducted,TOTAL,1671.0,2104.0,1557.0,1957.0,1867.0,1950.0,1846.0,1966.0,2072.0,2311.0,2008.0,2243.0,23552.0
East,14.14.c,Number of Adolescents counselled,TOTAL,605.0,624.0,742.0,836.0,665.0,665.0,531.0,692.0,436.0,543.0,485.0,631.0,7455.0
East,15.1.1.a,Number of Haemoglobin (Hb) tests conducted,TOTAL,21369.0,23636.0,19059.0,23742.0,20701.0,23801.0,22571.0,22078.0,17760.0,19815.0,22339.0,25503.0,262374.0
East,15.1.1.b,"Out of the total number of Hb tests conducted, number of cases having Hb less than 7gm/dl",TOTAL,660.0,862.0,766.0,545.0,568.0,466.0,568.0,511.0,476.0,471.0,570.0,518.0,6981.0
East,15.1.2.a,Number of HIV tests conducted on males,1. Number tested,1817.0,2074.0,1800.0,2054.0,1848.0,2020.0,1803.0,1872.0,1679.0,1822.0,1787.0,1753.0,22329.0
East,15.1.2.a,Number of HIV tests conducted on males,2. Number Positive,11.0,11.0,12.0,7.0,8.0,13.0,5.0,11.0,6.0,3.0,18.0,7.0,112.0
East,15.1.2.b,Number of HIV tests conducted on Female-Non ANC (i.e. non pregnant females),1. Number tested,1160.0,1369.0,1237.0,1172.0,1175.0,1195.0,1003.0,1313.0,1245.0,1090.0,1144.0,1328.0,14431.0
East,15.1.2.b,Number of HIV tests conducted on Female-Non ANC (i.e. non pregnant females),2. Number Positive,3.0,4.0,1.0,7.0,5.0,6.0,3.0,6.0,5.0,1.0,1.0,7.0,49.0
East,15.1.2.c,Number of HIV tests conducted on Female with ANC (i.e. pregnant females),1. Number tested,1405.0,1849.0,1479.0,1728.0,1535.0,1703.0,1275.0,1410.0,1375.0,1417.0,1253.0,1032.0,17461.0
East,15.1.2.c,Number of HIV tests conducted on Female with ANC (i.e. pregnant females),2. Number Positive,2.0,5.0,3.0,3.0,4.0,1.0,3.0,7.0,1.0,2.0,13.0,1.0,45.0
East,15.1.2.d,Total number of HIV tests conducted (sum of items 15.1.2.a to 15.1.2.c),1. Number tested,4382.0,5292.0,4516.0,4954.0,4558.0,4918.0,4081.0,4595.0,4299.0,4329.0,4184.0,4113.0,54221.0
East,15.1.2.d,Total number of HIV tests conducted (sum of items 15.1.2.a to 15.1.2.c),2. Number Positive,16.0,20.0,16.0,17.0,17.0,20.0,11.0,24.0,12.0,6.0,32.0,15.0,206.0
East,15.2,Number of Widal tests conducted,Number tested,932.0,1454.0,849.0,1118.0,1256.0,1257.0,853.0,1029.0,653.0,659.0,898.0,1003.0,11961.0
East,15.3.a,Number of VDRL tests conducted on males,Number tested,1230.0,1563.0,1292.0,1429.0,1119.0,1593.0,1254.0,1417.0,1009.0,1367.0,1147.0,1065.0,15485.0
East,15.3.b,Number of VDRL tests conducted on Female-Non ANC (i.e. non pregnant females),Number tested,331.0,396.0,330.0,212.0,204.0,257.0,208.0,324.0,236.0,309.0,376.0,428.0,3611.0
East,15.3.c,Number of VDRL tests conducted on Female with ANC (i.e. pregnant females),Number tested,779.0,802.0,877.0,864.0,552.0,1126.0,817.0,953.0,671.0,1092.0,862.0,678.0,10073.0
East,15.3.d,Total number of VDRL tests conducted (sum of items 15.3.a to 15.3.c),Number tested,2340.0,2761.0,2499.0,2505.0,1875.0,2976.0,2279.0,2694.0,1916.0,2768.0,2385.0,2171.0,29169.0
East,15.4.1,Number of blood smears examined for Malaria,TOTAL,557.0,572.0,491.0,494.0,642.0,792.0,567.0,618.0,368.0,518.0,386.0,510.0,6515.0
East,15.4.2,"Out of blood smears examined for malaria, number of blood smears tested positive for Plasmodium Vivax",TOTAL,3.0,10.0,13.0,11.0,25.0,33.0,13.0,9.0,1.0,1.0,0.0,3.0,122.0
East,15.4.3,"Out of blood smears examined for malaria, number of blood smears tested positive for Plasmodium Falciparum",TOTAL,0.0,1.0,0.0,0.0,5.0,1.0,5.0,3.0,0.0,0.0,0.0,0.0,15.0
East,16.1.1,Stock position of DPT vaccines,1. Balance From Previous Month,2210.0,640.0,4050.0,2620.0,2650.0,1170.0,600.0,1210.0,3150.0,1720.0,2200.0,4520.0,26740.0
East,16.1.1,Stock position of DPT vaccines,2. Stocks Received,,6000.0,,5000.0,,1000.0,2000.0,4000.0,0.0,2000.0,4000.0,0.0,24000.0
East,16.1.1,Stock position of DPT vaccines,3. Unusable Stock,,,,,,,0.0,0.0,0.0,0.0,0.0,0.0,0.0
East,16.1.1,Stock position of DPT vaccines,4. Stock Distributed,1570.0,2590.0,1430.0,4970.0,1480.0,1570.0,1390.0,2060.0,1430.0,1520.0,1680.0,2400.0,24090.0
East,16.1.1,Stock position of DPT vaccines,5. Total Stock,640.0,4050.0,2620.0,2650.0,1170.0,600.0,1210.0,3150.0,1720.0,2200.0,4520.0,2120.0,26650.0
East,16.1.1A,Stock Position of Pentavalent,1. Balance From Previous Month,3010.0,2970.0,3270.0,2200.0,5190.0,3430.0,1730.0,2870.0,5120.0,3080.0,4230.0,1860.0,38960.0
East,16.1.1A,Stock Position of Pentavalent,2. Stocks Received,2000.0,3000.0,,5000.0,,,3000.0,5000.0,0.0,3500.0,0.0,5000.0,26500.0
East,16.1.1A,Stock Position of Pentavalent,3. Unusable Stock,,,,,,,0.0,0.0,0.0,0.0,0.0,0.0,0.0
East,16.1.1A,Stock Position of Pentavalent,4. Stock Distributed,2040.0,2700.0,1070.0,2010.0,1760.0,3430.0,1860.0,2750.0,2040.0,2350.0,2370.0,3410.0,27790.0
East,16.1.1A,Stock Position of Pentavalent,5. Total Stock,2970.0,3270.0,2200.0,5190.0,3430.0,0.0,2870.0,5120.0,3080.0,4230.0,1860.0,3450.0,37670.0
East,16.1.2,Stock position of OPV vaccines,1. Balance From Previous Month,4000.0,5240.0,6060.0,3280.0,3700.0,4000.0,1300.0,2580.0,8780.0,5540.0,4340.0,7280.0,56100.0
East,16.1.2,Stock position of OPV vaccines,2. Stocks Received,2000.0,5000.0,,5000.0,,4000.0,4000.0,10000.0,0.0,10000.0,6000.0,7500.0,53500.0
East,16.1.2,Stock position of OPV vaccines,3. Unusable Stock,,,,,,,0.0,0.0,0.0,0.0,0.0,0.0,0.0
East,16.1.2,Stock position of OPV vaccines,4. Stock Distributed,760.0,4180.0,2780.0,4580.0,3300.0,6700.0,2720.0,4040.0,3240.0,11200.0,3060.0,5380.0,51940.0
East,16.1.2,Stock position of OPV vaccines,5. Total Stock,5240.0,6060.0,3280.0,3700.0,400.0,1300.0,2580.0,8540.0,5540.0,4340.0,7280.0,9400.0,57660.0
East,16.1.3,Stock position of TT vaccines,1. Balance From Previous Month,670.0,1830.0,2750.0,1570.0,3940.0,2380.0,1810.0,370.0,3680.0,2650.0,1230.0,4310.0,27190.0
East,16.1.3,Stock position of TT vaccines,2. Stocks Received,2000.0,3000.0,,5000.0,,1000.0,0.0,5000.0,0.0,0.0,4000.0,0.0,20000.0
East,16.1.3,Stock position of TT vaccines,3. Unusable Stock,,,,,,,0.0,0.0,0.0,0.0,0.0,0.0,0.0
East,16.1.3,Stock position of TT vaccines,4. Stock Distributed,840.0,2080.0,1180.0,2630.0,1560.0,1570.0,1440.0,1690.0,1030.0,1420.0,920.0,1860.0,18220.0
East,16.1.3,Stock position of TT vaccines,5. Total Stock,1830.0,2750.0,1570.0,3940.0,2380.0,1810.0,370.0,3680.0,2650.0,1230.0,4310.0,2450.0,28970.0
East,16.1.4,Stock position of DT vaccines,1. Balance From Previous Month,,,,,,,0.0,0.0,0.0,0.0,0.0,0.0,0.0
East,16.1.4,Stock position of DT vaccines,2. Stocks Received,,,,,,,0.0,0.0,0.0,0.0,0.0,0.0,0.0
East,16.1.4,Stock position of DT vaccines,3. Unusable Stock,,,,,,,0.0,0.0,0.0,0.0,0.0,0.0,0.0
East,16.1.4,Stock position of DT vaccines,4. Stock Distributed,,,,,,,0.0,0.0,0.0,0.0,0.0,0.0,0.0
East,16.1.4,Stock position of DT vaccines,5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
East,16.1.5,Stock position of BCG vaccines,1. Balance From Previous Month,1860.0,1190.0,2280.0,1930.0,4240.0,3570.0,2790.0,2210.0,2240.0,2450.0,1620.0,2790.0,29170.0
East,16.1.5,Stock position of BCG vaccines,2. Stocks Received,,2000.0,,5000.0,,,0.0,1000.0,1000.0,0.0,2000.0,1000.0,12000.0
East,16.1.5,Stock position of BCG vaccines,3. Unusable Stock,,,,,,,0.0,0.0,0.0,0.0,0.0,0.0,0.0
East,16.1.5,Stock position of BCG vaccines,4. Stock Distributed,670.0,910.0,350.0,2690.0,670.0,780.0,580.0,970.0,790.0,830.0,830.0,1070.0,11140.0
East,16.1.5,Stock position of BCG vaccines,5. Total Stock,1190.0,2280.0,1930.0,4240.0,3570.0,2790.0,2210.0,2240.0,2450.0,1620.0,2790.0,2720.0,30030.0
East,16.1.6,Stock position of Measles vaccines,1. Balance From Previous Month,575.0,12120.0,9530.0,13140.0,8000.0,2000.0,1400.0,475.0,1700.0,1890.0,3300.0,2875.0,57005.0
East,16.1.6,Stock position of Measles vaccines,2. Stocks Received,32000.0,,19000.0,,,,0.0,2000.0,1000.0,4000.0,1000.0,1000.0,60000.0
East,16.1.6,Stock position of Measles vaccines,3. Unusable Stock,,,,,,,0.0,0.0,0.0,0.0,0.0,0.0,0.0
East,16.1.6,Stock position of Measles vaccines,4. Stock Distributed,20455.0,2590.0,15390.0,5140.0,6000.0,600.0,925.0,775.0,810.0,2590.0,1425.0,2065.0,58765.0
East,16.1.6,Stock position of Measles vaccines,5. Total Stock,12120.0,9530.0,13140.0,8000.0,2000.0,1400.0,475.0,1700.0,1890.0,3300.0,2875.0,1810.0,58240.0
East,16.1.7,Stock position of JE vaccines,1. Balance From Previous Month,,,,,,,,,,0.0,,0.0,0.0
East,16.1.7,Stock position of JE vaccines,2. Stocks Received,,,,,,,,,,0.0,,0.0,0.0
East,16.1.7,Stock position of JE vaccines,3. Unusable Stock,,,,,,,,,,0.0,,0.0,0.0
East,16.1.7,Stock position of JE vaccines,4. Stock Distributed,,,,,,,,,,0.0,,0.0,0.0
East,16.1.7,Stock position of JE vaccines,5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
East,16.1.8,Stock position of Hepatitis B vaccines,1. Balance From Previous Month,1970.0,1530.0,660.0,320.0,3780.0,3360.0,2940.0,2690.0,2020.0,1610.0,1420.0,1110.0,23410.0
East,16.1.8,Stock position of Hepatitis B vaccines,2. Stocks Received,,,,5000.0,,,0.0,0.0,0.0,0.0,0.0,0.0,5000.0
East,16.1.8,Stock position of Hepatitis B vaccines,3. Unusable Stock,,,,,,,0.0,0.0,0.0,0.0,0.0,0.0,0.0
East,16.1.8,Stock position of Hepatitis B vaccines,4. Stock Distributed,440.0,870.0,340.0,1540.0,420.0,420.0,250.0,670.0,410.0,190.0,310.0,300.0,6160.0
East,16.1.8,Stock position of Hepatitis B vaccines,5. Total Stock,1530.0,660.0,320.0,3780.0,3360.0,2940.0,2690.0,2020.0,1610.0,1420.0,1110.0,810.0,22250.0
East,16.2.1,Stock Position of IU 380 A (to be used for Family Planning),1. Balance From Previous Month,465.0,415.0,333.0,243.0,643.0,623.0,583.0,578.0,533.0,523.0,483.0,418.0,5840.0
East,16.2.1,Stock Position of IU 380 A (to be used for Family Planning),2. Stocks Received,0.0,0.0,0.0,1000.0,,,0.0,0.0,0.0,0.0,0.0,0.0,1000.0
East,16.2.1,Stock Position of IU 380 A (to be used for Family Planning),3. Unusable Stock,,,,,,,0.0,0.0,0.0,0.0,0.0,0.0,0.0
East,16.2.1,Stock Position of IU 380 A (to be used for Family Planning),4. Stock Distributed,0.0,82.0,90.0,600.0,20.0,40.0,5.0,45.0,10.0,40.0,65.0,0.0,997.0
East,16.2.1,Stock Position of IU 380 A (to be used for Family Planning),5. Total Stock,465.0,333.0,243.0,643.0,623.0,583.0,578.0,533.0,523.0,483.0,418.0,418.0,5843.0
East,16.2.2,Stock Position of Condoms (to be used for Family Planning),1. Balance From Previous Month,,12000.0,8500.0,4000.0,36500.0,32000.0,27000.0,22000.0,20500.0,17000.0,11500.0,8500.0,199500.0
East,16.2.2,Stock Position of Condoms (to be used for Family Planning),2. Stocks Received,18000.0,,,40000.0,,,0.0,0.0,0.0,0.0,0.0,6000.0,64000.0
East,16.2.2,Stock Position of Condoms (to be used for Family Planning),3. Unusable Stock,,,,,,,0.0,0.0,0.0,0.0,0.0,0.0,0.0
East,16.2.2,Stock Position of Condoms (to be used for Family Planning),4. Stock Distributed,6000.0,3500.0,4500.0,7500.0,4500.0,5000.0,5000.0,1500.0,3500.0,5500.0,3000.0,6100.0,55600.0
East,16.2.2,Stock Position of Condoms (to be used for Family Planning),5. Total Stock,12000.0,8500.0,4000.0,36500.0,32000.0,27000.0,22000.0,20500.0,17000.0,11500.0,8500.0,8400.0,207900.0
East,16.2.3,Stock Position of Oral Contraceptive (to be used for Family Planning),1. Balance From Previous Month,953.0,893.0,578.0,348.0,538.0,538.0,1428.0,1358.0,1338.0,1338.0,1328.0,1258.0,11896.0
East,16.2.3,Stock Position of Oral Contraceptive (to be used for Family Planning),2. Stocks Received,,,,500.0,,1000.0,0.0,0.0,0.0,0.0,0.0,0.0,1500.0
East,16.2.3,Stock Position of Oral Contraceptive (to be used for Family Planning),3. Unusable Stock,,,,,,,0.0,0.0,0.0,0.0,0.0,0.0,0.0
East,16.2.3,Stock Position of Oral Contraceptive (to be used for Family Planning),4. Stock Distributed,60.0,315.0,230.0,310.0,0.0,110.0,70.0,20.0,0.0,10.0,70.0,150.0,1345.0
East,16.2.3,Stock Position of Oral Contraceptive (to be used for Family Planning),5. Total Stock,893.0,578.0,348.0,538.0,538.0,1428.0,1358.0,1338.0,1338.0,1328.0,1258.0,1108.0,12051.0
East,16.2.4,Stock Position of Emergency Contraceptive (to be used for Family Planning),1. Balance From Previous Month,,,,,,,0.0,0.0,0.0,0.0,0.0,0.0,0.0
East,16.2.4,Stock Position of Emergency Contraceptive (to be used for Family Planning),2. Stocks Received,,,,,,,0.0,0.0,0.0,0.0,0.0,0.0,0.0
East,16.2.4,Stock Position of Emergency Contraceptive (to be used for Family Planning),3. Unusable Stock,,,,,,,0.0,0.0,0.0,0.0,0.0,0.0,0.0
East,16.2.4,Stock Position of Emergency Contraceptive (to be used for Family Planning),4. Stock Distributed,,,,,,,0.0,0.0,0.0,0.0,0.0,0.0,0.0
East,16.2.4,Stock Position of Emergency Contraceptive (to be used for Family Planning),5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
East,16.2.5,Stock Position of Tubal Rings (to be used for Family Planning),1. Balance From Previous Month,,,,,,,0.0,0.0,0.0,0.0,0.0,0.0,0.0
East,16.2.5,Stock Position of Tubal Rings (to be used for Family Planning),2. Stocks Received,,,,,,,0.0,0.0,0.0,0.0,0.0,0.0,0.0
East,16.2.5,Stock Position of Tubal Rings (to be used for Family Planning),3. Unusable Stock,,,,,,,0.0,0.0,0.0,0.0,0.0,0.0,0.0
East,16.2.5,Stock Position of Tubal Rings (to be used for Family Planning),4. Stock Distributed,,,,,,,0.0,0.0,0.0,0.0,0.0,0.0,0.0
East,16.2.5,Stock Position of Tubal Rings (to be used for Family Planning),5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
East,16.3.01,Stock Position of Oxytocin Injection,1. Balance From Previous Month,,,,,,,0.0,0.0,0.0,0.0,0.0,0.0,0.0
East,16.3.01,Stock Position of Oxytocin Injection,2. Stocks Received,,,,,,,0.0,0.0,0.0,0.0,0.0,0.0,0.0
East,16.3.01,Stock Position of Oxytocin Injection,3. Unusable Stock,,,,,,,0.0,0.0,0.0,0.0,0.0,0.0,0.0
East,16.3.01,Stock Position of Oxytocin Injection,4. Stock Distributed,,,,,,,0.0,0.0,0.0,0.0,0.0,0.0,0.0
East,16.3.01,Stock Position of Oxytocin Injection,5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
East,16.3.02,Stock Position of Gloves,1. Balance From Previous Month,,,,,,,0.0,0.0,0.0,0.0,0.0,0.0,0.0
East,16.3.02,Stock Position of Gloves,2. Stocks Received,,,,,,,0.0,0.0,0.0,0.0,0.0,0.0,0.0
East,16.3.02,Stock Position of Gloves,3. Unusable Stock,,,,,,,0.0,0.0,0.0,0.0,0.0,0.0,0.0
East,16.3.02,Stock Position of Gloves,4. Stock Distributed,,,,,,,0.0,0.0,0.0,0.0,0.0,0.0,0.0
East,16.3.02,Stock Position of Gloves,5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
East,16.3.03,Stock Position of MVA Syringes,1. Balance From Previous Month,,,,,,,0.0,0.0,0.0,0.0,0.0,0.0,0.0
East,16.3.03,Stock Position of MVA Syringes,2. Stocks Received,,,,,,,0.0,0.0,0.0,0.0,0.0,0.0,0.0
East,16.3.03,Stock Position of MVA Syringes,3. Unusable Stock,,,,,,,0.0,0.0,0.0,0.0,0.0,0.0,0.0
East,16.3.03,Stock Position of MVA Syringes,4. Stock Distributed,,,,,,,0.0,0.0,0.0,0.0,0.0,0.0,0.0
East,16.3.03,Stock Position of MVA Syringes,5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
East,16.3.04,Stock Position of Fluconazole Tablets,1. Balance From Previous Month,,,,,,,0.0,0.0,0.0,0.0,0.0,0.0,0.0
East,16.3.04,Stock Position of Fluconazole Tablets,2. Stocks Received,,,,,,,0.0,0.0,0.0,0.0,0.0,0.0,0.0
East,16.3.04,Stock Position of Fluconazole Tablets,3. Unusable Stock,,,,,,,0.0,0.0,0.0,0.0,0.0,0.0,0.0
East,16.3.04,Stock Position of Fluconazole Tablets,4. Stock Distributed,,,,,,,0.0,0.0,0.0,0.0,0.0,0.0,0.0
East,16.3.04,Stock Position of Fluconazole Tablets,5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
East,16.3.05,Stock Position of Blood Transfusion Sets,1. Balance From Previous Month,,,,,,,0.0,0.0,0.0,0.0,0.0,0.0,0.0
East,16.3.05,Stock Position of Blood Transfusion Sets,2. Stocks Received,,,,,,,0.0,0.0,0.0,0.0,0.0,0.0,0.0
East,16.3.05,Stock Position of Blood Transfusion Sets,3. Unusable Stock,,,,,,,0.0,0.0,0.0,0.0,0.0,0.0,0.0
East,16.3.05,Stock Position of Blood Transfusion Sets,4. Stock Distributed,,,,,,,0.0,0.0,0.0,0.0,0.0,0.0,0.0
East,16.3.05,Stock Position of Blood Transfusion Sets,5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
East,16.3.06,Stock Position of Gluteraldehyde solution of 2% concentration,1. Balance From Previous Month,,,,,,,0.0,0.0,0.0,0.0,0.0,0.0,0.0
East,16.3.06,Stock Position of Gluteraldehyde solution of 2% concentration,2. Stocks Received,,,,,,,0.0,0.0,0.0,0.0,0.0,0.0,0.0
East,16.3.06,Stock Position of Gluteraldehyde solution of 2% concentration,3. Unusable Stock,,,,,,,0.0,0.0,0.0,0.0,0.0,0.0,0.0
East,16.3.06,Stock Position of Gluteraldehyde solution of 2% concentration,4. Stock Distributed,,,,,,,0.0,0.0,0.0,0.0,0.0,0.0,0.0
East,16.3.06,Stock Position of Gluteraldehyde solution of 2% concentration,5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
East,16.3.07,Stock Position of IFA Tablets,1. Balance From Previous Month,,,,,,,0.0,0.0,0.0,0.0,0.0,0.0,0.0
East,16.3.07,Stock Position of IFA Tablets,2. Stocks Received,,,,,,,0.0,0.0,0.0,0.0,0.0,0.0,0.0
East,16.3.07,Stock Position of IFA Tablets,3. Unusable Stock,,,,,,,0.0,0.0,0.0,0.0,0.0,0.0,0.0
East,16.3.07,Stock Position of IFA Tablets,4. Stock Distributed,,,,,,,0.0,0.0,0.0,0.0,0.0,0.0,0.0
East,16.3.07,Stock Position of IFA Tablets,5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
East,16.3.08,Stock Position of IFA Syrup (Paediatric),1. Balance From Previous Month,,,,,,,0.0,0.0,0.0,0.0,0.0,0.0,0.0
East,16.3.08,Stock Position of IFA Syrup (Paediatric),2. Stocks Received,,,,,,,0.0,0.0,0.0,0.0,0.0,0.0,0.0
East,16.3.08,Stock Position of IFA Syrup (Paediatric),3. Unusable Stock,,,,,,,0.0,0.0,0.0,0.0,0.0,0.0,0.0
East,16.3.08,Stock Position of IFA Syrup (Paediatric),4. Stock Distributed,,,,,,,0.0,0.0,0.0,0.0,0.0,0.0,0.0
East,16.3.08,Stock Position of IFA Syrup (Paediatric),5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
East,16.3.09,Stock Position of Paediatrics Antibiotics (Cotrimaxozole and Injectable Gentamicin),1. Balance From Previous Month,,,,,,,0.0,0.0,0.0,0.0,0.0,0.0,0.0
East,16.3.09,Stock Position of Paediatrics Antibiotics (Cotrimaxozole and Injectable Gentamicin),2. Stocks Received,,,,,,,0.0,0.0,0.0,0.0,0.0,0.0,0.0
East,16.3.09,Stock Position of Paediatrics Antibiotics (Cotrimaxozole and Injectable Gentamicin),3. Unusable Stock,,,,,,,0.0,0.0,0.0,0.0,0.0,0.0,0.0
East,16.3.09,Stock Position of Paediatrics Antibiotics (Cotrimaxozole and Injectable Gentamicin),4. Stock Distributed,,,,,,,0.0,0.0,0.0,0.0,0.0,0.0,0.0
East,16.3.09,Stock Position of Paediatrics Antibiotics (Cotrimaxozole and Injectable Gentamicin),5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
East,16.3.10,Stock Position of Vitamin A solution,1. Balance From Previous Month,234.0,384.0,320.0,320.0,1089.0,1089.0,279.0,179.0,9.0,0.0,0.0,218.0,4121.0
East,16.3.10,Stock Position of Vitamin A solution,2. Stocks Received,300.0,,,1000.0,,,0.0,0.0,0.0,0.0,300.0,100.0,1700.0
East,16.3.10,Stock Position of Vitamin A solution,3. Unusable Stock,,,,,,,0.0,0.0,0.0,0.0,0.0,0.0,0.0
East,16.3.10,Stock Position of Vitamin A solution,4. Stock Distributed,150.0,64.0,,231.0,406.0,810.0,100.0,170.0,9.0,0.0,82.0,71.0,2093.0
East,16.3.10,Stock Position of Vitamin A solution,5. Total Stock,384.0,320.0,320.0,1089.0,683.0,279.0,179.0,9.0,0.0,0.0,218.0,247.0,3728.0
East,16.3.11,Stock of ORS (New WHO formulation),1. Balance From Previous Month,,,,,,,0.0,0.0,0.0,0.0,0.0,0.0,0.0
East,16.3.11,Stock of ORS (New WHO formulation),2. Stocks Received,,,,,,,0.0,0.0,0.0,0.0,0.0,0.0,0.0
East,16.3.11,Stock of ORS (New WHO formulation),3. Unusable Stock,,,,,,,0.0,0.0,0.0,0.0,0.0,0.0,0.0
East,16.3.11,Stock of ORS (New WHO formulation),4. Stock Distributed,,,,,,,0.0,0.0,0.0,0.0,0.0,0.0,0.0
East,16.3.11,Stock of ORS (New WHO formulation),5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
East,16.4.1,Stock Position of 0.1 ml Syringes(AD),1. Balance From Previous Month,820.0,1685.0,2515.0,2215.0,1755.0,1495.0,1015.0,965.0,715.0,665.0,465.0,3045.0,17355.0
East,16.4.1,Stock Position of 0.1 ml Syringes(AD),2. Stocks Received,865.0,1000.0,,,,,0.0,0.0,0.0,0.0,3000.0,0.0,4865.0
East,16.4.1,Stock Position of 0.1 ml Syringes(AD),3. Unusable Stock,,,,,,,0.0,0.0,0.0,0.0,0.0,0.0,0.0
East,16.4.1,Stock Position of 0.1 ml Syringes(AD),4. Stock Distributed,,170.0,300.0,460.0,260.0,480.0,50.0,250.0,50.0,200.0,420.0,320.0,2960.0
East,16.4.1,Stock Position of 0.1 ml Syringes(AD),5. Total Stock,1685.0,2515.0,2215.0,1755.0,1495.0,1015.0,965.0,715.0,665.0,465.0,3045.0,2725.0,19260.0
East,16.4.2,Stock Position of 0.5 ml Syringes(AD),1. Balance From Previous Month,2200.0,12400.0,18200.0,10600.0,14000.0,9200.0,7800.0,7600.0,7400.0,2000.0,0.0,8700.0,100100.0
East,16.4.2,Stock Position of 0.5 ml Syringes(AD),2. Stocks Received,24000.0,20000.0,26000.0,10000.0,,4000.0,6000.0,6000.0,0.0,4000.0,14400.0,7200.0,121600.0
East,16.4.2,Stock Position of 0.5 ml Syringes(AD),3. Unusable Stock,,,,,,,0.0,0.0,0.0,0.0,0.0,0.0,0.0
East,16.4.2,Stock Position of 0.5 ml Syringes(AD),4. Stock Distributed,13800.0,14200.0,33600.0,6600.0,4800.0,5400.0,6200.0,6200.0,5400.0,6000.0,5700.0,11400.0,119300.0
East,16.4.2,Stock Position of 0.5 ml Syringes(AD),5. Total Stock,12400.0,18200.0,10600.0,14000.0,9200.0,7800.0,7600.0,7400.0,2000.0,0.0,8700.0,4500.0,102400.0
East,16.4.3,Stock Position of 5.0 ml Syringes(Disposable),1. Balance From Previous Month,,,,,,,0.0,,0.0,0.0,0.0,,0.0
East,16.4.3,Stock Position of 5.0 ml Syringes(Disposable),2. Stocks Received,,,,,,,0.0,,0.0,0.0,0.0,,0.0
East,16.4.3,Stock Position of 5.0 ml Syringes(Disposable),3. Unusable Stock,,,,,,,0.0,,0.0,0.0,0.0,,0.0
East,16.4.3,Stock Position of 5.0 ml Syringes(Disposable),4. Stock Distributed,,,,,,,0.0,,0.0,0.0,0.0,,0.0
East,16.4.3,Stock Position of 5.0 ml Syringes(Disposable),5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
East,17.1,Number of cases of Infant deaths within 24 hrs of birth,TOTAL,,,,,,,,,,,,,
East,17.2.1,Number of cases of Infant deaths 24 hours to 4 weeks of birth with the probable cause being Sepsis,1. Up to 1 Weeks of Birth,2.0,,3.0,1.0,2.0,1.0,7.0,1.0,10.0,8.0,4.0,2.0,41.0
East,17.2.1,Number of cases of Infant deaths 24 hours to 4 weeks of birth with the probable cause being Sepsis,2. Between 1 week & 4 weeks of birth,,,3.0,3.0,1.0,,1.0,,,,,2.0,10.0
East,17.2.1,Number of cases of Infant deaths 24 hours to 4 weeks of birth with the probable cause being Sepsis,3. Total,2.0,,6.0,4.0,3.0,1.0,8.0,1.0,10.0,8.0,4.0,4.0,51.0
East,17.2.2,Number of cases of Infant deaths 24 hours to 4 weeks of birth with the probable cause being Asphyxia,1. Up to 1 Weeks of Birth,3.0,2.0,5.0,4.0,6.0,1.0,8.0,3.0,4.0,3.0,1.0,4.0,44.0
East,17.2.2,Number of cases of Infant deaths 24 hours to 4 weeks of birth with the probable cause being Asphyxia,2. Between 1 week & 4 weeks of birth,,,,,,,,,,,,,
East,17.2.2,Number of cases of Infant deaths 24 hours to 4 weeks of birth with the probable cause being Asphyxia,3. Total,3.0,2.0,5.0,4.0,6.0,1.0,8.0,3.0,4.0,3.0,1.0,4.0,44.0
East,17.2.3,Number of cases of Infant deaths 24 hours to 4 weeks of birth with the probable cause being LBW,1. Up to 1 Weeks of Birth,,,,,,,,1.0,,,,,1.0
East,17.2.3,Number of cases of Infant deaths 24 hours to 4 weeks of birth with the probable cause being LBW,2. Between 1 week & 4 weeks of birth,,,,,,,,,,,,,
East,17.2.3,Number of cases of Infant deaths 24 hours to 4 weeks of birth with the probable cause being LBW,3. Total,,,,,,,,1.0,,,,,1.0
East,17.2.4,"Number of cases of Infant deaths 24 hours to 4 weeks of birth with the probable cause being other than Sepsis, Asphyxia and LBW",1. Up to 1 Weeks of Birth,2.0,1.0,,2.0,3.0,6.0,8.0,1.0,9.0,8.0,9.0,6.0,55.0
East,17.2.4,"Number of cases of Infant deaths 24 hours to 4 weeks of birth with the probable cause being other than Sepsis, Asphyxia and LBW",2. Between 1 week & 4 weeks of birth,1.0,,1.0,1.0,2.0,3.0,2.0,,,,,3.0,13.0
East,17.2.4,"Number of cases of Infant deaths 24 hours to 4 weeks of birth with the probable cause being other than Sepsis, Asphyxia and LBW",3. Total,3.0,1.0,1.0,3.0,5.0,9.0,10.0,1.0,9.0,8.0,9.0,9.0,68.0
East,17.3.1,Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being Pneumonia,1. Between 1 month and 11 months,12.0,,3.0,4.0,6.0,9.0,7.0,,2.0,8.0,6.0,12.0,69.0
East,17.3.1,Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being Pneumonia,2. Between 1 year & 5 years,3.0,,,1.0,6.0,1.0,1.0,,2.0,1.0,5.0,1.0,21.0
East,17.3.1,Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being Pneumonia,3. Total,15.0,,3.0,5.0,12.0,10.0,8.0,,4.0,9.0,11.0,13.0,90.0
East,17.3.2,Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being Diarrhoea,1. Between 1 month and 11 months,,,,,,,,,,,,,
East,17.3.2,Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being Diarrhoea,2. Between 1 year & 5 years,,,,,,,,,,,,,
East,17.3.2,Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being Diarrhoea,3. Total,,,,,,,,,,,,,
East,17.3.3,Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being Fever related,1. Between 1 month and 11 months,,,,,,,,,,,,,
East,17.3.3,Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being Fever related,2. Between 1 year & 5 years,,,,,,,,,,,,,
East,17.3.3,Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being Fever related,3. Total,,,,,,,,,,,,,
East,17.3.4,Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being Measles,1. Between 1 month and 11 months,,,,,,,,,,,,,
East,17.3.4,Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being Measles,2. Between 1 year & 5 years,,,,,,,,,,,,,
East,17.3.4,Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being Measles,3. Total,,,,,,,,,,,,,
East,17.3.5,"Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being other than Pneumonia, Diarrhoea, Fever related and Measles",1. Between 1 month and 11 months,5.0,1.0,17.0,6.0,15.0,12.0,14.0,,10.0,5.0,6.0,10.0,101.0
East,17.3.5,"Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being other than Pneumonia, Diarrhoea, Fever related and Measles",2. Between 1 year & 5 years,1.0,,6.0,2.0,3.0,5.0,4.0,,1.0,1.0,4.0,4.0,31.0
East,17.3.5,"Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being other than Pneumonia, Diarrhoea, Fever related and Measles",3. Total,6.0,1.0,23.0,8.0,18.0,17.0,18.0,,11.0,6.0,10.0,14.0,132.0
East,17.4.1,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Diarrhoeal diseases,1. 6-14 yrs,,,,,,,1.0,,,,,,1.0
East,17.4.1,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Diarrhoeal diseases,2. 15-55 yrs.,,1.0,1.0,,1.0,,,,,,,,3.0
East,17.4.1,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Diarrhoeal diseases,3. Above 55 yrs.,,1.0,,,2.0,,,,,,,,3.0
East,17.4.1,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Diarrhoeal diseases,4. Total,,2.0,1.0,,3.0,,1.0,,,,,,7.0
East,17.4.2,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Tuberculosis,1. 6-14 yrs,,,,,,,,,,,,,
East,17.4.2,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Tuberculosis,2. 15-55 yrs.,1.0,1.0,2.0,1.0,,1.0,,,,,,1.0,7.0
East,17.4.2,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Tuberculosis,3. Above 55 yrs.,1.0,,2.0,1.0,2.0,4.0,1.0,,,,,1.0,12.0
East,17.4.2,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Tuberculosis,4. Total,2.0,1.0,4.0,2.0,2.0,5.0,1.0,,,,,2.0,19.0
East,17.4.3,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Respiratory diseases including infections,1. 6-14 yrs,1.0,,1.0,2.0,,,,,,1.0,,,5.0
East,17.4.3,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Respiratory diseases including infections,2. 15-55 yrs.,2.0,3.0,6.0,2.0,3.0,5.0,1.0,2.0,3.0,2.0,1.0,1.0,31.0
East,17.4.3,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Respiratory diseases including infections,3. Above 55 yrs.,11.0,5.0,5.0,11.0,9.0,4.0,3.0,4.0,9.0,1.0,7.0,13.0,82.0
East,17.4.3,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Respiratory diseases including infections,4. Total,14.0,8.0,12.0,15.0,12.0,9.0,4.0,6.0,12.0,4.0,8.0,14.0,118.0
East,17.4.4,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Malaria,1. 6-14 yrs,,,,,,,,,,,,,
East,17.4.4,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Malaria,2. 15-55 yrs.,,,,,,1.0,,,,,,,1.0
East,17.4.4,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Malaria,3. Above 55 yrs.,,,,,,,,,,,,,
East,17.4.4,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Malaria,4. Total,,,,,,1.0,,,,,,,1.0
East,17.4.5,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being other Fever related,1. 6-14 yrs,,,,,,,,,,,,,
East,17.4.5,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being other Fever related,2. 15-55 yrs.,,,1.0,1.0,,,2.0,1.0,,,,,5.0
East,17.4.5,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being other Fever related,3. Above 55 yrs.,,1.0,1.0,,,2.0,,2.0,1.0,,,3.0,10.0
East,17.4.5,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being other Fever related,4. Total,,1.0,2.0,1.0,,2.0,2.0,3.0,1.0,,,3.0,15.0
East,17.4.6,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being HIV/AIDS,1. 6-14 yrs,,,,,,,,,,,,,
East,17.4.6,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being HIV/AIDS,2. 15-55 yrs.,,,,,,,,,,,,,
East,17.4.6,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being HIV/AIDS,3. Above 55 yrs.,,,,,,,,,,,,,
East,17.4.6,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being HIV/AIDS,4. Total,,,,,,,,,,,,,
East,17.4.7,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Heart disease or related to Hypertension,1. 6-14 yrs,,,,,,,,,,,,,
East,17.4.7,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Heart disease or related to Hypertension,2. 15-55 yrs.,9.0,6.0,2.0,5.0,8.0,10.0,12.0,7.0,4.0,5.0,6.0,2.0,76.0
East,17.4.7,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Heart disease or related to Hypertension,3. Above 55 yrs.,17.0,14.0,13.0,7.0,18.0,10.0,15.0,15.0,13.0,3.0,15.0,8.0,148.0
East,17.4.7,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Heart disease or related to Hypertension,4. Total,26.0,20.0,15.0,12.0,26.0,20.0,27.0,22.0,17.0,8.0,21.0,10.0,224.0
East,17.4.8,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Neurological disease including strokes,1. 6-14 yrs,,,,,,,,,,,,,
East,17.4.8,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Neurological disease including strokes,2. 15-55 yrs.,1.0,3.0,1.0,1.0,3.0,4.0,1.0,2.0,4.0,,,5.0,25.0
East,17.4.8,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Neurological disease including strokes,3. Above 55 yrs.,5.0,2.0,4.0,3.0,1.0,1.0,2.0,1.0,3.0,,2.0,3.0,27.0
East,17.4.8,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Neurological disease including strokes,4. Total,6.0,5.0,5.0,4.0,4.0,5.0,3.0,3.0,7.0,,2.0,8.0,52.0
East,17.4.9(a),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Abortion,1. 6-14 yrs,,,,,,,,,,,,,
East,17.4.9(a),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Abortion,2. 15-49 yrs,,,,,,,,,,,,,
East,17.4.9(a),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Abortion,3. Above 49 yrs.,,,,,,,,,,,,,
East,17.4.9(a),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Abortion,4. Total,,,,,,,,,,,,,
East,17.4.9(b),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Obstructed or prolonged labour,1. 6-14 yrs,,,,,,,,,,,,,
East,17.4.9(b),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Obstructed or prolonged labour,2. 15-49 yrs,,,,,,,,,,,,,
East,17.4.9(b),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Obstructed or prolonged labour,3. Above 49 yrs.,,,,,,,,,,,,,
East,17.4.9(b),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Obstructed or prolonged labour,4. Total,,,,,,,,,,,,,
East,17.4.9(c),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Severe hypertesnion or fits,1. 6-14 yrs,,,,,,,,,,,,,
East,17.4.9(c),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Severe hypertesnion or fits,2. 15-49 yrs,,,,,,,,,,,,,
East,17.4.9(c),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Severe hypertesnion or fits,3. Above 49 yrs.,,,,,,,,,,,,,
East,17.4.9(c),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Severe hypertesnion or fits,4. Total,,,,,,,,,,,,,
East,17.4.9(d),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Bleeding,1. 6-14 yrs,,,,,,,,,,,,,
East,17.4.9(d),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Bleeding,2. 15-49 yrs,,,,1.0,,,,,,,,,1.0
East,17.4.9(d),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Bleeding,3. Above 49 yrs.,,,,,,,,,,,,,
East,17.4.9(d),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Bleeding,4. Total,,,,1.0,,,,,,,,,1.0
East,17.4.9(e),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being High Fever,1. 6-14 yrs,,,,,,,,,,,,,
East,17.4.9(e),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being High Fever,2. 15-49 yrs,,,,,,,,,,,,,
East,17.4.9(e),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being High Fever,3. Above 49 yrs.,,,,,,,,,,,,,
East,17.4.9(e),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being High Fever,4. Total,,,,,,,,,,,,,
East,17.4.9(f),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being other causes (excluding abortion; obstructed or prolonged labour; severe hypertension or fits;,1. 6-14 yrs,,,,,,,,,,,,,
East,17.4.9(f),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being other causes (excluding abortion; obstructed or prolonged labour; severe hypertension or fits;,2. 15-49 yrs,,1.0,,,1.0,,2.0,,,,,,4.0
East,17.4.9(f),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being other causes (excluding abortion; obstructed or prolonged labour; severe hypertension or fits;,3. Above 49 yrs.,,,,,,,,,,,,,
East,17.4.9(f),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being other causes (excluding abortion; obstructed or prolonged labour; severe hypertension or fits;,4. Total,,1.0,,,1.0,,2.0,,,,,,4.0
East,17.4.10,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Trauma or Accidents or Burn cases,1. 6-14 yrs,,,,,,,,,,,,,
East,17.4.10,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Trauma or Accidents or Burn cases,2. 15-55 yrs.,2.0,1.0,5.0,5.0,5.0,6.0,3.0,7.0,2.0,1.0,1.0,1.0,39.0
East,17.4.10,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Trauma or Accidents or Burn cases,3. Above 55 yrs.,,1.0,2.0,,3.0,,,2.0,,,,,8.0
East,17.4.10,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Trauma or Accidents or Burn cases,4. Total,2.0,2.0,7.0,5.0,8.0,6.0,3.0,9.0,2.0,1.0,1.0,1.0,47.0
East,17.4.11,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being suicide,1. 6-14 yrs,,1.0,,,,,,,,,,,1.0
East,17.4.11,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being suicide,2. 15-55 yrs.,,,1.0,,,,1.0,,,,,,2.0
East,17.4.11,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being suicide,3. Above 55 yrs.,,,,,,,,,,,,,
East,17.4.11,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being suicide,4. Total,,1.0,1.0,,,,1.0,,,,,,3.0
East,17.4.12,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Animal bites and stings,1. 6-14 yrs,,,,,,,,,,,,,
East,17.4.12,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Animal bites and stings,2. 15-55 yrs.,,,,,,,,,,,,,
East,17.4.12,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Animal bites and stings,3. Above 55 yrs.,,,,,,,,,,,,,
East,17.4.12,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Animal bites and stings,4. Total,,,,,,,,,,,,,
East,17.4.13(a),Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Known Acute disease,1. 6-14 yrs,6.0,,3.0,11.0,4.0,5.0,5.0,,1.0,6.0,3.0,2.0,46.0
East,17.4.13(a),Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Known Acute disease,2. 15-55 yrs.,2.0,2.0,2.0,,1.0,1.0,1.0,1.0,,,2.0,1.0,13.0
East,17.4.13(a),Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Known Acute disease,3. Above 55 yrs.,,4.0,,1.0,1.0,2.0,1.0,2.0,,,1.0,,12.0
East,17.4.13(a),Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Known Acute disease,4. Total,8.0,6.0,5.0,12.0,6.0,8.0,7.0,3.0,1.0,6.0,6.0,3.0,71.0
East,17.4.13(b),Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Known Chronic disease,1. 6-14 yrs,2.0,,,1.0,,,,,1.0,,1.0,2.0,7.0
East,17.4.13(b),Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Known Chronic disease,2. 15-55 yrs.,10.0,11.0,8.0,16.0,8.0,12.0,15.0,3.0,7.0,3.0,5.0,4.0,102.0
East,17.4.13(b),Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Known Chronic disease,3. Above 55 yrs.,18.0,20.0,12.0,23.0,24.0,18.0,15.0,17.0,13.0,1.0,12.0,14.0,187.0
East,17.4.13(b),Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Known Chronic disease,4. Total,30.0,31.0,20.0,40.0,32.0,30.0,30.0,20.0,21.0,4.0,18.0,20.0,296.0
East,17.4.13(c),Number of cases of Adolescent or Adult deaths (age 6 years & above) where the cause was not known,1. 6-14 yrs,1.0,1.0,1.0,,1.0,,1.0,,,,,,5.0
East,17.4.13(c),Number of cases of Adolescent or Adult deaths (age 6 years & above) where the cause was not known,2. 15-55 yrs.,29.0,49.0,44.0,34.0,53.0,34.0,23.0,22.0,20.0,35.0,8.0,2.0,353.0
East,17.4.13(c),Number of cases of Adolescent or Adult deaths (age 6 years & above) where the cause was not known,3. Above 55 yrs.,20.0,18.0,13.0,21.0,19.0,14.0,1.0,23.0,2.0,19.0,15.0,1.0,166.0
East,17.4.13(c),Number of cases of Adolescent or Adult deaths (age 6 years & above) where the cause was not known,4. Total,50.0,68.0,58.0,55.0,73.0,48.0,25.0,45.0,22.0,54.0,23.0,3.0,524.0
New Delhi,1.1,Total number of pregnant women Registered for ANC,TOTAL,6302.0,5603.0,6136.0,7269.0,6562.0,6837.0,5332.0,4275.0,7480.0,8050.0,8102.0,7149.0,79097.0
New Delhi,1.1.1,Of which Number registered within first trimester (within 12 weeks),TOTAL,1343.0,1112.0,1430.0,1779.0,1473.0,1814.0,1417.0,1365.0,1616.0,1853.0,2020.0,1718.0,18940.0
New Delhi,1.2,Number of Pregnant women registered under JSY,TOTAL,133.0,215.0,141.0,188.0,129.0,216.0,209.0,163.0,195.0,181.0,215.0,210.0,2195.0
New Delhi,1.3,Number of pregnant women received 3 ANC check ups during pregnancy,TOTAL,3866.0,3078.0,4193.0,4631.0,4233.0,5623.0,4452.0,2704.0,5893.0,5485.0,5719.0,4531.0,54408.0
New Delhi,1.4.1,Number of pregnant women given TT1 during current pregnancy,TOTAL,1817.0,1992.0,1946.0,2085.0,1967.0,2072.0,1719.0,1716.0,1547.0,1744.0,1884.0,2211.0,22700.0
New Delhi,1.4.2,Number of pregnant women given TT2 or Booster during current pregnancy,TOTAL,1731.0,1878.0,1847.0,1978.0,1859.0,1920.0,1786.0,1587.0,1587.0,1721.0,1636.0,1977.0,21507.0
New Delhi,1.5,Total number of pregnant women given 100 IFA tablets,TOTAL,3718.0,2909.0,3639.0,3336.0,3925.0,4089.0,3461.0,1886.0,3681.0,4444.0,1627.0,4356.0,41071.0
New Delhi,1.6.1,Number of new cases of Hypertension (BP>140/90) detected in Pregnant women at the institution,TOTAL,159.0,109.0,242.0,342.0,395.0,158.0,164.0,223.0,263.0,82.0,292.0,251.0,2680.0
New Delhi,1.6.2,Number of Eclampsia cases managed during delivery,TOTAL,21.0,21.0,52.0,25.0,53.0,19.0,21.0,21.0,23.0,12.0,35.0,18.0,321.0
New Delhi,1.7.1,Number of Pregnant women with anaemia i.e. Hb level<11 (tested cases),TOTAL,3267.0,3696.0,3633.0,2993.0,3756.0,4288.0,3009.0,2272.0,2973.0,3108.0,2895.0,3094.0,38984.0
New Delhi,1.7.2,Number of Pregnant women having severe anaemia (Hb<7) treated at institution,TOTAL,92.0,138.0,169.0,129.0,176.0,167.0,130.0,138.0,99.0,141.0,98.0,160.0,1637.0
New Delhi,1.8,Number of pregnancy test kits used at SC level,TOTAL,6.0,0.0,0.0,0.0,10.0,2.0,0.0,35.0,60.0,0.0,24.0,0.0,137.0
New Delhi,2.1.1.a,Number of deliveries conducted at Home and attended by trained SBA(i.e. Doctor or Nurse or ANM),TOTAL,2.0,0.0,0.0,0.0,0.0,0.0,0.0,4.0,0.0,2.0,3.0,2.0,13.0
New Delhi,2.1.1.b,Number of deliveries conducted at Home and attended by non trained SBA (i.e. trained TBA or Relatives etc.),TOTAL,25.0,32.0,35.0,31.0,41.0,45.0,37.0,35.0,54.0,47.0,40.0,28.0,450.0
New Delhi,2.1.1.c,Total number of deliveries conducted at Home and attended by trained or non-trained SBA (i.e. sum of 2.1.1.a and 2.1.1.b),TOTAL,27.0,32.0,35.0,31.0,41.0,45.0,37.0,39.0,54.0,49.0,43.0,30.0,463.0
New Delhi,2.1.2,Number of newborns visited within 24 hours of delivery for deliveries conducted at home,TOTAL,23.0,20.0,12.0,14.0,27.0,43.0,22.0,31.0,46.0,26.0,30.0,27.0,321.0
New Delhi,2.1.3,Number of mothers paid JSY incentive for deliveries conducted at home,TOTAL,0.0,0.0,0.0,0.0,0.0,3.0,0.0,5.0,2.0,0.0,0.0,7.0,17.0
New Delhi,2.2,Deliveries conducted at Public Institutions (Including C-Sections),TOTAL,2707.0,2953.0,2986.0,3583.0,4267.0,4177.0,4036.0,3745.0,3722.0,3685.0,3278.0,3110.0,42249.0
New Delhi,2.2.1,"Out of 2.2, Number discharged under 48 hours of delivery",TOTAL,1478.0,1519.0,1664.0,2774.0,3371.0,3270.0,3089.0,2898.0,2727.0,2713.0,2293.0,2175.0,29971.0
New Delhi,2.2.2.a,Number of mothers paid JSY Incentive for deliveries conducted at Public Institutions,TOTAL,42.0,66.0,46.0,67.0,56.0,84.0,101.0,68.0,117.0,80.0,155.0,116.0,998.0
New Delhi,2.2.2.b,Number of ASHAs paid JSY Incentive for deliveries conducted at Public Institutions,TOTAL,31.0,28.0,33.0,34.0,29.0,38.0,42.0,59.0,40.0,65.0,39.0,73.0,511.0
New Delhi,2.2.2.c,Number of cases of deliveries conducted at Public Institutions where JSY incentive was paid to ANMs or AWWs [only for High Performing States (HPS)],TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
New Delhi,2.3,Deliveries conducted at Private Institutions (Including C-Sections),TOTAL,10.0,2.0,7.0,17.0,16.0,19.0,17.0,23.0,15.0,24.0,11.0,10.0,171.0
New Delhi,2.3.1.a,Number of mothers paid JSY Incentive for deliveries conducted at accredited Private Institutions,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
New Delhi,2.3.1.b,Number of ASHAs paid JSY Incentive for deliveries conducted at accredited Private Institutions,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
New Delhi,2.3.1.c,Number of cases of deliveries conducted at accredited Private Institutions where JSY incentive was paid to ANMs or AWWs [only for High Performing States (HPS)],TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
New Delhi,3.1.1,Number of Caesarean (C-Section) deliveries performed at PHCs (Primary Health Centre),TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
New Delhi,3.1.2,Number of Caesarean (C-Section) deliveries performed at CHCs (Community Health Centre),TOTAL,0.0,,,,,3.0,5.0,1.0,0.0,0.0,5.0,5.0,19.0
New Delhi,3.1.3,Number of Caesarean (C-Section) deliveries performed at SDHs (Sub-divisional Hospital) or DHs (District Hospital),TOTAL,674.0,643.0,641.0,778.0,811.0,830.0,893.0,728.0,856.0,926.0,749.0,780.0,9309.0
New Delhi,3.1.4,Number of Caesarean (C-Section) deliveries performed at other State owned public institutions,TOTAL,,,,,,,,,,,,,
New Delhi,3.1.5,"Total Number of Caesarean (C-Section) deliveries performed at Public facilities i.e. PHC, CHC, SDH, DH and other State owned public institutions (sum of items from 3.1.1 to 3.1.4)",TOTAL,674.0,643.0,641.0,778.0,811.0,833.0,898.0,729.0,856.0,926.0,754.0,785.0,9328.0
New Delhi,3.2,No. of C-section deliveries performed at Private facilities,TOTAL,4.0,2.0,4.0,9.0,7.0,10.0,9.0,12.0,8.0,13.0,4.0,7.0,89.0
New Delhi,4.1.1.a,Number of male live births,TOTAL,1426.0,1569.0,1615.0,1883.0,2274.0,2211.0,2101.0,1926.0,1941.0,1929.0,1711.0,1620.0,22206.0
New Delhi,4.1.1.b,Number of female live births,TOTAL,1303.0,1379.0,1361.0,1683.0,1974.0,1996.0,1939.0,1831.0,1781.0,1755.0,1547.0,1494.0,20043.0
New Delhi,4.1.1.c,Total number of male and female live births (4.1.1.a and 4.1.1.b),TOTAL,2729.0,2948.0,2976.0,3566.0,4248.0,4207.0,4040.0,3757.0,3722.0,3684.0,3258.0,3114.0,42249.0
New Delhi,4.1.2,Number of still births,TOTAL,77.0,77.0,86.0,108.0,125.0,106.0,89.0,78.0,102.0,95.0,89.0,88.0,1120.0
New Delhi,4.1.3,Number of Abortions (spontaneous or induced),TOTAL,326.0,243.0,236.0,284.0,265.0,278.0,185.0,200.0,209.0,273.0,310.0,323.0,3132.0
New Delhi,4.2.1,Number of Newborns weighed at birth,TOTAL,2708.0,2929.0,2951.0,3545.0,4222.0,4183.0,4015.0,3727.0,3686.0,3642.0,3235.0,3083.0,41926.0
New Delhi,4.2.2,Number of Newborns having weight less than 2.5 kg,TOTAL,509.0,594.0,584.0,497.0,580.0,745.0,712.0,805.0,542.0,674.0,498.0,629.0,7369.0
New Delhi,4.3,Number of Newborns breast fed within 1 hour of birth,TOTAL,2055.0,2401.0,2457.0,2548.0,3186.0,3442.0,3508.0,3117.0,3033.0,3046.0,2705.0,2439.0,33937.0
New Delhi,5.1.1,Number of cases of pregnant women with Obstetric Complications and attended at PHCs,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
New Delhi,5.1.2,Number of cases of pregnant women with Obstetric Complications and attended at CHCs,TOTAL,16.0,9.0,18.0,23.0,18.0,23.0,12.0,12.0,6.0,4.0,,1.0,142.0
New Delhi,5.1.3,Number of cases of pregnant women with Obstetric Complications and attended at SDHs or DHs,TOTAL,1399.0,1879.0,1949.0,1772.0,2282.0,1578.0,2112.0,1462.0,1833.0,770.0,955.0,794.0,18785.0
New Delhi,5.1.4,Number of cases of pregnant women with Obstetric Complications and attended at other State owned public institutions,TOTAL,,,,,,,,,,,,,
New Delhi,5.1.5,"Number of cases of pregnant women with Obstetric Complications and attended at Public facilities i.e. PHC, CHC, SDH, DH and other State owned public institutions (sum of items from 5.1.1 to 5.1.4)",TOTAL,1415.0,1888.0,1967.0,1795.0,2300.0,1601.0,2124.0,1474.0,1839.0,774.0,955.0,795.0,18927.0
New Delhi,5.2,Number of cases of pregnant women with Obstetric Complications and attended at Private facilities,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
New Delhi,5.3.1,Number of cases of complicated pregnancies treated with IV antibiotics,TOTAL,1071.0,1694.0,1550.0,1652.0,2119.0,1522.0,2070.0,1450.0,1502.0,662.0,920.0,765.0,16977.0
New Delhi,5.3.2,Number of cases of complicated pregnancies treated with IV Antihypertensive/Magsulph injection,TOTAL,49.0,55.0,179.0,397.0,93.0,76.0,100.0,100.0,178.0,208.0,117.0,138.0,1690.0
New Delhi,5.3.3,Number of cases of complicated pregnancies treated with IV Oxytocis,TOTAL,568.0,265.0,462.0,669.0,727.0,639.0,840.0,555.0,692.0,292.0,168.0,643.0,6520.0
New Delhi,5.3.4,Number of cases of complicated pregnancies treated with Blood Transfusion,TOTAL,154.0,194.0,475.0,215.0,258.0,254.0,200.0,165.0,236.0,146.0,144.0,222.0,2663.0
New Delhi,6.1,Women getting post partum check-up within 48 hours after delivery,TOTAL,2687.0,2897.0,2934.0,3514.0,4224.0,4154.0,4019.0,3649.0,3706.0,3746.0,3251.0,3079.0,41860.0
New Delhi,6.2,Women getting a post partum check up between 48 hours and 14 days after delivery,TOTAL,1209.0,967.0,1014.0,1032.0,1004.0,1107.0,854.0,915.0,1250.0,1227.0,1025.0,1443.0,13047.0
New Delhi,6.3,PNC maternal complications attended,TOTAL,44.0,40.0,46.0,98.0,107.0,99.0,89.0,57.0,60.0,62.0,54.0,61.0,817.0
New Delhi,7.1.1,Number of MTPs conducted at Public Institutions up to 12 weeks of pregnancy,TOTAL,134.0,110.0,105.0,120.0,107.0,111.0,92.0,92.0,98.0,134.0,142.0,109.0,1354.0
New Delhi,7.1.2,Number of MTPs conducted at Public Institutions for more than 12 weeks of pregnancy,TOTAL,21.0,9.0,10.0,13.0,15.0,14.0,9.0,15.0,11.0,10.0,13.0,21.0,161.0
New Delhi,7.1.3,Total number of MTPs conducted at Public Institutions (sum of items 7.1.1 and 7.1.2),TOTAL,155.0,119.0,115.0,133.0,122.0,125.0,101.0,107.0,109.0,144.0,155.0,130.0,1515.0
New Delhi,7.2,Number of MTPs conducted at Private Facilities,TOTAL,7.0,1.0,6.0,8.0,2.0,13.0,2.0,5.0,4.0,8.0,3.0,4.0,63.0
New Delhi,8.1.a,Number of new cases of RTI/STI in males for which treatment was initiated,TOTAL,499.0,446.0,539.0,565.0,475.0,408.0,346.0,578.0,766.0,860.0,382.0,542.0,6406.0
New Delhi,8.1.b,Number of new cases of RTI/STI in females for which treatment was initiated,TOTAL,1134.0,1156.0,1310.0,1537.0,1461.0,1420.0,1366.0,1636.0,1553.0,1689.0,1391.0,1457.0,17110.0
New Delhi,8.1.c,Total number of new cases of RTI/STI in males and females for which treatment was initiated (sum of items 8.1.a and 8.1.b),TOTAL,1633.0,1602.0,1849.0,2102.0,1936.0,1828.0,1712.0,2214.0,2319.0,2549.0,1773.0,1999.0,23516.0
New Delhi,8.2,Number of suspected RTI/STI cases for whom wet mount test was conducted,TOTAL,27.0,32.0,0.0,8.0,6.0,5.0,2.0,0.0,0.0,0.0,0.0,0.0,80.0
New Delhi,9.1.1.a,Number of NSV (No Scalpel Vasectomy) or Conventional Vasectomy conducted at PHCs,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
New Delhi,9.1.1.b,Number of NSV or Conventional Vasectomy conducted at CHCs,TOTAL,,,,,,,,0.0,0.0,0.0,,,0.0
New Delhi,9.1.1.c,Number of NSV or Conventional Vasectomy conducted at SDHs or DHs,TOTAL,7.0,2.0,14.0,5.0,6.0,21.0,9.0,4.0,7.0,10.0,9.0,4.0,98.0
New Delhi,9.1.1.d,Number of NSV or Conventional Vasectomy conducted at other State owned public institutions,TOTAL,,,,,,,,,,,,,
New Delhi,9.1.1.e,"Total Number of NSV or Conventional Vasectomy conducted at Public facilities i.e. PHC, CHC, SDH, DH and other State owned public institutions (sum of items from 9.1.1.a to 9.1.1.d)",TOTAL,7.0,2.0,14.0,5.0,6.0,21.0,9.0,4.0,7.0,10.0,9.0,4.0,98.0
New Delhi,9.1.2,Number of NSV or Conventional Vasectomy conducted at Private facilities,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
New Delhi,9.2.1.a,Number of Laparoscopic sterilizations conducted at PHCs,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
New Delhi,9.2.1.b,Number of Laparoscopic sterilizations conducted at CHCs,TOTAL,,,,,,,,1.0,1.0,1.0,3.0,1.0,7.0
New Delhi,9.2.1.c,Number of Laparoscopic sterilizations conducted at SDHs or DHs,TOTAL,139.0,124.0,107.0,73.0,74.0,85.0,79.0,123.0,124.0,135.0,133.0,103.0,1299.0
New Delhi,9.2.1.d,Number of Laparoscopic sterilizations conducted at other State owned public institutions,TOTAL,,,,,,,,,,,,,
New Delhi,9.2.1.e,"Total Number of Laparoscopic sterilizations conducted at Public facilities i.e. PHC, CHC, SDH, DH and other State owned public institutions (sum of items from 9.2.1.a to 9.2.1.d)",TOTAL,139.0,124.0,107.0,73.0,74.0,85.0,79.0,124.0,125.0,136.0,136.0,104.0,1306.0
New Delhi,9.2.2,Number of Laparoscopic sterilizations conducted at Private facilities,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
New Delhi,9.3.1.a,Number of Mini-lap sterilizations conducted at PHCs,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
New Delhi,9.3.1.b,Number of Mini-lap sterilizations conducted at CHCs,TOTAL,,,,,,,,,0.0,0.0,,,0.0
New Delhi,9.3.1.c,Number of Mini-lap sterilizations conducted at SDHs or DHs,TOTAL,13.0,115.0,10.0,82.0,108.0,60.0,71.0,76.0,85.0,78.0,69.0,63.0,830.0
New Delhi,9.3.1.d,Number of Mini-lap sterilizations conducted at other State owned public institutions,TOTAL,,,,,,,,,,,,,
New Delhi,9.3.1.e,"Total Number of Mini-lap sterilizations conducted at Public facilities i.e. PHC, CHC, SDH, DH and other State owned public institutions (sum of items from 9.3.1.a to 9.3.1.d)",TOTAL,13.0,115.0,10.0,82.0,108.0,60.0,71.0,76.0,85.0,78.0,69.0,63.0,830.0
New Delhi,9.3.2,Number of Mini-lap sterilizations conducted at Private facilities,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
New Delhi,9.4.1.a,Number of Post-Partum sterilizations conducted at PHCs,TOTAL,0.0,0.0,,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
New Delhi,9.4.1.b,Number of Post-Partum sterilizations conducted at CHCs,TOTAL,,,,,1.0,2.0,4.0,1.0,0.0,0.0,3.0,1.0,12.0
New Delhi,9.4.1.c,Number of Post-Partum sterilizations conducted at SDHs or DHs,TOTAL,89.0,10.0,106.0,70.0,134.0,59.0,82.0,78.0,67.0,74.0,55.0,53.0,877.0
New Delhi,9.4.1.d,Number of Post-Partum sterilizations conducted at other State owned public institutions,TOTAL,,,,,,,,,,,,,
New Delhi,9.4.1.e,"Total Number of Post-Partum sterilizations conducted at Public facilities i.e. PHC, CHC, SDH, DH and other State owned public institutions (sum of items from 9.4.1.a to 9.4.1.d)",TOTAL,89.0,10.0,106.0,70.0,135.0,61.0,86.0,79.0,67.0,74.0,58.0,54.0,889.0
New Delhi,9.4.2,Number of Post-Partum sterilizations conducted at Private facilities,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
New Delhi,9.5.1.a,Number of IUCD Insertions conducted at SCs,TOTAL,,,0.0,0.0,,,,0.0,,0.0,0.0,0.0,0.0
New Delhi,9.5.1.b,Number of IUCD Insertions conducted at PHCs,TOTAL,92.0,106.0,75.0,266.0,98.0,102.0,53.0,82.0,88.0,86.0,83.0,102.0,1233.0
New Delhi,9.5.1.c,Number of IUCD Insertions conducted at CHCs,TOTAL,10.0,9.0,7.0,72.0,37.0,6.0,17.0,15.0,23.0,16.0,22.0,17.0,251.0
New Delhi,9.5.1.d,Number of IUCD Insertions conducted at SDHs or DHs,TOTAL,307.0,325.0,319.0,388.0,471.0,556.0,499.0,435.0,802.0,557.0,468.0,566.0,5693.0
New Delhi,9.5.1.e,Number of IUCD Insertions conducted at other State owned public institutions,TOTAL,,,,,,,,,,,,,
New Delhi,9.5.1.f,"Total Number of IUCD Insertions conducted at Public facilities i.e. SC, PHC, CHC, SDH, DH and other State owned public institutions (sum of items from 9.5.1.a to 9.5.1.e)",TOTAL,409.0,440.0,401.0,726.0,606.0,664.0,569.0,532.0,913.0,659.0,573.0,685.0,7177.0
New Delhi,9.5.1A,"Out of above total, Post Partum (within 48 hours of delivery) IUCD insertions",TOTAL,68.0,74.0,76.0,89.0,75.0,60.0,69.0,76.0,143.0,165.0,432.0,496.0,1823.0
New Delhi,9.5.2,Number of IUCD Insertions conducted at Private facilities,TOTAL,5.0,3.0,2.0,4.0,1.0,4.0,0.0,1.0,0.0,1.0,1.0,0.0,22.0
New Delhi,9.06,Number of IUCD removals,TOTAL,65.0,80.0,76.0,60.0,92.0,66.0,64.0,77.0,68.0,63.0,90.0,75.0,876.0
New Delhi,9.07,Number of Oral Pills cycles distributed,TOTAL,1549.0,1374.0,1039.0,1489.0,1265.0,1391.0,1235.0,1101.0,1076.0,1384.0,1215.0,1054.0,15172.0
New Delhi,9.08,Number of Condom pieces distributed,TOTAL,28142.0,27623.0,23995.0,33911.0,26927.0,25798.0,23847.0,23591.0,19960.0,24706.0,24679.0,24587.0,307766.0
New Delhi,9.09,Number of Centchroman (weekly) pills given,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
New Delhi,9.10,Number of Emergency Contraceptive Pills distributed,TOTAL,13.0,11.0,8.0,24.0,9.0,13.0,18.0,13.0,22.0,34.0,14.0,14.0,193.0
New Delhi,9.11.1.a,Number of cases of complications following male sterilization,TOTAL,0.0,0.0,0.0,0.0,0.0,1.0,0.0,0.0,0.0,0.0,0.0,0.0,1.0
New Delhi,9.11.1.b,Number of cases of complications following female sterilization,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
New Delhi,9.11.2.a,Number of failures following male sterilization,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
New Delhi,9.11.2.b,Number of failures following female sterilization,TOTAL,1.0,1.0,0.0,0.0,1.0,1.0,1.0,0.0,1.0,2.0,0.0,1.0,9.0
New Delhi,9.11.3.a,Number of deaths following male sterilization,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
New Delhi,9.11.3.b,Number of deaths following female sterilization,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
New Delhi,9.12,Number of Institutions having NSV trained doctors,TOTAL,7.0,6.0,4.0,7.0,4.0,4.0,2.0,4.0,5.0,4.0,5.0,5.0,-1.0
New Delhi,10.1.01,Number of Infants (0 to 11 months old)received BCG immunisation,TOTAL,2945.0,3086.0,3265.0,3482.0,4441.0,3966.0,4414.0,4233.0,4194.0,4214.0,3635.0,3524.0,45399.0
New Delhi,10.1.02,Number of Infants (0 to 11 months old) received DPT1 immunisation,TOTAL,142.0,232.0,128.0,91.0,111.0,138.0,468.0,111.0,86.0,107.0,97.0,86.0,1797.0
New Delhi,10.1.03,Number of Infants (0 to 11 months old) received DPT2 immunisation,TOTAL,213.0,239.0,184.0,207.0,156.0,169.0,308.0,194.0,137.0,145.0,108.0,109.0,2169.0
New Delhi,10.1.04,Number of Infants (0 to 11 months old) received DPT3 immunisation,TOTAL,237.0,303.0,207.0,239.0,218.0,219.0,264.0,213.0,198.0,160.0,143.0,136.0,2537.0
New Delhi,10.1.04A,Number of Infants (0 to 11 months old) received Pentavalent1 immunisation,TOTAL,1213.0,1214.0,1118.0,1345.0,1254.0,1356.0,1525.0,1691.0,1630.0,1512.0,1403.0,1574.0,16835.0
New Delhi,10.1.04B,Number of Infants (0 to 11 months old) received Pentavalent2 immunisation,TOTAL,1165.0,1067.0,948.0,1125.0,1079.0,956.0,1057.0,1292.0,1414.0,1324.0,1180.0,1409.0,14016.0
New Delhi,10.1.04C,Number of Infants (0 to 11 months old) received Pentavalent3 immunisation,TOTAL,1109.0,1078.0,910.0,1099.0,886.0,881.0,861.0,967.0,1196.0,1207.0,1045.0,1236.0,12475.0
New Delhi,10.1.05,Number of Infants (0 to 11 months old) received OPV 0 (Birth Dose),TOTAL,2477.0,2572.0,2855.0,2988.0,3863.0,3358.0,3706.0,3528.0,3430.0,3564.0,3065.0,2899.0,38305.0
New Delhi,10.1.06,Number of Infants (0 to 11 months old) received OPV1 (First Dose),TOTAL,1350.0,1422.0,1285.0,1454.0,1381.0,1512.0,1685.0,1811.0,1674.0,1618.0,1500.0,1672.0,18364.0
New Delhi,10.1.07,Number of Infants (0 to 11 months old) received OPV2 (Second Dose),TOTAL,1359.0,1326.0,1145.0,1336.0,1250.0,1124.0,1223.0,1511.0,1542.0,1459.0,1259.0,1524.0,16058.0
New Delhi,10.1.08,Number of Infants (0 to 11 months old) received OPV3 (Third Dose),TOTAL,1326.0,1354.0,1175.0,1342.0,1140.0,1108.0,1029.0,1219.0,1396.0,1361.0,1199.0,1427.0,15076.0
New Delhi,10.1.09A,Number of Infants (upto 48 hrs of age) received Hepatitis-B0 immunisation,TOTAL,2445.0,2575.0,2922.0,3032.0,3885.0,3465.0,3808.0,3593.0,3468.0,3638.0,1292.0,2959.0,37082.0
New Delhi,10.1.09,Number of Infants (0 to 11 months old) received Hepatitis-B1 immunisation,TOTAL,109.0,173.0,142.0,110.0,117.0,136.0,442.0,102.0,95.0,101.0,89.0,69.0,1685.0
New Delhi,10.1.10,Number of Infants (0 to 11 months old) received Hepatitis-B2 immunisation,TOTAL,175.0,233.0,181.0,219.0,173.0,183.0,302.0,196.0,163.0,149.0,113.0,105.0,2192.0
New Delhi,10.1.11,Number of Infants (0 to 11 months old) received Hepatitis-B3 immunisation,TOTAL,222.0,267.0,204.0,256.0,262.0,213.0,258.0,229.0,209.0,185.0,143.0,130.0,2578.0
New Delhi,10.1.12,Number of Infants (0 to 11 months old) received Measles immunisation (First Dose),TOTAL,1977.0,1881.0,1603.0,1536.0,1575.0,1453.0,1176.0,1407.0,1153.0,1172.0,1049.0,1182.0,17164.0
New Delhi,10.1.12B,Number of Infants (more than 16 months old) received Measles immunisation (Second Dose),TOTAL,5575.0,2739.0,5153.0,911.0,371.0,94.0,65.0,92.0,65.0,53.0,84.0,112.0,15314.0
New Delhi,10.1A,No. of Children aged 9 to 12 months who received JE 1st dose,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
New Delhi,10.1.13.a,Total number of male children (9 to 11 months old) fully immunised (BCG+DPT123/Pentavalent123+OPV123+Measles) during the month,TOTAL,661.0,889.0,836.0,735.0,800.0,726.0,673.0,788.0,605.0,624.0,538.0,662.0,8537.0
New Delhi,10.1.13.b,Total number of female children (9 to 11 months old) fully immunised (BCG+DPT123/Pentavalent123+OPV123+Measles) during the month,TOTAL,561.0,678.0,722.0,645.0,716.0,649.0,494.0,596.0,511.0,536.0,489.0,483.0,7080.0
New Delhi,10.1.13.c,Total number of children (9 to 11 months old) fully immunised (BCG+DPT123/Pentavalent123+OPV123+Measles) during the month (sum of items 10.1.13.a and 10.1.13.b),TOTAL,1222.0,1567.0,1558.0,1380.0,1516.0,1375.0,1167.0,1384.0,1116.0,1160.0,1027.0,1145.0,15617.0
New Delhi,10.2.1,Number of Infants (more than 16 months old) received DPT Booster dose,TOTAL,1277.0,1615.0,1158.0,1391.0,1262.0,1137.0,933.0,1249.0,1211.0,1136.0,1095.0,1350.0,14814.0
New Delhi,10.2.2,Number of Infants (more than 16 months old) received OPV Booster dose,TOTAL,1263.0,1583.0,1149.0,1418.0,1300.0,1128.0,927.0,1243.0,1207.0,1129.0,1092.0,1352.0,14791.0
New Delhi,10.2.3,"Number of Infants (more than 16 months old) received Measles, Mumps, Rubella (MMR) Vaccination",TOTAL,114.0,68.0,262.0,98.0,1114.0,1422.0,1222.0,1714.0,1755.0,1475.0,1432.0,1467.0,12143.0
New Delhi,10.3.1.a,Total number of male children (12 to 23 months old) fully immunised (BCG+DPT123/Pentavalent123+OPV123+Measles) during the month,TOTAL,352.0,262.0,400.0,243.0,267.0,370.0,333.0,365.0,248.0,324.0,310.0,385.0,3859.0
New Delhi,10.3.1.b,Total number of female children (12 to 23 months old) fully immunised (BCG+DPT123/Pentavalent123+OPV123+Measles) during the month,TOTAL,257.0,220.0,288.0,193.0,216.0,320.0,242.0,267.0,207.0,257.0,238.0,304.0,3009.0
New Delhi,10.3.1.c,Total number of children (12 to 23 months old) fully immunised (BCG+DPT123+OPV123/Pentavalent123+Measles) during the month (sum of items 10.3.1.a and 10.3.1.b),TOTAL,609.0,482.0,688.0,436.0,483.0,690.0,575.0,632.0,455.0,581.0,548.0,689.0,6868.0
New Delhi,10.3.2,Number of children (more than 5 years old) given DT5,TOTAL,576.0,538.0,634.0,634.0,619.0,624.0,514.0,653.0,637.0,671.0,517.0,726.0,7343.0
New Delhi,10.3.3,Number of children (more than 10 years old) given TT10,TOTAL,390.0,366.0,425.0,329.0,320.0,356.0,351.0,322.0,341.0,385.0,253.0,367.0,4205.0
New Delhi,10.3.4,Number of children (more than 16 years old) given TT16,TOTAL,249.0,228.0,203.0,198.0,242.0,242.0,275.0,189.0,205.0,277.0,171.0,248.0,2727.0
New Delhi,10.3.5.a,Number of cases of Abscess reported following immunisation [Adverse Event Following Immunisation (AEFI)],TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
New Delhi,10.3.5.b,Number of cases of Death reported following immunisation [Adverse Event Following Immunisation (AEFI)],TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
New Delhi,10.3.5.c,Number of cases of other complications reported following immunisation [Adverse Event Following Immunisation (AEFI)],TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
New Delhi,10.4.1,Number of Immunisation sessions planned to be held during the month,TOTAL,576.0,527.0,592.0,498.0,487.0,471.0,501.0,479.0,545.0,500.0,457.0,467.0,6100.0
New Delhi,10.4.2,Number of Immunisation sessions held during the month,TOTAL,537.0,497.0,572.0,478.0,463.0,443.0,450.0,457.0,523.0,476.0,436.0,442.0,5774.0
New Delhi,10.4.3,Number of Immunisation sessions held during the month where ASHAs were present,TOTAL,228.0,229.0,291.0,185.0,184.0,176.0,152.0,191.0,215.0,202.0,169.0,158.0,2380.0
New Delhi,10.5.1,Number of children (more than 16 months old) received Japanese Encephalitis (JE) vaccination,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
New Delhi,11.1.1,Number of children (9 months to 5 years old) administered 1st dose of Vitamin A (Dose-1),TOTAL,1819.0,1823.0,1609.0,1483.0,1632.0,1613.0,1309.0,1674.0,1273.0,1222.0,900.0,1110.0,17467.0
New Delhi,11.1.2,Number of children (9 months to 5 years old) were administered 5th dose of Vitamin A (Dose-5),TOTAL,1575.0,1933.0,1459.0,919.0,846.0,1277.0,1439.0,1400.0,1117.0,1002.0,1029.0,1138.0,15134.0
New Delhi,11.1.3,Number of children (9 months to 5 years old) administered 9th dose of Vitamin A (Dose-9),TOTAL,1186.0,1056.0,1329.0,1164.0,970.0,1283.0,1375.0,1364.0,837.0,810.0,740.0,810.0,12924.0
New Delhi,12.1,Number of cases of Diptheria reported in children below 5 years of age,TOTAL,0.0,0.0,0.0,0.0,0.0,1.0,3.0,0.0,0.0,0.0,0.0,0.0,4.0
New Delhi,12.2,Number of cases of Pertusis reported in children below 5 years of age,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
New Delhi,12.3,Number of cases of Tetanus neonatarum reported in children below 5 years of age,TOTAL,0.0,0.0,0.0,1.0,3.0,1.0,0.0,0.0,2.0,1.0,3.0,0.0,11.0
New Delhi,12.4,Number of cases of Tetanus other than neonatarum reported in children below 5 years of age,TOTAL,1.0,0.0,1.0,1.0,1.0,2.0,3.0,2.0,3.0,2.0,3.0,3.0,22.0
New Delhi,12.5,Number of cases of Polio reported in children below 5 years of age,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
New Delhi,12.6,Number of cases of Measles reported in children below 5 years of age,TOTAL,25.0,11.0,24.0,14.0,14.0,3.0,3.0,10.0,4.0,5.0,11.0,9.0,133.0
New Delhi,12.7,Number of cases of Diarrhoea and Dehydration reported in children below 5 years of age,TOTAL,2414.0,3127.0,3039.0,3240.0,3157.0,1848.0,1456.0,1170.0,919.0,237.0,222.0,249.0,21078.0
New Delhi,12.8,Number of cases of Malaria reported in children below 5 years of age,TOTAL,14.0,9.0,21.0,26.0,19.0,37.0,26.0,19.0,6.0,7.0,14.0,13.0,211.0
New Delhi,12.9,Number of children below 5 years of age admitted with Respiratory Infections,TOTAL,524.0,283.0,338.0,452.0,475.0,417.0,549.0,393.0,471.0,943.0,1098.0,1113.0,7056.0
New Delhi,13.1,Number of Patients operated for cataract,TOTAL,337.0,584.0,437.0,303.0,416.0,618.0,583.0,706.0,928.0,676.0,735.0,851.0,7174.0
New Delhi,13.2,Number of Intraocular Lens(IOL) implantations,TOTAL,335.0,570.0,281.0,301.0,412.0,612.0,574.0,689.0,911.0,659.0,723.0,846.0,6913.0
New Delhi,13.3,Number of School children detected with Refractive errors,TOTAL,49.0,51.0,77.0,33.0,187.0,160.0,74.0,86.0,108.0,54.0,116.0,122.0,1117.0
New Delhi,13.4,Number of children provided free glasses,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
New Delhi,13.5,Number of eyes collected through eye donation,TOTAL,0.0,4.0,4.0,6.0,4.0,4.0,0.0,12.0,6.0,8.0,4.0,8.0,60.0
New Delhi,13.6,Number of eyes utilised for corneal transplant,TOTAL,0.0,2.0,2.0,4.0,0.0,2.0,0.0,2.0,1.0,6.0,3.0,2.0,24.0
New Delhi,14.01,Number of CHC or SDH or DH functioning as First Referral units (FRUs),TOTAL,2.0,2.0,2.0,2.0,2.0,3.0,4.0,4.0,4.0,4.0,4.0,4.0,-1.0
New Delhi,14.02,Number of PHCs functioning 24X7 with atleast 3 Staff Nurses,TOTAL,,,,,,1.0,,,,,,,-1.0
New Delhi,14.03,Number of Anganwadi centres reported to have conducted VHNDs,TOTAL,,,,,,,1.0,1.0,,0.0,0.0,0.0,-1.0
New Delhi,14.04,Number of facilities having a Rogi Kalyan Samiti (RKS),TOTAL,,,,,,,,,,,,,-1.0
New Delhi,14.05,Number of RKS meetings held during the month,TOTAL,1.0,1.0,0.0,0.0,1.0,1.0,0.0,0.0,0.0,0.0,0.0,0.0,4.0
New Delhi,14.06,Number of facilities having Ambulance services (Assured Referral Services),TOTAL,18.0,10.0,9.0,10.0,8.0,9.0,15.0,22.0,25.0,24.0,27.0,27.0,-1.0
New Delhi,14.07,Total Number of times the Ambulance was used for transporting patients during the month,TOTAL,320.0,330.0,326.0,405.0,329.0,394.0,390.0,673.0,681.0,869.0,1075.0,1209.0,7001.0
New Delhi,14.08,Number of Institutions having Operational Sick New Born and Child Care Units (SNCU),TOTAL,2.0,2.0,2.0,2.0,2.0,4.0,3.0,4.0,3.0,3.0,3.0,4.0,-1.0
New Delhi,14.09,Number of functional Laproscopes in CHC/SDH/DH,TOTAL,23.0,13.0,20.0,21.0,19.0,19.0,23.0,21.0,29.0,26.0,31.0,28.0,-1.0
New Delhi,14.10.1.a,Number of male patients admitted (Inpatients) during the month,1. Children,2172.0,2273.0,2052.0,2443.0,2829.0,3963.0,2371.0,2999.0,3065.0,6473.0,6224.0,6061.0,42925.0
New Delhi,14.10.1.a,Number of male patients admitted (Inpatients) during the month,2. Adults,1035.0,1069.0,3906.0,3738.0,4220.0,3097.0,4063.0,2684.0,3515.0,5752.0,6295.0,7020.0,46394.0
New Delhi,14.10.1.b,Number of female patients (Inpatients) admitted during the month,1. Children,1563.0,1427.0,1199.0,1746.0,1912.0,2491.0,1514.0,2415.0,2426.0,5636.0,5179.0,4820.0,32328.0
New Delhi,14.10.1.b,Number of female patients (Inpatients) admitted during the month,2. Adults,2977.0,3373.0,5190.0,5147.0,5487.0,5908.0,7040.0,4949.0,5123.0,10267.0,9753.0,10683.0,75897.0
New Delhi,14.10.1.c,Total number of patients admitted (Inpatients) during the month (sum of items 14.10.1.a and 14.10.1.b),1. Children,3735.0,3700.0,3251.0,4189.0,4741.0,6454.0,3885.0,5414.0,5491.0,12109.0,11403.0,10881.0,75253.0
New Delhi,14.10.1.c,Total number of patients admitted (Inpatients) during the month (sum of items 14.10.1.a and 14.10.1.b),2. Adults,4012.0,4442.0,9096.0,8885.0,9707.0,9005.0,11103.0,7633.0,8638.0,16019.0,16048.0,17703.0,122291.0
New Delhi,14.10.2.a,Number of death cases of Inpatient males,TOTAL,428.0,313.0,453.0,489.0,719.0,620.0,480.0,496.0,368.0,528.0,613.0,404.0,5911.0
New Delhi,14.10.2.b,Number of death cases of Inpatient females,TOTAL,271.0,197.0,290.0,265.0,523.0,662.0,446.0,271.0,249.0,335.0,398.0,253.0,4160.0
New Delhi,14.10.2.c,Number of cases of death of Inpatients (sum of items 14.10.2.a and 14.10.2.b),TOTAL,699.0,510.0,743.0,754.0,1242.0,1282.0,926.0,767.0,617.0,863.0,1011.0,657.0,10071.0
New Delhi,14.11,In-Patient Head Count at midnight,TOTAL,84169.0,84178.0,89098.0,82456.0,96607.0,100604.0,96570.0,92550.0,111837.0,93069.0,93310.0,99476.0,1123924.0
New Delhi,14.12.1,OPD attendance (All),TOTAL,468832.0,430469.0,540617.0,635893.0,553492.0,670633.0,712773.0,596182.0,594759.0,730582.0,779474.0,800809.0,7514515.0
New Delhi,14.13.1,Number of major operations carried out using general or spinal anaesthesia,TOTAL,1897.0,1856.0,2005.0,4497.0,3752.0,3512.0,3040.0,3337.0,11596.0,4951.0,4794.0,5269.0,50506.0
New Delhi,14.13.1A,"Out of 14.13.1,Gynecology- Hysterectomy surgeries",TOTAL,5.0,6.0,2.0,39.0,28.0,29.0,16.0,21.0,24.0,566.0,546.0,1078.0,2360.0
New Delhi,14.13.2,Number of minor operations carried out without anaesthesia or using local anaesthesia,TOTAL,2885.0,6135.0,4043.0,4461.0,5267.0,4750.0,5240.0,4240.0,12708.0,9412.0,8800.0,8772.0,76713.0
New Delhi,14.14.a,Number of patients given AYUSH treatment,TOTAL,5244.0,5740.0,5924.0,9144.0,9688.0,10308.0,8132.0,9543.0,14556.0,12740.0,10945.0,15843.0,117807.0
New Delhi,14.14.b,Number of patients on whom Dental Procedure was conducted,TOTAL,6495.0,6289.0,5218.0,8600.0,12502.0,18043.0,11472.0,8129.0,11526.0,10805.0,11387.0,12075.0,122541.0
New Delhi,14.14.c,Number of Adolescents counselled,TOTAL,329.0,315.0,316.0,406.0,409.0,454.0,302.0,390.0,342.0,342.0,267.0,455.0,4327.0
New Delhi,15.1.1.a,Number of Haemoglobin (Hb) tests conducted,TOTAL,37714.0,36401.0,37232.0,56665.0,40389.0,59715.0,52857.0,50896.0,51146.0,50652.0,54486.0,80613.0,608766.0
New Delhi,15.1.1.b,"Out of the total number of Hb tests conducted, number of cases having Hb less than 7gm/dl",TOTAL,5465.0,4869.0,5987.0,6183.0,5916.0,6110.0,6067.0,5743.0,5371.0,4779.0,6360.0,6494.0,69344.0
New Delhi,15.1.2.a,Number of HIV tests conducted on males,1. Number tested,1081.0,1241.0,1301.0,997.0,3067.0,2761.0,2176.0,2231.0,1456.0,2234.0,3216.0,2331.0,24092.0
New Delhi,15.1.2.a,Number of HIV tests conducted on males,2. Number Positive,6.0,7.0,7.0,39.0,14.0,30.0,15.0,20.0,16.0,41.0,92.0,54.0,341.0
New Delhi,15.1.2.b,Number of HIV tests conducted on Female-Non ANC (i.e. non pregnant females),1. Number tested,636.0,575.0,551.0,355.0,2495.0,1865.0,1098.0,1606.0,2257.0,2840.0,2041.0,1335.0,17654.0
New Delhi,15.1.2.b,Number of HIV tests conducted on Female-Non ANC (i.e. non pregnant females),2. Number Positive,1.0,0.0,3.0,4.0,7.0,15.0,26.0,9.0,6.0,15.0,40.0,25.0,151.0
New Delhi,15.1.2.c,Number of HIV tests conducted on Female with ANC (i.e. pregnant females),1. Number tested,2636.0,2989.0,2722.0,2917.0,2413.0,3159.0,2197.0,2389.0,2399.0,2353.0,2525.0,2682.0,31381.0
New Delhi,15.1.2.c,Number of HIV tests conducted on Female with ANC (i.e. pregnant females),2. Number Positive,4.0,7.0,2.0,5.0,4.0,8.0,9.0,4.0,7.0,1.0,3.0,6.0,60.0
New Delhi,15.1.2.d,Total number of HIV tests conducted (sum of items 15.1.2.a to 15.1.2.c),1. Number tested,4353.0,4805.0,4574.0,4269.0,7975.0,7785.0,5471.0,6226.0,6112.0,7427.0,7782.0,6348.0,73127.0
New Delhi,15.1.2.d,Total number of HIV tests conducted (sum of items 15.1.2.a to 15.1.2.c),2. Number Positive,11.0,14.0,12.0,48.0,25.0,53.0,50.0,33.0,29.0,57.0,135.0,85.0,552.0
New Delhi,15.2,Number of Widal tests conducted,Number tested,1222.0,1347.0,1397.0,1678.0,2702.0,2611.0,1961.0,1543.0,1011.0,899.0,1835.0,1525.0,19731.0
New Delhi,15.3.a,Number of VDRL tests conducted on males,Number tested,376.0,342.0,325.0,337.0,398.0,384.0,973.0,333.0,335.0,1058.0,848.0,626.0,6335.0
New Delhi,15.3.b,Number of VDRL tests conducted on Female-Non ANC (i.e. non pregnant females),Number tested,289.0,360.0,440.0,390.0,503.0,770.0,452.0,1082.0,1291.0,1771.0,1005.0,739.0,9092.0
New Delhi,15.3.c,Number of VDRL tests conducted on Female with ANC (i.e. pregnant females),Number tested,1262.0,1487.0,1142.0,1121.0,1529.0,1707.0,978.0,1547.0,1124.0,2112.0,1965.0,1192.0,17166.0
New Delhi,15.3.d,Total number of VDRL tests conducted (sum of items 15.3.a to 15.3.c),Number tested,1927.0,2189.0,1907.0,1848.0,2430.0,2861.0,2403.0,2962.0,2750.0,4941.0,3818.0,2557.0,32593.0
New Delhi,15.4.1,Number of blood smears examined for Malaria,TOTAL,2324.0,2421.0,2981.0,2803.0,3364.0,4243.0,3297.0,2652.0,2539.0,2188.0,2415.0,1769.0,32996.0
New Delhi,15.4.2,"Out of blood smears examined for malaria, number of blood smears tested positive for Plasmodium Vivax",TOTAL,9.0,13.0,31.0,26.0,57.0,76.0,35.0,12.0,2.0,3.0,2.0,2.0,268.0
New Delhi,15.4.3,"Out of blood smears examined for malaria, number of blood smears tested positive for Plasmodium Falciparum",TOTAL,1.0,1.0,0.0,0.0,0.0,1.0,1.0,4.0,1.0,1.0,3.0,1.0,14.0
New Delhi,16.1.1,Stock position of DPT vaccines,1. Balance From Previous Month,1490.0,2640.0,1580.0,1760.0,2820.0,2110.0,2170.0,2210.0,3130.0,2480.0,1990.0,1190.0,25570.0
New Delhi,16.1.1,Stock position of DPT vaccines,2. Stocks Received,2000.0,0.0,1000.0,2000.0,0.0,1000.0,500.0,2000.0,0.0,0.0,0.0,3000.0,11500.0
New Delhi,16.1.1,Stock position of DPT vaccines,3. Unusable Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
New Delhi,16.1.1,Stock position of DPT vaccines,4. Stock Distributed,850.0,1060.0,820.0,940.0,710.0,940.0,460.0,1080.0,650.0,490.0,800.0,820.0,9620.0
New Delhi,16.1.1,Stock position of DPT vaccines,5. Total Stock,2640.0,1580.0,1760.0,2820.0,2110.0,2170.0,2210.0,3130.0,2480.0,1990.0,1190.0,3370.0,27450.0
New Delhi,16.1.1A,Stock Position of Pentavalent,1. Balance From Previous Month,2480.0,2450.0,3510.0,2890.0,2770.0,2320.0,2260.0,3710.0,5730.0,4880.0,3980.0,2830.0,39810.0
New Delhi,16.1.1A,Stock Position of Pentavalent,2. Stocks Received,1000.0,2000.0,0.0,1000.0,0.0,1000.0,2000.0,3000.0,0.0,0.0,0.0,4000.0,14000.0
New Delhi,16.1.1A,Stock Position of Pentavalent,3. Unusable Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
New Delhi,16.1.1A,Stock Position of Pentavalent,4. Stock Distributed,1030.0,940.0,620.0,1120.0,450.0,1060.0,550.0,980.0,850.0,900.0,1150.0,1130.0,10780.0
New Delhi,16.1.1A,Stock Position of Pentavalent,5. Total Stock,2450.0,3510.0,2890.0,2770.0,2320.0,2260.0,3710.0,5730.0,4880.0,3980.0,2830.0,5700.0,43030.0
New Delhi,16.1.2,Stock position of OPV vaccines,1. Balance From Previous Month,4880.0,9060.0,7230.0,6170.0,3500.0,2400.0,4540.0,5340.0,6650.0,4880.0,7680.0,6080.0,68410.0
New Delhi,16.1.2,Stock position of OPV vaccines,2. Stocks Received,6000.0,0.0,0.0,0.0,0.0,4000.0,2000.0,3000.0,0.0,4000.0,0.0,3000.0,22000.0
New Delhi,16.1.2,Stock position of OPV vaccines,3. Unusable Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
New Delhi,16.1.2,Stock position of OPV vaccines,4. Stock Distributed,1820.0,1830.0,1060.0,2670.0,1100.0,1860.0,1200.0,1690.0,1770.0,1200.0,1600.0,1820.0,19620.0
New Delhi,16.1.2,Stock position of OPV vaccines,5. Total Stock,9060.0,7230.0,6170.0,3500.0,2400.0,4540.0,5340.0,6650.0,4880.0,7680.0,6080.0,7260.0,70790.0
New Delhi,16.1.3,Stock position of TT vaccines,1. Balance From Previous Month,1960.0,1500.0,3690.0,3210.0,2200.0,1590.0,2940.0,3260.0,3990.0,3210.0,2760.0,1880.0,32190.0
New Delhi,16.1.3,Stock position of TT vaccines,2. Stocks Received,0.0,3000.0,0.0,0.0,0.0,2000.0,1000.0,2000.0,0.0,0.0,0.0,0.0,8000.0
New Delhi,16.1.3,Stock position of TT vaccines,3. Unusable Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
New Delhi,16.1.3,Stock position of TT vaccines,4. Stock Distributed,460.0,810.0,480.0,1010.0,610.0,650.0,680.0,1270.0,780.0,450.0,880.0,470.0,8550.0
New Delhi,16.1.3,Stock position of TT vaccines,5. Total Stock,1500.0,3690.0,3210.0,2200.0,1590.0,2940.0,3260.0,3990.0,3210.0,2760.0,1880.0,1410.0,31640.0
New Delhi,16.1.4,Stock position of DT vaccines,1. Balance From Previous Month,,0.0,0.0,0.0,,,0.0,,,0.0,,,0.0
New Delhi,16.1.4,Stock position of DT vaccines,2. Stocks Received,,0.0,0.0,0.0,,,0.0,,,0.0,,,0.0
New Delhi,16.1.4,Stock position of DT vaccines,3. Unusable Stock,,0.0,0.0,0.0,,,0.0,,,0.0,,,0.0
New Delhi,16.1.4,Stock position of DT vaccines,4. Stock Distributed,,0.0,0.0,0.0,,,0.0,,,0.0,,,0.0
New Delhi,16.1.4,Stock position of DT vaccines,5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
New Delhi,16.1.5,Stock position of BCG vaccines,1. Balance From Previous Month,2290.0,1990.0,1450.0,1240.0,1720.0,1450.0,870.0,1590.0,2080.0,1550.0,2240.0,1810.0,20280.0
New Delhi,16.1.5,Stock position of BCG vaccines,2. Stocks Received,0.0,0.0,0.0,1000.0,0.0,0.0,1000.0,1000.0,0.0,1000.0,0.0,0.0,4000.0
New Delhi,16.1.5,Stock position of BCG vaccines,3. Unusable Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
New Delhi,16.1.5,Stock position of BCG vaccines,4. Stock Distributed,300.0,540.0,210.0,520.0,270.0,580.0,280.0,510.0,530.0,310.0,430.0,440.0,4920.0
New Delhi,16.1.5,Stock position of BCG vaccines,5. Total Stock,1990.0,1450.0,1240.0,1720.0,1450.0,870.0,1590.0,2080.0,1550.0,2240.0,1810.0,1370.0,19360.0
New Delhi,16.1.6,Stock position of Measles vaccines,1. Balance From Previous Month,170.0,4305.0,1105.0,1020.0,4900.0,4750.0,4000.0,3675.0,4110.0,3585.0,3190.0,2620.0,37430.0
New Delhi,16.1.6,Stock position of Measles vaccines,2. Stocks Received,11000.0,2000.0,9000.0,5000.0,0.0,0.0,0.0,2000.0,0.0,0.0,0.0,1500.0,30500.0
New Delhi,16.1.6,Stock position of Measles vaccines,3. Unusable Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
New Delhi,16.1.6,Stock position of Measles vaccines,4. Stock Distributed,6865.0,5200.0,9085.0,1120.0,150.0,750.0,325.0,1565.0,525.0,395.0,570.0,570.0,27120.0
New Delhi,16.1.6,Stock position of Measles vaccines,5. Total Stock,4305.0,1105.0,1020.0,4900.0,4750.0,4000.0,3675.0,4110.0,3585.0,3190.0,2620.0,3550.0,40810.0
New Delhi,16.1.7,Stock position of JE vaccines,1. Balance From Previous Month,,0.0,,,,0.0,,,,,,,0.0
New Delhi,16.1.7,Stock position of JE vaccines,2. Stocks Received,,0.0,,,,0.0,,,,,,,0.0
New Delhi,16.1.7,Stock position of JE vaccines,3. Unusable Stock,,0.0,,,,,,,,,,,0.0
New Delhi,16.1.7,Stock position of JE vaccines,4. Stock Distributed,,0.0,,,,,,,,,,,0.0
New Delhi,16.1.7,Stock position of JE vaccines,5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
New Delhi,16.1.8,Stock position of Hepatitis B vaccines,1. Balance From Previous Month,4500.0,4250.0,4060.0,3960.0,3730.0,3550.0,3290.0,3210.0,2080.0,1750.0,1640.0,1415.0,37435.0
New Delhi,16.1.8,Stock position of Hepatitis B vaccines,2. Stocks Received,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
New Delhi,16.1.8,Stock position of Hepatitis B vaccines,3. Unusable Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
New Delhi,16.1.8,Stock position of Hepatitis B vaccines,4. Stock Distributed,250.0,190.0,100.0,230.0,180.0,260.0,80.0,1130.0,330.0,110.0,225.0,260.0,3345.0
New Delhi,16.1.8,Stock position of Hepatitis B vaccines,5. Total Stock,4250.0,4060.0,3960.0,3730.0,3550.0,3290.0,3210.0,2080.0,1750.0,1640.0,1415.0,1155.0,34090.0
New Delhi,16.2.1,Stock Position of IU 380 A (to be used for Family Planning),1. Balance From Previous Month,255.0,220.0,207.0,177.0,57.0,37.0,0.0,100.0,100.0,88.0,68.0,18.0,1327.0
New Delhi,16.2.1,Stock Position of IU 380 A (to be used for Family Planning),2. Stocks Received,0.0,0.0,0.0,0.0,0.0,0.0,100.0,0.0,0.0,0.0,0.0,100.0,200.0
New Delhi,16.2.1,Stock Position of IU 380 A (to be used for Family Planning),3. Unusable Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
New Delhi,16.2.1,Stock Position of IU 380 A (to be used for Family Planning),4. Stock Distributed,35.0,13.0,30.0,120.0,20.0,37.0,0.0,0.0,12.0,20.0,50.0,38.0,375.0
New Delhi,16.2.1,Stock Position of IU 380 A (to be used for Family Planning),5. Total Stock,220.0,207.0,177.0,57.0,37.0,0.0,100.0,100.0,88.0,68.0,18.0,80.0,1152.0
New Delhi,16.2.2,Stock Position of Condoms (to be used for Family Planning),1. Balance From Previous Month,54500.0,50000.0,43000.0,38500.0,62500.0,59000.0,55500.0,54000.0,49500.0,44000.0,39500.0,35500.0,585500.0
New Delhi,16.2.2,Stock Position of Condoms (to be used for Family Planning),2. Stocks Received,0.0,0.0,0.0,42000.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,42000.0
New Delhi,16.2.2,Stock Position of Condoms (to be used for Family Planning),3. Unusable Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
New Delhi,16.2.2,Stock Position of Condoms (to be used for Family Planning),4. Stock Distributed,4500.0,7000.0,4500.0,18000.0,3500.0,3500.0,1500.0,4500.0,5500.0,4500.0,4000.0,5000.0,66000.0
New Delhi,16.2.2,Stock Position of Condoms (to be used for Family Planning),5. Total Stock,50000.0,43000.0,38500.0,62500.0,59000.0,55500.0,54000.0,49500.0,44000.0,39500.0,35500.0,30500.0,561500.0
New Delhi,16.2.3,Stock Position of Oral Contraceptive (to be used for Family Planning),1. Balance From Previous Month,550.0,1370.0,1260.0,910.0,640.0,600.0,1400.0,1380.0,1280.0,1130.0,1110.0,840.0,12470.0
New Delhi,16.2.3,Stock Position of Oral Contraceptive (to be used for Family Planning),2. Stocks Received,1000.0,0.0,0.0,0.0,0.0,1000.0,0.0,0.0,0.0,0.0,0.0,0.0,2000.0
New Delhi,16.2.3,Stock Position of Oral Contraceptive (to be used for Family Planning),3. Unusable Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
New Delhi,16.2.3,Stock Position of Oral Contraceptive (to be used for Family Planning),4. Stock Distributed,180.0,110.0,350.0,270.0,40.0,200.0,20.0,100.0,150.0,20.0,270.0,150.0,1860.0
New Delhi,16.2.3,Stock Position of Oral Contraceptive (to be used for Family Planning),5. Total Stock,1370.0,1260.0,910.0,640.0,600.0,1400.0,1380.0,1280.0,1130.0,1110.0,840.0,690.0,12610.0
New Delhi,16.2.4,Stock Position of Emergency Contraceptive (to be used for Family Planning),1. Balance From Previous Month,,0.0,0.0,,0.0,,,,0.0,,,0.0,0.0
New Delhi,16.2.4,Stock Position of Emergency Contraceptive (to be used for Family Planning),2. Stocks Received,,0.0,0.0,,0.0,,,,0.0,,,50.0,50.0
New Delhi,16.2.4,Stock Position of Emergency Contraceptive (to be used for Family Planning),3. Unusable Stock,,0.0,0.0,,0.0,,,,0.0,,,0.0,0.0
New Delhi,16.2.4,Stock Position of Emergency Contraceptive (to be used for Family Planning),4. Stock Distributed,,0.0,0.0,,0.0,,,,0.0,,,0.0,0.0
New Delhi,16.2.4,Stock Position of Emergency Contraceptive (to be used for Family Planning),5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,50.0,50.0
New Delhi,16.2.5,Stock Position of Tubal Rings (to be used for Family Planning),1. Balance From Previous Month,,0.0,0.0,0.0,0.0,,,,0.0,,,,0.0
New Delhi,16.2.5,Stock Position of Tubal Rings (to be used for Family Planning),2. Stocks Received,,0.0,0.0,0.0,0.0,,,,0.0,,,,0.0
New Delhi,16.2.5,Stock Position of Tubal Rings (to be used for Family Planning),3. Unusable Stock,,0.0,0.0,0.0,0.0,,,,0.0,,,,0.0
New Delhi,16.2.5,Stock Position of Tubal Rings (to be used for Family Planning),4. Stock Distributed,,0.0,0.0,0.0,0.0,,,,0.0,,,,0.0
New Delhi,16.2.5,Stock Position of Tubal Rings (to be used for Family Planning),5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
New Delhi,16.3.01,Stock Position of Oxytocin Injection,1. Balance From Previous Month,,,,,,,,,,,,,
New Delhi,16.3.01,Stock Position of Oxytocin Injection,2. Stocks Received,,,,,,,,,,,,,
New Delhi,16.3.01,Stock Position of Oxytocin Injection,3. Unusable Stock,,,,,,,,,,,,,
New Delhi,16.3.01,Stock Position of Oxytocin Injection,4. Stock Distributed,,,,,,,,,,,,,
New Delhi,16.3.01,Stock Position of Oxytocin Injection,5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
New Delhi,16.3.02,Stock Position of Gloves,1. Balance From Previous Month,,,,,,,,,,,,,
New Delhi,16.3.02,Stock Position of Gloves,2. Stocks Received,,,,,,,,,,,,,
New Delhi,16.3.02,Stock Position of Gloves,3. Unusable Stock,,,,,,,,,,,,,
New Delhi,16.3.02,Stock Position of Gloves,4. Stock Distributed,,,,,,,,,,,,,
New Delhi,16.3.02,Stock Position of Gloves,5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
New Delhi,16.3.03,Stock Position of MVA Syringes,1. Balance From Previous Month,,,,,,,,,,,,,
New Delhi,16.3.03,Stock Position of MVA Syringes,2. Stocks Received,,,,,,,,,,,,,
New Delhi,16.3.03,Stock Position of MVA Syringes,3. Unusable Stock,,,,,,,,,,,,,
New Delhi,16.3.03,Stock Position of MVA Syringes,4. Stock Distributed,,,,,,,,,,,,,
New Delhi,16.3.03,Stock Position of MVA Syringes,5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
New Delhi,16.3.04,Stock Position of Fluconazole Tablets,1. Balance From Previous Month,,,,,,,,,,,,,
New Delhi,16.3.04,Stock Position of Fluconazole Tablets,2. Stocks Received,,,,,,,,,,,,,
New Delhi,16.3.04,Stock Position of Fluconazole Tablets,3. Unusable Stock,,,,,,,,,,,,,
New Delhi,16.3.04,Stock Position of Fluconazole Tablets,4. Stock Distributed,,,,,,,,,,,,,
New Delhi,16.3.04,Stock Position of Fluconazole Tablets,5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
New Delhi,16.3.05,Stock Position of Blood Transfusion Sets,1. Balance From Previous Month,,,,,,,,,,,,,
New Delhi,16.3.05,Stock Position of Blood Transfusion Sets,2. Stocks Received,,,,,,,,,,,,,
New Delhi,16.3.05,Stock Position of Blood Transfusion Sets,3. Unusable Stock,,,,,,,,,,,,,
New Delhi,16.3.05,Stock Position of Blood Transfusion Sets,4. Stock Distributed,,,,,,,,,,,,,
New Delhi,16.3.05,Stock Position of Blood Transfusion Sets,5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
New Delhi,16.3.06,Stock Position of Gluteraldehyde solution of 2% concentration,1. Balance From Previous Month,,,,,,,,,,,,,
New Delhi,16.3.06,Stock Position of Gluteraldehyde solution of 2% concentration,2. Stocks Received,,,,,,,,,,,,,
New Delhi,16.3.06,Stock Position of Gluteraldehyde solution of 2% concentration,3. Unusable Stock,,,,,,,,,,,,,
New Delhi,16.3.06,Stock Position of Gluteraldehyde solution of 2% concentration,4. Stock Distributed,,,,,,,,,,,,,
New Delhi,16.3.06,Stock Position of Gluteraldehyde solution of 2% concentration,5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
New Delhi,16.3.07,Stock Position of IFA Tablets,1. Balance From Previous Month,173000.0,140000.0,118000.0,98000.0,72500.0,59000.0,45000.0,35500.0,20000.0,12000.0,8500.0,6000.0,787500.0
New Delhi,16.3.07,Stock Position of IFA Tablets,2. Stocks Received,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
New Delhi,16.3.07,Stock Position of IFA Tablets,3. Unusable Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
New Delhi,16.3.07,Stock Position of IFA Tablets,4. Stock Distributed,33000.0,22000.0,20000.0,25500.0,13500.0,14000.0,9500.0,15500.0,8000.0,3500.0,2500.0,2500.0,169500.0
New Delhi,16.3.07,Stock Position of IFA Tablets,5. Total Stock,140000.0,118000.0,98000.0,72500.0,59000.0,45000.0,35500.0,20000.0,12000.0,8500.0,6000.0,3500.0,618000.0
New Delhi,16.3.08,Stock Position of IFA Syrup (Paediatric),1. Balance From Previous Month,,,,,,,,,,,,,
New Delhi,16.3.08,Stock Position of IFA Syrup (Paediatric),2. Stocks Received,,,,,,,,,,,,,
New Delhi,16.3.08,Stock Position of IFA Syrup (Paediatric),3. Unusable Stock,,,,,,,,,,,,,
New Delhi,16.3.08,Stock Position of IFA Syrup (Paediatric),4. Stock Distributed,,,,,,,,,,,,,
New Delhi,16.3.08,Stock Position of IFA Syrup (Paediatric),5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
New Delhi,16.3.09,Stock Position of Paediatrics Antibiotics (Cotrimaxozole and Injectable Gentamicin),1. Balance From Previous Month,,,,,,,,,,,,,
New Delhi,16.3.09,Stock Position of Paediatrics Antibiotics (Cotrimaxozole and Injectable Gentamicin),2. Stocks Received,,,,,,,,,,,,,
New Delhi,16.3.09,Stock Position of Paediatrics Antibiotics (Cotrimaxozole and Injectable Gentamicin),3. Unusable Stock,,,,,,,,,,,,,
New Delhi,16.3.09,Stock Position of Paediatrics Antibiotics (Cotrimaxozole and Injectable Gentamicin),4. Stock Distributed,,,,,,,,,,,,,
New Delhi,16.3.09,Stock Position of Paediatrics Antibiotics (Cotrimaxozole and Injectable Gentamicin),5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
New Delhi,16.3.10,Stock Position of Vitamin A solution,1. Balance From Previous Month,198.0,110.0,43.0,233.0,241.0,161.0,111.0,81.0,51.0,45.0,100.0,62.0,1436.0
New Delhi,16.3.10,Stock Position of Vitamin A solution,2. Stocks Received,0.0,0.0,500.0,400.0,0.0,0.0,0.0,0.0,0.0,100.0,0.0,100.0,1100.0
New Delhi,16.3.10,Stock Position of Vitamin A solution,3. Unusable Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
New Delhi,16.3.10,Stock Position of Vitamin A solution,4. Stock Distributed,88.0,67.0,310.0,392.0,80.0,50.0,30.0,30.0,6.0,45.0,38.0,27.0,1163.0
New Delhi,16.3.10,Stock Position of Vitamin A solution,5. Total Stock,110.0,43.0,233.0,241.0,161.0,111.0,81.0,51.0,45.0,100.0,62.0,135.0,1373.0
New Delhi,16.3.11,Stock of ORS (New WHO formulation),1. Balance From Previous Month,1350.0,1175.0,3775.0,1900.0,22350.0,17200.0,17200.0,17200.0,17200.0,17200.0,17100.0,16900.0,150550.0
New Delhi,16.3.11,Stock of ORS (New WHO formulation),2. Stocks Received,0.0,5000.0,0.0,40000.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,45000.0
New Delhi,16.3.11,Stock of ORS (New WHO formulation),3. Unusable Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
New Delhi,16.3.11,Stock of ORS (New WHO formulation),4. Stock Distributed,175.0,2400.0,1875.0,19550.0,5150.0,0.0,0.0,0.0,0.0,100.0,200.0,250.0,29700.0
New Delhi,16.3.11,Stock of ORS (New WHO formulation),5. Total Stock,1175.0,3775.0,1900.0,22350.0,17200.0,17200.0,17200.0,17200.0,17200.0,17100.0,16900.0,16650.0,165850.0
New Delhi,16.4.1,Stock Position of 0.1 ml Syringes(AD),1. Balance From Previous Month,1510.0,1440.0,1150.0,1020.0,1970.0,1790.0,1550.0,1510.0,2400.0,2190.0,1990.0,1790.0,20310.0
New Delhi,16.4.1,Stock Position of 0.1 ml Syringes(AD),2. Stocks Received,0.0,0.0,0.0,1000.0,0.0,0.0,0.0,1000.0,0.0,0.0,0.0,0.0,2000.0
New Delhi,16.4.1,Stock Position of 0.1 ml Syringes(AD),3. Unusable Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
New Delhi,16.4.1,Stock Position of 0.1 ml Syringes(AD),4. Stock Distributed,70.0,290.0,130.0,50.0,180.0,240.0,40.0,110.0,210.0,200.0,200.0,220.0,1940.0
New Delhi,16.4.1,Stock Position of 0.1 ml Syringes(AD),5. Total Stock,1440.0,1150.0,1020.0,1970.0,1790.0,1550.0,1510.0,2400.0,2190.0,1990.0,1790.0,1570.0,20370.0
New Delhi,16.4.2,Stock Position of 0.5 ml Syringes(AD),1. Balance From Previous Month,8600.0,17000.0,10800.0,17000.0,11000.0,8800.0,12600.0,14400.0,16800.0,13800.0,11200.0,8000.0,150000.0
New Delhi,16.4.2,Stock Position of 0.5 ml Syringes(AD),2. Stocks Received,18000.0,0.0,16000.0,0.0,0.0,8000.0,4000.0,6000.0,0.0,0.0,0.0,3600.0,55600.0
New Delhi,16.4.2,Stock Position of 0.5 ml Syringes(AD),3. Unusable Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
New Delhi,16.4.2,Stock Position of 0.5 ml Syringes(AD),4. Stock Distributed,9600.0,6200.0,9800.0,6000.0,2200.0,4200.0,2200.0,3600.0,3000.0,2600.0,3200.0,2800.0,55400.0
New Delhi,16.4.2,Stock Position of 0.5 ml Syringes(AD),5. Total Stock,17000.0,10800.0,17000.0,11000.0,8800.0,12600.0,14400.0,16800.0,13800.0,11200.0,8000.0,8800.0,150200.0
New Delhi,16.4.3,Stock Position of 5.0 ml Syringes(Disposable),1. Balance From Previous Month,300.0,100.0,1300.0,1000.0,400.0,200.0,50.0,1100.0,800.0,650.0,600.0,500.0,7000.0
New Delhi,16.4.3,Stock Position of 5.0 ml Syringes(Disposable),2. Stocks Received,0.0,1200.0,0.0,0.0,0.0,0.0,1200.0,0.0,0.0,0.0,0.0,600.0,3000.0
New Delhi,16.4.3,Stock Position of 5.0 ml Syringes(Disposable),3. Unusable Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
New Delhi,16.4.3,Stock Position of 5.0 ml Syringes(Disposable),4. Stock Distributed,200.0,0.0,300.0,600.0,200.0,150.0,150.0,300.0,150.0,50.0,100.0,250.0,2450.0
New Delhi,16.4.3,Stock Position of 5.0 ml Syringes(Disposable),5. Total Stock,100.0,1300.0,1000.0,400.0,200.0,50.0,1100.0,800.0,650.0,600.0,500.0,850.0,7550.0
New Delhi,17.1,Number of cases of Infant deaths within 24 hrs of birth,TOTAL,,,2.0,2.0,3.0,3.0,6.0,5.0,2.0,,,,23.0
New Delhi,17.2.1,Number of cases of Infant deaths 24 hours to 4 weeks of birth with the probable cause being Sepsis,1. Up to 1 Weeks of Birth,38.0,15.0,70.0,73.0,84.0,90.0,64.0,43.0,25.0,17.0,12.0,20.0,551.0
New Delhi,17.2.1,Number of cases of Infant deaths 24 hours to 4 weeks of birth with the probable cause being Sepsis,2. Between 1 week & 4 weeks of birth,,,,5.0,4.0,5.0,,,1.0,6.0,4.0,1.0,26.0
New Delhi,17.2.1,Number of cases of Infant deaths 24 hours to 4 weeks of birth with the probable cause being Sepsis,3. Total,38.0,15.0,70.0,78.0,88.0,95.0,64.0,43.0,26.0,23.0,16.0,21.0,577.0
New Delhi,17.2.2,Number of cases of Infant deaths 24 hours to 4 weeks of birth with the probable cause being Asphyxia,1. Up to 1 Weeks of Birth,10.0,3.0,6.0,8.0,10.0,10.0,7.0,3.0,5.0,7.0,4.0,4.0,77.0
New Delhi,17.2.2,Number of cases of Infant deaths 24 hours to 4 weeks of birth with the probable cause being Asphyxia,2. Between 1 week & 4 weeks of birth,,,,2.0,1.0,,,,1.0,,,,4.0
New Delhi,17.2.2,Number of cases of Infant deaths 24 hours to 4 weeks of birth with the probable cause being Asphyxia,3. Total,10.0,3.0,6.0,10.0,11.0,10.0,7.0,3.0,6.0,7.0,4.0,4.0,81.0
New Delhi,17.2.3,Number of cases of Infant deaths 24 hours to 4 weeks of birth with the probable cause being LBW,1. Up to 1 Weeks of Birth,5.0,4.0,9.0,4.0,4.0,2.0,8.0,7.0,3.0,,5.0,4.0,55.0
New Delhi,17.2.3,Number of cases of Infant deaths 24 hours to 4 weeks of birth with the probable cause being LBW,2. Between 1 week & 4 weeks of birth,,,,2.0,,,,,,,,,2.0
New Delhi,17.2.3,Number of cases of Infant deaths 24 hours to 4 weeks of birth with the probable cause being LBW,3. Total,5.0,4.0,9.0,6.0,4.0,2.0,8.0,7.0,3.0,,5.0,4.0,57.0
New Delhi,17.2.4,"Number of cases of Infant deaths 24 hours to 4 weeks of birth with the probable cause being other than Sepsis, Asphyxia and LBW",1. Up to 1 Weeks of Birth,12.0,14.0,11.0,14.0,16.0,7.0,7.0,6.0,4.0,11.0,30.0,9.0,141.0
New Delhi,17.2.4,"Number of cases of Infant deaths 24 hours to 4 weeks of birth with the probable cause being other than Sepsis, Asphyxia and LBW",2. Between 1 week & 4 weeks of birth,,,,2.0,3.0,1.0,4.0,,,1.0,2.0,,13.0
New Delhi,17.2.4,"Number of cases of Infant deaths 24 hours to 4 weeks of birth with the probable cause being other than Sepsis, Asphyxia and LBW",3. Total,12.0,14.0,11.0,16.0,19.0,8.0,11.0,6.0,4.0,12.0,32.0,9.0,154.0
New Delhi,17.3.1,Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being Pneumonia,1. Between 1 month and 11 months,6.0,5.0,9.0,11.0,20.0,9.0,12.0,9.0,7.0,7.0,4.0,2.0,101.0
New Delhi,17.3.1,Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being Pneumonia,2. Between 1 year & 5 years,9.0,19.0,15.0,14.0,12.0,9.0,7.0,6.0,3.0,3.0,13.0,5.0,115.0
New Delhi,17.3.1,Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being Pneumonia,3. Total,15.0,24.0,24.0,25.0,32.0,18.0,19.0,15.0,10.0,10.0,17.0,7.0,216.0
New Delhi,17.3.2,Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being Diarrhoea,1. Between 1 month and 11 months,,,3.0,7.0,3.0,5.0,6.0,,1.0,,,1.0,26.0
New Delhi,17.3.2,Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being Diarrhoea,2. Between 1 year & 5 years,11.0,10.0,9.0,2.0,3.0,2.0,1.0,,,,,,38.0
New Delhi,17.3.2,Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being Diarrhoea,3. Total,11.0,10.0,12.0,9.0,6.0,7.0,7.0,,1.0,,,1.0,64.0
New Delhi,17.3.3,Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being Fever related,1. Between 1 month and 11 months,,2.0,9.0,6.0,13.0,7.0,16.0,5.0,9.0,8.0,2.0,5.0,82.0
New Delhi,17.3.3,Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being Fever related,2. Between 1 year & 5 years,9.0,1.0,7.0,8.0,10.0,4.0,17.0,8.0,9.0,8.0,5.0,4.0,90.0
New Delhi,17.3.3,Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being Fever related,3. Total,9.0,3.0,16.0,14.0,23.0,11.0,33.0,13.0,18.0,16.0,7.0,9.0,172.0
New Delhi,17.3.4,Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being Measles,1. Between 1 month and 11 months,,,,,,,,,,,,,
New Delhi,17.3.4,Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being Measles,2. Between 1 year & 5 years,,,,,,,,,,,,,
New Delhi,17.3.4,Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being Measles,3. Total,,,,,,,,,,,,,
New Delhi,17.3.5,"Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being other than Pneumonia, Diarrhoea, Fever related and Measles",1. Between 1 month and 11 months,17.0,12.0,17.0,9.0,24.0,14.0,19.0,13.0,13.0,32.0,20.0,15.0,205.0
New Delhi,17.3.5,"Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being other than Pneumonia, Diarrhoea, Fever related and Measles",2. Between 1 year & 5 years,6.0,8.0,11.0,9.0,14.0,21.0,12.0,11.0,5.0,16.0,25.0,10.0,148.0
New Delhi,17.3.5,"Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being other than Pneumonia, Diarrhoea, Fever related and Measles",3. Total,23.0,20.0,28.0,18.0,38.0,35.0,31.0,24.0,18.0,48.0,45.0,25.0,353.0
New Delhi,17.4.1,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Diarrhoeal diseases,1. 6-14 yrs,6.0,2.0,7.0,7.0,1.0,1.0,,,,,1.0,,25.0
New Delhi,17.4.1,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Diarrhoeal diseases,2. 15-55 yrs.,1.0,4.0,3.0,2.0,1.0,2.0,,,,,,,13.0
New Delhi,17.4.1,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Diarrhoeal diseases,3. Above 55 yrs.,,,,,,,,,,,,,
New Delhi,17.4.1,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Diarrhoeal diseases,4. Total,7.0,6.0,10.0,9.0,2.0,3.0,,,,,1.0,,38.0
New Delhi,17.4.2,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Tuberculosis,1. 6-14 yrs,2.0,3.0,1.0,2.0,,1.0,,1.0,2.0,,2.0,1.0,15.0
New Delhi,17.4.2,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Tuberculosis,2. 15-55 yrs.,11.0,7.0,19.0,15.0,32.0,35.0,29.0,13.0,21.0,18.0,21.0,11.0,232.0
New Delhi,17.4.2,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Tuberculosis,3. Above 55 yrs.,1.0,5.0,2.0,3.0,10.0,12.0,6.0,7.0,8.0,13.0,5.0,7.0,79.0
New Delhi,17.4.2,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Tuberculosis,4. Total,14.0,15.0,22.0,20.0,42.0,48.0,35.0,21.0,31.0,31.0,28.0,19.0,326.0
New Delhi,17.4.3,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Respiratory diseases including infections,1. 6-14 yrs,2.0,,2.0,1.0,3.0,2.0,1.0,2.0,1.0,1.0,1.0,1.0,17.0
New Delhi,17.4.3,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Respiratory diseases including infections,2. 15-55 yrs.,15.0,4.0,16.0,10.0,13.0,19.0,23.0,2.0,8.0,4.0,30.0,11.0,155.0
New Delhi,17.4.3,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Respiratory diseases including infections,3. Above 55 yrs.,12.0,6.0,19.0,6.0,6.0,8.0,21.0,5.0,9.0,11.0,26.0,5.0,134.0
New Delhi,17.4.3,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Respiratory diseases including infections,4. Total,29.0,10.0,37.0,17.0,22.0,29.0,45.0,9.0,18.0,16.0,57.0,17.0,306.0
New Delhi,17.4.4,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Malaria,1. 6-14 yrs,4.0,,1.0,,,,,,,,,,5.0
New Delhi,17.4.4,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Malaria,2. 15-55 yrs.,7.0,13.0,18.0,21.0,35.0,6.0,,,,,,,100.0
New Delhi,17.4.4,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Malaria,3. Above 55 yrs.,,2.0,1.0,1.0,3.0,,,,,,,,7.0
New Delhi,17.4.4,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Malaria,4. Total,11.0,15.0,20.0,22.0,38.0,6.0,,,,,,,112.0
New Delhi,17.4.5,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being other Fever related,1. 6-14 yrs,12.0,6.0,14.0,8.0,12.0,8.0,12.0,7.0,4.0,3.0,1.0,,87.0
New Delhi,17.4.5,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being other Fever related,2. 15-55 yrs.,78.0,47.0,86.0,62.0,73.0,95.0,60.0,23.0,28.0,35.0,78.0,50.0,715.0
New Delhi,17.4.5,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being other Fever related,3. Above 55 yrs.,1.0,5.0,5.0,1.0,16.0,17.0,4.0,5.0,3.0,5.0,19.0,10.0,91.0
New Delhi,17.4.5,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being other Fever related,4. Total,91.0,58.0,105.0,71.0,101.0,120.0,76.0,35.0,35.0,43.0,98.0,60.0,893.0
New Delhi,17.4.6,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being HIV/AIDS,1. 6-14 yrs,,,,,,,,,,,,,
New Delhi,17.4.6,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being HIV/AIDS,2. 15-55 yrs.,,,2.0,,,,,2.0,,1.0,,2.0,7.0
New Delhi,17.4.6,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being HIV/AIDS,3. Above 55 yrs.,,,,,,1.0,,1.0,,1.0,,,3.0
New Delhi,17.4.6,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being HIV/AIDS,4. Total,,,2.0,,,1.0,,3.0,,2.0,,2.0,10.0
New Delhi,17.4.7,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Heart disease or related to Hypertension,1. 6-14 yrs,,,,1.0,,,2.0,2.0,2.0,2.0,,,9.0
New Delhi,17.4.7,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Heart disease or related to Hypertension,2. 15-55 yrs.,58.0,39.0,41.0,71.0,72.0,78.0,93.0,65.0,34.0,44.0,104.0,55.0,754.0
New Delhi,17.4.7,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Heart disease or related to Hypertension,3. Above 55 yrs.,75.0,54.0,87.0,82.0,67.0,71.0,87.0,94.0,56.0,84.0,101.0,60.0,918.0
New Delhi,17.4.7,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Heart disease or related to Hypertension,4. Total,133.0,93.0,128.0,154.0,139.0,149.0,182.0,161.0,92.0,130.0,205.0,115.0,1681.0
New Delhi,17.4.8,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Neurological disease including strokes,1. 6-14 yrs,1.0,1.0,,,,,1.0,1.0,,,3.0,,7.0
New Delhi,17.4.8,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Neurological disease including strokes,2. 15-55 yrs.,20.0,20.0,32.0,63.0,62.0,56.0,16.0,7.0,7.0,31.0,43.0,16.0,373.0
New Delhi,17.4.8,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Neurological disease including strokes,3. Above 55 yrs.,47.0,15.0,30.0,38.0,35.0,32.0,7.0,12.0,12.0,45.0,61.0,13.0,347.0
New Delhi,17.4.8,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Neurological disease including strokes,4. Total,68.0,36.0,62.0,101.0,97.0,88.0,24.0,20.0,19.0,76.0,107.0,29.0,727.0
New Delhi,17.4.9(a),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Abortion,1. 6-14 yrs,,,,,,,,,,,,,
New Delhi,17.4.9(a),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Abortion,2. 15-49 yrs,2.0,,1.0,,1.0,,,,,,,1.0,5.0
New Delhi,17.4.9(a),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Abortion,3. Above 49 yrs.,,,,,,,,,,,,,
New Delhi,17.4.9(a),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Abortion,4. Total,2.0,,1.0,,1.0,,,,,,,1.0,5.0
New Delhi,17.4.9(b),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Obstructed or prolonged labour,1. 6-14 yrs,,,,,,,,,,,,,
New Delhi,17.4.9(b),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Obstructed or prolonged labour,2. 15-49 yrs,,,,,,,,,,,,1.0,1.0
New Delhi,17.4.9(b),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Obstructed or prolonged labour,3. Above 49 yrs.,,,,,,,,,,,,,
New Delhi,17.4.9(b),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Obstructed or prolonged labour,4. Total,,,,,,,,,,,,1.0,1.0
New Delhi,17.4.9(c),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Severe hypertesnion or fits,1. 6-14 yrs,,,,,,,,,,,,,
New Delhi,17.4.9(c),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Severe hypertesnion or fits,2. 15-49 yrs,1.0,2.0,3.0,4.0,2.0,1.0,2.0,3.0,6.0,1.0,,3.0,28.0
New Delhi,17.4.9(c),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Severe hypertesnion or fits,3. Above 49 yrs.,,,,,,,,,,,,,
New Delhi,17.4.9(c),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Severe hypertesnion or fits,4. Total,1.0,2.0,3.0,4.0,2.0,1.0,2.0,3.0,6.0,1.0,,3.0,28.0
New Delhi,17.4.9(d),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Bleeding,1. 6-14 yrs,,,,,,,,,,,,,
New Delhi,17.4.9(d),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Bleeding,2. 15-49 yrs,1.0,,,,1.0,,,2.0,1.0,,,,5.0
New Delhi,17.4.9(d),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Bleeding,3. Above 49 yrs.,,,,,,,,,,,,,
New Delhi,17.4.9(d),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Bleeding,4. Total,1.0,,,,1.0,,,2.0,1.0,,,,5.0
New Delhi,17.4.9(e),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being High Fever,1. 6-14 yrs,,,,,,,,,,,,,
New Delhi,17.4.9(e),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being High Fever,2. 15-49 yrs,2.0,,,3.0,1.0,1.0,4.0,,,1.0,2.0,1.0,15.0
New Delhi,17.4.9(e),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being High Fever,3. Above 49 yrs.,,,,,,,,,,,,,
New Delhi,17.4.9(e),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being High Fever,4. Total,2.0,,,3.0,1.0,1.0,4.0,,,1.0,2.0,1.0,15.0
New Delhi,17.4.9(f),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being other causes (excluding abortion; obstructed or prolonged labour; severe hypertension or fits;,1. 6-14 yrs,,,,,,,,,,,,,
New Delhi,17.4.9(f),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being other causes (excluding abortion; obstructed or prolonged labour; severe hypertension or fits;,2. 15-49 yrs,3.0,8.0,4.0,3.0,7.0,6.0,4.0,3.0,6.0,9.0,5.0,7.0,65.0
New Delhi,17.4.9(f),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being other causes (excluding abortion; obstructed or prolonged labour; severe hypertension or fits;,3. Above 49 yrs.,,,,,,,,,,,,,
New Delhi,17.4.9(f),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being other causes (excluding abortion; obstructed or prolonged labour; severe hypertension or fits;,4. Total,3.0,8.0,4.0,3.0,7.0,6.0,4.0,3.0,6.0,9.0,5.0,7.0,65.0
New Delhi,17.4.10,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Trauma or Accidents or Burn cases,1. 6-14 yrs,,,,,,,1.0,,,1.0,,,2.0
New Delhi,17.4.10,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Trauma or Accidents or Burn cases,2. 15-55 yrs.,11.0,7.0,8.0,11.0,8.0,9.0,19.0,25.0,23.0,5.0,15.0,14.0,155.0
New Delhi,17.4.10,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Trauma or Accidents or Burn cases,3. Above 55 yrs.,3.0,2.0,4.0,1.0,1.0,2.0,5.0,4.0,6.0,1.0,2.0,1.0,32.0
New Delhi,17.4.10,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Trauma or Accidents or Burn cases,4. Total,14.0,9.0,12.0,12.0,9.0,11.0,25.0,29.0,29.0,7.0,17.0,15.0,189.0
New Delhi,17.4.11,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being suicide,1. 6-14 yrs,,,,,,,,,,,,,
New Delhi,17.4.11,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being suicide,2. 15-55 yrs.,,,,1.0,,2.0,1.0,2.0,1.0,,,,7.0
New Delhi,17.4.11,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being suicide,3. Above 55 yrs.,,,,,,,,2.0,,,,,2.0
New Delhi,17.4.11,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being suicide,4. Total,,,,1.0,,2.0,1.0,4.0,1.0,,,,9.0
New Delhi,17.4.12,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Animal bites and stings,1. 6-14 yrs,,,,,,,,,,,,,
New Delhi,17.4.12,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Animal bites and stings,2. 15-55 yrs.,,,,,,,,,,,,1.0,1.0
New Delhi,17.4.12,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Animal bites and stings,3. Above 55 yrs.,,,,,,,,,,,,,
New Delhi,17.4.12,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Animal bites and stings,4. Total,,,,,,,,,,,,1.0,1.0
New Delhi,17.4.13(a),Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Known Acute disease,1. 6-14 yrs,2.0,,,1.0,2.0,,,,,,3.0,1.0,9.0
New Delhi,17.4.13(a),Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Known Acute disease,2. 15-55 yrs.,22.0,22.0,33.0,42.0,37.0,37.0,60.0,74.0,65.0,166.0,129.0,132.0,819.0
New Delhi,17.4.13(a),Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Known Acute disease,3. Above 55 yrs.,9.0,9.0,5.0,6.0,9.0,5.0,12.0,27.0,20.0,73.0,67.0,57.0,299.0
New Delhi,17.4.13(a),Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Known Acute disease,4. Total,33.0,31.0,38.0,49.0,48.0,42.0,72.0,101.0,85.0,239.0,199.0,190.0,1127.0
New Delhi,17.4.13(b),Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Known Chronic disease,1. 6-14 yrs,,,,,2.0,,1.0,,2.0,1.0,,,6.0
New Delhi,17.4.13(b),Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Known Chronic disease,2. 15-55 yrs.,15.0,16.0,11.0,19.0,12.0,23.0,23.0,43.0,28.0,22.0,38.0,47.0,297.0
New Delhi,17.4.13(b),Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Known Chronic disease,3. Above 55 yrs.,14.0,18.0,15.0,18.0,25.0,19.0,26.0,29.0,27.0,39.0,32.0,27.0,289.0
New Delhi,17.4.13(b),Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Known Chronic disease,4. Total,29.0,34.0,26.0,37.0,39.0,42.0,50.0,72.0,57.0,62.0,70.0,74.0,592.0
New Delhi,17.4.13(c),Number of cases of Adolescent or Adult deaths (age 6 years & above) where the cause was not known,1. 6-14 yrs,3.0,1.0,1.0,,4.0,,8.0,3.0,6.0,2.0,2.0,,30.0
New Delhi,17.4.13(c),Number of cases of Adolescent or Adult deaths (age 6 years & above) where the cause was not known,2. 15-55 yrs.,81.0,37.0,35.0,11.0,13.0,8.0,94.0,77.0,62.0,55.0,36.0,15.0,524.0
New Delhi,17.4.13(c),Number of cases of Adolescent or Adult deaths (age 6 years & above) where the cause was not known,3. Above 55 yrs.,8.0,5.0,12.0,4.0,5.0,5.0,64.0,53.0,45.0,40.0,5.0,4.0,250.0
New Delhi,17.4.13(c),Number of cases of Adolescent or Adult deaths (age 6 years & above) where the cause was not known,4. Total,92.0,43.0,48.0,15.0,22.0,13.0,166.0,133.0,113.0,97.0,43.0,19.0,804.0
North,1.1,Total number of pregnant women Registered for ANC,TOTAL,7299.0,8439.0,7018.0,8016.0,9074.0,8692.0,5425.0,6593.0,7128.0,6259.0,7385.0,7607.0,88935.0
North,1.1.1,Of which Number registered within first trimester (within 12 weeks),TOTAL,1846.0,1854.0,2000.0,1879.0,1834.0,2213.0,1602.0,1862.0,2357.0,2127.0,2530.0,2824.0,24928.0
North,1.2,Number of Pregnant women registered under JSY,TOTAL,130.0,195.0,310.0,356.0,436.0,388.0,309.0,270.0,331.0,278.0,155.0,130.0,3288.0
North,1.3,Number of pregnant women received 3 ANC check ups during pregnancy,TOTAL,3406.0,3896.0,4034.0,4693.0,4374.0,4951.0,4201.0,3750.0,4210.0,3978.0,2889.0,3241.0,47623.0
North,1.4.1,Number of pregnant women given TT1 during current pregnancy,TOTAL,1993.0,2132.0,1955.0,2219.0,2134.0,2186.0,1620.0,1693.0,1682.0,1680.0,2062.0,2469.0,23825.0
North,1.4.2,Number of pregnant women given TT2 or Booster during current pregnancy,TOTAL,1618.0,1812.0,1696.0,1941.0,1727.0,1899.0,1782.0,1530.0,1574.0,1529.0,1406.0,1936.0,20450.0
North,1.5,Total number of pregnant women given 100 IFA tablets,TOTAL,4899.0,5325.0,5333.0,6024.0,5695.0,6793.0,4444.0,4046.0,5187.0,5528.0,4951.0,5008.0,63233.0
North,1.6.1,Number of new cases of Hypertension (BP>140/90) detected in Pregnant women at the institution,TOTAL,39.0,87.0,66.0,62.0,62.0,48.0,38.0,87.0,181.0,153.0,109.0,107.0,1039.0
North,1.6.2,Number of Eclampsia cases managed during delivery,TOTAL,4.0,5.0,3.0,6.0,4.0,3.0,1.0,14.0,2.0,0.0,0.0,24.0,66.0
North,1.7.1,Number of Pregnant women with anaemia i.e. Hb level<11 (tested cases),TOTAL,2254.0,2788.0,2539.0,2451.0,2974.0,2561.0,2111.0,2331.0,2417.0,2319.0,2676.0,2910.0,30331.0
North,1.7.2,Number of Pregnant women having severe anaemia (Hb<7) treated at institution,TOTAL,259.0,271.0,302.0,226.0,195.0,231.0,209.0,121.0,91.0,107.0,102.0,104.0,2218.0
North,1.8,Number of pregnancy test kits used at SC level,TOTAL,0.0,11.0,8.0,9.0,38.0,61.0,40.0,104.0,282.0,35.0,16.0,14.0,618.0
North,2.1.1.a,Number of deliveries conducted at Home and attended by trained SBA(i.e. Doctor or Nurse or ANM),TOTAL,10.0,6.0,11.0,41.0,40.0,41.0,22.0,0.0,5.0,1.0,1.0,5.0,183.0
North,2.1.1.b,Number of deliveries conducted at Home and attended by non trained SBA (i.e. trained TBA or Relatives etc.),TOTAL,118.0,117.0,92.0,131.0,212.0,217.0,173.0,239.0,234.0,247.0,256.0,198.0,2234.0
North,2.1.1.c,Total number of deliveries conducted at Home and attended by trained or non-trained SBA (i.e. sum of 2.1.1.a and 2.1.1.b),TOTAL,128.0,123.0,103.0,172.0,252.0,258.0,195.0,239.0,239.0,248.0,257.0,203.0,2417.0
North,2.1.2,Number of newborns visited within 24 hours of delivery for deliveries conducted at home,TOTAL,36.0,32.0,25.0,47.0,89.0,96.0,106.0,97.0,113.0,116.0,154.0,123.0,1034.0
North,2.1.3,Number of mothers paid JSY incentive for deliveries conducted at home,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,3.0,0.0,0.0,0.0,0.0,0.0,3.0
North,2.2,Deliveries conducted at Public Institutions (Including C-Sections),TOTAL,400.0,452.0,447.0,667.0,708.0,706.0,558.0,508.0,446.0,537.0,456.0,416.0,6301.0
North,2.2.1,"Out of 2.2, Number discharged under 48 hours of delivery",TOTAL,221.0,237.0,312.0,456.0,489.0,496.0,356.0,349.0,300.0,420.0,337.0,315.0,4288.0
North,2.2.2.a,Number of mothers paid JSY Incentive for deliveries conducted at Public Institutions,TOTAL,61.0,78.0,112.0,141.0,114.0,149.0,121.0,90.0,92.0,133.0,97.0,109.0,1297.0
North,2.2.2.b,Number of ASHAs paid JSY Incentive for deliveries conducted at Public Institutions,TOTAL,1.0,2.0,0.0,2.0,3.0,6.0,0.0,0.0,0.0,7.0,2.0,0.0,23.0
North,2.2.2.c,Number of cases of deliveries conducted at Public Institutions where JSY incentive was paid to ANMs or AWWs [only for High Performing States (HPS)],TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
North,2.3,Deliveries conducted at Private Institutions (Including C-Sections),TOTAL,82.0,31.0,75.0,108.0,85.0,79.0,86.0,92.0,101.0,84.0,84.0,91.0,998.0
North,2.3.1.a,Number of mothers paid JSY Incentive for deliveries conducted at accredited Private Institutions,TOTAL,,0.0,,,,,,,,,,,0.0
North,2.3.1.b,Number of ASHAs paid JSY Incentive for deliveries conducted at accredited Private Institutions,TOTAL,,,,,,,,,,,,,
North,2.3.1.c,Number of cases of deliveries conducted at accredited Private Institutions where JSY incentive was paid to ANMs or AWWs [only for High Performing States (HPS)],TOTAL,,0.0,,,,,,,,,,,0.0
North,3.1.1,Number of Caesarean (C-Section) deliveries performed at PHCs (Primary Health Centre),TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,,,0.0,0.0,0.0,0.0
North,3.1.2,Number of Caesarean (C-Section) deliveries performed at CHCs (Community Health Centre),TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,,,0.0,,,0.0
North,3.1.3,Number of Caesarean (C-Section) deliveries performed at SDHs (Sub-divisional Hospital) or DHs (District Hospital),TOTAL,25.0,43.0,32.0,46.0,45.0,53.0,39.0,42.0,25.0,42.0,43.0,33.0,468.0
North,3.1.4,Number of Caesarean (C-Section) deliveries performed at other State owned public institutions,TOTAL,,,,,,,,,,,,,
North,3.1.5,"Total Number of Caesarean (C-Section) deliveries performed at Public facilities i.e. PHC, CHC, SDH, DH and other State owned public institutions (sum of items from 3.1.1 to 3.1.4)",TOTAL,25.0,43.0,32.0,46.0,45.0,53.0,39.0,42.0,25.0,42.0,43.0,33.0,468.0
North,3.2,No. of C-section deliveries performed at Private facilities,TOTAL,31.0,19.0,23.0,22.0,20.0,17.0,18.0,24.0,25.0,32.0,31.0,25.0,287.0
North,4.1.1.a,Number of male live births,TOTAL,313.0,310.0,353.0,482.0,565.0,533.0,421.0,436.0,420.0,464.0,410.0,344.0,5051.0
North,4.1.1.b,Number of female live births,TOTAL,290.0,303.0,280.0,454.0,475.0,501.0,409.0,406.0,359.0,399.0,381.0,355.0,4612.0
North,4.1.1.c,Total number of male and female live births (4.1.1.a and 4.1.1.b),TOTAL,603.0,613.0,633.0,936.0,1040.0,1034.0,830.0,842.0,779.0,863.0,791.0,699.0,9663.0
North,4.1.2,Number of still births,TOTAL,9.0,7.0,12.0,12.0,6.0,9.0,13.0,2.0,8.0,9.0,9.0,12.0,108.0
North,4.1.3,Number of Abortions (spontaneous or induced),TOTAL,192.0,114.0,128.0,148.0,133.0,152.0,142.0,102.0,127.0,135.0,140.0,109.0,1622.0
North,4.2.1,Number of Newborns weighed at birth,TOTAL,528.0,516.0,572.0,851.0,893.0,841.0,698.0,752.0,699.0,772.0,735.0,651.0,8508.0
North,4.2.2,Number of Newborns having weight less than 2.5 kg,TOTAL,116.0,102.0,149.0,161.0,198.0,247.0,141.0,122.0,88.0,146.0,158.0,139.0,1767.0
North,4.3,Number of Newborns breast fed within 1 hour of birth,TOTAL,491.0,458.0,525.0,798.0,867.0,864.0,679.0,728.0,651.0,715.0,649.0,589.0,8014.0
North,5.1.1,Number of cases of pregnant women with Obstetric Complications and attended at PHCs,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,,,0.0,0.0,0.0,0.0
North,5.1.2,Number of cases of pregnant women with Obstetric Complications and attended at CHCs,TOTAL,0.0,7.0,1.0,0.0,,1.0,0.0,,0.0,0.0,0.0,0.0,9.0
North,5.1.3,Number of cases of pregnant women with Obstetric Complications and attended at SDHs or DHs,TOTAL,319.0,448.0,289.0,586.0,240.0,316.0,229.0,185.0,147.0,194.0,168.0,214.0,3335.0
North,5.1.4,Number of cases of pregnant women with Obstetric Complications and attended at other State owned public institutions,TOTAL,,,,,,,,,,,,,
North,5.1.5,"Number of cases of pregnant women with Obstetric Complications and attended at Public facilities i.e. PHC, CHC, SDH, DH and other State owned public institutions (sum of items from 5.1.1 to 5.1.4)",TOTAL,319.0,455.0,290.0,586.0,240.0,317.0,229.0,185.0,147.0,194.0,168.0,214.0,3344.0
North,5.2,Number of cases of pregnant women with Obstetric Complications and attended at Private facilities,TOTAL,60.0,5.0,42.0,54.0,45.0,46.0,53.0,55.0,45.0,43.0,49.0,42.0,539.0
North,5.3.1,Number of cases of complicated pregnancies treated with IV antibiotics,TOTAL,184.0,138.0,126.0,212.0,194.0,199.0,241.0,177.0,158.0,142.0,88.0,128.0,1987.0
North,5.3.2,Number of cases of complicated pregnancies treated with IV Antihypertensive/Magsulph injection,TOTAL,11.0,7.0,12.0,14.0,10.0,13.0,11.0,26.0,29.0,7.0,4.0,14.0,158.0
North,5.3.3,Number of cases of complicated pregnancies treated with IV Oxytocis,TOTAL,379.0,460.0,330.0,580.0,179.0,262.0,185.0,234.0,124.0,203.0,110.0,178.0,3224.0
North,5.3.4,Number of cases of complicated pregnancies treated with Blood Transfusion,TOTAL,47.0,67.0,27.0,55.0,65.0,24.0,30.0,24.0,8.0,9.0,25.0,37.0,418.0
North,6.1,Women getting post partum check-up within 48 hours after delivery,TOTAL,543.0,539.0,611.0,893.0,964.0,960.0,769.0,820.0,723.0,827.0,769.0,707.0,9125.0
North,6.2,Women getting a post partum check up between 48 hours and 14 days after delivery,TOTAL,546.0,622.0,559.0,640.0,889.0,823.0,794.0,832.0,695.0,755.0,642.0,649.0,8446.0
North,6.3,PNC maternal complications attended,TOTAL,46.0,70.0,18.0,28.0,41.0,13.0,48.0,15.0,20.0,26.0,18.0,30.0,373.0
North,7.1.1,Number of MTPs conducted at Public Institutions up to 12 weeks of pregnancy,TOTAL,27.0,15.0,16.0,23.0,31.0,17.0,34.0,18.0,17.0,26.0,28.0,27.0,279.0
North,7.1.2,Number of MTPs conducted at Public Institutions for more than 12 weeks of pregnancy,TOTAL,5.0,0.0,0.0,1.0,3.0,1.0,0.0,3.0,3.0,1.0,6.0,5.0,28.0
North,7.1.3,Total number of MTPs conducted at Public Institutions (sum of items 7.1.1 and 7.1.2),TOTAL,32.0,15.0,16.0,24.0,34.0,18.0,34.0,21.0,20.0,27.0,34.0,32.0,307.0
North,7.2,Number of MTPs conducted at Private Facilities,TOTAL,35.0,22.0,24.0,21.0,30.0,34.0,38.0,38.0,37.0,30.0,35.0,34.0,378.0
North,8.1.a,Number of new cases of RTI/STI in males for which treatment was initiated,TOTAL,281.0,496.0,494.0,485.0,414.0,304.0,237.0,218.0,264.0,336.0,364.0,326.0,4219.0
North,8.1.b,Number of new cases of RTI/STI in females for which treatment was initiated,TOTAL,1209.0,1472.0,1325.0,1421.0,1731.0,1410.0,1027.0,1320.0,1167.0,1091.0,1137.0,1177.0,15487.0
North,8.1.c,Total number of new cases of RTI/STI in males and females for which treatment was initiated (sum of items 8.1.a and 8.1.b),TOTAL,1490.0,1968.0,1819.0,1906.0,2145.0,1714.0,1264.0,1538.0,1431.0,1427.0,1501.0,1503.0,19706.0
North,8.2,Number of suspected RTI/STI cases for whom wet mount test was conducted,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
North,9.1.1.a,Number of NSV (No Scalpel Vasectomy) or Conventional Vasectomy conducted at PHCs,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,,,0.0,0.0,0.0,0.0
North,9.1.1.b,Number of NSV or Conventional Vasectomy conducted at CHCs,TOTAL,0.0,0.0,0.0,0.0,,0.0,0.0,0.0,,,,,0.0
North,9.1.1.c,Number of NSV or Conventional Vasectomy conducted at SDHs or DHs,TOTAL,0.0,0.0,0.0,2.0,0.0,2.0,1.0,0.0,0.0,0.0,1.0,0.0,6.0
North,9.1.1.d,Number of NSV or Conventional Vasectomy conducted at other State owned public institutions,TOTAL,,,,,,,,,,,,,
North,9.1.1.e,"Total Number of NSV or Conventional Vasectomy conducted at Public facilities i.e. PHC, CHC, SDH, DH and other State owned public institutions (sum of items from 9.1.1.a to 9.1.1.d)",TOTAL,0.0,0.0,0.0,2.0,0.0,2.0,1.0,0.0,0.0,0.0,1.0,0.0,6.0
North,9.1.2,Number of NSV or Conventional Vasectomy conducted at Private facilities,TOTAL,,,0.0,,,,,1.0,0.0,0.0,0.0,,1.0
North,9.2.1.a,Number of Laparoscopic sterilizations conducted at PHCs,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,,,0.0,0.0,0.0,0.0
North,9.2.1.b,Number of Laparoscopic sterilizations conducted at CHCs,TOTAL,0.0,0.0,0.0,0.0,,0.0,0.0,0.0,,,,,0.0
North,9.2.1.c,Number of Laparoscopic sterilizations conducted at SDHs or DHs,TOTAL,21.0,10.0,3.0,23.0,9.0,12.0,5.0,7.0,15.0,13.0,22.0,13.0,153.0
North,9.2.1.d,Number of Laparoscopic sterilizations conducted at other State owned public institutions,TOTAL,,,,,,,,,,,,,
North,9.2.1.e,"Total Number of Laparoscopic sterilizations conducted at Public facilities i.e. PHC, CHC, SDH, DH and other State owned public institutions (sum of items from 9.2.1.a to 9.2.1.d)",TOTAL,21.0,10.0,3.0,23.0,9.0,12.0,5.0,7.0,15.0,13.0,22.0,13.0,153.0
North,9.2.2,Number of Laparoscopic sterilizations conducted at Private facilities,TOTAL,1.0,,1.0,1.0,2.0,1.0,4.0,2.0,2.0,0.0,0.0,,14.0
North,9.3.1.a,Number of Mini-lap sterilizations conducted at PHCs,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,,,0.0,0.0,0.0,0.0
North,9.3.1.b,Number of Mini-lap sterilizations conducted at CHCs,TOTAL,0.0,0.0,0.0,0.0,,0.0,0.0,,,,,,0.0
North,9.3.1.c,Number of Mini-lap sterilizations conducted at SDHs or DHs,TOTAL,2.0,1.0,2.0,7.0,3.0,1.0,2.0,2.0,4.0,6.0,6.0,12.0,48.0
North,9.3.1.d,Number of Mini-lap sterilizations conducted at other State owned public institutions,TOTAL,,,,,,,,,,,,,
North,9.3.1.e,"Total Number of Mini-lap sterilizations conducted at Public facilities i.e. PHC, CHC, SDH, DH and other State owned public institutions (sum of items from 9.3.1.a to 9.3.1.d)",TOTAL,2.0,1.0,2.0,7.0,3.0,1.0,2.0,2.0,4.0,6.0,6.0,12.0,48.0
North,9.3.2,Number of Mini-lap sterilizations conducted at Private facilities,TOTAL,1.0,1.0,1.0,0.0,0.0,0.0,0.0,0.0,1.0,3.0,2.0,1.0,10.0
North,9.4.1.a,Number of Post-Partum sterilizations conducted at PHCs,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,,,0.0,0.0,0.0,0.0
North,9.4.1.b,Number of Post-Partum sterilizations conducted at CHCs,TOTAL,0.0,0.0,0.0,0.0,,0.0,0.0,,,,,,0.0
North,9.4.1.c,Number of Post-Partum sterilizations conducted at SDHs or DHs,TOTAL,4.0,0.0,0.0,0.0,2.0,0.0,0.0,1.0,0.0,3.0,4.0,3.0,17.0
North,9.4.1.d,Number of Post-Partum sterilizations conducted at other State owned public institutions,TOTAL,,,,,,,,,,,,,
North,9.4.1.e,"Total Number of Post-Partum sterilizations conducted at Public facilities i.e. PHC, CHC, SDH, DH and other State owned public institutions (sum of items from 9.4.1.a to 9.4.1.d)",TOTAL,4.0,0.0,0.0,0.0,2.0,0.0,0.0,1.0,0.0,3.0,4.0,3.0,17.0
North,9.4.2,Number of Post-Partum sterilizations conducted at Private facilities,TOTAL,1.0,,1.0,1.0,1.0,0.0,0.0,1.0,2.0,4.0,1.0,0.0,12.0
North,9.5.1.a,Number of IUCD Insertions conducted at SCs,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,,0.0,0.0,0.0,0.0,0.0
North,9.5.1.b,Number of IUCD Insertions conducted at PHCs,TOTAL,150.0,166.0,121.0,226.0,141.0,114.0,137.0,139.0,158.0,119.0,93.0,107.0,1671.0
North,9.5.1.c,Number of IUCD Insertions conducted at CHCs,TOTAL,76.0,89.0,54.0,77.0,68.0,53.0,50.0,58.0,47.0,51.0,40.0,68.0,731.0
North,9.5.1.d,Number of IUCD Insertions conducted at SDHs or DHs,TOTAL,192.0,200.0,256.0,365.0,376.0,342.0,208.0,229.0,186.0,302.0,312.0,184.0,3152.0
North,9.5.1.e,Number of IUCD Insertions conducted at other State owned public institutions,TOTAL,,,,,,,,,,,,,
North,9.5.1.f,"Total Number of IUCD Insertions conducted at Public facilities i.e. SC, PHC, CHC, SDH, DH and other State owned public institutions (sum of items from 9.5.1.a to 9.5.1.e)",TOTAL,418.0,455.0,431.0,668.0,585.0,509.0,395.0,426.0,391.0,472.0,445.0,359.0,5554.0
North,9.5.1A,"Out of above total, Post Partum (within 48 hours of delivery) IUCD insertions",TOTAL,32.0,139.0,177.0,273.0,330.0,275.0,148.0,157.0,130.0,213.0,237.0,148.0,2259.0
North,9.5.2,Number of IUCD Insertions conducted at Private facilities,TOTAL,19.0,9.0,22.0,21.0,29.0,32.0,35.0,20.0,17.0,10.0,29.0,15.0,258.0
North,9.06,Number of IUCD removals,TOTAL,75.0,79.0,80.0,87.0,76.0,94.0,69.0,78.0,74.0,70.0,64.0,71.0,917.0
North,9.07,Number of Oral Pills cycles distributed,TOTAL,1582.0,1748.0,1505.0,2166.0,1764.0,1490.0,1502.0,1326.0,1527.0,1418.0,1531.0,1540.0,19099.0
North,9.08,Number of Condom pieces distributed,TOTAL,36228.0,37105.0,29949.0,58279.0,35233.0,35603.0,25126.0,30650.0,31836.0,26615.0,34348.0,28422.0,409394.0
North,9.09,Number of Centchroman (weekly) pills given,TOTAL,5.0,5.0,0.0,9.0,5.0,442.0,736.0,1.0,0.0,0.0,0.0,0.0,1203.0
North,9.10,Number of Emergency Contraceptive Pills distributed,TOTAL,83.0,87.0,141.0,160.0,170.0,138.0,103.0,110.0,148.0,130.0,99.0,97.0,1466.0
North,9.11.1.a,Number of cases of complications following male sterilization,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
North,9.11.1.b,Number of cases of complications following female sterilization,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,1.0,1.0
North,9.11.2.a,Number of failures following male sterilization,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
North,9.11.2.b,Number of failures following female sterilization,TOTAL,1.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,1.0
North,9.11.3.a,Number of deaths following male sterilization,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
North,9.11.3.b,Number of deaths following female sterilization,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
North,9.12,Number of Institutions having NSV trained doctors,TOTAL,2.0,2.0,2.0,2.0,2.0,2.0,2.0,4.0,2.0,2.0,3.0,3.0,-1.0
North,10.1.01,Number of Infants (0 to 11 months old)received BCG immunisation,TOTAL,1169.0,1157.0,1077.0,1500.0,1716.0,1702.0,1467.0,1635.0,1500.0,1408.0,1318.0,1435.0,17084.0
North,10.1.02,Number of Infants (0 to 11 months old) received DPT1 immunisation,TOTAL,247.0,289.0,224.0,403.0,537.0,363.0,271.0,255.0,260.0,280.0,183.0,119.0,3431.0
North,10.1.03,Number of Infants (0 to 11 months old) received DPT2 immunisation,TOTAL,374.0,367.0,249.0,460.0,566.0,420.0,378.0,312.0,390.0,301.0,225.0,148.0,4190.0
North,10.1.04,Number of Infants (0 to 11 months old) received DPT3 immunisation,TOTAL,385.0,396.0,347.0,481.0,581.0,397.0,401.0,362.0,379.0,286.0,253.0,184.0,4452.0
North,10.1.04A,Number of Infants (0 to 11 months old) received Pentavalent1 immunisation,TOTAL,1616.0,1652.0,1235.0,1606.0,1473.0,1642.0,2075.0,2571.0,2505.0,2060.0,1912.0,2376.0,22723.0
North,10.1.04B,Number of Infants (0 to 11 months old) received Pentavalent2 immunisation,TOTAL,1669.0,1735.0,1265.0,1472.0,1319.0,1237.0,1447.0,2018.0,2318.0,2098.0,1634.0,2233.0,20445.0
North,10.1.04C,Number of Infants (0 to 11 months old) received Pentavalent3 immunisation,TOTAL,1625.0,1626.0,1274.0,1498.0,1220.0,1113.0,1158.0,1615.0,1775.0,1900.0,1650.0,2080.0,18534.0
North,10.1.05,Number of Infants (0 to 11 months old) received OPV 0 (Birth Dose),TOTAL,602.0,597.0,620.0,894.0,907.0,1007.0,762.0,767.0,689.0,760.0,698.0,596.0,8899.0
North,10.1.06,Number of Infants (0 to 11 months old) received OPV1 (First Dose),TOTAL,1803.0,1945.0,1429.0,1805.0,1933.0,1875.0,2398.0,2676.0,2622.0,2059.0,1986.0,2437.0,24968.0
North,10.1.07,Number of Infants (0 to 11 months old) received OPV2 (Second Dose),TOTAL,1899.0,2088.0,1463.0,1714.0,1819.0,1591.0,1826.0,2220.0,2538.0,2174.0,1755.0,2333.0,23420.0
North,10.1.08,Number of Infants (0 to 11 months old) received OPV3 (Third Dose),TOTAL,1821.0,1999.0,1564.0,1855.0,1735.0,1456.0,1565.0,1834.0,2018.0,2081.0,1791.0,2250.0,21969.0
North,10.1.09A,Number of Infants (upto 48 hrs of age) received Hepatitis-B0 immunisation,TOTAL,274.0,445.0,500.0,729.0,637.0,909.0,683.0,615.0,578.0,651.0,589.0,522.0,7132.0
North,10.1.09,Number of Infants (0 to 11 months old) received Hepatitis-B1 immunisation,TOTAL,242.0,284.0,173.0,213.0,263.0,168.0,135.0,147.0,136.0,85.0,76.0,102.0,2024.0
North,10.1.10,Number of Infants (0 to 11 months old) received Hepatitis-B2 immunisation,TOTAL,353.0,359.0,207.0,285.0,269.0,253.0,238.0,219.0,235.0,143.0,116.0,120.0,2797.0
North,10.1.11,Number of Infants (0 to 11 months old) received Hepatitis-B3 immunisation,TOTAL,391.0,382.0,293.0,318.0,287.0,224.0,263.0,243.0,261.0,171.0,146.0,164.0,3143.0
North,10.1.12,Number of Infants (0 to 11 months old) received Measles immunisation (First Dose),TOTAL,3684.0,2469.0,2392.0,2240.0,2184.0,2084.0,1970.0,2460.0,1908.0,1525.0,1295.0,2062.0,26273.0
North,10.1.12B,Number of Infants (more than 16 months old) received Measles immunisation (Second Dose),TOTAL,8265.0,2213.0,8014.0,1275.0,211.0,290.0,127.0,128.0,130.0,108.0,135.0,38.0,20934.0
North,10.1A,No. of Children aged 9 to 12 months who received JE 1st dose,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
North,10.1.13.a,Total number of male children (9 to 11 months old) fully immunised (BCG+DPT123/Pentavalent123+OPV123+Measles) during the month,TOTAL,1481.0,1394.0,1167.0,1136.0,1168.0,1102.0,1031.0,1249.0,974.0,785.0,667.0,1099.0,13253.0
North,10.1.13.b,Total number of female children (9 to 11 months old) fully immunised (BCG+DPT123/Pentavalent123+OPV123+Measles) during the month,TOTAL,1195.0,1021.0,1007.0,985.0,1016.0,957.0,902.0,1101.0,841.0,679.0,587.0,949.0,11240.0
North,10.1.13.c,Total number of children (9 to 11 months old) fully immunised (BCG+DPT123/Pentavalent123+OPV123+Measles) during the month (sum of items 10.1.13.a and 10.1.13.b),TOTAL,2676.0,2415.0,2174.0,2121.0,2184.0,2059.0,1933.0,2350.0,1815.0,1464.0,1254.0,2048.0,24493.0
North,10.2.1,Number of Infants (more than 16 months old) received DPT Booster dose,TOTAL,1611.0,2391.0,1284.0,1748.0,1772.0,1567.0,1147.0,1782.0,1825.0,1491.0,1457.0,2228.0,20303.0
North,10.2.2,Number of Infants (more than 16 months old) received OPV Booster dose,TOTAL,1488.0,2390.0,1285.0,1746.0,1759.0,1566.0,1138.0,1780.0,1824.0,1488.0,1456.0,2244.0,20164.0
North,10.2.3,"Number of Infants (more than 16 months old) received Measles, Mumps, Rubella (MMR) Vaccination",TOTAL,2233.0,634.0,2006.0,376.0,1666.0,1666.0,1561.0,2321.0,2494.0,1868.0,1694.0,1902.0,20421.0
North,10.3.1.a,Total number of male children (12 to 23 months old) fully immunised (BCG+DPT123/Pentavalent123+OPV123+Measles) during the month,TOTAL,618.0,495.0,341.0,715.0,553.0,558.0,426.0,416.0,391.0,322.0,357.0,339.0,5531.0
North,10.3.1.b,Total number of female children (12 to 23 months old) fully immunised (BCG+DPT123/Pentavalent123+OPV123+Measles) during the month,TOTAL,459.0,365.0,254.0,588.0,471.0,461.0,342.0,339.0,281.0,260.0,284.0,247.0,4351.0
North,10.3.1.c,Total number of children (12 to 23 months old) fully immunised (BCG+DPT123+OPV123/Pentavalent123+Measles) during the month (sum of items 10.3.1.a and 10.3.1.b),TOTAL,1077.0,860.0,595.0,1303.0,1024.0,1019.0,768.0,755.0,672.0,582.0,641.0,586.0,9882.0
North,10.3.2,Number of children (more than 5 years old) given DT5,TOTAL,774.0,1173.0,787.0,635.0,737.0,747.0,664.0,907.0,924.0,862.0,632.0,992.0,9834.0
North,10.3.3,Number of children (more than 10 years old) given TT10,TOTAL,129.0,278.0,224.0,192.0,183.0,213.0,170.0,160.0,197.0,238.0,158.0,242.0,2384.0
North,10.3.4,Number of children (more than 16 years old) given TT16,TOTAL,129.0,243.0,226.0,160.0,171.0,168.0,160.0,171.0,197.0,222.0,182.0,196.0,2225.0
North,10.3.5.a,Number of cases of Abscess reported following immunisation [Adverse Event Following Immunisation (AEFI)],TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
North,10.3.5.b,Number of cases of Death reported following immunisation [Adverse Event Following Immunisation (AEFI)],TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
North,10.3.5.c,Number of cases of other complications reported following immunisation [Adverse Event Following Immunisation (AEFI)],TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
North,10.4.1,Number of Immunisation sessions planned to be held during the month,TOTAL,627.0,533.0,606.0,434.0,429.0,486.0,472.0,500.0,597.0,538.0,485.0,522.0,6229.0
North,10.4.2,Number of Immunisation sessions held during the month,TOTAL,597.0,518.0,603.0,423.0,410.0,453.0,413.0,468.0,564.0,504.0,445.0,483.0,5881.0
North,10.4.3,Number of Immunisation sessions held during the month where ASHAs were present,TOTAL,257.0,226.0,296.0,201.0,174.0,213.0,179.0,191.0,272.0,231.0,200.0,238.0,2678.0
North,10.5.1,Number of children (more than 16 months old) received Japanese Encephalitis (JE) vaccination,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
North,11.1.1,Number of children (9 months to 5 years old) administered 1st dose of Vitamin A (Dose-1),TOTAL,3756.0,2829.0,4396.0,2211.0,2220.0,1832.0,1845.0,2317.0,1930.0,1668.0,860.0,1682.0,27546.0
North,11.1.2,Number of children (9 months to 5 years old) were administered 5th dose of Vitamin A (Dose-5),TOTAL,7708.0,2890.0,6647.0,1765.0,2163.0,1907.0,2026.0,2884.0,3069.0,2534.0,1323.0,2112.0,37028.0
North,11.1.3,Number of children (9 months to 5 years old) administered 9th dose of Vitamin A (Dose-9),TOTAL,5200.0,894.0,3546.0,1256.0,508.0,474.0,511.0,793.0,1402.0,1286.0,323.0,942.0,17135.0
North,12.1,Number of cases of Diptheria reported in children below 5 years of age,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
North,12.2,Number of cases of Pertusis reported in children below 5 years of age,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
North,12.3,Number of cases of Tetanus neonatarum reported in children below 5 years of age,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
North,12.4,Number of cases of Tetanus other than neonatarum reported in children below 5 years of age,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
North,12.5,Number of cases of Polio reported in children below 5 years of age,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
North,12.6,Number of cases of Measles reported in children below 5 years of age,TOTAL,23.0,46.0,10.0,0.0,0.0,1.0,0.0,4.0,21.0,40.0,27.0,23.0,195.0
North,12.7,Number of cases of Diarrhoea and Dehydration reported in children below 5 years of age,TOTAL,1438.0,1569.0,1518.0,785.0,1833.0,568.0,706.0,488.0,347.0,474.0,322.0,427.0,10475.0
North,12.8,Number of cases of Malaria reported in children below 5 years of age,TOTAL,7.0,2.0,9.0,4.0,14.0,9.0,7.0,0.0,0.0,0.0,0.0,0.0,52.0
North,12.9,Number of children below 5 years of age admitted with Respiratory Infections,TOTAL,369.0,45.0,32.0,59.0,51.0,86.0,90.0,82.0,48.0,78.0,184.0,62.0,1186.0
North,13.1,Number of Patients operated for cataract,TOTAL,23.0,33.0,10.0,49.0,26.0,45.0,21.0,47.0,71.0,28.0,57.0,137.0,547.0
North,13.2,Number of Intraocular Lens(IOL) implantations,TOTAL,21.0,30.0,9.0,47.0,26.0,44.0,20.0,45.0,71.0,28.0,55.0,136.0,532.0
North,13.3,Number of School children detected with Refractive errors,TOTAL,127.0,168.0,133.0,131.0,166.0,263.0,104.0,199.0,132.0,218.0,255.0,195.0,2091.0
North,13.4,Number of children provided free glasses,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
North,13.5,Number of eyes collected through eye donation,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
North,13.6,Number of eyes utilised for corneal transplant,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
North,14.01,Number of CHC or SDH or DH functioning as First Referral units (FRUs),TOTAL,2.0,1.0,1.0,2.0,2.0,4.0,3.0,3.0,3.0,3.0,3.0,3.0,-1.0
North,14.02,Number of PHCs functioning 24X7 with atleast 3 Staff Nurses,TOTAL,,,,,,,,,,,,,-1.0
North,14.03,Number of Anganwadi centres reported to have conducted VHNDs,TOTAL,11.0,18.0,2.0,9.0,9.0,16.0,18.0,25.0,44.0,32.0,20.0,19.0,-1.0
North,14.04,Number of facilities having a Rogi Kalyan Samiti (RKS),TOTAL,1.0,2.0,2.0,3.0,2.0,2.0,3.0,3.0,2.0,2.0,2.0,3.0,-1.0
North,14.05,Number of RKS meetings held during the month,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,1.0,1.0
North,14.06,Number of facilities having Ambulance services (Assured Referral Services),TOTAL,6.0,5.0,6.0,6.0,7.0,6.0,6.0,7.0,6.0,6.0,6.0,4.0,-1.0
North,14.07,Total Number of times the Ambulance was used for transporting patients during the month,TOTAL,233.0,217.0,257.0,265.0,241.0,224.0,200.0,197.0,199.0,205.0,227.0,137.0,2602.0
North,14.08,Number of Institutions having Operational Sick New Born and Child Care Units (SNCU),TOTAL,2.0,2.0,2.0,3.0,3.0,3.0,3.0,3.0,3.0,3.0,3.0,3.0,-1.0
North,14.09,Number of functional Laproscopes in CHC/SDH/DH,TOTAL,5.0,5.0,6.0,6.0,6.0,7.0,6.0,6.0,5.0,6.0,6.0,4.0,-1.0
North,14.10.1.a,Number of male patients admitted (Inpatients) during the month,1. Children,478.0,472.0,583.0,563.0,739.0,724.0,600.0,559.0,486.0,548.0,610.0,404.0,6766.0
North,14.10.1.a,Number of male patients admitted (Inpatients) during the month,2. Adults,364.0,435.0,385.0,524.0,520.0,460.0,359.0,430.0,355.0,371.0,365.0,358.0,4926.0
North,14.10.1.b,Number of female patients (Inpatients) admitted during the month,1. Children,330.0,530.0,466.0,489.0,571.0,583.0,468.0,453.0,360.0,408.0,415.0,383.0,5456.0
North,14.10.1.b,Number of female patients (Inpatients) admitted during the month,2. Adults,1117.0,960.0,1037.0,1604.0,1412.0,1470.0,1243.0,1234.0,1150.0,1243.0,1191.0,1057.0,14718.0
North,14.10.1.c,Total number of patients admitted (Inpatients) during the month (sum of items 14.10.1.a and 14.10.1.b),1. Children,808.0,1002.0,1049.0,1052.0,1310.0,1307.0,1068.0,1012.0,846.0,956.0,1025.0,787.0,12222.0
North,14.10.1.c,Total number of patients admitted (Inpatients) during the month (sum of items 14.10.1.a and 14.10.1.b),2. Adults,1481.0,1395.0,1422.0,2128.0,1932.0,1930.0,1602.0,1664.0,1505.0,1614.0,1556.0,1415.0,19644.0
North,14.10.2.a,Number of death cases of Inpatient males,TOTAL,29.0,16.0,37.0,38.0,40.0,32.0,26.0,43.0,30.0,30.0,31.0,33.0,385.0
North,14.10.2.b,Number of death cases of Inpatient females,TOTAL,4.0,3.0,25.0,22.0,15.0,19.0,6.0,14.0,17.0,24.0,15.0,23.0,187.0
North,14.10.2.c,Number of cases of death of Inpatients (sum of items 14.10.2.a and 14.10.2.b),TOTAL,33.0,19.0,62.0,60.0,55.0,51.0,32.0,57.0,47.0,54.0,46.0,56.0,572.0
North,14.11,In-Patient Head Count at midnight,TOTAL,5795.0,4083.0,3836.0,8362.0,8098.0,7786.0,6709.0,7481.0,7437.0,8419.0,7170.0,6794.0,81970.0
North,14.12.1,OPD attendance (All),TOTAL,216264.0,220900.0,213432.0,238963.0,235196.0,256928.0,215078.0,237344.0,224287.0,216440.0,263822.0,264078.0,2802732.0
North,14.13.1,Number of major operations carried out using general or spinal anaesthesia,TOTAL,197.0,249.0,205.0,283.0,276.0,296.0,193.0,341.0,332.0,273.0,312.0,313.0,3270.0
North,14.13.1A,"Out of 14.13.1,Gynecology- Hysterectomy surgeries",TOTAL,10.0,13.0,11.0,14.0,17.0,17.0,25.0,9.0,8.0,9.0,13.0,14.0,160.0
North,14.13.2,Number of minor operations carried out without anaesthesia or using local anaesthesia,TOTAL,2020.0,1925.0,2613.0,2958.0,3066.0,3172.0,2630.0,2493.0,2141.0,2407.0,2709.0,2508.0,30642.0
North,14.14.a,Number of patients given AYUSH treatment,TOTAL,12823.0,14933.0,14036.0,15822.0,14795.0,16660.0,13251.0,15529.0,15689.0,15250.0,17177.0,12908.0,178873.0
North,14.14.b,Number of patients on whom Dental Procedure was conducted,TOTAL,2561.0,3074.0,2889.0,2976.0,3363.0,3385.0,2397.0,2919.0,3049.0,1931.0,2901.0,2593.0,34038.0
North,14.14.c,Number of Adolescents counselled,TOTAL,787.0,744.0,634.0,613.0,688.0,758.0,606.0,693.0,586.0,700.0,774.0,573.0,8156.0
North,15.1.1.a,Number of Haemoglobin (Hb) tests conducted,TOTAL,7025.0,7585.0,7882.0,8145.0,8708.0,13114.0,65943.0,9751.0,7754.0,7340.0,9767.0,10513.0,163527.0
North,15.1.1.b,"Out of the total number of Hb tests conducted, number of cases having Hb less than 7gm/dl",TOTAL,400.0,424.0,455.0,526.0,502.0,508.0,365.0,323.0,217.0,442.0,555.0,359.0,5076.0
North,15.1.2.a,Number of HIV tests conducted on males,1. Number tested,624.0,716.0,695.0,733.0,762.0,885.0,487.0,601.0,619.0,742.0,682.0,590.0,8136.0
North,15.1.2.a,Number of HIV tests conducted on males,2. Number Positive,17.0,6.0,19.0,20.0,12.0,16.0,3.0,12.0,10.0,10.0,17.0,21.0,163.0
North,15.1.2.b,Number of HIV tests conducted on Female-Non ANC (i.e. non pregnant females),1. Number tested,597.0,580.0,660.0,844.0,700.0,917.0,540.0,675.0,652.0,605.0,794.0,977.0,8541.0
North,15.1.2.b,Number of HIV tests conducted on Female-Non ANC (i.e. non pregnant females),2. Number Positive,3.0,4.0,5.0,5.0,3.0,3.0,1.0,2.0,2.0,3.0,3.0,6.0,40.0
North,15.1.2.c,Number of HIV tests conducted on Female with ANC (i.e. pregnant females),1. Number tested,1337.0,1570.0,1352.0,1215.0,1487.0,2164.0,1315.0,1747.0,1655.0,1652.0,2037.0,1631.0,19162.0
North,15.1.2.c,Number of HIV tests conducted on Female with ANC (i.e. pregnant females),2. Number Positive,1.0,0.0,3.0,14.0,5.0,1.0,1.0,3.0,3.0,2.0,2.0,1.0,36.0
North,15.1.2.d,Total number of HIV tests conducted (sum of items 15.1.2.a to 15.1.2.c),1. Number tested,2558.0,2866.0,2707.0,2792.0,2949.0,3966.0,2342.0,3023.0,2926.0,2999.0,3513.0,3198.0,35839.0
North,15.1.2.d,Total number of HIV tests conducted (sum of items 15.1.2.a to 15.1.2.c),2. Number Positive,21.0,10.0,27.0,39.0,20.0,20.0,5.0,17.0,15.0,15.0,22.0,28.0,239.0
North,15.2,Number of Widal tests conducted,Number tested,884.0,588.0,652.0,1482.0,1762.0,1673.0,1514.0,1257.0,914.0,683.0,880.0,884.0,13173.0
North,15.3.a,Number of VDRL tests conducted on males,Number tested,76.0,32.0,179.0,28.0,107.0,235.0,182.0,208.0,123.0,169.0,216.0,339.0,1894.0
North,15.3.b,Number of VDRL tests conducted on Female-Non ANC (i.e. non pregnant females),Number tested,106.0,509.0,158.0,210.0,198.0,281.0,251.0,268.0,252.0,237.0,325.0,546.0,3341.0
North,15.3.c,Number of VDRL tests conducted on Female with ANC (i.e. pregnant females),Number tested,277.0,738.0,1199.0,750.0,1461.0,1417.0,1335.0,1505.0,1555.0,1578.0,1591.0,1631.0,15037.0
North,15.3.d,Total number of VDRL tests conducted (sum of items 15.3.a to 15.3.c),Number tested,459.0,1279.0,1536.0,988.0,1766.0,1933.0,1768.0,1981.0,1930.0,1984.0,2132.0,2516.0,20272.0
North,15.4.1,Number of blood smears examined for Malaria,TOTAL,1194.0,1315.0,1186.0,1947.0,1925.0,1825.0,1991.0,1584.0,729.0,645.0,968.0,1199.0,16508.0
North,15.4.2,"Out of blood smears examined for malaria, number of blood smears tested positive for Plasmodium Vivax",TOTAL,4.0,5.0,5.0,8.0,6.0,22.0,4.0,3.0,0.0,0.0,1.0,0.0,58.0
North,15.4.3,"Out of blood smears examined for malaria, number of blood smears tested positive for Plasmodium Falciparum",TOTAL,1.0,0.0,0.0,2.0,0.0,0.0,2.0,2.0,0.0,0.0,0.0,0.0,7.0
North,16.1.1,Stock position of DPT vaccines,1. Balance From Previous Month,4770.0,3640.0,3410.0,2000.0,2550.0,1760.0,2270.0,3910.0,,3180.0,2390.0,2530.0,32410.0
North,16.1.1,Stock position of DPT vaccines,2. Stocks Received,0.0,1500.0,0.0,2000.0,2000.0,2000.0,2500.0,0.0,,0.0,1000.0,3500.0,14500.0
North,16.1.1,Stock position of DPT vaccines,3. Unusable Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,,0.0,0.0,0.0,0.0
North,16.1.1,Stock position of DPT vaccines,4. Stock Distributed,1130.0,1730.0,1410.0,1450.0,2240.0,1490.0,860.0,1110.0,,790.0,860.0,2840.0,15910.0
North,16.1.1,Stock position of DPT vaccines,5. Total Stock,3640.0,3410.0,2000.0,2550.0,2310.0,2270.0,3910.0,2800.0,0.0,2390.0,2530.0,3190.0,31000.0
North,16.1.1A,Stock Position of Pentavalent,1. Balance From Previous Month,4120.0,2870.0,2940.0,1720.0,2530.0,1420.0,2280.0,3750.0,,3530.0,1460.0,1900.0,28520.0
North,16.1.1A,Stock Position of Pentavalent,2. Stocks Received,1000.0,1500.0,0.0,2500.0,2500.0,2500.0,3000.0,0.0,,0.0,2500.0,4500.0,20000.0
North,16.1.1A,Stock Position of Pentavalent,3. Unusable Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,,0.0,0.0,0.0,0.0
North,16.1.1A,Stock Position of Pentavalent,4. Stock Distributed,2250.0,1430.0,1220.0,1690.0,2800.0,1640.0,1530.0,2300.0,,2070.0,2060.0,3660.0,22650.0
North,16.1.1A,Stock Position of Pentavalent,5. Total Stock,2870.0,2940.0,1720.0,2530.0,2230.0,2280.0,3750.0,1450.0,0.0,1460.0,1900.0,2740.0,25870.0
North,16.1.2,Stock position of OPV vaccines,1. Balance From Previous Month,5020.0,2440.0,6120.0,3560.0,4560.0,2580.0,4540.0,5120.0,,4940.0,2000.0,1400.0,42280.0
North,16.1.2,Stock position of OPV vaccines,2. Stocks Received,1000.0,7000.0,0.0,4000.0,4000.0,5000.0,3000.0,0.0,,0.0,4000.0,7000.0,35000.0
North,16.1.2,Stock position of OPV vaccines,3. Unusable Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,,0.0,0.0,0.0,0.0
North,16.1.2,Stock position of OPV vaccines,4. Stock Distributed,3580.0,3320.0,1040.0,3000.0,4980.0,3040.0,2420.0,3380.0,,2940.0,4600.0,4760.0,37060.0
North,16.1.2,Stock position of OPV vaccines,5. Total Stock,2440.0,6120.0,5080.0,4560.0,3580.0,4540.0,5120.0,1740.0,0.0,2000.0,1400.0,3640.0,40220.0
North,16.1.3,Stock position of TT vaccines,1. Balance From Previous Month,1370.0,940.0,1990.0,950.0,1970.0,990.0,1430.0,2520.0,,2930.0,2050.0,2160.0,19300.0
North,16.1.3,Stock position of TT vaccines,2. Stocks Received,500.0,2500.0,0.0,2500.0,2500.0,2000.0,2500.0,0.0,,0.0,2000.0,4000.0,18500.0
North,16.1.3,Stock position of TT vaccines,3. Unusable Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,,0.0,0.0,0.0,0.0
North,16.1.3,Stock position of TT vaccines,4. Stock Distributed,930.0,1450.0,1040.0,1480.0,2460.0,1560.0,1410.0,1230.0,,880.0,1890.0,1490.0,15820.0
North,16.1.3,Stock position of TT vaccines,5. Total Stock,940.0,1990.0,950.0,1970.0,2010.0,1430.0,2520.0,1290.0,0.0,2050.0,2160.0,4670.0,21980.0
North,16.1.4,Stock position of DT vaccines,1. Balance From Previous Month,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,,0.0,0.0,,0.0
North,16.1.4,Stock position of DT vaccines,2. Stocks Received,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,,0.0,0.0,,0.0
North,16.1.4,Stock position of DT vaccines,3. Unusable Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,,0.0,0.0,,0.0
North,16.1.4,Stock position of DT vaccines,4. Stock Distributed,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,,0.0,0.0,,0.0
North,16.1.4,Stock position of DT vaccines,5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
North,16.1.5,Stock position of BCG vaccines,1. Balance From Previous Month,2210.0,1380.0,2190.0,1630.0,2010.0,1520.0,1610.0,2710.0,,2780.0,1970.0,2220.0,22230.0
North,16.1.5,Stock position of BCG vaccines,2. Stocks Received,0.0,1500.0,0.0,1000.0,1000.0,1000.0,2000.0,0.0,,0.0,1000.0,2000.0,9500.0
North,16.1.5,Stock position of BCG vaccines,3. Unusable Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,,0.0,0.0,,0.0
North,16.1.5,Stock position of BCG vaccines,4. Stock Distributed,830.0,690.0,560.0,620.0,1110.0,910.0,900.0,900.0,,810.0,750.0,1170.0,9250.0
North,16.1.5,Stock position of BCG vaccines,5. Total Stock,1380.0,2190.0,1630.0,2010.0,1900.0,1610.0,2710.0,1810.0,0.0,1970.0,2220.0,3050.0,22480.0
North,16.1.6,Stock position of Measles vaccines,1. Balance From Previous Month,2105.0,1370.0,5055.0,3045.0,3045.0,2380.0,1670.0,1020.0,,2010.0,1120.0,1135.0,23955.0
North,16.1.6,Stock position of Measles vaccines,2. Stocks Received,10000.0,9500.0,15000.0,0.0,0.0,0.0,0.0,0.0,,0.0,1000.0,1500.0,37000.0
North,16.1.6,Stock position of Measles vaccines,3. Unusable Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,,0.0,0.0,,0.0
North,16.1.6,Stock position of Measles vaccines,4. Stock Distributed,10735.0,5815.0,17010.0,475.0,665.0,710.0,650.0,615.0,,890.0,1085.0,1260.0,39910.0
North,16.1.6,Stock position of Measles vaccines,5. Total Stock,1370.0,5055.0,3045.0,2570.0,2380.0,1670.0,1020.0,405.0,0.0,1120.0,1035.0,1375.0,21045.0
North,16.1.7,Stock position of JE vaccines,1. Balance From Previous Month,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,,0.0,0.0,,0.0
North,16.1.7,Stock position of JE vaccines,2. Stocks Received,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,,0.0,0.0,,0.0
North,16.1.7,Stock position of JE vaccines,3. Unusable Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,,0.0,0.0,,0.0
North,16.1.7,Stock position of JE vaccines,4. Stock Distributed,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,,0.0,0.0,,0.0
North,16.1.7,Stock position of JE vaccines,5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
North,16.1.8,Stock position of Hepatitis B vaccines,1. Balance From Previous Month,2710.0,2380.0,1830.0,1620.0,1620.0,800.0,360.0,1070.0,,710.0,540.0,450.0,14090.0
North,16.1.8,Stock position of Hepatitis B vaccines,2. Stocks Received,0.0,0.0,0.0,0.0,0.0,0.0,900.0,0.0,,0.0,0.0,300.0,1200.0
North,16.1.8,Stock position of Hepatitis B vaccines,3. Unusable Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,,0.0,0.0,,0.0
North,16.1.8,Stock position of Hepatitis B vaccines,4. Stock Distributed,330.0,550.0,210.0,470.0,820.0,440.0,190.0,330.0,,170.0,90.0,200.0,3800.0
North,16.1.8,Stock position of Hepatitis B vaccines,5. Total Stock,2380.0,1830.0,1620.0,1150.0,800.0,360.0,1070.0,740.0,0.0,540.0,450.0,550.0,11490.0
North,16.2.1,Stock Position of IU 380 A (to be used for Family Planning),1. Balance From Previous Month,215.0,240.0,240.0,195.0,308.0,258.0,368.0,388.0,,368.0,368.0,338.0,3286.0
North,16.2.1,Stock Position of IU 380 A (to be used for Family Planning),2. Stocks Received,100.0,0.0,0.0,200.0,200.0,300.0,150.0,0.0,,0.0,0.0,,950.0
North,16.2.1,Stock Position of IU 380 A (to be used for Family Planning),3. Unusable Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,,0.0,0.0,,0.0
North,16.2.1,Stock Position of IU 380 A (to be used for Family Planning),4. Stock Distributed,25.0,0.0,45.0,87.0,137.0,190.0,130.0,20.0,,0.0,30.0,,664.0
North,16.2.1,Stock Position of IU 380 A (to be used for Family Planning),5. Total Stock,290.0,240.0,195.0,308.0,371.0,368.0,388.0,368.0,0.0,368.0,338.0,338.0,3572.0
North,16.2.2,Stock Position of Condoms (to be used for Family Planning),1. Balance From Previous Month,44300.0,5180.0,14420.0,5180.0,38820.0,9260.0,34460.0,14300.0,,45740.0,13590.0,4040.0,229290.0
North,16.2.2,Stock Position of Condoms (to be used for Family Planning),2. Stocks Received,18000.0,25200.0,15120.0,92400.0,92400.0,25200.0,0.0,0.0,,0.0,22080.0,90240.0,380640.0
North,16.2.2,Stock Position of Condoms (to be used for Family Planning),3. Unusable Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,,0.0,0.0,,0.0
North,16.2.2,Stock Position of Condoms (to be used for Family Planning),4. Stock Distributed,57120.0,15960.0,24360.0,58760.0,88320.0,0.0,20160.0,5040.0,,32150.0,31630.0,46120.0,379620.0
North,16.2.2,Stock Position of Condoms (to be used for Family Planning),5. Total Stock,5180.0,14420.0,5180.0,38820.0,42900.0,34460.0,14300.0,9260.0,0.0,13590.0,4040.0,48160.0,230310.0
North,16.2.3,Stock Position of Oral Contraceptive (to be used for Family Planning),1. Balance From Previous Month,865.0,1415.0,1165.0,1745.0,4295.0,2745.0,2395.0,2245.0,,2370.0,1655.0,1456.0,22351.0
North,16.2.3,Stock Position of Oral Contraceptive (to be used for Family Planning),2. Stocks Received,600.0,600.0,1500.0,6000.0,6600.0,600.0,1000.0,0.0,,0.0,0.0,,16900.0
North,16.2.3,Stock Position of Oral Contraceptive (to be used for Family Planning),3. Unusable Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,,0.0,0.0,,0.0
North,16.2.3,Stock Position of Oral Contraceptive (to be used for Family Planning),4. Stock Distributed,50.0,850.0,920.0,3450.0,5600.0,950.0,1150.0,425.0,,715.0,200.0,300.0,14610.0
North,16.2.3,Stock Position of Oral Contraceptive (to be used for Family Planning),5. Total Stock,1415.0,1165.0,1745.0,4295.0,5295.0,2395.0,2245.0,1820.0,0.0,1655.0,1455.0,1156.0,24641.0
North,16.2.4,Stock Position of Emergency Contraceptive (to be used for Family Planning),1. Balance From Previous Month,50.0,0.0,0.0,18.0,853.0,603.0,583.0,244.0,,119.0,62.0,42.0,2574.0
North,16.2.4,Stock Position of Emergency Contraceptive (to be used for Family Planning),2. Stocks Received,0.0,0.0,200.0,1200.0,1200.0,0.0,0.0,0.0,,0.0,0.0,100.0,2700.0
North,16.2.4,Stock Position of Emergency Contraceptive (to be used for Family Planning),3. Unusable Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,,0.0,0.0,,0.0
North,16.2.4,Stock Position of Emergency Contraceptive (to be used for Family Planning),4. Stock Distributed,50.0,0.0,182.0,365.0,615.0,20.0,339.0,100.0,,57.0,20.0,15.0,1763.0
North,16.2.4,Stock Position of Emergency Contraceptive (to be used for Family Planning),5. Total Stock,0.0,0.0,18.0,853.0,1438.0,583.0,244.0,144.0,0.0,62.0,42.0,127.0,3511.0
North,16.2.5,Stock Position of Tubal Rings (to be used for Family Planning),1. Balance From Previous Month,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,,,,,0.0
North,16.2.5,Stock Position of Tubal Rings (to be used for Family Planning),2. Stocks Received,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,,,,,0.0
North,16.2.5,Stock Position of Tubal Rings (to be used for Family Planning),3. Unusable Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,,,,,0.0
North,16.2.5,Stock Position of Tubal Rings (to be used for Family Planning),4. Stock Distributed,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,,,,,0.0
North,16.2.5,Stock Position of Tubal Rings (to be used for Family Planning),5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
North,16.3.01,Stock Position of Oxytocin Injection,1. Balance From Previous Month,0.0,,0.0,0.0,0.0,0.0,0.0,0.0,,,,,0.0
North,16.3.01,Stock Position of Oxytocin Injection,2. Stocks Received,,,0.0,0.0,0.0,0.0,0.0,0.0,,,,,0.0
North,16.3.01,Stock Position of Oxytocin Injection,3. Unusable Stock,,,0.0,0.0,0.0,0.0,0.0,0.0,,,,,0.0
North,16.3.01,Stock Position of Oxytocin Injection,4. Stock Distributed,,,0.0,0.0,0.0,0.0,0.0,0.0,,,,,0.0
North,16.3.01,Stock Position of Oxytocin Injection,5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
North,16.3.02,Stock Position of Gloves,1. Balance From Previous Month,,,0.0,0.0,0.0,0.0,0.0,0.0,,,,,0.0
North,16.3.02,Stock Position of Gloves,2. Stocks Received,,,0.0,0.0,0.0,0.0,0.0,0.0,,,,,0.0
North,16.3.02,Stock Position of Gloves,3. Unusable Stock,,,0.0,0.0,0.0,0.0,0.0,0.0,,,,,0.0
North,16.3.02,Stock Position of Gloves,4. Stock Distributed,,,0.0,0.0,0.0,0.0,0.0,0.0,,,,,0.0
North,16.3.02,Stock Position of Gloves,5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
North,16.3.03,Stock Position of MVA Syringes,1. Balance From Previous Month,,,0.0,0.0,0.0,0.0,0.0,0.0,,,,,0.0
North,16.3.03,Stock Position of MVA Syringes,2. Stocks Received,,,0.0,0.0,0.0,0.0,0.0,0.0,,,,,0.0
North,16.3.03,Stock Position of MVA Syringes,3. Unusable Stock,,,0.0,0.0,0.0,0.0,0.0,0.0,,,,,0.0
North,16.3.03,Stock Position of MVA Syringes,4. Stock Distributed,,,0.0,0.0,0.0,0.0,0.0,0.0,,,,,0.0
North,16.3.03,Stock Position of MVA Syringes,5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
North,16.3.04,Stock Position of Fluconazole Tablets,1. Balance From Previous Month,,,0.0,0.0,0.0,0.0,0.0,0.0,,,,,0.0
North,16.3.04,Stock Position of Fluconazole Tablets,2. Stocks Received,,,0.0,0.0,0.0,0.0,0.0,0.0,,,,,0.0
North,16.3.04,Stock Position of Fluconazole Tablets,3. Unusable Stock,,,0.0,0.0,0.0,0.0,0.0,0.0,,,,,0.0
North,16.3.04,Stock Position of Fluconazole Tablets,4. Stock Distributed,,,0.0,0.0,0.0,0.0,0.0,0.0,,,,,0.0
North,16.3.04,Stock Position of Fluconazole Tablets,5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
North,16.3.05,Stock Position of Blood Transfusion Sets,1. Balance From Previous Month,,,0.0,0.0,0.0,0.0,0.0,0.0,,,,,0.0
North,16.3.05,Stock Position of Blood Transfusion Sets,2. Stocks Received,,,0.0,0.0,0.0,0.0,0.0,0.0,,,,,0.0
North,16.3.05,Stock Position of Blood Transfusion Sets,3. Unusable Stock,,,0.0,0.0,0.0,0.0,0.0,0.0,,,,,0.0
North,16.3.05,Stock Position of Blood Transfusion Sets,4. Stock Distributed,,,0.0,0.0,0.0,0.0,0.0,0.0,,,,,0.0
North,16.3.05,Stock Position of Blood Transfusion Sets,5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
North,16.3.06,Stock Position of Gluteraldehyde solution of 2% concentration,1. Balance From Previous Month,,,0.0,0.0,0.0,0.0,0.0,0.0,,,,,0.0
North,16.3.06,Stock Position of Gluteraldehyde solution of 2% concentration,2. Stocks Received,,,0.0,0.0,0.0,0.0,0.0,0.0,,,,,0.0
North,16.3.06,Stock Position of Gluteraldehyde solution of 2% concentration,3. Unusable Stock,,,0.0,0.0,0.0,0.0,0.0,0.0,,,,,0.0
North,16.3.06,Stock Position of Gluteraldehyde solution of 2% concentration,4. Stock Distributed,,,0.0,0.0,0.0,0.0,0.0,0.0,,,,,0.0
North,16.3.06,Stock Position of Gluteraldehyde solution of 2% concentration,5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
North,16.3.07,Stock Position of IFA Tablets,1. Balance From Previous Month,80000.0,67000.0,44500.0,44500.0,44500.0,1500.0,1500.0,0.0,,,,,283500.0
North,16.3.07,Stock Position of IFA Tablets,2. Stocks Received,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,,,,,0.0
North,16.3.07,Stock Position of IFA Tablets,3. Unusable Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,,,,,0.0
North,16.3.07,Stock Position of IFA Tablets,4. Stock Distributed,13000.0,22500.0,0.0,43000.0,43000.0,0.0,1500.0,0.0,,,,,123000.0
North,16.3.07,Stock Position of IFA Tablets,5. Total Stock,67000.0,44500.0,44500.0,1500.0,1500.0,1500.0,0.0,0.0,0.0,0.0,0.0,0.0,160500.0
North,16.3.08,Stock Position of IFA Syrup (Paediatric),1. Balance From Previous Month,101000.0,94000.0,67000.0,139000.0,139000.0,69000.0,105000.0,85500.0,,,,,799500.0
North,16.3.08,Stock Position of IFA Syrup (Paediatric),2. Stocks Received,0.0,0.0,72000.0,360000.0,360000.0,36000.0,0.0,0.0,,,,,828000.0
North,16.3.08,Stock Position of IFA Syrup (Paediatric),3. Unusable Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,,,,,0.0
North,16.3.08,Stock Position of IFA Syrup (Paediatric),4. Stock Distributed,7000.0,27000.0,0.0,417500.0,430000.0,0.0,19500.0,39000.0,,,,,940000.0
North,16.3.08,Stock Position of IFA Syrup (Paediatric),5. Total Stock,94000.0,67000.0,139000.0,81500.0,69000.0,105000.0,85500.0,46500.0,0.0,0.0,0.0,0.0,687500.0
North,16.3.09,Stock Position of Paediatrics Antibiotics (Cotrimaxozole and Injectable Gentamicin),1. Balance From Previous Month,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,,,,,0.0
North,16.3.09,Stock Position of Paediatrics Antibiotics (Cotrimaxozole and Injectable Gentamicin),2. Stocks Received,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,,,,,0.0
North,16.3.09,Stock Position of Paediatrics Antibiotics (Cotrimaxozole and Injectable Gentamicin),3. Unusable Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,,,,,0.0
North,16.3.09,Stock Position of Paediatrics Antibiotics (Cotrimaxozole and Injectable Gentamicin),4. Stock Distributed,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,,,,,0.0
North,16.3.09,Stock Position of Paediatrics Antibiotics (Cotrimaxozole and Injectable Gentamicin),5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
North,16.3.10,Stock Position of Vitamin A solution,1. Balance From Previous Month,232.0,36.0,96.0,670.0,670.0,12.0,500.0,478.0,,368.0,258.0,141.0,3461.0
North,16.3.10,Stock Position of Vitamin A solution,2. Stocks Received,0.0,200.0,1200.0,0.0,0.0,500.0,0.0,0.0,,0.0,0.0,200.0,2100.0
North,16.3.10,Stock Position of Vitamin A solution,3. Unusable Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,,0.0,0.0,,0.0
North,16.3.10,Stock Position of Vitamin A solution,4. Stock Distributed,196.0,140.0,626.0,503.0,658.0,12.0,22.0,0.0,,110.0,117.0,64.0,2448.0
North,16.3.10,Stock Position of Vitamin A solution,5. Total Stock,36.0,96.0,670.0,167.0,12.0,500.0,478.0,478.0,0.0,258.0,141.0,277.0,3113.0
North,16.3.11,Stock of ORS (New WHO formulation),1. Balance From Previous Month,1000.0,1500.0,2750.0,500.0,2750.0,1000.0,500.0,0.0,,,0.0,,10000.0
North,16.3.11,Stock of ORS (New WHO formulation),2. Stocks Received,2500.0,11500.0,500.0,20000.0,25000.0,0.0,0.0,0.0,,,0.0,,59500.0
North,16.3.11,Stock of ORS (New WHO formulation),3. Unusable Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,,,0.0,,0.0
North,16.3.11,Stock of ORS (New WHO formulation),4. Stock Distributed,2000.0,10250.0,2750.0,17750.0,24500.0,500.0,500.0,0.0,,,0.0,,58250.0
North,16.3.11,Stock of ORS (New WHO formulation),5. Total Stock,1500.0,2750.0,500.0,2750.0,3250.0,500.0,0.0,0.0,0.0,0.0,0.0,0.0,11250.0
North,16.4.1,Stock Position of 0.1 ml Syringes(AD),1. Balance From Previous Month,1790.0,890.0,1440.0,1040.0,2140.0,1740.0,840.0,2000.0,,2625.0,1625.0,1725.0,17855.0
North,16.4.1,Stock Position of 0.1 ml Syringes(AD),2. Stocks Received,0.0,1000.0,0.0,1100.0,1100.0,0.0,2000.0,0.0,,0.0,2000.0,2000.0,9200.0
North,16.4.1,Stock Position of 0.1 ml Syringes(AD),3. Unusable Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,,0.0,0.0,,0.0
North,16.4.1,Stock Position of 0.1 ml Syringes(AD),4. Stock Distributed,900.0,450.0,400.0,0.0,400.0,900.0,840.0,900.0,,1000.0,1900.0,600.0,8290.0
North,16.4.1,Stock Position of 0.1 ml Syringes(AD),5. Total Stock,890.0,1440.0,1040.0,2140.0,2840.0,840.0,2000.0,1100.0,0.0,1625.0,1725.0,3125.0,18765.0
North,16.4.2,Stock Position of 0.5 ml Syringes(AD),1. Balance From Previous Month,7150.0,2655.0,19240.0,8540.0,8540.0,3740.0,14190.0,13190.0,,11890.0,10940.0,10340.0,110415.0
North,16.4.2,Stock Position of 0.5 ml Syringes(AD),2. Stocks Received,10000.0,30000.0,20000.0,4000.0,4000.0,14000.0,10000.0,0.0,,0.0,10000.0,10800.0,112800.0
North,16.4.2,Stock Position of 0.5 ml Syringes(AD),3. Unusable Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,,0.0,0.0,,0.0
North,16.4.2,Stock Position of 0.5 ml Syringes(AD),4. Stock Distributed,14500.0,13415.0,30700.0,5600.0,8800.0,3550.0,11000.0,3300.0,,950.0,10600.0,4600.0,107015.0
North,16.4.2,Stock Position of 0.5 ml Syringes(AD),5. Total Stock,2650.0,19240.0,8540.0,6940.0,3740.0,14190.0,13190.0,9890.0,0.0,10940.0,10340.0,16540.0,116200.0
North,16.4.3,Stock Position of 5.0 ml Syringes(Disposable),1. Balance From Previous Month,351.0,0.0,400.0,0.0,0.0,0.0,600.0,1600.0,,1200.0,600.0,400.0,5151.0
North,16.4.3,Stock Position of 5.0 ml Syringes(Disposable),2. Stocks Received,0.0,400.0,0.0,0.0,0.0,600.0,1600.0,0.0,,0.0,0.0,1000.0,3600.0
North,16.4.3,Stock Position of 5.0 ml Syringes(Disposable),3. Unusable Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,,0.0,0.0,,0.0
North,16.4.3,Stock Position of 5.0 ml Syringes(Disposable),4. Stock Distributed,351.0,0.0,400.0,0.0,0.0,0.0,600.0,400.0,,600.0,200.0,400.0,2951.0
North,16.4.3,Stock Position of 5.0 ml Syringes(Disposable),5. Total Stock,0.0,400.0,0.0,0.0,0.0,600.0,1600.0,1200.0,0.0,600.0,400.0,1000.0,5800.0
North,17.1,Number of cases of Infant deaths within 24 hrs of birth,TOTAL,,,,1.0,2.0,,1.0,,,,,,4.0
North,17.2.1,Number of cases of Infant deaths 24 hours to 4 weeks of birth with the probable cause being Sepsis,1. Up to 1 Weeks of Birth,1.0,,,,,,,3.0,1.0,,1.0,1.0,7.0
North,17.2.1,Number of cases of Infant deaths 24 hours to 4 weeks of birth with the probable cause being Sepsis,2. Between 1 week & 4 weeks of birth,,,,,,1.0,1.0,1.0,,,,,3.0
North,17.2.1,Number of cases of Infant deaths 24 hours to 4 weeks of birth with the probable cause being Sepsis,3. Total,1.0,,,,,1.0,1.0,4.0,1.0,,1.0,1.0,10.0
North,17.2.2,Number of cases of Infant deaths 24 hours to 4 weeks of birth with the probable cause being Asphyxia,1. Up to 1 Weeks of Birth,,,,1.0,,,1.0,,,,,1.0,3.0
North,17.2.2,Number of cases of Infant deaths 24 hours to 4 weeks of birth with the probable cause being Asphyxia,2. Between 1 week & 4 weeks of birth,,,,,,,,,,,,1.0,1.0
North,17.2.2,Number of cases of Infant deaths 24 hours to 4 weeks of birth with the probable cause being Asphyxia,3. Total,,,,1.0,,,1.0,,,,,2.0,4.0
North,17.2.3,Number of cases of Infant deaths 24 hours to 4 weeks of birth with the probable cause being LBW,1. Up to 1 Weeks of Birth,1.0,,3.0,,,,,1.0,1.0,,,,6.0
North,17.2.3,Number of cases of Infant deaths 24 hours to 4 weeks of birth with the probable cause being LBW,2. Between 1 week & 4 weeks of birth,,,,,,,,,,,,,
North,17.2.3,Number of cases of Infant deaths 24 hours to 4 weeks of birth with the probable cause being LBW,3. Total,1.0,,3.0,,,,,1.0,1.0,,,,6.0
North,17.2.4,"Number of cases of Infant deaths 24 hours to 4 weeks of birth with the probable cause being other than Sepsis, Asphyxia and LBW",1. Up to 1 Weeks of Birth,,,,1.0,,,,,1.0,,1.0,,3.0
North,17.2.4,"Number of cases of Infant deaths 24 hours to 4 weeks of birth with the probable cause being other than Sepsis, Asphyxia and LBW",2. Between 1 week & 4 weeks of birth,,,,1.0,1.0,,,,,,,1.0,3.0
North,17.2.4,"Number of cases of Infant deaths 24 hours to 4 weeks of birth with the probable cause being other than Sepsis, Asphyxia and LBW",3. Total,,,,2.0,1.0,,,,1.0,,1.0,1.0,6.0
North,17.3.1,Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being Pneumonia,1. Between 1 month and 11 months,,1.0,,,,,1.0,,,1.0,1.0,,4.0
North,17.3.1,Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being Pneumonia,2. Between 1 year & 5 years,1.0,,,,,,,,,,,,1.0
North,17.3.1,Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being Pneumonia,3. Total,1.0,1.0,,,,,1.0,,,1.0,1.0,,5.0
North,17.3.2,Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being Diarrhoea,1. Between 1 month and 11 months,,,,,,,,1.0,,,,,1.0
North,17.3.2,Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being Diarrhoea,2. Between 1 year & 5 years,,,,,,,,,,,,,
North,17.3.2,Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being Diarrhoea,3. Total,,,,,,,,1.0,,,,,1.0
North,17.3.3,Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being Fever related,1. Between 1 month and 11 months,,1.0,,,,,1.0,,,1.0,2.0,,5.0
North,17.3.3,Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being Fever related,2. Between 1 year & 5 years,,,,,,,,,,1.0,,,1.0
North,17.3.3,Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being Fever related,3. Total,,1.0,,,,,1.0,,,2.0,2.0,,6.0
North,17.3.4,Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being Measles,1. Between 1 month and 11 months,,,,,,,,,,,,,
North,17.3.4,Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being Measles,2. Between 1 year & 5 years,,,,,,,,,,,,,
North,17.3.4,Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being Measles,3. Total,,,,,,,,,,,,,
North,17.3.5,"Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being other than Pneumonia, Diarrhoea, Fever related and Measles",1. Between 1 month and 11 months,,1.0,2.0,,1.0,2.0,,1.0,1.0,1.0,1.0,,10.0
North,17.3.5,"Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being other than Pneumonia, Diarrhoea, Fever related and Measles",2. Between 1 year & 5 years,,,1.0,,,,,,,,,,1.0
North,17.3.5,"Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being other than Pneumonia, Diarrhoea, Fever related and Measles",3. Total,,1.0,3.0,,1.0,2.0,,1.0,1.0,1.0,1.0,,11.0
North,17.4.1,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Diarrhoeal diseases,1. 6-14 yrs,,,,,,,,,,,,,
North,17.4.1,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Diarrhoeal diseases,2. 15-55 yrs.,,,,,,,,1.0,,,,,1.0
North,17.4.1,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Diarrhoeal diseases,3. Above 55 yrs.,2.0,,1.0,,,,,,,,,,3.0
North,17.4.1,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Diarrhoeal diseases,4. Total,2.0,,1.0,,,,,1.0,,,,,4.0
North,17.4.2,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Tuberculosis,1. 6-14 yrs,,,,,,,,,1.0,,,1.0,2.0
North,17.4.2,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Tuberculosis,2. 15-55 yrs.,1.0,,2.0,1.0,,,,,,1.0,,1.0,6.0
North,17.4.2,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Tuberculosis,3. Above 55 yrs.,,,,,,,,,1.0,,,,1.0
North,17.4.2,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Tuberculosis,4. Total,1.0,,2.0,1.0,,,,,2.0,1.0,,2.0,9.0
North,17.4.3,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Respiratory diseases including infections,1. 6-14 yrs,,,,,1.0,,,,,,,,1.0
North,17.4.3,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Respiratory diseases including infections,2. 15-55 yrs.,,,5.0,,1.0,1.0,2.0,,2.0,,3.0,1.0,15.0
North,17.4.3,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Respiratory diseases including infections,3. Above 55 yrs.,4.0,1.0,1.0,2.0,3.0,1.0,1.0,9.0,3.0,6.0,2.0,3.0,36.0
North,17.4.3,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Respiratory diseases including infections,4. Total,4.0,1.0,6.0,2.0,5.0,2.0,3.0,9.0,5.0,6.0,5.0,4.0,52.0
North,17.4.4,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Malaria,1. 6-14 yrs,,,,,,,,,,,,,
North,17.4.4,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Malaria,2. 15-55 yrs.,,,,,,,,,,,,,
North,17.4.4,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Malaria,3. Above 55 yrs.,,,,,,,,,,,,,
North,17.4.4,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Malaria,4. Total,,,,,,,,,,,,,
North,17.4.5,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being other Fever related,1. 6-14 yrs,,,,,,1.0,,1.0,,,,,2.0
North,17.4.5,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being other Fever related,2. 15-55 yrs.,,,,1.0,,1.0,,1.0,1.0,,1.0,1.0,6.0
North,17.4.5,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being other Fever related,3. Above 55 yrs.,,,,,,,,2.0,,1.0,1.0,,4.0
North,17.4.5,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being other Fever related,4. Total,,,,1.0,,2.0,,4.0,1.0,1.0,2.0,1.0,12.0
North,17.4.6,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being HIV/AIDS,1. 6-14 yrs,,,,,,,,,,,,,
North,17.4.6,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being HIV/AIDS,2. 15-55 yrs.,,,,,,,,,,,,1.0,1.0
North,17.4.6,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being HIV/AIDS,3. Above 55 yrs.,,,,,,,,,,,,,
North,17.4.6,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being HIV/AIDS,4. Total,,,,,,,,,,,,1.0,1.0
North,17.4.7,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Heart disease or related to Hypertension,1. 6-14 yrs,,,1.0,,,,,,,,,,1.0
North,17.4.7,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Heart disease or related to Hypertension,2. 15-55 yrs.,2.0,1.0,2.0,2.0,,1.0,7.0,9.0,3.0,3.0,7.0,8.0,45.0
North,17.4.7,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Heart disease or related to Hypertension,3. Above 55 yrs.,7.0,,,3.0,2.0,2.0,2.0,4.0,5.0,3.0,8.0,6.0,42.0
North,17.4.7,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Heart disease or related to Hypertension,4. Total,9.0,1.0,3.0,5.0,2.0,3.0,9.0,13.0,8.0,6.0,15.0,14.0,88.0
North,17.4.8,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Neurological disease including strokes,1. 6-14 yrs,,,,,,,,1.0,,,,,1.0
North,17.4.8,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Neurological disease including strokes,2. 15-55 yrs.,5.0,1.0,,,4.0,,,2.0,4.0,1.0,2.0,,19.0
North,17.4.8,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Neurological disease including strokes,3. Above 55 yrs.,,3.0,,,,,,,2.0,2.0,3.0,,10.0
North,17.4.8,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Neurological disease including strokes,4. Total,5.0,4.0,,,4.0,,,3.0,6.0,3.0,5.0,,30.0
North,17.4.9(a),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Abortion,1. 6-14 yrs,,,,,,,,,,,,,
North,17.4.9(a),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Abortion,2. 15-49 yrs,,,,,,,,,,,,,
North,17.4.9(a),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Abortion,3. Above 49 yrs.,,,,,,,,,,,,,
North,17.4.9(a),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Abortion,4. Total,,,,,,,,,,,,,
North,17.4.9(b),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Obstructed or prolonged labour,1. 6-14 yrs,,,,,,,,,,,,,
North,17.4.9(b),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Obstructed or prolonged labour,2. 15-49 yrs,,,,,,,,,,,,,
North,17.4.9(b),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Obstructed or prolonged labour,3. Above 49 yrs.,,,,,,,,,,,,,
North,17.4.9(b),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Obstructed or prolonged labour,4. Total,,,,,,,,,,,,,
North,17.4.9(c),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Severe hypertesnion or fits,1. 6-14 yrs,,,,,,,,,,,,,
North,17.4.9(c),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Severe hypertesnion or fits,2. 15-49 yrs,,,,,,,,1.0,,,,,1.0
North,17.4.9(c),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Severe hypertesnion or fits,3. Above 49 yrs.,,,,,,,,,,,,,
North,17.4.9(c),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Severe hypertesnion or fits,4. Total,,,,,,,,1.0,,,,,1.0
North,17.4.9(d),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Bleeding,1. 6-14 yrs,,,,,,,,,,,,,
North,17.4.9(d),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Bleeding,2. 15-49 yrs,,,,,1.0,,,,,,,,1.0
North,17.4.9(d),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Bleeding,3. Above 49 yrs.,,,,,,,,,,,,,
North,17.4.9(d),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Bleeding,4. Total,,,,,1.0,,,,,,,,1.0
North,17.4.9(e),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being High Fever,1. 6-14 yrs,,,,,,,,,,,,,
North,17.4.9(e),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being High Fever,2. 15-49 yrs,,,1.0,,,,,,,,,,1.0
North,17.4.9(e),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being High Fever,3. Above 49 yrs.,,,,,,,,,,,,,
North,17.4.9(e),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being High Fever,4. Total,,,1.0,,,,,,,,,,1.0
North,17.4.9(f),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being other causes (excluding abortion; obstructed or prolonged labour; severe hypertension or fits;,1. 6-14 yrs,,,,,,,,,,,,,
North,17.4.9(f),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being other causes (excluding abortion; obstructed or prolonged labour; severe hypertension or fits;,2. 15-49 yrs,,,1.0,1.0,,,,,,1.0,,,3.0
North,17.4.9(f),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being other causes (excluding abortion; obstructed or prolonged labour; severe hypertension or fits;,3. Above 49 yrs.,,,,,,,,,,,,,
North,17.4.9(f),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being other causes (excluding abortion; obstructed or prolonged labour; severe hypertension or fits;,4. Total,,,1.0,1.0,,,,,,1.0,,,3.0
North,17.4.10,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Trauma or Accidents or Burn cases,1. 6-14 yrs,,1.0,1.0,,1.0,1.0,,,,,,,4.0
North,17.4.10,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Trauma or Accidents or Burn cases,2. 15-55 yrs.,4.0,2.0,1.0,3.0,3.0,1.0,,4.0,,4.0,4.0,,26.0
North,17.4.10,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Trauma or Accidents or Burn cases,3. Above 55 yrs.,1.0,,,1.0,,,,1.0,,1.0,,,4.0
North,17.4.10,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Trauma or Accidents or Burn cases,4. Total,5.0,3.0,2.0,4.0,4.0,2.0,,5.0,,5.0,4.0,,34.0
North,17.4.11,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being suicide,1. 6-14 yrs,,,,,,,,,,,,,
North,17.4.11,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being suicide,2. 15-55 yrs.,2.0,1.0,1.0,1.0,,1.0,,,,,2.0,,8.0
North,17.4.11,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being suicide,3. Above 55 yrs.,,,,,1.0,,,1.0,,,,,2.0
North,17.4.11,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being suicide,4. Total,2.0,1.0,1.0,1.0,1.0,1.0,,1.0,,,2.0,,10.0
North,17.4.12,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Animal bites and stings,1. 6-14 yrs,,,,,,1.0,,,1.0,,,,2.0
North,17.4.12,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Animal bites and stings,2. 15-55 yrs.,,,,,,,1.0,,1.0,,,,2.0
North,17.4.12,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Animal bites and stings,3. Above 55 yrs.,,,,,,,,,,,,,
North,17.4.12,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Animal bites and stings,4. Total,,,,,,1.0,1.0,,2.0,,,,4.0
North,17.4.13(a),Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Known Acute disease,1. 6-14 yrs,,,,,,,,,,,,,
North,17.4.13(a),Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Known Acute disease,2. 15-55 yrs.,,,1.0,,2.0,2.0,,1.0,,,4.0,4.0,14.0
North,17.4.13(a),Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Known Acute disease,3. Above 55 yrs.,,,1.0,,,,,,,2.0,1.0,4.0,8.0
North,17.4.13(a),Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Known Acute disease,4. Total,,,2.0,,2.0,2.0,,1.0,,2.0,5.0,8.0,22.0
North,17.4.13(b),Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Known Chronic disease,1. 6-14 yrs,,,,,,,,,,,,,
North,17.4.13(b),Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Known Chronic disease,2. 15-55 yrs.,3.0,,2.0,1.0,,1.0,,,,,,1.0,8.0
North,17.4.13(b),Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Known Chronic disease,3. Above 55 yrs.,2.0,,,,,,,1.0,,1.0,1.0,1.0,6.0
North,17.4.13(b),Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Known Chronic disease,4. Total,5.0,,2.0,1.0,,1.0,,1.0,,1.0,1.0,2.0,14.0
North,17.4.13(c),Number of cases of Adolescent or Adult deaths (age 6 years & above) where the cause was not known,1. 6-14 yrs,,,,,1.0,,,,,,,,1.0
North,17.4.13(c),Number of cases of Adolescent or Adult deaths (age 6 years & above) where the cause was not known,2. 15-55 yrs.,8.0,4.0,5.0,13.0,13.0,10.0,3.0,3.0,3.0,3.0,,,65.0
North,17.4.13(c),Number of cases of Adolescent or Adult deaths (age 6 years & above) where the cause was not known,3. Above 55 yrs.,1.0,2.0,1.0,5.0,,4.0,2.0,,,,1.0,1.0,17.0
North,17.4.13(c),Number of cases of Adolescent or Adult deaths (age 6 years & above) where the cause was not known,4. Total,9.0,6.0,6.0,18.0,14.0,14.0,5.0,3.0,3.0,3.0,1.0,1.0,83.0
North East,1.1,Total number of pregnant women Registered for ANC,TOTAL,3476.0,4528.0,3911.0,3971.0,3985.0,4373.0,3008.0,3940.0,3899.0,4226.0,4606.0,5151.0,49074.0
North East,1.1.1,Of which Number registered within first trimester (within 12 weeks),TOTAL,1023.0,1413.0,1215.0,1613.0,1055.0,1255.0,943.0,1618.0,1306.0,1586.0,1644.0,1649.0,16320.0
North East,1.2,Number of Pregnant women registered under JSY,TOTAL,56.0,47.0,44.0,39.0,48.0,48.0,36.0,52.0,117.0,125.0,127.0,117.0,856.0
North East,1.3,Number of pregnant women received 3 ANC check ups during pregnancy,TOTAL,1885.0,2353.0,2305.0,2229.0,2312.0,2518.0,1930.0,3395.0,2010.0,1912.0,2180.0,2106.0,27135.0
North East,1.4.1,Number of pregnant women given TT1 during current pregnancy,TOTAL,1482.0,1986.0,1583.0,1446.0,1584.0,1754.0,1268.0,1341.0,1390.0,1496.0,1813.0,1952.0,19095.0
North East,1.4.2,Number of pregnant women given TT2 or Booster during current pregnancy,TOTAL,1150.0,1441.0,1730.0,1486.0,1524.0,1643.0,1448.0,1328.0,1201.0,1241.0,1323.0,1581.0,17096.0
North East,1.5,Total number of pregnant women given 100 IFA tablets,TOTAL,1712.0,2092.0,2226.0,1993.0,2228.0,2396.0,1846.0,3049.0,1874.0,1781.0,2017.0,1970.0,25184.0
North East,1.6.1,Number of new cases of Hypertension (BP>140/90) detected in Pregnant women at the institution,TOTAL,45.0,62.0,39.0,36.0,49.0,55.0,75.0,70.0,68.0,66.0,57.0,66.0,688.0
North East,1.6.2,Number of Eclampsia cases managed during delivery,TOTAL,1.0,2.0,2.0,2.0,2.0,2.0,2.0,2.0,2.0,1.0,1.0,1.0,20.0
North East,1.7.1,Number of Pregnant women with anaemia i.e. Hb level<11 (tested cases),TOTAL,834.0,1240.0,1288.0,1322.0,1163.0,1207.0,1000.0,1002.0,1107.0,1278.0,1473.0,1710.0,14624.0
North East,1.7.2,Number of Pregnant women having severe anaemia (Hb<7) treated at institution,TOTAL,14.0,24.0,25.0,29.0,16.0,19.0,15.0,18.0,15.0,63.0,12.0,13.0,263.0
North East,1.8,Number of pregnancy test kits used at SC level,TOTAL,78.0,19.0,18.0,57.0,75.0,18.0,62.0,130.0,335.0,27.0,3.0,0.0,822.0
North East,2.1.1.a,Number of deliveries conducted at Home and attended by trained SBA(i.e. Doctor or Nurse or ANM),TOTAL,10.0,2.0,0.0,0.0,17.0,16.0,42.0,9.0,9.0,16.0,0.0,0.0,121.0
North East,2.1.1.b,Number of deliveries conducted at Home and attended by non trained SBA (i.e. trained TBA or Relatives etc.),TOTAL,114.0,150.0,147.0,146.0,162.0,209.0,168.0,189.0,191.0,228.0,186.0,170.0,2060.0
North East,2.1.1.c,Total number of deliveries conducted at Home and attended by trained or non-trained SBA (i.e. sum of 2.1.1.a and 2.1.1.b),TOTAL,124.0,152.0,147.0,146.0,179.0,225.0,210.0,198.0,200.0,244.0,186.0,170.0,2181.0
North East,2.1.2,Number of newborns visited within 24 hours of delivery for deliveries conducted at home,TOTAL,78.0,75.0,82.0,56.0,132.0,146.0,119.0,128.0,137.0,169.0,128.0,111.0,1361.0
North East,2.1.3,Number of mothers paid JSY incentive for deliveries conducted at home,TOTAL,1.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,1.0,0.0,0.0,2.0
North East,2.2,Deliveries conducted at Public Institutions (Including C-Sections),TOTAL,291.0,397.0,386.0,451.0,499.0,319.0,374.0,357.0,416.0,439.0,382.0,340.0,4651.0
North East,2.2.1,"Out of 2.2, Number discharged under 48 hours of delivery",TOTAL,211.0,333.0,283.0,327.0,373.0,252.0,288.0,271.0,319.0,353.0,287.0,274.0,3571.0
North East,2.2.2.a,Number of mothers paid JSY Incentive for deliveries conducted at Public Institutions,TOTAL,7.0,13.0,6.0,6.0,12.0,15.0,9.0,8.0,40.0,23.0,47.0,31.0,217.0
North East,2.2.2.b,Number of ASHAs paid JSY Incentive for deliveries conducted at Public Institutions,TOTAL,0.0,4.0,0.0,0.0,4.0,4.0,1.0,0.0,0.0,3.0,17.0,3.0,36.0
North East,2.2.2.c,Number of cases of deliveries conducted at Public Institutions where JSY incentive was paid to ANMs or AWWs [only for High Performing States (HPS)],TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
North East,2.3,Deliveries conducted at Private Institutions (Including C-Sections),TOTAL,21.0,33.0,46.0,22.0,30.0,19.0,20.0,51.0,22.0,48.0,29.0,26.0,367.0
North East,2.3.1.a,Number of mothers paid JSY Incentive for deliveries conducted at accredited Private Institutions,TOTAL,,,0.0,,,,,,,1.0,,,1.0
North East,2.3.1.b,Number of ASHAs paid JSY Incentive for deliveries conducted at accredited Private Institutions,TOTAL,,,0.0,,,,,,,,,,0.0
North East,2.3.1.c,Number of cases of deliveries conducted at accredited Private Institutions where JSY incentive was paid to ANMs or AWWs [only for High Performing States (HPS)],TOTAL,,,0.0,,,,,,,,,,0.0
North East,3.1.1,Number of Caesarean (C-Section) deliveries performed at PHCs (Primary Health Centre),TOTAL,,,0.0,0.0,0.0,0.0,,,,0.0,0.0,,0.0
North East,3.1.2,Number of Caesarean (C-Section) deliveries performed at CHCs (Community Health Centre),TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
North East,3.1.3,Number of Caesarean (C-Section) deliveries performed at SDHs (Sub-divisional Hospital) or DHs (District Hospital),TOTAL,39.0,37.0,39.0,53.0,53.0,23.0,42.0,46.0,47.0,53.0,56.0,53.0,541.0
North East,3.1.4,Number of Caesarean (C-Section) deliveries performed at other State owned public institutions,TOTAL,,,,,,,,,,,,,
North East,3.1.5,"Total Number of Caesarean (C-Section) deliveries performed at Public facilities i.e. PHC, CHC, SDH, DH and other State owned public institutions (sum of items from 3.1.1 to 3.1.4)",TOTAL,39.0,37.0,39.0,53.0,53.0,23.0,42.0,46.0,47.0,53.0,56.0,53.0,541.0
North East,3.2,No. of C-section deliveries performed at Private facilities,TOTAL,10.0,14.0,23.0,11.0,12.0,12.0,8.0,20.0,15.0,26.0,15.0,13.0,179.0
North East,4.1.1.a,Number of male live births,TOTAL,231.0,304.0,324.0,315.0,364.0,265.0,323.0,324.0,310.0,368.0,338.0,287.0,3753.0
North East,4.1.1.b,Number of female live births,TOTAL,205.0,273.0,254.0,302.0,345.0,292.0,312.0,287.0,325.0,359.0,258.0,247.0,3459.0
North East,4.1.1.c,Total number of male and female live births (4.1.1.a and 4.1.1.b),TOTAL,436.0,577.0,578.0,617.0,709.0,557.0,635.0,611.0,635.0,727.0,596.0,534.0,7212.0
North East,4.1.2,Number of still births,TOTAL,1.0,5.0,2.0,2.0,6.0,7.0,4.0,8.0,7.0,6.0,2.0,3.0,53.0
North East,4.1.3,Number of Abortions (spontaneous or induced),TOTAL,68.0,79.0,53.0,70.0,56.0,16.0,15.0,23.0,68.0,80.0,95.0,82.0,705.0
North East,4.2.1,Number of Newborns weighed at birth,TOTAL,359.0,506.0,516.0,562.0,656.0,465.0,501.0,504.0,594.0,637.0,541.0,470.0,6311.0
North East,4.2.2,Number of Newborns having weight less than 2.5 kg,TOTAL,57.0,99.0,125.0,153.0,175.0,66.0,124.0,108.0,113.0,111.0,64.0,88.0,1283.0
North East,4.3,Number of Newborns breast fed within 1 hour of birth,TOTAL,363.0,499.0,483.0,546.0,631.0,478.0,524.0,544.0,577.0,602.0,510.0,436.0,6193.0
North East,5.1.1,Number of cases of pregnant women with Obstetric Complications and attended at PHCs,TOTAL,,,0.0,0.0,0.0,0.0,,,,0.0,0.0,,0.0
North East,5.1.2,Number of cases of pregnant women with Obstetric Complications and attended at CHCs,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
North East,5.1.3,Number of cases of pregnant women with Obstetric Complications and attended at SDHs or DHs,TOTAL,24.0,28.0,32.0,29.0,35.0,15.0,24.0,25.0,35.0,30.0,19.0,25.0,321.0
North East,5.1.4,Number of cases of pregnant women with Obstetric Complications and attended at other State owned public institutions,TOTAL,,,,,,,,,,,,,
North East,5.1.5,"Number of cases of pregnant women with Obstetric Complications and attended at Public facilities i.e. PHC, CHC, SDH, DH and other State owned public institutions (sum of items from 5.1.1 to 5.1.4)",TOTAL,24.0,28.0,32.0,29.0,35.0,15.0,24.0,25.0,35.0,30.0,19.0,25.0,321.0
North East,5.2,Number of cases of pregnant women with Obstetric Complications and attended at Private facilities,TOTAL,,30.0,10.0,1.0,5.0,12.0,4.0,11.0,13.0,3.0,5.0,3.0,97.0
North East,5.3.1,Number of cases of complicated pregnancies treated with IV antibiotics,TOTAL,23.0,55.0,42.0,22.0,35.0,26.0,20.0,26.0,33.0,21.0,20.0,28.0,351.0
North East,5.3.2,Number of cases of complicated pregnancies treated with IV Antihypertensive/Magsulph injection,TOTAL,1.0,6.0,2.0,1.0,1.0,11.0,2.0,3.0,21.0,2.0,1.0,8.0,59.0
North East,5.3.3,Number of cases of complicated pregnancies treated with IV Oxytocis,TOTAL,18.0,50.0,23.0,16.0,25.0,22.0,18.0,21.0,38.0,23.0,16.0,23.0,293.0
North East,5.3.4,Number of cases of complicated pregnancies treated with Blood Transfusion,TOTAL,12.0,11.0,11.0,21.0,11.0,8.0,7.0,16.0,7.0,5.0,7.0,6.0,122.0
North East,6.1,Women getting post partum check-up within 48 hours after delivery,TOTAL,400.0,504.0,465.0,546.0,695.0,519.0,368.0,555.0,563.0,675.0,544.0,557.0,6391.0
North East,6.2,Women getting a post partum check up between 48 hours and 14 days after delivery,TOTAL,271.0,429.0,392.0,384.0,576.0,452.0,426.0,587.0,499.0,511.0,471.0,688.0,5686.0
North East,6.3,PNC maternal complications attended,TOTAL,0.0,1.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,1.0,2.0
North East,7.1.1,Number of MTPs conducted at Public Institutions up to 12 weeks of pregnancy,TOTAL,0.0,0.0,0.0,14.0,1.0,0.0,0.0,1.0,10.0,8.0,8.0,3.0,45.0
North East,7.1.2,Number of MTPs conducted at Public Institutions for more than 12 weeks of pregnancy,TOTAL,0.0,0.0,0.0,0.0,1.0,0.0,0.0,1.0,0.0,1.0,0.0,0.0,3.0
North East,7.1.3,Total number of MTPs conducted at Public Institutions (sum of items 7.1.1 and 7.1.2),TOTAL,0.0,0.0,0.0,14.0,2.0,0.0,0.0,2.0,10.0,9.0,8.0,3.0,48.0
North East,7.2,Number of MTPs conducted at Private Facilities,TOTAL,4.0,16.0,56.0,32.0,5.0,13.0,26.0,30.0,5.0,19.0,3.0,23.0,232.0
North East,8.1.a,Number of new cases of RTI/STI in males for which treatment was initiated,TOTAL,28.0,43.0,42.0,20.0,18.0,24.0,21.0,232.0,24.0,47.0,40.0,49.0,588.0
North East,8.1.b,Number of new cases of RTI/STI in females for which treatment was initiated,TOTAL,649.0,738.0,791.0,634.0,592.0,1029.0,739.0,1174.0,860.0,812.0,832.0,881.0,9731.0
North East,8.1.c,Total number of new cases of RTI/STI in males and females for which treatment was initiated (sum of items 8.1.a and 8.1.b),TOTAL,677.0,781.0,833.0,654.0,610.0,1053.0,760.0,1406.0,884.0,859.0,872.0,930.0,10319.0
North East,8.2,Number of suspected RTI/STI cases for whom wet mount test was conducted,TOTAL,0.0,20.0,2.0,0.0,0.0,2.0,0.0,0.0,0.0,0.0,0.0,0.0,24.0
North East,9.1.1.a,Number of NSV (No Scalpel Vasectomy) or Conventional Vasectomy conducted at PHCs,TOTAL,0.0,0.0,,,0.0,0.0,,,,0.0,0.0,,0.0
North East,9.1.1.b,Number of NSV or Conventional Vasectomy conducted at CHCs,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
North East,9.1.1.c,Number of NSV or Conventional Vasectomy conducted at SDHs or DHs,TOTAL,,,,,,,,6.0,,,,,6.0
North East,9.1.1.d,Number of NSV or Conventional Vasectomy conducted at other State owned public institutions,TOTAL,,,,,,,,,,,,,
North East,9.1.1.e,"Total Number of NSV or Conventional Vasectomy conducted at Public facilities i.e. PHC, CHC, SDH, DH and other State owned public institutions (sum of items from 9.1.1.a to 9.1.1.d)",TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,6.0,0.0,0.0,0.0,0.0,6.0
North East,9.1.2,Number of NSV or Conventional Vasectomy conducted at Private facilities,TOTAL,,,0.0,,,,,,,,,,0.0
North East,9.2.1.a,Number of Laparoscopic sterilizations conducted at PHCs,TOTAL,0.0,0.0,,,0.0,0.0,,,,0.0,0.0,0.0,0.0
North East,9.2.1.b,Number of Laparoscopic sterilizations conducted at CHCs,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
North East,9.2.1.c,Number of Laparoscopic sterilizations conducted at SDHs or DHs,TOTAL,,,,,,,,2.0,5.0,1.0,1.0,0.0,9.0
North East,9.2.1.d,Number of Laparoscopic sterilizations conducted at other State owned public institutions,TOTAL,,,,,,,,,,,,,
North East,9.2.1.e,"Total Number of Laparoscopic sterilizations conducted at Public facilities i.e. PHC, CHC, SDH, DH and other State owned public institutions (sum of items from 9.2.1.a to 9.2.1.d)",TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,2.0,5.0,1.0,1.0,0.0,9.0
North East,9.2.2,Number of Laparoscopic sterilizations conducted at Private facilities,TOTAL,,,0.0,,,,,,,,,,0.0
North East,9.3.1.a,Number of Mini-lap sterilizations conducted at PHCs,TOTAL,,,,,0.0,0.0,,,,0.0,0.0,,0.0
North East,9.3.1.b,Number of Mini-lap sterilizations conducted at CHCs,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
North East,9.3.1.c,Number of Mini-lap sterilizations conducted at SDHs or DHs,TOTAL,,,,,,,,,,2.0,,0.0,2.0
North East,9.3.1.d,Number of Mini-lap sterilizations conducted at other State owned public institutions,TOTAL,,,,,,,,,,,,,
North East,9.3.1.e,"Total Number of Mini-lap sterilizations conducted at Public facilities i.e. PHC, CHC, SDH, DH and other State owned public institutions (sum of items from 9.3.1.a to 9.3.1.d)",TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,2.0,0.0,0.0,2.0
North East,9.3.2,Number of Mini-lap sterilizations conducted at Private facilities,TOTAL,,,0.0,,,,1.0,,,,,,1.0
North East,9.4.1.a,Number of Post-Partum sterilizations conducted at PHCs,TOTAL,,,,,0.0,0.0,,,,0.0,0.0,,0.0
North East,9.4.1.b,Number of Post-Partum sterilizations conducted at CHCs,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
North East,9.4.1.c,Number of Post-Partum sterilizations conducted at SDHs or DHs,TOTAL,,,,,,,,5.0,9.0,17.0,5.0,2.0,38.0
North East,9.4.1.d,Number of Post-Partum sterilizations conducted at other State owned public institutions,TOTAL,,,,,,,,,,,,,
North East,9.4.1.e,"Total Number of Post-Partum sterilizations conducted at Public facilities i.e. PHC, CHC, SDH, DH and other State owned public institutions (sum of items from 9.4.1.a to 9.4.1.d)",TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,5.0,9.0,17.0,5.0,2.0,38.0
North East,9.4.2,Number of Post-Partum sterilizations conducted at Private facilities,TOTAL,,,0.0,,,,,,,,,,0.0
North East,9.5.1.a,Number of IUCD Insertions conducted at SCs,TOTAL,0.0,18.0,28.0,28.0,35.0,19.0,10.0,0.0,0.0,0.0,0.0,0.0,138.0
North East,9.5.1.b,Number of IUCD Insertions conducted at PHCs,TOTAL,180.0,157.0,168.0,256.0,197.0,201.0,106.0,152.0,171.0,169.0,285.0,163.0,2205.0
North East,9.5.1.c,Number of IUCD Insertions conducted at CHCs,TOTAL,51.0,79.0,48.0,94.0,68.0,47.0,36.0,63.0,51.0,66.0,70.0,47.0,720.0
North East,9.5.1.d,Number of IUCD Insertions conducted at SDHs or DHs,TOTAL,47.0,25.0,23.0,110.0,70.0,46.0,65.0,186.0,185.0,151.0,94.0,134.0,1136.0
North East,9.5.1.e,Number of IUCD Insertions conducted at other State owned public institutions,TOTAL,,,,,,,,,,,,,
North East,9.5.1.f,"Total Number of IUCD Insertions conducted at Public facilities i.e. SC, PHC, CHC, SDH, DH and other State owned public institutions (sum of items from 9.5.1.a to 9.5.1.e)",TOTAL,278.0,279.0,267.0,488.0,370.0,313.0,217.0,401.0,407.0,386.0,449.0,344.0,4199.0
North East,9.5.1A,"Out of above total, Post Partum (within 48 hours of delivery) IUCD insertions",TOTAL,3.0,45.0,42.0,45.0,35.0,10.0,66.0,4.0,5.0,133.0,107.0,129.0,624.0
North East,9.5.2,Number of IUCD Insertions conducted at Private facilities,TOTAL,7.0,16.0,13.0,5.0,10.0,2.0,5.0,11.0,4.0,11.0,8.0,8.0,100.0
North East,9.06,Number of IUCD removals,TOTAL,59.0,85.0,97.0,79.0,67.0,68.0,47.0,67.0,61.0,62.0,101.0,66.0,859.0
North East,9.07,Number of Oral Pills cycles distributed,TOTAL,495.0,652.0,1191.0,1216.0,660.0,616.0,464.0,622.0,926.0,774.0,642.0,646.0,8904.0
North East,9.08,Number of Condom pieces distributed,TOTAL,11363.0,22149.0,14171.0,45490.0,23430.0,15901.0,11724.0,11326.0,21448.0,20562.0,19930.0,19085.0,236579.0
North East,9.09,Number of Centchroman (weekly) pills given,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,17.0,3.0,0.0,0.0,2.0,0.0,22.0
North East,9.10,Number of Emergency Contraceptive Pills distributed,TOTAL,19.0,37.0,35.0,18.0,34.0,27.0,16.0,38.0,65.0,51.0,44.0,62.0,446.0
North East,9.11.1.a,Number of cases of complications following male sterilization,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
North East,9.11.1.b,Number of cases of complications following female sterilization,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
North East,9.11.2.a,Number of failures following male sterilization,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
North East,9.11.2.b,Number of failures following female sterilization,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
North East,9.11.3.a,Number of deaths following male sterilization,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
North East,9.11.3.b,Number of deaths following female sterilization,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
North East,9.12,Number of Institutions having NSV trained doctors,TOTAL,,,,,,,,1.0,,,,,-1.0
North East,10.1.01,Number of Infants (0 to 11 months old)received BCG immunisation,TOTAL,1042.0,1074.0,890.0,995.0,1250.0,1119.0,936.0,1236.0,1321.0,1012.0,1093.0,1088.0,13056.0
North East,10.1.02,Number of Infants (0 to 11 months old) received DPT1 immunisation,TOTAL,264.0,487.0,247.0,190.0,243.0,277.0,143.0,240.0,104.0,54.0,49.0,117.0,2415.0
North East,10.1.03,Number of Infants (0 to 11 months old) received DPT2 immunisation,TOTAL,351.0,525.0,301.0,259.0,289.0,281.0,199.0,276.0,167.0,136.0,123.0,151.0,3058.0
North East,10.1.04,Number of Infants (0 to 11 months old) received DPT3 immunisation,TOTAL,376.0,485.0,308.0,300.0,290.0,357.0,206.0,246.0,152.0,153.0,138.0,138.0,3149.0
North East,10.1.04A,Number of Infants (0 to 11 months old) received Pentavalent1 immunisation,TOTAL,1902.0,1647.0,1370.0,1710.0,2043.0,1939.0,2013.0,2612.0,2482.0,2204.0,2302.0,2429.0,24653.0
North East,10.1.04B,Number of Infants (0 to 11 months old) received Pentavalent2 immunisation,TOTAL,1776.0,1650.0,1431.0,1380.0,1772.0,1511.0,1644.0,2050.0,2474.0,2279.0,2110.0,2317.0,22394.0
North East,10.1.04C,Number of Infants (0 to 11 months old) received Pentavalent3 immunisation,TOTAL,1669.0,1622.0,1362.0,1510.0,1650.0,1297.0,1381.0,1789.0,1803.0,2177.0,1985.0,2148.0,20393.0
North East,10.1.05,Number of Infants (0 to 11 months old) received OPV 0 (Birth Dose),TOTAL,436.0,565.0,578.0,617.0,709.0,557.0,603.0,611.0,635.0,727.0,596.0,534.0,7168.0
North East,10.1.06,Number of Infants (0 to 11 months old) received OPV1 (First Dose),TOTAL,1944.0,2015.0,1561.0,1647.0,1979.0,2116.0,2083.0,2651.0,2600.0,2151.0,2245.0,2419.0,25411.0
North East,10.1.07,Number of Infants (0 to 11 months old) received OPV2 (Second Dose),TOTAL,1957.0,2096.0,1662.0,1459.0,1795.0,1682.0,1795.0,2259.0,2534.0,2316.0,2170.0,2268.0,23993.0
North East,10.1.08,Number of Infants (0 to 11 months old) received OPV3 (Third Dose),TOTAL,1894.0,2024.0,1629.0,1703.0,1715.0,1617.0,1570.0,1957.0,1941.0,2234.0,2018.0,2195.0,22497.0
North East,10.1.09A,Number of Infants (upto 48 hrs of age) received Hepatitis-B0 immunisation,TOTAL,322.0,549.0,461.0,526.0,549.0,348.0,382.0,588.0,532.0,600.0,458.0,513.0,5828.0
North East,10.1.09,Number of Infants (0 to 11 months old) received Hepatitis-B1 immunisation,TOTAL,83.0,305.0,117.0,53.0,81.0,206.0,38.0,215.0,89.0,90.0,24.0,19.0,1320.0
North East,10.1.10,Number of Infants (0 to 11 months old) received Hepatitis-B2 immunisation,TOTAL,215.0,414.0,205.0,135.0,131.0,211.0,87.0,230.0,118.0,136.0,79.0,78.0,2039.0
North East,10.1.11,Number of Infants (0 to 11 months old) received Hepatitis-B3 immunisation,TOTAL,248.0,398.0,251.0,188.0,188.0,274.0,90.0,225.0,138.0,119.0,96.0,74.0,2289.0
North East,10.1.12,Number of Infants (0 to 11 months old) received Measles immunisation (First Dose),TOTAL,7017.0,2250.0,2418.0,1899.0,2501.0,2045.0,1943.0,2577.0,1954.0,1650.0,1609.0,1974.0,29837.0
North East,10.1.12B,Number of Infants (more than 16 months old) received Measles immunisation (Second Dose),TOTAL,13558.0,1997.0,8139.0,866.0,473.0,184.0,242.0,212.0,184.0,114.0,191.0,391.0,26551.0
North East,10.1A,No. of Children aged 9 to 12 months who received JE 1st dose,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
North East,10.1.13.a,Total number of male children (9 to 11 months old) fully immunised (BCG+DPT123/Pentavalent123+OPV123+Measles) during the month,TOTAL,1979.0,1161.0,1191.0,997.0,1266.0,1054.0,1054.0,1410.0,962.0,807.0,765.0,980.0,13626.0
North East,10.1.13.b,Total number of female children (9 to 11 months old) fully immunised (BCG+DPT123/Pentavalent123+OPV123+Measles) during the month,TOTAL,1679.0,995.0,948.0,883.0,1173.0,934.0,879.0,1145.0,905.0,706.0,681.0,868.0,11796.0
North East,10.1.13.c,Total number of children (9 to 11 months old) fully immunised (BCG+DPT123/Pentavalent123+OPV123+Measles) during the month (sum of items 10.1.13.a and 10.1.13.b),TOTAL,3658.0,2156.0,2139.0,1880.0,2439.0,1988.0,1933.0,2555.0,1867.0,1513.0,1446.0,1848.0,25422.0
North East,10.2.1,Number of Infants (more than 16 months old) received DPT Booster dose,TOTAL,1289.0,2438.0,1682.0,1527.0,1819.0,1956.0,1437.0,2163.0,1941.0,1765.0,1980.0,2390.0,22387.0
North East,10.2.2,Number of Infants (more than 16 months old) received OPV Booster dose,TOTAL,1286.0,2476.0,1663.0,1539.0,1816.0,1943.0,1450.0,2181.0,1950.0,1766.0,1993.0,2399.0,22462.0
North East,10.2.3,"Number of Infants (more than 16 months old) received Measles, Mumps, Rubella (MMR) Vaccination",TOTAL,929.0,367.0,539.0,152.0,1288.0,2136.0,1472.0,2432.0,2467.0,2010.0,2214.0,1404.0,17410.0
North East,10.3.1.a,Total number of male children (12 to 23 months old) fully immunised (BCG+DPT123/Pentavalent123+OPV123+Measles) during the month,TOTAL,915.0,391.0,523.0,355.0,471.0,329.0,488.0,273.0,258.0,248.0,269.0,199.0,4719.0
North East,10.3.1.b,Total number of female children (12 to 23 months old) fully immunised (BCG+DPT123/Pentavalent123+OPV123+Measles) during the month,TOTAL,799.0,369.0,434.0,315.0,468.0,348.0,404.0,214.0,217.0,196.0,249.0,217.0,4230.0
North East,10.3.1.c,Total number of children (12 to 23 months old) fully immunised (BCG+DPT123+OPV123/Pentavalent123+Measles) during the month (sum of items 10.3.1.a and 10.3.1.b),TOTAL,1714.0,760.0,957.0,670.0,939.0,677.0,892.0,487.0,475.0,444.0,518.0,416.0,8949.0
North East,10.3.2,Number of children (more than 5 years old) given DT5,TOTAL,439.0,1131.0,470.0,452.0,538.0,668.0,524.0,774.0,846.0,796.0,717.0,848.0,8203.0
North East,10.3.3,Number of children (more than 10 years old) given TT10,TOTAL,334.0,820.0,295.0,262.0,188.0,380.0,319.0,276.0,284.0,380.0,398.0,407.0,4343.0
North East,10.3.4,Number of children (more than 16 years old) given TT16,TOTAL,303.0,360.0,159.0,111.0,92.0,200.0,185.0,190.0,173.0,157.0,293.0,214.0,2437.0
North East,10.3.5.a,Number of cases of Abscess reported following immunisation [Adverse Event Following Immunisation (AEFI)],TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,1.0,0.0,0.0,0.0,1.0
North East,10.3.5.b,Number of cases of Death reported following immunisation [Adverse Event Following Immunisation (AEFI)],TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
North East,10.3.5.c,Number of cases of other complications reported following immunisation [Adverse Event Following Immunisation (AEFI)],TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
North East,10.4.1,Number of Immunisation sessions planned to be held during the month,TOTAL,632.0,528.0,411.0,258.0,240.0,311.0,306.0,338.0,502.0,383.0,360.0,330.0,4599.0
North East,10.4.2,Number of Immunisation sessions held during the month,TOTAL,602.0,505.0,396.0,255.0,229.0,303.0,264.0,326.0,482.0,366.0,335.0,306.0,4369.0
North East,10.4.3,Number of Immunisation sessions held during the month where ASHAs were present,TOTAL,430.0,359.0,275.0,182.0,173.0,212.0,198.0,238.0,399.0,289.0,265.0,249.0,3269.0
North East,10.5.1,Number of children (more than 16 months old) received Japanese Encephalitis (JE) vaccination,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
North East,11.1.1,Number of children (9 months to 5 years old) administered 1st dose of Vitamin A (Dose-1),TOTAL,6287.0,2433.0,2207.0,1854.0,2407.0,2092.0,1870.0,2435.0,2035.0,1695.0,1603.0,2036.0,28954.0
North East,11.1.2,Number of children (9 months to 5 years old) were administered 5th dose of Vitamin A (Dose-5),TOTAL,15909.0,1663.0,2559.0,805.0,974.0,1371.0,1157.0,1698.0,1704.0,1264.0,1222.0,1374.0,31700.0
North East,11.1.3,Number of children (9 months to 5 years old) administered 9th dose of Vitamin A (Dose-9),TOTAL,4071.0,1156.0,2857.0,517.0,677.0,730.0,617.0,917.0,955.0,770.0,740.0,831.0,14838.0
North East,12.1,Number of cases of Diptheria reported in children below 5 years of age,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
North East,12.2,Number of cases of Pertusis reported in children below 5 years of age,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
North East,12.3,Number of cases of Tetanus neonatarum reported in children below 5 years of age,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
North East,12.4,Number of cases of Tetanus other than neonatarum reported in children below 5 years of age,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
North East,12.5,Number of cases of Polio reported in children below 5 years of age,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
North East,12.6,Number of cases of Measles reported in children below 5 years of age,TOTAL,17.0,22.0,2.0,0.0,0.0,1.0,0.0,0.0,0.0,11.0,2.0,0.0,55.0
North East,12.7,Number of cases of Diarrhoea and Dehydration reported in children below 5 years of age,TOTAL,297.0,392.0,279.0,305.0,368.0,289.0,282.0,149.0,142.0,141.0,129.0,144.0,2917.0
North East,12.8,Number of cases of Malaria reported in children below 5 years of age,TOTAL,0.0,4.0,0.0,1.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,5.0
North East,12.9,Number of children below 5 years of age admitted with Respiratory Infections,TOTAL,0.0,1.0,3.0,0.0,62.0,0.0,15.0,0.0,0.0,0.0,0.0,0.0,81.0
North East,13.1,Number of Patients operated for cataract,TOTAL,64.0,55.0,29.0,20.0,30.0,44.0,13.0,37.0,55.0,38.0,33.0,37.0,455.0
North East,13.2,Number of Intraocular Lens(IOL) implantations,TOTAL,64.0,55.0,28.0,20.0,30.0,44.0,13.0,37.0,55.0,37.0,33.0,37.0,453.0
North East,13.3,Number of School children detected with Refractive errors,TOTAL,58.0,80.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,138.0
North East,13.4,Number of children provided free glasses,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
North East,13.5,Number of eyes collected through eye donation,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
North East,13.6,Number of eyes utilised for corneal transplant,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
North East,14.01,Number of CHC or SDH or DH functioning as First Referral units (FRUs),TOTAL,2.0,1.0,2.0,1.0,1.0,1.0,1.0,1.0,1.0,1.0,1.0,,-1.0
North East,14.02,Number of PHCs functioning 24X7 with atleast 3 Staff Nurses,TOTAL,,,,,,,,,,,,,-1.0
North East,14.03,Number of Anganwadi centres reported to have conducted VHNDs,TOTAL,32.0,29.0,0.0,0.0,0.0,0.0,0.0,1.0,18.0,33.0,35.0,29.0,-1.0
North East,14.04,Number of facilities having a Rogi Kalyan Samiti (RKS),TOTAL,3.0,3.0,3.0,3.0,3.0,2.0,2.0,2.0,2.0,2.0,2.0,2.0,-1.0
North East,14.05,Number of RKS meetings held during the month,TOTAL,1.0,0.0,1.0,0.0,1.0,1.0,1.0,1.0,1.0,1.0,1.0,1.0,10.0
North East,14.06,Number of facilities having Ambulance services (Assured Referral Services),TOTAL,2.0,3.0,4.0,3.0,3.0,3.0,4.0,4.0,4.0,6.0,4.0,4.0,-1.0
North East,14.07,Total Number of times the Ambulance was used for transporting patients during the month,TOTAL,82.0,66.0,74.0,70.0,76.0,69.0,79.0,61.0,92.0,87.0,58.0,36.0,850.0
North East,14.08,Number of Institutions having Operational Sick New Born and Child Care Units (SNCU),TOTAL,1.0,1.0,1.0,1.0,1.0,,,1.0,1.0,,,,-1.0
North East,14.09,Number of functional Laproscopes in CHC/SDH/DH,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,-1.0
North East,14.10.1.a,Number of male patients admitted (Inpatients) during the month,1. Children,97.0,84.0,140.0,265.0,339.0,177.0,207.0,246.0,245.0,247.0,272.0,223.0,2542.0
North East,14.10.1.a,Number of male patients admitted (Inpatients) during the month,2. Adults,426.0,693.0,634.0,206.0,187.0,223.0,156.0,158.0,140.0,173.0,211.0,241.0,3448.0
North East,14.10.1.b,Number of female patients (Inpatients) admitted during the month,1. Children,89.0,41.0,103.0,259.0,279.0,182.0,174.0,221.0,221.0,198.0,212.0,260.0,2239.0
North East,14.10.1.b,Number of female patients (Inpatients) admitted during the month,2. Adults,928.0,1077.0,1092.0,268.0,959.0,648.0,660.0,739.0,710.0,633.0,830.0,785.0,9329.0
North East,14.10.1.c,Total number of patients admitted (Inpatients) during the month (sum of items 14.10.1.a and 14.10.1.b),1. Children,186.0,125.0,243.0,524.0,618.0,359.0,381.0,467.0,466.0,445.0,484.0,483.0,4781.0
North East,14.10.1.c,Total number of patients admitted (Inpatients) during the month (sum of items 14.10.1.a and 14.10.1.b),2. Adults,1354.0,1770.0,1726.0,474.0,1146.0,871.0,816.0,897.0,850.0,806.0,1041.0,1026.0,12777.0
North East,14.10.2.a,Number of death cases of Inpatient males,TOTAL,2.0,3.0,6.0,3.0,2.0,4.0,5.0,2.0,2.0,1.0,4.0,0.0,34.0
North East,14.10.2.b,Number of death cases of Inpatient females,TOTAL,0.0,0.0,6.0,1.0,1.0,1.0,4.0,2.0,1.0,2.0,4.0,3.0,25.0
North East,14.10.2.c,Number of cases of death of Inpatients (sum of items 14.10.2.a and 14.10.2.b),TOTAL,2.0,3.0,12.0,4.0,3.0,5.0,9.0,4.0,3.0,3.0,8.0,3.0,59.0
North East,14.11,In-Patient Head Count at midnight,TOTAL,2072.0,3350.0,2239.0,2275.0,2319.0,1224.0,1265.0,1961.0,2180.0,2533.0,1585.0,2074.0,25077.0
North East,14.12.1,OPD attendance (All),TOTAL,201094.0,197985.0,177045.0,185306.0,189296.0,214023.0,168828.0,212642.0,201073.0,192108.0,229707.0,219267.0,2388374.0
North East,14.13.1,Number of major operations carried out using general or spinal anaesthesia,TOTAL,213.0,214.0,177.0,183.0,186.0,216.0,106.0,49.0,209.0,192.0,181.0,1459.0,3385.0
North East,14.13.1A,"Out of 14.13.1,Gynecology- Hysterectomy surgeries",TOTAL,0.0,14.0,7.0,9.0,0.0,0.0,10.0,0.0,0.0,14.0,4.0,56.0,114.0
North East,14.13.2,Number of minor operations carried out without anaesthesia or using local anaesthesia,TOTAL,1091.0,1253.0,1434.0,1779.0,1712.0,1709.0,1327.0,904.0,1097.0,1177.0,1181.0,193.0,14857.0
North East,14.14.a,Number of patients given AYUSH treatment,TOTAL,438.0,422.0,420.0,1140.0,0.0,0.0,110.0,763.0,715.0,550.0,0.0,654.0,5212.0
North East,14.14.b,Number of patients on whom Dental Procedure was conducted,TOTAL,71.0,71.0,61.0,78.0,0.0,15.0,86.0,73.0,104.0,103.0,0.0,78.0,740.0
North East,14.14.c,Number of Adolescents counselled,TOTAL,103.0,130.0,154.0,115.0,278.0,105.0,511.0,577.0,342.0,356.0,279.0,378.0,3328.0
North East,15.1.1.a,Number of Haemoglobin (Hb) tests conducted,TOTAL,4796.0,5806.0,4787.0,5476.0,5222.0,4934.0,2927.0,3695.0,3662.0,4176.0,5186.0,5757.0,56424.0
North East,15.1.1.b,"Out of the total number of Hb tests conducted, number of cases having Hb less than 7gm/dl",TOTAL,216.0,224.0,199.0,217.0,203.0,207.0,84.0,202.0,202.0,112.0,255.0,136.0,2257.0
North East,15.1.2.a,Number of HIV tests conducted on males,1. Number tested,420.0,494.0,405.0,467.0,421.0,450.0,351.0,598.0,974.0,689.0,762.0,392.0,6423.0
North East,15.1.2.a,Number of HIV tests conducted on males,2. Number Positive,12.0,11.0,8.0,13.0,6.0,7.0,7.0,6.0,7.0,12.0,9.0,5.0,103.0
North East,15.1.2.b,Number of HIV tests conducted on Female-Non ANC (i.e. non pregnant females),1. Number tested,445.0,581.0,491.0,397.0,558.0,497.0,468.0,655.0,545.0,699.0,619.0,495.0,6450.0
North East,15.1.2.b,Number of HIV tests conducted on Female-Non ANC (i.e. non pregnant females),2. Number Positive,2.0,3.0,1.0,5.0,2.0,1.0,3.0,4.0,3.0,1.0,4.0,2.0,31.0
North East,15.1.2.c,Number of HIV tests conducted on Female with ANC (i.e. pregnant females),1. Number tested,1459.0,1746.0,1509.0,1299.0,1439.0,1644.0,996.0,1136.0,1386.0,1504.0,1553.0,1020.0,16691.0
North East,15.1.2.c,Number of HIV tests conducted on Female with ANC (i.e. pregnant females),2. Number Positive,1.0,1.0,1.0,15.0,0.0,4.0,9.0,3.0,0.0,2.0,2.0,1.0,39.0
North East,15.1.2.d,Total number of HIV tests conducted (sum of items 15.1.2.a to 15.1.2.c),1. Number tested,2324.0,2821.0,2405.0,2163.0,2418.0,2591.0,1815.0,2389.0,2905.0,2892.0,2934.0,1907.0,29564.0
North East,15.1.2.d,Total number of HIV tests conducted (sum of items 15.1.2.a to 15.1.2.c),2. Number Positive,15.0,15.0,10.0,33.0,8.0,12.0,19.0,13.0,10.0,15.0,15.0,8.0,173.0
North East,15.2,Number of Widal tests conducted,Number tested,478.0,598.0,515.0,265.0,568.0,87.0,113.0,407.0,173.0,132.0,258.0,242.0,3836.0
North East,15.3.a,Number of VDRL tests conducted on males,Number tested,2.0,29.0,53.0,3.0,0.0,2.0,6.0,48.0,37.0,9.0,34.0,4.0,227.0
North East,15.3.b,Number of VDRL tests conducted on Female-Non ANC (i.e. non pregnant females),Number tested,35.0,38.0,126.0,61.0,100.0,90.0,20.0,73.0,50.0,4.0,37.0,0.0,634.0
North East,15.3.c,Number of VDRL tests conducted on Female with ANC (i.e. pregnant females),Number tested,302.0,391.0,320.0,456.0,512.0,430.0,112.0,332.0,534.0,565.0,487.0,514.0,4955.0
North East,15.3.d,Total number of VDRL tests conducted (sum of items 15.3.a to 15.3.c),Number tested,339.0,458.0,499.0,520.0,612.0,522.0,138.0,453.0,621.0,578.0,558.0,518.0,5816.0
North East,15.4.1,Number of blood smears examined for Malaria,TOTAL,265.0,572.0,339.0,632.0,425.0,474.0,231.0,349.0,611.0,207.0,266.0,107.0,4478.0
North East,15.4.2,"Out of blood smears examined for malaria, number of blood smears tested positive for Plasmodium Vivax",TOTAL,0.0,30.0,2.0,3.0,4.0,14.0,3.0,2.0,2.0,1.0,2.0,0.0,63.0
North East,15.4.3,"Out of blood smears examined for malaria, number of blood smears tested positive for Plasmodium Falciparum",TOTAL,0.0,2.0,1.0,0.0,0.0,0.0,1.0,0.0,0.0,0.0,0.0,0.0,4.0
North East,16.1.1,Stock position of DPT vaccines,1. Balance From Previous Month,1870.0,2520.0,1530.0,1630.0,2750.0,2810.0,920.0,3320.0,3740.0,2600.0,2540.0,4550.0,30780.0
North East,16.1.1,Stock position of DPT vaccines,2. Stocks Received,3000.0,3000.0,2000.0,3000.0,2000.0,1500.0,4000.0,3000.0,2000.0,2000.0,5000.0,2500.0,33000.0
North East,16.1.1,Stock position of DPT vaccines,3. Unusable Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
North East,16.1.1,Stock position of DPT vaccines,4. Stock Distributed,2350.0,3990.0,1900.0,1880.0,1940.0,3390.0,1600.0,2580.0,3140.0,2060.0,2990.0,3610.0,31430.0
North East,16.1.1,Stock position of DPT vaccines,5. Total Stock,2520.0,1530.0,1630.0,2750.0,2810.0,920.0,3320.0,3740.0,2600.0,2540.0,4550.0,3440.0,32350.0
North East,16.1.1A,Stock Position of Pentavalent,1. Balance From Previous Month,1360.0,1570.0,2320.0,1770.0,3390.0,4020.0,3310.0,4030.0,3050.0,1590.0,1500.0,5400.0,33310.0
North East,16.1.1A,Stock Position of Pentavalent,2. Stocks Received,4500.0,5500.0,2500.0,5500.0,4000.0,4000.0,4000.0,4000.0,4000.0,4000.0,9000.0,4000.0,55000.0
North East,16.1.1A,Stock Position of Pentavalent,3. Unusable Stock,0.0,0.0,0.0,0.0,0.0,,0.0,0.0,0.0,0.0,0.0,0.0,0.0
North East,16.1.1A,Stock Position of Pentavalent,4. Stock Distributed,4290.0,4750.0,3050.0,3880.0,3370.0,4710.0,3280.0,4980.0,5460.0,4090.0,5100.0,6820.0,53780.0
North East,16.1.1A,Stock Position of Pentavalent,5. Total Stock,1570.0,2320.0,1770.0,3390.0,4020.0,3310.0,4030.0,3050.0,1590.0,1500.0,5400.0,2580.0,34530.0
North East,16.1.2,Stock position of OPV vaccines,1. Balance From Previous Month,2600.0,1460.0,2580.0,2160.0,3780.0,6700.0,5880.0,6240.0,6210.0,3750.0,5590.0,8230.0,55180.0
North East,16.1.2,Stock position of OPV vaccines,2. Stocks Received,6000.0,9000.0,4000.0,7000.0,7500.0,7000.0,5000.0,7000.0,5000.0,6000.0,9000.0,6000.0,78500.0
North East,16.1.2,Stock position of OPV vaccines,3. Unusable Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
North East,16.1.2,Stock position of OPV vaccines,4. Stock Distributed,7140.0,7880.0,4420.0,5380.0,4580.0,7820.0,4640.0,7030.0,7460.0,4160.0,6360.0,8520.0,75390.0
North East,16.1.2,Stock position of OPV vaccines,5. Total Stock,1460.0,2580.0,2160.0,3780.0,6700.0,5880.0,6240.0,6210.0,3750.0,5590.0,8230.0,5710.0,58290.0
North East,16.1.3,Stock position of TT vaccines,1. Balance From Previous Month,940.0,1770.0,1880.0,1590.0,3390.0,3660.0,3300.0,3020.0,2850.0,1470.0,11010.0,3910.0,38790.0
North East,16.1.3,Stock position of TT vaccines,2. Stocks Received,3000.0,4000.0,1500.0,4000.0,2000.0,3000.0,1500.0,2000.0,1000.0,11000.0,0.0,1000.0,34000.0
North East,16.1.3,Stock position of TT vaccines,3. Unusable Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
North East,16.1.3,Stock position of TT vaccines,4. Stock Distributed,2170.0,3890.0,1790.0,2200.0,1730.0,3360.0,1780.0,2170.0,2380.0,1460.0,7100.0,2160.0,32190.0
North East,16.1.3,Stock position of TT vaccines,5. Total Stock,1770.0,1880.0,1590.0,3390.0,3660.0,3300.0,3020.0,2850.0,1470.0,11010.0,3910.0,2750.0,40600.0
North East,16.1.4,Stock position of DT vaccines,1. Balance From Previous Month,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
North East,16.1.4,Stock position of DT vaccines,2. Stocks Received,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
North East,16.1.4,Stock position of DT vaccines,3. Unusable Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
North East,16.1.4,Stock position of DT vaccines,4. Stock Distributed,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
North East,16.1.4,Stock position of DT vaccines,5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
North East,16.1.5,Stock position of BCG vaccines,1. Balance From Previous Month,1630.0,1400.0,1720.0,1990.0,1870.0,2880.0,2580.0,2440.0,1330.0,1770.0,2500.0,3070.0,25180.0
North East,16.1.5,Stock position of BCG vaccines,2. Stocks Received,1500.0,2000.0,1000.0,1000.0,2000.0,1500.0,1000.0,500.0,2000.0,2000.0,2000.0,500.0,17000.0
North East,16.1.5,Stock position of BCG vaccines,3. Unusable Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
North East,16.1.5,Stock position of BCG vaccines,4. Stock Distributed,1730.0,1680.0,730.0,1120.0,990.0,1800.0,1140.0,1590.0,1560.0,1270.0,1430.0,2400.0,17440.0
North East,16.1.5,Stock position of BCG vaccines,5. Total Stock,1400.0,1720.0,1990.0,1870.0,2880.0,2580.0,2440.0,1350.0,1770.0,2500.0,3070.0,1170.0,24740.0
North East,16.1.6,Stock position of Measles vaccines,1. Balance From Previous Month,1540.0,8540.0,4855.0,110.0,4195.0,3840.0,2080.0,3235.0,4010.0,3660.0,4345.0,3745.0,44155.0
North East,16.1.6,Stock position of Measles vaccines,2. Stocks Received,75475.0,0.0,10000.0,6000.0,1500.0,1000.0,2500.0,3000.0,2000.0,2000.0,1500.0,1000.0,105975.0
North East,16.1.6,Stock position of Measles vaccines,3. Unusable Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
North East,16.1.6,Stock position of Measles vaccines,4. Stock Distributed,68475.0,3685.0,14745.0,1915.0,1855.0,2760.0,1345.0,2225.0,2350.0,1265.0,2100.0,3260.0,105980.0
North East,16.1.6,Stock position of Measles vaccines,5. Total Stock,8540.0,4855.0,110.0,4195.0,3840.0,2080.0,3235.0,4010.0,3660.0,4395.0,3745.0,1485.0,44150.0
North East,16.1.7,Stock position of JE vaccines,1. Balance From Previous Month,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
North East,16.1.7,Stock position of JE vaccines,2. Stocks Received,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
North East,16.1.7,Stock position of JE vaccines,3. Unusable Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
North East,16.1.7,Stock position of JE vaccines,4. Stock Distributed,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
North East,16.1.7,Stock position of JE vaccines,5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
North East,16.1.8,Stock position of Hepatitis B vaccines,1. Balance From Previous Month,1220.0,1790.0,630.0,1390.0,2010.0,1580.0,2620.0,2180.0,1650.0,880.0,1270.0,1350.0,18570.0
North East,16.1.8,Stock position of Hepatitis B vaccines,2. Stocks Received,1000.0,0.0,1000.0,1000.0,0.0,2000.0,0.0,0.0,0.0,600.0,600.0,300.0,6500.0
North East,16.1.8,Stock position of Hepatitis B vaccines,3. Unusable Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
North East,16.1.8,Stock position of Hepatitis B vaccines,4. Stock Distributed,430.0,1160.0,240.0,380.0,430.0,960.0,440.0,530.0,770.0,210.0,520.0,780.0,6850.0
North East,16.1.8,Stock position of Hepatitis B vaccines,5. Total Stock,1790.0,630.0,1390.0,2010.0,1580.0,2620.0,2180.0,1650.0,880.0,1270.0,1350.0,870.0,18220.0
North East,16.2.1,Stock Position of IU 380 A (to be used for Family Planning),1. Balance From Previous Month,87.0,612.0,402.0,397.0,197.0,97.0,600.0,390.0,290.0,370.0,360.0,790.0,4592.0
North East,16.2.1,Stock Position of IU 380 A (to be used for Family Planning),2. Stocks Received,600.0,0.0,0.0,0.0,0.0,600.0,0.0,0.0,100.0,0.0,600.0,0.0,1900.0
North East,16.2.1,Stock Position of IU 380 A (to be used for Family Planning),3. Unusable Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
North East,16.2.1,Stock Position of IU 380 A (to be used for Family Planning),4. Stock Distributed,75.0,210.0,5.0,200.0,100.0,97.0,210.0,100.0,20.0,10.0,170.0,120.0,1317.0
North East,16.2.1,Stock Position of IU 380 A (to be used for Family Planning),5. Total Stock,612.0,402.0,397.0,197.0,97.0,600.0,390.0,290.0,370.0,360.0,790.0,670.0,5175.0
North East,16.2.2,Stock Position of Condoms (to be used for Family Planning),1. Balance From Previous Month,0.0,13000.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,37500.0,30500.0,17500.0,98500.0
North East,16.2.2,Stock Position of Condoms (to be used for Family Planning),2. Stocks Received,24000.0,0.0,0.0,42000.0,0.0,0.0,0.0,0.0,42000.0,0.0,0.0,90000.0,198000.0
North East,16.2.2,Stock Position of Condoms (to be used for Family Planning),3. Unusable Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
North East,16.2.2,Stock Position of Condoms (to be used for Family Planning),4. Stock Distributed,11000.0,13000.0,0.0,42000.0,0.0,0.0,0.0,0.0,4500.0,7000.0,13000.0,5000.0,95500.0
North East,16.2.2,Stock Position of Condoms (to be used for Family Planning),5. Total Stock,13000.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,37500.0,30500.0,17500.0,102500.0,201000.0
North East,16.2.3,Stock Position of Oral Contraceptive (to be used for Family Planning),1. Balance From Previous Month,1520.0,1450.0,1220.0,1120.0,1700.0,1630.0,1510.0,1510.0,1365.0,1365.0,1265.0,1065.0,16720.0
North East,16.2.3,Stock Position of Oral Contraceptive (to be used for Family Planning),2. Stocks Received,0.0,0.0,0.0,1000.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,1000.0
North East,16.2.3,Stock Position of Oral Contraceptive (to be used for Family Planning),3. Unusable Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
North East,16.2.3,Stock Position of Oral Contraceptive (to be used for Family Planning),4. Stock Distributed,70.0,230.0,100.0,420.0,70.0,120.0,0.0,145.0,0.0,100.0,200.0,90.0,1545.0
North East,16.2.3,Stock Position of Oral Contraceptive (to be used for Family Planning),5. Total Stock,1450.0,1220.0,1120.0,1700.0,1630.0,1510.0,1510.0,1365.0,1365.0,1265.0,1065.0,975.0,16175.0
North East,16.2.4,Stock Position of Emergency Contraceptive (to be used for Family Planning),1. Balance From Previous Month,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
North East,16.2.4,Stock Position of Emergency Contraceptive (to be used for Family Planning),2. Stocks Received,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,100.0,100.0
North East,16.2.4,Stock Position of Emergency Contraceptive (to be used for Family Planning),3. Unusable Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
North East,16.2.4,Stock Position of Emergency Contraceptive (to be used for Family Planning),4. Stock Distributed,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,30.0,30.0
North East,16.2.4,Stock Position of Emergency Contraceptive (to be used for Family Planning),5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,70.0,70.0
North East,16.2.5,Stock Position of Tubal Rings (to be used for Family Planning),1. Balance From Previous Month,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
North East,16.2.5,Stock Position of Tubal Rings (to be used for Family Planning),2. Stocks Received,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
North East,16.2.5,Stock Position of Tubal Rings (to be used for Family Planning),3. Unusable Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
North East,16.2.5,Stock Position of Tubal Rings (to be used for Family Planning),4. Stock Distributed,0.0,0.0,0.0,0.0,0.0,,0.0,0.0,0.0,0.0,0.0,0.0,0.0
North East,16.2.5,Stock Position of Tubal Rings (to be used for Family Planning),5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
North East,16.3.01,Stock Position of Oxytocin Injection,1. Balance From Previous Month,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
North East,16.3.01,Stock Position of Oxytocin Injection,2. Stocks Received,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
North East,16.3.01,Stock Position of Oxytocin Injection,3. Unusable Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
North East,16.3.01,Stock Position of Oxytocin Injection,4. Stock Distributed,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
North East,16.3.01,Stock Position of Oxytocin Injection,5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
North East,16.3.02,Stock Position of Gloves,1. Balance From Previous Month,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
North East,16.3.02,Stock Position of Gloves,2. Stocks Received,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
North East,16.3.02,Stock Position of Gloves,3. Unusable Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
North East,16.3.02,Stock Position of Gloves,4. Stock Distributed,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
North East,16.3.02,Stock Position of Gloves,5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
North East,16.3.03,Stock Position of MVA Syringes,1. Balance From Previous Month,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
North East,16.3.03,Stock Position of MVA Syringes,2. Stocks Received,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
North East,16.3.03,Stock Position of MVA Syringes,3. Unusable Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
North East,16.3.03,Stock Position of MVA Syringes,4. Stock Distributed,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
North East,16.3.03,Stock Position of MVA Syringes,5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
North East,16.3.04,Stock Position of Fluconazole Tablets,1. Balance From Previous Month,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
North East,16.3.04,Stock Position of Fluconazole Tablets,2. Stocks Received,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
North East,16.3.04,Stock Position of Fluconazole Tablets,3. Unusable Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
North East,16.3.04,Stock Position of Fluconazole Tablets,4. Stock Distributed,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
North East,16.3.04,Stock Position of Fluconazole Tablets,5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
North East,16.3.05,Stock Position of Blood Transfusion Sets,1. Balance From Previous Month,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
North East,16.3.05,Stock Position of Blood Transfusion Sets,2. Stocks Received,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
North East,16.3.05,Stock Position of Blood Transfusion Sets,3. Unusable Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
North East,16.3.05,Stock Position of Blood Transfusion Sets,4. Stock Distributed,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
North East,16.3.05,Stock Position of Blood Transfusion Sets,5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
North East,16.3.06,Stock Position of Gluteraldehyde solution of 2% concentration,1. Balance From Previous Month,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
North East,16.3.06,Stock Position of Gluteraldehyde solution of 2% concentration,2. Stocks Received,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
North East,16.3.06,Stock Position of Gluteraldehyde solution of 2% concentration,3. Unusable Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
North East,16.3.06,Stock Position of Gluteraldehyde solution of 2% concentration,4. Stock Distributed,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
North East,16.3.06,Stock Position of Gluteraldehyde solution of 2% concentration,5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
North East,16.3.07,Stock Position of IFA Tablets,1. Balance From Previous Month,24500.0,50500.0,62000.0,16000.0,18000.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,171000.0
North East,16.3.07,Stock Position of IFA Tablets,2. Stocks Received,60000.0,40000.0,0.0,40000.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,140000.0
North East,16.3.07,Stock Position of IFA Tablets,3. Unusable Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
North East,16.3.07,Stock Position of IFA Tablets,4. Stock Distributed,34000.0,28500.0,46000.0,38000.0,18000.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,164500.0
North East,16.3.07,Stock Position of IFA Tablets,5. Total Stock,50500.0,62000.0,16000.0,18000.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,146500.0
North East,16.3.08,Stock Position of IFA Syrup (Paediatric),1. Balance From Previous Month,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
North East,16.3.08,Stock Position of IFA Syrup (Paediatric),2. Stocks Received,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
North East,16.3.08,Stock Position of IFA Syrup (Paediatric),3. Unusable Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
North East,16.3.08,Stock Position of IFA Syrup (Paediatric),4. Stock Distributed,0.0,0.0,,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
North East,16.3.08,Stock Position of IFA Syrup (Paediatric),5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
North East,16.3.09,Stock Position of Paediatrics Antibiotics (Cotrimaxozole and Injectable Gentamicin),1. Balance From Previous Month,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,,0.0,0.0,0.0,0.0
North East,16.3.09,Stock Position of Paediatrics Antibiotics (Cotrimaxozole and Injectable Gentamicin),2. Stocks Received,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,,0.0,0.0,0.0,0.0
North East,16.3.09,Stock Position of Paediatrics Antibiotics (Cotrimaxozole and Injectable Gentamicin),3. Unusable Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,,0.0,0.0,0.0,0.0
North East,16.3.09,Stock Position of Paediatrics Antibiotics (Cotrimaxozole and Injectable Gentamicin),4. Stock Distributed,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,,0.0,0.0,0.0,0.0
North East,16.3.09,Stock Position of Paediatrics Antibiotics (Cotrimaxozole and Injectable Gentamicin),5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
North East,16.3.10,Stock Position of Vitamin A solution,1. Balance From Previous Month,134.0,207.0,199.0,331.0,768.0,704.0,603.0,293.0,314.0,299.0,228.0,297.0,4377.0
North East,16.3.10,Stock Position of Vitamin A solution,2. Stocks Received,500.0,200.0,200.0,500.0,0.0,0.0,100.0,100.0,0.0,0.0,200.0,0.0,1800.0
North East,16.3.10,Stock Position of Vitamin A solution,3. Unusable Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
North East,16.3.10,Stock Position of Vitamin A solution,4. Stock Distributed,427.0,208.0,68.0,63.0,64.0,101.0,410.0,79.0,15.0,71.0,131.0,109.0,1746.0
North East,16.3.10,Stock Position of Vitamin A solution,5. Total Stock,207.0,199.0,331.0,768.0,704.0,603.0,293.0,314.0,299.0,228.0,297.0,188.0,4431.0
North East,16.3.11,Stock of ORS (New WHO formulation),1. Balance From Previous Month,1525.0,1025.0,7400.0,6775.0,7075.0,3000.0,1000.0,1000.0,0.0,0.0,0.0,0.0,28800.0
North East,16.3.11,Stock of ORS (New WHO formulation),2. Stocks Received,0.0,50000.0,0.0,20000.0,9000.0,1000.0,0.0,0.0,0.0,0.0,0.0,0.0,80000.0
North East,16.3.11,Stock of ORS (New WHO formulation),3. Unusable Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
North East,16.3.11,Stock of ORS (New WHO formulation),4. Stock Distributed,500.0,43625.0,625.0,19700.0,13075.0,3000.0,0.0,1000.0,0.0,0.0,0.0,0.0,81525.0
North East,16.3.11,Stock of ORS (New WHO formulation),5. Total Stock,1025.0,7400.0,6775.0,7075.0,3000.0,1000.0,1000.0,0.0,0.0,0.0,0.0,0.0,27275.0
North East,16.4.1,Stock Position of 0.1 ml Syringes(AD),1. Balance From Previous Month,1720.0,2055.0,1665.0,2345.0,2925.0,1925.0,1205.0,2485.0,1605.0,2625.0,2215.0,3415.0,26185.0
North East,16.4.1,Stock Position of 0.1 ml Syringes(AD),2. Stocks Received,1600.0,400.0,1000.0,1000.0,0.0,0.0,2000.0,0.0,2000.0,0.0,2000.0,0.0,10000.0
North East,16.4.1,Stock Position of 0.1 ml Syringes(AD),3. Unusable Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
North East,16.4.1,Stock Position of 0.1 ml Syringes(AD),4. Stock Distributed,1265.0,790.0,320.0,420.0,1000.0,720.0,720.0,880.0,1100.0,310.0,800.0,1170.0,9495.0
North East,16.4.1,Stock Position of 0.1 ml Syringes(AD),5. Total Stock,2055.0,1665.0,2345.0,2925.0,1925.0,1205.0,2485.0,1605.0,2505.0,2315.0,3415.0,2245.0,26690.0
North East,16.4.2,Stock Position of 0.5 ml Syringes(AD),1. Balance From Previous Month,13000.0,7600.0,22200.0,8000.0,26000.0,24400.0,17200.0,20400.0,9200.0,12600.0,17000.0,19200.0,196800.0
North East,16.4.2,Stock Position of 0.5 ml Syringes(AD),2. Stocks Received,86000.0,30000.0,10000.0,30000.0,10000.0,10000.0,10000.0,8000.0,14000.0,14000.0,24400.0,7200.0,253600.0
North East,16.4.2,Stock Position of 0.5 ml Syringes(AD),3. Unusable Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
North East,16.4.2,Stock Position of 0.5 ml Syringes(AD),4. Stock Distributed,91400.0,15400.0,24200.0,12000.0,11600.0,17200.0,6800.0,19200.0,10600.0,9600.0,22200.0,14000.0,254200.0
North East,16.4.2,Stock Position of 0.5 ml Syringes(AD),5. Total Stock,7600.0,22200.0,8000.0,26000.0,24400.0,17200.0,20400.0,9200.0,12600.0,17000.0,19200.0,12400.0,196200.0
North East,16.4.3,Stock Position of 5.0 ml Syringes(Disposable),1. Balance From Previous Month,400.0,500.0,1000.0,1000.0,3200.0,1800.0,3400.0,3200.0,4600.0,3800.0,3400.0,4800.0,31100.0
North East,16.4.3,Stock Position of 5.0 ml Syringes(Disposable),2. Stocks Received,1600.0,1000.0,0.0,2400.0,0.0,2400.0,0.0,2400.0,0.0,0.0,2400.0,0.0,12200.0
North East,16.4.3,Stock Position of 5.0 ml Syringes(Disposable),3. Unusable Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
North East,16.4.3,Stock Position of 5.0 ml Syringes(Disposable),4. Stock Distributed,1500.0,500.0,0.0,200.0,1400.0,800.0,200.0,1000.0,800.0,400.0,1000.0,0.0,7800.0
North East,16.4.3,Stock Position of 5.0 ml Syringes(Disposable),5. Total Stock,500.0,1000.0,1000.0,3200.0,1800.0,3400.0,3200.0,4600.0,3800.0,3400.0,4800.0,4800.0,35500.0
North East,17.1,Number of cases of Infant deaths within 24 hrs of birth,TOTAL,,,1.0,,,,1.0,,,,5.0,,7.0
North East,17.2.1,Number of cases of Infant deaths 24 hours to 4 weeks of birth with the probable cause being Sepsis,1. Up to 1 Weeks of Birth,,,1.0,2.0,1.0,,,1.0,,1.0,,,6.0
North East,17.2.1,Number of cases of Infant deaths 24 hours to 4 weeks of birth with the probable cause being Sepsis,2. Between 1 week & 4 weeks of birth,,,,,,,,,,,,,
North East,17.2.1,Number of cases of Infant deaths 24 hours to 4 weeks of birth with the probable cause being Sepsis,3. Total,,,1.0,2.0,1.0,,,1.0,,1.0,,,6.0
North East,17.2.2,Number of cases of Infant deaths 24 hours to 4 weeks of birth with the probable cause being Asphyxia,1. Up to 1 Weeks of Birth,,,1.0,,,,,,,,,,1.0
North East,17.2.2,Number of cases of Infant deaths 24 hours to 4 weeks of birth with the probable cause being Asphyxia,2. Between 1 week & 4 weeks of birth,,,,,,,,,,,,,
North East,17.2.2,Number of cases of Infant deaths 24 hours to 4 weeks of birth with the probable cause being Asphyxia,3. Total,,,1.0,,,,,,,,,,1.0
North East,17.2.3,Number of cases of Infant deaths 24 hours to 4 weeks of birth with the probable cause being LBW,1. Up to 1 Weeks of Birth,,,1.0,1.0,,,,,,,,,2.0
North East,17.2.3,Number of cases of Infant deaths 24 hours to 4 weeks of birth with the probable cause being LBW,2. Between 1 week & 4 weeks of birth,,,,,,,,,,,,,
North East,17.2.3,Number of cases of Infant deaths 24 hours to 4 weeks of birth with the probable cause being LBW,3. Total,,,1.0,1.0,,,,,,,,,2.0
North East,17.2.4,"Number of cases of Infant deaths 24 hours to 4 weeks of birth with the probable cause being other than Sepsis, Asphyxia and LBW",1. Up to 1 Weeks of Birth,,1.0,,1.0,,5.0,1.0,,2.0,3.0,3.0,,16.0
North East,17.2.4,"Number of cases of Infant deaths 24 hours to 4 weeks of birth with the probable cause being other than Sepsis, Asphyxia and LBW",2. Between 1 week & 4 weeks of birth,,1.0,,,,,,,,,,,1.0
North East,17.2.4,"Number of cases of Infant deaths 24 hours to 4 weeks of birth with the probable cause being other than Sepsis, Asphyxia and LBW",3. Total,,2.0,,1.0,,5.0,1.0,,2.0,3.0,3.0,,17.0
North East,17.3.1,Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being Pneumonia,1. Between 1 month and 11 months,,,,1.0,,,,,,1.0,,,2.0
North East,17.3.1,Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being Pneumonia,2. Between 1 year & 5 years,,,,,,,,,,,,,
North East,17.3.1,Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being Pneumonia,3. Total,,,,1.0,,,,,,1.0,,,2.0
North East,17.3.2,Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being Diarrhoea,1. Between 1 month and 11 months,,2.0,,,,,,,,,,,2.0
North East,17.3.2,Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being Diarrhoea,2. Between 1 year & 5 years,,,,,,,,,,,,,
North East,17.3.2,Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being Diarrhoea,3. Total,,2.0,,,,,,,,,,,2.0
North East,17.3.3,Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being Fever related,1. Between 1 month and 11 months,,,,2.0,,,,1.0,,,,,3.0
North East,17.3.3,Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being Fever related,2. Between 1 year & 5 years,,,,,,,,1.0,,,,,1.0
North East,17.3.3,Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being Fever related,3. Total,,,,2.0,,,,2.0,,,,,4.0
North East,17.3.4,Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being Measles,1. Between 1 month and 11 months,,,,,,,,,,,,,
North East,17.3.4,Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being Measles,2. Between 1 year & 5 years,,,,,,,,,,,,,
North East,17.3.4,Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being Measles,3. Total,,,,,,,,,,,,,
North East,17.3.5,"Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being other than Pneumonia, Diarrhoea, Fever related and Measles",1. Between 1 month and 11 months,,,,,,1.0,,1.0,2.0,,1.0,,5.0
North East,17.3.5,"Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being other than Pneumonia, Diarrhoea, Fever related and Measles",2. Between 1 year & 5 years,,,,,,,,,1.0,,,2.0,3.0
North East,17.3.5,"Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being other than Pneumonia, Diarrhoea, Fever related and Measles",3. Total,,,,,,1.0,,1.0,3.0,,1.0,2.0,8.0
North East,17.4.1,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Diarrhoeal diseases,1. 6-14 yrs,,,,,,,,,,,,,
North East,17.4.1,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Diarrhoeal diseases,2. 15-55 yrs.,,,,,,,,,,,,,
North East,17.4.1,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Diarrhoeal diseases,3. Above 55 yrs.,,,,,,,,,,,,,
North East,17.4.1,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Diarrhoeal diseases,4. Total,,,,,,,,,,,,,
North East,17.4.2,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Tuberculosis,1. 6-14 yrs,,,,,,,,,,,,,
North East,17.4.2,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Tuberculosis,2. 15-55 yrs.,,,,,,,,,,,,,
North East,17.4.2,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Tuberculosis,3. Above 55 yrs.,,,,,,,,,,,,,
North East,17.4.2,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Tuberculosis,4. Total,,,,,,,,,,,,,
North East,17.4.3,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Respiratory diseases including infections,1. 6-14 yrs,,,,,,,,,,,,,
North East,17.4.3,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Respiratory diseases including infections,2. 15-55 yrs.,,,,,,,,,,,,,
North East,17.4.3,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Respiratory diseases including infections,3. Above 55 yrs.,,,,,,,1.0,,,,,,1.0
North East,17.4.3,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Respiratory diseases including infections,4. Total,,,,,,,1.0,,,,,,1.0
North East,17.4.4,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Malaria,1. 6-14 yrs,,,,,,,,,,,,,
North East,17.4.4,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Malaria,2. 15-55 yrs.,,,,,,,,,,,,,
North East,17.4.4,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Malaria,3. Above 55 yrs.,,,,,,,,,,,,,
North East,17.4.4,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Malaria,4. Total,,,,,,,,,,,,,
North East,17.4.5,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being other Fever related,1. 6-14 yrs,,,,,,,,,,,,,
North East,17.4.5,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being other Fever related,2. 15-55 yrs.,,,,,,,,,,,,,
North East,17.4.5,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being other Fever related,3. Above 55 yrs.,,,,,,,,,,,,,
North East,17.4.5,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being other Fever related,4. Total,,,,,,,,,,,,,
North East,17.4.6,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being HIV/AIDS,1. 6-14 yrs,,,,,,,,,,,,,
North East,17.4.6,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being HIV/AIDS,2. 15-55 yrs.,,,,,,,,,,,,,
North East,17.4.6,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being HIV/AIDS,3. Above 55 yrs.,,,,,,,,,,,,,
North East,17.4.6,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being HIV/AIDS,4. Total,,,,,,,,,,,,,
North East,17.4.7,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Heart disease or related to Hypertension,1. 6-14 yrs,,,,,,,,,,,,,
North East,17.4.7,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Heart disease or related to Hypertension,2. 15-55 yrs.,,,,,,,,,,,,,
North East,17.4.7,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Heart disease or related to Hypertension,3. Above 55 yrs.,,,,,,,,,,,,,
North East,17.4.7,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Heart disease or related to Hypertension,4. Total,,,,,,,,,,,,,
North East,17.4.8,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Neurological disease including strokes,1. 6-14 yrs,,,,,,,,,,,,,
North East,17.4.8,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Neurological disease including strokes,2. 15-55 yrs.,,,,,,,,,,,,,
North East,17.4.8,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Neurological disease including strokes,3. Above 55 yrs.,,,,,,,,,,,,,
North East,17.4.8,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Neurological disease including strokes,4. Total,,,,,,,,,,,,,
North East,17.4.9(a),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Abortion,1. 6-14 yrs,,,,,,,,,,,,,
North East,17.4.9(a),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Abortion,2. 15-49 yrs,,,,,,,,,,,,,
North East,17.4.9(a),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Abortion,3. Above 49 yrs.,,,,,,,,,,,,,
North East,17.4.9(a),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Abortion,4. Total,,,,,,,,,,,,,
North East,17.4.9(b),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Obstructed or prolonged labour,1. 6-14 yrs,,,,,,,,,,,,,
North East,17.4.9(b),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Obstructed or prolonged labour,2. 15-49 yrs,,,,,,,,,,,,,
North East,17.4.9(b),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Obstructed or prolonged labour,3. Above 49 yrs.,,,,,,,,,,,,,
North East,17.4.9(b),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Obstructed or prolonged labour,4. Total,,,,,,,,,,,,,
North East,17.4.9(c),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Severe hypertesnion or fits,1. 6-14 yrs,,,,,,,,,,,,,
North East,17.4.9(c),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Severe hypertesnion or fits,2. 15-49 yrs,,,,,,,,,,,,,
North East,17.4.9(c),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Severe hypertesnion or fits,3. Above 49 yrs.,,,,,,,,,,,,,
North East,17.4.9(c),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Severe hypertesnion or fits,4. Total,,,,,,,,,,,,,
North East,17.4.9(d),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Bleeding,1. 6-14 yrs,,,,,,,,,,,,,
North East,17.4.9(d),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Bleeding,2. 15-49 yrs,,,,,,,,,,,,,
North East,17.4.9(d),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Bleeding,3. Above 49 yrs.,,,,,,,,,,,,,
North East,17.4.9(d),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Bleeding,4. Total,,,,,,,,,,,,,
North East,17.4.9(e),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being High Fever,1. 6-14 yrs,,,,,,,,,,,,,
North East,17.4.9(e),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being High Fever,2. 15-49 yrs,,,,,,,,,,,,,
North East,17.4.9(e),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being High Fever,3. Above 49 yrs.,,,,,,,,,,,,,
North East,17.4.9(e),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being High Fever,4. Total,,,,,,,,,,,,,
North East,17.4.9(f),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being other causes (excluding abortion; obstructed or prolonged labour; severe hypertension or fits;,1. 6-14 yrs,,,,,,,,,,,,,
North East,17.4.9(f),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being other causes (excluding abortion; obstructed or prolonged labour; severe hypertension or fits;,2. 15-49 yrs,,,,,,,,,,,,,
North East,17.4.9(f),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being other causes (excluding abortion; obstructed or prolonged labour; severe hypertension or fits;,3. Above 49 yrs.,,,,,,,,,,,,,
North East,17.4.9(f),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being other causes (excluding abortion; obstructed or prolonged labour; severe hypertension or fits;,4. Total,,,,,,,,,,,,,
North East,17.4.10,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Trauma or Accidents or Burn cases,1. 6-14 yrs,,,,,,,,,,,,,
North East,17.4.10,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Trauma or Accidents or Burn cases,2. 15-55 yrs.,,,,,,,,,,,,,
North East,17.4.10,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Trauma or Accidents or Burn cases,3. Above 55 yrs.,,,,,,,,,,,,,
North East,17.4.10,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Trauma or Accidents or Burn cases,4. Total,,,,,,,,,,,,,
North East,17.4.11,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being suicide,1. 6-14 yrs,,,,,,,,,,,,,
North East,17.4.11,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being suicide,2. 15-55 yrs.,,,,,,,,,,,,,
North East,17.4.11,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being suicide,3. Above 55 yrs.,,,,,,,,,,,,,
North East,17.4.11,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being suicide,4. Total,,,,,,,,,,,,,
North East,17.4.12,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Animal bites and stings,1. 6-14 yrs,,,,,,,,,,,,,
North East,17.4.12,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Animal bites and stings,2. 15-55 yrs.,,,,,,,,,,,,,
North East,17.4.12,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Animal bites and stings,3. Above 55 yrs.,,,,,,,,,,,,,
North East,17.4.12,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Animal bites and stings,4. Total,,,,,,,,,,,,,
North East,17.4.13(a),Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Known Acute disease,1. 6-14 yrs,,,,,,,,,,,,,
North East,17.4.13(a),Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Known Acute disease,2. 15-55 yrs.,,,1.0,,,,,,,,,,1.0
North East,17.4.13(a),Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Known Acute disease,3. Above 55 yrs.,,,,,,,,,,,,,
North East,17.4.13(a),Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Known Acute disease,4. Total,,,1.0,,,,,,,,,,1.0
North East,17.4.13(b),Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Known Chronic disease,1. 6-14 yrs,,,,,,,,,,,,,
North East,17.4.13(b),Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Known Chronic disease,2. 15-55 yrs.,,,,,,,,,,,,,
North East,17.4.13(b),Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Known Chronic disease,3. Above 55 yrs.,,,,,,,,,,,,,
North East,17.4.13(b),Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Known Chronic disease,4. Total,,,,,,,,,,,,,
North East,17.4.13(c),Number of cases of Adolescent or Adult deaths (age 6 years & above) where the cause was not known,1. 6-14 yrs,,,,,,,,,,,,,
North East,17.4.13(c),Number of cases of Adolescent or Adult deaths (age 6 years & above) where the cause was not known,2. 15-55 yrs.,,,,,,,,,,,,,
North East,17.4.13(c),Number of cases of Adolescent or Adult deaths (age 6 years & above) where the cause was not known,3. Above 55 yrs.,,,,,,,,,,,,,
North East,17.4.13(c),Number of cases of Adolescent or Adult deaths (age 6 years & above) where the cause was not known,4. Total,,,,,,,,,,,,,
North West,1.1,Total number of pregnant women Registered for ANC,TOTAL,9840.0,9178.0,9913.0,12152.0,10128.0,10698.0,8883.0,10185.0,7797.0,7729.0,8796.0,9554.0,114853.0
North West,1.1.1,Of which Number registered within first trimester (within 12 weeks),TOTAL,3507.0,3470.0,2327.0,3503.0,4301.0,3088.0,2224.0,3278.0,2583.0,2631.0,4453.0,3984.0,39349.0
North West,1.2,Number of Pregnant women registered under JSY,TOTAL,184.0,225.0,243.0,340.0,313.0,241.0,253.0,258.0,356.0,377.0,302.0,376.0,3468.0
North West,1.3,Number of pregnant women received 3 ANC check ups during pregnancy,TOTAL,7108.0,7449.0,7389.0,6285.0,5192.0,6654.0,5427.0,5934.0,5143.0,6559.0,7259.0,7569.0,77968.0
North West,1.4.1,Number of pregnant women given TT1 during current pregnancy,TOTAL,3446.0,3523.0,2960.0,3557.0,3101.0,3174.0,2558.0,2663.0,2701.0,2746.0,3087.0,3703.0,37219.0
North West,1.4.2,Number of pregnant women given TT2 or Booster during current pregnancy,TOTAL,3052.0,3050.0,3039.0,3120.0,3076.0,3120.0,2564.0,2507.0,2547.0,2336.0,2304.0,3060.0,33775.0
North West,1.5,Total number of pregnant women given 100 IFA tablets,TOTAL,5569.0,5312.0,5605.0,6305.0,5110.0,5676.0,5819.0,5060.0,5429.0,4655.0,5796.0,6624.0,66960.0
North West,1.6.1,Number of new cases of Hypertension (BP>140/90) detected in Pregnant women at the institution,TOTAL,825.0,831.0,525.0,664.0,547.0,631.0,496.0,564.0,555.0,480.0,532.0,549.0,7199.0
North West,1.6.2,Number of Eclampsia cases managed during delivery,TOTAL,13.0,5.0,12.0,23.0,20.0,15.0,16.0,20.0,20.0,8.0,10.0,12.0,174.0
North West,1.7.1,Number of Pregnant women with anaemia i.e. Hb level<11 (tested cases),TOTAL,3267.0,4089.0,4161.0,4825.0,5559.0,3701.0,3535.0,4076.0,3874.0,3461.0,4720.0,4291.0,49559.0
North West,1.7.2,Number of Pregnant women having severe anaemia (Hb<7) treated at institution,TOTAL,565.0,702.0,625.0,479.0,438.0,380.0,425.0,373.0,306.0,462.0,639.0,528.0,5922.0
North West,1.8,Number of pregnancy test kits used at SC level,TOTAL,37.0,42.0,19.0,24.0,38.0,17.0,23.0,25.0,31.0,0.0,0.0,4.0,260.0
North West,2.1.1.a,Number of deliveries conducted at Home and attended by trained SBA(i.e. Doctor or Nurse or ANM),TOTAL,0.0,0.0,0.0,0.0,2.0,1.0,4.0,6.0,5.0,8.0,18.0,21.0,65.0
North West,2.1.1.b,Number of deliveries conducted at Home and attended by non trained SBA (i.e. trained TBA or Relatives etc.),TOTAL,77.0,74.0,60.0,64.0,69.0,80.0,94.0,100.0,76.0,93.0,123.0,96.0,1006.0
North West,2.1.1.c,Total number of deliveries conducted at Home and attended by trained or non-trained SBA (i.e. sum of 2.1.1.a and 2.1.1.b),TOTAL,77.0,74.0,60.0,64.0,71.0,81.0,98.0,106.0,81.0,101.0,141.0,117.0,1071.0
North West,2.1.2,Number of newborns visited within 24 hours of delivery for deliveries conducted at home,TOTAL,27.0,14.0,20.0,30.0,43.0,38.0,26.0,36.0,38.0,39.0,31.0,27.0,369.0
North West,2.1.3,Number of mothers paid JSY incentive for deliveries conducted at home,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,1.0,0.0,0.0,1.0
North West,2.2,Deliveries conducted at Public Institutions (Including C-Sections),TOTAL,1935.0,2065.0,2091.0,2792.0,3191.0,3144.0,2973.0,2906.0,2967.0,2788.0,2472.0,2384.0,31708.0
North West,2.2.1,"Out of 2.2, Number discharged under 48 hours of delivery",TOTAL,948.0,262.0,295.0,705.0,1493.0,679.0,543.0,558.0,1457.0,1269.0,1200.0,1144.0,10553.0
North West,2.2.2.a,Number of mothers paid JSY Incentive for deliveries conducted at Public Institutions,TOTAL,421.0,255.0,198.0,208.0,228.0,188.0,127.0,407.0,239.0,278.0,255.0,181.0,2985.0
North West,2.2.2.b,Number of ASHAs paid JSY Incentive for deliveries conducted at Public Institutions,TOTAL,2.0,0.0,33.0,0.0,0.0,0.0,0.0,4.0,0.0,2.0,0.0,2.0,43.0
North West,2.2.2.c,Number of cases of deliveries conducted at Public Institutions where JSY incentive was paid to ANMs or AWWs [only for High Performing States (HPS)],TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
North West,2.3,Deliveries conducted at Private Institutions (Including C-Sections),TOTAL,530.0,489.0,481.0,513.0,586.0,578.0,626.0,582.0,587.0,626.0,488.0,480.0,6566.0
North West,2.3.1.a,Number of mothers paid JSY Incentive for deliveries conducted at accredited Private Institutions,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
North West,2.3.1.b,Number of ASHAs paid JSY Incentive for deliveries conducted at accredited Private Institutions,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
North West,2.3.1.c,Number of cases of deliveries conducted at accredited Private Institutions where JSY incentive was paid to ANMs or AWWs [only for High Performing States (HPS)],TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
North West,3.1.1,Number of Caesarean (C-Section) deliveries performed at PHCs (Primary Health Centre),TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
North West,3.1.2,Number of Caesarean (C-Section) deliveries performed at CHCs (Community Health Centre),TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
North West,3.1.3,Number of Caesarean (C-Section) deliveries performed at SDHs (Sub-divisional Hospital) or DHs (District Hospital),TOTAL,455.0,458.0,515.0,562.0,724.0,669.0,671.0,591.0,631.0,645.0,609.0,559.0,7089.0
North West,3.1.4,Number of Caesarean (C-Section) deliveries performed at other State owned public institutions,TOTAL,,,,,,,,,,,,,
North West,3.1.5,"Total Number of Caesarean (C-Section) deliveries performed at Public facilities i.e. PHC, CHC, SDH, DH and other State owned public institutions (sum of items from 3.1.1 to 3.1.4)",TOTAL,455.0,458.0,515.0,562.0,724.0,669.0,671.0,591.0,631.0,645.0,609.0,559.0,7089.0
North West,3.2,No. of C-section deliveries performed at Private facilities,TOTAL,308.0,344.0,323.0,366.0,383.0,384.0,404.0,403.0,391.0,399.0,288.0,301.0,4294.0
North West,4.1.1.a,Number of male live births,TOTAL,1326.0,1382.0,1421.0,1795.0,2032.0,1985.0,1880.0,1838.0,1903.0,1837.0,1690.0,1556.0,20645.0
North West,4.1.1.b,Number of female live births,TOTAL,1211.0,1232.0,1261.0,1543.0,1806.0,1799.0,1786.0,1752.0,1738.0,1658.0,1358.0,1398.0,18542.0
North West,4.1.1.c,Total number of male and female live births (4.1.1.a and 4.1.1.b),TOTAL,2537.0,2614.0,2682.0,3338.0,3838.0,3784.0,3666.0,3590.0,3641.0,3495.0,3048.0,2954.0,39187.0
North West,4.1.2,Number of still births,TOTAL,39.0,50.0,31.0,62.0,55.0,42.0,56.0,66.0,63.0,61.0,56.0,50.0,631.0
North West,4.1.3,Number of Abortions (spontaneous or induced),TOTAL,314.0,309.0,271.0,465.0,350.0,361.0,343.0,286.0,382.0,443.0,460.0,453.0,4437.0
North West,4.2.1,Number of Newborns weighed at birth,TOTAL,2461.0,2567.0,2642.0,3269.0,3689.0,2503.0,3471.0,3510.0,3565.0,3410.0,2896.0,2825.0,36808.0
North West,4.2.2,Number of Newborns having weight less than 2.5 kg,TOTAL,484.0,589.0,612.0,745.0,781.0,776.0,778.0,828.0,672.0,724.0,609.0,682.0,8280.0
North West,4.3,Number of Newborns breast fed within 1 hour of birth,TOTAL,1668.0,1705.0,1701.0,2445.0,2675.0,1701.0,2655.0,2723.0,2618.0,2322.0,1847.0,2065.0,26125.0
North West,5.1.1,Number of cases of pregnant women with Obstetric Complications and attended at PHCs,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
North West,5.1.2,Number of cases of pregnant women with Obstetric Complications and attended at CHCs,TOTAL,4.0,9.0,26.0,28.0,27.0,11.0,22.0,9.0,4.0,0.0,0.0,3.0,143.0
North West,5.1.3,Number of cases of pregnant women with Obstetric Complications and attended at SDHs or DHs,TOTAL,610.0,679.0,737.0,581.0,574.0,831.0,767.0,753.0,876.0,646.0,718.0,582.0,8354.0
North West,5.1.4,Number of cases of pregnant women with Obstetric Complications and attended at other State owned public institutions,TOTAL,,,,,,,,,,,,,
North West,5.1.5,"Number of cases of pregnant women with Obstetric Complications and attended at Public facilities i.e. PHC, CHC, SDH, DH and other State owned public institutions (sum of items from 5.1.1 to 5.1.4)",TOTAL,614.0,688.0,763.0,609.0,601.0,842.0,789.0,762.0,880.0,646.0,718.0,585.0,8497.0
North West,5.2,Number of cases of pregnant women with Obstetric Complications and attended at Private facilities,TOTAL,91.0,96.0,156.0,39.0,16.0,99.0,42.0,63.0,48.0,68.0,16.0,56.0,790.0
North West,5.3.1,Number of cases of complicated pregnancies treated with IV antibiotics,TOTAL,264.0,279.0,411.0,396.0,317.0,699.0,543.0,509.0,620.0,611.0,693.0,623.0,5965.0
North West,5.3.2,Number of cases of complicated pregnancies treated with IV Antihypertensive/Magsulph injection,TOTAL,27.0,16.0,22.0,24.0,21.0,25.0,29.0,23.0,20.0,21.0,15.0,15.0,258.0
North West,5.3.3,Number of cases of complicated pregnancies treated with IV Oxytocis,TOTAL,259.0,252.0,377.0,336.0,276.0,648.0,608.0,579.0,621.0,343.0,462.0,436.0,5197.0
North West,5.3.4,Number of cases of complicated pregnancies treated with Blood Transfusion,TOTAL,236.0,335.0,279.0,257.0,413.0,466.0,246.0,336.0,103.0,235.0,187.0,237.0,3330.0
North West,6.1,Women getting post partum check-up within 48 hours after delivery,TOTAL,2143.0,2418.0,2463.0,3234.0,3511.0,3481.0,2309.0,3314.0,3478.0,3265.0,2934.0,2812.0,35362.0
North West,6.2,Women getting a post partum check up between 48 hours and 14 days after delivery,TOTAL,1220.0,1296.0,1356.0,1666.0,2019.0,1665.0,1764.0,1762.0,2058.0,2035.0,2015.0,1854.0,20710.0
North West,6.3,PNC maternal complications attended,TOTAL,43.0,36.0,45.0,38.0,68.0,60.0,54.0,47.0,74.0,66.0,53.0,126.0,710.0
North West,7.1.1,Number of MTPs conducted at Public Institutions up to 12 weeks of pregnancy,TOTAL,196.0,99.0,169.0,129.0,88.0,168.0,59.0,87.0,98.0,111.0,112.0,129.0,1445.0
North West,7.1.2,Number of MTPs conducted at Public Institutions for more than 12 weeks of pregnancy,TOTAL,8.0,6.0,9.0,1.0,2.0,13.0,3.0,3.0,0.0,1.0,7.0,1.0,54.0
North West,7.1.3,Total number of MTPs conducted at Public Institutions (sum of items 7.1.1 and 7.1.2),TOTAL,204.0,105.0,178.0,130.0,90.0,181.0,62.0,90.0,98.0,112.0,119.0,130.0,1499.0
North West,7.2,Number of MTPs conducted at Private Facilities,TOTAL,160.0,150.0,113.0,173.0,135.0,131.0,130.0,138.0,173.0,182.0,217.0,131.0,1833.0
North West,8.1.a,Number of new cases of RTI/STI in males for which treatment was initiated,TOTAL,316.0,218.0,212.0,257.0,197.0,175.0,196.0,190.0,221.0,169.0,148.0,163.0,2462.0
North West,8.1.b,Number of new cases of RTI/STI in females for which treatment was initiated,TOTAL,1259.0,1207.0,1126.0,1131.0,1266.0,1316.0,1363.0,1548.0,1496.0,1424.0,1231.0,1167.0,15534.0
North West,8.1.c,Total number of new cases of RTI/STI in males and females for which treatment was initiated (sum of items 8.1.a and 8.1.b),TOTAL,1575.0,1425.0,1338.0,1388.0,1463.0,1491.0,1559.0,1738.0,1717.0,1593.0,1379.0,1330.0,17996.0
North West,8.2,Number of suspected RTI/STI cases for whom wet mount test was conducted,TOTAL,3.0,5.0,14.0,24.0,5.0,29.0,3.0,3.0,2.0,2.0,0.0,4.0,94.0
North West,9.1.1.a,Number of NSV (No Scalpel Vasectomy) or Conventional Vasectomy conducted at PHCs,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
North West,9.1.1.b,Number of NSV or Conventional Vasectomy conducted at CHCs,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
North West,9.1.1.c,Number of NSV or Conventional Vasectomy conducted at SDHs or DHs,TOTAL,2.0,3.0,4.0,5.0,5.0,4.0,3.0,13.0,1.0,1.0,5.0,1.0,47.0
North West,9.1.1.d,Number of NSV or Conventional Vasectomy conducted at other State owned public institutions,TOTAL,,,,,,,,,,,,,
North West,9.1.1.e,"Total Number of NSV or Conventional Vasectomy conducted at Public facilities i.e. PHC, CHC, SDH, DH and other State owned public institutions (sum of items from 9.1.1.a to 9.1.1.d)",TOTAL,2.0,3.0,4.0,5.0,5.0,4.0,3.0,13.0,1.0,1.0,5.0,1.0,47.0
North West,9.1.2,Number of NSV or Conventional Vasectomy conducted at Private facilities,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
North West,9.2.1.a,Number of Laparoscopic sterilizations conducted at PHCs,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
North West,9.2.1.b,Number of Laparoscopic sterilizations conducted at CHCs,TOTAL,129.0,0.0,106.0,0.0,0.0,77.0,0.0,0.0,0.0,0.0,0.0,0.0,312.0
North West,9.2.1.c,Number of Laparoscopic sterilizations conducted at SDHs or DHs,TOTAL,76.0,80.0,71.0,82.0,61.0,65.0,49.0,68.0,109.0,103.0,96.0,93.0,953.0
North West,9.2.1.d,Number of Laparoscopic sterilizations conducted at other State owned public institutions,TOTAL,,,,,,,,,,,,,
North West,9.2.1.e,"Total Number of Laparoscopic sterilizations conducted at Public facilities i.e. PHC, CHC, SDH, DH and other State owned public institutions (sum of items from 9.2.1.a to 9.2.1.d)",TOTAL,205.0,80.0,177.0,82.0,61.0,142.0,49.0,68.0,109.0,103.0,96.0,93.0,1265.0
North West,9.2.2,Number of Laparoscopic sterilizations conducted at Private facilities,TOTAL,130.0,159.0,107.0,63.0,66.0,78.0,75.0,154.0,211.0,201.0,219.0,143.0,1606.0
North West,9.3.1.a,Number of Mini-lap sterilizations conducted at PHCs,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
North West,9.3.1.b,Number of Mini-lap sterilizations conducted at CHCs,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
North West,9.3.1.c,Number of Mini-lap sterilizations conducted at SDHs or DHs,TOTAL,7.0,4.0,4.0,8.0,4.0,3.0,2.0,1.0,3.0,7.0,10.0,6.0,59.0
North West,9.3.1.d,Number of Mini-lap sterilizations conducted at other State owned public institutions,TOTAL,,,,,,,,,,,,,
North West,9.3.1.e,"Total Number of Mini-lap sterilizations conducted at Public facilities i.e. PHC, CHC, SDH, DH and other State owned public institutions (sum of items from 9.3.1.a to 9.3.1.d)",TOTAL,7.0,4.0,4.0,8.0,4.0,3.0,2.0,1.0,3.0,7.0,10.0,6.0,59.0
North West,9.3.2,Number of Mini-lap sterilizations conducted at Private facilities,TOTAL,2.0,0.0,1.0,1.0,2.0,0.0,0.0,1.0,2.0,0.0,0.0,0.0,9.0
North West,9.4.1.a,Number of Post-Partum sterilizations conducted at PHCs,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
North West,9.4.1.b,Number of Post-Partum sterilizations conducted at CHCs,TOTAL,0.0,0.0,0.0,0.0,0.0,2.0,0.0,0.0,0.0,0.0,0.0,0.0,2.0
North West,9.4.1.c,Number of Post-Partum sterilizations conducted at SDHs or DHs,TOTAL,61.0,72.0,82.0,125.0,113.0,96.0,101.0,94.0,107.0,116.0,97.0,94.0,1158.0
North West,9.4.1.d,Number of Post-Partum sterilizations conducted at other State owned public institutions,TOTAL,,,,,,,,,,,,,
North West,9.4.1.e,"Total Number of Post-Partum sterilizations conducted at Public facilities i.e. PHC, CHC, SDH, DH and other State owned public institutions (sum of items from 9.4.1.a to 9.4.1.d)",TOTAL,61.0,72.0,82.0,125.0,113.0,98.0,101.0,94.0,107.0,116.0,97.0,94.0,1160.0
North West,9.4.2,Number of Post-Partum sterilizations conducted at Private facilities,TOTAL,13.0,4.0,2.0,3.0,0.0,4.0,2.0,3.0,4.0,3.0,1.0,1.0,40.0
North West,9.5.1.a,Number of IUCD Insertions conducted at SCs,TOTAL,7.0,5.0,9.0,0.0,1.0,0.0,0.0,1.0,0.0,0.0,0.0,0.0,23.0
North West,9.5.1.b,Number of IUCD Insertions conducted at PHCs,TOTAL,164.0,156.0,150.0,366.0,209.0,244.0,138.0,161.0,169.0,167.0,143.0,172.0,2239.0
North West,9.5.1.c,Number of IUCD Insertions conducted at CHCs,TOTAL,94.0,90.0,112.0,154.0,136.0,134.0,61.0,97.0,97.0,79.0,93.0,105.0,1252.0
North West,9.5.1.d,Number of IUCD Insertions conducted at SDHs or DHs,TOTAL,331.0,295.0,298.0,537.0,478.0,461.0,296.0,339.0,431.0,428.0,495.0,598.0,4987.0
North West,9.5.1.e,Number of IUCD Insertions conducted at other State owned public institutions,TOTAL,,,,,,,,,,,,,
North West,9.5.1.f,"Total Number of IUCD Insertions conducted at Public facilities i.e. SC, PHC, CHC, SDH, DH and other State owned public institutions (sum of items from 9.5.1.a to 9.5.1.e)",TOTAL,596.0,546.0,569.0,1057.0,824.0,839.0,495.0,598.0,697.0,674.0,731.0,875.0,8501.0
North West,9.5.1A,"Out of above total, Post Partum (within 48 hours of delivery) IUCD insertions",TOTAL,254.0,173.0,191.0,388.0,440.0,343.0,232.0,261.0,340.0,310.0,394.0,472.0,3798.0
North West,9.5.2,Number of IUCD Insertions conducted at Private facilities,TOTAL,94.0,55.0,53.0,65.0,44.0,44.0,36.0,58.0,46.0,46.0,48.0,39.0,628.0
North West,9.06,Number of IUCD removals,TOTAL,155.0,142.0,143.0,179.0,130.0,135.0,99.0,122.0,152.0,119.0,132.0,136.0,1644.0
North West,9.07,Number of Oral Pills cycles distributed,TOTAL,1726.0,1717.0,1495.0,3148.0,1387.0,1527.0,1523.0,1485.0,1575.0,1414.0,1495.0,1660.0,20152.0
North West,9.08,Number of Condom pieces distributed,TOTAL,40965.0,42429.0,40018.0,89940.0,38730.0,29580.0,26178.0,16568.0,25436.0,30414.0,30322.0,24493.0,435073.0
North West,9.09,Number of Centchroman (weekly) pills given,TOTAL,1.0,1.0,1.0,1.0,1.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,5.0
North West,9.10,Number of Emergency Contraceptive Pills distributed,TOTAL,26.0,29.0,14.0,93.0,50.0,70.0,62.0,80.0,43.0,77.0,61.0,59.0,664.0
North West,9.11.1.a,Number of cases of complications following male sterilization,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
North West,9.11.1.b,Number of cases of complications following female sterilization,TOTAL,0.0,0.0,3.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,3.0
North West,9.11.2.a,Number of failures following male sterilization,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
North West,9.11.2.b,Number of failures following female sterilization,TOTAL,1.0,1.0,2.0,0.0,1.0,1.0,0.0,0.0,0.0,1.0,1.0,2.0,10.0
North West,9.11.3.a,Number of deaths following male sterilization,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
North West,9.11.3.b,Number of deaths following female sterilization,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
North West,9.12,Number of Institutions having NSV trained doctors,TOTAL,5.0,7.0,9.0,11.0,11.0,11.0,11.0,10.0,11.0,11.0,12.0,12.0,-1.0
North West,10.1.01,Number of Infants (0 to 11 months old)received BCG immunisation,TOTAL,3083.0,3193.0,3072.0,3872.0,4055.0,4062.0,3994.0,3939.0,4243.0,3753.0,3308.0,3456.0,44030.0
North West,10.1.02,Number of Infants (0 to 11 months old) received DPT1 immunisation,TOTAL,545.0,440.0,279.0,338.0,336.0,363.0,390.0,409.0,396.0,410.0,238.0,296.0,4440.0
North West,10.1.03,Number of Infants (0 to 11 months old) received DPT2 immunisation,TOTAL,560.0,476.0,398.0,364.0,317.0,310.0,367.0,398.0,469.0,415.0,305.0,303.0,4682.0
North West,10.1.04,Number of Infants (0 to 11 months old) received DPT3 immunisation,TOTAL,580.0,500.0,401.0,506.0,384.0,406.0,405.0,396.0,416.0,442.0,290.0,340.0,5066.0
North West,10.1.04A,Number of Infants (0 to 11 months old) received Pentavalent1 immunisation,TOTAL,2437.0,2331.0,1972.0,2565.0,2903.0,2573.0,3100.0,3505.0,3491.0,2926.0,2795.0,3320.0,33918.0
North West,10.1.04B,Number of Infants (0 to 11 months old) received Pentavalent2 immunisation,TOTAL,2193.0,2367.0,1910.0,2182.0,2098.0,1931.0,2340.0,2831.0,3387.0,2941.0,2371.0,3081.0,29632.0
North West,10.1.04C,Number of Infants (0 to 11 months old) received Pentavalent3 immunisation,TOTAL,2114.0,2246.0,1980.0,2335.0,2054.0,1863.0,1867.0,2158.0,2761.0,2749.0,2447.0,2795.0,27369.0
North West,10.1.05,Number of Infants (0 to 11 months old) received OPV 0 (Birth Dose),TOTAL,2342.0,2492.0,2569.0,3121.0,2997.0,3524.0,3346.0,3224.0,3466.0,3086.0,2772.0,2705.0,35644.0
North West,10.1.06,Number of Infants (0 to 11 months old) received OPV1 (First Dose),TOTAL,2657.0,2797.0,2266.0,2873.0,3210.0,2834.0,3300.0,3753.0,3738.0,3169.0,2946.0,3475.0,37018.0
North West,10.1.07,Number of Infants (0 to 11 months old) received OPV2 (Second Dose),TOTAL,2586.0,2912.0,2408.0,2632.0,2506.0,2345.0,2615.0,3141.0,3746.0,3300.0,2658.0,3388.0,34237.0
North West,10.1.08,Number of Infants (0 to 11 months old) received OPV3 (Third Dose),TOTAL,2639.0,2806.0,2443.0,2865.0,2467.0,2194.0,2151.0,2471.0,3072.0,3125.0,2744.0,3060.0,32037.0
North West,10.1.09A,Number of Infants (upto 48 hrs of age) received Hepatitis-B0 immunisation,TOTAL,1910.0,1875.0,2381.0,2972.0,2805.0,3317.0,2628.0,2508.0,2647.0,2402.0,2597.0,2487.0,30529.0
North West,10.1.09,Number of Infants (0 to 11 months old) received Hepatitis-B1 immunisation,TOTAL,525.0,350.0,314.0,340.0,373.0,378.0,331.0,386.0,460.0,332.0,264.0,237.0,4290.0
North West,10.1.10,Number of Infants (0 to 11 months old) received Hepatitis-B2 immunisation,TOTAL,505.0,436.0,456.0,367.0,368.0,380.0,286.0,367.0,521.0,328.0,287.0,247.0,4548.0
North West,10.1.11,Number of Infants (0 to 11 months old) received Hepatitis-B3 immunisation,TOTAL,595.0,437.0,490.0,521.0,451.0,431.0,319.0,354.0,422.0,382.0,328.0,323.0,5053.0
North West,10.1.12,Number of Infants (0 to 11 months old) received Measles immunisation (First Dose),TOTAL,4024.0,3517.0,3745.0,3279.0,3173.0,2919.0,2532.0,2993.0,2975.0,2263.0,2099.0,2633.0,36152.0
North West,10.1.12B,Number of Infants (more than 16 months old) received Measles immunisation (Second Dose),TOTAL,4502.0,5852.0,5215.0,2344.0,420.0,167.0,59.0,48.0,67.0,103.0,28.0,236.0,19041.0
North West,10.1A,No. of Children aged 9 to 12 months who received JE 1st dose,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
North West,10.1.13.a,Total number of male children (9 to 11 months old) fully immunised (BCG+DPT123/Pentavalent123+OPV123+Measles) during the month,TOTAL,1984.0,1779.0,1954.0,1543.0,1679.0,1467.0,1284.0,1558.0,1526.0,1180.0,1150.0,1362.0,18466.0
North West,10.1.13.b,Total number of female children (9 to 11 months old) fully immunised (BCG+DPT123/Pentavalent123+OPV123+Measles) during the month,TOTAL,1703.0,1523.0,1564.0,1294.0,1368.0,1215.0,1132.0,1336.0,1358.0,1011.0,931.0,1181.0,15616.0
North West,10.1.13.c,Total number of children (9 to 11 months old) fully immunised (BCG+DPT123/Pentavalent123+OPV123+Measles) during the month (sum of items 10.1.13.a and 10.1.13.b),TOTAL,3687.0,3302.0,3518.0,2837.0,3047.0,2682.0,2416.0,2894.0,2884.0,2191.0,2081.0,2543.0,34082.0
North West,10.2.1,Number of Infants (more than 16 months old) received DPT Booster dose,TOTAL,2972.0,2934.0,2144.0,2363.0,2427.0,2265.0,1701.0,2660.0,3084.0,2278.0,2497.0,3252.0,30577.0
North West,10.2.2,Number of Infants (more than 16 months old) received OPV Booster dose,TOTAL,2933.0,2954.0,2158.0,2377.0,2455.0,2250.0,1663.0,2616.0,3044.0,2235.0,2443.0,3233.0,30361.0
North West,10.2.3,"Number of Infants (more than 16 months old) received Measles, Mumps, Rubella (MMR) Vaccination",TOTAL,187.0,385.0,159.0,546.0,2192.0,2721.0,2181.0,3655.0,4368.0,2965.0,2866.0,3070.0,25295.0
North West,10.3.1.a,Total number of male children (12 to 23 months old) fully immunised (BCG+DPT123/Pentavalent123+OPV123+Measles) during the month,TOTAL,746.0,521.0,504.0,287.0,369.0,411.0,344.0,506.0,429.0,422.0,425.0,423.0,5387.0
North West,10.3.1.b,Total number of female children (12 to 23 months old) fully immunised (BCG+DPT123/Pentavalent123+OPV123+Measles) during the month,TOTAL,812.0,450.0,472.0,257.0,293.0,321.0,257.0,428.0,319.0,351.0,341.0,361.0,4662.0
North West,10.3.1.c,Total number of children (12 to 23 months old) fully immunised (BCG+DPT123+OPV123/Pentavalent123+Measles) during the month (sum of items 10.3.1.a and 10.3.1.b),TOTAL,1558.0,971.0,976.0,544.0,662.0,732.0,601.0,934.0,748.0,773.0,766.0,784.0,10049.0
North West,10.3.2,Number of children (more than 5 years old) given DT5,TOTAL,1051.0,1281.0,1069.0,846.0,850.0,822.0,827.0,1129.0,1365.0,1254.0,968.0,1454.0,12916.0
North West,10.3.3,Number of children (more than 10 years old) given TT10,TOTAL,265.0,297.0,342.0,210.0,205.0,254.0,208.0,240.0,250.0,264.0,263.0,327.0,3125.0
North West,10.3.4,Number of children (more than 16 years old) given TT16,TOTAL,149.0,192.0,245.0,167.0,156.0,227.0,178.0,187.0,147.0,122.0,172.0,188.0,2130.0
North West,10.3.5.a,Number of cases of Abscess reported following immunisation [Adverse Event Following Immunisation (AEFI)],TOTAL,0.0,0.0,0.0,0.0,0.0,1.0,0.0,0.0,0.0,0.0,0.0,0.0,1.0
North West,10.3.5.b,Number of cases of Death reported following immunisation [Adverse Event Following Immunisation (AEFI)],TOTAL,0.0,0.0,0.0,1.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,1.0,2.0
North West,10.3.5.c,Number of cases of other complications reported following immunisation [Adverse Event Following Immunisation (AEFI)],TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
North West,10.4.1,Number of Immunisation sessions planned to be held during the month,TOTAL,1015.0,914.0,886.0,700.0,686.0,692.0,731.0,773.0,978.0,840.0,761.0,755.0,9731.0
North West,10.4.2,Number of Immunisation sessions held during the month,TOTAL,958.0,858.0,854.0,679.0,647.0,643.0,645.0,722.0,941.0,790.0,714.0,703.0,9154.0
North West,10.4.3,Number of Immunisation sessions held during the month where ASHAs were present,TOTAL,294.0,275.0,264.0,198.0,191.0,198.0,184.0,202.0,338.0,249.0,228.0,247.0,2868.0
North West,10.5.1,Number of children (more than 16 months old) received Japanese Encephalitis (JE) vaccination,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
North West,11.1.1,Number of children (9 months to 5 years old) administered 1st dose of Vitamin A (Dose-1),TOTAL,5187.0,4358.0,6093.0,3573.0,2836.0,2989.0,3709.0,3191.0,3445.0,2501.0,1719.0,2381.0,41982.0
North West,11.1.2,Number of children (9 months to 5 years old) were administered 5th dose of Vitamin A (Dose-5),TOTAL,5609.0,2861.0,4322.0,2322.0,2063.0,2841.0,1872.0,2474.0,2684.0,2074.0,1744.0,1955.0,32821.0
North West,11.1.3,Number of children (9 months to 5 years old) administered 9th dose of Vitamin A (Dose-9),TOTAL,2025.0,2157.0,1430.0,1372.0,997.0,1092.0,1003.0,1160.0,1875.0,1286.0,813.0,1100.0,16310.0
North West,12.1,Number of cases of Diptheria reported in children below 5 years of age,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
North West,12.2,Number of cases of Pertusis reported in children below 5 years of age,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
North West,12.3,Number of cases of Tetanus neonatarum reported in children below 5 years of age,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
North West,12.4,Number of cases of Tetanus other than neonatarum reported in children below 5 years of age,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
North West,12.5,Number of cases of Polio reported in children below 5 years of age,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
North West,12.6,Number of cases of Measles reported in children below 5 years of age,TOTAL,29.0,52.0,6.0,4.0,0.0,6.0,3.0,2.0,0.0,24.0,24.0,71.0,221.0
North West,12.7,Number of cases of Diarrhoea and Dehydration reported in children below 5 years of age,TOTAL,1819.0,2395.0,2168.0,2367.0,2581.0,1737.0,1756.0,1696.0,1927.0,1979.0,1687.0,1391.0,23503.0
North West,12.8,Number of cases of Malaria reported in children below 5 years of age,TOTAL,0.0,3.0,21.0,4.0,8.0,7.0,5.0,2.0,0.0,1.0,0.0,0.0,51.0
North West,12.9,Number of children below 5 years of age admitted with Respiratory Infections,TOTAL,259.0,287.0,183.0,573.0,337.0,361.0,307.0,241.0,232.0,286.0,488.0,210.0,3764.0
North West,13.1,Number of Patients operated for cataract,TOTAL,389.0,371.0,242.0,240.0,213.0,206.0,242.0,327.0,422.0,328.0,333.0,448.0,3761.0
North West,13.2,Number of Intraocular Lens(IOL) implantations,TOTAL,267.0,243.0,159.0,171.0,146.0,127.0,153.0,188.0,303.0,250.0,249.0,320.0,2576.0
North West,13.3,Number of School children detected with Refractive errors,TOTAL,321.0,147.0,330.0,276.0,319.0,321.0,220.0,281.0,225.0,219.0,267.0,426.0,3352.0
North West,13.4,Number of children provided free glasses,TOTAL,45.0,40.0,60.0,40.0,67.0,40.0,28.0,35.0,30.0,30.0,33.0,0.0,448.0
North West,13.5,Number of eyes collected through eye donation,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
North West,13.6,Number of eyes utilised for corneal transplant,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
North West,14.01,Number of CHC or SDH or DH functioning as First Referral units (FRUs),TOTAL,7.0,7.0,6.0,9.0,5.0,10.0,8.0,8.0,9.0,9.0,8.0,10.0,-1.0
North West,14.02,Number of PHCs functioning 24X7 with atleast 3 Staff Nurses,TOTAL,,1.0,,,,,,,,,,,-1.0
North West,14.03,Number of Anganwadi centres reported to have conducted VHNDs,TOTAL,23.0,23.0,22.0,23.0,21.0,22.0,15.0,20.0,22.0,33.0,53.0,40.0,-1.0
North West,14.04,Number of facilities having a Rogi Kalyan Samiti (RKS),TOTAL,1.0,1.0,2.0,4.0,3.0,4.0,4.0,4.0,6.0,6.0,5.0,5.0,-1.0
North West,14.05,Number of RKS meetings held during the month,TOTAL,2.0,1.0,2.0,2.0,1.0,1.0,1.0,1.0,2.0,2.0,1.0,0.0,16.0
North West,14.06,Number of facilities having Ambulance services (Assured Referral Services),TOTAL,17.0,16.0,16.0,19.0,15.0,20.0,21.0,17.0,19.0,17.0,19.0,18.0,-1.0
North West,14.07,Total Number of times the Ambulance was used for transporting patients during the month,TOTAL,249.0,263.0,265.0,302.0,264.0,358.0,213.0,225.0,321.0,342.0,270.0,275.0,3347.0
North West,14.08,Number of Institutions having Operational Sick New Born and Child Care Units (SNCU),TOTAL,7.0,5.0,5.0,9.0,7.0,7.0,7.0,8.0,7.0,7.0,8.0,8.0,-1.0
North West,14.09,Number of functional Laproscopes in CHC/SDH/DH,TOTAL,18.0,17.0,17.0,21.0,16.0,15.0,14.0,17.0,17.0,22.0,17.0,16.0,-1.0
North West,14.10.1.a,Number of male patients admitted (Inpatients) during the month,1. Children,1910.0,1719.0,2472.0,4088.0,1607.0,2523.0,4090.0,3735.0,3099.0,3080.0,2419.0,2872.0,33614.0
North West,14.10.1.a,Number of male patients admitted (Inpatients) during the month,2. Adults,4989.0,7434.0,5958.0,10231.0,4511.0,5386.0,5205.0,5802.0,3887.0,4785.0,5287.0,5123.0,68598.0
North West,14.10.1.b,Number of female patients (Inpatients) admitted during the month,1. Children,1746.0,1504.0,1581.0,3038.0,1201.0,2029.0,3196.0,2983.0,2728.0,2538.0,2739.0,2203.0,27486.0
North West,14.10.1.b,Number of female patients (Inpatients) admitted during the month,2. Adults,7504.0,8779.0,8178.0,14742.0,7780.0,9481.0,8639.0,8353.0,7769.0,8448.0,7989.0,8493.0,106155.0
North West,14.10.1.c,Total number of patients admitted (Inpatients) during the month (sum of items 14.10.1.a and 14.10.1.b),1. Children,3656.0,3223.0,4053.0,7126.0,2808.0,4552.0,7286.0,6718.0,5827.0,5618.0,5158.0,5075.0,61100.0
North West,14.10.1.c,Total number of patients admitted (Inpatients) during the month (sum of items 14.10.1.a and 14.10.1.b),2. Adults,12493.0,16213.0,14136.0,24973.0,12291.0,14867.0,13844.0,14155.0,11656.0,13233.0,13276.0,13616.0,174753.0
North West,14.10.2.a,Number of death cases of Inpatient males,TOTAL,192.0,217.0,243.0,258.0,239.0,245.0,242.0,251.0,248.0,300.0,289.0,253.0,2977.0
North West,14.10.2.b,Number of death cases of Inpatient females,TOTAL,142.0,167.0,141.0,163.0,175.0,160.0,169.0,152.0,140.0,164.0,155.0,170.0,1898.0
North West,14.10.2.c,Number of cases of death of Inpatients (sum of items 14.10.2.a and 14.10.2.b),TOTAL,334.0,384.0,384.0,421.0,414.0,405.0,411.0,403.0,388.0,464.0,444.0,423.0,4875.0
North West,14.11,In-Patient Head Count at midnight,TOTAL,33267.0,35599.0,33663.0,49524.0,26946.0,32257.0,27639.0,30257.0,52340.0,48584.0,49851.0,51463.0,471390.0
North West,14.12.1,OPD attendance (All),TOTAL,472041.0,571380.0,511231.0,492561.0,413138.0,497821.0,494885.0,543612.0,466943.0,492970.0,565691.0,547026.0,6069299.0
North West,14.13.1,Number of major operations carried out using general or spinal anaesthesia,TOTAL,3046.0,2962.0,2621.0,2655.0,1764.0,2955.0,2402.0,2249.0,2738.0,3182.0,3069.0,3212.0,32855.0
North West,14.13.1A,"Out of 14.13.1,Gynecology- Hysterectomy surgeries",TOTAL,58.0,69.0,52.0,78.0,44.0,59.0,43.0,42.0,80.0,57.0,96.0,99.0,777.0
North West,14.13.2,Number of minor operations carried out without anaesthesia or using local anaesthesia,TOTAL,4165.0,2850.0,4678.0,3914.0,3877.0,5809.0,5303.0,5057.0,4487.0,5810.0,6280.0,5440.0,57670.0
North West,14.14.a,Number of patients given AYUSH treatment,TOTAL,14373.0,14119.0,8308.0,6627.0,7194.0,9463.0,7323.0,13220.0,12976.0,12185.0,9305.0,12675.0,127768.0
North West,14.14.b,Number of patients on whom Dental Procedure was conducted,TOTAL,7950.0,8812.0,5856.0,1680.0,1409.0,8649.0,7258.0,7633.0,8311.0,8846.0,7776.0,7002.0,81182.0
North West,14.14.c,Number of Adolescents counselled,TOTAL,658.0,1114.0,1081.0,828.0,848.0,725.0,728.0,909.0,773.0,777.0,718.0,802.0,9961.0
North West,15.1.1.a,Number of Haemoglobin (Hb) tests conducted,TOTAL,34148.0,38518.0,40023.0,39222.0,33516.0,40084.0,36120.0,37806.0,30953.0,33251.0,33834.0,41164.0,438639.0
North West,15.1.1.b,"Out of the total number of Hb tests conducted, number of cases having Hb less than 7gm/dl",TOTAL,1365.0,1223.0,1287.0,1647.0,1418.0,1296.0,1046.0,1197.0,1205.0,1546.0,1359.0,1099.0,15688.0
North West,15.1.2.a,Number of HIV tests conducted on males,1. Number tested,2505.0,3288.0,2958.0,3096.0,2813.0,3211.0,2318.0,3135.0,2652.0,2428.0,2953.0,3025.0,34382.0
North West,15.1.2.a,Number of HIV tests conducted on males,2. Number Positive,66.0,57.0,49.0,52.0,49.0,52.0,45.0,51.0,41.0,23.0,52.0,26.0,563.0
North West,15.1.2.b,Number of HIV tests conducted on Female-Non ANC (i.e. non pregnant females),1. Number tested,1817.0,2253.0,2342.0,2339.0,2006.0,2118.0,1479.0,1934.0,1705.0,1589.0,2103.0,2437.0,24122.0
North West,15.1.2.b,Number of HIV tests conducted on Female-Non ANC (i.e. non pregnant females),2. Number Positive,42.0,32.0,25.0,30.0,19.0,16.0,21.0,21.0,18.0,11.0,16.0,7.0,258.0
North West,15.1.2.c,Number of HIV tests conducted on Female with ANC (i.e. pregnant females),1. Number tested,3796.0,4109.0,3505.0,3626.0,3656.0,4635.0,3265.0,3506.0,3459.0,3209.0,3685.0,3127.0,43578.0
North West,15.1.2.c,Number of HIV tests conducted on Female with ANC (i.e. pregnant females),2. Number Positive,6.0,8.0,8.0,45.0,19.0,10.0,8.0,5.0,6.0,5.0,4.0,4.0,128.0
North West,15.1.2.d,Total number of HIV tests conducted (sum of items 15.1.2.a to 15.1.2.c),1. Number tested,8118.0,9650.0,8805.0,9061.0,8475.0,9964.0,7062.0,8575.0,7816.0,7226.0,8741.0,8589.0,102082.0
North West,15.1.2.d,Total number of HIV tests conducted (sum of items 15.1.2.a to 15.1.2.c),2. Number Positive,114.0,97.0,82.0,127.0,87.0,78.0,74.0,77.0,65.0,39.0,72.0,37.0,949.0
North West,15.2,Number of Widal tests conducted,Number tested,1707.0,1615.0,940.0,1516.0,2241.0,2556.0,2309.0,1788.0,848.0,575.0,1255.0,1449.0,18799.0
North West,15.3.a,Number of VDRL tests conducted on males,Number tested,239.0,164.0,305.0,262.0,218.0,142.0,104.0,119.0,108.0,77.0,222.0,228.0,2188.0
North West,15.3.b,Number of VDRL tests conducted on Female-Non ANC (i.e. non pregnant females),Number tested,158.0,465.0,399.0,402.0,142.0,149.0,171.0,145.0,215.0,310.0,363.0,559.0,3478.0
North West,15.3.c,Number of VDRL tests conducted on Female with ANC (i.e. pregnant females),Number tested,2619.0,2691.0,2152.0,1394.0,1525.0,1879.0,1887.0,3415.0,2157.0,2806.0,3508.0,3628.0,29661.0
North West,15.3.d,Total number of VDRL tests conducted (sum of items 15.3.a to 15.3.c),Number tested,3016.0,3320.0,2856.0,2058.0,1885.0,2170.0,2162.0,3679.0,2480.0,3193.0,4093.0,4415.0,35327.0
North West,15.4.1,Number of blood smears examined for Malaria,TOTAL,2265.0,2261.0,2811.0,3681.0,3332.0,2291.0,3298.0,2860.0,2075.0,1076.0,1749.0,1951.0,29650.0
North West,15.4.2,"Out of blood smears examined for malaria, number of blood smears tested positive for Plasmodium Vivax",TOTAL,5.0,14.0,26.0,29.0,43.0,49.0,23.0,8.0,4.0,1.0,3.0,1.0,206.0
North West,15.4.3,"Out of blood smears examined for malaria, number of blood smears tested positive for Plasmodium Falciparum",TOTAL,0.0,0.0,0.0,0.0,0.0,2.0,2.0,1.0,0.0,0.0,0.0,0.0,5.0
North West,16.1.1,Stock position of DPT vaccines,1. Balance From Previous Month,10260.0,6830.0,9890.0,7870.0,6370.0,4970.0,5010.0,5200.0,10490.0,8370.0,6580.0,5210.0,87050.0
North West,16.1.1,Stock position of DPT vaccines,2. Stocks Received,,5000.0,0.0,0.0,0.0,2000.0,1500.0,8000.0,,,,3000.0,19500.0
North West,16.1.1,Stock position of DPT vaccines,3. Unusable Stock,6830.0,9890.0,7870.0,6370.0,1400.0,5010.0,5200.0,10490.0,8370.0,6580.0,5210.0,4930.0,78150.0
North West,16.1.1,Stock position of DPT vaccines,4. Stock Distributed,3430.0,1940.0,1020.0,1500.0,6370.0,1960.0,1310.0,2710.0,2120.0,1790.0,1370.0,3280.0,28800.0
North West,16.1.1,Stock position of DPT vaccines,5. Total Stock,0.0,0.0,1000.0,0.0,-1400.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,-400.0
North West,16.1.1A,Stock Position of Pentavalent,1. Balance From Previous Month,6160.0,6860.0,7510.0,6100.0,6710.0,4750.0,1840.0,7380.0,8760.0,6040.0,5760.0,5580.0,73450.0
North West,16.1.1A,Stock Position of Pentavalent,2. Stocks Received,4000.0,3000.0,1000.0,3000.0,0.0,,8000.0,6000.0,,3000.0,2000.0,4000.0,34000.0
North West,16.1.1A,Stock Position of Pentavalent,3. Unusable Stock,6860.0,7510.0,6100.0,6710.0,1960.0,1840.0,7380.0,8760.0,6040.0,5760.0,5580.0,4910.0,69410.0
North West,16.1.1A,Stock Position of Pentavalent,4. Stock Distributed,3300.0,2350.0,2410.0,2390.0,6710.0,2910.0,2460.0,4620.0,2720.0,3280.0,2180.0,4670.0,40000.0
North West,16.1.1A,Stock Position of Pentavalent,5. Total Stock,0.0,0.0,0.0,0.0,-1960.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,-1960.0
North West,16.1.2,Stock position of OPV vaccines,1. Balance From Previous Month,10400.0,11420.0,11480.0,11500.0,8920.0,4660.0,5620.0,6580.0,8300.0,5740.0,6080.0,5780.0,96480.0
North West,16.1.2,Stock position of OPV vaccines,2. Stocks Received,8000.0,4000.0,5000.0,6000.0,0.0,6000.0,5000.0,8000.0,3000.0,5000.0,3000.0,5000.0,58000.0
North West,16.1.2,Stock position of OPV vaccines,3. Unusable Stock,11420.0,11480.0,11500.0,8920.0,4660.0,5620.0,6580.0,8300.0,5740.0,6080.0,5780.0,3960.0,90040.0
North West,16.1.2,Stock position of OPV vaccines,4. Stock Distributed,6980.0,3940.0,4980.0,8580.0,4260.0,5040.0,4040.0,6280.0,5560.0,4660.0,3300.0,6820.0,64440.0
North West,16.1.2,Stock position of OPV vaccines,5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
North West,16.1.3,Stock position of TT vaccines,1. Balance From Previous Month,3100.0,4120.0,5110.0,3470.0,4390.0,2900.0,2720.0,3210.0,5790.0,3960.0,2250.0,2850.0,43870.0
North West,16.1.3,Stock position of TT vaccines,2. Stocks Received,3000.0,3000.0,0.0,3000.0,,2000.0,2000.0,5000.0,,,2000.0,2000.0,22000.0
North West,16.1.3,Stock position of TT vaccines,3. Unusable Stock,4120.0,5110.0,3470.0,4390.0,2900.0,2720.0,3210.0,5790.0,3960.0,2250.0,2850.0,2540.0,43310.0
North West,16.1.3,Stock position of TT vaccines,4. Stock Distributed,1980.0,2010.0,1640.0,2080.0,1490.0,2180.0,1510.0,2420.0,1830.0,1710.0,1400.0,2310.0,22560.0
North West,16.1.3,Stock position of TT vaccines,5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
North West,16.1.4,Stock position of DT vaccines,1. Balance From Previous Month,,,,,,,,,,,,,
North West,16.1.4,Stock position of DT vaccines,2. Stocks Received,,,,,,,,,,,,,
North West,16.1.4,Stock position of DT vaccines,3. Unusable Stock,,,,,,,,,,,,,
North West,16.1.4,Stock position of DT vaccines,4. Stock Distributed,,,,,,,,,,,,,
North West,16.1.4,Stock position of DT vaccines,5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
North West,16.1.5,Stock position of BCG vaccines,1. Balance From Previous Month,4300.0,4380.0,5340.0,4340.0,3160.0,2150.0,2820.0,2830.0,3760.0,2240.0,2730.0,1930.0,39980.0
North West,16.1.5,Stock position of BCG vaccines,2. Stocks Received,2000.0,2000.0,0.0,,0.0,2000.0,1000.0,3000.0,,2000.0,,3000.0,15000.0
North West,16.1.5,Stock position of BCG vaccines,3. Unusable Stock,4380.0,5340.0,4340.0,3160.0,2150.0,2820.0,2830.0,3760.0,2240.0,2730.0,1930.0,3040.0,38720.0
North West,16.1.5,Stock position of BCG vaccines,4. Stock Distributed,1920.0,1040.0,1000.0,1180.0,1010.0,1330.0,990.0,2070.0,1520.0,1510.0,800.0,1890.0,16260.0
North West,16.1.5,Stock position of BCG vaccines,5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
North West,16.1.6,Stock position of Measles vaccines,1. Balance From Previous Month,5510.0,5415.0,5615.0,3350.0,3665.0,2400.0,960.0,685.0,3065.0,1765.0,1455.0,1660.0,35545.0
North West,16.1.6,Stock position of Measles vaccines,2. Stocks Received,15500.0,3500.0,8000.0,2000.0,,,1000.0,5000.0,500.0,1000.0,1000.0,2000.0,39500.0
North West,16.1.6,Stock position of Measles vaccines,3. Unusable Stock,5415.0,5915.0,3350.0,3665.0,2400.0,960.0,685.0,3065.0,1765.0,1455.0,1660.0,955.0,31290.0
North West,16.1.6,Stock position of Measles vaccines,4. Stock Distributed,15595.0,3000.0,10265.0,1685.0,1265.0,1440.0,1275.0,2620.0,1800.0,1310.0,795.0,2705.0,43755.0
North West,16.1.6,Stock position of Measles vaccines,5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
North West,16.1.7,Stock position of JE vaccines,1. Balance From Previous Month,,,,,,,,,,,,,
North West,16.1.7,Stock position of JE vaccines,2. Stocks Received,,,,,,,,,,,,,
North West,16.1.7,Stock position of JE vaccines,3. Unusable Stock,,,,,,,,,,,,,
North West,16.1.7,Stock position of JE vaccines,4. Stock Distributed,,,,,,,,,,,,,
North West,16.1.7,Stock position of JE vaccines,5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
North West,16.1.8,Stock position of Hepatitis B vaccines,1. Balance From Previous Month,2660.0,4650.0,4180.0,3730.0,3120.0,2630.0,2110.0,1820.0,5770.0,4820.0,4490.0,4290.0,44270.0
North West,16.1.8,Stock position of Hepatitis B vaccines,2. Stocks Received,3000.0,,0.0,,,,0.0,4800.0,,,,,7800.0
North West,16.1.8,Stock position of Hepatitis B vaccines,3. Unusable Stock,4650.0,4180.0,3730.0,3120.0,2630.0,2110.0,1820.0,5770.0,4820.0,4490.0,4290.0,3480.0,45090.0
North West,16.1.8,Stock position of Hepatitis B vaccines,4. Stock Distributed,1010.0,470.0,450.0,610.0,490.0,520.0,290.0,850.0,950.0,330.0,200.0,810.0,6980.0
North West,16.1.8,Stock position of Hepatitis B vaccines,5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
North West,16.2.1,Stock Position of IU 380 A (to be used for Family Planning),1. Balance From Previous Month,352.0,237.0,237.0,157.0,300.0,230.0,710.0,610.0,455.0,355.0,255.0,205.0,4103.0
North West,16.2.1,Stock Position of IU 380 A (to be used for Family Planning),2. Stocks Received,,,0.0,300.0,,600.0,0.0,,,,,100.0,1000.0
North West,16.2.1,Stock Position of IU 380 A (to be used for Family Planning),3. Unusable Stock,237.0,237.0,157.0,300.0,230.0,710.0,610.0,455.0,355.0,255.0,205.0,120.0,3871.0
North West,16.2.1,Stock Position of IU 380 A (to be used for Family Planning),4. Stock Distributed,115.0,,80.0,157.0,70.0,120.0,100.0,155.0,100.0,100.0,50.0,185.0,1232.0
North West,16.2.1,Stock Position of IU 380 A (to be used for Family Planning),5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
North West,16.2.2,Stock Position of Condoms (to be used for Family Planning),1. Balance From Previous Month,116000.0,60000.0,34000.0,56000.0,6000.0,,0.0,,,20500.0,4000.0,,296500.0
North West,16.2.2,Stock Position of Condoms (to be used for Family Planning),2. Stocks Received,,,48000.0,,,,0.0,,30000.0,18000.0,,180000.0,276000.0
North West,16.2.2,Stock Position of Condoms (to be used for Family Planning),3. Unusable Stock,60000.0,34000.0,56000.0,6000.0,6000.0,,0.0,,20500.0,4000.0,,115000.0,301500.0
North West,16.2.2,Stock Position of Condoms (to be used for Family Planning),4. Stock Distributed,56000.0,26000.0,26000.0,50000.0,6000.0,,0.0,,9500.0,34500.0,4000.0,65000.0,277000.0
North West,16.2.2,Stock Position of Condoms (to be used for Family Planning),5. Total Stock,0.0,0.0,0.0,0.0,-6000.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,-6000.0
North West,16.2.3,Stock Position of Oral Contraceptive (to be used for Family Planning),1. Balance From Previous Month,4130.0,3490.0,3270.0,2990.0,2765.0,2545.0,2045.0,1775.0,2555.0,2375.0,2205.0,1845.0,31990.0
North West,16.2.3,Stock Position of Oral Contraceptive (to be used for Family Planning),2. Stocks Received,,,0.0,1000.0,,,0.0,1000.0,,,,,2000.0
North West,16.2.3,Stock Position of Oral Contraceptive (to be used for Family Planning),3. Unusable Stock,3490.0,3270.0,2990.0,2765.0,2545.0,2045.0,1775.0,2555.0,2375.0,2205.0,1845.0,1285.0,29145.0
North West,16.2.3,Stock Position of Oral Contraceptive (to be used for Family Planning),4. Stock Distributed,640.0,220.0,280.0,1225.0,220.0,500.0,270.0,220.0,180.0,170.0,360.0,560.0,4845.0
North West,16.2.3,Stock Position of Oral Contraceptive (to be used for Family Planning),5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
North West,16.2.4,Stock Position of Emergency Contraceptive (to be used for Family Planning),1. Balance From Previous Month,,,,1200.0,450.0,220.0,140.0,140.0,80.0,,,,2230.0
North West,16.2.4,Stock Position of Emergency Contraceptive (to be used for Family Planning),2. Stocks Received,,,,,,,0.0,,,,,100.0,100.0
North West,16.2.4,Stock Position of Emergency Contraceptive (to be used for Family Planning),3. Unusable Stock,,,,450.0,220.0,140.0,140.0,80.0,,,,70.0,1100.0
North West,16.2.4,Stock Position of Emergency Contraceptive (to be used for Family Planning),4. Stock Distributed,,,,750.0,230.0,80.0,,60.0,80.0,,,30.0,1230.0
North West,16.2.4,Stock Position of Emergency Contraceptive (to be used for Family Planning),5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
North West,16.2.5,Stock Position of Tubal Rings (to be used for Family Planning),1. Balance From Previous Month,,,,,,,,,,,,,
North West,16.2.5,Stock Position of Tubal Rings (to be used for Family Planning),2. Stocks Received,,,,,,,,,,,,,
North West,16.2.5,Stock Position of Tubal Rings (to be used for Family Planning),3. Unusable Stock,,,,,,,,,,,,,
North West,16.2.5,Stock Position of Tubal Rings (to be used for Family Planning),4. Stock Distributed,,,,,,,,,,,,,
North West,16.2.5,Stock Position of Tubal Rings (to be used for Family Planning),5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
North West,16.3.01,Stock Position of Oxytocin Injection,1. Balance From Previous Month,,,,,,,,,,,,,
North West,16.3.01,Stock Position of Oxytocin Injection,2. Stocks Received,,,,,,,,,,,,,
North West,16.3.01,Stock Position of Oxytocin Injection,3. Unusable Stock,,,,,,,,,,,,,
North West,16.3.01,Stock Position of Oxytocin Injection,4. Stock Distributed,,,,,,,,,,,,,
North West,16.3.01,Stock Position of Oxytocin Injection,5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
North West,16.3.02,Stock Position of Gloves,1. Balance From Previous Month,,,,,,,,,,,,,
North West,16.3.02,Stock Position of Gloves,2. Stocks Received,,,,,,,,,,,,,
North West,16.3.02,Stock Position of Gloves,3. Unusable Stock,,,,,,,,,,,,,
North West,16.3.02,Stock Position of Gloves,4. Stock Distributed,,,,,,,,,,,,,
North West,16.3.02,Stock Position of Gloves,5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
North West,16.3.03,Stock Position of MVA Syringes,1. Balance From Previous Month,,,,,,,,,,,,,
North West,16.3.03,Stock Position of MVA Syringes,2. Stocks Received,,,,,,,,,,,,,
North West,16.3.03,Stock Position of MVA Syringes,3. Unusable Stock,,,,,,,,,,,,,
North West,16.3.03,Stock Position of MVA Syringes,4. Stock Distributed,,,,,,,,,,,,,
North West,16.3.03,Stock Position of MVA Syringes,5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
North West,16.3.04,Stock Position of Fluconazole Tablets,1. Balance From Previous Month,,,,,,,,,,,,,
North West,16.3.04,Stock Position of Fluconazole Tablets,2. Stocks Received,,,,,,,,,,,,,
North West,16.3.04,Stock Position of Fluconazole Tablets,3. Unusable Stock,,,,,,,,,,,,,
North West,16.3.04,Stock Position of Fluconazole Tablets,4. Stock Distributed,,,,,,,,,,,,,
North West,16.3.04,Stock Position of Fluconazole Tablets,5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
North West,16.3.05,Stock Position of Blood Transfusion Sets,1. Balance From Previous Month,,,,,,,,,,,,,
North West,16.3.05,Stock Position of Blood Transfusion Sets,2. Stocks Received,,,,,,,,,,,,,
North West,16.3.05,Stock Position of Blood Transfusion Sets,3. Unusable Stock,,,,,,,,,,,,,
North West,16.3.05,Stock Position of Blood Transfusion Sets,4. Stock Distributed,,,,,,,,,,,,,
North West,16.3.05,Stock Position of Blood Transfusion Sets,5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
North West,16.3.06,Stock Position of Gluteraldehyde solution of 2% concentration,1. Balance From Previous Month,,,,,,,,,,,,,
North West,16.3.06,Stock Position of Gluteraldehyde solution of 2% concentration,2. Stocks Received,,,,,,,,,,,,,
North West,16.3.06,Stock Position of Gluteraldehyde solution of 2% concentration,3. Unusable Stock,,,,,,,,,,,,,
North West,16.3.06,Stock Position of Gluteraldehyde solution of 2% concentration,4. Stock Distributed,,,,,,,,,,,,,
North West,16.3.06,Stock Position of Gluteraldehyde solution of 2% concentration,5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
North West,16.3.07,Stock Position of IFA Tablets,1. Balance From Previous Month,50000.0,48000.0,36000.0,42000.0,19000.0,,,,,,,,195000.0
North West,16.3.07,Stock Position of IFA Tablets,2. Stocks Received,40000.0,20000.0,40000.0,40000.0,,,,,,,,,140000.0
North West,16.3.07,Stock Position of IFA Tablets,3. Unusable Stock,48000.0,36000.0,42000.0,19000.0,19000.0,,,,,,,,164000.0
North West,16.3.07,Stock Position of IFA Tablets,4. Stock Distributed,42000.0,32000.0,34000.0,63000.0,19000.0,,,,,,,,190000.0
North West,16.3.07,Stock Position of IFA Tablets,5. Total Stock,0.0,0.0,0.0,0.0,-19000.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,-19000.0
North West,16.3.08,Stock Position of IFA Syrup (Paediatric),1. Balance From Previous Month,,,,,,,,,,,,,
North West,16.3.08,Stock Position of IFA Syrup (Paediatric),2. Stocks Received,,,,,,,,,,,,,
North West,16.3.08,Stock Position of IFA Syrup (Paediatric),3. Unusable Stock,,,,,,,,,,,,,
North West,16.3.08,Stock Position of IFA Syrup (Paediatric),4. Stock Distributed,,,,,,,,,,,,,
North West,16.3.08,Stock Position of IFA Syrup (Paediatric),5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
North West,16.3.09,Stock Position of Paediatrics Antibiotics (Cotrimaxozole and Injectable Gentamicin),1. Balance From Previous Month,,,,,,,,,,,,,
North West,16.3.09,Stock Position of Paediatrics Antibiotics (Cotrimaxozole and Injectable Gentamicin),2. Stocks Received,,,,,,,,,,,,,
North West,16.3.09,Stock Position of Paediatrics Antibiotics (Cotrimaxozole and Injectable Gentamicin),3. Unusable Stock,,,,,,,,,,,,,
North West,16.3.09,Stock Position of Paediatrics Antibiotics (Cotrimaxozole and Injectable Gentamicin),4. Stock Distributed,,,,,,,,,,,,,
North West,16.3.09,Stock Position of Paediatrics Antibiotics (Cotrimaxozole and Injectable Gentamicin),5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
North West,16.3.10,Stock Position of Vitamin A solution,1. Balance From Previous Month,240.0,185.0,269.0,974.0,154.0,34.0,0.0,,68.0,51.0,52.0,92.0,2119.0
North West,16.3.10,Stock Position of Vitamin A solution,2. Stocks Received,200.0,200.0,2000.0,,,,0.0,100.0,,100.0,100.0,600.0,3300.0
North West,16.3.10,Stock Position of Vitamin A solution,3. Unusable Stock,185.0,269.0,974.0,154.0,34.0,,0.0,68.0,51.0,52.0,92.0,426.0,2305.0
North West,16.3.10,Stock Position of Vitamin A solution,4. Stock Distributed,255.0,116.0,1295.0,820.0,120.0,34.0,0.0,32.0,17.0,99.0,60.0,266.0,3114.0
North West,16.3.10,Stock Position of Vitamin A solution,5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
North West,16.3.11,Stock of ORS (New WHO formulation),1. Balance From Previous Month,9000.0,6000.0,2000.0,26500.0,,9500.0,6000.0,4000.0,,,,,63000.0
North West,16.3.11,Stock of ORS (New WHO formulation),2. Stocks Received,,,30000.0,20000.0,18000.0,,0.0,,,,,,68000.0
North West,16.3.11,Stock of ORS (New WHO formulation),3. Unusable Stock,6000.0,2000.0,26500.0,,9500.0,6000.0,4000.0,,,,,,54000.0
North West,16.3.11,Stock of ORS (New WHO formulation),4. Stock Distributed,3000.0,4000.0,5500.0,46500.0,8500.0,3500.0,2000.0,4000.0,,,,,77000.0
North West,16.3.11,Stock of ORS (New WHO formulation),5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
North West,16.4.1,Stock Position of 0.1 ml Syringes(AD),1. Balance From Previous Month,4420.0,3490.0,3070.0,5420.0,4420.0,3920.0,3340.0,3240.0,4920.0,4020.0,3050.0,3050.0,46360.0
North West,16.4.1,Stock Position of 0.1 ml Syringes(AD),2. Stocks Received,,,3000.0,,,,0.0,3000.0,,,,,6000.0
North West,16.4.1,Stock Position of 0.1 ml Syringes(AD),3. Unusable Stock,3490.0,3070.0,5420.0,4420.0,3920.0,3340.0,3240.0,4920.0,4020.0,3050.0,3050.0,2000.0,43940.0
North West,16.4.1,Stock Position of 0.1 ml Syringes(AD),4. Stock Distributed,930.0,420.0,650.0,1000.0,500.0,580.0,100.0,1320.0,900.0,970.0,,1050.0,8420.0
North West,16.4.1,Stock Position of 0.1 ml Syringes(AD),5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
North West,16.4.2,Stock Position of 0.5 ml Syringes(AD),1. Balance From Previous Month,46800.0,21200.0,10000.0,31600.0,58200.0,52600.0,42200.0,34200.0,21200.0,11200.0,32000.0,26400.0,387600.0
North West,16.4.2,Stock Position of 0.5 ml Syringes(AD),2. Stocks Received,,,40000.0,40000.0,,,0.0,,,30000.0,,,110000.0
North West,16.4.2,Stock Position of 0.5 ml Syringes(AD),3. Unusable Stock,21200.0,10000.0,31600.0,58200.0,52600.0,42200.0,34200.0,21200.0,11200.0,32000.0,26400.0,11400.0,352200.0
North West,16.4.2,Stock Position of 0.5 ml Syringes(AD),4. Stock Distributed,25600.0,11200.0,18400.0,13400.0,58200.0,10400.0,8000.0,13000.0,10000.0,9200.0,5600.0,15000.0,198000.0
North West,16.4.2,Stock Position of 0.5 ml Syringes(AD),5. Total Stock,0.0,0.0,0.0,0.0,-52600.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,-52600.0
North West,16.4.3,Stock Position of 5.0 ml Syringes(Disposable),1. Balance From Previous Month,1500.0,100.0,1000.0,2900.0,1200.0,400.0,0.0,2200.0,800.0,800.0,,,10900.0
North West,16.4.3,Stock Position of 5.0 ml Syringes(Disposable),2. Stocks Received,,1000.0,2400.0,,,,2400.0,,,,,4800.0,10600.0
North West,16.4.3,Stock Position of 5.0 ml Syringes(Disposable),3. Unusable Stock,100.0,1000.0,2900.0,1200.0,400.0,,2200.0,800.0,600.0,,,4400.0,13600.0
North West,16.4.3,Stock Position of 5.0 ml Syringes(Disposable),4. Stock Distributed,1400.0,100.0,500.0,1700.0,800.0,400.0,200.0,1400.0,200.0,800.0,,400.0,7900.0
North West,16.4.3,Stock Position of 5.0 ml Syringes(Disposable),5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
North West,17.1,Number of cases of Infant deaths within 24 hrs of birth,TOTAL,2.0,1.0,,7.0,3.0,1.0,6.0,4.0,6.0,4.0,5.0,6.0,45.0
North West,17.2.1,Number of cases of Infant deaths 24 hours to 4 weeks of birth with the probable cause being Sepsis,1. Up to 1 Weeks of Birth,6.0,3.0,4.0,9.0,4.0,,3.0,3.0,6.0,6.0,3.0,2.0,49.0
North West,17.2.1,Number of cases of Infant deaths 24 hours to 4 weeks of birth with the probable cause being Sepsis,2. Between 1 week & 4 weeks of birth,2.0,,1.0,1.0,2.0,,4.0,,,1.0,,,11.0
North West,17.2.1,Number of cases of Infant deaths 24 hours to 4 weeks of birth with the probable cause being Sepsis,3. Total,8.0,3.0,5.0,10.0,6.0,,7.0,3.0,6.0,7.0,3.0,2.0,60.0
North West,17.2.2,Number of cases of Infant deaths 24 hours to 4 weeks of birth with the probable cause being Asphyxia,1. Up to 1 Weeks of Birth,6.0,3.0,6.0,5.0,8.0,2.0,13.0,11.0,12.0,8.0,6.0,9.0,89.0
North West,17.2.2,Number of cases of Infant deaths 24 hours to 4 weeks of birth with the probable cause being Asphyxia,2. Between 1 week & 4 weeks of birth,,,,1.0,,1.0,1.0,,,,2.0,,5.0
North West,17.2.2,Number of cases of Infant deaths 24 hours to 4 weeks of birth with the probable cause being Asphyxia,3. Total,6.0,3.0,6.0,6.0,8.0,3.0,14.0,11.0,12.0,8.0,8.0,9.0,94.0
North West,17.2.3,Number of cases of Infant deaths 24 hours to 4 weeks of birth with the probable cause being LBW,1. Up to 1 Weeks of Birth,12.0,6.0,4.0,7.0,13.0,3.0,10.0,8.0,7.0,9.0,12.0,12.0,103.0
North West,17.2.3,Number of cases of Infant deaths 24 hours to 4 weeks of birth with the probable cause being LBW,2. Between 1 week & 4 weeks of birth,1.0,2.0,,2.0,1.0,1.0,,,,,,,7.0
North West,17.2.3,Number of cases of Infant deaths 24 hours to 4 weeks of birth with the probable cause being LBW,3. Total,13.0,8.0,4.0,9.0,14.0,4.0,10.0,8.0,7.0,9.0,12.0,12.0,110.0
North West,17.2.4,"Number of cases of Infant deaths 24 hours to 4 weeks of birth with the probable cause being other than Sepsis, Asphyxia and LBW",1. Up to 1 Weeks of Birth,5.0,,4.0,4.0,7.0,3.0,4.0,5.0,6.0,4.0,2.0,6.0,50.0
North West,17.2.4,"Number of cases of Infant deaths 24 hours to 4 weeks of birth with the probable cause being other than Sepsis, Asphyxia and LBW",2. Between 1 week & 4 weeks of birth,2.0,,,1.0,1.0,,1.0,3.0,,4.0,,1.0,13.0
North West,17.2.4,"Number of cases of Infant deaths 24 hours to 4 weeks of birth with the probable cause being other than Sepsis, Asphyxia and LBW",3. Total,7.0,,4.0,5.0,8.0,3.0,5.0,8.0,6.0,8.0,2.0,7.0,63.0
North West,17.3.1,Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being Pneumonia,1. Between 1 month and 11 months,3.0,2.0,2.0,4.0,1.0,2.0,5.0,1.0,2.0,2.0,3.0,2.0,29.0
North West,17.3.1,Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being Pneumonia,2. Between 1 year & 5 years,,,,,1.0,,,,,,,,1.0
North West,17.3.1,Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being Pneumonia,3. Total,3.0,2.0,2.0,4.0,2.0,2.0,5.0,1.0,2.0,2.0,3.0,2.0,30.0
North West,17.3.2,Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being Diarrhoea,1. Between 1 month and 11 months,2.0,1.0,1.0,,,,,2.0,,,,,6.0
North West,17.3.2,Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being Diarrhoea,2. Between 1 year & 5 years,,,,,,,,,1.0,,,,1.0
North West,17.3.2,Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being Diarrhoea,3. Total,2.0,1.0,1.0,,,,,2.0,1.0,,,,7.0
North West,17.3.3,Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being Fever related,1. Between 1 month and 11 months,1.0,1.0,3.0,1.0,,,,1.0,,,,3.0,10.0
North West,17.3.3,Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being Fever related,2. Between 1 year & 5 years,,,1.0,1.0,,,,,,,,,2.0
North West,17.3.3,Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being Fever related,3. Total,1.0,1.0,4.0,2.0,,,,1.0,,,,3.0,12.0
North West,17.3.4,Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being Measles,1. Between 1 month and 11 months,,1.0,,,,,,,,,,,1.0
North West,17.3.4,Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being Measles,2. Between 1 year & 5 years,,1.0,,,,,,,,,,,1.0
North West,17.3.4,Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being Measles,3. Total,,2.0,,,,,,,,,,,2.0
North West,17.3.5,"Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being other than Pneumonia, Diarrhoea, Fever related and Measles",1. Between 1 month and 11 months,,2.0,4.0,2.0,3.0,2.0,,3.0,6.0,2.0,4.0,3.0,31.0
North West,17.3.5,"Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being other than Pneumonia, Diarrhoea, Fever related and Measles",2. Between 1 year & 5 years,,,,1.0,3.0,,,,2.0,,1.0,5.0,12.0
North West,17.3.5,"Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being other than Pneumonia, Diarrhoea, Fever related and Measles",3. Total,,2.0,4.0,3.0,6.0,2.0,,3.0,8.0,2.0,5.0,8.0,43.0
North West,17.4.1,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Diarrhoeal diseases,1. 6-14 yrs,2.0,,,,,,1.0,,,,,,3.0
North West,17.4.1,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Diarrhoeal diseases,2. 15-55 yrs.,3.0,,2.0,1.0,2.0,1.0,1.0,3.0,1.0,1.0,1.0,3.0,19.0
North West,17.4.1,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Diarrhoeal diseases,3. Above 55 yrs.,2.0,1.0,,3.0,1.0,,,,,1.0,,,8.0
North West,17.4.1,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Diarrhoeal diseases,4. Total,7.0,1.0,2.0,4.0,3.0,1.0,2.0,3.0,1.0,2.0,1.0,3.0,30.0
North West,17.4.2,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Tuberculosis,1. 6-14 yrs,,1.0,,1.0,,1.0,,,2.0,,,1.0,6.0
North West,17.4.2,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Tuberculosis,2. 15-55 yrs.,4.0,10.0,3.0,11.0,8.0,7.0,9.0,10.0,13.0,13.0,11.0,16.0,115.0
North West,17.4.2,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Tuberculosis,3. Above 55 yrs.,2.0,1.0,2.0,5.0,4.0,1.0,2.0,3.0,8.0,6.0,7.0,8.0,49.0
North West,17.4.2,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Tuberculosis,4. Total,6.0,12.0,5.0,17.0,12.0,9.0,11.0,13.0,23.0,19.0,18.0,25.0,170.0
North West,17.4.3,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Respiratory diseases including infections,1. 6-14 yrs,1.0,1.0,1.0,1.0,2.0,,2.0,2.0,,,,,10.0
North West,17.4.3,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Respiratory diseases including infections,2. 15-55 yrs.,11.0,9.0,11.0,13.0,16.0,3.0,9.0,16.0,13.0,9.0,23.0,22.0,155.0
North West,17.4.3,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Respiratory diseases including infections,3. Above 55 yrs.,19.0,12.0,14.0,25.0,27.0,7.0,28.0,24.0,24.0,37.0,36.0,32.0,285.0
North West,17.4.3,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Respiratory diseases including infections,4. Total,31.0,22.0,26.0,39.0,45.0,10.0,39.0,42.0,37.0,46.0,59.0,54.0,450.0
North West,17.4.4,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Malaria,1. 6-14 yrs,,,,,,,,,,,,,
North West,17.4.4,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Malaria,2. 15-55 yrs.,,,,,,,,,,,,1.0,1.0
North West,17.4.4,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Malaria,3. Above 55 yrs.,,,,,1.0,,,,,,,,1.0
North West,17.4.4,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Malaria,4. Total,,,,,1.0,,,,,,,1.0,2.0
North West,17.4.5,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being other Fever related,1. 6-14 yrs,2.0,1.0,,,1.0,1.0,,,,,1.0,,6.0
North West,17.4.5,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being other Fever related,2. 15-55 yrs.,7.0,6.0,8.0,6.0,4.0,11.0,9.0,17.0,5.0,4.0,7.0,5.0,89.0
North West,17.4.5,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being other Fever related,3. Above 55 yrs.,3.0,7.0,3.0,12.0,3.0,15.0,5.0,8.0,5.0,1.0,2.0,2.0,66.0
North West,17.4.5,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being other Fever related,4. Total,12.0,14.0,11.0,18.0,8.0,27.0,14.0,25.0,10.0,5.0,10.0,7.0,161.0
North West,17.4.6,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being HIV/AIDS,1. 6-14 yrs,,,,,,,,,,,,,
North West,17.4.6,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being HIV/AIDS,2. 15-55 yrs.,3.0,4.0,4.0,1.0,5.0,,2.0,,4.0,3.0,3.0,1.0,30.0
North West,17.4.6,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being HIV/AIDS,3. Above 55 yrs.,,,1.0,,,1.0,,,,2.0,,,4.0
North West,17.4.6,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being HIV/AIDS,4. Total,3.0,4.0,5.0,1.0,5.0,1.0,2.0,,4.0,5.0,3.0,1.0,34.0
North West,17.4.7,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Heart disease or related to Hypertension,1. 6-14 yrs,2.0,1.0,,,,1.0,2.0,,,,1.0,,7.0
North West,17.4.7,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Heart disease or related to Hypertension,2. 15-55 yrs.,9.0,14.0,8.0,7.0,15.0,7.0,7.0,20.0,15.0,12.0,15.0,14.0,143.0
North West,17.4.7,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Heart disease or related to Hypertension,3. Above 55 yrs.,9.0,20.0,8.0,10.0,32.0,16.0,17.0,21.0,29.0,32.0,25.0,38.0,257.0
North West,17.4.7,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Heart disease or related to Hypertension,4. Total,20.0,35.0,16.0,17.0,47.0,24.0,26.0,41.0,44.0,44.0,41.0,52.0,407.0
North West,17.4.8,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Neurological disease including strokes,1. 6-14 yrs,,3.0,1.0,1.0,,,,1.0,,2.0,2.0,2.0,12.0
North West,17.4.8,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Neurological disease including strokes,2. 15-55 yrs.,5.0,7.0,6.0,8.0,4.0,6.0,4.0,7.0,8.0,9.0,7.0,17.0,88.0
North West,17.4.8,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Neurological disease including strokes,3. Above 55 yrs.,6.0,10.0,7.0,12.0,9.0,,7.0,12.0,14.0,17.0,19.0,20.0,133.0
North West,17.4.8,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Neurological disease including strokes,4. Total,11.0,20.0,14.0,21.0,13.0,6.0,11.0,20.0,22.0,28.0,28.0,39.0,233.0
North West,17.4.9(a),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Abortion,1. 6-14 yrs,,,,,,,,,,,,,
North West,17.4.9(a),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Abortion,2. 15-49 yrs,2.0,,,,,,,,,,,,2.0
North West,17.4.9(a),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Abortion,3. Above 49 yrs.,,,,,,,,,,,,,
North West,17.4.9(a),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Abortion,4. Total,2.0,,,,,,,,,,,,2.0
North West,17.4.9(b),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Obstructed or prolonged labour,1. 6-14 yrs,,,,,,,,,,,,,
North West,17.4.9(b),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Obstructed or prolonged labour,2. 15-49 yrs,,,,,1.0,,,,,,,,1.0
North West,17.4.9(b),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Obstructed or prolonged labour,3. Above 49 yrs.,,,,,,,,,,,,,
North West,17.4.9(b),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Obstructed or prolonged labour,4. Total,,,,,1.0,,,,,,,,1.0
North West,17.4.9(c),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Severe hypertesnion or fits,1. 6-14 yrs,,,,,,,,,,,,,
North West,17.4.9(c),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Severe hypertesnion or fits,2. 15-49 yrs,1.0,1.0,,1.0,,,1.0,,1.0,,1.0,,6.0
North West,17.4.9(c),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Severe hypertesnion or fits,3. Above 49 yrs.,,,,,,,,,,,,,
North West,17.4.9(c),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Severe hypertesnion or fits,4. Total,1.0,1.0,,1.0,,,1.0,,1.0,,1.0,,6.0
North West,17.4.9(d),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Bleeding,1. 6-14 yrs,,,,,,,,,,,,,
North West,17.4.9(d),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Bleeding,2. 15-49 yrs,4.0,1.0,,,1.0,2.0,,1.0,2.0,,,1.0,12.0
North West,17.4.9(d),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Bleeding,3. Above 49 yrs.,,,,,,,,,,,,,
North West,17.4.9(d),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Bleeding,4. Total,4.0,1.0,,,1.0,2.0,,1.0,2.0,,,1.0,12.0
North West,17.4.9(e),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being High Fever,1. 6-14 yrs,,,,,,,,,,,,,
North West,17.4.9(e),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being High Fever,2. 15-49 yrs,,,,,1.0,1.0,1.0,,1.0,,,1.0,5.0
North West,17.4.9(e),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being High Fever,3. Above 49 yrs.,,,,,,,,,,,,,
North West,17.4.9(e),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being High Fever,4. Total,,,,,1.0,1.0,1.0,,1.0,,,1.0,5.0
North West,17.4.9(f),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being other causes (excluding abortion; obstructed or prolonged labour; severe hypertension or fits;,1. 6-14 yrs,,,,,,,,,,,,,
North West,17.4.9(f),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being other causes (excluding abortion; obstructed or prolonged labour; severe hypertension or fits;,2. 15-49 yrs,,3.0,5.0,7.0,4.0,2.0,5.0,3.0,,6.0,3.0,3.0,41.0
North West,17.4.9(f),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being other causes (excluding abortion; obstructed or prolonged labour; severe hypertension or fits;,3. Above 49 yrs.,,,,,,,,,,,,,
North West,17.4.9(f),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being other causes (excluding abortion; obstructed or prolonged labour; severe hypertension or fits;,4. Total,,3.0,5.0,7.0,4.0,2.0,5.0,3.0,,6.0,3.0,3.0,41.0
North West,17.4.10,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Trauma or Accidents or Burn cases,1. 6-14 yrs,,1.0,2.0,1.0,1.0,,,,1.0,,1.0,,7.0
North West,17.4.10,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Trauma or Accidents or Burn cases,2. 15-55 yrs.,14.0,4.0,16.0,10.0,16.0,10.0,14.0,11.0,12.0,7.0,2.0,11.0,127.0
North West,17.4.10,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Trauma or Accidents or Burn cases,3. Above 55 yrs.,,1.0,1.0,,3.0,4.0,5.0,1.0,3.0,7.0,2.0,2.0,29.0
North West,17.4.10,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Trauma or Accidents or Burn cases,4. Total,14.0,6.0,19.0,11.0,20.0,14.0,19.0,12.0,16.0,14.0,5.0,13.0,163.0
North West,17.4.11,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being suicide,1. 6-14 yrs,,,,,,,,,,,,1.0,1.0
North West,17.4.11,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being suicide,2. 15-55 yrs.,,,,1.0,,1.0,3.0,3.0,,1.0,1.0,2.0,12.0
North West,17.4.11,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being suicide,3. Above 55 yrs.,,,,,,,,,,,,,
North West,17.4.11,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being suicide,4. Total,,,,1.0,,1.0,3.0,3.0,,1.0,1.0,3.0,13.0
North West,17.4.12,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Animal bites and stings,1. 6-14 yrs,,,,,,,,,,,,,
North West,17.4.12,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Animal bites and stings,2. 15-55 yrs.,,,,,,,,1.0,,,,,1.0
North West,17.4.12,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Animal bites and stings,3. Above 55 yrs.,,,,,,,,,,,,,
North West,17.4.12,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Animal bites and stings,4. Total,,,,,,,,1.0,,,,,1.0
North West,17.4.13(a),Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Known Acute disease,1. 6-14 yrs,,,,,,,1.0,,1.0,1.0,1.0,,4.0
North West,17.4.13(a),Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Known Acute disease,2. 15-55 yrs.,3.0,8.0,7.0,8.0,9.0,7.0,32.0,11.0,15.0,20.0,16.0,4.0,140.0
North West,17.4.13(a),Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Known Acute disease,3. Above 55 yrs.,5.0,9.0,7.0,6.0,11.0,5.0,27.0,10.0,8.0,14.0,7.0,8.0,117.0
North West,17.4.13(a),Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Known Acute disease,4. Total,8.0,17.0,14.0,14.0,20.0,12.0,60.0,21.0,24.0,35.0,24.0,12.0,261.0
North West,17.4.13(b),Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Known Chronic disease,1. 6-14 yrs,,1.0,1.0,,1.0,1.0,1.0,,1.0,,,,6.0
North West,17.4.13(b),Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Known Chronic disease,2. 15-55 yrs.,15.0,12.0,23.0,28.0,27.0,15.0,34.0,25.0,29.0,31.0,18.0,25.0,282.0
North West,17.4.13(b),Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Known Chronic disease,3. Above 55 yrs.,8.0,11.0,15.0,27.0,9.0,15.0,25.0,23.0,20.0,36.0,30.0,31.0,250.0
North West,17.4.13(b),Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Known Chronic disease,4. Total,23.0,24.0,39.0,55.0,37.0,31.0,60.0,48.0,50.0,67.0,48.0,56.0,538.0
North West,17.4.13(c),Number of cases of Adolescent or Adult deaths (age 6 years & above) where the cause was not known,1. 6-14 yrs,,,,1.0,,,,1.0,,,,1.0,3.0
North West,17.4.13(c),Number of cases of Adolescent or Adult deaths (age 6 years & above) where the cause was not known,2. 15-55 yrs.,6.0,1.0,,16.0,5.0,8.0,7.0,6.0,15.0,16.0,17.0,13.0,110.0
North West,17.4.13(c),Number of cases of Adolescent or Adult deaths (age 6 years & above) where the cause was not known,3. Above 55 yrs.,2.0,3.0,2.0,19.0,10.0,10.0,17.0,14.0,27.0,19.0,16.0,12.0,151.0
North West,17.4.13(c),Number of cases of Adolescent or Adult deaths (age 6 years & above) where the cause was not known,4. Total,8.0,4.0,2.0,36.0,15.0,18.0,24.0,21.0,42.0,35.0,33.0,26.0,264.0
Shahdara,1.1,Total number of pregnant women Registered for ANC,TOTAL,9914.0,9017.0,8720.0,10502.0,8493.0,9690.0,9457.0,9830.0,8998.0,7610.0,7654.0,9892.0,109777.0
Shahdara,1.1.1,Of which Number registered within first trimester (within 12 weeks),TOTAL,3985.0,3727.0,3553.0,3754.0,3944.0,4159.0,3488.0,3991.0,3782.0,3531.0,3880.0,3736.0,45530.0
Shahdara,1.2,Number of Pregnant women registered under JSY,TOTAL,600.0,467.0,457.0,446.0,482.0,533.0,311.0,379.0,163.0,277.0,111.0,389.0,4615.0
Shahdara,1.3,Number of pregnant women received 3 ANC check ups during pregnancy,TOTAL,3363.0,3139.0,3817.0,4136.0,3476.0,4622.0,3830.0,4748.0,3976.0,3609.0,3732.0,6263.0,48711.0
Shahdara,1.4.1,Number of pregnant women given TT1 during current pregnancy,TOTAL,3371.0,2950.0,2998.0,2640.0,2569.0,3837.0,2451.0,2173.0,2597.0,3468.0,3661.0,3912.0,36627.0
Shahdara,1.4.2,Number of pregnant women given TT2 or Booster during current pregnancy,TOTAL,3395.0,2204.0,2292.0,2200.0,2157.0,3152.0,1834.0,1947.0,2075.0,2661.0,2721.0,2978.0,29616.0
Shahdara,1.5,Total number of pregnant women given 100 IFA tablets,TOTAL,3352.0,3155.0,3625.0,3909.0,3311.0,4152.0,3376.0,4340.0,3497.0,3430.0,3438.0,6227.0,45812.0
Shahdara,1.6.1,Number of new cases of Hypertension (BP>140/90) detected in Pregnant women at the institution,TOTAL,147.0,133.0,130.0,160.0,133.0,130.0,140.0,153.0,125.0,372.0,313.0,372.0,2308.0
Shahdara,1.6.2,Number of Eclampsia cases managed during delivery,TOTAL,17.0,14.0,11.0,8.0,10.0,10.0,8.0,22.0,8.0,118.0,133.0,142.0,501.0
Shahdara,1.7.1,Number of Pregnant women with anaemia i.e. Hb level<11 (tested cases),TOTAL,3052.0,3745.0,3136.0,2349.0,3246.0,3254.0,2969.0,3183.0,2949.0,4689.0,4904.0,4688.0,42164.0
Shahdara,1.7.2,Number of Pregnant women having severe anaemia (Hb<7) treated at institution,TOTAL,173.0,199.0,173.0,149.0,124.0,183.0,154.0,195.0,202.0,412.0,360.0,501.0,2825.0
Shahdara,1.8,Number of pregnancy test kits used at SC level,TOTAL,0.0,3.0,3.0,5.0,1.0,10.0,0.0,0.0,49.0,33.0,0.0,4.0,108.0
Shahdara,2.1.1.a,Number of deliveries conducted at Home and attended by trained SBA(i.e. Doctor or Nurse or ANM),TOTAL,6.0,5.0,7.0,10.0,1.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,29.0
Shahdara,2.1.1.b,Number of deliveries conducted at Home and attended by non trained SBA (i.e. trained TBA or Relatives etc.),TOTAL,35.0,38.0,43.0,53.0,86.0,92.0,85.0,78.0,83.0,88.0,79.0,72.0,832.0
Shahdara,2.1.1.c,Total number of deliveries conducted at Home and attended by trained or non-trained SBA (i.e. sum of 2.1.1.a and 2.1.1.b),TOTAL,41.0,43.0,50.0,63.0,87.0,92.0,85.0,78.0,83.0,88.0,79.0,72.0,861.0
Shahdara,2.1.2,Number of newborns visited within 24 hours of delivery for deliveries conducted at home,TOTAL,22.0,27.0,18.0,32.0,34.0,56.0,55.0,32.0,49.0,67.0,64.0,62.0,518.0
Shahdara,2.1.3,Number of mothers paid JSY incentive for deliveries conducted at home,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Shahdara,2.2,Deliveries conducted at Public Institutions (Including C-Sections),TOTAL,2025.0,2322.0,2227.0,2397.0,3449.0,3147.0,2961.0,3065.0,2897.0,3238.0,3268.0,3243.0,34239.0
Shahdara,2.2.1,"Out of 2.2, Number discharged under 48 hours of delivery",TOTAL,1328.0,1859.0,1416.0,1662.0,2351.0,2447.0,2036.0,2196.0,2457.0,2511.0,2495.0,2362.0,25120.0
Shahdara,2.2.2.a,Number of mothers paid JSY Incentive for deliveries conducted at Public Institutions,TOTAL,61.0,48.0,64.0,117.0,102.0,83.0,71.0,54.0,117.0,106.0,115.0,121.0,1059.0
Shahdara,2.2.2.b,Number of ASHAs paid JSY Incentive for deliveries conducted at Public Institutions,TOTAL,2.0,0.0,3.0,0.0,1.0,2.0,4.0,0.0,1.0,1.0,4.0,3.0,21.0
Shahdara,2.2.2.c,Number of cases of deliveries conducted at Public Institutions where JSY incentive was paid to ANMs or AWWs [only for High Performing States (HPS)],TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Shahdara,2.3,Deliveries conducted at Private Institutions (Including C-Sections),TOTAL,122.0,70.0,139.0,141.0,134.0,229.0,204.0,210.0,226.0,222.0,152.0,149.0,1998.0
Shahdara,2.3.1.a,Number of mothers paid JSY Incentive for deliveries conducted at accredited Private Institutions,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Shahdara,2.3.1.b,Number of ASHAs paid JSY Incentive for deliveries conducted at accredited Private Institutions,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Shahdara,2.3.1.c,Number of cases of deliveries conducted at accredited Private Institutions where JSY incentive was paid to ANMs or AWWs [only for High Performing States (HPS)],TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Shahdara,3.1.1,Number of Caesarean (C-Section) deliveries performed at PHCs (Primary Health Centre),TOTAL,,,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Shahdara,3.1.2,Number of Caesarean (C-Section) deliveries performed at CHCs (Community Health Centre),TOTAL,,0.0,,0.0,0.0,,,,,,,0.0,0.0
Shahdara,3.1.3,Number of Caesarean (C-Section) deliveries performed at SDHs (Sub-divisional Hospital) or DHs (District Hospital),TOTAL,544.0,607.0,564.0,626.0,736.0,677.0,769.0,952.0,697.0,880.0,914.0,1012.0,8978.0
Shahdara,3.1.4,Number of Caesarean (C-Section) deliveries performed at other State owned public institutions,TOTAL,,,,,,,,,,,,,
Shahdara,3.1.5,"Total Number of Caesarean (C-Section) deliveries performed at Public facilities i.e. PHC, CHC, SDH, DH and other State owned public institutions (sum of items from 3.1.1 to 3.1.4)",TOTAL,544.0,607.0,564.0,626.0,736.0,677.0,769.0,952.0,697.0,880.0,914.0,1012.0,8978.0
Shahdara,3.2,No. of C-section deliveries performed at Private facilities,TOTAL,78.0,34.0,86.0,86.0,84.0,119.0,128.0,117.0,126.0,124.0,79.0,101.0,1162.0
Shahdara,4.1.1.a,Number of male live births,TOTAL,1194.0,1275.0,1212.0,1402.0,1912.0,1910.0,1729.0,1800.0,1631.0,1823.0,1577.0,1574.0,19039.0
Shahdara,4.1.1.b,Number of female live births,TOTAL,974.0,1124.0,1145.0,1190.0,1707.0,1530.0,1501.0,1530.0,1565.0,1696.0,1911.0,1872.0,17745.0
Shahdara,4.1.1.c,Total number of male and female live births (4.1.1.a and 4.1.1.b),TOTAL,2168.0,2399.0,2357.0,2592.0,3619.0,3440.0,3230.0,3330.0,3196.0,3519.0,3488.0,3446.0,36784.0
Shahdara,4.1.2,Number of still births,TOTAL,28.0,36.0,61.0,38.0,78.0,47.0,35.0,35.0,34.0,45.0,47.0,43.0,527.0
Shahdara,4.1.3,Number of Abortions (spontaneous or induced),TOTAL,330.0,248.0,252.0,324.0,207.0,256.0,251.0,169.0,152.0,223.0,215.0,357.0,2984.0
Shahdara,4.2.1,Number of Newborns weighed at birth,TOTAL,2138.0,2364.0,2331.0,2575.0,3521.0,3292.0,3137.0,3278.0,3113.0,3505.0,3468.0,3437.0,36159.0
Shahdara,4.2.2,Number of Newborns having weight less than 2.5 kg,TOTAL,581.0,719.0,858.0,857.0,591.0,1093.0,1165.0,1093.0,410.0,419.0,412.0,538.0,8736.0
Shahdara,4.3,Number of Newborns breast fed within 1 hour of birth,TOTAL,1664.0,1949.0,1829.0,2103.0,2700.0,2556.0,2492.0,2546.0,2776.0,2892.0,2936.0,2800.0,29243.0
Shahdara,5.1.1,Number of cases of pregnant women with Obstetric Complications and attended at PHCs,TOTAL,,,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Shahdara,5.1.2,Number of cases of pregnant women with Obstetric Complications and attended at CHCs,TOTAL,,,,38.0,26.0,27.0,24.0,26.0,30.0,20.0,2.0,18.0,211.0
Shahdara,5.1.3,Number of cases of pregnant women with Obstetric Complications and attended at SDHs or DHs,TOTAL,549.0,794.0,345.0,377.0,486.0,565.0,633.0,483.0,553.0,966.0,1041.0,990.0,7782.0
Shahdara,5.1.4,Number of cases of pregnant women with Obstetric Complications and attended at other State owned public institutions,TOTAL,,,,,,,,,,,,,
Shahdara,5.1.5,"Number of cases of pregnant women with Obstetric Complications and attended at Public facilities i.e. PHC, CHC, SDH, DH and other State owned public institutions (sum of items from 5.1.1 to 5.1.4)",TOTAL,549.0,794.0,345.0,415.0,512.0,592.0,657.0,509.0,583.0,986.0,1043.0,1008.0,7993.0
Shahdara,5.2,Number of cases of pregnant women with Obstetric Complications and attended at Private facilities,TOTAL,68.0,9.0,18.0,35.0,33.0,65.0,65.0,47.0,58.0,97.0,38.0,41.0,574.0
Shahdara,5.3.1,Number of cases of complicated pregnancies treated with IV antibiotics,TOTAL,391.0,699.0,342.0,385.0,463.0,574.0,620.0,556.0,639.0,830.0,741.0,701.0,6941.0
Shahdara,5.3.2,Number of cases of complicated pregnancies treated with IV Antihypertensive/Magsulph injection,TOTAL,17.0,409.0,86.0,95.0,90.0,104.0,62.0,110.0,102.0,277.0,329.0,395.0,2076.0
Shahdara,5.3.3,Number of cases of complicated pregnancies treated with IV Oxytocis,TOTAL,282.0,714.0,275.0,281.0,451.0,456.0,593.0,441.0,572.0,732.0,1036.0,976.0,6809.0
Shahdara,5.3.4,Number of cases of complicated pregnancies treated with Blood Transfusion,TOTAL,47.0,103.0,125.0,96.0,118.0,108.0,117.0,188.0,127.0,180.0,107.0,155.0,1471.0
Shahdara,6.1,Women getting post partum check-up within 48 hours after delivery,TOTAL,1917.0,2288.0,2267.0,2590.0,3553.0,3176.0,3052.0,2714.0,2910.0,3182.0,3205.0,3172.0,34026.0
Shahdara,6.2,Women getting a post partum check up between 48 hours and 14 days after delivery,TOTAL,1192.0,835.0,962.0,1239.0,1633.0,1024.0,1395.0,1579.0,1279.0,1190.0,1048.0,1084.0,14460.0
Shahdara,6.3,PNC maternal complications attended,TOTAL,4.0,3.0,4.0,40.0,10.0,8.0,6.0,11.0,3.0,45.0,59.0,62.0,255.0
Shahdara,7.1.1,Number of MTPs conducted at Public Institutions up to 12 weeks of pregnancy,TOTAL,61.0,75.0,83.0,94.0,72.0,74.0,57.0,69.0,79.0,63.0,58.0,65.0,850.0
Shahdara,7.1.2,Number of MTPs conducted at Public Institutions for more than 12 weeks of pregnancy,TOTAL,3.0,6.0,10.0,0.0,4.0,8.0,5.0,2.0,18.0,11.0,8.0,15.0,90.0
Shahdara,7.1.3,Total number of MTPs conducted at Public Institutions (sum of items 7.1.1 and 7.1.2),TOTAL,64.0,81.0,93.0,94.0,76.0,82.0,62.0,71.0,97.0,74.0,66.0,80.0,940.0
Shahdara,7.2,Number of MTPs conducted at Private Facilities,TOTAL,32.0,242.0,50.0,128.0,49.0,95.0,79.0,90.0,33.0,142.0,124.0,132.0,1196.0
Shahdara,8.1.a,Number of new cases of RTI/STI in males for which treatment was initiated,TOTAL,98.0,101.0,77.0,79.0,123.0,108.0,139.0,143.0,196.0,653.0,175.0,150.0,2042.0
Shahdara,8.1.b,Number of new cases of RTI/STI in females for which treatment was initiated,TOTAL,1198.0,1332.0,1245.0,1359.0,1384.0,1419.0,1426.0,1576.0,1595.0,1455.0,1961.0,1796.0,17746.0
Shahdara,8.1.c,Total number of new cases of RTI/STI in males and females for which treatment was initiated (sum of items 8.1.a and 8.1.b),TOTAL,1296.0,1433.0,1322.0,1438.0,1507.0,1527.0,1565.0,1719.0,1791.0,2108.0,2136.0,1946.0,19788.0
Shahdara,8.2,Number of suspected RTI/STI cases for whom wet mount test was conducted,TOTAL,1.0,14.0,0.0,0.0,25.0,0.0,34.0,34.0,31.0,0.0,0.0,0.0,139.0
Shahdara,9.1.1.a,Number of NSV (No Scalpel Vasectomy) or Conventional Vasectomy conducted at PHCs,TOTAL,,,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Shahdara,9.1.1.b,Number of NSV or Conventional Vasectomy conducted at CHCs,TOTAL,,,,,0.0,,,,,,,,0.0
Shahdara,9.1.1.c,Number of NSV or Conventional Vasectomy conducted at SDHs or DHs,TOTAL,3.0,1.0,2.0,3.0,2.0,2.0,0.0,0.0,2.0,4.0,3.0,1.0,23.0
Shahdara,9.1.1.d,Number of NSV or Conventional Vasectomy conducted at other State owned public institutions,TOTAL,,,,,,,,,,,,,
Shahdara,9.1.1.e,"Total Number of NSV or Conventional Vasectomy conducted at Public facilities i.e. PHC, CHC, SDH, DH and other State owned public institutions (sum of items from 9.1.1.a to 9.1.1.d)",TOTAL,3.0,1.0,2.0,3.0,2.0,2.0,0.0,0.0,2.0,4.0,3.0,1.0,23.0
Shahdara,9.1.2,Number of NSV or Conventional Vasectomy conducted at Private facilities,TOTAL,5.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,5.0
Shahdara,9.2.1.a,Number of Laparoscopic sterilizations conducted at PHCs,TOTAL,,,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Shahdara,9.2.1.b,Number of Laparoscopic sterilizations conducted at CHCs,TOTAL,0.0,3.0,1.0,11.0,3.0,6.0,3.0,0.0,2.0,,,2.0,31.0
Shahdara,9.2.1.c,Number of Laparoscopic sterilizations conducted at SDHs or DHs,TOTAL,56.0,62.0,48.0,51.0,45.0,44.0,31.0,54.0,73.0,56.0,52.0,44.0,616.0
Shahdara,9.2.1.d,Number of Laparoscopic sterilizations conducted at other State owned public institutions,TOTAL,,,,,,,,,,,,,
Shahdara,9.2.1.e,"Total Number of Laparoscopic sterilizations conducted at Public facilities i.e. PHC, CHC, SDH, DH and other State owned public institutions (sum of items from 9.2.1.a to 9.2.1.d)",TOTAL,56.0,65.0,49.0,62.0,48.0,50.0,34.0,54.0,75.0,56.0,52.0,46.0,647.0
Shahdara,9.2.2,Number of Laparoscopic sterilizations conducted at Private facilities,TOTAL,5.0,58.0,0.0,47.0,1.0,43.0,0.0,52.0,8.0,65.0,81.0,68.0,428.0
Shahdara,9.3.1.a,Number of Mini-lap sterilizations conducted at PHCs,TOTAL,8.0,,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,8.0
Shahdara,9.3.1.b,Number of Mini-lap sterilizations conducted at CHCs,TOTAL,,,,,0.0,,,,,,,,0.0
Shahdara,9.3.1.c,Number of Mini-lap sterilizations conducted at SDHs or DHs,TOTAL,8.0,19.0,13.0,13.0,16.0,8.0,10.0,9.0,19.0,17.0,12.0,24.0,168.0
Shahdara,9.3.1.d,Number of Mini-lap sterilizations conducted at other State owned public institutions,TOTAL,,,,,,,,,,,,,
Shahdara,9.3.1.e,"Total Number of Mini-lap sterilizations conducted at Public facilities i.e. PHC, CHC, SDH, DH and other State owned public institutions (sum of items from 9.3.1.a to 9.3.1.d)",TOTAL,16.0,19.0,13.0,13.0,16.0,8.0,10.0,9.0,19.0,17.0,12.0,24.0,176.0
Shahdara,9.3.2,Number of Mini-lap sterilizations conducted at Private facilities,TOTAL,8.0,0.0,0.0,2.0,0.0,2.0,3.0,1.0,0.0,1.0,0.0,0.0,17.0
Shahdara,9.4.1.a,Number of Post-Partum sterilizations conducted at PHCs,TOTAL,,,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Shahdara,9.4.1.b,Number of Post-Partum sterilizations conducted at CHCs,TOTAL,,,,,0.0,,,,,,,,0.0
Shahdara,9.4.1.c,Number of Post-Partum sterilizations conducted at SDHs or DHs,TOTAL,43.0,75.0,75.0,86.0,82.0,86.0,82.0,34.0,82.0,62.0,49.0,43.0,799.0
Shahdara,9.4.1.d,Number of Post-Partum sterilizations conducted at other State owned public institutions,TOTAL,,,,,,,,,,,,,
Shahdara,9.4.1.e,"Total Number of Post-Partum sterilizations conducted at Public facilities i.e. PHC, CHC, SDH, DH and other State owned public institutions (sum of items from 9.4.1.a to 9.4.1.d)",TOTAL,43.0,75.0,75.0,86.0,82.0,86.0,82.0,34.0,82.0,62.0,49.0,43.0,799.0
Shahdara,9.4.2,Number of Post-Partum sterilizations conducted at Private facilities,TOTAL,9.0,1.0,1.0,0.0,2.0,0.0,3.0,0.0,1.0,0.0,0.0,1.0,18.0
Shahdara,9.5.1.a,Number of IUCD Insertions conducted at SCs,TOTAL,0.0,0.0,6.0,17.0,0.0,0.0,0.0,0.0,0.0,0.0,1.0,8.0,32.0
Shahdara,9.5.1.b,Number of IUCD Insertions conducted at PHCs,TOTAL,90.0,120.0,117.0,222.0,105.0,108.0,83.0,105.0,106.0,93.0,112.0,118.0,1379.0
Shahdara,9.5.1.c,Number of IUCD Insertions conducted at CHCs,TOTAL,46.0,64.0,55.0,136.0,103.0,77.0,41.0,48.0,54.0,18.0,39.0,78.0,759.0
Shahdara,9.5.1.d,Number of IUCD Insertions conducted at SDHs or DHs,TOTAL,402.0,299.0,284.0,352.0,433.0,289.0,439.0,616.0,496.0,583.0,442.0,411.0,5046.0
Shahdara,9.5.1.e,Number of IUCD Insertions conducted at other State owned public institutions,TOTAL,,,,,,,,,,,,,
Shahdara,9.5.1.f,"Total Number of IUCD Insertions conducted at Public facilities i.e. SC, PHC, CHC, SDH, DH and other State owned public institutions (sum of items from 9.5.1.a to 9.5.1.e)",TOTAL,538.0,483.0,462.0,727.0,641.0,474.0,563.0,769.0,656.0,694.0,594.0,615.0,7216.0
Shahdara,9.5.1A,"Out of above total, Post Partum (within 48 hours of delivery) IUCD insertions",TOTAL,58.0,69.0,105.0,83.0,101.0,86.0,450.0,323.0,324.0,428.0,245.0,236.0,2508.0
Shahdara,9.5.2,Number of IUCD Insertions conducted at Private facilities,TOTAL,52.0,29.0,33.0,35.0,16.0,22.0,23.0,26.0,32.0,33.0,30.0,29.0,360.0
Shahdara,9.06,Number of IUCD removals,TOTAL,66.0,73.0,64.0,83.0,46.0,55.0,51.0,68.0,64.0,46.0,52.0,70.0,738.0
Shahdara,9.07,Number of Oral Pills cycles distributed,TOTAL,1172.0,1482.0,1080.0,1739.0,1186.0,1185.0,1706.0,1228.0,1402.0,1421.0,1281.0,1238.0,16120.0
Shahdara,9.08,Number of Condom pieces distributed,TOTAL,25300.0,26673.0,35888.0,65581.0,36632.0,30648.0,28139.0,29790.0,20001.0,22897.0,26262.0,25688.0,373499.0
Shahdara,9.09,Number of Centchroman (weekly) pills given,TOTAL,0.0,17.0,0.0,0.0,101.0,0.0,0.0,0.0,0.0,2.0,0.0,0.0,120.0
Shahdara,9.10,Number of Emergency Contraceptive Pills distributed,TOTAL,16.0,19.0,11.0,49.0,39.0,29.0,31.0,19.0,19.0,8.0,13.0,9.0,262.0
Shahdara,9.11.1.a,Number of cases of complications following male sterilization,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Shahdara,9.11.1.b,Number of cases of complications following female sterilization,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,2.0,0.0,0.0,0.0,2.0,4.0
Shahdara,9.11.2.a,Number of failures following male sterilization,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Shahdara,9.11.2.b,Number of failures following female sterilization,TOTAL,2.0,0.0,0.0,2.0,2.0,4.0,1.0,0.0,0.0,2.0,1.0,2.0,16.0
Shahdara,9.11.3.a,Number of deaths following male sterilization,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Shahdara,9.11.3.b,Number of deaths following female sterilization,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Shahdara,9.12,Number of Institutions having NSV trained doctors,TOTAL,3.0,5.0,5.0,4.0,4.0,4.0,5.0,4.0,6.0,3.0,4.0,4.0,-1.0
Shahdara,10.1.01,Number of Infants (0 to 11 months old)received BCG immunisation,TOTAL,2517.0,2664.0,2634.0,3096.0,3975.0,3352.0,3418.0,3396.0,3409.0,3744.0,3898.0,3746.0,39849.0
Shahdara,10.1.02,Number of Infants (0 to 11 months old) received DPT1 immunisation,TOTAL,450.0,275.0,162.0,180.0,360.0,223.0,217.0,157.0,191.0,262.0,271.0,307.0,3055.0
Shahdara,10.1.03,Number of Infants (0 to 11 months old) received DPT2 immunisation,TOTAL,463.0,298.0,185.0,184.0,341.0,243.0,266.0,210.0,229.0,283.0,283.0,244.0,3229.0
Shahdara,10.1.04,Number of Infants (0 to 11 months old) received DPT3 immunisation,TOTAL,467.0,346.0,241.0,255.0,353.0,257.0,232.0,193.0,219.0,266.0,282.0,247.0,3358.0
Shahdara,10.1.04A,Number of Infants (0 to 11 months old) received Pentavalent1 immunisation,TOTAL,1688.0,1650.0,1456.0,1698.0,1735.0,1751.0,2170.0,2430.0,2443.0,2706.0,2444.0,2056.0,24227.0
Shahdara,10.1.04B,Number of Infants (0 to 11 months old) received Pentavalent2 immunisation,TOTAL,1565.0,1598.0,1389.0,1440.0,1454.0,1328.0,1534.0,1902.0,2154.0,2665.0,2364.0,1822.0,21215.0
Shahdara,10.1.04C,Number of Infants (0 to 11 months old) received Pentavalent3 immunisation,TOTAL,1451.0,1460.0,1432.0,1474.0,1377.0,1202.0,1229.0,1567.0,1788.0,2686.0,2521.0,1785.0,19972.0
Shahdara,10.1.05,Number of Infants (0 to 11 months old) received OPV 0 (Birth Dose),TOTAL,2168.0,2399.0,2357.0,2592.0,3539.0,3440.0,3230.0,3330.0,3196.0,3519.0,3487.0,3446.0,36703.0
Shahdara,10.1.06,Number of Infants (0 to 11 months old) received OPV1 (First Dose),TOTAL,1819.0,1648.0,1325.0,1522.0,1826.0,1729.0,2003.0,2113.0,2273.0,2079.0,2081.0,2001.0,22419.0
Shahdara,10.1.07,Number of Infants (0 to 11 months old) received OPV2 (Second Dose),TOTAL,1813.0,1658.0,1328.0,1392.0,1610.0,1428.0,1618.0,1838.0,2205.0,2128.0,1878.0,1957.0,20853.0
Shahdara,10.1.08,Number of Infants (0 to 11 months old) received OPV3 (Third Dose),TOTAL,1750.0,1580.0,1375.0,1526.0,1540.0,1319.0,1304.0,1549.0,1794.0,1976.0,1869.0,1787.0,19369.0
Shahdara,10.1.09A,Number of Infants (upto 48 hrs of age) received Hepatitis-B0 immunisation,TOTAL,2040.0,2273.0,1742.0,2503.0,3337.0,2987.0,2816.0,3064.0,2879.0,3383.0,3304.0,3092.0,33420.0
Shahdara,10.1.09,Number of Infants (0 to 11 months old) received Hepatitis-B1 immunisation,TOTAL,483.0,253.0,166.0,202.0,334.0,239.0,246.0,187.0,200.0,883.0,891.0,371.0,4455.0
Shahdara,10.1.10,Number of Infants (0 to 11 months old) received Hepatitis-B2 immunisation,TOTAL,476.0,356.0,199.0,203.0,301.0,285.0,227.0,239.0,245.0,876.0,836.0,321.0,4564.0
Shahdara,10.1.11,Number of Infants (0 to 11 months old) received Hepatitis-B3 immunisation,TOTAL,464.0,330.0,201.0,256.0,332.0,258.0,219.0,237.0,182.0,834.0,862.0,1068.0,5243.0
Shahdara,10.1.12,Number of Infants (0 to 11 months old) received Measles immunisation (First Dose),TOTAL,2629.0,2204.0,1950.0,2062.0,2440.0,2000.0,1762.0,2235.0,1860.0,1730.0,1695.0,1702.0,24269.0
Shahdara,10.1.12B,Number of Infants (more than 16 months old) received Measles immunisation (Second Dose),TOTAL,10641.0,1555.0,4098.0,1087.0,470.0,116.0,275.0,28.0,30.0,324.0,432.0,290.0,19346.0
Shahdara,10.1A,No. of Children aged 9 to 12 months who received JE 1st dose,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Shahdara,10.1.13.a,Total number of male children (9 to 11 months old) fully immunised (BCG+DPT123/Pentavalent123+OPV123+Measles) during the month,TOTAL,1297.0,975.0,862.0,975.0,1160.0,974.0,873.0,1131.0,922.0,843.0,787.0,816.0,11615.0
Shahdara,10.1.13.b,Total number of female children (9 to 11 months old) fully immunised (BCG+DPT123/Pentavalent123+OPV123+Measles) during the month,TOTAL,1277.0,916.0,772.0,883.0,1036.0,879.0,830.0,985.0,837.0,778.0,719.0,790.0,10702.0
Shahdara,10.1.13.c,Total number of children (9 to 11 months old) fully immunised (BCG+DPT123/Pentavalent123+OPV123+Measles) during the month (sum of items 10.1.13.a and 10.1.13.b),TOTAL,2574.0,1891.0,1634.0,1858.0,2196.0,1853.0,1703.0,2116.0,1759.0,1621.0,1506.0,1606.0,22317.0
Shahdara,10.2.1,Number of Infants (more than 16 months old) received DPT Booster dose,TOTAL,1601.0,1989.0,1697.0,1493.0,1779.0,1865.0,1456.0,1910.0,2126.0,1598.0,1687.0,1815.0,21016.0
Shahdara,10.2.2,Number of Infants (more than 16 months old) received OPV Booster dose,TOTAL,1580.0,1946.0,1647.0,1469.0,1772.0,1815.0,1408.0,1902.0,2063.0,1531.0,1634.0,1767.0,20534.0
Shahdara,10.2.3,"Number of Infants (more than 16 months old) received Measles, Mumps, Rubella (MMR) Vaccination",TOTAL,473.0,141.0,225.0,50.0,1354.0,1966.0,1477.0,2427.0,2938.0,1893.0,1843.0,1404.0,16191.0
Shahdara,10.3.1.a,Total number of male children (12 to 23 months old) fully immunised (BCG+DPT123/Pentavalent123+OPV123+Measles) during the month,TOTAL,683.0,394.0,900.0,440.0,284.0,500.0,423.0,468.0,511.0,335.0,362.0,401.0,5701.0
Shahdara,10.3.1.b,Total number of female children (12 to 23 months old) fully immunised (BCG+DPT123/Pentavalent123+OPV123+Measles) during the month,TOTAL,655.0,337.0,750.0,378.0,230.0,415.0,344.0,414.0,473.0,307.0,349.0,395.0,5047.0
Shahdara,10.3.1.c,Total number of children (12 to 23 months old) fully immunised (BCG+DPT123+OPV123/Pentavalent123+Measles) during the month (sum of items 10.3.1.a and 10.3.1.b),TOTAL,1338.0,731.0,1650.0,818.0,514.0,915.0,767.0,882.0,984.0,642.0,711.0,796.0,10748.0
Shahdara,10.3.2,Number of children (more than 5 years old) given DT5,TOTAL,576.0,1023.0,687.0,529.0,730.0,784.0,602.0,842.0,934.0,781.0,650.0,847.0,8985.0
Shahdara,10.3.3,Number of children (more than 10 years old) given TT10,TOTAL,227.0,319.0,339.0,201.0,193.0,232.0,303.0,314.0,236.0,247.0,171.0,283.0,3065.0
Shahdara,10.3.4,Number of children (more than 16 years old) given TT16,TOTAL,208.0,188.0,187.0,181.0,229.0,156.0,242.0,215.0,119.0,151.0,118.0,308.0,2302.0
Shahdara,10.3.5.a,Number of cases of Abscess reported following immunisation [Adverse Event Following Immunisation (AEFI)],TOTAL,1.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,1.0
Shahdara,10.3.5.b,Number of cases of Death reported following immunisation [Adverse Event Following Immunisation (AEFI)],TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Shahdara,10.3.5.c,Number of cases of other complications reported following immunisation [Adverse Event Following Immunisation (AEFI)],TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,1.0,0.0,0.0,0.0,1.0
Shahdara,10.4.1,Number of Immunisation sessions planned to be held during the month,TOTAL,547.0,393.0,336.0,325.0,401.0,414.0,439.0,450.0,581.0,477.0,433.0,427.0,5223.0
Shahdara,10.4.2,Number of Immunisation sessions held during the month,TOTAL,539.0,382.0,333.0,316.0,387.0,397.0,422.0,410.0,565.0,453.0,409.0,403.0,5016.0
Shahdara,10.4.3,Number of Immunisation sessions held during the month where ASHAs were present,TOTAL,298.0,186.0,142.0,94.0,166.0,204.0,208.0,155.0,236.0,219.0,197.0,194.0,2299.0
Shahdara,10.5.1,Number of children (more than 16 months old) received Japanese Encephalitis (JE) vaccination,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Shahdara,11.1.1,Number of children (9 months to 5 years old) administered 1st dose of Vitamin A (Dose-1),TOTAL,2819.0,2043.0,1850.0,2090.0,2330.0,1864.0,1817.0,2042.0,1898.0,1637.0,1233.0,1430.0,23053.0
Shahdara,11.1.2,Number of children (9 months to 5 years old) were administered 5th dose of Vitamin A (Dose-5),TOTAL,6549.0,1572.0,1747.0,1252.0,1194.0,1686.0,1437.0,2110.0,1900.0,1423.0,823.0,1033.0,22726.0
Shahdara,11.1.3,Number of children (9 months to 5 years old) administered 9th dose of Vitamin A (Dose-9),TOTAL,2519.0,1086.0,1450.0,566.0,550.0,825.0,688.0,937.0,782.0,667.0,419.0,506.0,10995.0
Shahdara,12.1,Number of cases of Diptheria reported in children below 5 years of age,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Shahdara,12.2,Number of cases of Pertusis reported in children below 5 years of age,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Shahdara,12.3,Number of cases of Tetanus neonatarum reported in children below 5 years of age,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Shahdara,12.4,Number of cases of Tetanus other than neonatarum reported in children below 5 years of age,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Shahdara,12.5,Number of cases of Polio reported in children below 5 years of age,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Shahdara,12.6,Number of cases of Measles reported in children below 5 years of age,TOTAL,14.0,36.0,13.0,0.0,0.0,1.0,0.0,2.0,13.0,9.0,10.0,4.0,102.0
Shahdara,12.7,Number of cases of Diarrhoea and Dehydration reported in children below 5 years of age,TOTAL,970.0,806.0,8630.0,2519.0,560.0,467.0,634.0,690.0,459.0,355.0,521.0,458.0,17069.0
Shahdara,12.8,Number of cases of Malaria reported in children below 5 years of age,TOTAL,0.0,1.0,12.0,24.0,13.0,27.0,7.0,16.0,5.0,0.0,2.0,5.0,112.0
Shahdara,12.9,Number of children below 5 years of age admitted with Respiratory Infections,TOTAL,84.0,419.0,549.0,77.0,70.0,149.0,110.0,217.0,65.0,84.0,116.0,207.0,2147.0
Shahdara,13.1,Number of Patients operated for cataract,TOTAL,174.0,375.0,228.0,418.0,198.0,245.0,268.0,208.0,266.0,226.0,256.0,280.0,3142.0
Shahdara,13.2,Number of Intraocular Lens(IOL) implantations,TOTAL,174.0,375.0,223.0,290.0,177.0,240.0,264.0,176.0,262.0,223.0,255.0,272.0,2931.0
Shahdara,13.3,Number of School children detected with Refractive errors,TOTAL,11.0,18.0,37.0,17.0,27.0,60.0,65.0,63.0,53.0,21.0,26.0,157.0,555.0
Shahdara,13.4,Number of children provided free glasses,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Shahdara,13.5,Number of eyes collected through eye donation,TOTAL,0.0,4.0,3.0,2.0,0.0,0.0,2.0,3.0,4.0,0.0,0.0,0.0,18.0
Shahdara,13.6,Number of eyes utilised for corneal transplant,TOTAL,0.0,4.0,3.0,2.0,0.0,0.0,2.0,3.0,4.0,0.0,0.0,0.0,18.0
Shahdara,14.01,Number of CHC or SDH or DH functioning as First Referral units (FRUs),TOTAL,3.0,4.0,4.0,4.0,4.0,3.0,3.0,4.0,4.0,3.0,2.0,2.0,-1.0
Shahdara,14.02,Number of PHCs functioning 24X7 with atleast 3 Staff Nurses,TOTAL,,,4.0,,,1.0,,,1.0,1.0,,1.0,-1.0
Shahdara,14.03,Number of Anganwadi centres reported to have conducted VHNDs,TOTAL,0.0,3.0,2.0,0.0,0.0,4.0,0.0,0.0,0.0,11.0,23.0,29.0,-1.0
Shahdara,14.04,Number of facilities having a Rogi Kalyan Samiti (RKS),TOTAL,4.0,4.0,4.0,3.0,3.0,3.0,4.0,4.0,5.0,3.0,4.0,4.0,-1.0
Shahdara,14.05,Number of RKS meetings held during the month,TOTAL,0.0,3.0,2.0,1.0,1.0,0.0,1.0,0.0,2.0,1.0,0.0,2.0,13.0
Shahdara,14.06,Number of facilities having Ambulance services (Assured Referral Services),TOTAL,6.0,8.0,7.0,6.0,6.0,8.0,9.0,7.0,10.0,8.0,8.0,8.0,-1.0
Shahdara,14.07,Total Number of times the Ambulance was used for transporting patients during the month,TOTAL,171.0,322.0,307.0,268.0,179.0,150.0,429.0,244.0,418.0,341.0,370.0,101.0,3300.0
Shahdara,14.08,Number of Institutions having Operational Sick New Born and Child Care Units (SNCU),TOTAL,3.0,4.0,3.0,3.0,3.0,3.0,4.0,3.0,2.0,3.0,1.0,2.0,-1.0
Shahdara,14.09,Number of functional Laproscopes in CHC/SDH/DH,TOTAL,4.0,4.0,5.0,5.0,5.0,4.0,5.0,5.0,5.0,4.0,4.0,4.0,-1.0
Shahdara,14.10.1.a,Number of male patients admitted (Inpatients) during the month,1. Children,733.0,900.0,863.0,958.0,898.0,647.0,584.0,846.0,783.0,1565.0,1580.0,1636.0,11993.0
Shahdara,14.10.1.a,Number of male patients admitted (Inpatients) during the month,2. Adults,3251.0,3688.0,3678.0,3737.0,3252.0,3583.0,3054.0,3087.0,3057.0,3980.0,4048.0,4201.0,42616.0
Shahdara,14.10.1.b,Number of female patients (Inpatients) admitted during the month,1. Children,657.0,581.0,744.0,930.0,691.0,584.0,617.0,766.0,772.0,1606.0,1730.0,1792.0,11470.0
Shahdara,14.10.1.b,Number of female patients (Inpatients) admitted during the month,2. Adults,4715.0,5315.0,5190.0,5748.0,5817.0,5779.0,4971.0,5706.0,6092.0,5941.0,5779.0,7348.0,68401.0
Shahdara,14.10.1.c,Total number of patients admitted (Inpatients) during the month (sum of items 14.10.1.a and 14.10.1.b),1. Children,1390.0,1481.0,1607.0,1888.0,1589.0,1231.0,1201.0,1612.0,1555.0,3171.0,3310.0,3428.0,23463.0
Shahdara,14.10.1.c,Total number of patients admitted (Inpatients) during the month (sum of items 14.10.1.a and 14.10.1.b),2. Adults,7966.0,9003.0,8868.0,9485.0,9069.0,9362.0,8025.0,8793.0,9149.0,9921.0,9827.0,11549.0,111017.0
Shahdara,14.10.2.a,Number of death cases of Inpatient males,TOTAL,45.0,32.0,46.0,49.0,46.0,39.0,62.0,32.0,49.0,43.0,38.0,35.0,516.0
Shahdara,14.10.2.b,Number of death cases of Inpatient females,TOTAL,33.0,26.0,41.0,31.0,37.0,30.0,44.0,31.0,40.0,34.0,31.0,32.0,410.0
Shahdara,14.10.2.c,Number of cases of death of Inpatients (sum of items 14.10.2.a and 14.10.2.b),TOTAL,78.0,58.0,87.0,80.0,83.0,69.0,106.0,63.0,89.0,77.0,69.0,67.0,926.0
Shahdara,14.11,In-Patient Head Count at midnight,TOTAL,13195.0,16510.0,17921.0,20829.0,18314.0,14761.0,13100.0,17334.0,17914.0,22623.0,24791.0,24052.0,221344.0
Shahdara,14.12.1,OPD attendance (All),TOTAL,223660.0,356250.0,335047.0,327241.0,313453.0,331542.0,274852.0,329149.0,279250.0,268494.0,294485.0,335915.0,3669338.0
Shahdara,14.13.1,Number of major operations carried out using general or spinal anaesthesia,TOTAL,913.0,1191.0,983.0,1091.0,823.0,954.0,984.0,1027.0,1246.0,1526.0,1405.0,1427.0,13570.0
Shahdara,14.13.1A,"Out of 14.13.1,Gynecology- Hysterectomy surgeries",TOTAL,90.0,175.0,135.0,169.0,164.0,156.0,65.0,27.0,73.0,80.0,54.0,32.0,1220.0
Shahdara,14.13.2,Number of minor operations carried out without anaesthesia or using local anaesthesia,TOTAL,985.0,844.0,1476.0,1359.0,1121.0,562.0,499.0,931.0,1159.0,789.0,748.0,1244.0,11717.0
Shahdara,14.14.a,Number of patients given AYUSH treatment,TOTAL,5185.0,6294.0,5961.0,4134.0,5845.0,6762.0,6141.0,6076.0,10495.0,12145.0,12438.0,12715.0,94191.0
Shahdara,14.14.b,Number of patients on whom Dental Procedure was conducted,TOTAL,1717.0,2211.0,1930.0,534.0,1680.0,1767.0,1782.0,951.0,786.0,664.0,662.0,798.0,15482.0
Shahdara,14.14.c,Number of Adolescents counselled,TOTAL,220.0,209.0,255.0,359.0,273.0,301.0,175.0,216.0,143.0,189.0,133.0,167.0,2640.0
Shahdara,15.1.1.a,Number of Haemoglobin (Hb) tests conducted,TOTAL,13776.0,18763.0,17964.0,16944.0,15431.0,18255.0,15811.0,18403.0,22384.0,14775.0,16049.0,16428.0,204983.0
Shahdara,15.1.1.b,"Out of the total number of Hb tests conducted, number of cases having Hb less than 7gm/dl",TOTAL,763.0,774.0,998.0,829.0,536.0,706.0,557.0,600.0,689.0,717.0,434.0,462.0,8065.0
Shahdara,15.1.2.a,Number of HIV tests conducted on males,1. Number tested,665.0,1108.0,1001.0,997.0,873.0,1009.0,918.0,1068.0,1142.0,1447.0,1442.0,1724.0,13394.0
Shahdara,15.1.2.a,Number of HIV tests conducted on males,2. Number Positive,15.0,19.0,19.0,19.0,20.0,20.0,21.0,16.0,18.0,9.0,13.0,13.0,202.0
Shahdara,15.1.2.b,Number of HIV tests conducted on Female-Non ANC (i.e. non pregnant females),1. Number tested,842.0,1290.0,1098.0,1084.0,916.0,861.0,823.0,1122.0,1179.0,1146.0,1095.0,1391.0,12847.0
Shahdara,15.1.2.b,Number of HIV tests conducted on Female-Non ANC (i.e. non pregnant females),2. Number Positive,4.0,8.0,4.0,4.0,5.0,5.0,4.0,11.0,10.0,6.0,9.0,10.0,80.0
Shahdara,15.1.2.c,Number of HIV tests conducted on Female with ANC (i.e. pregnant females),1. Number tested,2348.0,2935.0,2972.0,3220.0,3210.0,3084.0,3018.0,3773.0,4868.0,3414.0,3527.0,3723.0,40092.0
Shahdara,15.1.2.c,Number of HIV tests conducted on Female with ANC (i.e. pregnant females),2. Number Positive,6.0,22.0,19.0,22.0,19.0,27.0,30.0,32.0,25.0,25.0,27.0,36.0,290.0
Shahdara,15.1.2.d,Total number of HIV tests conducted (sum of items 15.1.2.a to 15.1.2.c),1. Number tested,3855.0,5333.0,5071.0,5301.0,4999.0,4954.0,4759.0,5963.0,7189.0,6007.0,6064.0,6838.0,66333.0
Shahdara,15.1.2.d,Total number of HIV tests conducted (sum of items 15.1.2.a to 15.1.2.c),2. Number Positive,25.0,49.0,42.0,45.0,44.0,52.0,55.0,59.0,53.0,40.0,49.0,59.0,572.0
Shahdara,15.2,Number of Widal tests conducted,Number tested,899.0,1351.0,1429.0,1852.0,1653.0,2977.0,1944.0,1495.0,1616.0,1134.0,1201.0,1458.0,19009.0
Shahdara,15.3.a,Number of VDRL tests conducted on males,Number tested,81.0,49.0,45.0,47.0,202.0,123.0,145.0,440.0,409.0,124.0,44.0,218.0,1927.0
Shahdara,15.3.b,Number of VDRL tests conducted on Female-Non ANC (i.e. non pregnant females),Number tested,238.0,178.0,187.0,225.0,196.0,363.0,245.0,369.0,298.0,196.0,191.0,186.0,2872.0
Shahdara,15.3.c,Number of VDRL tests conducted on Female with ANC (i.e. pregnant females),Number tested,804.0,671.0,782.0,872.0,1132.0,1823.0,1130.0,2799.0,2376.0,638.0,358.0,572.0,13957.0
Shahdara,15.3.d,Total number of VDRL tests conducted (sum of items 15.3.a to 15.3.c),Number tested,1123.0,898.0,1014.0,1144.0,1530.0,2309.0,1520.0,3608.0,3083.0,958.0,593.0,976.0,18756.0
Shahdara,15.4.1,Number of blood smears examined for Malaria,TOTAL,1334.0,1786.0,1990.0,2344.0,1870.0,1477.0,8740.0,1998.0,1190.0,846.0,813.0,3215.0,27603.0
Shahdara,15.4.2,"Out of blood smears examined for malaria, number of blood smears tested positive for Plasmodium Vivax",TOTAL,11.0,15.0,34.0,57.0,30.0,13.0,5.0,3.0,20.0,6.0,9.0,6.0,209.0
Shahdara,15.4.3,"Out of blood smears examined for malaria, number of blood smears tested positive for Plasmodium Falciparum",TOTAL,0.0,0.0,4.0,7.0,4.0,2.0,0.0,1.0,2.0,0.0,0.0,1.0,21.0
Shahdara,16.1.1,Stock position of DPT vaccines,1. Balance From Previous Month,1980.0,2450.0,2750.0,1760.0,2360.0,3460.0,980.0,770.0,1980.0,2260.0,3420.0,3430.0,27600.0
Shahdara,16.1.1,Stock position of DPT vaccines,2. Stocks Received,3000.0,3000.0,500.0,3000.0,3000.0,0.0,1500.0,3000.0,3000.0,3000.0,1500.0,2500.0,27000.0
Shahdara,16.1.1,Stock position of DPT vaccines,3. Unusable Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Shahdara,16.1.1,Stock position of DPT vaccines,4. Stock Distributed,2500.0,2700.0,1490.0,2400.0,1900.0,2480.0,1710.0,1790.0,2720.0,1840.0,1490.0,2250.0,25270.0
Shahdara,16.1.1,Stock position of DPT vaccines,5. Total Stock,2480.0,2750.0,1760.0,2360.0,3460.0,980.0,770.0,1980.0,2260.0,3420.0,3430.0,3680.0,29330.0
Shahdara,16.1.1A,Stock Position of Pentavalent,1. Balance From Previous Month,1040.0,1920.0,2610.0,2340.0,2570.0,3390.0,1070.0,1940.0,1390.0,1190.0,1980.0,3340.0,24780.0
Shahdara,16.1.1A,Stock Position of Pentavalent,2. Stocks Received,4000.0,4000.0,1000.0,3000.0,3000.0,0.0,3500.0,3000.0,3500.0,4000.0,4000.0,4000.0,37000.0
Shahdara,16.1.1A,Stock Position of Pentavalent,3. Unusable Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Shahdara,16.1.1A,Stock Position of Pentavalent,4. Stock Distributed,3120.0,3310.0,1270.0,2770.0,2180.0,2320.0,2630.0,3550.0,3700.0,3210.0,2640.0,3430.0,34130.0
Shahdara,16.1.1A,Stock Position of Pentavalent,5. Total Stock,1920.0,2610.0,2340.0,2570.0,3390.0,1070.0,1940.0,1390.0,1190.0,1980.0,3340.0,3910.0,27650.0
Shahdara,16.1.2,Stock position of OPV vaccines,1. Balance From Previous Month,2560.0,3640.0,2660.0,2440.0,3540.0,6460.0,1800.0,3700.0,5400.0,4340.0,6640.0,3120.0,46300.0
Shahdara,16.1.2,Stock position of OPV vaccines,2. Stocks Received,6000.0,5000.0,3000.0,6000.0,7000.0,0.0,6000.0,7000.0,5000.0,7000.0,1000.0,7000.0,60000.0
Shahdara,16.1.2,Stock position of OPV vaccines,3. Unusable Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Shahdara,16.1.2,Stock position of OPV vaccines,4. Stock Distributed,4920.0,5980.0,3220.0,4900.0,4080.0,4660.0,4100.0,5300.0,6060.0,4640.0,4400.0,4720.0,56980.0
Shahdara,16.1.2,Stock position of OPV vaccines,5. Total Stock,3640.0,2660.0,2440.0,3540.0,6460.0,1800.0,3700.0,5400.0,4340.0,6700.0,3240.0,5400.0,49320.0
Shahdara,16.1.3,Stock position of TT vaccines,1. Balance From Previous Month,570.0,1540.0,2560.0,1240.0,3020.0,3820.0,2100.0,2290.0,2050.0,1350.0,1460.0,5370.0,27370.0
Shahdara,16.1.3,Stock position of TT vaccines,2. Stocks Received,2500.0,3500.0,0.0,3500.0,2500.0,0.0,2000.0,2000.0,1000.0,2000.0,5000.0,0.0,24000.0
Shahdara,16.1.3,Stock position of TT vaccines,3. Unusable Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Shahdara,16.1.3,Stock position of TT vaccines,4. Stock Distributed,1530.0,2480.0,1320.0,1720.0,1700.0,1720.0,1810.0,2240.0,1700.0,1890.0,1090.0,1230.0,20430.0
Shahdara,16.1.3,Stock position of TT vaccines,5. Total Stock,1540.0,2560.0,1240.0,3020.0,3820.0,2100.0,2290.0,2050.0,1350.0,1460.0,5370.0,4140.0,30940.0
Shahdara,16.1.4,Stock position of DT vaccines,1. Balance From Previous Month,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Shahdara,16.1.4,Stock position of DT vaccines,2. Stocks Received,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Shahdara,16.1.4,Stock position of DT vaccines,3. Unusable Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Shahdara,16.1.4,Stock position of DT vaccines,4. Stock Distributed,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Shahdara,16.1.4,Stock position of DT vaccines,5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Shahdara,16.1.5,Stock position of BCG vaccines,1. Balance From Previous Month,1200.0,1990.0,2020.0,1400.0,2890.0,2520.0,1370.0,1630.0,1840.0,1540.0,1270.0,1510.0,21180.0
Shahdara,16.1.5,Stock position of BCG vaccines,2. Stocks Received,2000.0,2000.0,0.0,2500.0,1000.0,0.0,1500.0,2000.0,1000.0,1000.0,1500.0,1500.0,16000.0
Shahdara,16.1.5,Stock position of BCG vaccines,3. Unusable Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Shahdara,16.1.5,Stock position of BCG vaccines,4. Stock Distributed,1240.0,1970.0,620.0,1010.0,1370.0,1150.0,1240.0,1790.0,1300.0,1200.0,1260.0,1170.0,15320.0
Shahdara,16.1.5,Stock position of BCG vaccines,5. Total Stock,1960.0,2020.0,1400.0,2890.0,2520.0,1370.0,1630.0,1840.0,1540.0,1340.0,1510.0,1840.0,21860.0
Shahdara,16.1.6,Stock position of Measles vaccines,1. Balance From Previous Month,1995.0,3340.0,900.0,0.0,3100.0,2840.0,1160.0,1185.0,2250.0,2215.0,2950.0,3790.0,25725.0
Shahdara,16.1.6,Stock position of Measles vaccines,2. Stocks Received,23975.0,0.0,4000.0,6000.0,1500.0,0.0,1500.0,3000.0,2000.0,2000.0,2000.0,500.0,46475.0
Shahdara,16.1.6,Stock position of Measles vaccines,3. Unusable Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Shahdara,16.1.6,Stock position of Measles vaccines,4. Stock Distributed,22750.0,2440.0,4900.0,2900.0,1760.0,1680.0,1475.0,1935.0,2035.0,1265.0,1160.0,1595.0,45895.0
Shahdara,16.1.6,Stock position of Measles vaccines,5. Total Stock,3220.0,900.0,0.0,3100.0,2840.0,1160.0,1185.0,2250.0,2215.0,2950.0,3790.0,2695.0,26305.0
Shahdara,16.1.7,Stock position of JE vaccines,1. Balance From Previous Month,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,,0.0
Shahdara,16.1.7,Stock position of JE vaccines,2. Stocks Received,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,,0.0
Shahdara,16.1.7,Stock position of JE vaccines,3. Unusable Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,,,0.0
Shahdara,16.1.7,Stock position of JE vaccines,4. Stock Distributed,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,,0.0
Shahdara,16.1.7,Stock position of JE vaccines,5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Shahdara,16.1.8,Stock position of Hepatitis B vaccines,1. Balance From Previous Month,1690.0,2050.0,1600.0,1130.0,1600.0,1890.0,1290.0,1390.0,1520.0,990.0,1320.0,1270.0,17740.0
Shahdara,16.1.8,Stock position of Hepatitis B vaccines,2. Stocks Received,1000.0,0.0,0.0,1000.0,600.0,0.0,600.0,600.0,0.0,600.0,0.0,0.0,4400.0
Shahdara,16.1.8,Stock position of Hepatitis B vaccines,3. Unusable Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Shahdara,16.1.8,Stock position of Hepatitis B vaccines,4. Stock Distributed,640.0,450.0,470.0,530.0,310.0,600.0,500.0,470.0,530.0,270.0,50.0,300.0,5120.0
Shahdara,16.1.8,Stock position of Hepatitis B vaccines,5. Total Stock,2050.0,1600.0,1130.0,1600.0,1890.0,1290.0,1390.0,1520.0,990.0,1320.0,1270.0,970.0,17020.0
Shahdara,16.2.1,Stock Position of IU 380 A (to be used for Family Planning),1. Balance From Previous Month,235.0,717.0,612.0,590.0,870.0,840.0,805.0,805.0,795.0,790.0,690.0,650.0,8399.0
Shahdara,16.2.1,Stock Position of IU 380 A (to be used for Family Planning),2. Stocks Received,600.0,0.0,0.0,300.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,900.0
Shahdara,16.2.1,Stock Position of IU 380 A (to be used for Family Planning),3. Unusable Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,10.0,0.0,0.0,0.0,0.0,10.0
Shahdara,16.2.1,Stock Position of IU 380 A (to be used for Family Planning),4. Stock Distributed,118.0,105.0,22.0,20.0,30.0,35.0,0.0,0.0,5.0,100.0,40.0,50.0,525.0
Shahdara,16.2.1,Stock Position of IU 380 A (to be used for Family Planning),5. Total Stock,717.0,612.0,590.0,870.0,840.0,805.0,805.0,795.0,790.0,690.0,650.0,600.0,8764.0
Shahdara,16.2.2,Stock Position of Condoms (to be used for Family Planning),1. Balance From Previous Month,0.0,3000.0,0.0,0.0,6500.0,500.0,0.0,0.0,0.0,37000.0,26000.0,20500.0,93500.0
Shahdara,16.2.2,Stock Position of Condoms (to be used for Family Planning),2. Stocks Received,12000.0,18000.0,0.0,42000.0,0.0,0.0,0.0,0.0,42000.0,0.0,0.0,60000.0,174000.0
Shahdara,16.2.2,Stock Position of Condoms (to be used for Family Planning),3. Unusable Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Shahdara,16.2.2,Stock Position of Condoms (to be used for Family Planning),4. Stock Distributed,9000.0,21000.0,0.0,35500.0,6000.0,500.0,0.0,0.0,5000.0,11000.0,5500.0,19000.0,112500.0
Shahdara,16.2.2,Stock Position of Condoms (to be used for Family Planning),5. Total Stock,3000.0,0.0,0.0,6500.0,500.0,0.0,0.0,0.0,37000.0,26000.0,20500.0,61500.0,155000.0
Shahdara,16.2.3,Stock Position of Oral Contraceptive (to be used for Family Planning),1. Balance From Previous Month,778.0,1158.0,588.0,233.0,983.0,883.0,773.0,648.0,648.0,568.0,168.0,0.0,7428.0
Shahdara,16.2.3,Stock Position of Oral Contraceptive (to be used for Family Planning),2. Stocks Received,500.0,0.0,0.0,1000.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,1000.0,2500.0
Shahdara,16.2.3,Stock Position of Oral Contraceptive (to be used for Family Planning),3. Unusable Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Shahdara,16.2.3,Stock Position of Oral Contraceptive (to be used for Family Planning),4. Stock Distributed,120.0,570.0,355.0,250.0,100.0,110.0,125.0,0.0,80.0,400.0,168.0,40.0,2318.0
Shahdara,16.2.3,Stock Position of Oral Contraceptive (to be used for Family Planning),5. Total Stock,1158.0,588.0,233.0,983.0,883.0,773.0,648.0,648.0,568.0,168.0,0.0,960.0,7610.0
Shahdara,16.2.4,Stock Position of Emergency Contraceptive (to be used for Family Planning),1. Balance From Previous Month,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Shahdara,16.2.4,Stock Position of Emergency Contraceptive (to be used for Family Planning),2. Stocks Received,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,150.0,150.0
Shahdara,16.2.4,Stock Position of Emergency Contraceptive (to be used for Family Planning),3. Unusable Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Shahdara,16.2.4,Stock Position of Emergency Contraceptive (to be used for Family Planning),4. Stock Distributed,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Shahdara,16.2.4,Stock Position of Emergency Contraceptive (to be used for Family Planning),5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,150.0,150.0
Shahdara,16.2.5,Stock Position of Tubal Rings (to be used for Family Planning),1. Balance From Previous Month,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Shahdara,16.2.5,Stock Position of Tubal Rings (to be used for Family Planning),2. Stocks Received,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Shahdara,16.2.5,Stock Position of Tubal Rings (to be used for Family Planning),3. Unusable Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Shahdara,16.2.5,Stock Position of Tubal Rings (to be used for Family Planning),4. Stock Distributed,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Shahdara,16.2.5,Stock Position of Tubal Rings (to be used for Family Planning),5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Shahdara,16.3.01,Stock Position of Oxytocin Injection,1. Balance From Previous Month,0.0,0.0,0.0,0.0,0.0,0.0,0.0,,0.0,0.0,0.0,0.0,0.0
Shahdara,16.3.01,Stock Position of Oxytocin Injection,2. Stocks Received,0.0,0.0,0.0,0.0,0.0,0.0,0.0,,0.0,0.0,0.0,0.0,0.0
Shahdara,16.3.01,Stock Position of Oxytocin Injection,3. Unusable Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,,0.0,0.0,0.0,0.0,0.0
Shahdara,16.3.01,Stock Position of Oxytocin Injection,4. Stock Distributed,0.0,0.0,0.0,0.0,0.0,0.0,0.0,,0.0,0.0,0.0,0.0,0.0
Shahdara,16.3.01,Stock Position of Oxytocin Injection,5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Shahdara,16.3.02,Stock Position of Gloves,1. Balance From Previous Month,0.0,0.0,0.0,0.0,0.0,0.0,0.0,,0.0,0.0,0.0,0.0,0.0
Shahdara,16.3.02,Stock Position of Gloves,2. Stocks Received,0.0,0.0,0.0,0.0,0.0,0.0,0.0,,0.0,0.0,0.0,0.0,0.0
Shahdara,16.3.02,Stock Position of Gloves,3. Unusable Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,,0.0,0.0,0.0,0.0,0.0
Shahdara,16.3.02,Stock Position of Gloves,4. Stock Distributed,0.0,0.0,0.0,0.0,0.0,0.0,0.0,,0.0,0.0,0.0,0.0,0.0
Shahdara,16.3.02,Stock Position of Gloves,5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Shahdara,16.3.03,Stock Position of MVA Syringes,1. Balance From Previous Month,0.0,0.0,0.0,0.0,0.0,0.0,0.0,,0.0,0.0,0.0,0.0,0.0
Shahdara,16.3.03,Stock Position of MVA Syringes,2. Stocks Received,0.0,0.0,0.0,0.0,0.0,0.0,0.0,,0.0,0.0,0.0,0.0,0.0
Shahdara,16.3.03,Stock Position of MVA Syringes,3. Unusable Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,,0.0,0.0,0.0,0.0,0.0
Shahdara,16.3.03,Stock Position of MVA Syringes,4. Stock Distributed,0.0,0.0,0.0,0.0,0.0,0.0,0.0,,0.0,0.0,0.0,0.0,0.0
Shahdara,16.3.03,Stock Position of MVA Syringes,5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Shahdara,16.3.04,Stock Position of Fluconazole Tablets,1. Balance From Previous Month,0.0,0.0,0.0,0.0,0.0,0.0,0.0,,0.0,0.0,0.0,0.0,0.0
Shahdara,16.3.04,Stock Position of Fluconazole Tablets,2. Stocks Received,0.0,0.0,0.0,0.0,0.0,0.0,0.0,,0.0,0.0,0.0,0.0,0.0
Shahdara,16.3.04,Stock Position of Fluconazole Tablets,3. Unusable Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,,0.0,0.0,0.0,0.0,0.0
Shahdara,16.3.04,Stock Position of Fluconazole Tablets,4. Stock Distributed,0.0,0.0,0.0,0.0,0.0,0.0,0.0,,0.0,0.0,0.0,0.0,0.0
Shahdara,16.3.04,Stock Position of Fluconazole Tablets,5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Shahdara,16.3.05,Stock Position of Blood Transfusion Sets,1. Balance From Previous Month,0.0,0.0,0.0,0.0,0.0,0.0,0.0,,0.0,0.0,0.0,0.0,0.0
Shahdara,16.3.05,Stock Position of Blood Transfusion Sets,2. Stocks Received,0.0,0.0,0.0,0.0,0.0,0.0,0.0,,0.0,0.0,0.0,0.0,0.0
Shahdara,16.3.05,Stock Position of Blood Transfusion Sets,3. Unusable Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,,0.0,0.0,0.0,0.0,0.0
Shahdara,16.3.05,Stock Position of Blood Transfusion Sets,4. Stock Distributed,0.0,0.0,0.0,0.0,0.0,0.0,0.0,,0.0,0.0,0.0,0.0,0.0
Shahdara,16.3.05,Stock Position of Blood Transfusion Sets,5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Shahdara,16.3.06,Stock Position of Gluteraldehyde solution of 2% concentration,1. Balance From Previous Month,0.0,0.0,0.0,0.0,0.0,0.0,0.0,,0.0,0.0,0.0,0.0,0.0
Shahdara,16.3.06,Stock Position of Gluteraldehyde solution of 2% concentration,2. Stocks Received,0.0,0.0,0.0,0.0,0.0,0.0,0.0,,0.0,0.0,0.0,0.0,0.0
Shahdara,16.3.06,Stock Position of Gluteraldehyde solution of 2% concentration,3. Unusable Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,,0.0,0.0,0.0,0.0,0.0
Shahdara,16.3.06,Stock Position of Gluteraldehyde solution of 2% concentration,4. Stock Distributed,0.0,0.0,0.0,0.0,0.0,0.0,0.0,,0.0,0.0,0.0,0.0,0.0
Shahdara,16.3.06,Stock Position of Gluteraldehyde solution of 2% concentration,5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Shahdara,16.3.07,Stock Position of IFA Tablets,1. Balance From Previous Month,67500.0,81500.0,51500.0,25500.0,7000.0,0.0,0.0,,0.0,0.0,0.0,0.0,233000.0
Shahdara,16.3.07,Stock Position of IFA Tablets,2. Stocks Received,20000.0,0.0,0.0,0.0,0.0,0.0,0.0,,0.0,0.0,0.0,0.0,20000.0
Shahdara,16.3.07,Stock Position of IFA Tablets,3. Unusable Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,,0.0,0.0,0.0,0.0,0.0
Shahdara,16.3.07,Stock Position of IFA Tablets,4. Stock Distributed,6000.0,30000.0,26000.0,18500.0,7000.0,0.0,0.0,,0.0,0.0,0.0,0.0,87500.0
Shahdara,16.3.07,Stock Position of IFA Tablets,5. Total Stock,81500.0,51500.0,25500.0,7000.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,165500.0
Shahdara,16.3.08,Stock Position of IFA Syrup (Paediatric),1. Balance From Previous Month,0.0,0.0,0.0,0.0,0.0,0.0,0.0,,0.0,0.0,0.0,0.0,0.0
Shahdara,16.3.08,Stock Position of IFA Syrup (Paediatric),2. Stocks Received,0.0,0.0,0.0,0.0,0.0,0.0,0.0,,0.0,0.0,0.0,0.0,0.0
Shahdara,16.3.08,Stock Position of IFA Syrup (Paediatric),3. Unusable Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,,0.0,0.0,0.0,0.0,0.0
Shahdara,16.3.08,Stock Position of IFA Syrup (Paediatric),4. Stock Distributed,0.0,0.0,0.0,0.0,0.0,0.0,0.0,,0.0,0.0,0.0,0.0,0.0
Shahdara,16.3.08,Stock Position of IFA Syrup (Paediatric),5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Shahdara,16.3.09,Stock Position of Paediatrics Antibiotics (Cotrimaxozole and Injectable Gentamicin),1. Balance From Previous Month,0.0,0.0,0.0,0.0,0.0,0.0,0.0,,0.0,0.0,0.0,0.0,0.0
Shahdara,16.3.09,Stock Position of Paediatrics Antibiotics (Cotrimaxozole and Injectable Gentamicin),2. Stocks Received,0.0,0.0,0.0,0.0,0.0,0.0,0.0,,0.0,0.0,0.0,0.0,0.0
Shahdara,16.3.09,Stock Position of Paediatrics Antibiotics (Cotrimaxozole and Injectable Gentamicin),3. Unusable Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,,0.0,0.0,0.0,0.0,0.0
Shahdara,16.3.09,Stock Position of Paediatrics Antibiotics (Cotrimaxozole and Injectable Gentamicin),4. Stock Distributed,0.0,0.0,0.0,0.0,0.0,0.0,0.0,,0.0,0.0,0.0,0.0,0.0
Shahdara,16.3.09,Stock Position of Paediatrics Antibiotics (Cotrimaxozole and Injectable Gentamicin),5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Shahdara,16.3.10,Stock Position of Vitamin A solution,1. Balance From Previous Month,82.0,167.0,220.0,234.0,195.0,147.0,106.0,,220.0,216.0,155.0,87.0,1829.0
Shahdara,16.3.10,Stock Position of Vitamin A solution,2. Stocks Received,300.0,200.0,100.0,0.0,0.0,0.0,100.0,,0.0,0.0,0.0,200.0,900.0
Shahdara,16.3.10,Stock Position of Vitamin A solution,3. Unusable Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,,0.0,0.0,0.0,0.0,0.0
Shahdara,16.3.10,Stock Position of Vitamin A solution,4. Stock Distributed,205.0,147.0,86.0,39.0,48.0,41.0,149.0,,4.0,61.0,68.0,56.0,904.0
Shahdara,16.3.10,Stock Position of Vitamin A solution,5. Total Stock,177.0,220.0,234.0,195.0,147.0,106.0,57.0,0.0,216.0,155.0,87.0,231.0,1825.0
Shahdara,16.3.11,Stock of ORS (New WHO formulation),1. Balance From Previous Month,2175.0,1675.0,10425.0,6925.0,11400.0,8400.0,7400.0,,5900.0,5900.0,5900.0,5900.0,72000.0
Shahdara,16.3.11,Stock of ORS (New WHO formulation),2. Stocks Received,0.0,40000.0,0.0,20000.0,4000.0,0.0,0.0,,0.0,0.0,0.0,0.0,64000.0
Shahdara,16.3.11,Stock of ORS (New WHO formulation),3. Unusable Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,,0.0,0.0,0.0,0.0,0.0
Shahdara,16.3.11,Stock of ORS (New WHO formulation),4. Stock Distributed,500.0,31250.0,3500.0,15525.0,7000.0,1000.0,1000.0,,0.0,0.0,0.0,500.0,60275.0
Shahdara,16.3.11,Stock of ORS (New WHO formulation),5. Total Stock,1675.0,10425.0,6925.0,11400.0,8400.0,7400.0,6400.0,0.0,5900.0,5900.0,5900.0,5400.0,75725.0
Shahdara,16.4.1,Stock Position of 0.1 ml Syringes(AD),1. Balance From Previous Month,1440.0,2480.0,2450.0,2170.0,1800.0,1550.0,1080.0,,1390.0,2902.0,2172.0,3512.0,22946.0
Shahdara,16.4.1,Stock Position of 0.1 ml Syringes(AD),2. Stocks Received,2000.0,600.0,0.0,0.0,0.0,0.0,1400.0,,2000.0,0.0,2000.0,0.0,8000.0
Shahdara,16.4.1,Stock Position of 0.1 ml Syringes(AD),3. Unusable Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,,0.0,0.0,0.0,0.0,0.0
Shahdara,16.4.1,Stock Position of 0.1 ml Syringes(AD),4. Stock Distributed,760.0,630.0,280.0,370.0,250.0,470.0,400.0,,488.0,430.0,660.0,500.0,5238.0
Shahdara,16.4.1,Stock Position of 0.1 ml Syringes(AD),5. Total Stock,2680.0,2450.0,2170.0,1800.0,1550.0,1080.0,2080.0,0.0,2902.0,2472.0,3512.0,3012.0,25708.0
Shahdara,16.4.2,Stock Position of 0.5 ml Syringes(AD),1. Balance From Previous Month,14050.0,3050.0,19650.0,17450.0,15850.0,19650.0,9250.0,,9050.0,11050.0,19050.0,24650.0,162750.0
Shahdara,16.4.2,Stock Position of 0.5 ml Syringes(AD),2. Stocks Received,34000.0,32000.0,10000.0,10000.0,10000.0,0.0,16000.0,,14000.0,14000.0,10000.0,3600.0,153600.0
Shahdara,16.4.2,Stock Position of 0.5 ml Syringes(AD),3. Unusable Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,,0.0,0.0,0.0,0.0,0.0
Shahdara,16.4.2,Stock Position of 0.5 ml Syringes(AD),4. Stock Distributed,45300.0,15400.0,12200.0,11600.0,6200.0,10400.0,6400.0,,12000.0,6000.0,4400.0,11850.0,141750.0
Shahdara,16.4.2,Stock Position of 0.5 ml Syringes(AD),5. Total Stock,2750.0,19650.0,17450.0,15850.0,19650.0,9250.0,18850.0,0.0,11050.0,19050.0,24650.0,16400.0,174600.0
Shahdara,16.4.3,Stock Position of 5.0 ml Syringes(Disposable),1. Balance From Previous Month,1495.0,1295.0,3295.0,2495.0,2095.0,1495.0,1295.0,,2695.0,1895.0,1995.0,1795.0,21845.0
Shahdara,16.4.3,Stock Position of 5.0 ml Syringes(Disposable),2. Stocks Received,1000.0,2400.0,0.0,0.0,0.0,0.0,0.0,,0.0,500.0,0.0,2400.0,6300.0
Shahdara,16.4.3,Stock Position of 5.0 ml Syringes(Disposable),3. Unusable Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,,0.0,0.0,0.0,0.0,0.0
Shahdara,16.4.3,Stock Position of 5.0 ml Syringes(Disposable),4. Stock Distributed,1200.0,400.0,800.0,400.0,600.0,200.0,200.0,,800.0,400.0,200.0,1100.0,6300.0
Shahdara,16.4.3,Stock Position of 5.0 ml Syringes(Disposable),5. Total Stock,1295.0,3295.0,2495.0,2095.0,1495.0,1295.0,1095.0,0.0,1895.0,1995.0,1795.0,3095.0,21845.0
Shahdara,17.1,Number of cases of Infant deaths within 24 hrs of birth,TOTAL,,,,1.0,1.0,,,,,1.0,1.0,,4.0
Shahdara,17.2.1,Number of cases of Infant deaths 24 hours to 4 weeks of birth with the probable cause being Sepsis,1. Up to 1 Weeks of Birth,4.0,,,,1.0,,,1.0,1.0,,2.0,2.0,11.0
Shahdara,17.2.1,Number of cases of Infant deaths 24 hours to 4 weeks of birth with the probable cause being Sepsis,2. Between 1 week & 4 weeks of birth,,,,,,,,,,1.0,,,1.0
Shahdara,17.2.1,Number of cases of Infant deaths 24 hours to 4 weeks of birth with the probable cause being Sepsis,3. Total,4.0,,,,1.0,,,1.0,1.0,1.0,2.0,2.0,12.0
Shahdara,17.2.2,Number of cases of Infant deaths 24 hours to 4 weeks of birth with the probable cause being Asphyxia,1. Up to 1 Weeks of Birth,2.0,,,1.0,,,,,2.0,,1.0,,6.0
Shahdara,17.2.2,Number of cases of Infant deaths 24 hours to 4 weeks of birth with the probable cause being Asphyxia,2. Between 1 week & 4 weeks of birth,,,,,,,,,,,,,
Shahdara,17.2.2,Number of cases of Infant deaths 24 hours to 4 weeks of birth with the probable cause being Asphyxia,3. Total,2.0,,,1.0,,,,,2.0,,1.0,,6.0
Shahdara,17.2.3,Number of cases of Infant deaths 24 hours to 4 weeks of birth with the probable cause being LBW,1. Up to 1 Weeks of Birth,,2.0,2.0,1.0,,1.0,1.0,,2.0,1.0,,1.0,11.0
Shahdara,17.2.3,Number of cases of Infant deaths 24 hours to 4 weeks of birth with the probable cause being LBW,2. Between 1 week & 4 weeks of birth,,,,1.0,,,,,,,,,1.0
Shahdara,17.2.3,Number of cases of Infant deaths 24 hours to 4 weeks of birth with the probable cause being LBW,3. Total,,2.0,2.0,2.0,,1.0,1.0,,2.0,1.0,,1.0,12.0
Shahdara,17.2.4,"Number of cases of Infant deaths 24 hours to 4 weeks of birth with the probable cause being other than Sepsis, Asphyxia and LBW",1. Up to 1 Weeks of Birth,,,1.0,,,,,,,,,1.0,2.0
Shahdara,17.2.4,"Number of cases of Infant deaths 24 hours to 4 weeks of birth with the probable cause being other than Sepsis, Asphyxia and LBW",2. Between 1 week & 4 weeks of birth,,1.0,,,,,,,,,,,1.0
Shahdara,17.2.4,"Number of cases of Infant deaths 24 hours to 4 weeks of birth with the probable cause being other than Sepsis, Asphyxia and LBW",3. Total,,1.0,1.0,,,,,,,,,1.0,3.0
Shahdara,17.3.1,Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being Pneumonia,1. Between 1 month and 11 months,,,,,1.0,,,,1.0,,,,2.0
Shahdara,17.3.1,Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being Pneumonia,2. Between 1 year & 5 years,,,,,,,,,,,,,
Shahdara,17.3.1,Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being Pneumonia,3. Total,,,,,1.0,,,,1.0,,,,2.0
Shahdara,17.3.2,Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being Diarrhoea,1. Between 1 month and 11 months,1.0,,,,,,,,,,,,1.0
Shahdara,17.3.2,Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being Diarrhoea,2. Between 1 year & 5 years,,,,,,,,,,,,,
Shahdara,17.3.2,Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being Diarrhoea,3. Total,1.0,,,,,,,,,,,,1.0
Shahdara,17.3.3,Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being Fever related,1. Between 1 month and 11 months,,,,1.0,,,1.0,,,,,,2.0
Shahdara,17.3.3,Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being Fever related,2. Between 1 year & 5 years,,,2.0,,,,,1.0,,,,,3.0
Shahdara,17.3.3,Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being Fever related,3. Total,,,2.0,1.0,,,1.0,1.0,,,,,5.0
Shahdara,17.3.4,Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being Measles,1. Between 1 month and 11 months,,,,,,,,,,,,,
Shahdara,17.3.4,Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being Measles,2. Between 1 year & 5 years,,,,,,,,,,,,,
Shahdara,17.3.4,Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being Measles,3. Total,,,,,,,,,,,,,
Shahdara,17.3.5,"Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being other than Pneumonia, Diarrhoea, Fever related and Measles",1. Between 1 month and 11 months,,,1.0,1.0,,,,1.0,,2.0,,,5.0
Shahdara,17.3.5,"Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being other than Pneumonia, Diarrhoea, Fever related and Measles",2. Between 1 year & 5 years,,,,,,,1.0,,,,,3.0,4.0
Shahdara,17.3.5,"Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being other than Pneumonia, Diarrhoea, Fever related and Measles",3. Total,,,1.0,1.0,,,1.0,1.0,,2.0,,3.0,9.0
Shahdara,17.4.1,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Diarrhoeal diseases,1. 6-14 yrs,,,,,,,,,,,,,
Shahdara,17.4.1,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Diarrhoeal diseases,2. 15-55 yrs.,,,,,3.0,,,,,,,,3.0
Shahdara,17.4.1,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Diarrhoeal diseases,3. Above 55 yrs.,1.0,,,,,,,,,,,,1.0
Shahdara,17.4.1,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Diarrhoeal diseases,4. Total,1.0,,,,3.0,,,,,,,,4.0
Shahdara,17.4.2,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Tuberculosis,1. 6-14 yrs,,,,,,,1.0,,,,,,1.0
Shahdara,17.4.2,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Tuberculosis,2. 15-55 yrs.,1.0,,3.0,,1.0,,,1.0,,,,,6.0
Shahdara,17.4.2,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Tuberculosis,3. Above 55 yrs.,,,,,1.0,,3.0,,,,,,4.0
Shahdara,17.4.2,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Tuberculosis,4. Total,1.0,,3.0,,2.0,,4.0,1.0,,,,,11.0
Shahdara,17.4.3,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Respiratory diseases including infections,1. 6-14 yrs,,,,,,,,,1.0,,,,1.0
Shahdara,17.4.3,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Respiratory diseases including infections,2. 15-55 yrs.,6.0,1.0,2.0,1.0,3.0,2.0,5.0,4.0,4.0,3.0,4.0,2.0,37.0
Shahdara,17.4.3,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Respiratory diseases including infections,3. Above 55 yrs.,7.0,5.0,,2.0,6.0,7.0,8.0,4.0,7.0,2.0,10.0,5.0,63.0
Shahdara,17.4.3,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Respiratory diseases including infections,4. Total,13.0,6.0,2.0,3.0,9.0,9.0,13.0,8.0,12.0,5.0,14.0,7.0,101.0
Shahdara,17.4.4,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Malaria,1. 6-14 yrs,,,,,,,,,,,,,
Shahdara,17.4.4,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Malaria,2. 15-55 yrs.,,,1.0,,,,,,,,,,1.0
Shahdara,17.4.4,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Malaria,3. Above 55 yrs.,,,,,,,,,,,,,
Shahdara,17.4.4,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Malaria,4. Total,,,1.0,,,,,,,,,,1.0
Shahdara,17.4.5,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being other Fever related,1. 6-14 yrs,,,,,,,,,,,,,
Shahdara,17.4.5,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being other Fever related,2. 15-55 yrs.,,,,,2.0,1.0,2.0,,1.0,2.0,,,8.0
Shahdara,17.4.5,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being other Fever related,3. Above 55 yrs.,,1.0,,,,,,,1.0,1.0,,,3.0
Shahdara,17.4.5,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being other Fever related,4. Total,,1.0,,,2.0,1.0,2.0,,2.0,3.0,,,11.0
Shahdara,17.4.6,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being HIV/AIDS,1. 6-14 yrs,,,,,,,,,,,,,
Shahdara,17.4.6,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being HIV/AIDS,2. 15-55 yrs.,,,,,,,,,,,,,
Shahdara,17.4.6,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being HIV/AIDS,3. Above 55 yrs.,,,,,,,,,,,,,
Shahdara,17.4.6,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being HIV/AIDS,4. Total,,,,,,,,,,,,,
Shahdara,17.4.7,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Heart disease or related to Hypertension,1. 6-14 yrs,,,,,,,,,,,,,
Shahdara,17.4.7,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Heart disease or related to Hypertension,2. 15-55 yrs.,7.0,2.0,6.0,4.0,3.0,1.0,2.0,,1.0,2.0,2.0,1.0,31.0
Shahdara,17.4.7,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Heart disease or related to Hypertension,3. Above 55 yrs.,12.0,7.0,5.0,9.0,4.0,1.0,7.0,1.0,3.0,7.0,1.0,1.0,58.0
Shahdara,17.4.7,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Heart disease or related to Hypertension,4. Total,19.0,9.0,11.0,13.0,7.0,2.0,9.0,1.0,4.0,9.0,3.0,2.0,89.0
Shahdara,17.4.8,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Neurological disease including strokes,1. 6-14 yrs,,,,,,,,,,,1.0,1.0,2.0
Shahdara,17.4.8,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Neurological disease including strokes,2. 15-55 yrs.,,2.0,,1.0,1.0,1.0,,,,,2.0,1.0,8.0
Shahdara,17.4.8,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Neurological disease including strokes,3. Above 55 yrs.,1.0,,,,,,,,,1.0,,,2.0
Shahdara,17.4.8,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Neurological disease including strokes,4. Total,1.0,2.0,,1.0,1.0,1.0,,,,1.0,3.0,2.0,12.0
Shahdara,17.4.9(a),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Abortion,1. 6-14 yrs,,,,,,,,,,,,,
Shahdara,17.4.9(a),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Abortion,2. 15-49 yrs,,,,,,,,,,,,,
Shahdara,17.4.9(a),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Abortion,3. Above 49 yrs.,,,,,,,,,,,,,
Shahdara,17.4.9(a),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Abortion,4. Total,,,,,,,,,,,,,
Shahdara,17.4.9(b),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Obstructed or prolonged labour,1. 6-14 yrs,,,,,,,,,,,,,
Shahdara,17.4.9(b),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Obstructed or prolonged labour,2. 15-49 yrs,,,1.0,1.0,,,,,,,,,2.0
Shahdara,17.4.9(b),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Obstructed or prolonged labour,3. Above 49 yrs.,,,,,,,,,,,,,
Shahdara,17.4.9(b),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Obstructed or prolonged labour,4. Total,,,1.0,1.0,,,,,,,,,2.0
Shahdara,17.4.9(c),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Severe hypertesnion or fits,1. 6-14 yrs,,,,,,,,,,,,,
Shahdara,17.4.9(c),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Severe hypertesnion or fits,2. 15-49 yrs,1.0,2.0,1.0,1.0,,,1.0,,,1.0,1.0,,8.0
Shahdara,17.4.9(c),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Severe hypertesnion or fits,3. Above 49 yrs.,,,,,,,,,,,,,
Shahdara,17.4.9(c),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Severe hypertesnion or fits,4. Total,1.0,2.0,1.0,1.0,,,1.0,,,1.0,1.0,,8.0
Shahdara,17.4.9(d),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Bleeding,1. 6-14 yrs,,,,,,,,,,,,,
Shahdara,17.4.9(d),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Bleeding,2. 15-49 yrs,,1.0,,1.0,,,,3.0,1.0,1.0,2.0,1.0,10.0
Shahdara,17.4.9(d),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Bleeding,3. Above 49 yrs.,,,,,,,,,,,,,
Shahdara,17.4.9(d),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Bleeding,4. Total,,1.0,,1.0,,,,3.0,1.0,1.0,2.0,1.0,10.0
Shahdara,17.4.9(e),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being High Fever,1. 6-14 yrs,,,,,,,,,,,,,
Shahdara,17.4.9(e),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being High Fever,2. 15-49 yrs,,3.0,2.0,6.0,,,2.0,3.0,4.0,,3.0,1.0,24.0
Shahdara,17.4.9(e),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being High Fever,3. Above 49 yrs.,,,,,,,,,,,,,
Shahdara,17.4.9(e),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being High Fever,4. Total,,3.0,2.0,6.0,,,2.0,3.0,4.0,,3.0,1.0,24.0
Shahdara,17.4.9(f),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being other causes (excluding abortion; obstructed or prolonged labour; severe hypertension or fits;,1. 6-14 yrs,,,,,,,,,,,,,
Shahdara,17.4.9(f),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being other causes (excluding abortion; obstructed or prolonged labour; severe hypertension or fits;,2. 15-49 yrs,6.0,3.0,3.0,,3.0,2.0,2.0,1.0,3.0,,1.0,,24.0
Shahdara,17.4.9(f),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being other causes (excluding abortion; obstructed or prolonged labour; severe hypertension or fits;,3. Above 49 yrs.,,,,,,,,,,,,,
Shahdara,17.4.9(f),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being other causes (excluding abortion; obstructed or prolonged labour; severe hypertension or fits;,4. Total,6.0,3.0,3.0,,3.0,2.0,2.0,1.0,3.0,,1.0,,24.0
Shahdara,17.4.10,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Trauma or Accidents or Burn cases,1. 6-14 yrs,,,,,,,,,,,,,
Shahdara,17.4.10,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Trauma or Accidents or Burn cases,2. 15-55 yrs.,1.0,4.0,3.0,3.0,1.0,,2.0,,5.0,,,,19.0
Shahdara,17.4.10,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Trauma or Accidents or Burn cases,3. Above 55 yrs.,,3.0,1.0,1.0,3.0,,1.0,,,,,,9.0
Shahdara,17.4.10,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Trauma or Accidents or Burn cases,4. Total,1.0,7.0,4.0,4.0,4.0,,3.0,,5.0,,,,28.0
Shahdara,17.4.11,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being suicide,1. 6-14 yrs,,,,,,,,,,,,,
Shahdara,17.4.11,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being suicide,2. 15-55 yrs.,1.0,1.0,,,,,,,2.0,,,,4.0
Shahdara,17.4.11,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being suicide,3. Above 55 yrs.,,,,,,,,,,,,,
Shahdara,17.4.11,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being suicide,4. Total,1.0,1.0,,,,,,,2.0,,,,4.0
Shahdara,17.4.12,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Animal bites and stings,1. 6-14 yrs,,,,,,,,,,,,,
Shahdara,17.4.12,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Animal bites and stings,2. 15-55 yrs.,,,,,,,,,2.0,,,,2.0
Shahdara,17.4.12,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Animal bites and stings,3. Above 55 yrs.,,,,,,,1.0,,,,,,1.0
Shahdara,17.4.12,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Animal bites and stings,4. Total,,,,,,,1.0,,2.0,,,,3.0
Shahdara,17.4.13(a),Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Known Acute disease,1. 6-14 yrs,,,1.0,,,,,,,,,,1.0
Shahdara,17.4.13(a),Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Known Acute disease,2. 15-55 yrs.,2.0,2.0,1.0,1.0,,,1.0,1.0,,,1.0,1.0,10.0
Shahdara,17.4.13(a),Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Known Acute disease,3. Above 55 yrs.,3.0,2.0,3.0,4.0,2.0,,1.0,,1.0,1.0,,,17.0
Shahdara,17.4.13(a),Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Known Acute disease,4. Total,5.0,4.0,5.0,5.0,2.0,,2.0,1.0,1.0,1.0,1.0,1.0,28.0
Shahdara,17.4.13(b),Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Known Chronic disease,1. 6-14 yrs,1.0,,,,,,,,,,,,1.0
Shahdara,17.4.13(b),Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Known Chronic disease,2. 15-55 yrs.,4.0,4.0,10.0,2.0,4.0,6.0,3.0,4.0,2.0,,7.0,5.0,51.0
Shahdara,17.4.13(b),Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Known Chronic disease,3. Above 55 yrs.,6.0,3.0,13.0,4.0,4.0,3.0,5.0,6.0,4.0,6.0,7.0,2.0,63.0
Shahdara,17.4.13(b),Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Known Chronic disease,4. Total,11.0,7.0,23.0,6.0,8.0,9.0,8.0,10.0,6.0,6.0,14.0,7.0,115.0
Shahdara,17.4.13(c),Number of cases of Adolescent or Adult deaths (age 6 years & above) where the cause was not known,1. 6-14 yrs,,,,,,,,,,,,,
Shahdara,17.4.13(c),Number of cases of Adolescent or Adult deaths (age 6 years & above) where the cause was not known,2. 15-55 yrs.,3.0,1.0,4.0,3.0,1.0,2.0,1.0,,2.0,7.0,2.0,1.0,27.0
Shahdara,17.4.13(c),Number of cases of Adolescent or Adult deaths (age 6 years & above) where the cause was not known,3. Above 55 yrs.,1.0,1.0,3.0,5.0,1.0,,1.0,3.0,3.0,10.0,8.0,,36.0
Shahdara,17.4.13(c),Number of cases of Adolescent or Adult deaths (age 6 years & above) where the cause was not known,4. Total,4.0,2.0,7.0,8.0,2.0,2.0,2.0,3.0,5.0,17.0,10.0,1.0,63.0
South,1.1,Total number of pregnant women Registered for ANC,TOTAL,3294.0,4198.0,3862.0,3639.0,3667.0,3433.0,2646.0,2879.0,3005.0,3029.0,3515.0,3568.0,40735.0
South,1.1.1,Of which Number registered within first trimester (within 12 weeks),TOTAL,1040.0,1598.0,1387.0,1412.0,1113.0,1075.0,846.0,1042.0,1145.0,1253.0,1467.0,1655.0,15033.0
South,1.2,Number of Pregnant women registered under JSY,TOTAL,24.0,23.0,26.0,12.0,11.0,14.0,12.0,24.0,16.0,31.0,30.0,26.0,249.0
South,1.3,Number of pregnant women received 3 ANC check ups during pregnancy,TOTAL,1780.0,2268.0,2226.0,2466.0,1901.0,2309.0,1991.0,2064.0,2321.0,2306.0,2035.0,2339.0,26006.0
South,1.4.1,Number of pregnant women given TT1 during current pregnancy,TOTAL,1308.0,1334.0,1469.0,1456.0,1217.0,1134.0,1012.0,1172.0,1046.0,1087.0,1160.0,1340.0,14735.0
South,1.4.2,Number of pregnant women given TT2 or Booster during current pregnancy,TOTAL,971.0,1229.0,1285.0,1253.0,1129.0,1108.0,1047.0,880.0,920.0,843.0,954.0,1193.0,12812.0
South,1.5,Total number of pregnant women given 100 IFA tablets,TOTAL,1155.0,1582.0,1555.0,1542.0,2038.0,2496.0,2603.0,2159.0,2203.0,2137.0,2377.0,2234.0,24081.0
South,1.6.1,Number of new cases of Hypertension (BP>140/90) detected in Pregnant women at the institution,TOTAL,129.0,136.0,110.0,181.0,80.0,160.0,79.0,79.0,89.0,92.0,90.0,109.0,1334.0
South,1.6.2,Number of Eclampsia cases managed during delivery,TOTAL,1.0,2.0,2.0,1.0,3.0,2.0,1.0,0.0,1.0,2.0,2.0,2.0,19.0
South,1.7.1,Number of Pregnant women with anaemia i.e. Hb level<11 (tested cases),TOTAL,619.0,678.0,667.0,749.0,806.0,764.0,694.0,679.0,785.0,936.0,1025.0,896.0,9298.0
South,1.7.2,Number of Pregnant women having severe anaemia (Hb<7) treated at institution,TOTAL,25.0,26.0,25.0,35.0,33.0,29.0,30.0,24.0,26.0,22.0,33.0,166.0,474.0
South,1.8,Number of pregnancy test kits used at SC level,TOTAL,10.0,15.0,16.0,12.0,15.0,12.0,16.0,56.0,127.0,33.0,0.0,0.0,312.0
South,2.1.1.a,Number of deliveries conducted at Home and attended by trained SBA(i.e. Doctor or Nurse or ANM),TOTAL,33.0,46.0,36.0,34.0,44.0,72.0,46.0,56.0,71.0,48.0,34.0,48.0,568.0
South,2.1.1.b,Number of deliveries conducted at Home and attended by non trained SBA (i.e. trained TBA or Relatives etc.),TOTAL,80.0,106.0,111.0,110.0,150.0,136.0,135.0,130.0,148.0,148.0,111.0,123.0,1488.0
South,2.1.1.c,Total number of deliveries conducted at Home and attended by trained or non-trained SBA (i.e. sum of 2.1.1.a and 2.1.1.b),TOTAL,113.0,152.0,147.0,144.0,194.0,208.0,181.0,186.0,219.0,196.0,145.0,171.0,2056.0
South,2.1.2,Number of newborns visited within 24 hours of delivery for deliveries conducted at home,TOTAL,37.0,34.0,27.0,21.0,53.0,52.0,41.0,22.0,76.0,79.0,55.0,45.0,542.0
South,2.1.3,Number of mothers paid JSY incentive for deliveries conducted at home,TOTAL,1.0,0.0,0.0,1.0,3.0,0.0,1.0,0.0,1.0,0.0,2.0,0.0,9.0
South,2.2,Deliveries conducted at Public Institutions (Including C-Sections),TOTAL,426.0,393.0,411.0,534.0,568.0,580.0,529.0,463.0,582.0,543.0,421.0,461.0,5911.0
South,2.2.1,"Out of 2.2, Number discharged under 48 hours of delivery",TOTAL,297.0,302.0,293.0,296.0,419.0,363.0,401.0,319.0,320.0,305.0,293.0,316.0,3924.0
South,2.2.2.a,Number of mothers paid JSY Incentive for deliveries conducted at Public Institutions,TOTAL,13.0,12.0,22.0,6.0,20.0,13.0,7.0,14.0,11.0,19.0,13.0,11.0,161.0
South,2.2.2.b,Number of ASHAs paid JSY Incentive for deliveries conducted at Public Institutions,TOTAL,8.0,9.0,6.0,5.0,16.0,9.0,8.0,11.0,4.0,10.0,8.0,5.0,99.0
South,2.2.2.c,Number of cases of deliveries conducted at Public Institutions where JSY incentive was paid to ANMs or AWWs [only for High Performing States (HPS)],TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
South,2.3,Deliveries conducted at Private Institutions (Including C-Sections),TOTAL,218.0,393.0,338.0,350.0,443.0,411.0,465.0,442.0,417.0,453.0,347.0,425.0,4702.0
South,2.3.1.a,Number of mothers paid JSY Incentive for deliveries conducted at accredited Private Institutions,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
South,2.3.1.b,Number of ASHAs paid JSY Incentive for deliveries conducted at accredited Private Institutions,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
South,2.3.1.c,Number of cases of deliveries conducted at accredited Private Institutions where JSY incentive was paid to ANMs or AWWs [only for High Performing States (HPS)],TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
South,3.1.1,Number of Caesarean (C-Section) deliveries performed at PHCs (Primary Health Centre),TOTAL,,0.0,0.0,0.0,,0.0,,,,0.0,0.0,0.0,0.0
South,3.1.2,Number of Caesarean (C-Section) deliveries performed at CHCs (Community Health Centre),TOTAL,,,,,,,,,,,,,
South,3.1.3,Number of Caesarean (C-Section) deliveries performed at SDHs (Sub-divisional Hospital) or DHs (District Hospital),TOTAL,124.0,111.0,120.0,145.0,147.0,145.0,133.0,144.0,147.0,171.0,124.0,144.0,1655.0
South,3.1.4,Number of Caesarean (C-Section) deliveries performed at other State owned public institutions,TOTAL,,,,,,,,,,,,,
South,3.1.5,"Total Number of Caesarean (C-Section) deliveries performed at Public facilities i.e. PHC, CHC, SDH, DH and other State owned public institutions (sum of items from 3.1.1 to 3.1.4)",TOTAL,124.0,111.0,120.0,145.0,147.0,145.0,133.0,144.0,147.0,171.0,124.0,144.0,1655.0
South,3.2,No. of C-section deliveries performed at Private facilities,TOTAL,77.0,201.0,138.0,147.0,191.0,198.0,206.0,180.0,186.0,195.0,158.0,156.0,2033.0
South,4.1.1.a,Number of male live births,TOTAL,431.0,516.0,486.0,568.0,664.0,618.0,617.0,583.0,633.0,621.0,498.0,570.0,6805.0
South,4.1.1.b,Number of female live births,TOTAL,327.0,426.0,417.0,470.0,550.0,591.0,566.0,517.0,591.0,568.0,417.0,493.0,5933.0
South,4.1.1.c,Total number of male and female live births (4.1.1.a and 4.1.1.b),TOTAL,758.0,942.0,903.0,1038.0,1214.0,1209.0,1183.0,1100.0,1224.0,1189.0,915.0,1063.0,12738.0
South,4.1.2,Number of still births,TOTAL,7.0,3.0,9.0,8.0,7.0,9.0,5.0,8.0,8.0,14.0,9.0,6.0,93.0
South,4.1.3,Number of Abortions (spontaneous or induced),TOTAL,162.0,206.0,186.0,171.0,250.0,165.0,148.0,152.0,210.0,202.0,233.0,308.0,2393.0
South,4.2.1,Number of Newborns weighed at birth,TOTAL,653.0,861.0,852.0,964.0,1126.0,1128.0,1122.0,1018.0,1174.0,1125.0,866.0,980.0,11869.0
South,4.2.2,Number of Newborns having weight less than 2.5 kg,TOTAL,130.0,159.0,240.0,156.0,222.0,205.0,180.0,163.0,169.0,155.0,177.0,145.0,2101.0
South,4.3,Number of Newborns breast fed within 1 hour of birth,TOTAL,515.0,693.0,604.0,836.0,897.0,862.0,868.0,827.0,1023.0,970.0,710.0,739.0,9544.0
South,5.1.1,Number of cases of pregnant women with Obstetric Complications and attended at PHCs,TOTAL,,0.0,0.0,0.0,,0.0,0.0,,0.0,0.0,0.0,0.0,0.0
South,5.1.2,Number of cases of pregnant women with Obstetric Complications and attended at CHCs,TOTAL,,,,,,,,,,,,,
South,5.1.3,Number of cases of pregnant women with Obstetric Complications and attended at SDHs or DHs,TOTAL,430.0,366.0,184.0,198.0,199.0,182.0,259.0,231.0,300.0,304.0,243.0,269.0,3165.0
South,5.1.4,Number of cases of pregnant women with Obstetric Complications and attended at other State owned public institutions,TOTAL,,,,,,,,,,,,,
South,5.1.5,"Number of cases of pregnant women with Obstetric Complications and attended at Public facilities i.e. PHC, CHC, SDH, DH and other State owned public institutions (sum of items from 5.1.1 to 5.1.4)",TOTAL,430.0,366.0,184.0,198.0,199.0,182.0,259.0,231.0,300.0,304.0,243.0,269.0,3165.0
South,5.2,Number of cases of pregnant women with Obstetric Complications and attended at Private facilities,TOTAL,57.0,164.0,72.0,107.0,123.0,101.0,156.0,156.0,128.0,158.0,115.0,125.0,1462.0
South,5.3.1,Number of cases of complicated pregnancies treated with IV antibiotics,TOTAL,319.0,289.0,224.0,142.0,254.0,282.0,296.0,184.0,296.0,288.0,194.0,275.0,3043.0
South,5.3.2,Number of cases of complicated pregnancies treated with IV Antihypertensive/Magsulph injection,TOTAL,23.0,36.0,18.0,7.0,90.0,10.0,32.0,34.0,12.0,43.0,19.0,30.0,354.0
South,5.3.3,Number of cases of complicated pregnancies treated with IV Oxytocis,TOTAL,183.0,289.0,188.0,231.0,274.0,198.0,276.0,212.0,384.0,451.0,157.0,236.0,3079.0
South,5.3.4,Number of cases of complicated pregnancies treated with Blood Transfusion,TOTAL,4.0,14.0,8.0,20.0,15.0,17.0,13.0,8.0,7.0,12.0,37.0,6.0,161.0
South,6.1,Women getting post partum check-up within 48 hours after delivery,TOTAL,569.0,819.0,607.0,663.0,897.0,815.0,856.0,756.0,911.0,892.0,758.0,788.0,9331.0
South,6.2,Women getting a post partum check up between 48 hours and 14 days after delivery,TOTAL,565.0,772.0,625.0,696.0,896.0,926.0,925.0,917.0,844.0,1004.0,727.0,631.0,9528.0
South,6.3,PNC maternal complications attended,TOTAL,10.0,15.0,1.0,6.0,5.0,8.0,13.0,6.0,7.0,16.0,15.0,13.0,115.0
South,7.1.1,Number of MTPs conducted at Public Institutions up to 12 weeks of pregnancy,TOTAL,51.0,76.0,63.0,62.0,54.0,48.0,55.0,60.0,73.0,75.0,64.0,63.0,744.0
South,7.1.2,Number of MTPs conducted at Public Institutions for more than 12 weeks of pregnancy,TOTAL,22.0,16.0,12.0,21.0,23.0,16.0,7.0,7.0,24.0,16.0,24.0,26.0,214.0
South,7.1.3,Total number of MTPs conducted at Public Institutions (sum of items 7.1.1 and 7.1.2),TOTAL,73.0,92.0,75.0,83.0,77.0,64.0,62.0,67.0,97.0,91.0,88.0,89.0,958.0
South,7.2,Number of MTPs conducted at Private Facilities,TOTAL,57.0,76.0,76.0,69.0,73.0,66.0,53.0,66.0,77.0,60.0,73.0,65.0,811.0
South,8.1.a,Number of new cases of RTI/STI in males for which treatment was initiated,TOTAL,247.0,175.0,183.0,147.0,166.0,114.0,59.0,121.0,63.0,88.0,72.0,165.0,1600.0
South,8.1.b,Number of new cases of RTI/STI in females for which treatment was initiated,TOTAL,517.0,443.0,410.0,448.0,501.0,309.0,360.0,425.0,386.0,467.0,644.0,651.0,5561.0
South,8.1.c,Total number of new cases of RTI/STI in males and females for which treatment was initiated (sum of items 8.1.a and 8.1.b),TOTAL,764.0,618.0,593.0,595.0,667.0,423.0,419.0,546.0,449.0,555.0,716.0,816.0,7161.0
South,8.2,Number of suspected RTI/STI cases for whom wet mount test was conducted,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
South,9.1.1.a,Number of NSV (No Scalpel Vasectomy) or Conventional Vasectomy conducted at PHCs,TOTAL,,0.0,0.0,0.0,,0.0,,0.0,,0.0,0.0,0.0,0.0
South,9.1.1.b,Number of NSV or Conventional Vasectomy conducted at CHCs,TOTAL,,,,,,,,,,,,,
South,9.1.1.c,Number of NSV or Conventional Vasectomy conducted at SDHs or DHs,TOTAL,3.0,1.0,3.0,0.0,0.0,2.0,0.0,5.0,4.0,1.0,2.0,3.0,24.0
South,9.1.1.d,Number of NSV or Conventional Vasectomy conducted at other State owned public institutions,TOTAL,,,,,,,,,,,,,
South,9.1.1.e,"Total Number of NSV or Conventional Vasectomy conducted at Public facilities i.e. PHC, CHC, SDH, DH and other State owned public institutions (sum of items from 9.1.1.a to 9.1.1.d)",TOTAL,3.0,1.0,3.0,0.0,0.0,2.0,0.0,5.0,4.0,1.0,2.0,3.0,24.0
South,9.1.2,Number of NSV or Conventional Vasectomy conducted at Private facilities,TOTAL,0.0,0.0,1.0,0.0,0.0,0.0,2.0,0.0,0.0,0.0,0.0,0.0,3.0
South,9.2.1.a,Number of Laparoscopic sterilizations conducted at PHCs,TOTAL,,0.0,0.0,0.0,,0.0,,,,0.0,0.0,0.0,0.0
South,9.2.1.b,Number of Laparoscopic sterilizations conducted at CHCs,TOTAL,,,,,,,,,,,,,
South,9.2.1.c,Number of Laparoscopic sterilizations conducted at SDHs or DHs,TOTAL,60.0,76.0,68.0,74.0,47.0,34.0,42.0,68.0,93.0,92.0,90.0,76.0,820.0
South,9.2.1.d,Number of Laparoscopic sterilizations conducted at other State owned public institutions,TOTAL,,,,,,,,,,,,,
South,9.2.1.e,"Total Number of Laparoscopic sterilizations conducted at Public facilities i.e. PHC, CHC, SDH, DH and other State owned public institutions (sum of items from 9.2.1.a to 9.2.1.d)",TOTAL,60.0,76.0,68.0,74.0,47.0,34.0,42.0,68.0,93.0,92.0,90.0,76.0,820.0
South,9.2.2,Number of Laparoscopic sterilizations conducted at Private facilities,TOTAL,0.0,3.0,1.0,0.0,0.0,1.0,0.0,2.0,2.0,0.0,1.0,6.0,16.0
South,9.3.1.a,Number of Mini-lap sterilizations conducted at PHCs,TOTAL,,0.0,0.0,0.0,,0.0,,,,0.0,0.0,0.0,0.0
South,9.3.1.b,Number of Mini-lap sterilizations conducted at CHCs,TOTAL,,,,,,,,,,,,,
South,9.3.1.c,Number of Mini-lap sterilizations conducted at SDHs or DHs,TOTAL,1.0,3.0,2.0,2.0,5.0,1.0,4.0,4.0,3.0,6.0,4.0,5.0,40.0
South,9.3.1.d,Number of Mini-lap sterilizations conducted at other State owned public institutions,TOTAL,,,,,,,,,,,,,
South,9.3.1.e,"Total Number of Mini-lap sterilizations conducted at Public facilities i.e. PHC, CHC, SDH, DH and other State owned public institutions (sum of items from 9.3.1.a to 9.3.1.d)",TOTAL,1.0,3.0,2.0,2.0,5.0,1.0,4.0,4.0,3.0,6.0,4.0,5.0,40.0
South,9.3.2,Number of Mini-lap sterilizations conducted at Private facilities,TOTAL,0.0,0.0,0.0,2.0,2.0,0.0,0.0,0.0,1.0,0.0,0.0,0.0,5.0
South,9.4.1.a,Number of Post-Partum sterilizations conducted at PHCs,TOTAL,,0.0,0.0,0.0,,0.0,,,,0.0,0.0,0.0,0.0
South,9.4.1.b,Number of Post-Partum sterilizations conducted at CHCs,TOTAL,,,,,,,,,,,,,
South,9.4.1.c,Number of Post-Partum sterilizations conducted at SDHs or DHs,TOTAL,11.0,16.0,15.0,19.0,9.0,10.0,7.0,14.0,9.0,15.0,9.0,10.0,144.0
South,9.4.1.d,Number of Post-Partum sterilizations conducted at other State owned public institutions,TOTAL,,,,,,,,,,,,,
South,9.4.1.e,"Total Number of Post-Partum sterilizations conducted at Public facilities i.e. PHC, CHC, SDH, DH and other State owned public institutions (sum of items from 9.4.1.a to 9.4.1.d)",TOTAL,11.0,16.0,15.0,19.0,9.0,10.0,7.0,14.0,9.0,15.0,9.0,10.0,144.0
South,9.4.2,Number of Post-Partum sterilizations conducted at Private facilities,TOTAL,0.0,1.0,2.0,1.0,1.0,0.0,1.0,0.0,2.0,0.0,0.0,0.0,8.0
South,9.5.1.a,Number of IUCD Insertions conducted at SCs,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,,,0.0,0.0,0.0,0.0,0.0
South,9.5.1.b,Number of IUCD Insertions conducted at PHCs,TOTAL,127.0,136.0,138.0,287.0,181.0,176.0,134.0,150.0,152.0,147.0,156.0,147.0,1931.0
South,9.5.1.c,Number of IUCD Insertions conducted at CHCs,TOTAL,,,,,,,,,,,,,
South,9.5.1.d,Number of IUCD Insertions conducted at SDHs or DHs,TOTAL,133.0,164.0,204.0,268.0,246.0,206.0,172.0,140.0,201.0,200.0,161.0,160.0,2255.0
South,9.5.1.e,Number of IUCD Insertions conducted at other State owned public institutions,TOTAL,,,,,,,,,,,,,
South,9.5.1.f,"Total Number of IUCD Insertions conducted at Public facilities i.e. SC, PHC, CHC, SDH, DH and other State owned public institutions (sum of items from 9.5.1.a to 9.5.1.e)",TOTAL,260.0,300.0,342.0,555.0,427.0,382.0,306.0,290.0,353.0,347.0,317.0,307.0,4186.0
South,9.5.1A,"Out of above total, Post Partum (within 48 hours of delivery) IUCD insertions",TOTAL,62.0,97.0,109.0,196.0,161.0,137.0,124.0,91.0,130.0,118.0,82.0,77.0,1384.0
South,9.5.2,Number of IUCD Insertions conducted at Private facilities,TOTAL,14.0,20.0,14.0,10.0,17.0,15.0,11.0,14.0,18.0,14.0,17.0,17.0,181.0
South,9.06,Number of IUCD removals,TOTAL,77.0,76.0,66.0,64.0,82.0,79.0,34.0,78.0,63.0,57.0,63.0,70.0,809.0
South,9.07,Number of Oral Pills cycles distributed,TOTAL,1371.0,1546.0,966.0,1113.0,848.0,867.0,657.0,842.0,1650.0,890.0,864.0,835.0,12449.0
South,9.08,Number of Condom pieces distributed,TOTAL,19452.0,18701.0,19032.0,34455.0,23326.0,19868.0,22492.0,21763.0,26747.0,37167.0,24847.0,25416.0,293266.0
South,9.09,Number of Centchroman (weekly) pills given,TOTAL,6.0,2.0,4.0,9.0,3.0,2.0,1.0,6.0,1.0,5.0,4.0,3.0,46.0
South,9.10,Number of Emergency Contraceptive Pills distributed,TOTAL,81.0,48.0,35.0,54.0,54.0,28.0,23.0,64.0,140.0,83.0,96.0,68.0,774.0
South,9.11.1.a,Number of cases of complications following male sterilization,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
South,9.11.1.b,Number of cases of complications following female sterilization,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
South,9.11.2.a,Number of failures following male sterilization,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
South,9.11.2.b,Number of failures following female sterilization,TOTAL,1.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,1.0
South,9.11.3.a,Number of deaths following male sterilization,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
South,9.11.3.b,Number of deaths following female sterilization,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
South,9.12,Number of Institutions having NSV trained doctors,TOTAL,3.0,5.0,7.0,7.0,5.0,7.0,9.0,9.0,10.0,8.0,9.0,7.0,-1.0
South,10.1.01,Number of Infants (0 to 11 months old)received BCG immunisation,TOTAL,971.0,1111.0,981.0,1304.0,1368.0,1250.0,1373.0,1347.0,1438.0,1305.0,1151.0,1128.0,14727.0
South,10.1.02,Number of Infants (0 to 11 months old) received DPT1 immunisation,TOTAL,280.0,374.0,253.0,225.0,297.0,352.0,217.0,277.0,287.0,248.0,235.0,318.0,3363.0
South,10.1.03,Number of Infants (0 to 11 months old) received DPT2 immunisation,TOTAL,279.0,438.0,266.0,280.0,347.0,277.0,260.0,265.0,229.0,179.0,243.0,312.0,3375.0
South,10.1.04,Number of Infants (0 to 11 months old) received DPT3 immunisation,TOTAL,328.0,432.0,308.0,326.0,322.0,331.0,260.0,265.0,229.0,217.0,211.0,220.0,3449.0
South,10.1.04A,Number of Infants (0 to 11 months old) received Pentavalent1 immunisation,TOTAL,1046.0,953.0,805.0,846.0,921.0,1093.0,1305.0,1412.0,1561.0,1502.0,1505.0,1281.0,14230.0
South,10.1.04B,Number of Infants (0 to 11 months old) received Pentavalent2 immunisation,TOTAL,1076.0,1021.0,897.0,930.0,877.0,810.0,948.0,1212.0,1626.0,1481.0,1282.0,1316.0,13476.0
South,10.1.04C,Number of Infants (0 to 11 months old) received Pentavalent3 immunisation,TOTAL,1046.0,940.0,907.0,978.0,913.0,732.0,831.0,970.0,1273.0,1325.0,1250.0,1084.0,12249.0
South,10.1.05,Number of Infants (0 to 11 months old) received OPV 0 (Birth Dose),TOTAL,693.0,923.0,752.0,998.0,1138.0,1051.0,996.0,895.0,1006.0,991.0,808.0,842.0,11093.0
South,10.1.06,Number of Infants (0 to 11 months old) received OPV1 (First Dose),TOTAL,1241.0,1225.0,1013.0,1007.0,1138.0,1302.0,1434.0,1503.0,1500.0,1356.0,1290.0,1239.0,15248.0
South,10.1.07,Number of Infants (0 to 11 months old) received OPV2 (Second Dose),TOTAL,1301.0,1441.0,1121.0,1135.0,1130.0,1074.0,1120.0,1459.0,1682.0,1405.0,1241.0,1309.0,15418.0
South,10.1.08,Number of Infants (0 to 11 months old) received OPV3 (Third Dose),TOTAL,1339.0,1363.0,1204.0,1210.0,1144.0,1041.0,1009.0,1182.0,1329.0,1344.0,1340.0,1163.0,14668.0
South,10.1.09A,Number of Infants (upto 48 hrs of age) received Hepatitis-B0 immunisation,TOTAL,639.0,786.0,666.0,941.0,1080.0,1059.0,1015.0,795.0,958.0,897.0,749.0,676.0,10261.0
South,10.1.09,Number of Infants (0 to 11 months old) received Hepatitis-B1 immunisation,TOTAL,286.0,336.0,253.0,224.0,266.0,256.0,211.0,154.0,170.0,147.0,149.0,292.0,2744.0
South,10.1.10,Number of Infants (0 to 11 months old) received Hepatitis-B2 immunisation,TOTAL,265.0,444.0,287.0,311.0,356.0,322.0,292.0,288.0,267.0,219.0,177.0,230.0,3458.0
South,10.1.11,Number of Infants (0 to 11 months old) received Hepatitis-B3 immunisation,TOTAL,340.0,402.0,380.0,348.0,333.0,338.0,283.0,243.0,237.0,235.0,228.0,240.0,3607.0
South,10.1.12,Number of Infants (0 to 11 months old) received Measles immunisation (First Dose),TOTAL,1803.0,1914.0,1776.0,1823.0,1730.0,1574.0,1444.0,1673.0,1414.0,1298.0,1213.0,1322.0,18984.0
South,10.1.12B,Number of Infants (more than 16 months old) received Measles immunisation (Second Dose),TOTAL,2305.0,1734.0,2059.0,1152.0,253.0,70.0,55.0,74.0,51.0,90.0,46.0,192.0,8081.0
South,10.1A,No. of Children aged 9 to 12 months who received JE 1st dose,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
South,10.1.13.a,Total number of male children (9 to 11 months old) fully immunised (BCG+DPT123/Pentavalent123+OPV123+Measles) during the month,TOTAL,797.0,969.0,840.0,863.0,838.0,703.0,671.0,848.0,743.0,578.0,620.0,715.0,9185.0
South,10.1.13.b,Total number of female children (9 to 11 months old) fully immunised (BCG+DPT123/Pentavalent123+OPV123+Measles) during the month,TOTAL,673.0,771.0,720.0,751.0,699.0,626.0,594.0,703.0,607.0,520.0,541.0,608.0,7813.0
South,10.1.13.c,Total number of children (9 to 11 months old) fully immunised (BCG+DPT123/Pentavalent123+OPV123+Measles) during the month (sum of items 10.1.13.a and 10.1.13.b),TOTAL,1470.0,1740.0,1560.0,1614.0,1537.0,1329.0,1265.0,1551.0,1350.0,1098.0,1161.0,1323.0,16998.0
South,10.2.1,Number of Infants (more than 16 months old) received DPT Booster dose,TOTAL,1472.0,1603.0,1361.0,1361.0,1443.0,1365.0,1142.0,1423.0,1426.0,1395.0,1691.0,1773.0,17455.0
South,10.2.2,Number of Infants (more than 16 months old) received OPV Booster dose,TOTAL,1490.0,1629.0,1380.0,1345.0,1439.0,1384.0,1164.0,1444.0,1464.0,1429.0,1432.0,1826.0,17426.0
South,10.2.3,"Number of Infants (more than 16 months old) received Measles, Mumps, Rubella (MMR) Vaccination",TOTAL,85.0,183.0,261.0,164.0,1687.0,2032.0,1600.0,2238.0,2079.0,1816.0,1697.0,1366.0,15208.0
South,10.3.1.a,Total number of male children (12 to 23 months old) fully immunised (BCG+DPT123/Pentavalent123+OPV123+Measles) during the month,TOTAL,155.0,188.0,228.0,187.0,171.0,207.0,123.0,238.0,297.0,155.0,266.0,356.0,2571.0
South,10.3.1.b,Total number of female children (12 to 23 months old) fully immunised (BCG+DPT123/Pentavalent123+OPV123+Measles) during the month,TOTAL,94.0,139.0,186.0,161.0,138.0,156.0,97.0,183.0,238.0,143.0,221.0,249.0,2005.0
South,10.3.1.c,Total number of children (12 to 23 months old) fully immunised (BCG+DPT123+OPV123/Pentavalent123+Measles) during the month (sum of items 10.3.1.a and 10.3.1.b),TOTAL,249.0,327.0,414.0,348.0,309.0,363.0,220.0,421.0,535.0,298.0,487.0,605.0,4576.0
South,10.3.2,Number of children (more than 5 years old) given DT5,TOTAL,616.0,970.0,925.0,596.0,626.0,658.0,595.0,735.0,680.0,624.0,603.0,900.0,8528.0
South,10.3.3,Number of children (more than 10 years old) given TT10,TOTAL,236.0,356.0,373.0,276.0,229.0,255.0,255.0,234.0,245.0,270.0,251.0,371.0,3351.0
South,10.3.4,Number of children (more than 16 years old) given TT16,TOTAL,222.0,206.0,247.0,254.0,169.0,194.0,135.0,146.0,146.0,150.0,121.0,155.0,2145.0
South,10.3.5.a,Number of cases of Abscess reported following immunisation [Adverse Event Following Immunisation (AEFI)],TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,1.0,0.0,0.0,0.0,1.0,2.0
South,10.3.5.b,Number of cases of Death reported following immunisation [Adverse Event Following Immunisation (AEFI)],TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
South,10.3.5.c,Number of cases of other complications reported following immunisation [Adverse Event Following Immunisation (AEFI)],TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
South,10.4.1,Number of Immunisation sessions planned to be held during the month,TOTAL,510.0,507.0,378.0,396.0,373.0,414.0,485.0,495.0,558.0,426.0,414.0,439.0,5395.0
South,10.4.2,Number of Immunisation sessions held during the month,TOTAL,499.0,492.0,384.0,392.0,374.0,403.0,464.0,485.0,544.0,418.0,407.0,420.0,5282.0
South,10.4.3,Number of Immunisation sessions held during the month where ASHAs were present,TOTAL,170.0,162.0,126.0,124.0,125.0,135.0,116.0,157.0,194.0,173.0,167.0,163.0,1812.0
South,10.5.1,Number of children (more than 16 months old) received Japanese Encephalitis (JE) vaccination,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
South,11.1.1,Number of children (9 months to 5 years old) administered 1st dose of Vitamin A (Dose-1),TOTAL,1956.0,2432.0,1832.0,1964.0,1985.0,1876.0,1697.0,2047.0,1554.0,1331.0,1030.0,1359.0,21063.0
South,11.1.2,Number of children (9 months to 5 years old) were administered 5th dose of Vitamin A (Dose-5),TOTAL,1394.0,1853.0,1547.0,1107.0,1211.0,970.0,1012.0,1322.0,1291.0,1015.0,849.0,974.0,14545.0
South,11.1.3,Number of children (9 months to 5 years old) administered 9th dose of Vitamin A (Dose-9),TOTAL,390.0,582.0,518.0,475.0,519.0,606.0,469.0,626.0,520.0,466.0,357.0,538.0,6066.0
South,12.1,Number of cases of Diptheria reported in children below 5 years of age,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
South,12.2,Number of cases of Pertusis reported in children below 5 years of age,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
South,12.3,Number of cases of Tetanus neonatarum reported in children below 5 years of age,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
South,12.4,Number of cases of Tetanus other than neonatarum reported in children below 5 years of age,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
South,12.5,Number of cases of Polio reported in children below 5 years of age,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
South,12.6,Number of cases of Measles reported in children below 5 years of age,TOTAL,3.0,9.0,6.0,3.0,0.0,0.0,2.0,1.0,1.0,1.0,10.0,7.0,43.0
South,12.7,Number of cases of Diarrhoea and Dehydration reported in children below 5 years of age,TOTAL,291.0,496.0,597.0,590.0,409.0,385.0,367.0,298.0,371.0,234.0,191.0,236.0,4465.0
South,12.8,Number of cases of Malaria reported in children below 5 years of age,TOTAL,2.0,0.0,4.0,5.0,8.0,8.0,8.0,4.0,1.0,0.0,0.0,0.0,40.0
South,12.9,Number of children below 5 years of age admitted with Respiratory Infections,TOTAL,159.0,150.0,202.0,142.0,155.0,211.0,243.0,174.0,220.0,288.0,287.0,218.0,2449.0
South,13.1,Number of Patients operated for cataract,TOTAL,0.0,20.0,22.0,16.0,16.0,37.0,29.0,39.0,53.0,17.0,43.0,67.0,359.0
South,13.2,Number of Intraocular Lens(IOL) implantations,TOTAL,0.0,19.0,22.0,16.0,16.0,37.0,28.0,38.0,53.0,17.0,41.0,65.0,352.0
South,13.3,Number of School children detected with Refractive errors,TOTAL,419.0,485.0,461.0,0.0,349.0,251.0,291.0,239.0,253.0,294.0,280.0,97.0,3419.0
South,13.4,Number of children provided free glasses,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
South,13.5,Number of eyes collected through eye donation,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
South,13.6,Number of eyes utilised for corneal transplant,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
South,14.01,Number of CHC or SDH or DH functioning as First Referral units (FRUs),TOTAL,1.0,1.0,1.0,1.0,1.0,1.0,1.0,1.0,1.0,1.0,1.0,1.0,-1.0
South,14.02,Number of PHCs functioning 24X7 with atleast 3 Staff Nurses,TOTAL,,,,,,,,,,,,,-1.0
South,14.03,Number of Anganwadi centres reported to have conducted VHNDs,TOTAL,17.0,16.0,18.0,19.0,17.0,21.0,23.0,40.0,25.0,30.0,35.0,39.0,-1.0
South,14.04,Number of facilities having a Rogi Kalyan Samiti (RKS),TOTAL,,,,,,,,,,,,,-1.0
South,14.05,Number of RKS meetings held during the month,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
South,14.06,Number of facilities having Ambulance services (Assured Referral Services),TOTAL,3.0,6.0,7.0,8.0,6.0,8.0,8.0,9.0,8.0,9.0,8.0,6.0,-1.0
South,14.07,Total Number of times the Ambulance was used for transporting patients during the month,TOTAL,24.0,27.0,102.0,106.0,127.0,134.0,95.0,92.0,130.0,125.0,113.0,88.0,1163.0
South,14.08,Number of Institutions having Operational Sick New Born and Child Care Units (SNCU),TOTAL,2.0,4.0,7.0,6.0,5.0,7.0,6.0,8.0,7.0,8.0,5.0,5.0,-1.0
South,14.09,Number of functional Laproscopes in CHC/SDH/DH,TOTAL,4.0,4.0,4.0,5.0,4.0,4.0,5.0,4.0,5.0,4.0,4.0,4.0,-1.0
South,14.10.1.a,Number of male patients admitted (Inpatients) during the month,1. Children,473.0,2014.0,1966.0,2352.0,744.0,735.0,760.0,518.0,646.0,745.0,730.0,585.0,12268.0
South,14.10.1.a,Number of male patients admitted (Inpatients) during the month,2. Adults,885.0,4237.0,4322.0,5562.0,1633.0,1739.0,1504.0,1566.0,1539.0,1453.0,1431.0,1616.0,27487.0
South,14.10.1.b,Number of female patients (Inpatients) admitted during the month,1. Children,327.0,1251.0,1124.0,1358.0,590.0,594.0,614.0,317.0,545.0,572.0,493.0,436.0,8221.0
South,14.10.1.b,Number of female patients (Inpatients) admitted during the month,2. Adults,1568.0,4941.0,5245.0,6008.0,2628.0,2540.0,2337.0,2215.0,2331.0,2383.0,2227.0,2460.0,36883.0
South,14.10.1.c,Total number of patients admitted (Inpatients) during the month (sum of items 14.10.1.a and 14.10.1.b),1. Children,800.0,3265.0,3090.0,3710.0,1334.0,1329.0,1374.0,835.0,1191.0,1317.0,1223.0,1021.0,20489.0
South,14.10.1.c,Total number of patients admitted (Inpatients) during the month (sum of items 14.10.1.a and 14.10.1.b),2. Adults,2453.0,9178.0,9567.0,11570.0,4261.0,4279.0,3841.0,3781.0,3870.0,3836.0,3658.0,4076.0,64370.0
South,14.10.2.a,Number of death cases of Inpatient males,TOTAL,21.0,143.0,167.0,207.0,48.0,33.0,51.0,53.0,42.0,33.0,38.0,27.0,863.0
South,14.10.2.b,Number of death cases of Inpatient females,TOTAL,10.0,73.0,87.0,141.0,38.0,24.0,20.0,20.0,16.0,31.0,34.0,31.0,525.0
South,14.10.2.c,Number of cases of death of Inpatients (sum of items 14.10.2.a and 14.10.2.b),TOTAL,31.0,216.0,254.0,348.0,86.0,57.0,71.0,73.0,58.0,64.0,72.0,58.0,1388.0
South,14.11,In-Patient Head Count at midnight,TOTAL,7539.0,37801.0,39871.0,52892.0,12158.0,17186.0,16263.0,15327.0,16895.0,17028.0,13493.0,13334.0,259787.0
South,14.12.1,OPD attendance (All),TOTAL,156454.0,339694.0,323827.0,337454.0,188894.0,208403.0,179147.0,185968.0,179326.0,197564.0,210777.0,216595.0,2724103.0
South,14.13.1,Number of major operations carried out using general or spinal anaesthesia,TOTAL,927.0,1356.0,2529.0,3486.0,1513.0,1594.0,1518.0,1582.0,1446.0,1585.0,961.0,1040.0,19537.0
South,14.13.1A,"Out of 14.13.1,Gynecology- Hysterectomy surgeries",TOTAL,11.0,44.0,40.0,41.0,49.0,40.0,43.0,40.0,48.0,59.0,21.0,30.0,466.0
South,14.13.2,Number of minor operations carried out without anaesthesia or using local anaesthesia,TOTAL,269.0,5369.0,5263.0,5615.0,399.0,487.0,347.0,387.0,367.0,278.0,871.0,368.0,20020.0
South,14.14.a,Number of patients given AYUSH treatment,TOTAL,4229.0,4234.0,3885.0,3771.0,3710.0,4344.0,4578.0,4906.0,4001.0,6353.0,2592.0,2533.0,49136.0
South,14.14.b,Number of patients on whom Dental Procedure was conducted,TOTAL,1654.0,1620.0,795.0,1593.0,1094.0,1059.0,1275.0,1400.0,1502.0,1409.0,601.0,1614.0,15616.0
South,14.14.c,Number of Adolescents counselled,TOTAL,79.0,75.0,73.0,87.0,77.0,72.0,79.0,75.0,51.0,53.0,57.0,74.0,852.0
South,15.1.1.a,Number of Haemoglobin (Hb) tests conducted,TOTAL,17634.0,17696.0,19504.0,20747.0,24623.0,26105.0,23726.0,23834.0,25090.0,28397.0,27609.0,31449.0,286414.0
South,15.1.1.b,"Out of the total number of Hb tests conducted, number of cases having Hb less than 7gm/dl",TOTAL,99.0,136.0,204.0,453.0,130.0,177.0,122.0,147.0,100.0,169.0,176.0,187.0,2100.0
South,15.1.2.a,Number of HIV tests conducted on males,1. Number tested,1588.0,2112.0,2352.0,2039.0,1947.0,2135.0,1803.0,1927.0,2017.0,2143.0,2061.0,2187.0,24311.0
South,15.1.2.a,Number of HIV tests conducted on males,2. Number Positive,7.0,11.0,12.0,10.0,7.0,14.0,6.0,4.0,15.0,2.0,10.0,11.0,109.0
South,15.1.2.b,Number of HIV tests conducted on Female-Non ANC (i.e. non pregnant females),1. Number tested,990.0,1180.0,1165.0,1037.0,840.0,1205.0,1159.0,1190.0,1275.0,1488.0,1453.0,1465.0,14447.0
South,15.1.2.b,Number of HIV tests conducted on Female-Non ANC (i.e. non pregnant females),2. Number Positive,1.0,7.0,4.0,4.0,1.0,5.0,3.0,1.0,4.0,2.0,5.0,1.0,38.0
South,15.1.2.c,Number of HIV tests conducted on Female with ANC (i.e. pregnant females),1. Number tested,1139.0,1243.0,1095.0,552.0,815.0,1049.0,709.0,889.0,953.0,973.0,1220.0,1145.0,11782.0
South,15.1.2.c,Number of HIV tests conducted on Female with ANC (i.e. pregnant females),2. Number Positive,5.0,4.0,1.0,1.0,3.0,4.0,1.0,5.0,4.0,2.0,4.0,7.0,41.0
South,15.1.2.d,Total number of HIV tests conducted (sum of items 15.1.2.a to 15.1.2.c),1. Number tested,3717.0,4535.0,4612.0,3628.0,3602.0,4389.0,3671.0,4006.0,4245.0,4604.0,4734.0,4797.0,50540.0
South,15.1.2.d,Total number of HIV tests conducted (sum of items 15.1.2.a to 15.1.2.c),2. Number Positive,13.0,22.0,17.0,15.0,11.0,23.0,10.0,10.0,23.0,6.0,19.0,19.0,188.0
South,15.2,Number of Widal tests conducted,Number tested,761.0,1008.0,1261.0,1077.0,1416.0,1160.0,958.0,910.0,645.0,726.0,829.0,875.0,11626.0
South,15.3.a,Number of VDRL tests conducted on males,Number tested,191.0,206.0,171.0,175.0,244.0,210.0,259.0,340.0,310.0,386.0,336.0,349.0,3177.0
South,15.3.b,Number of VDRL tests conducted on Female-Non ANC (i.e. non pregnant females),Number tested,454.0,423.0,301.0,346.0,379.0,453.0,400.0,419.0,336.0,472.0,408.0,394.0,4785.0
South,15.3.c,Number of VDRL tests conducted on Female with ANC (i.e. pregnant females),Number tested,84.0,89.0,102.0,68.0,96.0,107.0,85.0,94.0,487.0,486.0,384.0,493.0,2575.0
South,15.3.d,Total number of VDRL tests conducted (sum of items 15.3.a to 15.3.c),Number tested,729.0,718.0,574.0,589.0,719.0,770.0,744.0,853.0,1133.0,1344.0,1128.0,1236.0,10537.0
South,15.4.1,Number of blood smears examined for Malaria,TOTAL,14318.0,15869.0,14341.0,15141.0,16790.0,17161.0,17850.0,18876.0,20838.0,20813.0,19493.0,19336.0,210826.0
South,15.4.2,"Out of blood smears examined for malaria, number of blood smears tested positive for Plasmodium Vivax",TOTAL,1.0,2.0,7.0,8.0,8.0,16.0,11.0,5.0,2.0,6.0,1.0,4.0,71.0
South,15.4.3,"Out of blood smears examined for malaria, number of blood smears tested positive for Plasmodium Falciparum",TOTAL,0.0,0.0,1.0,2.0,0.0,1.0,6.0,4.0,0.0,0.0,0.0,0.0,14.0
South,16.1.1,Stock position of DPT vaccines,1. Balance From Previous Month,2260.0,3930.0,2500.0,1200.0,3620.0,2230.0,3830.0,3600.0,4040.0,2340.0,1680.0,1130.0,32360.0
South,16.1.1,Stock position of DPT vaccines,2. Stocks Received,3000.0,,,4000.0,0.0,3000.0,500.0,1800.0,0.0,0.0,0.0,4000.0,16300.0
South,16.1.1,Stock position of DPT vaccines,3. Unusable Stock,,,,,0.0,,,,0.0,0.0,,,0.0
South,16.1.1,Stock position of DPT vaccines,4. Stock Distributed,1330.0,1430.0,1300.0,1580.0,1390.0,1400.0,730.0,1360.0,1700.0,660.0,550.0,2340.0,15770.0
South,16.1.1,Stock position of DPT vaccines,5. Total Stock,3930.0,2500.0,1200.0,3620.0,2230.0,3830.0,3600.0,4040.0,2340.0,1680.0,1130.0,2790.0,32890.0
South,16.1.1A,Stock Position of Pentavalent,1. Balance From Previous Month,4210.0,4000.0,2490.0,3310.0,4640.0,3430.0,3920.0,3310.0,3230.0,2010.0,550.0,0.0,35100.0
South,16.1.1A,Stock Position of Pentavalent,2. Stocks Received,2000.0,,2000.0,3000.0,0.0,2000.0,1000.0,2000.0,0.0,0.0,0.0,4000.0,16000.0
South,16.1.1A,Stock Position of Pentavalent,3. Unusable Stock,,,,,0.0,,,,0.0,0.0,,,0.0
South,16.1.1A,Stock Position of Pentavalent,4. Stock Distributed,2210.0,1510.0,1180.0,1670.0,1210.0,1510.0,1610.0,2080.0,1220.0,1460.0,550.0,2720.0,18930.0
South,16.1.1A,Stock Position of Pentavalent,5. Total Stock,4000.0,2490.0,3310.0,4640.0,3430.0,3920.0,3310.0,3230.0,2010.0,550.0,0.0,1280.0,32170.0
South,16.1.2,Stock position of OPV vaccines,1. Balance From Previous Month,2000.0,4920.0,6840.0,7460.0,8540.0,5140.0,6860.0,5420.0,10080.0,5620.0,2500.0,4380.0,69760.0
South,16.1.2,Stock position of OPV vaccines,2. Stocks Received,8000.0,5000.0,3000.0,5000.0,0.0,5500.0,1000.0,8000.0,0.0,0.0,5000.0,8000.0,48500.0
South,16.1.2,Stock position of OPV vaccines,3. Unusable Stock,,,,,0.0,,,,0.0,0.0,,,0.0
South,16.1.2,Stock position of OPV vaccines,4. Stock Distributed,5080.0,3080.0,2380.0,3920.0,3400.0,3780.0,2440.0,3340.0,4460.0,3120.0,3120.0,5000.0,43120.0
South,16.1.2,Stock position of OPV vaccines,5. Total Stock,4920.0,6840.0,7460.0,8540.0,5140.0,6860.0,5420.0,10080.0,5620.0,2500.0,4380.0,7380.0,75140.0
South,16.1.3,Stock position of TT vaccines,1. Balance From Previous Month,1890.0,2910.0,2090.0,920.0,960.0,0.0,2360.0,2520.0,3600.0,2130.0,3280.0,2680.0,25340.0
South,16.1.3,Stock position of TT vaccines,2. Stocks Received,2000.0,,,1500.0,0.0,3500.0,1000.0,2000.0,0.0,2000.0,0.0,2500.0,14500.0
South,16.1.3,Stock position of TT vaccines,3. Unusable Stock,,,,,0.0,0.0,,,0.0,0.0,0.0,0.0,0.0
South,16.1.3,Stock position of TT vaccines,4. Stock Distributed,980.0,820.0,1170.0,1460.0,0.0,1140.0,840.0,920.0,1470.0,850.0,600.0,2100.0,12350.0
South,16.1.3,Stock position of TT vaccines,5. Total Stock,2910.0,2090.0,920.0,960.0,960.0,2360.0,2520.0,3600.0,2130.0,3280.0,2680.0,3080.0,27490.0
South,16.1.4,Stock position of DT vaccines,1. Balance From Previous Month,,,,,,,,,,,,,
South,16.1.4,Stock position of DT vaccines,2. Stocks Received,,,,,,,,,,,,,
South,16.1.4,Stock position of DT vaccines,3. Unusable Stock,,,,,,,,,,,,,
South,16.1.4,Stock position of DT vaccines,4. Stock Distributed,,,,,,,,,,,,,
South,16.1.4,Stock position of DT vaccines,5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
South,16.1.5,Stock position of BCG vaccines,1. Balance From Previous Month,2130.0,1640.0,880.0,310.0,1410.0,1320.0,2720.0,2750.0,3140.0,2040.0,1110.0,290.0,19740.0
South,16.1.5,Stock position of BCG vaccines,2. Stocks Received,1000.0,,,2530.0,0.0,2500.0,1000.0,1500.0,0.0,0.0,0.0,3500.0,12030.0
South,16.1.5,Stock position of BCG vaccines,3. Unusable Stock,,,,,0.0,,,,0.0,0.0,0.0,,0.0
South,16.1.5,Stock position of BCG vaccines,4. Stock Distributed,1110.0,760.0,570.0,1430.0,90.0,1100.0,970.0,1110.0,1100.0,930.0,820.0,1530.0,11520.0
South,16.1.5,Stock position of BCG vaccines,5. Total Stock,2020.0,880.0,310.0,1410.0,1320.0,2720.0,2750.0,3140.0,2040.0,1110.0,290.0,2260.0,20250.0
South,16.1.6,Stock position of Measles vaccines,1. Balance From Previous Month,3520.0,4315.0,3365.0,3570.0,3405.0,2330.0,2595.0,2310.0,3090.0,2265.0,1550.0,970.0,33285.0
South,16.1.6,Stock position of Measles vaccines,2. Stocks Received,4000.0,,3000.0,2000.0,0.0,1500.0,500.0,2000.0,0.0,0.0,0.0,2500.0,15500.0
South,16.1.6,Stock position of Measles vaccines,3. Unusable Stock,,,,,0.0,,,,0.0,0.0,0.0,,0.0
South,16.1.6,Stock position of Measles vaccines,4. Stock Distributed,3205.0,950.0,2795.0,2165.0,1075.0,1235.0,785.0,1220.0,825.0,715.0,580.0,1775.0,17325.0
South,16.1.6,Stock position of Measles vaccines,5. Total Stock,4315.0,3365.0,3570.0,3405.0,2330.0,2595.0,2310.0,3090.0,2265.0,1550.0,970.0,1695.0,31460.0
South,16.1.7,Stock position of JE vaccines,1. Balance From Previous Month,,,,,,,,,0.0,,,,0.0
South,16.1.7,Stock position of JE vaccines,2. Stocks Received,,,,,,,,,0.0,,,,0.0
South,16.1.7,Stock position of JE vaccines,3. Unusable Stock,,,,,,,,,0.0,,,,0.0
South,16.1.7,Stock position of JE vaccines,4. Stock Distributed,,,,,,,,,0.0,,,,0.0
South,16.1.7,Stock position of JE vaccines,5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
South,16.1.8,Stock position of Hepatitis B vaccines,1. Balance From Previous Month,2040.0,1930.0,1370.0,920.0,2070.0,1410.0,2420.0,2310.0,2690.0,2060.0,1430.0,1140.0,21790.0
South,16.1.8,Stock position of Hepatitis B vaccines,2. Stocks Received,1000.0,,,2000.0,0.0,1800.0,300.0,1500.0,0.0,0.0,0.0,0.0,6600.0
South,16.1.8,Stock position of Hepatitis B vaccines,3. Unusable Stock,,,,,0.0,,,,0.0,0.0,0.0,0.0,0.0
South,16.1.8,Stock position of Hepatitis B vaccines,4. Stock Distributed,1110.0,560.0,450.0,850.0,660.0,790.0,620.0,910.0,630.0,630.0,290.0,870.0,8370.0
South,16.1.8,Stock position of Hepatitis B vaccines,5. Total Stock,1930.0,1370.0,920.0,2070.0,1410.0,2420.0,2100.0,2900.0,2060.0,1430.0,1140.0,270.0,20020.0
South,16.2.1,Stock Position of IU 380 A (to be used for Family Planning),1. Balance From Previous Month,2547.0,2527.0,2432.0,2332.0,2222.0,2222.0,2217.0,2217.0,2187.0,2137.0,2007.0,1967.0,27014.0
South,16.2.1,Stock Position of IU 380 A (to be used for Family Planning),2. Stocks Received,0.0,,,,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
South,16.2.1,Stock Position of IU 380 A (to be used for Family Planning),3. Unusable Stock,,,,,0.0,0.0,,,0.0,0.0,0.0,0.0,0.0
South,16.2.1,Stock Position of IU 380 A (to be used for Family Planning),4. Stock Distributed,20.0,95.0,100.0,110.0,0.0,5.0,0.0,30.0,50.0,130.0,40.0,295.0,875.0
South,16.2.1,Stock Position of IU 380 A (to be used for Family Planning),5. Total Stock,2527.0,2432.0,2332.0,2222.0,2222.0,2217.0,2217.0,2187.0,2137.0,2007.0,1967.0,1672.0,26139.0
South,16.2.2,Stock Position of Condoms (to be used for Family Planning),1. Balance From Previous Month,,,,,,,,,,,,,
South,16.2.2,Stock Position of Condoms (to be used for Family Planning),2. Stocks Received,,,,,,,,,,,,,
South,16.2.2,Stock Position of Condoms (to be used for Family Planning),3. Unusable Stock,,,,,,,,,,,,,
South,16.2.2,Stock Position of Condoms (to be used for Family Planning),4. Stock Distributed,,,,,,,,,,,,,
South,16.2.2,Stock Position of Condoms (to be used for Family Planning),5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
South,16.2.3,Stock Position of Oral Contraceptive (to be used for Family Planning),1. Balance From Previous Month,4800.0,4600.0,4600.0,4400.0,3700.0,3600.0,3500.0,3400.0,3100.0,3000.0,3000.0,2600.0,44300.0
South,16.2.3,Stock Position of Oral Contraceptive (to be used for Family Planning),2. Stocks Received,,,,,0.0,0.0,,0.0,0.0,0.0,0.0,0.0,0.0
South,16.2.3,Stock Position of Oral Contraceptive (to be used for Family Planning),3. Unusable Stock,,,,,0.0,0.0,,0.0,0.0,0.0,0.0,0.0,0.0
South,16.2.3,Stock Position of Oral Contraceptive (to be used for Family Planning),4. Stock Distributed,200.0,,200.0,700.0,100.0,100.0,100.0,300.0,100.0,0.0,400.0,700.0,2900.0
South,16.2.3,Stock Position of Oral Contraceptive (to be used for Family Planning),5. Total Stock,4600.0,4600.0,4400.0,3700.0,3600.0,3500.0,3400.0,3100.0,3000.0,3000.0,2600.0,1900.0,41400.0
South,16.2.4,Stock Position of Emergency Contraceptive (to be used for Family Planning),1. Balance From Previous Month,5.0,5.0,5.0,5.0,5.0,0.0,,,,,,,25.0
South,16.2.4,Stock Position of Emergency Contraceptive (to be used for Family Planning),2. Stocks Received,,,,,0.0,0.0,,,,,,,0.0
South,16.2.4,Stock Position of Emergency Contraceptive (to be used for Family Planning),3. Unusable Stock,,,,,0.0,0.0,,,,,,,0.0
South,16.2.4,Stock Position of Emergency Contraceptive (to be used for Family Planning),4. Stock Distributed,,,,,0.0,0.0,,,,,,,0.0
South,16.2.4,Stock Position of Emergency Contraceptive (to be used for Family Planning),5. Total Stock,5.0,5.0,5.0,5.0,5.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,25.0
South,16.2.5,Stock Position of Tubal Rings (to be used for Family Planning),1. Balance From Previous Month,,,,,,0.0,,,,,,,0.0
South,16.2.5,Stock Position of Tubal Rings (to be used for Family Planning),2. Stocks Received,,,,,,,,,,,,,
South,16.2.5,Stock Position of Tubal Rings (to be used for Family Planning),3. Unusable Stock,,,,,,,,,,,,,
South,16.2.5,Stock Position of Tubal Rings (to be used for Family Planning),4. Stock Distributed,,,,,,,,,,,,,
South,16.2.5,Stock Position of Tubal Rings (to be used for Family Planning),5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
South,16.3.01,Stock Position of Oxytocin Injection,1. Balance From Previous Month,,,,,,,,,,,,,
South,16.3.01,Stock Position of Oxytocin Injection,2. Stocks Received,,,,,,,,,,,,,
South,16.3.01,Stock Position of Oxytocin Injection,3. Unusable Stock,,,,,,,,,,,,,
South,16.3.01,Stock Position of Oxytocin Injection,4. Stock Distributed,,,,,,,,,,,,,
South,16.3.01,Stock Position of Oxytocin Injection,5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
South,16.3.02,Stock Position of Gloves,1. Balance From Previous Month,,,,,,,,,,,,,
South,16.3.02,Stock Position of Gloves,2. Stocks Received,,,,,,,,,,,,,
South,16.3.02,Stock Position of Gloves,3. Unusable Stock,,,,,,,,,,,,,
South,16.3.02,Stock Position of Gloves,4. Stock Distributed,,,,,,,,,,,,,
South,16.3.02,Stock Position of Gloves,5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
South,16.3.03,Stock Position of MVA Syringes,1. Balance From Previous Month,,,,,,,,,,,,,
South,16.3.03,Stock Position of MVA Syringes,2. Stocks Received,,,,,,,,,,,,,
South,16.3.03,Stock Position of MVA Syringes,3. Unusable Stock,,,,,,,,,,,,,
South,16.3.03,Stock Position of MVA Syringes,4. Stock Distributed,,,,,,,,,,,,,
South,16.3.03,Stock Position of MVA Syringes,5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
South,16.3.04,Stock Position of Fluconazole Tablets,1. Balance From Previous Month,,,,,,,,,,,,,
South,16.3.04,Stock Position of Fluconazole Tablets,2. Stocks Received,,,,,,,,,,,,,
South,16.3.04,Stock Position of Fluconazole Tablets,3. Unusable Stock,,,,,,,,,,,,,
South,16.3.04,Stock Position of Fluconazole Tablets,4. Stock Distributed,,,,,,,,,,,,,
South,16.3.04,Stock Position of Fluconazole Tablets,5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
South,16.3.05,Stock Position of Blood Transfusion Sets,1. Balance From Previous Month,,,,,,,,,,,,,
South,16.3.05,Stock Position of Blood Transfusion Sets,2. Stocks Received,,,,,,,,,,,,,
South,16.3.05,Stock Position of Blood Transfusion Sets,3. Unusable Stock,,,,,,,,,,,,,
South,16.3.05,Stock Position of Blood Transfusion Sets,4. Stock Distributed,,,,,,,,,,,,,
South,16.3.05,Stock Position of Blood Transfusion Sets,5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
South,16.3.06,Stock Position of Gluteraldehyde solution of 2% concentration,1. Balance From Previous Month,,,,,,,,,,,,,
South,16.3.06,Stock Position of Gluteraldehyde solution of 2% concentration,2. Stocks Received,,,,,,,,,,,,,
South,16.3.06,Stock Position of Gluteraldehyde solution of 2% concentration,3. Unusable Stock,,,,,,,,,,,,,
South,16.3.06,Stock Position of Gluteraldehyde solution of 2% concentration,4. Stock Distributed,,,,,,,,,,,,,
South,16.3.06,Stock Position of Gluteraldehyde solution of 2% concentration,5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
South,16.3.07,Stock Position of IFA Tablets,1. Balance From Previous Month,,,,,,,,,,,,,
South,16.3.07,Stock Position of IFA Tablets,2. Stocks Received,,,,,,,,,,,,,
South,16.3.07,Stock Position of IFA Tablets,3. Unusable Stock,,,,,,,,,,,,,
South,16.3.07,Stock Position of IFA Tablets,4. Stock Distributed,,,,,,,,,,,,,
South,16.3.07,Stock Position of IFA Tablets,5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
South,16.3.08,Stock Position of IFA Syrup (Paediatric),1. Balance From Previous Month,,,,,,,,,,,,,
South,16.3.08,Stock Position of IFA Syrup (Paediatric),2. Stocks Received,,,,,,,,,,,,,
South,16.3.08,Stock Position of IFA Syrup (Paediatric),3. Unusable Stock,,,,,,,,,,,,,
South,16.3.08,Stock Position of IFA Syrup (Paediatric),4. Stock Distributed,,,,,,,,,,,,,
South,16.3.08,Stock Position of IFA Syrup (Paediatric),5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
South,16.3.09,Stock Position of Paediatrics Antibiotics (Cotrimaxozole and Injectable Gentamicin),1. Balance From Previous Month,,,,,,,,,,,,,
South,16.3.09,Stock Position of Paediatrics Antibiotics (Cotrimaxozole and Injectable Gentamicin),2. Stocks Received,,,,,,,,,,,,,
South,16.3.09,Stock Position of Paediatrics Antibiotics (Cotrimaxozole and Injectable Gentamicin),3. Unusable Stock,,,,,,,,,,,,,
South,16.3.09,Stock Position of Paediatrics Antibiotics (Cotrimaxozole and Injectable Gentamicin),4. Stock Distributed,,,,,,,,,,,,,
South,16.3.09,Stock Position of Paediatrics Antibiotics (Cotrimaxozole and Injectable Gentamicin),5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
South,16.3.10,Stock Position of Vitamin A solution,1. Balance From Previous Month,,,,,,,,,,,,0.0,0.0
South,16.3.10,Stock Position of Vitamin A solution,2. Stocks Received,,,,,,,,,,,,300.0,300.0
South,16.3.10,Stock Position of Vitamin A solution,3. Unusable Stock,,,,,,,,,,,,0.0,0.0
South,16.3.10,Stock Position of Vitamin A solution,4. Stock Distributed,,,,,,,,,,,,16.0,16.0
South,16.3.10,Stock Position of Vitamin A solution,5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,284.0,284.0
South,16.3.11,Stock of ORS (New WHO formulation),1. Balance From Previous Month,,,,,,,,,,,,,
South,16.3.11,Stock of ORS (New WHO formulation),2. Stocks Received,,,,,,,,,,,,,
South,16.3.11,Stock of ORS (New WHO formulation),3. Unusable Stock,,,,,,,,,,,,,
South,16.3.11,Stock of ORS (New WHO formulation),4. Stock Distributed,,,,,,,,,,,,,
South,16.3.11,Stock of ORS (New WHO formulation),5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
South,16.4.1,Stock Position of 0.1 ml Syringes(AD),1. Balance From Previous Month,5600.0,4200.0,3400.0,2400.0,4400.0,3400.0,2600.0,1600.0,1600.0,1600.0,1400.0,1200.0,33400.0
South,16.4.1,Stock Position of 0.1 ml Syringes(AD),2. Stocks Received,,,,3000.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,3000.0
South,16.4.1,Stock Position of 0.1 ml Syringes(AD),3. Unusable Stock,,,,,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
South,16.4.1,Stock Position of 0.1 ml Syringes(AD),4. Stock Distributed,1400.0,800.0,1000.0,1000.0,1000.0,800.0,1000.0,0.0,0.0,200.0,200.0,200.0,7600.0
South,16.4.1,Stock Position of 0.1 ml Syringes(AD),5. Total Stock,4200.0,3400.0,2400.0,4400.0,3400.0,2600.0,1600.0,1600.0,1600.0,1400.0,1200.0,1000.0,28800.0
South,16.4.2,Stock Position of 0.5 ml Syringes(AD),1. Balance From Previous Month,26500.0,18100.0,18300.0,16900.0,11700.0,8500.0,9300.0,13100.0,10500.0,4500.0,1500.0,0.0,138900.0
South,16.4.2,Stock Position of 0.5 ml Syringes(AD),2. Stocks Received,,6000.0,6000.0,1600.0,0.0,10000.0,8000.0,4000.0,0.0,0.0,0.0,21600.0,57200.0
South,16.4.2,Stock Position of 0.5 ml Syringes(AD),3. Unusable Stock,,,,,0.0,,,,0.0,0.0,0.0,0.0,0.0
South,16.4.2,Stock Position of 0.5 ml Syringes(AD),4. Stock Distributed,8400.0,5800.0,7400.0,6800.0,3200.0,9200.0,4200.0,6600.0,6000.0,3000.0,1500.0,9700.0,71800.0
South,16.4.2,Stock Position of 0.5 ml Syringes(AD),5. Total Stock,18100.0,18300.0,16900.0,11700.0,8500.0,9300.0,13100.0,10500.0,4500.0,1500.0,0.0,11900.0,124300.0
South,16.4.3,Stock Position of 5.0 ml Syringes(Disposable),1. Balance From Previous Month,800.0,800.0,800.0,800.0,700.0,700.0,700.0,700.0,500.0,300.0,300.0,0.0,7100.0
South,16.4.3,Stock Position of 5.0 ml Syringes(Disposable),2. Stocks Received,,,,,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
South,16.4.3,Stock Position of 5.0 ml Syringes(Disposable),3. Unusable Stock,,,,,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
South,16.4.3,Stock Position of 5.0 ml Syringes(Disposable),4. Stock Distributed,,,,100.0,0.0,0.0,0.0,200.0,200.0,0.0,300.0,0.0,800.0
South,16.4.3,Stock Position of 5.0 ml Syringes(Disposable),5. Total Stock,800.0,800.0,800.0,700.0,700.0,700.0,700.0,500.0,300.0,300.0,0.0,0.0,6300.0
South,17.1,Number of cases of Infant deaths within 24 hrs of birth,TOTAL,,,,,1.0,1.0,,,,,,,2.0
South,17.2.1,Number of cases of Infant deaths 24 hours to 4 weeks of birth with the probable cause being Sepsis,1. Up to 1 Weeks of Birth,,,,,,1.0,,,,,,,1.0
South,17.2.1,Number of cases of Infant deaths 24 hours to 4 weeks of birth with the probable cause being Sepsis,2. Between 1 week & 4 weeks of birth,,,,,,,,,,,,,
South,17.2.1,Number of cases of Infant deaths 24 hours to 4 weeks of birth with the probable cause being Sepsis,3. Total,,,,,,1.0,,,,,,,1.0
South,17.2.2,Number of cases of Infant deaths 24 hours to 4 weeks of birth with the probable cause being Asphyxia,1. Up to 1 Weeks of Birth,,,,,,,1.0,,1.0,,,,2.0
South,17.2.2,Number of cases of Infant deaths 24 hours to 4 weeks of birth with the probable cause being Asphyxia,2. Between 1 week & 4 weeks of birth,,,,,,,,,,,,,
South,17.2.2,Number of cases of Infant deaths 24 hours to 4 weeks of birth with the probable cause being Asphyxia,3. Total,,,,,,,1.0,,1.0,,,,2.0
South,17.2.3,Number of cases of Infant deaths 24 hours to 4 weeks of birth with the probable cause being LBW,1. Up to 1 Weeks of Birth,1.0,,1.0,,,1.0,1.0,,,,,,4.0
South,17.2.3,Number of cases of Infant deaths 24 hours to 4 weeks of birth with the probable cause being LBW,2. Between 1 week & 4 weeks of birth,,,,,,,,,,,,,
South,17.2.3,Number of cases of Infant deaths 24 hours to 4 weeks of birth with the probable cause being LBW,3. Total,1.0,,1.0,,,1.0,1.0,,,,,,4.0
South,17.2.4,"Number of cases of Infant deaths 24 hours to 4 weeks of birth with the probable cause being other than Sepsis, Asphyxia and LBW",1. Up to 1 Weeks of Birth,,,1.0,,,,,,1.0,1.0,1.0,1.0,5.0
South,17.2.4,"Number of cases of Infant deaths 24 hours to 4 weeks of birth with the probable cause being other than Sepsis, Asphyxia and LBW",2. Between 1 week & 4 weeks of birth,,,,,,,,,,,,,
South,17.2.4,"Number of cases of Infant deaths 24 hours to 4 weeks of birth with the probable cause being other than Sepsis, Asphyxia and LBW",3. Total,,,1.0,,,,,,1.0,1.0,1.0,1.0,5.0
South,17.3.1,Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being Pneumonia,1. Between 1 month and 11 months,2.0,,1.0,1.0,,,,,,1.0,,,5.0
South,17.3.1,Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being Pneumonia,2. Between 1 year & 5 years,,,,,,,,,,,,,
South,17.3.1,Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being Pneumonia,3. Total,2.0,,1.0,1.0,,,,,,1.0,,,5.0
South,17.3.2,Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being Diarrhoea,1. Between 1 month and 11 months,,,,,,,,,,,,,
South,17.3.2,Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being Diarrhoea,2. Between 1 year & 5 years,,,,,,,,,,,,,
South,17.3.2,Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being Diarrhoea,3. Total,,,,,,,,,,,,,
South,17.3.3,Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being Fever related,1. Between 1 month and 11 months,,,,,,,,,,,,,
South,17.3.3,Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being Fever related,2. Between 1 year & 5 years,,,,,,,,,,,,,
South,17.3.3,Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being Fever related,3. Total,,,,,,,,,,,,,
South,17.3.4,Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being Measles,1. Between 1 month and 11 months,,,,,,,,,,,,,
South,17.3.4,Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being Measles,2. Between 1 year & 5 years,,,,,,,,,,,,,
South,17.3.4,Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being Measles,3. Total,,,,,,,,,,,,,
South,17.3.5,"Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being other than Pneumonia, Diarrhoea, Fever related and Measles",1. Between 1 month and 11 months,,1.0,1.0,,,,,,,,,1.0,3.0
South,17.3.5,"Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being other than Pneumonia, Diarrhoea, Fever related and Measles",2. Between 1 year & 5 years,1.0,,,,,,,,,,,,1.0
South,17.3.5,"Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being other than Pneumonia, Diarrhoea, Fever related and Measles",3. Total,1.0,1.0,1.0,,,,,,,,,1.0,4.0
South,17.4.1,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Diarrhoeal diseases,1. 6-14 yrs,,,,,,,,,,,,,
South,17.4.1,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Diarrhoeal diseases,2. 15-55 yrs.,,,,,,,,,,,,,
South,17.4.1,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Diarrhoeal diseases,3. Above 55 yrs.,1.0,,,,,,,,,,,,1.0
South,17.4.1,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Diarrhoeal diseases,4. Total,1.0,,,,,,,,,,,,1.0
South,17.4.2,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Tuberculosis,1. 6-14 yrs,,,,,,,,,,,,,
South,17.4.2,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Tuberculosis,2. 15-55 yrs.,,,,,1.0,1.0,,,,,,,2.0
South,17.4.2,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Tuberculosis,3. Above 55 yrs.,,,,,1.0,,,1.0,,,,,2.0
South,17.4.2,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Tuberculosis,4. Total,,,,,2.0,1.0,,1.0,,,,,4.0
South,17.4.3,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Respiratory diseases including infections,1. 6-14 yrs,,,,1.0,,,,,,,,,1.0
South,17.4.3,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Respiratory diseases including infections,2. 15-55 yrs.,,,1.0,1.0,3.0,,2.0,,1.0,,,,8.0
South,17.4.3,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Respiratory diseases including infections,3. Above 55 yrs.,,1.0,4.0,8.0,6.0,6.0,7.0,8.0,3.0,5.0,,4.0,52.0
South,17.4.3,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Respiratory diseases including infections,4. Total,,1.0,5.0,10.0,9.0,6.0,9.0,8.0,4.0,5.0,,4.0,61.0
South,17.4.4,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Malaria,1. 6-14 yrs,,,,,,,,,,,,,
South,17.4.4,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Malaria,2. 15-55 yrs.,,,,,,,,,,,,,
South,17.4.4,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Malaria,3. Above 55 yrs.,,,,,,,,,,,,,
South,17.4.4,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Malaria,4. Total,,,,,,,,,,,,,
South,17.4.5,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being other Fever related,1. 6-14 yrs,,,,,,,,,,,,,
South,17.4.5,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being other Fever related,2. 15-55 yrs.,,,1.0,1.0,,,,,,,,,2.0
South,17.4.5,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being other Fever related,3. Above 55 yrs.,2.0,,,,,,1.0,1.0,,,,,4.0
South,17.4.5,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being other Fever related,4. Total,2.0,,1.0,1.0,,,1.0,1.0,,,,,6.0
South,17.4.6,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being HIV/AIDS,1. 6-14 yrs,,,,,,,,,,,,,
South,17.4.6,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being HIV/AIDS,2. 15-55 yrs.,,,,,,,,,,,,,
South,17.4.6,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being HIV/AIDS,3. Above 55 yrs.,,,,,,,,,,,,,
South,17.4.6,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being HIV/AIDS,4. Total,,,,,,,,,,,,,
South,17.4.7,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Heart disease or related to Hypertension,1. 6-14 yrs,,,,,,,,,,,,,
South,17.4.7,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Heart disease or related to Hypertension,2. 15-55 yrs.,1.0,1.0,1.0,1.0,4.0,1.0,2.0,3.0,,5.0,3.0,1.0,23.0
South,17.4.7,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Heart disease or related to Hypertension,3. Above 55 yrs.,1.0,,5.0,7.0,4.0,5.0,9.0,6.0,11.0,10.0,5.0,7.0,70.0
South,17.4.7,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Heart disease or related to Hypertension,4. Total,2.0,1.0,6.0,8.0,8.0,6.0,11.0,9.0,11.0,15.0,8.0,8.0,93.0
South,17.4.8,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Neurological disease including strokes,1. 6-14 yrs,,,,,,,,,,,,,
South,17.4.8,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Neurological disease including strokes,2. 15-55 yrs.,2.0,,4.0,3.0,3.0,2.0,,,1.0,1.0,,1.0,17.0
South,17.4.8,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Neurological disease including strokes,3. Above 55 yrs.,2.0,,1.0,8.0,6.0,3.0,6.0,5.0,5.0,5.0,,5.0,46.0
South,17.4.8,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Neurological disease including strokes,4. Total,4.0,,5.0,11.0,9.0,5.0,6.0,5.0,6.0,6.0,,6.0,63.0
South,17.4.9(a),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Abortion,1. 6-14 yrs,,,,,,,,,,,,,
South,17.4.9(a),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Abortion,2. 15-49 yrs,,,,,,,,,,,,,
South,17.4.9(a),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Abortion,3. Above 49 yrs.,,,,,,,,,,,,,
South,17.4.9(a),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Abortion,4. Total,,,,,,,,,,,,,
South,17.4.9(b),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Obstructed or prolonged labour,1. 6-14 yrs,,,,,,,,,,,,,
South,17.4.9(b),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Obstructed or prolonged labour,2. 15-49 yrs,,,,,,,,,,,,,
South,17.4.9(b),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Obstructed or prolonged labour,3. Above 49 yrs.,,,,,,,,,,,,,
South,17.4.9(b),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Obstructed or prolonged labour,4. Total,,,,,,,,,,,,,
South,17.4.9(c),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Severe hypertesnion or fits,1. 6-14 yrs,,,,,,,,,,,,,
South,17.4.9(c),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Severe hypertesnion or fits,2. 15-49 yrs,,,,,,,,,,,,,
South,17.4.9(c),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Severe hypertesnion or fits,3. Above 49 yrs.,,,,,,,,,,,,,
South,17.4.9(c),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Severe hypertesnion or fits,4. Total,,,,,,,,,,,,,
South,17.4.9(d),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Bleeding,1. 6-14 yrs,,,,,,,,,,,,,
South,17.4.9(d),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Bleeding,2. 15-49 yrs,,,,,,,,,,,,,
South,17.4.9(d),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Bleeding,3. Above 49 yrs.,,,,,,,,,,,,,
South,17.4.9(d),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Bleeding,4. Total,,,,,,,,,,,,,
South,17.4.9(e),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being High Fever,1. 6-14 yrs,,,,,,,,,,,,,
South,17.4.9(e),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being High Fever,2. 15-49 yrs,,,,,,,,,,,,,
South,17.4.9(e),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being High Fever,3. Above 49 yrs.,,,,,,,,,,,,,
South,17.4.9(e),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being High Fever,4. Total,,,,,,,,,,,,,
South,17.4.9(f),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being other causes (excluding abortion; obstructed or prolonged labour; severe hypertension or fits;,1. 6-14 yrs,,,,,,,,,,,,,
South,17.4.9(f),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being other causes (excluding abortion; obstructed or prolonged labour; severe hypertension or fits;,2. 15-49 yrs,,,,,,,,,,,1.0,1.0,2.0
South,17.4.9(f),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being other causes (excluding abortion; obstructed or prolonged labour; severe hypertension or fits;,3. Above 49 yrs.,,,,,,,,,,,,,
South,17.4.9(f),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being other causes (excluding abortion; obstructed or prolonged labour; severe hypertension or fits;,4. Total,,,,,,,,,,,1.0,1.0,2.0
South,17.4.10,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Trauma or Accidents or Burn cases,1. 6-14 yrs,,,,,,,1.0,1.0,,,,,2.0
South,17.4.10,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Trauma or Accidents or Burn cases,2. 15-55 yrs.,1.0,,,,,3.0,3.0,2.0,1.0,,,,10.0
South,17.4.10,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Trauma or Accidents or Burn cases,3. Above 55 yrs.,,,2.0,1.0,,,,,,,,,3.0
South,17.4.10,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Trauma or Accidents or Burn cases,4. Total,1.0,,2.0,1.0,,3.0,4.0,3.0,1.0,,,,15.0
South,17.4.11,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being suicide,1. 6-14 yrs,,,,,,,,,,,,,
South,17.4.11,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being suicide,2. 15-55 yrs.,,,1.0,,,2.0,,,,,,,3.0
South,17.4.11,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being suicide,3. Above 55 yrs.,,,,,,,,,,,,,
South,17.4.11,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being suicide,4. Total,,,1.0,,,2.0,,,,,,,3.0
South,17.4.12,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Animal bites and stings,1. 6-14 yrs,,,,,,,,,,,,,
South,17.4.12,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Animal bites and stings,2. 15-55 yrs.,,,,,,,,,,,,,
South,17.4.12,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Animal bites and stings,3. Above 55 yrs.,,,,,,,,,,,,,
South,17.4.12,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Animal bites and stings,4. Total,,,,,,,,,,,,,
South,17.4.13(a),Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Known Acute disease,1. 6-14 yrs,,,,,1.0,,,,,,,,1.0
South,17.4.13(a),Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Known Acute disease,2. 15-55 yrs.,,,,3.0,4.0,,,,,,,,7.0
South,17.4.13(a),Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Known Acute disease,3. Above 55 yrs.,2.0,,,2.0,4.0,6.0,5.0,,,,,,19.0
South,17.4.13(a),Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Known Acute disease,4. Total,2.0,,,5.0,9.0,6.0,5.0,,,,,,27.0
South,17.4.13(b),Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Known Chronic disease,1. 6-14 yrs,,,,,,,1.0,1.0,,,,,2.0
South,17.4.13(b),Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Known Chronic disease,2. 15-55 yrs.,1.0,,5.0,1.0,5.0,4.0,3.0,4.0,6.0,2.0,,1.0,32.0
South,17.4.13(b),Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Known Chronic disease,3. Above 55 yrs.,,,8.0,5.0,12.0,5.0,7.0,11.0,9.0,10.0,,5.0,72.0
South,17.4.13(b),Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Known Chronic disease,4. Total,1.0,,13.0,6.0,17.0,9.0,11.0,16.0,15.0,12.0,,6.0,106.0
South,17.4.13(c),Number of cases of Adolescent or Adult deaths (age 6 years & above) where the cause was not known,1. 6-14 yrs,,,,,,,,,,,,,
South,17.4.13(c),Number of cases of Adolescent or Adult deaths (age 6 years & above) where the cause was not known,2. 15-55 yrs.,,,,,4.0,,1.0,,,,,,5.0
South,17.4.13(c),Number of cases of Adolescent or Adult deaths (age 6 years & above) where the cause was not known,3. Above 55 yrs.,,,,3.0,19.0,1.0,1.0,,,,,,24.0
South,17.4.13(c),Number of cases of Adolescent or Adult deaths (age 6 years & above) where the cause was not known,4. Total,,,,3.0,23.0,1.0,2.0,,,,,,29.0
South East,1.1,Total number of pregnant women Registered for ANC,TOTAL,3469.0,4265.0,3685.0,3858.0,3755.0,3936.0,3240.0,3384.0,3776.0,3874.0,4016.0,4776.0,46034.0
South East,1.1.1,Of which Number registered within first trimester (within 12 weeks),TOTAL,1357.0,1564.0,1456.0,1613.0,1434.0,1457.0,1218.0,1403.0,1857.0,1927.0,2027.0,2248.0,19561.0
South East,1.2,Number of Pregnant women registered under JSY,TOTAL,77.0,105.0,85.0,63.0,93.0,68.0,83.0,65.0,85.0,107.0,139.0,177.0,1147.0
South East,1.3,Number of pregnant women received 3 ANC check ups during pregnancy,TOTAL,1505.0,1844.0,1581.0,1869.0,2125.0,1467.0,2059.0,1980.0,2178.0,2193.0,1271.0,2215.0,22287.0
South East,1.4.1,Number of pregnant women given TT1 during current pregnancy,TOTAL,1427.0,1737.0,1320.0,1647.0,1525.0,1645.0,1339.0,1408.0,1546.0,1611.0,1800.0,2226.0,19231.0
South East,1.4.2,Number of pregnant women given TT2 or Booster during current pregnancy,TOTAL,1239.0,1736.0,1442.0,1483.0,1521.0,1549.0,1324.0,1434.0,1462.0,1467.0,1324.0,1971.0,17952.0
South East,1.5,Total number of pregnant women given 100 IFA tablets,TOTAL,917.0,1546.0,1253.0,1431.0,1599.0,1631.0,1572.0,1718.0,1716.0,1708.0,1569.0,1848.0,18508.0
South East,1.6.1,Number of new cases of Hypertension (BP>140/90) detected in Pregnant women at the institution,TOTAL,28.0,40.0,34.0,44.0,44.0,28.0,29.0,27.0,23.0,34.0,38.0,52.0,421.0
South East,1.6.2,Number of Eclampsia cases managed during delivery,TOTAL,0.0,0.0,1.0,1.0,1.0,1.0,1.0,1.0,2.0,0.0,1.0,6.0,15.0
South East,1.7.1,Number of Pregnant women with anaemia i.e. Hb level<11 (tested cases),TOTAL,1197.0,1485.0,1228.0,1613.0,1462.0,1597.0,1099.0,1202.0,997.0,1176.0,1208.0,1537.0,15801.0
South East,1.7.2,Number of Pregnant women having severe anaemia (Hb<7) treated at institution,TOTAL,23.0,27.0,19.0,16.0,33.0,20.0,19.0,31.0,32.0,17.0,22.0,25.0,284.0
South East,1.8,Number of pregnancy test kits used at SC level,TOTAL,0.0,0.0,34.0,0.0,0.0,0.0,15.0,0.0,74.0,12.0,1.0,0.0,136.0
South East,2.1.1.a,Number of deliveries conducted at Home and attended by trained SBA(i.e. Doctor or Nurse or ANM),TOTAL,16.0,30.0,19.0,146.0,132.0,100.0,50.0,149.0,26.0,40.0,24.0,26.0,758.0
South East,2.1.1.b,Number of deliveries conducted at Home and attended by non trained SBA (i.e. trained TBA or Relatives etc.),TOTAL,69.0,120.0,78.0,114.0,93.0,73.0,99.0,123.0,154.0,137.0,119.0,114.0,1293.0
South East,2.1.1.c,Total number of deliveries conducted at Home and attended by trained or non-trained SBA (i.e. sum of 2.1.1.a and 2.1.1.b),TOTAL,85.0,150.0,97.0,260.0,225.0,173.0,149.0,272.0,180.0,177.0,143.0,140.0,2051.0
South East,2.1.2,Number of newborns visited within 24 hours of delivery for deliveries conducted at home,TOTAL,50.0,49.0,59.0,91.0,71.0,61.0,95.0,87.0,118.0,113.0,73.0,76.0,943.0
South East,2.1.3,Number of mothers paid JSY incentive for deliveries conducted at home,TOTAL,1.0,1.0,0.0,0.0,1.0,0.0,1.0,0.0,1.0,0.0,5.0,2.0,12.0
South East,2.2,Deliveries conducted at Public Institutions (Including C-Sections),TOTAL,260.0,295.0,276.0,283.0,397.0,349.0,327.0,308.0,296.0,314.0,283.0,237.0,3625.0
South East,2.2.1,"Out of 2.2, Number discharged under 48 hours of delivery",TOTAL,90.0,139.0,144.0,205.0,226.0,186.0,136.0,155.0,121.0,125.0,108.0,127.0,1762.0
South East,2.2.2.a,Number of mothers paid JSY Incentive for deliveries conducted at Public Institutions,TOTAL,12.0,31.0,9.0,4.0,17.0,10.0,5.0,9.0,26.0,17.0,27.0,23.0,190.0
South East,2.2.2.b,Number of ASHAs paid JSY Incentive for deliveries conducted at Public Institutions,TOTAL,4.0,22.0,2.0,4.0,13.0,2.0,4.0,7.0,20.0,12.0,13.0,19.0,122.0
South East,2.2.2.c,Number of cases of deliveries conducted at Public Institutions where JSY incentive was paid to ANMs or AWWs [only for High Performing States (HPS)],TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
South East,2.3,Deliveries conducted at Private Institutions (Including C-Sections),TOTAL,300.0,286.0,338.0,348.0,452.0,383.0,428.0,386.0,486.0,409.0,319.0,523.0,4658.0
South East,2.3.1.a,Number of mothers paid JSY Incentive for deliveries conducted at accredited Private Institutions,TOTAL,,0.0,0.0,0.0,0.0,0.0,3.0,0.0,0.0,0.0,0.0,0.0,3.0
South East,2.3.1.b,Number of ASHAs paid JSY Incentive for deliveries conducted at accredited Private Institutions,TOTAL,,0.0,0.0,,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
South East,2.3.1.c,Number of cases of deliveries conducted at accredited Private Institutions where JSY incentive was paid to ANMs or AWWs [only for High Performing States (HPS)],TOTAL,,0.0,0.0,,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
South East,3.1.1,Number of Caesarean (C-Section) deliveries performed at PHCs (Primary Health Centre),TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
South East,3.1.2,Number of Caesarean (C-Section) deliveries performed at CHCs (Community Health Centre),TOTAL,,,,0.0,,0.0,0.0,,0.0,,,0.0,0.0
South East,3.1.3,Number of Caesarean (C-Section) deliveries performed at SDHs (Sub-divisional Hospital) or DHs (District Hospital),TOTAL,40.0,46.0,30.0,30.0,45.0,38.0,36.0,36.0,39.0,38.0,27.0,29.0,434.0
South East,3.1.4,Number of Caesarean (C-Section) deliveries performed at other State owned public institutions,TOTAL,,,,,,,,,,,,,
South East,3.1.5,"Total Number of Caesarean (C-Section) deliveries performed at Public facilities i.e. PHC, CHC, SDH, DH and other State owned public institutions (sum of items from 3.1.1 to 3.1.4)",TOTAL,40.0,46.0,30.0,30.0,45.0,38.0,36.0,36.0,39.0,38.0,27.0,29.0,434.0
South East,3.2,No. of C-section deliveries performed at Private facilities,TOTAL,195.0,141.0,231.0,196.0,240.0,218.0,251.0,230.0,255.0,240.0,192.0,284.0,2673.0
South East,4.1.1.a,Number of male live births,TOTAL,353.0,401.0,385.0,485.0,550.0,473.0,478.0,493.0,514.0,488.0,394.0,455.0,5469.0
South East,4.1.1.b,Number of female live births,TOTAL,295.0,335.0,333.0,414.0,532.0,432.0,437.0,481.0,469.0,416.0,351.0,453.0,4948.0
South East,4.1.1.c,Total number of male and female live births (4.1.1.a and 4.1.1.b),TOTAL,648.0,736.0,718.0,899.0,1082.0,905.0,915.0,974.0,983.0,904.0,745.0,908.0,10417.0
South East,4.1.2,Number of still births,TOTAL,2.0,4.0,2.0,2.0,5.0,8.0,2.0,2.0,3.0,9.0,6.0,3.0,48.0
South East,4.1.3,Number of Abortions (spontaneous or induced),TOTAL,207.0,208.0,227.0,257.0,218.0,235.0,192.0,260.0,171.0,277.0,206.0,333.0,2791.0
South East,4.2.1,Number of Newborns weighed at birth,TOTAL,531.0,508.0,581.0,677.0,917.0,726.0,717.0,687.0,740.0,694.0,655.0,744.0,8177.0
South East,4.2.2,Number of Newborns having weight less than 2.5 kg,TOTAL,95.0,97.0,98.0,111.0,168.0,89.0,91.0,118.0,138.0,104.0,95.0,99.0,1303.0
South East,4.3,Number of Newborns breast fed within 1 hour of birth,TOTAL,442.0,567.0,481.0,600.0,772.0,646.0,601.0,680.0,634.0,598.0,505.0,693.0,7219.0
South East,5.1.1,Number of cases of pregnant women with Obstetric Complications and attended at PHCs,TOTAL,1.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,1.0
South East,5.1.2,Number of cases of pregnant women with Obstetric Complications and attended at CHCs,TOTAL,,53.0,,8.0,,,,,96.0,2.0,2.0,,161.0
South East,5.1.3,Number of cases of pregnant women with Obstetric Complications and attended at SDHs or DHs,TOTAL,23.0,61.0,30.0,0.0,28.0,38.0,23.0,,48.0,32.0,28.0,29.0,340.0
South East,5.1.4,Number of cases of pregnant women with Obstetric Complications and attended at other State owned public institutions,TOTAL,,,,,,,,,,,,,
South East,5.1.5,"Number of cases of pregnant women with Obstetric Complications and attended at Public facilities i.e. PHC, CHC, SDH, DH and other State owned public institutions (sum of items from 5.1.1 to 5.1.4)",TOTAL,24.0,114.0,30.0,8.0,28.0,38.0,23.0,0.0,144.0,34.0,30.0,29.0,502.0
South East,5.2,Number of cases of pregnant women with Obstetric Complications and attended at Private facilities,TOTAL,79.0,100.0,80.0,106.0,126.0,110.0,148.0,96.0,134.0,130.0,115.0,237.0,1461.0
South East,5.3.1,Number of cases of complicated pregnancies treated with IV antibiotics,TOTAL,102.0,159.0,109.0,106.0,154.0,148.0,170.0,96.0,185.0,162.0,143.0,266.0,1800.0
South East,5.3.2,Number of cases of complicated pregnancies treated with IV Antihypertensive/Magsulph injection,TOTAL,6.0,6.0,21.0,5.0,21.0,44.0,13.0,2.0,31.0,20.0,12.0,6.0,187.0
South East,5.3.3,Number of cases of complicated pregnancies treated with IV Oxytocis,TOTAL,100.0,183.0,105.0,114.0,150.0,142.0,134.0,89.0,183.0,158.0,140.0,213.0,1711.0
South East,5.3.4,Number of cases of complicated pregnancies treated with Blood Transfusion,TOTAL,10.0,16.0,6.0,4.0,16.0,3.0,17.0,5.0,16.0,9.0,22.0,5.0,129.0
South East,6.1,Women getting post partum check-up within 48 hours after delivery,TOTAL,539.0,630.0,515.0,529.0,745.0,685.0,733.0,731.0,782.0,732.0,635.0,793.0,8049.0
South East,6.2,Women getting a post partum check up between 48 hours and 14 days after delivery,TOTAL,732.0,705.0,789.0,895.0,989.0,996.0,1086.0,1147.0,1236.0,1093.0,974.0,1190.0,11832.0
South East,6.3,PNC maternal complications attended,TOTAL,6.0,9.0,12.0,12.0,15.0,17.0,16.0,22.0,24.0,21.0,13.0,43.0,210.0
South East,7.1.1,Number of MTPs conducted at Public Institutions up to 12 weeks of pregnancy,TOTAL,31.0,34.0,24.0,31.0,21.0,20.0,21.0,12.0,26.0,19.0,28.0,14.0,281.0
South East,7.1.2,Number of MTPs conducted at Public Institutions for more than 12 weeks of pregnancy,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
South East,7.1.3,Total number of MTPs conducted at Public Institutions (sum of items 7.1.1 and 7.1.2),TOTAL,31.0,34.0,24.0,31.0,21.0,20.0,21.0,12.0,26.0,19.0,28.0,14.0,281.0
South East,7.2,Number of MTPs conducted at Private Facilities,TOTAL,128.0,103.0,156.0,151.0,128.0,141.0,122.0,167.0,174.0,161.0,208.0,179.0,1818.0
South East,8.1.a,Number of new cases of RTI/STI in males for which treatment was initiated,TOTAL,175.0,210.0,219.0,215.0,173.0,215.0,212.0,247.0,200.0,280.0,206.0,219.0,2571.0
South East,8.1.b,Number of new cases of RTI/STI in females for which treatment was initiated,TOTAL,574.0,542.0,599.0,511.0,568.0,585.0,707.0,662.0,607.0,684.0,640.0,765.0,7444.0
South East,8.1.c,Total number of new cases of RTI/STI in males and females for which treatment was initiated (sum of items 8.1.a and 8.1.b),TOTAL,749.0,752.0,818.0,726.0,741.0,800.0,919.0,909.0,807.0,964.0,846.0,984.0,10015.0
South East,8.2,Number of suspected RTI/STI cases for whom wet mount test was conducted,TOTAL,3.0,5.0,1.0,3.0,3.0,4.0,3.0,0.0,0.0,7.0,2.0,2.0,33.0
South East,9.1.1.a,Number of NSV (No Scalpel Vasectomy) or Conventional Vasectomy conducted at PHCs,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
South East,9.1.1.b,Number of NSV or Conventional Vasectomy conducted at CHCs,TOTAL,,,,0.0,,0.0,0.0,,,,,0.0,0.0
South East,9.1.1.c,Number of NSV or Conventional Vasectomy conducted at SDHs or DHs,TOTAL,0.0,0.0,,0.0,0.0,0.0,0.0,0.0,,0.0,,1.0,1.0
South East,9.1.1.d,Number of NSV or Conventional Vasectomy conducted at other State owned public institutions,TOTAL,,,,,,,,,,,,,
South East,9.1.1.e,"Total Number of NSV or Conventional Vasectomy conducted at Public facilities i.e. PHC, CHC, SDH, DH and other State owned public institutions (sum of items from 9.1.1.a to 9.1.1.d)",TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,1.0,1.0
South East,9.1.2,Number of NSV or Conventional Vasectomy conducted at Private facilities,TOTAL,1.0,1.0,2.0,0.0,0.0,0.0,1.0,0.0,0.0,0.0,1.0,1.0,7.0
South East,9.2.1.a,Number of Laparoscopic sterilizations conducted at PHCs,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
South East,9.2.1.b,Number of Laparoscopic sterilizations conducted at CHCs,TOTAL,,1.0,2.0,10.0,,0.0,0.0,,,0.0,0.0,0.0,13.0
South East,9.2.1.c,Number of Laparoscopic sterilizations conducted at SDHs or DHs,TOTAL,13.0,11.0,10.0,10.0,5.0,6.0,3.0,6.0,12.0,9.0,6.0,5.0,96.0
South East,9.2.1.d,Number of Laparoscopic sterilizations conducted at other State owned public institutions,TOTAL,,,,,,,,,,,,,
South East,9.2.1.e,"Total Number of Laparoscopic sterilizations conducted at Public facilities i.e. PHC, CHC, SDH, DH and other State owned public institutions (sum of items from 9.2.1.a to 9.2.1.d)",TOTAL,13.0,12.0,12.0,20.0,5.0,6.0,3.0,6.0,12.0,9.0,6.0,5.0,109.0
South East,9.2.2,Number of Laparoscopic sterilizations conducted at Private facilities,TOTAL,25.0,18.0,15.0,11.0,22.0,22.0,22.0,36.0,59.0,35.0,49.0,25.0,339.0
South East,9.3.1.a,Number of Mini-lap sterilizations conducted at PHCs,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
South East,9.3.1.b,Number of Mini-lap sterilizations conducted at CHCs,TOTAL,,,,0.0,,0.0,0.0,,,,,0.0,0.0
South East,9.3.1.c,Number of Mini-lap sterilizations conducted at SDHs or DHs,TOTAL,2.0,3.0,1.0,1.0,0.0,0.0,1.0,1.0,1.0,0.0,,,10.0
South East,9.3.1.d,Number of Mini-lap sterilizations conducted at other State owned public institutions,TOTAL,,,,,,,,,,,,,
South East,9.3.1.e,"Total Number of Mini-lap sterilizations conducted at Public facilities i.e. PHC, CHC, SDH, DH and other State owned public institutions (sum of items from 9.3.1.a to 9.3.1.d)",TOTAL,2.0,3.0,1.0,1.0,0.0,0.0,1.0,1.0,1.0,0.0,0.0,0.0,10.0
South East,9.3.2,Number of Mini-lap sterilizations conducted at Private facilities,TOTAL,0.0,1.0,0.0,2.0,0.0,4.0,3.0,5.0,1.0,4.0,0.0,1.0,21.0
South East,9.4.1.a,Number of Post-Partum sterilizations conducted at PHCs,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
South East,9.4.1.b,Number of Post-Partum sterilizations conducted at CHCs,TOTAL,,,,0.0,,0.0,0.0,2.0,,,,0.0,2.0
South East,9.4.1.c,Number of Post-Partum sterilizations conducted at SDHs or DHs,TOTAL,1.0,4.0,1.0,1.0,1.0,2.0,0.0,1.0,1.0,3.0,1.0,,16.0
South East,9.4.1.d,Number of Post-Partum sterilizations conducted at other State owned public institutions,TOTAL,,,,,,,,,,,,,
South East,9.4.1.e,"Total Number of Post-Partum sterilizations conducted at Public facilities i.e. PHC, CHC, SDH, DH and other State owned public institutions (sum of items from 9.4.1.a to 9.4.1.d)",TOTAL,1.0,4.0,1.0,1.0,1.0,2.0,0.0,3.0,1.0,3.0,1.0,0.0,18.0
South East,9.4.2,Number of Post-Partum sterilizations conducted at Private facilities,TOTAL,0.0,0.0,1.0,1.0,2.0,0.0,0.0,2.0,4.0,4.0,4.0,1.0,19.0
South East,9.5.1.a,Number of IUCD Insertions conducted at SCs,TOTAL,,0.0,,0.0,0.0,0.0,0.0,0.0,0.0,,0.0,,0.0
South East,9.5.1.b,Number of IUCD Insertions conducted at PHCs,TOTAL,112.0,112.0,146.0,256.0,214.0,185.0,133.0,215.0,181.0,191.0,158.0,177.0,2080.0
South East,9.5.1.c,Number of IUCD Insertions conducted at CHCs,TOTAL,43.0,46.0,48.0,111.0,52.0,48.0,45.0,39.0,56.0,60.0,66.0,68.0,682.0
South East,9.5.1.d,Number of IUCD Insertions conducted at SDHs or DHs,TOTAL,54.0,59.0,50.0,57.0,60.0,50.0,38.0,26.0,30.0,56.0,95.0,40.0,615.0
South East,9.5.1.e,Number of IUCD Insertions conducted at other State owned public institutions,TOTAL,,,,,,,,,,,,,
South East,9.5.1.f,"Total Number of IUCD Insertions conducted at Public facilities i.e. SC, PHC, CHC, SDH, DH and other State owned public institutions (sum of items from 9.5.1.a to 9.5.1.e)",TOTAL,209.0,217.0,244.0,424.0,326.0,283.0,216.0,280.0,267.0,307.0,319.0,285.0,3377.0
South East,9.5.1A,"Out of above total, Post Partum (within 48 hours of delivery) IUCD insertions",TOTAL,22.0,28.0,10.0,24.0,13.0,16.0,0.0,2.0,5.0,31.0,47.0,19.0,217.0
South East,9.5.2,Number of IUCD Insertions conducted at Private facilities,TOTAL,25.0,29.0,29.0,60.0,41.0,63.0,35.0,68.0,33.0,53.0,40.0,42.0,518.0
South East,9.06,Number of IUCD removals,TOTAL,61.0,66.0,54.0,80.0,88.0,144.0,44.0,79.0,65.0,49.0,86.0,95.0,911.0
South East,9.07,Number of Oral Pills cycles distributed,TOTAL,1589.0,1974.0,1614.0,1801.0,1525.0,1574.0,1412.0,1851.0,1836.0,2170.0,1514.0,1544.0,20404.0
South East,9.08,Number of Condom pieces distributed,TOTAL,29182.0,36555.0,29471.0,51657.0,40733.0,38792.0,30002.0,27718.0,28895.0,24498.0,24350.0,27392.0,389245.0
South East,9.09,Number of Centchroman (weekly) pills given,TOTAL,1.0,0.0,2.0,0.0,3.0,3.0,3.0,3.0,0.0,0.0,0.0,0.0,15.0
South East,9.10,Number of Emergency Contraceptive Pills distributed,TOTAL,56.0,20.0,19.0,18.0,32.0,54.0,62.0,68.0,77.0,48.0,29.0,49.0,532.0
South East,9.11.1.a,Number of cases of complications following male sterilization,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
South East,9.11.1.b,Number of cases of complications following female sterilization,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
South East,9.11.2.a,Number of failures following male sterilization,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
South East,9.11.2.b,Number of failures following female sterilization,TOTAL,1.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,1.0
South East,9.11.3.a,Number of deaths following male sterilization,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
South East,9.11.3.b,Number of deaths following female sterilization,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
South East,9.12,Number of Institutions having NSV trained doctors,TOTAL,1.0,1.0,1.0,4.0,2.0,5.0,6.0,7.0,1.0,,2.0,3.0,-1.0
South East,10.1.01,Number of Infants (0 to 11 months old)received BCG immunisation,TOTAL,1030.0,1118.0,972.0,1259.0,1433.0,1351.0,1435.0,1369.0,1395.0,1302.0,1177.0,1412.0,15253.0
South East,10.1.02,Number of Infants (0 to 11 months old) received DPT1 immunisation,TOTAL,452.0,547.0,425.0,500.0,444.0,537.0,489.0,455.0,484.0,352.0,276.0,317.0,5278.0
South East,10.1.03,Number of Infants (0 to 11 months old) received DPT2 immunisation,TOTAL,539.0,630.0,503.0,591.0,534.0,447.0,500.0,500.0,585.0,557.0,309.0,427.0,6122.0
South East,10.1.04,Number of Infants (0 to 11 months old) received DPT3 immunisation,TOTAL,640.0,632.0,605.0,630.0,602.0,626.0,483.0,556.0,605.0,660.0,442.0,513.0,6994.0
South East,10.1.04A,Number of Infants (0 to 11 months old) received Pentavalent1 immunisation,TOTAL,1307.0,1469.0,1101.0,1294.0,1292.0,1418.0,1772.0,1921.0,2181.0,1935.0,1874.0,1781.0,19345.0
South East,10.1.04B,Number of Infants (0 to 11 months old) received Pentavalent2 immunisation,TOTAL,1266.0,1418.0,1187.0,1330.0,1307.0,1187.0,1365.0,1627.0,2082.0,1976.0,4754.0,1912.0,21411.0
South East,10.1.04C,Number of Infants (0 to 11 months old) received Pentavalent3 immunisation,TOTAL,1192.0,1414.0,1107.0,1251.0,1358.0,1071.0,1196.0,1292.0,1747.0,1811.0,1505.0,1624.0,16568.0
South East,10.1.05,Number of Infants (0 to 11 months old) received OPV 0 (Birth Dose),TOTAL,447.0,532.0,489.0,697.0,739.0,748.0,723.0,535.0,549.0,592.0,490.0,639.0,7180.0
South East,10.1.06,Number of Infants (0 to 11 months old) received OPV1 (First Dose),TOTAL,1691.0,1909.0,1499.0,1744.0,1683.0,1985.0,2205.0,2370.0,2525.0,2290.0,2005.0,2128.0,24034.0
South East,10.1.07,Number of Infants (0 to 11 months old) received OPV2 (Second Dose),TOTAL,1743.0,1954.0,1632.0,1880.0,1776.0,1617.0,1855.0,2154.0,2610.0,2495.0,1872.0,2230.0,23818.0
South East,10.1.08,Number of Infants (0 to 11 months old) received OPV3 (Third Dose),TOTAL,1756.0,1932.0,1667.0,1839.0,1830.0,1695.0,1686.0,1898.0,2293.0,2517.0,1894.0,2126.0,23133.0
South East,10.1.09A,Number of Infants (upto 48 hrs of age) received Hepatitis-B0 immunisation,TOTAL,425.0,455.0,436.0,510.0,724.0,635.0,727.0,521.0,575.0,557.0,453.0,606.0,6624.0
South East,10.1.09,Number of Infants (0 to 11 months old) received Hepatitis-B1 immunisation,TOTAL,419.0,484.0,402.0,478.0,423.0,527.0,421.0,462.0,459.0,398.0,243.0,255.0,4971.0
South East,10.1.10,Number of Infants (0 to 11 months old) received Hepatitis-B2 immunisation,TOTAL,492.0,511.0,419.0,545.0,462.0,439.0,429.0,456.0,531.0,448.0,330.0,306.0,5368.0
South East,10.1.11,Number of Infants (0 to 11 months old) received Hepatitis-B3 immunisation,TOTAL,511.0,523.0,437.0,565.0,495.0,487.0,433.0,507.0,548.0,502.0,362.0,333.0,5703.0
South East,10.1.12,Number of Infants (0 to 11 months old) received Measles immunisation (First Dose),TOTAL,2618.0,3748.0,2100.0,2352.0,2324.0,2132.0,2031.0,2496.0,2222.0,1961.0,1919.0,2086.0,27989.0
South East,10.1.12B,Number of Infants (more than 16 months old) received Measles immunisation (Second Dose),TOTAL,4672.0,3746.0,3650.0,1825.0,507.0,189.0,166.0,123.0,179.0,385.0,354.0,414.0,16210.0
South East,10.1A,No. of Children aged 9 to 12 months who received JE 1st dose,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
South East,10.1.13.a,Total number of male children (9 to 11 months old) fully immunised (BCG+DPT123/Pentavalent123+OPV123+Measles) during the month,TOTAL,1231.0,1829.0,980.0,1075.0,1169.0,910.0,1027.0,1211.0,1130.0,993.0,945.0,1019.0,13519.0
South East,10.1.13.b,Total number of female children (9 to 11 months old) fully immunised (BCG+DPT123/Pentavalent123+OPV123+Measles) during the month,TOTAL,1163.0,1617.0,907.0,972.0,1012.0,831.0,897.0,1038.0,987.0,867.0,838.0,920.0,12049.0
South East,10.1.13.c,Total number of children (9 to 11 months old) fully immunised (BCG+DPT123/Pentavalent123+OPV123+Measles) during the month (sum of items 10.1.13.a and 10.1.13.b),TOTAL,2394.0,3446.0,1887.0,2047.0,2181.0,1741.0,1924.0,2249.0,2117.0,1860.0,1783.0,1939.0,25568.0
South East,10.2.1,Number of Infants (more than 16 months old) received DPT Booster dose,TOTAL,1634.0,2062.0,1572.0,1916.0,1845.0,1831.0,1573.0,1994.0,2228.0,1945.0,2203.0,2452.0,23255.0
South East,10.2.2,Number of Infants (more than 16 months old) received OPV Booster dose,TOTAL,1660.0,2053.0,1561.0,1917.0,1837.0,1834.0,1575.0,1990.0,2215.0,1947.0,2197.0,2415.0,23201.0
South East,10.2.3,"Number of Infants (more than 16 months old) received Measles, Mumps, Rubella (MMR) Vaccination",TOTAL,120.0,328.0,150.0,224.0,1868.0,2328.0,1938.0,3038.0,3007.0,1960.0,2228.0,1956.0,19145.0
South East,10.3.1.a,Total number of male children (12 to 23 months old) fully immunised (BCG+DPT123/Pentavalent123+OPV123+Measles) during the month,TOTAL,316.0,453.0,366.0,313.0,224.0,328.0,308.0,404.0,214.0,172.0,220.0,239.0,3557.0
South East,10.3.1.b,Total number of female children (12 to 23 months old) fully immunised (BCG+DPT123/Pentavalent123+OPV123+Measles) during the month,TOTAL,259.0,453.0,288.0,262.0,211.0,324.0,250.0,314.0,180.0,148.0,198.0,199.0,3086.0
South East,10.3.1.c,Total number of children (12 to 23 months old) fully immunised (BCG+DPT123+OPV123/Pentavalent123+Measles) during the month (sum of items 10.3.1.a and 10.3.1.b),TOTAL,575.0,906.0,654.0,575.0,435.0,652.0,558.0,718.0,394.0,320.0,418.0,438.0,6643.0
South East,10.3.2,Number of children (more than 5 years old) given DT5,TOTAL,732.0,1142.0,1084.0,759.0,870.0,907.0,892.0,993.0,1401.0,1153.0,832.0,1187.0,11952.0
South East,10.3.3,Number of children (more than 10 years old) given TT10,TOTAL,276.0,544.0,414.0,318.0,254.0,273.0,305.0,276.0,324.0,306.0,242.0,353.0,3885.0
South East,10.3.4,Number of children (more than 16 years old) given TT16,TOTAL,124.0,216.0,183.0,125.0,139.0,159.0,162.0,178.0,196.0,208.0,178.0,169.0,2037.0
South East,10.3.5.a,Number of cases of Abscess reported following immunisation [Adverse Event Following Immunisation (AEFI)],TOTAL,1.0,0.0,0.0,0.0,0.0,1.0,0.0,0.0,2.0,0.0,0.0,1.0,5.0
South East,10.3.5.b,Number of cases of Death reported following immunisation [Adverse Event Following Immunisation (AEFI)],TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
South East,10.3.5.c,Number of cases of other complications reported following immunisation [Adverse Event Following Immunisation (AEFI)],TOTAL,0.0,0.0,0.0,0.0,1.0,0.0,0.0,0.0,1.0,0.0,0.0,0.0,2.0
South East,10.4.1,Number of Immunisation sessions planned to be held during the month,TOTAL,618.0,677.0,614.0,615.0,557.0,538.0,545.0,589.0,706.0,655.0,632.0,627.0,7373.0
South East,10.4.2,Number of Immunisation sessions held during the month,TOTAL,593.0,671.0,593.0,604.0,546.0,512.0,507.0,562.0,682.0,632.0,603.0,597.0,7102.0
South East,10.4.3,Number of Immunisation sessions held during the month where ASHAs were present,TOTAL,206.0,260.0,228.0,199.0,215.0,191.0,227.0,252.0,351.0,298.0,283.0,275.0,2985.0
South East,10.5.1,Number of children (more than 16 months old) received Japanese Encephalitis (JE) vaccination,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
South East,11.1.1,Number of children (9 months to 5 years old) administered 1st dose of Vitamin A (Dose-1),TOTAL,2404.0,3801.0,2110.0,2171.0,2301.0,1993.0,2062.0,2397.0,2215.0,1596.0,1055.0,983.0,25088.0
South East,11.1.2,Number of children (9 months to 5 years old) were administered 5th dose of Vitamin A (Dose-5),TOTAL,1715.0,2142.0,2146.0,1464.0,1658.0,1617.0,1587.0,1838.0,2071.0,1191.0,874.0,672.0,18975.0
South East,11.1.3,Number of children (9 months to 5 years old) administered 9th dose of Vitamin A (Dose-9),TOTAL,789.0,1451.0,969.0,799.0,1221.0,886.0,1146.0,1312.0,1149.0,651.0,303.0,396.0,11072.0
South East,12.1,Number of cases of Diptheria reported in children below 5 years of age,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
South East,12.2,Number of cases of Pertusis reported in children below 5 years of age,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
South East,12.3,Number of cases of Tetanus neonatarum reported in children below 5 years of age,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
South East,12.4,Number of cases of Tetanus other than neonatarum reported in children below 5 years of age,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
South East,12.5,Number of cases of Polio reported in children below 5 years of age,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
South East,12.6,Number of cases of Measles reported in children below 5 years of age,TOTAL,12.0,20.0,0.0,0.0,1.0,2.0,0.0,0.0,1.0,1.0,0.0,0.0,37.0
South East,12.7,Number of cases of Diarrhoea and Dehydration reported in children below 5 years of age,TOTAL,693.0,816.0,845.0,795.0,802.0,717.0,650.0,576.0,524.0,472.0,330.0,299.0,7519.0
South East,12.8,Number of cases of Malaria reported in children below 5 years of age,TOTAL,0.0,0.0,2.0,2.0,7.0,7.0,2.0,2.0,20.0,0.0,0.0,0.0,42.0
South East,12.9,Number of children below 5 years of age admitted with Respiratory Infections,TOTAL,6.0,13.0,10.0,12.0,14.0,17.0,57.0,56.0,22.0,36.0,46.0,24.0,313.0
South East,13.1,Number of Patients operated for cataract,TOTAL,320.0,204.0,174.0,231.0,164.0,212.0,128.0,271.0,271.0,126.0,225.0,316.0,2642.0
South East,13.2,Number of Intraocular Lens(IOL) implantations,TOTAL,313.0,204.0,164.0,220.0,158.0,205.0,127.0,269.0,250.0,122.0,217.0,290.0,2539.0
South East,13.3,Number of School children detected with Refractive errors,TOTAL,122.0,101.0,56.0,155.0,23.0,89.0,60.0,21.0,64.0,72.0,111.0,76.0,950.0
South East,13.4,Number of children provided free glasses,TOTAL,0.0,0.0,0.0,10.0,10.0,9.0,0.0,0.0,0.0,0.0,33.0,0.0,62.0
South East,13.5,Number of eyes collected through eye donation,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
South East,13.6,Number of eyes utilised for corneal transplant,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
South East,14.01,Number of CHC or SDH or DH functioning as First Referral units (FRUs),TOTAL,,,,,,,,,,,,2.0,-1.0
South East,14.02,Number of PHCs functioning 24X7 with atleast 3 Staff Nurses,TOTAL,,,,,,,,,1.0,,,1.0,-1.0
South East,14.03,Number of Anganwadi centres reported to have conducted VHNDs,TOTAL,38.0,47.0,42.0,38.0,33.0,31.0,37.0,43.0,41.0,46.0,31.0,41.0,-1.0
South East,14.04,Number of facilities having a Rogi Kalyan Samiti (RKS),TOTAL,,,,,,,,,,,,1.0,-1.0
South East,14.05,Number of RKS meetings held during the month,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
South East,14.06,Number of facilities having Ambulance services (Assured Referral Services),TOTAL,3.0,5.0,5.0,4.0,4.0,4.0,7.0,5.0,10.0,10.0,11.0,11.0,-1.0
South East,14.07,Total Number of times the Ambulance was used for transporting patients during the month,TOTAL,243.0,257.0,265.0,257.0,295.0,258.0,267.0,260.0,327.0,366.0,381.0,372.0,3548.0
South East,14.08,Number of Institutions having Operational Sick New Born and Child Care Units (SNCU),TOTAL,2.0,2.0,2.0,1.0,2.0,5.0,4.0,4.0,4.0,5.0,5.0,8.0,-1.0
South East,14.09,Number of functional Laproscopes in CHC/SDH/DH,TOTAL,6.0,11.0,23.0,10.0,15.0,14.0,8.0,19.0,14.0,17.0,17.0,14.0,-1.0
South East,14.10.1.a,Number of male patients admitted (Inpatients) during the month,1. Children,380.0,529.0,571.0,569.0,620.0,587.0,710.0,780.0,970.0,661.0,462.0,1299.0,8138.0
South East,14.10.1.a,Number of male patients admitted (Inpatients) during the month,2. Adults,2107.0,1551.0,2134.0,2222.0,2239.0,2355.0,2102.0,2252.0,2480.0,3157.0,2556.0,3080.0,28235.0
South East,14.10.1.b,Number of female patients (Inpatients) admitted during the month,1. Children,209.0,322.0,341.0,377.0,442.0,378.0,519.0,524.0,615.0,447.0,387.0,688.0,5249.0
South East,14.10.1.b,Number of female patients (Inpatients) admitted during the month,2. Adults,2157.0,2933.0,2234.0,2298.0,2462.0,2531.0,2402.0,2453.0,2827.0,3297.0,2654.0,3739.0,31987.0
South East,14.10.1.c,Total number of patients admitted (Inpatients) during the month (sum of items 14.10.1.a and 14.10.1.b),1. Children,589.0,851.0,912.0,946.0,1062.0,965.0,1229.0,1304.0,1585.0,1108.0,849.0,1987.0,13387.0
South East,14.10.1.c,Total number of patients admitted (Inpatients) during the month (sum of items 14.10.1.a and 14.10.1.b),2. Adults,4264.0,4484.0,4368.0,4520.0,4701.0,4886.0,4504.0,4705.0,5307.0,6454.0,5210.0,6819.0,60222.0
South East,14.10.2.a,Number of death cases of Inpatient males,TOTAL,82.0,55.0,70.0,73.0,66.0,69.0,78.0,73.0,84.0,70.0,88.0,89.0,897.0
South East,14.10.2.b,Number of death cases of Inpatient females,TOTAL,32.0,32.0,41.0,38.0,39.0,35.0,51.0,42.0,47.0,47.0,45.0,56.0,505.0
South East,14.10.2.c,Number of cases of death of Inpatients (sum of items 14.10.2.a and 14.10.2.b),TOTAL,114.0,87.0,111.0,111.0,105.0,104.0,129.0,115.0,131.0,117.0,133.0,145.0,1402.0
South East,14.11,In-Patient Head Count at midnight,TOTAL,18234.0,21902.0,22842.0,24156.0,24558.0,25676.0,21982.0,23973.0,27847.0,25947.0,21078.0,29596.0,287791.0
South East,14.12.1,OPD attendance (All),TOTAL,188603.0,232812.0,180370.0,197473.0,206108.0,244796.0,203421.0,216205.0,202114.0,247976.0,250014.0,256402.0,2626294.0
South East,14.13.1,Number of major operations carried out using general or spinal anaesthesia,TOTAL,2178.0,1774.0,1633.0,1756.0,1942.0,1842.0,1777.0,1824.0,2092.0,1813.0,1981.0,2190.0,22802.0
South East,14.13.1A,"Out of 14.13.1,Gynecology- Hysterectomy surgeries",TOTAL,50.0,95.0,137.0,51.0,99.0,13.0,15.0,52.0,58.0,60.0,60.0,48.0,738.0
South East,14.13.2,Number of minor operations carried out without anaesthesia or using local anaesthesia,TOTAL,654.0,550.0,478.0,607.0,697.0,760.0,654.0,595.0,1352.0,1168.0,881.0,1209.0,9605.0
South East,14.14.a,Number of patients given AYUSH treatment,TOTAL,929.0,958.0,755.0,70.0,979.0,941.0,31.0,80.0,1003.0,2284.0,2491.0,2439.0,12960.0
South East,14.14.b,Number of patients on whom Dental Procedure was conducted,TOTAL,491.0,397.0,574.0,318.0,522.0,454.0,571.0,407.0,408.0,2056.0,2006.0,2172.0,10376.0
South East,14.14.c,Number of Adolescents counselled,TOTAL,151.0,205.0,75.0,91.0,107.0,234.0,208.0,254.0,287.0,137.0,138.0,157.0,2044.0
South East,15.1.1.a,Number of Haemoglobin (Hb) tests conducted,TOTAL,4668.0,6711.0,4267.0,6314.0,6790.0,7169.0,9787.0,6591.0,9234.0,10907.0,13998.0,10991.0,97427.0
South East,15.1.1.b,"Out of the total number of Hb tests conducted, number of cases having Hb less than 7gm/dl",TOTAL,135.0,139.0,129.0,131.0,109.0,141.0,103.0,89.0,108.0,153.0,145.0,86.0,1468.0
South East,15.1.2.a,Number of HIV tests conducted on males,1. Number tested,116.0,96.0,112.0,229.0,90.0,102.0,82.0,81.0,377.0,345.0,414.0,683.0,2727.0
South East,15.1.2.a,Number of HIV tests conducted on males,2. Number Positive,0.0,7.0,2.0,8.0,2.0,1.0,0.0,3.0,4.0,1.0,2.0,8.0,38.0
South East,15.1.2.b,Number of HIV tests conducted on Female-Non ANC (i.e. non pregnant females),1. Number tested,67.0,232.0,103.0,311.0,324.0,321.0,290.0,216.0,690.0,736.0,778.0,808.0,4876.0
South East,15.1.2.b,Number of HIV tests conducted on Female-Non ANC (i.e. non pregnant females),2. Number Positive,1.0,0.0,1.0,2.0,1.0,3.0,0.0,0.0,3.0,1.0,1.0,7.0,20.0
South East,15.1.2.c,Number of HIV tests conducted on Female with ANC (i.e. pregnant females),1. Number tested,466.0,612.0,396.0,774.0,559.0,474.0,416.0,553.0,907.0,944.0,769.0,928.0,7798.0
South East,15.1.2.c,Number of HIV tests conducted on Female with ANC (i.e. pregnant females),2. Number Positive,0.0,0.0,0.0,0.0,1.0,0.0,1.0,1.0,0.0,0.0,0.0,0.0,3.0
South East,15.1.2.d,Total number of HIV tests conducted (sum of items 15.1.2.a to 15.1.2.c),1. Number tested,649.0,940.0,611.0,1314.0,973.0,897.0,788.0,850.0,1974.0,2025.0,1961.0,2419.0,15401.0
South East,15.1.2.d,Total number of HIV tests conducted (sum of items 15.1.2.a to 15.1.2.c),2. Number Positive,1.0,7.0,3.0,10.0,4.0,4.0,1.0,4.0,7.0,2.0,3.0,15.0,61.0
South East,15.2,Number of Widal tests conducted,Number tested,313.0,554.0,351.0,692.0,784.0,1078.0,948.0,807.0,987.0,806.0,1157.0,636.0,9113.0
South East,15.3.a,Number of VDRL tests conducted on males,Number tested,67.0,30.0,36.0,55.0,43.0,122.0,66.0,50.0,208.0,68.0,91.0,164.0,1000.0
South East,15.3.b,Number of VDRL tests conducted on Female-Non ANC (i.e. non pregnant females),Number tested,40.0,187.0,34.0,229.0,220.0,333.0,259.0,199.0,523.0,189.0,204.0,155.0,2572.0
South East,15.3.c,Number of VDRL tests conducted on Female with ANC (i.e. pregnant females),Number tested,413.0,302.0,172.0,251.0,170.0,315.0,306.0,121.0,166.0,328.0,552.0,717.0,3813.0
South East,15.3.d,Total number of VDRL tests conducted (sum of items 15.3.a to 15.3.c),Number tested,520.0,519.0,242.0,535.0,433.0,770.0,631.0,370.0,897.0,585.0,847.0,1036.0,7385.0
South East,15.4.1,Number of blood smears examined for Malaria,TOTAL,781.0,868.0,592.0,881.0,1219.0,1578.0,1474.0,1092.0,1188.0,1013.0,1518.0,787.0,12991.0
South East,15.4.2,"Out of blood smears examined for malaria, number of blood smears tested positive for Plasmodium Vivax",TOTAL,3.0,3.0,5.0,8.0,18.0,24.0,11.0,5.0,104.0,1.0,2.0,0.0,184.0
South East,15.4.3,"Out of blood smears examined for malaria, number of blood smears tested positive for Plasmodium Falciparum",TOTAL,0.0,0.0,0.0,0.0,1.0,1.0,2.0,1.0,1.0,0.0,2.0,0.0,8.0
South East,16.1.1,Stock position of DPT vaccines,1. Balance From Previous Month,3820.0,4880.0,2040.0,3110.0,4660.0,3000.0,3170.0,2570.0,2030.0,2890.0,1010.0,4090.0,37270.0
South East,16.1.1,Stock position of DPT vaccines,2. Stocks Received,4000.0,,3000.0,4000.0,0.0,3000.0,1000.0,2500.0,3000.0,0.0,5000.0,4000.0,29500.0
South East,16.1.1,Stock position of DPT vaccines,3. Unusable Stock,,,,,0.0,,,,,0.0,,,0.0
South East,16.1.1,Stock position of DPT vaccines,4. Stock Distributed,2940.0,2840.0,1930.0,2450.0,1660.0,2830.0,1600.0,3040.0,2140.0,1880.0,1920.0,3970.0,29200.0
South East,16.1.1,Stock position of DPT vaccines,5. Total Stock,4880.0,2040.0,3110.0,4660.0,3000.0,3170.0,2570.0,2030.0,2890.0,1010.0,4090.0,4120.0,37570.0
South East,16.1.1A,Stock Position of Pentavalent,1. Balance From Previous Month,3200.0,3590.0,4890.0,4040.0,4620.0,3160.0,5290.0,5190.0,5130.0,3980.0,1490.0,1680.0,46260.0
South East,16.1.1A,Stock Position of Pentavalent,2. Stocks Received,3000.0,4000.0,1000.0,2500.0,0.0,4500.0,1500.0,3000.0,1500.0,0.0,3500.0,6000.0,30500.0
South East,16.1.1A,Stock Position of Pentavalent,3. Unusable Stock,,,,,0.0,,,,,0.0,0.0,,0.0
South East,16.1.1A,Stock Position of Pentavalent,4. Stock Distributed,2610.0,2700.0,1850.0,1920.0,1460.0,2370.0,1600.0,3060.0,2650.0,2490.0,3310.0,4500.0,30520.0
South East,16.1.1A,Stock Position of Pentavalent,5. Total Stock,3590.0,4890.0,4040.0,4620.0,3160.0,5290.0,5190.0,5130.0,3980.0,1490.0,1680.0,3180.0,46240.0
South East,16.1.2,Stock position of OPV vaccines,1. Balance From Previous Month,1040.0,8000.0,7160.0,7940.0,7380.0,4180.0,7100.0,4700.0,7000.0,3880.0,340.0,4960.0,63680.0
South East,16.1.2,Stock position of OPV vaccines,2. Stocks Received,10000.0,5000.0,5000.0,4000.0,0.0,4000.0,1000.0,8000.0,2000.0,0.0,10000.0,10000.0,59000.0
South East,16.1.2,Stock position of OPV vaccines,3. Unusable Stock,,,,,0.0,,,,,0.0,0.0,,0.0
South East,16.1.2,Stock position of OPV vaccines,4. Stock Distributed,3040.0,5840.0,4220.0,4560.0,3200.0,1080.0,3400.0,5700.0,5120.0,3540.0,5380.0,9900.0,54980.0
South East,16.1.2,Stock position of OPV vaccines,5. Total Stock,8000.0,7160.0,7940.0,7380.0,4180.0,7100.0,4700.0,7000.0,3880.0,340.0,4960.0,5060.0,67700.0
South East,16.1.3,Stock position of TT vaccines,1. Balance From Previous Month,1130.0,2330.0,2970.0,3610.0,4720.0,3200.0,3790.0,4330.0,4460.0,5380.0,4310.0,2270.0,42500.0
South East,16.1.3,Stock position of TT vaccines,2. Stocks Received,3000.0,3000.0,2000.0,3000.0,0.0,2500.0,2000.0,2000.0,3000.0,0.0,0.0,4000.0,24500.0
South East,16.1.3,Stock position of TT vaccines,3. Unusable Stock,,,,,0.0,,,,,0.0,0.0,,0.0
South East,16.1.3,Stock position of TT vaccines,4. Stock Distributed,1800.0,2360.0,1360.0,1890.0,1520.0,1910.0,1460.0,1870.0,2080.0,1070.0,2040.0,2970.0,22330.0
South East,16.1.3,Stock position of TT vaccines,5. Total Stock,2330.0,2970.0,3610.0,4720.0,3200.0,3790.0,4330.0,4460.0,5380.0,4310.0,2270.0,3300.0,44670.0
South East,16.1.4,Stock position of DT vaccines,1. Balance From Previous Month,,,,,,,,,,,,,
South East,16.1.4,Stock position of DT vaccines,2. Stocks Received,,,,,,,,,,,,,
South East,16.1.4,Stock position of DT vaccines,3. Unusable Stock,,,,,,,,,,,,,
South East,16.1.4,Stock position of DT vaccines,4. Stock Distributed,,,,,,,,,,,,,
South East,16.1.4,Stock position of DT vaccines,5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
South East,16.1.5,Stock position of BCG vaccines,1. Balance From Previous Month,2450.0,3170.0,1980.0,1400.0,3230.0,2470.0,3550.0,3600.0,4230.0,4900.0,4070.0,2810.0,37860.0
South East,16.1.5,Stock position of BCG vaccines,2. Stocks Received,2000.0,,,3000.0,0.0,2000.0,1000.0,2000.0,2000.0,0.0,0.0,3000.0,15000.0
South East,16.1.5,Stock position of BCG vaccines,3. Unusable Stock,,,,,0.0,,,,,0.0,0.0,,0.0
South East,16.1.5,Stock position of BCG vaccines,4. Stock Distributed,1280.0,1190.0,580.0,1170.0,760.0,920.0,950.0,1370.0,1330.0,830.0,1260.0,2230.0,13870.0
South East,16.1.5,Stock position of BCG vaccines,5. Total Stock,3170.0,1980.0,1400.0,3230.0,2470.0,3550.0,3600.0,4230.0,4900.0,4070.0,2810.0,3580.0,38990.0
South East,16.1.6,Stock position of Measles vaccines,1. Balance From Previous Month,2935.0,3415.0,550.0,4050.0,2220.0,1175.0,1595.0,1095.0,1865.0,2760.0,1515.0,3180.0,26355.0
South East,16.1.6,Stock position of Measles vaccines,2. Stocks Received,5000.0,2500.0,10000.0,900.0,120.0,2500.0,1000.0,3000.0,2500.0,0.0,3000.0,1000.0,31520.0
South East,16.1.6,Stock position of Measles vaccines,3. Unusable Stock,,,,,0.0,,,,,0.0,0.0,,0.0
South East,16.1.6,Stock position of Measles vaccines,4. Stock Distributed,4520.0,5365.0,6500.0,2730.0,1165.0,2080.0,1500.0,2230.0,1605.0,1245.0,1335.0,2810.0,33085.0
South East,16.1.6,Stock position of Measles vaccines,5. Total Stock,3415.0,550.0,4050.0,2220.0,1175.0,1595.0,1095.0,1865.0,2760.0,1515.0,3180.0,1370.0,24790.0
South East,16.1.7,Stock position of JE vaccines,1. Balance From Previous Month,,,,,,,,,,,,,
South East,16.1.7,Stock position of JE vaccines,2. Stocks Received,,,,,,,,,,,,,
South East,16.1.7,Stock position of JE vaccines,3. Unusable Stock,,,,,,,,,,,,,
South East,16.1.7,Stock position of JE vaccines,4. Stock Distributed,,,,,,,,,,,,,
South East,16.1.7,Stock position of JE vaccines,5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
South East,16.1.8,Stock position of Hepatitis B vaccines,1. Balance From Previous Month,1720.0,2430.0,2180.0,4120.0,3930.0,3380.0,3990.0,3410.0,1940.0,1650.0,1230.0,1450.0,31430.0
South East,16.1.8,Stock position of Hepatitis B vaccines,2. Stocks Received,2000.0,500.0,2500.0,1000.0,0.0,1500.0,0.0,0.0,1000.0,0.0,600.0,600.0,9700.0
South East,16.1.8,Stock position of Hepatitis B vaccines,3. Unusable Stock,,,,,0.0,,,,,0.0,0.0,,0.0
South East,16.1.8,Stock position of Hepatitis B vaccines,4. Stock Distributed,1290.0,750.0,560.0,1190.0,550.0,890.0,580.0,1470.0,1290.0,420.0,380.0,630.0,10000.0
South East,16.1.8,Stock position of Hepatitis B vaccines,5. Total Stock,2430.0,2180.0,4120.0,3930.0,3380.0,3990.0,3410.0,1940.0,1650.0,1230.0,1450.0,1420.0,31130.0
South East,16.2.1,Stock Position of IU 380 A (to be used for Family Planning),1. Balance From Previous Month,970.0,970.0,720.0,720.0,490.0,440.0,440.0,440.0,310.0,285.0,245.0,235.0,6265.0
South East,16.2.1,Stock Position of IU 380 A (to be used for Family Planning),2. Stocks Received,,,,,0.0,0.0,0.0,,0.0,0.0,0.0,0.0,0.0
South East,16.2.1,Stock Position of IU 380 A (to be used for Family Planning),3. Unusable Stock,,,,,0.0,0.0,0.0,,0.0,0.0,0.0,,0.0
South East,16.2.1,Stock Position of IU 380 A (to be used for Family Planning),4. Stock Distributed,,250.0,,230.0,50.0,0.0,0.0,130.0,25.0,40.0,10.0,235.0,970.0
South East,16.2.1,Stock Position of IU 380 A (to be used for Family Planning),5. Total Stock,970.0,720.0,720.0,490.0,440.0,440.0,440.0,310.0,285.0,245.0,235.0,0.0,5295.0
South East,16.2.2,Stock Position of Condoms (to be used for Family Planning),1. Balance From Previous Month,,,,,0.0,,,,,0.0,,,0.0
South East,16.2.2,Stock Position of Condoms (to be used for Family Planning),2. Stocks Received,,,,,0.0,,,,,0.0,,,0.0
South East,16.2.2,Stock Position of Condoms (to be used for Family Planning),3. Unusable Stock,,,,,0.0,,,,,0.0,,,0.0
South East,16.2.2,Stock Position of Condoms (to be used for Family Planning),4. Stock Distributed,,,,,0.0,,,,,0.0,,,0.0
South East,16.2.2,Stock Position of Condoms (to be used for Family Planning),5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
South East,16.2.3,Stock Position of Oral Contraceptive (to be used for Family Planning),1. Balance From Previous Month,2800.0,2375.0,2275.0,1875.0,1575.0,1475.0,1275.0,1170.0,975.0,875.0,875.0,575.0,18120.0
South East,16.2.3,Stock Position of Oral Contraceptive (to be used for Family Planning),2. Stocks Received,,,,,0.0,0.0,0.0,,0.0,0.0,0.0,,0.0
South East,16.2.3,Stock Position of Oral Contraceptive (to be used for Family Planning),3. Unusable Stock,,,,,0.0,0.0,0.0,,0.0,0.0,0.0,,0.0
South East,16.2.3,Stock Position of Oral Contraceptive (to be used for Family Planning),4. Stock Distributed,425.0,100.0,400.0,300.0,100.0,200.0,105.0,195.0,100.0,0.0,300.0,575.0,2800.0
South East,16.2.3,Stock Position of Oral Contraceptive (to be used for Family Planning),5. Total Stock,2375.0,2275.0,1875.0,1575.0,1475.0,1275.0,1170.0,975.0,875.0,875.0,575.0,0.0,15320.0
South East,16.2.4,Stock Position of Emergency Contraceptive (to be used for Family Planning),1. Balance From Previous Month,,,,,,,,,,,,,
South East,16.2.4,Stock Position of Emergency Contraceptive (to be used for Family Planning),2. Stocks Received,,,,,,,,,,,,,
South East,16.2.4,Stock Position of Emergency Contraceptive (to be used for Family Planning),3. Unusable Stock,,,,,,,,,,,,,
South East,16.2.4,Stock Position of Emergency Contraceptive (to be used for Family Planning),4. Stock Distributed,,,,,,,,,,,,,
South East,16.2.4,Stock Position of Emergency Contraceptive (to be used for Family Planning),5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
South East,16.2.5,Stock Position of Tubal Rings (to be used for Family Planning),1. Balance From Previous Month,,,,,,,,,,,,,
South East,16.2.5,Stock Position of Tubal Rings (to be used for Family Planning),2. Stocks Received,,,,,,,,,,,,,
South East,16.2.5,Stock Position of Tubal Rings (to be used for Family Planning),3. Unusable Stock,,,,,,,,,,,,,
South East,16.2.5,Stock Position of Tubal Rings (to be used for Family Planning),4. Stock Distributed,,,,,,,,,,,,,
South East,16.2.5,Stock Position of Tubal Rings (to be used for Family Planning),5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
South East,16.3.01,Stock Position of Oxytocin Injection,1. Balance From Previous Month,,,,,,,,,,,,,
South East,16.3.01,Stock Position of Oxytocin Injection,2. Stocks Received,,,,,,,,,,,,,
South East,16.3.01,Stock Position of Oxytocin Injection,3. Unusable Stock,,,,,,,,,,,,,
South East,16.3.01,Stock Position of Oxytocin Injection,4. Stock Distributed,,,,,,,,,,,,,
South East,16.3.01,Stock Position of Oxytocin Injection,5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
South East,16.3.02,Stock Position of Gloves,1. Balance From Previous Month,,,,,,,,,,,,,
South East,16.3.02,Stock Position of Gloves,2. Stocks Received,,,,,,,,,,,,,
South East,16.3.02,Stock Position of Gloves,3. Unusable Stock,,,,,,,,,,,,,
South East,16.3.02,Stock Position of Gloves,4. Stock Distributed,,,,,,,,,,,,,
South East,16.3.02,Stock Position of Gloves,5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
South East,16.3.03,Stock Position of MVA Syringes,1. Balance From Previous Month,,,,,,,,,,,,,
South East,16.3.03,Stock Position of MVA Syringes,2. Stocks Received,,,,,,,,,,,,,
South East,16.3.03,Stock Position of MVA Syringes,3. Unusable Stock,,,,,,,,,,,,,
South East,16.3.03,Stock Position of MVA Syringes,4. Stock Distributed,,,,,,,,,,,,,
South East,16.3.03,Stock Position of MVA Syringes,5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
South East,16.3.04,Stock Position of Fluconazole Tablets,1. Balance From Previous Month,,,,,,,,,,,,,
South East,16.3.04,Stock Position of Fluconazole Tablets,2. Stocks Received,,,,,,,,,,,,,
South East,16.3.04,Stock Position of Fluconazole Tablets,3. Unusable Stock,,,,,,,,,,,,,
South East,16.3.04,Stock Position of Fluconazole Tablets,4. Stock Distributed,,,,,,,,,,,,,
South East,16.3.04,Stock Position of Fluconazole Tablets,5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
South East,16.3.05,Stock Position of Blood Transfusion Sets,1. Balance From Previous Month,,,,,,,,,,,,,
South East,16.3.05,Stock Position of Blood Transfusion Sets,2. Stocks Received,,,,,,,,,,,,,
South East,16.3.05,Stock Position of Blood Transfusion Sets,3. Unusable Stock,,,,,,,,,,,,,
South East,16.3.05,Stock Position of Blood Transfusion Sets,4. Stock Distributed,,,,,,,,,,,,,
South East,16.3.05,Stock Position of Blood Transfusion Sets,5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
South East,16.3.06,Stock Position of Gluteraldehyde solution of 2% concentration,1. Balance From Previous Month,,,,,,,,,,,,,
South East,16.3.06,Stock Position of Gluteraldehyde solution of 2% concentration,2. Stocks Received,,,,,,,,,,,,,
South East,16.3.06,Stock Position of Gluteraldehyde solution of 2% concentration,3. Unusable Stock,,,,,,,,,,,,,
South East,16.3.06,Stock Position of Gluteraldehyde solution of 2% concentration,4. Stock Distributed,,,,,,,,,,,,,
South East,16.3.06,Stock Position of Gluteraldehyde solution of 2% concentration,5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
South East,16.3.07,Stock Position of IFA Tablets,1. Balance From Previous Month,,,,,,,,,,,,,
South East,16.3.07,Stock Position of IFA Tablets,2. Stocks Received,,,,,,,,,,,,,
South East,16.3.07,Stock Position of IFA Tablets,3. Unusable Stock,,,,,,,,,,,,,
South East,16.3.07,Stock Position of IFA Tablets,4. Stock Distributed,,,,,,,,,,,,,
South East,16.3.07,Stock Position of IFA Tablets,5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
South East,16.3.08,Stock Position of IFA Syrup (Paediatric),1. Balance From Previous Month,,,,,,,,,,,,,
South East,16.3.08,Stock Position of IFA Syrup (Paediatric),2. Stocks Received,,,,,,,,,,,,,
South East,16.3.08,Stock Position of IFA Syrup (Paediatric),3. Unusable Stock,,,,,,,,,,,,,
South East,16.3.08,Stock Position of IFA Syrup (Paediatric),4. Stock Distributed,,,,,,,,,,,,,
South East,16.3.08,Stock Position of IFA Syrup (Paediatric),5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
South East,16.3.09,Stock Position of Paediatrics Antibiotics (Cotrimaxozole and Injectable Gentamicin),1. Balance From Previous Month,,,,,,,,,,,,,
South East,16.3.09,Stock Position of Paediatrics Antibiotics (Cotrimaxozole and Injectable Gentamicin),2. Stocks Received,,,,,,,,,,,,,
South East,16.3.09,Stock Position of Paediatrics Antibiotics (Cotrimaxozole and Injectable Gentamicin),3. Unusable Stock,,,,,,,,,,,,,
South East,16.3.09,Stock Position of Paediatrics Antibiotics (Cotrimaxozole and Injectable Gentamicin),4. Stock Distributed,,,,,,,,,,,,,
South East,16.3.09,Stock Position of Paediatrics Antibiotics (Cotrimaxozole and Injectable Gentamicin),5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
South East,16.3.10,Stock Position of Vitamin A solution,1. Balance From Previous Month,153.0,215.0,119.0,1179.0,1016.0,933.0,613.0,555.0,183.0,,,0.0,4966.0
South East,16.3.10,Stock Position of Vitamin A solution,2. Stocks Received,100.0,,1200.0,,0.0,0.0,0.0,,0.0,,,500.0,1800.0
South East,16.3.10,Stock Position of Vitamin A solution,3. Unusable Stock,,,,,0.0,0.0,0.0,,0.0,,,,0.0
South East,16.3.10,Stock Position of Vitamin A solution,4. Stock Distributed,38.0,96.0,140.0,163.0,83.0,320.0,58.0,372.0,183.0,,,180.0,1633.0
South East,16.3.10,Stock Position of Vitamin A solution,5. Total Stock,215.0,119.0,1179.0,1016.0,933.0,613.0,555.0,183.0,0.0,0.0,0.0,320.0,5133.0
South East,16.3.11,Stock of ORS (New WHO formulation),1. Balance From Previous Month,,,,,,,,,,,,,
South East,16.3.11,Stock of ORS (New WHO formulation),2. Stocks Received,,,,,,,,,,,,,
South East,16.3.11,Stock of ORS (New WHO formulation),3. Unusable Stock,,,,,,,,,,,,,
South East,16.3.11,Stock of ORS (New WHO formulation),4. Stock Distributed,,,,,,,,,,,,,
South East,16.3.11,Stock of ORS (New WHO formulation),5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
South East,16.4.1,Stock Position of 0.1 ml Syringes(AD),1. Balance From Previous Month,2600.0,1700.0,900.0,1300.0,2300.0,2100.0,1900.0,1500.0,700.0,2100.0,1700.0,2900.0,21700.0
South East,16.4.1,Stock Position of 0.1 ml Syringes(AD),2. Stocks Received,,,2000.0,2000.0,0.0,0.0,0.0,,2000.0,0.0,2000.0,0.0,8000.0
South East,16.4.1,Stock Position of 0.1 ml Syringes(AD),3. Unusable Stock,,,,,0.0,0.0,0.0,,0.0,0.0,0.0,,0.0
South East,16.4.1,Stock Position of 0.1 ml Syringes(AD),4. Stock Distributed,900.0,800.0,1600.0,1000.0,200.0,200.0,400.0,800.0,600.0,400.0,800.0,1300.0,9000.0
South East,16.4.1,Stock Position of 0.1 ml Syringes(AD),5. Total Stock,1700.0,900.0,1300.0,2300.0,2100.0,1900.0,1500.0,700.0,2100.0,1700.0,2900.0,1600.0,20700.0
South East,16.4.2,Stock Position of 0.5 ml Syringes(AD),1. Balance From Previous Month,14500.0,6500.0,1500.0,6900.0,1600.0,0.0,6000.0,14600.0,3600.0,12400.0,3200.0,12400.0,83200.0
South East,16.4.2,Stock Position of 0.5 ml Syringes(AD),2. Stocks Received,4000.0,6000.0,10000.0,4000.0,0.0,16000.0,18000.0,2000.0,16000.0,0.0,21600.0,21600.0,119200.0
South East,16.4.2,Stock Position of 0.5 ml Syringes(AD),3. Unusable Stock,,,,,0.0,0.0,,,0.0,0.0,0.0,,0.0
South East,16.4.2,Stock Position of 0.5 ml Syringes(AD),4. Stock Distributed,12000.0,11000.0,4600.0,9300.0,1600.0,10000.0,9400.0,13000.0,7200.0,9200.0,12400.0,15200.0,114900.0
South East,16.4.2,Stock Position of 0.5 ml Syringes(AD),5. Total Stock,6500.0,1500.0,6900.0,1600.0,0.0,6000.0,14600.0,3600.0,12400.0,3200.0,12400.0,18800.0,87500.0
South East,16.4.3,Stock Position of 5.0 ml Syringes(Disposable),1. Balance From Previous Month,300.0,200.0,100.0,900.0,500.0,0.0,600.0,1200.0,300.0,1000.0,500.0,500.0,6100.0
South East,16.4.3,Stock Position of 5.0 ml Syringes(Disposable),2. Stocks Received,400.0,,1000.0,,0.0,1000.0,1000.0,0.0,1000.0,0.0,1400.0,1000.0,6800.0
South East,16.4.3,Stock Position of 5.0 ml Syringes(Disposable),3. Unusable Stock,,,,,0.0,0.0,,,0.0,0.0,0.0,,0.0
South East,16.4.3,Stock Position of 5.0 ml Syringes(Disposable),4. Stock Distributed,500.0,100.0,200.0,400.0,500.0,400.0,400.0,900.0,300.0,500.0,1400.0,1100.0,6700.0
South East,16.4.3,Stock Position of 5.0 ml Syringes(Disposable),5. Total Stock,200.0,100.0,900.0,500.0,0.0,600.0,1200.0,300.0,1000.0,500.0,500.0,400.0,6200.0
South East,17.1,Number of cases of Infant deaths within 24 hrs of birth,TOTAL,,,1.0,,,,,,,,,,1.0
South East,17.2.1,Number of cases of Infant deaths 24 hours to 4 weeks of birth with the probable cause being Sepsis,1. Up to 1 Weeks of Birth,,,,,,,1.0,,,,,,1.0
South East,17.2.1,Number of cases of Infant deaths 24 hours to 4 weeks of birth with the probable cause being Sepsis,2. Between 1 week & 4 weeks of birth,,,,,,,,,,,,,
South East,17.2.1,Number of cases of Infant deaths 24 hours to 4 weeks of birth with the probable cause being Sepsis,3. Total,,,,,,,1.0,,,,,,1.0
South East,17.2.2,Number of cases of Infant deaths 24 hours to 4 weeks of birth with the probable cause being Asphyxia,1. Up to 1 Weeks of Birth,,,,,,,,,,,,,
South East,17.2.2,Number of cases of Infant deaths 24 hours to 4 weeks of birth with the probable cause being Asphyxia,2. Between 1 week & 4 weeks of birth,,,,,,,,,,,,,
South East,17.2.2,Number of cases of Infant deaths 24 hours to 4 weeks of birth with the probable cause being Asphyxia,3. Total,,,,,,,,,,,,,
South East,17.2.3,Number of cases of Infant deaths 24 hours to 4 weeks of birth with the probable cause being LBW,1. Up to 1 Weeks of Birth,,,,,,,,,,,,,
South East,17.2.3,Number of cases of Infant deaths 24 hours to 4 weeks of birth with the probable cause being LBW,2. Between 1 week & 4 weeks of birth,,,,,,,,,,,,,
South East,17.2.3,Number of cases of Infant deaths 24 hours to 4 weeks of birth with the probable cause being LBW,3. Total,,,,,,,,,,,,,
South East,17.2.4,"Number of cases of Infant deaths 24 hours to 4 weeks of birth with the probable cause being other than Sepsis, Asphyxia and LBW",1. Up to 1 Weeks of Birth,,,3.0,5.0,4.0,2.0,2.0,6.0,3.0,3.0,6.0,2.0,36.0
South East,17.2.4,"Number of cases of Infant deaths 24 hours to 4 weeks of birth with the probable cause being other than Sepsis, Asphyxia and LBW",2. Between 1 week & 4 weeks of birth,,,,,,,,,,,,,
South East,17.2.4,"Number of cases of Infant deaths 24 hours to 4 weeks of birth with the probable cause being other than Sepsis, Asphyxia and LBW",3. Total,,,3.0,5.0,4.0,2.0,2.0,6.0,3.0,3.0,6.0,2.0,36.0
South East,17.3.1,Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being Pneumonia,1. Between 1 month and 11 months,,,,,,,,,,,,,
South East,17.3.1,Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being Pneumonia,2. Between 1 year & 5 years,,,,,,,,,,,,,
South East,17.3.1,Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being Pneumonia,3. Total,,,,,,,,,,,,,
South East,17.3.2,Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being Diarrhoea,1. Between 1 month and 11 months,,,,,,,,,,,,,
South East,17.3.2,Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being Diarrhoea,2. Between 1 year & 5 years,,,,,,,,,,,,,
South East,17.3.2,Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being Diarrhoea,3. Total,,,,,,,,,,,,,
South East,17.3.3,Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being Fever related,1. Between 1 month and 11 months,,,,,,,,,,,,,
South East,17.3.3,Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being Fever related,2. Between 1 year & 5 years,,,,,,,,,,,,,
South East,17.3.3,Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being Fever related,3. Total,,,,,,,,,,,,,
South East,17.3.4,Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being Measles,1. Between 1 month and 11 months,,,,,,,,,,,,,
South East,17.3.4,Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being Measles,2. Between 1 year & 5 years,,,,,,,,,,,,,
South East,17.3.4,Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being Measles,3. Total,,,,,,,,,,,,,
South East,17.3.5,"Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being other than Pneumonia, Diarrhoea, Fever related and Measles",1. Between 1 month and 11 months,5.0,,3.0,3.0,3.0,,7.0,3.0,,,2.0,,26.0
South East,17.3.5,"Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being other than Pneumonia, Diarrhoea, Fever related and Measles",2. Between 1 year & 5 years,1.0,,1.0,1.0,1.0,,4.0,1.0,1.0,,,,10.0
South East,17.3.5,"Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being other than Pneumonia, Diarrhoea, Fever related and Measles",3. Total,6.0,,4.0,4.0,4.0,,11.0,4.0,1.0,,2.0,,36.0
South East,17.4.1,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Diarrhoeal diseases,1. 6-14 yrs,,,,,,,,,,,,,
South East,17.4.1,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Diarrhoeal diseases,2. 15-55 yrs.,,,,,,,,,,,,,
South East,17.4.1,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Diarrhoeal diseases,3. Above 55 yrs.,,,,,,,,,,,,,
South East,17.4.1,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Diarrhoeal diseases,4. Total,,,,,,,,,,,,,
South East,17.4.2,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Tuberculosis,1. 6-14 yrs,,,,,,,,,,,,,
South East,17.4.2,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Tuberculosis,2. 15-55 yrs.,,,,,,,,,,,,,
South East,17.4.2,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Tuberculosis,3. Above 55 yrs.,,,1.0,,,,,,,,,,1.0
South East,17.4.2,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Tuberculosis,4. Total,,,1.0,,,,,,,,,,1.0
South East,17.4.3,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Respiratory diseases including infections,1. 6-14 yrs,,,,,,,,,,,,,
South East,17.4.3,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Respiratory diseases including infections,2. 15-55 yrs.,,,,,,1.0,3.0,1.0,2.0,1.0,,1.0,9.0
South East,17.4.3,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Respiratory diseases including infections,3. Above 55 yrs.,,,,1.0,3.0,1.0,2.0,4.0,6.0,2.0,,5.0,24.0
South East,17.4.3,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Respiratory diseases including infections,4. Total,,,,1.0,3.0,2.0,5.0,5.0,8.0,3.0,,6.0,33.0
South East,17.4.4,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Malaria,1. 6-14 yrs,,,,,,,,,,,,,
South East,17.4.4,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Malaria,2. 15-55 yrs.,,,,,,,,,,,,,
South East,17.4.4,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Malaria,3. Above 55 yrs.,,,,,,,,,,,,,
South East,17.4.4,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Malaria,4. Total,,,,,,,,,,,,,
South East,17.4.5,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being other Fever related,1. 6-14 yrs,,,,,,,,,,,,,
South East,17.4.5,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being other Fever related,2. 15-55 yrs.,,,,,,,,1.0,,,,,1.0
South East,17.4.5,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being other Fever related,3. Above 55 yrs.,,,,,,,2.0,1.0,,,,,3.0
South East,17.4.5,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being other Fever related,4. Total,,,,,,,2.0,2.0,,,,,4.0
South East,17.4.6,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being HIV/AIDS,1. 6-14 yrs,,,,,,,,,,,,,
South East,17.4.6,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being HIV/AIDS,2. 15-55 yrs.,,,,,,,,,,,,,
South East,17.4.6,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being HIV/AIDS,3. Above 55 yrs.,,,,,,,,,,,,,
South East,17.4.6,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being HIV/AIDS,4. Total,,,,,,,,,,,,,
South East,17.4.7,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Heart disease or related to Hypertension,1. 6-14 yrs,,,,,,,,,,,,,
South East,17.4.7,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Heart disease or related to Hypertension,2. 15-55 yrs.,,,2.0,,,1.0,,,2.0,1.0,,1.0,7.0
South East,17.4.7,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Heart disease or related to Hypertension,3. Above 55 yrs.,,,6.0,1.0,4.0,6.0,3.0,2.0,5.0,4.0,,2.0,33.0
South East,17.4.7,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Heart disease or related to Hypertension,4. Total,,,8.0,1.0,4.0,7.0,3.0,2.0,7.0,5.0,,3.0,40.0
South East,17.4.8,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Neurological disease including strokes,1. 6-14 yrs,,,,,,,,,,,,,
South East,17.4.8,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Neurological disease including strokes,2. 15-55 yrs.,,,,,,,,,,,,,
South East,17.4.8,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Neurological disease including strokes,3. Above 55 yrs.,,,,,,,,,,,,,
South East,17.4.8,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Neurological disease including strokes,4. Total,,,,,,,,,,,,,
South East,17.4.9(a),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Abortion,1. 6-14 yrs,,,,,,,,,,,,,
South East,17.4.9(a),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Abortion,2. 15-49 yrs,,,,,,,,,,,,,
South East,17.4.9(a),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Abortion,3. Above 49 yrs.,,,,,,,,,,,,,
South East,17.4.9(a),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Abortion,4. Total,,,,,,,,,,,,,
South East,17.4.9(b),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Obstructed or prolonged labour,1. 6-14 yrs,,,,,,,,,,,,,
South East,17.4.9(b),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Obstructed or prolonged labour,2. 15-49 yrs,,,,,,,,,,,,,
South East,17.4.9(b),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Obstructed or prolonged labour,3. Above 49 yrs.,,,,,,,,,,,,,
South East,17.4.9(b),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Obstructed or prolonged labour,4. Total,,,,,,,,,,,,,
South East,17.4.9(c),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Severe hypertesnion or fits,1. 6-14 yrs,,,,,,,,,,,,,
South East,17.4.9(c),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Severe hypertesnion or fits,2. 15-49 yrs,,,,,,,,,,,,,
South East,17.4.9(c),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Severe hypertesnion or fits,3. Above 49 yrs.,,,,,,,,,,,,,
South East,17.4.9(c),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Severe hypertesnion or fits,4. Total,,,,,,,,,,,,,
South East,17.4.9(d),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Bleeding,1. 6-14 yrs,,,,,,,,,,,,,
South East,17.4.9(d),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Bleeding,2. 15-49 yrs,,,,,,,,,,,,,
South East,17.4.9(d),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Bleeding,3. Above 49 yrs.,,,,,,,,,,,,,
South East,17.4.9(d),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Bleeding,4. Total,,,,,,,,,,,,,
South East,17.4.9(e),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being High Fever,1. 6-14 yrs,,,,,,,,,,,,,
South East,17.4.9(e),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being High Fever,2. 15-49 yrs,,,,,,,,,,,,,
South East,17.4.9(e),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being High Fever,3. Above 49 yrs.,,,,,,,,,,,,,
South East,17.4.9(e),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being High Fever,4. Total,,,,,,,,,,,,,
South East,17.4.9(f),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being other causes (excluding abortion; obstructed or prolonged labour; severe hypertension or fits;,1. 6-14 yrs,,,,,,,,,,,,,
South East,17.4.9(f),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being other causes (excluding abortion; obstructed or prolonged labour; severe hypertension or fits;,2. 15-49 yrs,,,1.0,,1.0,,2.0,1.0,1.0,,,,6.0
South East,17.4.9(f),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being other causes (excluding abortion; obstructed or prolonged labour; severe hypertension or fits;,3. Above 49 yrs.,,,,,,,,,,,,,
South East,17.4.9(f),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being other causes (excluding abortion; obstructed or prolonged labour; severe hypertension or fits;,4. Total,,,1.0,,1.0,,2.0,1.0,1.0,,,,6.0
South East,17.4.10,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Trauma or Accidents or Burn cases,1. 6-14 yrs,,,,,,,,,,,,,
South East,17.4.10,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Trauma or Accidents or Burn cases,2. 15-55 yrs.,,,,,,,,,1.0,,,,1.0
South East,17.4.10,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Trauma or Accidents or Burn cases,3. Above 55 yrs.,,,,,,,,1.0,,,,,1.0
South East,17.4.10,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Trauma or Accidents or Burn cases,4. Total,,,,,,,,1.0,1.0,,,,2.0
South East,17.4.11,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being suicide,1. 6-14 yrs,,,,,,,,,,,,,
South East,17.4.11,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being suicide,2. 15-55 yrs.,,,,,,,1.0,,,,,,1.0
South East,17.4.11,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being suicide,3. Above 55 yrs.,,,,,,,,,,,,,
South East,17.4.11,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being suicide,4. Total,,,,,,,1.0,,,,,,1.0
South East,17.4.12,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Animal bites and stings,1. 6-14 yrs,,,,,,,,,,,,,
South East,17.4.12,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Animal bites and stings,2. 15-55 yrs.,,,,,,,,,,,,,
South East,17.4.12,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Animal bites and stings,3. Above 55 yrs.,,,,,,,,,,,,,
South East,17.4.12,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Animal bites and stings,4. Total,,,,,,,,,,,,,
South East,17.4.13(a),Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Known Acute disease,1. 6-14 yrs,,,,,,,,,,,,,
South East,17.4.13(a),Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Known Acute disease,2. 15-55 yrs.,,,,,,,38.0,,,,,,38.0
South East,17.4.13(a),Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Known Acute disease,3. Above 55 yrs.,,,2.0,,,,47.0,,,,,,49.0
South East,17.4.13(a),Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Known Acute disease,4. Total,,,2.0,,,,85.0,,,,,,87.0
South East,17.4.13(b),Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Known Chronic disease,1. 6-14 yrs,,,,,,,,,,,,,
South East,17.4.13(b),Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Known Chronic disease,2. 15-55 yrs.,,,,,,,,,,,,,
South East,17.4.13(b),Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Known Chronic disease,3. Above 55 yrs.,,,,,,,,,,,,,
South East,17.4.13(b),Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Known Chronic disease,4. Total,,,,,,,,,,,,,
South East,17.4.13(c),Number of cases of Adolescent or Adult deaths (age 6 years & above) where the cause was not known,1. 6-14 yrs,,,,,,4.0,,,,,1.0,,5.0
South East,17.4.13(c),Number of cases of Adolescent or Adult deaths (age 6 years & above) where the cause was not known,2. 15-55 yrs.,,,,2.0,1.0,35.0,,,,,3.0,,41.0
South East,17.4.13(c),Number of cases of Adolescent or Adult deaths (age 6 years & above) where the cause was not known,3. Above 55 yrs.,,,,1.0,2.0,48.0,1.0,2.0,1.0,,4.0,,59.0
South East,17.4.13(c),Number of cases of Adolescent or Adult deaths (age 6 years & above) where the cause was not known,4. Total,,,,3.0,3.0,87.0,1.0,2.0,1.0,,8.0,,105.0
South West,1.1,Total number of pregnant women Registered for ANC,TOTAL,3175.0,2998.0,2758.0,3209.0,2773.0,3400.0,2451.0,2757.0,2763.0,2914.0,3294.0,3100.0,35592.0
South West,1.1.1,Of which Number registered within first trimester (within 12 weeks),TOTAL,1541.0,1334.0,1222.0,1455.0,1208.0,1535.0,1029.0,1243.0,1349.0,1538.0,1608.0,1575.0,16637.0
South West,1.2,Number of Pregnant women registered under JSY,TOTAL,119.0,146.0,150.0,143.0,139.0,257.0,191.0,153.0,139.0,194.0,245.0,173.0,2049.0
South West,1.3,Number of pregnant women received 3 ANC check ups during pregnancy,TOTAL,2371.0,2612.0,2604.0,2884.0,2642.0,2546.0,2533.0,2590.0,2003.0,2401.0,2438.0,1938.0,29562.0
South West,1.4.1,Number of pregnant women given TT1 during current pregnancy,TOTAL,1713.0,1673.0,1429.0,1566.0,1611.0,1596.0,1352.0,1321.0,1280.0,1368.0,1427.0,1650.0,17986.0
South West,1.4.2,Number of pregnant women given TT2 or Booster during current pregnancy,TOTAL,1788.0,1436.0,1401.0,1497.0,1532.0,1445.0,1302.0,1254.0,1225.0,1192.0,1107.0,1332.0,16511.0
South West,1.5,Total number of pregnant women given 100 IFA tablets,TOTAL,1578.0,2105.0,1523.0,1768.0,2389.0,1953.0,2322.0,2467.0,1856.0,2340.0,2436.0,1366.0,24103.0
South West,1.6.1,Number of new cases of Hypertension (BP>140/90) detected in Pregnant women at the institution,TOTAL,635.0,643.0,62.0,101.0,61.0,73.0,69.0,109.0,63.0,102.0,37.0,52.0,2007.0
South West,1.6.2,Number of Eclampsia cases managed during delivery,TOTAL,0.0,0.0,1.0,0.0,1.0,2.0,1.0,0.0,2.0,0.0,1.0,1.0,9.0
South West,1.7.1,Number of Pregnant women with anaemia i.e. Hb level<11 (tested cases),TOTAL,1985.0,1975.0,2007.0,2195.0,2760.0,2728.0,1934.0,2677.0,1420.0,1491.0,1827.0,1345.0,24344.0
South West,1.7.2,Number of Pregnant women having severe anaemia (Hb<7) treated at institution,TOTAL,85.0,81.0,108.0,170.0,158.0,115.0,97.0,112.0,74.0,70.0,101.0,100.0,1271.0
South West,1.8,Number of pregnancy test kits used at SC level,TOTAL,0.0,0.0,4.0,8.0,4.0,28.0,14.0,5.0,176.0,11.0,23.0,9.0,282.0
South West,2.1.1.a,Number of deliveries conducted at Home and attended by trained SBA(i.e. Doctor or Nurse or ANM),TOTAL,4.0,6.0,10.0,11.0,7.0,2.0,5.0,10.0,3.0,10.0,1.0,5.0,74.0
South West,2.1.1.b,Number of deliveries conducted at Home and attended by non trained SBA (i.e. trained TBA or Relatives etc.),TOTAL,96.0,91.0,83.0,117.0,122.0,132.0,122.0,93.0,142.0,128.0,122.0,77.0,1325.0
South West,2.1.1.c,Total number of deliveries conducted at Home and attended by trained or non-trained SBA (i.e. sum of 2.1.1.a and 2.1.1.b),TOTAL,100.0,97.0,93.0,128.0,129.0,134.0,127.0,103.0,145.0,138.0,123.0,82.0,1399.0
South West,2.1.2,Number of newborns visited within 24 hours of delivery for deliveries conducted at home,TOTAL,44.0,40.0,51.0,82.0,74.0,84.0,75.0,56.0,78.0,70.0,63.0,49.0,766.0
South West,2.1.3,Number of mothers paid JSY incentive for deliveries conducted at home,TOTAL,3.0,3.0,2.0,0.0,1.0,2.0,5.0,2.0,5.0,1.0,3.0,2.0,29.0
South West,2.2,Deliveries conducted at Public Institutions (Including C-Sections),TOTAL,538.0,610.0,649.0,873.0,992.0,982.0,940.0,874.0,892.0,860.0,701.0,718.0,9629.0
South West,2.2.1,"Out of 2.2, Number discharged under 48 hours of delivery",TOTAL,300.0,479.0,524.0,697.0,721.0,792.0,695.0,640.0,706.0,663.0,556.0,503.0,7276.0
South West,2.2.2.a,Number of mothers paid JSY Incentive for deliveries conducted at Public Institutions,TOTAL,83.0,121.0,94.0,85.0,119.0,178.0,106.0,202.0,95.0,121.0,248.0,220.0,1672.0
South West,2.2.2.b,Number of ASHAs paid JSY Incentive for deliveries conducted at Public Institutions,TOTAL,73.0,102.0,77.0,80.0,83.0,79.0,57.0,81.0,77.0,83.0,69.0,116.0,977.0
South West,2.2.2.c,Number of cases of deliveries conducted at Public Institutions where JSY incentive was paid to ANMs or AWWs [only for High Performing States (HPS)],TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
South West,2.3,Deliveries conducted at Private Institutions (Including C-Sections),TOTAL,79.0,65.0,70.0,112.0,142.0,121.0,119.0,124.0,134.0,118.0,89.0,110.0,1283.0
South West,2.3.1.a,Number of mothers paid JSY Incentive for deliveries conducted at accredited Private Institutions,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
South West,2.3.1.b,Number of ASHAs paid JSY Incentive for deliveries conducted at accredited Private Institutions,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
South West,2.3.1.c,Number of cases of deliveries conducted at accredited Private Institutions where JSY incentive was paid to ANMs or AWWs [only for High Performing States (HPS)],TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
South West,3.1.1,Number of Caesarean (C-Section) deliveries performed at PHCs (Primary Health Centre),TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
South West,3.1.2,Number of Caesarean (C-Section) deliveries performed at CHCs (Community Health Centre),TOTAL,,,,,,,,,,,,,
South West,3.1.3,Number of Caesarean (C-Section) deliveries performed at SDHs (Sub-divisional Hospital) or DHs (District Hospital),TOTAL,75.0,81.0,93.0,142.0,148.0,121.0,136.0,128.0,137.0,128.0,114.0,148.0,1451.0
South West,3.1.4,Number of Caesarean (C-Section) deliveries performed at other State owned public institutions,TOTAL,,,,,,,,,,,,,
South West,3.1.5,"Total Number of Caesarean (C-Section) deliveries performed at Public facilities i.e. PHC, CHC, SDH, DH and other State owned public institutions (sum of items from 3.1.1 to 3.1.4)",TOTAL,75.0,81.0,93.0,142.0,148.0,121.0,136.0,128.0,137.0,128.0,114.0,148.0,1451.0
South West,3.2,No. of C-section deliveries performed at Private facilities,TOTAL,47.0,47.0,46.0,60.0,88.0,75.0,76.0,76.0,78.0,71.0,49.0,67.0,780.0
South West,4.1.1.a,Number of male live births,TOTAL,367.0,417.0,456.0,601.0,670.0,685.0,606.0,559.0,602.0,590.0,473.0,500.0,6526.0
South West,4.1.1.b,Number of female live births,TOTAL,346.0,348.0,350.0,503.0,591.0,558.0,573.0,538.0,564.0,519.0,435.0,402.0,5727.0
South West,4.1.1.c,Total number of male and female live births (4.1.1.a and 4.1.1.b),TOTAL,713.0,765.0,806.0,1104.0,1261.0,1243.0,1179.0,1097.0,1166.0,1109.0,908.0,902.0,12253.0
South West,4.1.2,Number of still births,TOTAL,4.0,7.0,6.0,10.0,9.0,14.0,7.0,7.0,8.0,10.0,5.0,10.0,97.0
South West,4.1.3,Number of Abortions (spontaneous or induced),TOTAL,99.0,88.0,66.0,97.0,109.0,83.0,95.0,103.0,141.0,123.0,108.0,169.0,1281.0
South West,4.2.1,Number of Newborns weighed at birth,TOTAL,660.0,639.0,762.0,1016.0,1195.0,1180.0,1128.0,1045.0,1094.0,1050.0,861.0,873.0,11503.0
South West,4.2.2,Number of Newborns having weight less than 2.5 kg,TOTAL,111.0,94.0,112.0,103.0,210.0,205.0,224.0,177.0,168.0,150.0,109.0,92.0,1755.0
South West,4.3,Number of Newborns breast fed within 1 hour of birth,TOTAL,547.0,618.0,728.0,946.0,1003.0,1170.0,1092.0,978.0,989.0,938.0,708.0,686.0,10403.0
South West,5.1.1,Number of cases of pregnant women with Obstetric Complications and attended at PHCs,TOTAL,0.0,0.0,0.0,,0.0,,,0.0,0.0,0.0,,0.0,0.0
South West,5.1.2,Number of cases of pregnant women with Obstetric Complications and attended at CHCs,TOTAL,,,,,,,,,,,,,
South West,5.1.3,Number of cases of pregnant women with Obstetric Complications and attended at SDHs or DHs,TOTAL,120.0,119.0,364.0,92.0,115.0,59.0,126.0,110.0,108.0,109.0,73.0,113.0,1508.0
South West,5.1.4,Number of cases of pregnant women with Obstetric Complications and attended at other State owned public institutions,TOTAL,,,,,,,,,,,,,
South West,5.1.5,"Number of cases of pregnant women with Obstetric Complications and attended at Public facilities i.e. PHC, CHC, SDH, DH and other State owned public institutions (sum of items from 5.1.1 to 5.1.4)",TOTAL,120.0,119.0,364.0,92.0,115.0,59.0,126.0,110.0,108.0,109.0,73.0,113.0,1508.0
South West,5.2,Number of cases of pregnant women with Obstetric Complications and attended at Private facilities,TOTAL,22.0,14.0,16.0,31.0,35.0,28.0,28.0,27.0,33.0,12.0,7.0,21.0,274.0
South West,5.3.1,Number of cases of complicated pregnancies treated with IV antibiotics,TOTAL,81.0,71.0,28.0,65.0,64.0,79.0,79.0,61.0,71.0,63.0,39.0,48.0,749.0
South West,5.3.2,Number of cases of complicated pregnancies treated with IV Antihypertensive/Magsulph injection,TOTAL,1.0,1.0,3.0,6.0,1.0,4.0,6.0,6.0,5.0,0.0,2.0,7.0,42.0
South West,5.3.3,Number of cases of complicated pregnancies treated with IV Oxytocis,TOTAL,61.0,58.0,334.0,87.0,62.0,50.0,64.0,75.0,75.0,48.0,43.0,62.0,1019.0
South West,5.3.4,Number of cases of complicated pregnancies treated with Blood Transfusion,TOTAL,10.0,16.0,29.0,36.0,34.0,33.0,21.0,17.0,10.0,33.0,12.0,41.0,292.0
South West,6.1,Women getting post partum check-up within 48 hours after delivery,TOTAL,698.0,725.0,761.0,1004.0,1202.0,1194.0,1139.0,1058.0,1098.0,1013.0,898.0,826.0,11616.0
South West,6.2,Women getting a post partum check up between 48 hours and 14 days after delivery,TOTAL,1101.0,1028.0,945.0,1197.0,1403.0,1298.0,1233.0,1110.0,1082.0,1079.0,1106.0,1415.0,13997.0
South West,6.3,PNC maternal complications attended,TOTAL,25.0,18.0,13.0,12.0,20.0,23.0,43.0,37.0,35.0,43.0,27.0,52.0,348.0
South West,7.1.1,Number of MTPs conducted at Public Institutions up to 12 weeks of pregnancy,TOTAL,9.0,10.0,17.0,20.0,19.0,19.0,11.0,14.0,19.0,25.0,22.0,19.0,204.0
South West,7.1.2,Number of MTPs conducted at Public Institutions for more than 12 weeks of pregnancy,TOTAL,3.0,1.0,1.0,3.0,1.0,3.0,1.0,0.0,0.0,0.0,2.0,6.0,21.0
South West,7.1.3,Total number of MTPs conducted at Public Institutions (sum of items 7.1.1 and 7.1.2),TOTAL,12.0,11.0,18.0,23.0,20.0,22.0,12.0,14.0,19.0,25.0,24.0,25.0,225.0
South West,7.2,Number of MTPs conducted at Private Facilities,TOTAL,19.0,21.0,25.0,29.0,30.0,18.0,14.0,24.0,33.0,17.0,20.0,21.0,271.0
South West,8.1.a,Number of new cases of RTI/STI in males for which treatment was initiated,TOTAL,199.0,255.0,218.0,249.0,245.0,296.0,222.0,264.0,237.0,293.0,300.0,205.0,2983.0
South West,8.1.b,Number of new cases of RTI/STI in females for which treatment was initiated,TOTAL,778.0,812.0,752.0,926.0,952.0,921.0,825.0,860.0,917.0,921.0,1108.0,906.0,10678.0
South West,8.1.c,Total number of new cases of RTI/STI in males and females for which treatment was initiated (sum of items 8.1.a and 8.1.b),TOTAL,977.0,1067.0,970.0,1175.0,1197.0,1217.0,1047.0,1124.0,1154.0,1214.0,1408.0,1111.0,13661.0
South West,8.2,Number of suspected RTI/STI cases for whom wet mount test was conducted,TOTAL,6.0,7.0,3.0,5.0,5.0,75.0,4.0,3.0,3.0,4.0,0.0,4.0,119.0
South West,9.1.1.a,Number of NSV (No Scalpel Vasectomy) or Conventional Vasectomy conducted at PHCs,TOTAL,0.0,0.0,,,0.0,,,0.0,0.0,0.0,,0.0,0.0
South West,9.1.1.b,Number of NSV or Conventional Vasectomy conducted at CHCs,TOTAL,,,,,,,,,,,,,
South West,9.1.1.c,Number of NSV or Conventional Vasectomy conducted at SDHs or DHs,TOTAL,3.0,5.0,2.0,24.0,3.0,2.0,2.0,11.0,1.0,3.0,2.0,0.0,58.0
South West,9.1.1.d,Number of NSV or Conventional Vasectomy conducted at other State owned public institutions,TOTAL,,,,,,,,,,,,,
South West,9.1.1.e,"Total Number of NSV or Conventional Vasectomy conducted at Public facilities i.e. PHC, CHC, SDH, DH and other State owned public institutions (sum of items from 9.1.1.a to 9.1.1.d)",TOTAL,3.0,5.0,2.0,24.0,3.0,2.0,2.0,11.0,1.0,3.0,2.0,0.0,58.0
South West,9.1.2,Number of NSV or Conventional Vasectomy conducted at Private facilities,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
South West,9.2.1.a,Number of Laparoscopic sterilizations conducted at PHCs,TOTAL,0.0,0.0,,,0.0,,,0.0,0.0,0.0,,0.0,0.0
South West,9.2.1.b,Number of Laparoscopic sterilizations conducted at CHCs,TOTAL,,,,,,,,,,,,,
South West,9.2.1.c,Number of Laparoscopic sterilizations conducted at SDHs or DHs,TOTAL,3.0,7.0,17.0,57.0,18.0,21.0,8.0,16.0,15.0,25.0,19.0,24.0,230.0
South West,9.2.1.d,Number of Laparoscopic sterilizations conducted at other State owned public institutions,TOTAL,,,,,,,,,,,,,
South West,9.2.1.e,"Total Number of Laparoscopic sterilizations conducted at Public facilities i.e. PHC, CHC, SDH, DH and other State owned public institutions (sum of items from 9.2.1.a to 9.2.1.d)",TOTAL,3.0,7.0,17.0,57.0,18.0,21.0,8.0,16.0,15.0,25.0,19.0,24.0,230.0
South West,9.2.2,Number of Laparoscopic sterilizations conducted at Private facilities,TOTAL,2.0,0.0,1.0,1.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,4.0
South West,9.3.1.a,Number of Mini-lap sterilizations conducted at PHCs,TOTAL,0.0,0.0,0.0,0.0,0.0,,,0.0,0.0,0.0,,0.0,0.0
South West,9.3.1.b,Number of Mini-lap sterilizations conducted at CHCs,TOTAL,,,,,,,,,,,,,
South West,9.3.1.c,Number of Mini-lap sterilizations conducted at SDHs or DHs,TOTAL,4.0,11.0,1.0,10.0,5.0,1.0,1.0,4.0,6.0,0.0,7.0,5.0,55.0
South West,9.3.1.d,Number of Mini-lap sterilizations conducted at other State owned public institutions,TOTAL,,,,,,,,,,,,,
South West,9.3.1.e,"Total Number of Mini-lap sterilizations conducted at Public facilities i.e. PHC, CHC, SDH, DH and other State owned public institutions (sum of items from 9.3.1.a to 9.3.1.d)",TOTAL,4.0,11.0,1.0,10.0,5.0,1.0,1.0,4.0,6.0,0.0,7.0,5.0,55.0
South West,9.3.2,Number of Mini-lap sterilizations conducted at Private facilities,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,1.0,1.0,1.0,1.0,0.0,0.0,4.0
South West,9.4.1.a,Number of Post-Partum sterilizations conducted at PHCs,TOTAL,0.0,0.0,0.0,0.0,0.0,,,0.0,0.0,0.0,,0.0,0.0
South West,9.4.1.b,Number of Post-Partum sterilizations conducted at CHCs,TOTAL,,,,,,,,,,,,,
South West,9.4.1.c,Number of Post-Partum sterilizations conducted at SDHs or DHs,TOTAL,12.0,2.0,2.0,6.0,4.0,0.0,3.0,0.0,2.0,5.0,4.0,1.0,41.0
South West,9.4.1.d,Number of Post-Partum sterilizations conducted at other State owned public institutions,TOTAL,,,,,,,,,,,,,
South West,9.4.1.e,"Total Number of Post-Partum sterilizations conducted at Public facilities i.e. PHC, CHC, SDH, DH and other State owned public institutions (sum of items from 9.4.1.a to 9.4.1.d)",TOTAL,12.0,2.0,2.0,6.0,4.0,0.0,3.0,0.0,2.0,5.0,4.0,1.0,41.0
South West,9.4.2,Number of Post-Partum sterilizations conducted at Private facilities,TOTAL,0.0,0.0,1.0,1.0,1.0,1.0,1.0,0.0,0.0,0.0,1.0,0.0,6.0
South West,9.5.1.a,Number of IUCD Insertions conducted at SCs,TOTAL,0.0,0.0,,,0.0,0.0,0.0,0.0,0.0,0.0,0.0,,0.0
South West,9.5.1.b,Number of IUCD Insertions conducted at PHCs,TOTAL,202.0,188.0,124.0,842.0,250.0,218.0,106.0,204.0,202.0,172.0,169.0,215.0,2892.0
South West,9.5.1.c,Number of IUCD Insertions conducted at CHCs,TOTAL,17.0,22.0,12.0,77.0,39.0,23.0,14.0,29.0,16.0,22.0,13.0,17.0,301.0
South West,9.5.1.d,Number of IUCD Insertions conducted at SDHs or DHs,TOTAL,78.0,276.0,90.0,577.0,444.0,304.0,106.0,200.0,489.0,288.0,184.0,131.0,3167.0
South West,9.5.1.e,Number of IUCD Insertions conducted at other State owned public institutions,TOTAL,,,,,,,,,,,,,
South West,9.5.1.f,"Total Number of IUCD Insertions conducted at Public facilities i.e. SC, PHC, CHC, SDH, DH and other State owned public institutions (sum of items from 9.5.1.a to 9.5.1.e)",TOTAL,297.0,486.0,226.0,1496.0,733.0,545.0,226.0,433.0,707.0,482.0,366.0,363.0,6360.0
South West,9.5.1A,"Out of above total, Post Partum (within 48 hours of delivery) IUCD insertions",TOTAL,91.0,225.0,379.0,499.0,159.0,291.0,82.0,172.0,450.0,256.0,150.0,102.0,2856.0
South West,9.5.2,Number of IUCD Insertions conducted at Private facilities,TOTAL,12.0,12.0,13.0,11.0,9.0,16.0,6.0,12.0,18.0,10.0,10.0,9.0,138.0
South West,9.06,Number of IUCD removals,TOTAL,86.0,69.0,62.0,85.0,103.0,104.0,69.0,93.0,78.0,52.0,75.0,79.0,955.0
South West,9.07,Number of Oral Pills cycles distributed,TOTAL,1229.0,1143.0,1367.0,1865.0,1268.0,1225.0,952.0,1418.0,1191.0,1085.0,1042.0,1264.0,15049.0
South West,9.08,Number of Condom pieces distributed,TOTAL,40731.0,39906.0,39968.0,49379.0,36325.0,38632.0,27463.0,27616.0,23797.0,30231.0,30001.0,33622.0,417671.0
South West,9.09,Number of Centchroman (weekly) pills given,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
South West,9.10,Number of Emergency Contraceptive Pills distributed,TOTAL,41.0,33.0,9.0,70.0,64.0,52.0,40.0,249.0,94.0,59.0,74.0,47.0,832.0
South West,9.11.1.a,Number of cases of complications following male sterilization,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
South West,9.11.1.b,Number of cases of complications following female sterilization,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
South West,9.11.2.a,Number of failures following male sterilization,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
South West,9.11.2.b,Number of failures following female sterilization,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,1.0,1.0,2.0
South West,9.11.3.a,Number of deaths following male sterilization,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
South West,9.11.3.b,Number of deaths following female sterilization,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
South West,9.12,Number of Institutions having NSV trained doctors,TOTAL,8.0,3.0,2.0,1.0,2.0,1.0,3.0,3.0,4.0,3.0,3.0,4.0,-1.0
South West,10.1.01,Number of Infants (0 to 11 months old)received BCG immunisation,TOTAL,996.0,979.0,909.0,1343.0,1442.0,1496.0,1383.0,1505.0,1433.0,1295.0,1113.0,1182.0,15076.0
South West,10.1.02,Number of Infants (0 to 11 months old) received DPT1 immunisation,TOTAL,110.0,139.0,122.0,122.0,110.0,118.0,105.0,87.0,53.0,48.0,49.0,42.0,1105.0
South West,10.1.03,Number of Infants (0 to 11 months old) received DPT2 immunisation,TOTAL,234.0,207.0,175.0,229.0,206.0,187.0,156.0,162.0,135.0,92.0,60.0,81.0,1924.0
South West,10.1.04,Number of Infants (0 to 11 months old) received DPT3 immunisation,TOTAL,306.0,221.0,235.0,251.0,266.0,279.0,194.0,238.0,174.0,143.0,111.0,114.0,2532.0
South West,10.1.04A,Number of Infants (0 to 11 months old) received Pentavalent1 immunisation,TOTAL,1655.0,1486.0,1264.0,1589.0,1619.0,1862.0,1980.0,2036.0,2011.0,1849.0,1691.0,1890.0,20932.0
South West,10.1.04B,Number of Infants (0 to 11 months old) received Pentavalent2 immunisation,TOTAL,1771.0,1500.0,1278.0,1523.0,1505.0,1455.0,1593.0,1786.0,2036.0,1779.0,1613.0,1833.0,19672.0
South West,10.1.04C,Number of Infants (0 to 11 months old) received Pentavalent3 immunisation,TOTAL,1719.0,1585.0,1329.0,1566.0,1398.0,1346.0,1328.0,1533.0,1704.0,1793.0,1510.0,1800.0,18611.0
South West,10.1.05,Number of Infants (0 to 11 months old) received OPV 0 (Birth Dose),TOTAL,664.0,708.0,694.0,1002.0,1158.0,1210.0,1129.0,1037.0,1138.0,1022.0,798.0,807.0,11367.0
South West,10.1.06,Number of Infants (0 to 11 months old) received OPV1 (First Dose),TOTAL,1761.0,1466.0,1359.0,1705.0,1651.0,1916.0,2042.0,2119.0,2050.0,1904.0,1744.0,1915.0,21632.0
South West,10.1.07,Number of Infants (0 to 11 months old) received OPV2 (Second Dose),TOTAL,1993.0,1594.0,1413.0,1724.0,1643.0,1559.0,1700.0,1936.0,2174.0,1869.0,1679.0,1890.0,21174.0
South West,10.1.08,Number of Infants (0 to 11 months old) received OPV3 (Third Dose),TOTAL,2016.0,1690.0,1528.0,1800.0,1565.0,1561.0,1466.0,1756.0,1861.0,1931.0,1634.0,1892.0,20700.0
South West,10.1.09A,Number of Infants (upto 48 hrs of age) received Hepatitis-B0 immunisation,TOTAL,598.0,692.0,636.0,920.0,1140.0,1159.0,1081.0,1066.0,1097.0,1004.0,772.0,780.0,10945.0
South West,10.1.09,Number of Infants (0 to 11 months old) received Hepatitis-B1 immunisation,TOTAL,150.0,142.0,93.0,121.0,133.0,126.0,97.0,87.0,79.0,102.0,81.0,34.0,1245.0
South West,10.1.10,Number of Infants (0 to 11 months old) received Hepatitis-B2 immunisation,TOTAL,266.0,192.0,157.0,212.0,184.0,160.0,136.0,151.0,144.0,130.0,58.0,84.0,1874.0
South West,10.1.11,Number of Infants (0 to 11 months old) received Hepatitis-B3 immunisation,TOTAL,377.0,281.0,231.0,269.0,291.0,276.0,180.0,232.0,182.0,184.0,163.0,136.0,2802.0
South West,10.1.12,Number of Infants (0 to 11 months old) received Measles immunisation (First Dose),TOTAL,2319.0,2299.0,2888.0,2589.0,2266.0,2037.0,1796.0,2193.0,1811.0,1513.0,1565.0,1835.0,25111.0
South West,10.1.12B,Number of Infants (more than 16 months old) received Measles immunisation (Second Dose),TOTAL,5352.0,2611.0,3427.0,1673.0,575.0,250.0,190.0,170.0,234.0,292.0,198.0,364.0,15336.0
South West,10.1A,No. of Children aged 9 to 12 months who received JE 1st dose,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
South West,10.1.13.a,Total number of male children (9 to 11 months old) fully immunised (BCG+DPT123/Pentavalent123+OPV123+Measles) during the month,TOTAL,1194.0,1260.0,1296.0,1332.0,1188.0,1061.0,917.0,1200.0,942.0,789.0,807.0,997.0,12983.0
South West,10.1.13.b,Total number of female children (9 to 11 months old) fully immunised (BCG+DPT123/Pentavalent123+OPV123+Measles) during the month,TOTAL,953.0,1034.0,1033.0,1069.0,1010.0,914.0,792.0,944.0,808.0,687.0,724.0,786.0,10754.0
South West,10.1.13.c,Total number of children (9 to 11 months old) fully immunised (BCG+DPT123/Pentavalent123+OPV123+Measles) during the month (sum of items 10.1.13.a and 10.1.13.b),TOTAL,2147.0,2294.0,2329.0,2401.0,2198.0,1975.0,1709.0,2144.0,1750.0,1476.0,1531.0,1783.0,23737.0
South West,10.2.1,Number of Infants (more than 16 months old) received DPT Booster dose,TOTAL,1979.0,1996.0,1858.0,2355.0,1822.0,1591.0,1286.0,1781.0,1588.0,1481.0,1631.0,2183.0,21551.0
South West,10.2.2,Number of Infants (more than 16 months old) received OPV Booster dose,TOTAL,1973.0,1936.0,1859.0,2321.0,2041.0,1599.0,1280.0,1792.0,1583.0,1479.0,1631.0,2192.0,21686.0
South West,10.2.3,"Number of Infants (more than 16 months old) received Measles, Mumps, Rubella (MMR) Vaccination",TOTAL,356.0,202.0,1188.0,256.0,1502.0,1570.0,1681.0,2201.0,2343.0,2045.0,1788.0,2112.0,17244.0
South West,10.3.1.a,Total number of male children (12 to 23 months old) fully immunised (BCG+DPT123/Pentavalent123+OPV123+Measles) during the month,TOTAL,304.0,422.0,359.0,346.0,284.0,188.0,139.0,232.0,290.0,304.0,258.0,440.0,3566.0
South West,10.3.1.b,Total number of female children (12 to 23 months old) fully immunised (BCG+DPT123/Pentavalent123+OPV123+Measles) during the month,TOTAL,203.0,328.0,223.0,231.0,185.0,150.0,129.0,173.0,223.0,211.0,164.0,266.0,2486.0
South West,10.3.1.c,Total number of children (12 to 23 months old) fully immunised (BCG+DPT123+OPV123/Pentavalent123+Measles) during the month (sum of items 10.3.1.a and 10.3.1.b),TOTAL,507.0,750.0,582.0,577.0,469.0,338.0,268.0,405.0,513.0,515.0,422.0,706.0,6052.0
South West,10.3.2,Number of children (more than 5 years old) given DT5,TOTAL,1004.0,1202.0,1167.0,885.0,897.0,870.0,804.0,1068.0,1046.0,964.0,767.0,1274.0,11948.0
South West,10.3.3,Number of children (more than 10 years old) given TT10,TOTAL,218.0,286.0,319.0,264.0,216.0,296.0,251.0,268.0,244.0,243.0,190.0,310.0,3105.0
South West,10.3.4,Number of children (more than 16 years old) given TT16,TOTAL,199.0,235.0,219.0,193.0,212.0,226.0,155.0,159.0,191.0,147.0,141.0,217.0,2294.0
South West,10.3.5.a,Number of cases of Abscess reported following immunisation [Adverse Event Following Immunisation (AEFI)],TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
South West,10.3.5.b,Number of cases of Death reported following immunisation [Adverse Event Following Immunisation (AEFI)],TOTAL,0.0,1.0,0.0,0.0,0.0,0.0,0.0,1.0,0.0,0.0,0.0,0.0,2.0
South West,10.3.5.c,Number of cases of other complications reported following immunisation [Adverse Event Following Immunisation (AEFI)],TOTAL,0.0,1.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,1.0
South West,10.4.1,Number of Immunisation sessions planned to be held during the month,TOTAL,564.0,438.0,517.0,400.0,356.0,375.0,410.0,434.0,479.0,430.0,397.0,391.0,5191.0
South West,10.4.2,Number of Immunisation sessions held during the month,TOTAL,538.0,402.0,488.0,381.0,329.0,346.0,353.0,416.0,463.0,411.0,374.0,365.0,4866.0
South West,10.4.3,Number of Immunisation sessions held during the month where ASHAs were present,TOTAL,390.0,297.0,387.0,279.0,261.0,252.0,246.0,313.0,344.0,304.0,263.0,242.0,3578.0
South West,10.5.1,Number of children (more than 16 months old) received Japanese Encephalitis (JE) vaccination,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
South West,11.1.1,Number of children (9 months to 5 years old) administered 1st dose of Vitamin A (Dose-1),TOTAL,2162.0,2353.0,3370.0,2378.0,2192.0,2153.0,1753.0,2310.0,1829.0,1452.0,1091.0,1402.0,24445.0
South West,11.1.2,Number of children (9 months to 5 years old) were administered 5th dose of Vitamin A (Dose-5),TOTAL,2764.0,1607.0,2165.0,1026.0,751.0,764.0,701.0,978.0,1018.0,762.0,535.0,568.0,13639.0
South West,11.1.3,Number of children (9 months to 5 years old) administered 9th dose of Vitamin A (Dose-9),TOTAL,941.0,753.0,1745.0,682.0,140.0,427.0,263.0,383.0,437.0,347.0,127.0,378.0,6623.0
South West,12.1,Number of cases of Diptheria reported in children below 5 years of age,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
South West,12.2,Number of cases of Pertusis reported in children below 5 years of age,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
South West,12.3,Number of cases of Tetanus neonatarum reported in children below 5 years of age,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
South West,12.4,Number of cases of Tetanus other than neonatarum reported in children below 5 years of age,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
South West,12.5,Number of cases of Polio reported in children below 5 years of age,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
South West,12.6,Number of cases of Measles reported in children below 5 years of age,TOTAL,28.0,28.0,9.0,1.0,0.0,0.0,0.0,1.0,0.0,0.0,0.0,0.0,67.0
South West,12.7,Number of cases of Diarrhoea and Dehydration reported in children below 5 years of age,TOTAL,1013.0,1106.0,1228.0,1365.0,1225.0,1803.0,867.0,850.0,584.0,345.0,417.0,414.0,11217.0
South West,12.8,Number of cases of Malaria reported in children below 5 years of age,TOTAL,0.0,0.0,1.0,0.0,2.0,0.0,3.0,7.0,0.0,0.0,0.0,0.0,13.0
South West,12.9,Number of children below 5 years of age admitted with Respiratory Infections,TOTAL,463.0,433.0,493.0,553.0,514.0,572.0,559.0,563.0,47.0,22.0,44.0,41.0,4304.0
South West,13.1,Number of Patients operated for cataract,TOTAL,17.0,8.0,8.0,17.0,15.0,19.0,9.0,17.0,13.0,15.0,9.0,19.0,166.0
South West,13.2,Number of Intraocular Lens(IOL) implantations,TOTAL,13.0,8.0,4.0,11.0,14.0,18.0,9.0,17.0,13.0,13.0,8.0,19.0,147.0
South West,13.3,Number of School children detected with Refractive errors,TOTAL,196.0,182.0,178.0,117.0,132.0,132.0,52.0,87.0,69.0,91.0,58.0,69.0,1363.0
South West,13.4,Number of children provided free glasses,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
South West,13.5,Number of eyes collected through eye donation,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
South West,13.6,Number of eyes utilised for corneal transplant,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
South West,14.01,Number of CHC or SDH or DH functioning as First Referral units (FRUs),TOTAL,1.0,,1.0,,1.0,1.0,1.0,,1.0,1.0,1.0,1.0,-1.0
South West,14.02,Number of PHCs functioning 24X7 with atleast 3 Staff Nurses,TOTAL,,,1.0,,,,,,,,,,-1.0
South West,14.03,Number of Anganwadi centres reported to have conducted VHNDs,TOTAL,6.0,6.0,1.0,4.0,6.0,8.0,12.0,15.0,10.0,16.0,13.0,17.0,-1.0
South West,14.04,Number of facilities having a Rogi Kalyan Samiti (RKS),TOTAL,2.0,1.0,1.0,1.0,1.0,1.0,1.0,1.0,1.0,1.0,1.0,1.0,-1.0
South West,14.05,Number of RKS meetings held during the month,TOTAL,0.0,0.0,0.0,0.0,1.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,1.0
South West,14.06,Number of facilities having Ambulance services (Assured Referral Services),TOTAL,27.0,14.0,11.0,11.0,10.0,10.0,12.0,20.0,23.0,22.0,20.0,18.0,-1.0
South West,14.07,Total Number of times the Ambulance was used for transporting patients during the month,TOTAL,137.0,124.0,137.0,152.0,170.0,148.0,149.0,152.0,156.0,174.0,153.0,110.0,1762.0
South West,14.08,Number of Institutions having Operational Sick New Born and Child Care Units (SNCU),TOTAL,1.0,1.0,,1.0,2.0,1.0,1.0,,,,,1.0,-1.0
South West,14.09,Number of functional Laproscopes in CHC/SDH/DH,TOTAL,1.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,1.0,-1.0
South West,14.10.1.a,Number of male patients admitted (Inpatients) during the month,1. Children,637.0,644.0,720.0,858.0,907.0,898.0,843.0,723.0,736.0,653.0,586.0,615.0,8820.0
South West,14.10.1.a,Number of male patients admitted (Inpatients) during the month,2. Adults,1211.0,1001.0,1441.0,1244.0,1135.0,1110.0,1028.0,953.0,894.0,1254.0,1105.0,1191.0,13567.0
South West,14.10.1.b,Number of female patients (Inpatients) admitted during the month,1. Children,529.0,497.0,564.0,595.0,724.0,669.0,738.0,662.0,609.0,560.0,497.0,480.0,7124.0
South West,14.10.1.b,Number of female patients (Inpatients) admitted during the month,2. Adults,2054.0,1846.0,2167.0,2413.0,2511.0,2478.0,2045.0,2091.0,2104.0,1605.0,1906.0,2179.0,25399.0
South West,14.10.1.c,Total number of patients admitted (Inpatients) during the month (sum of items 14.10.1.a and 14.10.1.b),1. Children,1166.0,1141.0,1284.0,1453.0,1631.0,1567.0,1581.0,1385.0,1345.0,1213.0,1083.0,1095.0,15944.0
South West,14.10.1.c,Total number of patients admitted (Inpatients) during the month (sum of items 14.10.1.a and 14.10.1.b),2. Adults,3265.0,2847.0,3608.0,3657.0,3646.0,3588.0,3073.0,3044.0,2998.0,2859.0,3011.0,3370.0,38966.0
South West,14.10.2.a,Number of death cases of Inpatient males,TOTAL,16.0,10.0,12.0,15.0,19.0,16.0,12.0,11.0,11.0,21.0,15.0,18.0,176.0
South West,14.10.2.b,Number of death cases of Inpatient females,TOTAL,13.0,8.0,6.0,7.0,11.0,8.0,9.0,5.0,7.0,14.0,3.0,13.0,104.0
South West,14.10.2.c,Number of cases of death of Inpatients (sum of items 14.10.2.a and 14.10.2.b),TOTAL,29.0,18.0,18.0,22.0,30.0,24.0,21.0,16.0,18.0,35.0,18.0,31.0,280.0
South West,14.11,In-Patient Head Count at midnight,TOTAL,4160.0,4800.0,4891.0,5993.0,6410.0,6124.0,5526.0,5020.0,5086.0,5615.0,4949.0,7205.0,65779.0
South West,14.12.1,OPD attendance (All),TOTAL,279682.0,289935.0,259521.0,306826.0,311077.0,307011.0,262271.0,299976.0,281188.0,272700.0,319094.0,302464.0,3491745.0
South West,14.13.1,Number of major operations carried out using general or spinal anaesthesia,TOTAL,382.0,428.0,427.0,566.0,550.0,534.0,505.0,538.0,543.0,626.0,444.0,513.0,6056.0
South West,14.13.1A,"Out of 14.13.1,Gynecology- Hysterectomy surgeries",TOTAL,5.0,8.0,21.0,5.0,8.0,8.0,5.0,4.0,6.0,4.0,7.0,9.0,90.0
South West,14.13.2,Number of minor operations carried out without anaesthesia or using local anaesthesia,TOTAL,631.0,757.0,654.0,851.0,970.0,887.0,580.0,861.0,764.0,501.0,473.0,367.0,8296.0
South West,14.14.a,Number of patients given AYUSH treatment,TOTAL,4124.0,2471.0,1878.0,5401.0,5980.0,2090.0,2062.0,629.0,2045.0,6673.0,6934.0,5548.0,45835.0
South West,14.14.b,Number of patients on whom Dental Procedure was conducted,TOTAL,2755.0,3052.0,3048.0,3481.0,2148.0,2067.0,1664.0,1922.0,1802.0,2353.0,2345.0,1684.0,28321.0
South West,14.14.c,Number of Adolescents counselled,TOTAL,679.0,677.0,626.0,625.0,688.0,536.0,621.0,710.0,694.0,653.0,667.0,619.0,7795.0
South West,15.1.1.a,Number of Haemoglobin (Hb) tests conducted,TOTAL,14183.0,14428.0,13444.0,16034.0,15517.0,15955.0,13749.0,14380.0,9404.0,11820.0,13569.0,14816.0,167299.0
South West,15.1.1.b,"Out of the total number of Hb tests conducted, number of cases having Hb less than 7gm/dl",TOTAL,373.0,374.0,447.0,530.0,379.0,408.0,330.0,318.0,253.0,267.0,259.0,308.0,4246.0
South West,15.1.2.a,Number of HIV tests conducted on males,1. Number tested,728.0,768.0,721.0,676.0,662.0,769.0,578.0,604.0,848.0,915.0,898.0,593.0,8760.0
South West,15.1.2.a,Number of HIV tests conducted on males,2. Number Positive,11.0,10.0,6.0,5.0,6.0,7.0,5.0,2.0,6.0,0.0,7.0,6.0,71.0
South West,15.1.2.b,Number of HIV tests conducted on Female-Non ANC (i.e. non pregnant females),1. Number tested,583.0,567.0,561.0,564.0,587.0,799.0,400.0,551.0,499.0,559.0,664.0,600.0,6934.0
South West,15.1.2.b,Number of HIV tests conducted on Female-Non ANC (i.e. non pregnant females),2. Number Positive,3.0,10.0,5.0,6.0,5.0,9.0,1.0,1.0,2.0,2.0,1.0,2.0,47.0
South West,15.1.2.c,Number of HIV tests conducted on Female with ANC (i.e. pregnant females),1. Number tested,2332.0,2303.0,1937.0,1956.0,2006.0,2143.0,1545.0,1896.0,2265.0,2066.0,2348.0,2473.0,25270.0
South West,15.1.2.c,Number of HIV tests conducted on Female with ANC (i.e. pregnant females),2. Number Positive,3.0,0.0,0.0,2.0,2.0,1.0,1.0,0.0,2.0,0.0,3.0,0.0,14.0
South West,15.1.2.d,Total number of HIV tests conducted (sum of items 15.1.2.a to 15.1.2.c),1. Number tested,3643.0,3638.0,3219.0,3196.0,3255.0,3711.0,2523.0,3051.0,3612.0,3540.0,3910.0,3666.0,40964.0
South West,15.1.2.d,Total number of HIV tests conducted (sum of items 15.1.2.a to 15.1.2.c),2. Number Positive,17.0,20.0,11.0,13.0,13.0,17.0,7.0,3.0,10.0,2.0,11.0,8.0,132.0
South West,15.2,Number of Widal tests conducted,Number tested,1260.0,1204.0,1006.0,1176.0,1449.0,1306.0,1263.0,1073.0,625.0,563.0,1498.0,1253.0,13676.0
South West,15.3.a,Number of VDRL tests conducted on males,Number tested,73.0,79.0,50.0,70.0,116.0,92.0,66.0,90.0,85.0,65.0,77.0,63.0,926.0
South West,15.3.b,Number of VDRL tests conducted on Female-Non ANC (i.e. non pregnant females),Number tested,100.0,150.0,62.0,137.0,233.0,143.0,149.0,172.0,70.0,106.0,111.0,203.0,1636.0
South West,15.3.c,Number of VDRL tests conducted on Female with ANC (i.e. pregnant females),Number tested,743.0,926.0,357.0,1852.0,2358.0,2368.0,885.0,2005.0,1310.0,1283.0,1618.0,1796.0,17501.0
South West,15.3.d,Total number of VDRL tests conducted (sum of items 15.3.a to 15.3.c),Number tested,916.0,1155.0,469.0,2059.0,2707.0,2603.0,1100.0,2267.0,1465.0,1454.0,1806.0,2062.0,20063.0
South West,15.4.1,Number of blood smears examined for Malaria,TOTAL,2094.0,2197.0,1481.0,1964.0,2025.0,2083.0,1655.0,1540.0,1007.0,1073.0,1756.0,2037.0,20912.0
South West,15.4.2,"Out of blood smears examined for malaria, number of blood smears tested positive for Plasmodium Vivax",TOTAL,7.0,13.0,37.0,29.0,31.0,33.0,19.0,5.0,2.0,1.0,1.0,5.0,183.0
South West,15.4.3,"Out of blood smears examined for malaria, number of blood smears tested positive for Plasmodium Falciparum",TOTAL,0.0,0.0,1.0,0.0,0.0,0.0,4.0,0.0,1.0,0.0,0.0,1.0,7.0
South West,16.1.1,Stock position of DPT vaccines,1. Balance From Previous Month,3260.0,3710.0,4140.0,1790.0,4510.0,1970.0,950.0,1520.0,4740.0,1730.0,4050.0,2460.0,34830.0
South West,16.1.1,Stock position of DPT vaccines,2. Stocks Received,0.0,3000.0,0.0,6000.0,0.0,1000.0,2000.0,5500.0,0.0,4000.0,0.0,5000.0,26500.0
South West,16.1.1,Stock position of DPT vaccines,3. Unusable Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
South West,16.1.1,Stock position of DPT vaccines,4. Stock Distributed,2230.0,2570.0,2350.0,3280.0,2540.0,2020.0,1430.0,2280.0,3010.0,1680.0,1590.0,2750.0,27730.0
South West,16.1.1,Stock position of DPT vaccines,5. Total Stock,1030.0,4140.0,1790.0,4510.0,1970.0,950.0,1520.0,4740.0,1730.0,4050.0,2460.0,4710.0,33600.0
South West,16.1.1A,Stock Position of Pentavalent,1. Balance From Previous Month,4330.0,4030.0,6830.0,4270.0,4830.0,1500.0,1230.0,960.0,7500.0,3020.0,4790.0,1440.0,44730.0
South West,16.1.1A,Stock Position of Pentavalent,2. Stocks Received,0.0,6000.0,0.0,5000.0,0.0,3000.0,3000.0,11430.0,0.0,5000.0,0.0,8000.0,41430.0
South West,16.1.1A,Stock Position of Pentavalent,3. Unusable Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
South West,16.1.1A,Stock Position of Pentavalent,4. Stock Distributed,4130.0,3200.0,2560.0,4440.0,3330.0,3270.0,3270.0,4890.0,4480.0,3230.0,3350.0,4180.0,44330.0
South West,16.1.1A,Stock Position of Pentavalent,5. Total Stock,200.0,6830.0,4270.0,4830.0,1500.0,1230.0,960.0,7500.0,3020.0,4790.0,1440.0,5260.0,41830.0
South West,16.1.2,Stock position of OPV vaccines,1. Balance From Previous Month,8860.0,9540.0,12840.0,6420.0,9200.0,4540.0,820.0,4560.0,6300.0,540.0,9900.0,4660.0,78180.0
South West,16.1.2,Stock position of OPV vaccines,2. Stocks Received,0.0,10000.0,0.0,12000.0,0.0,4000.0,10000.0,8000.0,0.0,15000.0,0.0,18000.0,77000.0
South West,16.1.2,Stock position of OPV vaccines,3. Unusable Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
South West,16.1.2,Stock position of OPV vaccines,4. Stock Distributed,7960.0,6700.0,6420.0,9220.0,4660.0,7720.0,6260.0,6260.0,5760.0,5640.0,5240.0,6380.0,78220.0
South West,16.1.2,Stock position of OPV vaccines,5. Total Stock,900.0,12840.0,6420.0,9200.0,4540.0,820.0,4560.0,6300.0,540.0,9900.0,4660.0,16280.0,76960.0
South West,16.1.3,Stock position of TT vaccines,1. Balance From Previous Month,1960.0,4440.0,7620.0,5410.0,3720.0,940.0,1040.0,2980.0,5410.0,2830.0,4740.0,21700.0,62790.0
South West,16.1.3,Stock position of TT vaccines,2. Stocks Received,0.0,6000.0,0.0,2000.0,0.0,3000.0,4000.0,5500.0,0.0,4000.0,20000.0,0.0,44500.0
South West,16.1.3,Stock position of TT vaccines,3. Unusable Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
South West,16.1.3,Stock position of TT vaccines,4. Stock Distributed,1760.0,2820.0,2210.0,3690.0,2780.0,2900.0,2060.0,3070.0,2580.0,2090.0,3040.0,2600.0,31600.0
South West,16.1.3,Stock position of TT vaccines,5. Total Stock,200.0,7620.0,5410.0,3720.0,940.0,1040.0,2980.0,5410.0,2830.0,4740.0,21700.0,19100.0,75690.0
South West,16.1.4,Stock position of DT vaccines,1. Balance From Previous Month,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
South West,16.1.4,Stock position of DT vaccines,2. Stocks Received,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
South West,16.1.4,Stock position of DT vaccines,3. Unusable Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
South West,16.1.4,Stock position of DT vaccines,4. Stock Distributed,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
South West,16.1.4,Stock position of DT vaccines,5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
South West,16.1.5,Stock position of BCG vaccines,1. Balance From Previous Month,3230.0,2740.0,4550.0,3000.0,2690.0,760.0,1800.0,2110.0,4820.0,1780.0,5090.0,4160.0,36730.0
South West,16.1.5,Stock position of BCG vaccines,2. Stocks Received,0.0,3000.0,0.0,2000.0,0.0,3000.0,3000.0,4000.0,0.0,4000.0,0.0,0.0,19000.0
South West,16.1.5,Stock position of BCG vaccines,3. Unusable Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
South West,16.1.5,Stock position of BCG vaccines,4. Stock Distributed,2380.0,1190.0,1550.0,2310.0,1930.0,1960.0,2690.0,1290.0,3040.0,690.0,930.0,810.0,20770.0
South West,16.1.5,Stock position of BCG vaccines,5. Total Stock,850.0,4550.0,3000.0,2690.0,760.0,1800.0,2110.0,4820.0,1780.0,5090.0,4160.0,3350.0,34960.0
South West,16.1.6,Stock position of Measles vaccines,1. Balance From Previous Month,4965.0,3015.0,1580.0,7105.0,3710.0,1720.0,400.0,660.0,5180.0,2310.0,5910.0,4455.0,41010.0
South West,16.1.6,Stock position of Measles vaccines,2. Stocks Received,0.0,3200.0,16000.0,0.0,0.0,500.0,2000.0,6000.0,0.0,5000.0,0.0,1500.0,34200.0
South West,16.1.6,Stock position of Measles vaccines,3. Unusable Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
South West,16.1.6,Stock position of Measles vaccines,4. Stock Distributed,2955.0,4635.0,10475.0,3395.0,1990.0,1820.0,1740.0,1480.0,2870.0,1400.0,1455.0,1680.0,35895.0
South West,16.1.6,Stock position of Measles vaccines,5. Total Stock,2010.0,1580.0,7105.0,3710.0,1720.0,400.0,660.0,5180.0,2310.0,5910.0,4455.0,4275.0,39315.0
South West,16.1.7,Stock position of JE vaccines,1. Balance From Previous Month,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
South West,16.1.7,Stock position of JE vaccines,2. Stocks Received,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
South West,16.1.7,Stock position of JE vaccines,3. Unusable Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
South West,16.1.7,Stock position of JE vaccines,4. Stock Distributed,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
South West,16.1.7,Stock position of JE vaccines,5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
South West,16.1.8,Stock position of Hepatitis B vaccines,1. Balance From Previous Month,4120.0,5050.0,4230.0,3650.0,2520.0,1180.0,1260.0,1170.0,4380.0,3070.0,3790.0,3400.0,37820.0
South West,16.1.8,Stock position of Hepatitis B vaccines,2. Stocks Received,0.0,0.0,0.0,0.0,0.0,900.0,1800.0,4000.0,0.0,900.0,0.0,0.0,7600.0
South West,16.1.8,Stock position of Hepatitis B vaccines,3. Unusable Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
South West,16.1.8,Stock position of Hepatitis B vaccines,4. Stock Distributed,900.0,820.0,580.0,1130.0,1340.0,820.0,1890.0,790.0,1310.0,180.0,390.0,300.0,10450.0
South West,16.1.8,Stock position of Hepatitis B vaccines,5. Total Stock,3220.0,4230.0,3650.0,2520.0,1180.0,1260.0,1170.0,4380.0,3070.0,3790.0,3400.0,3100.0,34970.0
South West,16.2.1,Stock Position of IU 380 A (to be used for Family Planning),1. Balance From Previous Month,2360.0,785.0,1760.0,1500.0,1310.0,565.0,225.0,805.0,805.0,125.0,665.0,315.0,11220.0
South West,16.2.1,Stock Position of IU 380 A (to be used for Family Planning),2. Stocks Received,0.0,1800.0,0.0,0.0,0.0,0.0,600.0,0.0,0.0,600.0,0.0,100.0,3100.0
South West,16.2.1,Stock Position of IU 380 A (to be used for Family Planning),3. Unusable Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
South West,16.2.1,Stock Position of IU 380 A (to be used for Family Planning),4. Stock Distributed,160.0,825.0,260.0,190.0,745.0,340.0,20.0,0.0,680.0,60.0,350.0,30.0,3660.0
South West,16.2.1,Stock Position of IU 380 A (to be used for Family Planning),5. Total Stock,2200.0,1760.0,1500.0,1310.0,565.0,225.0,805.0,805.0,125.0,665.0,315.0,385.0,10660.0
South West,16.2.2,Stock Position of Condoms (to be used for Family Planning),1. Balance From Previous Month,71500.0,33500.0,21500.0,10500.0,23500.0,12000.0,1500.0,1500.0,1500.0,1500.0,10500.0,6000.0,195000.0
South West,16.2.2,Stock Position of Condoms (to be used for Family Planning),2. Stocks Received,0.0,0.0,0.0,42000.0,0.0,0.0,0.0,0.0,0.0,18000.0,0.0,0.0,60000.0
South West,16.2.2,Stock Position of Condoms (to be used for Family Planning),3. Unusable Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
South West,16.2.2,Stock Position of Condoms (to be used for Family Planning),4. Stock Distributed,9500.0,12000.0,11000.0,29000.0,11500.0,10500.0,0.0,0.0,0.0,9000.0,4500.0,6000.0,103000.0
South West,16.2.2,Stock Position of Condoms (to be used for Family Planning),5. Total Stock,62000.0,21500.0,10500.0,23500.0,12000.0,1500.0,1500.0,1500.0,1500.0,10500.0,6000.0,0.0,152000.0
South West,16.2.3,Stock Position of Oral Contraceptive (to be used for Family Planning),1. Balance From Previous Month,3400.0,3625.0,2805.0,2835.0,1935.0,1855.0,1710.0,1380.0,1040.0,810.0,1580.0,1205.0,24180.0
South West,16.2.3,Stock Position of Oral Contraceptive (to be used for Family Planning),2. Stocks Received,0.0,0.0,1000.0,0.0,0.0,0.0,0.0,0.0,0.0,1000.0,0.0,1000.0,3000.0
South West,16.2.3,Stock Position of Oral Contraceptive (to be used for Family Planning),3. Unusable Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
South West,16.2.3,Stock Position of Oral Contraceptive (to be used for Family Planning),4. Stock Distributed,285.0,820.0,970.0,900.0,80.0,145.0,330.0,340.0,230.0,230.0,375.0,340.0,5045.0
South West,16.2.3,Stock Position of Oral Contraceptive (to be used for Family Planning),5. Total Stock,3115.0,2805.0,2835.0,1935.0,1855.0,1710.0,1380.0,1040.0,810.0,1580.0,1205.0,1865.0,22135.0
South West,16.2.4,Stock Position of Emergency Contraceptive (to be used for Family Planning),1. Balance From Previous Month,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
South West,16.2.4,Stock Position of Emergency Contraceptive (to be used for Family Planning),2. Stocks Received,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
South West,16.2.4,Stock Position of Emergency Contraceptive (to be used for Family Planning),3. Unusable Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
South West,16.2.4,Stock Position of Emergency Contraceptive (to be used for Family Planning),4. Stock Distributed,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
South West,16.2.4,Stock Position of Emergency Contraceptive (to be used for Family Planning),5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
South West,16.2.5,Stock Position of Tubal Rings (to be used for Family Planning),1. Balance From Previous Month,0.0,400.0,400.0,400.0,400.0,400.0,400.0,400.0,0.0,0.0,800.0,600.0,4200.0
South West,16.2.5,Stock Position of Tubal Rings (to be used for Family Planning),2. Stocks Received,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
South West,16.2.5,Stock Position of Tubal Rings (to be used for Family Planning),3. Unusable Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
South West,16.2.5,Stock Position of Tubal Rings (to be used for Family Planning),4. Stock Distributed,0.0,0.0,0.0,0.0,0.0,0.0,0.0,400.0,0.0,0.0,200.0,200.0,800.0
South West,16.2.5,Stock Position of Tubal Rings (to be used for Family Planning),5. Total Stock,0.0,400.0,400.0,400.0,400.0,400.0,400.0,0.0,0.0,0.0,600.0,400.0,3400.0
South West,16.3.01,Stock Position of Oxytocin Injection,1. Balance From Previous Month,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
South West,16.3.01,Stock Position of Oxytocin Injection,2. Stocks Received,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
South West,16.3.01,Stock Position of Oxytocin Injection,3. Unusable Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
South West,16.3.01,Stock Position of Oxytocin Injection,4. Stock Distributed,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
South West,16.3.01,Stock Position of Oxytocin Injection,5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
South West,16.3.02,Stock Position of Gloves,1. Balance From Previous Month,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
South West,16.3.02,Stock Position of Gloves,2. Stocks Received,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
South West,16.3.02,Stock Position of Gloves,3. Unusable Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
South West,16.3.02,Stock Position of Gloves,4. Stock Distributed,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
South West,16.3.02,Stock Position of Gloves,5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
South West,16.3.03,Stock Position of MVA Syringes,1. Balance From Previous Month,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
South West,16.3.03,Stock Position of MVA Syringes,2. Stocks Received,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
South West,16.3.03,Stock Position of MVA Syringes,3. Unusable Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
South West,16.3.03,Stock Position of MVA Syringes,4. Stock Distributed,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
South West,16.3.03,Stock Position of MVA Syringes,5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
South West,16.3.04,Stock Position of Fluconazole Tablets,1. Balance From Previous Month,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
South West,16.3.04,Stock Position of Fluconazole Tablets,2. Stocks Received,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
South West,16.3.04,Stock Position of Fluconazole Tablets,3. Unusable Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
South West,16.3.04,Stock Position of Fluconazole Tablets,4. Stock Distributed,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
South West,16.3.04,Stock Position of Fluconazole Tablets,5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
South West,16.3.05,Stock Position of Blood Transfusion Sets,1. Balance From Previous Month,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
South West,16.3.05,Stock Position of Blood Transfusion Sets,2. Stocks Received,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
South West,16.3.05,Stock Position of Blood Transfusion Sets,3. Unusable Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
South West,16.3.05,Stock Position of Blood Transfusion Sets,4. Stock Distributed,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
South West,16.3.05,Stock Position of Blood Transfusion Sets,5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
South West,16.3.06,Stock Position of Gluteraldehyde solution of 2% concentration,1. Balance From Previous Month,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
South West,16.3.06,Stock Position of Gluteraldehyde solution of 2% concentration,2. Stocks Received,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
South West,16.3.06,Stock Position of Gluteraldehyde solution of 2% concentration,3. Unusable Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
South West,16.3.06,Stock Position of Gluteraldehyde solution of 2% concentration,4. Stock Distributed,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
South West,16.3.06,Stock Position of Gluteraldehyde solution of 2% concentration,5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
South West,16.3.07,Stock Position of IFA Tablets,1. Balance From Previous Month,330500.0,407500.0,286500.0,255500.0,123500.0,73500.0,16000.0,7500.0,6000.0,5000.0,5000.0,3000.0,1519500.0
South West,16.3.07,Stock Position of IFA Tablets,2. Stocks Received,0.0,0.0,100000.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,100000.0
South West,16.3.07,Stock Position of IFA Tablets,3. Unusable Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
South West,16.3.07,Stock Position of IFA Tablets,4. Stock Distributed,100000.0,121000.0,131000.0,132000.0,50000.0,57500.0,8500.0,1500.0,1000.0,0.0,2000.0,3000.0,607500.0
South West,16.3.07,Stock Position of IFA Tablets,5. Total Stock,230500.0,286500.0,255500.0,123500.0,73500.0,16000.0,7500.0,6000.0,5000.0,5000.0,3000.0,0.0,1012000.0
South West,16.3.08,Stock Position of IFA Syrup (Paediatric),1. Balance From Previous Month,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
South West,16.3.08,Stock Position of IFA Syrup (Paediatric),2. Stocks Received,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
South West,16.3.08,Stock Position of IFA Syrup (Paediatric),3. Unusable Stock,,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
South West,16.3.08,Stock Position of IFA Syrup (Paediatric),4. Stock Distributed,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
South West,16.3.08,Stock Position of IFA Syrup (Paediatric),5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
South West,16.3.09,Stock Position of Paediatrics Antibiotics (Cotrimaxozole and Injectable Gentamicin),1. Balance From Previous Month,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
South West,16.3.09,Stock Position of Paediatrics Antibiotics (Cotrimaxozole and Injectable Gentamicin),2. Stocks Received,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
South West,16.3.09,Stock Position of Paediatrics Antibiotics (Cotrimaxozole and Injectable Gentamicin),3. Unusable Stock,,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
South West,16.3.09,Stock Position of Paediatrics Antibiotics (Cotrimaxozole and Injectable Gentamicin),4. Stock Distributed,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
South West,16.3.09,Stock Position of Paediatrics Antibiotics (Cotrimaxozole and Injectable Gentamicin),5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
South West,16.3.10,Stock Position of Vitamin A solution,1. Balance From Previous Month,1970.0,1624.0,1491.0,1004.0,78.0,58.0,61.0,43.0,23.0,0.0,93.0,16.0,6461.0
South West,16.3.10,Stock Position of Vitamin A solution,2. Stocks Received,0.0,0.0,400.0,0.0,0.0,10.0,0.0,0.0,0.0,100.0,0.0,200.0,710.0
South West,16.3.10,Stock Position of Vitamin A solution,3. Unusable Stock,,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
South West,16.3.10,Stock Position of Vitamin A solution,4. Stock Distributed,44.0,133.0,887.0,926.0,20.0,7.0,18.0,20.0,23.0,7.0,77.0,82.0,2244.0
South West,16.3.10,Stock Position of Vitamin A solution,5. Total Stock,1926.0,1491.0,1004.0,78.0,58.0,61.0,43.0,23.0,0.0,93.0,16.0,134.0,4927.0
South West,16.3.11,Stock of ORS (New WHO formulation),1. Balance From Previous Month,2125.0,300.0,1950.0,2650.0,29625.0,8325.0,7625.0,7625.0,7625.0,7325.0,7325.0,7225.0,89725.0
South West,16.3.11,Stock of ORS (New WHO formulation),2. Stocks Received,0.0,15000.0,3000.0,40000.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,58000.0
South West,16.3.11,Stock of ORS (New WHO formulation),3. Unusable Stock,,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
South West,16.3.11,Stock of ORS (New WHO formulation),4. Stock Distributed,1000.0,13350.0,2300.0,13025.0,21300.0,700.0,0.0,0.0,300.0,0.0,100.0,0.0,52075.0
South West,16.3.11,Stock of ORS (New WHO formulation),5. Total Stock,1125.0,1950.0,2650.0,29625.0,8325.0,7625.0,7625.0,7625.0,7325.0,7325.0,7225.0,7225.0,95650.0
South West,16.4.1,Stock Position of 0.1 ml Syringes(AD),1. Balance From Previous Month,4890.0,6035.0,5115.0,3995.0,6795.0,5955.0,4725.0,2435.0,4505.0,4055.0,4745.0,4415.0,57665.0
South West,16.4.1,Stock Position of 0.1 ml Syringes(AD),2. Stocks Received,0.0,0.0,0.0,4000.0,0.0,0.0,0.0,3000.0,0.0,1000.0,0.0,0.0,8000.0
South West,16.4.1,Stock Position of 0.1 ml Syringes(AD),3. Unusable Stock,,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
South West,16.4.1,Stock Position of 0.1 ml Syringes(AD),4. Stock Distributed,1680.0,920.0,1120.0,1200.0,840.0,1230.0,2290.0,930.0,450.0,310.0,330.0,280.0,11580.0
South West,16.4.1,Stock Position of 0.1 ml Syringes(AD),5. Total Stock,3210.0,5115.0,3995.0,6795.0,5955.0,4725.0,2435.0,4505.0,4055.0,4745.0,4415.0,4135.0,54085.0
South West,16.4.2,Stock Position of 0.5 ml Syringes(AD),1. Balance From Previous Month,57100.0,32600.0,28000.0,23400.0,20800.0,9000.0,1800.0,14200.0,17900.0,4900.0,15800.0,4700.0,230200.0
South West,16.4.2,Stock Position of 0.5 ml Syringes(AD),2. Stocks Received,0.0,10000.0,10000.0,10000.0,0.0,4000.0,20000.0,16000.0,0.0,20000.0,0.0,18000.0,108000.0
South West,16.4.2,Stock Position of 0.5 ml Syringes(AD),3. Unusable Stock,,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
South West,16.4.2,Stock Position of 0.5 ml Syringes(AD),4. Stock Distributed,15500.0,14600.0,14600.0,12600.0,11800.0,11200.0,7600.0,12300.0,13000.0,9100.0,11100.0,11650.0,145050.0
South West,16.4.2,Stock Position of 0.5 ml Syringes(AD),5. Total Stock,41600.0,28000.0,23400.0,20800.0,9000.0,1800.0,14200.0,17900.0,4900.0,15800.0,4700.0,11050.0,193150.0
South West,16.4.3,Stock Position of 5.0 ml Syringes(Disposable),1. Balance From Previous Month,2900.0,1000.0,1800.0,1300.0,1300.0,1300.0,900.0,900.0,900.0,800.0,650.0,500.0,14250.0
South West,16.4.3,Stock Position of 5.0 ml Syringes(Disposable),2. Stocks Received,0.0,1200.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,2400.0,3600.0
South West,16.4.3,Stock Position of 5.0 ml Syringes(Disposable),3. Unusable Stock,,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
South West,16.4.3,Stock Position of 5.0 ml Syringes(Disposable),4. Stock Distributed,200.0,400.0,500.0,0.0,0.0,400.0,0.0,0.0,100.0,150.0,150.0,335.0,2235.0
South West,16.4.3,Stock Position of 5.0 ml Syringes(Disposable),5. Total Stock,2700.0,1800.0,1300.0,1300.0,1300.0,900.0,900.0,900.0,800.0,650.0,500.0,2565.0,15615.0
South West,17.1,Number of cases of Infant deaths within 24 hrs of birth,TOTAL,1.0,1.0,,1.0,,,,,,,,1.0,4.0
South West,17.2.1,Number of cases of Infant deaths 24 hours to 4 weeks of birth with the probable cause being Sepsis,1. Up to 1 Weeks of Birth,,,,,2.0,1.0,,,,1.0,,,4.0
South West,17.2.1,Number of cases of Infant deaths 24 hours to 4 weeks of birth with the probable cause being Sepsis,2. Between 1 week & 4 weeks of birth,,,,,,,1.0,,,,,,1.0
South West,17.2.1,Number of cases of Infant deaths 24 hours to 4 weeks of birth with the probable cause being Sepsis,3. Total,,,,,2.0,1.0,1.0,,,1.0,,,5.0
South West,17.2.2,Number of cases of Infant deaths 24 hours to 4 weeks of birth with the probable cause being Asphyxia,1. Up to 1 Weeks of Birth,,,,,1.0,,,,,,,,1.0
South West,17.2.2,Number of cases of Infant deaths 24 hours to 4 weeks of birth with the probable cause being Asphyxia,2. Between 1 week & 4 weeks of birth,,,,,,,,1.0,,,,,1.0
South West,17.2.2,Number of cases of Infant deaths 24 hours to 4 weeks of birth with the probable cause being Asphyxia,3. Total,,,,,1.0,,,1.0,,,,,2.0
South West,17.2.3,Number of cases of Infant deaths 24 hours to 4 weeks of birth with the probable cause being LBW,1. Up to 1 Weeks of Birth,,,,,,1.0,,,1.0,,1.0,1.0,4.0
South West,17.2.3,Number of cases of Infant deaths 24 hours to 4 weeks of birth with the probable cause being LBW,2. Between 1 week & 4 weeks of birth,,,,,,,,,,,,,
South West,17.2.3,Number of cases of Infant deaths 24 hours to 4 weeks of birth with the probable cause being LBW,3. Total,,,,,,1.0,,,1.0,,1.0,1.0,4.0
South West,17.2.4,"Number of cases of Infant deaths 24 hours to 4 weeks of birth with the probable cause being other than Sepsis, Asphyxia and LBW",1. Up to 1 Weeks of Birth,,1.0,1.0,,2.0,,3.0,1.0,,,1.0,2.0,11.0
South West,17.2.4,"Number of cases of Infant deaths 24 hours to 4 weeks of birth with the probable cause being other than Sepsis, Asphyxia and LBW",2. Between 1 week & 4 weeks of birth,,,,,,,1.0,1.0,,,,1.0,3.0
South West,17.2.4,"Number of cases of Infant deaths 24 hours to 4 weeks of birth with the probable cause being other than Sepsis, Asphyxia and LBW",3. Total,,1.0,1.0,,2.0,,4.0,2.0,,,1.0,3.0,14.0
South West,17.3.1,Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being Pneumonia,1. Between 1 month and 11 months,,,,,,,,,,1.0,1.0,,2.0
South West,17.3.1,Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being Pneumonia,2. Between 1 year & 5 years,,,,,,,,,,,,,
South West,17.3.1,Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being Pneumonia,3. Total,,,,,,,,,,1.0,1.0,,2.0
South West,17.3.2,Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being Diarrhoea,1. Between 1 month and 11 months,,,,,,,,,,,,,
South West,17.3.2,Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being Diarrhoea,2. Between 1 year & 5 years,,,,,,,,,,,,,
South West,17.3.2,Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being Diarrhoea,3. Total,,,,,,,,,,,,,
South West,17.3.3,Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being Fever related,1. Between 1 month and 11 months,1.0,1.0,,,,,,,,,,,2.0
South West,17.3.3,Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being Fever related,2. Between 1 year & 5 years,,,,,,,,,,,,,
South West,17.3.3,Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being Fever related,3. Total,1.0,1.0,,,,,,,,,,,2.0
South West,17.3.4,Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being Measles,1. Between 1 month and 11 months,,,,,,,,,,,,,
South West,17.3.4,Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being Measles,2. Between 1 year & 5 years,,,,,,,,,,,,,
South West,17.3.4,Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being Measles,3. Total,,,,,,,,,,,,,
South West,17.3.5,"Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being other than Pneumonia, Diarrhoea, Fever related and Measles",1. Between 1 month and 11 months,,2.0,,2.0,1.0,1.0,,1.0,,,1.0,,8.0
South West,17.3.5,"Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being other than Pneumonia, Diarrhoea, Fever related and Measles",2. Between 1 year & 5 years,,,,,,,,1.0,1.0,,,,2.0
South West,17.3.5,"Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being other than Pneumonia, Diarrhoea, Fever related and Measles",3. Total,,2.0,,2.0,1.0,1.0,,2.0,1.0,,1.0,,10.0
South West,17.4.1,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Diarrhoeal diseases,1. 6-14 yrs,,,,,,,,,,,,,
South West,17.4.1,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Diarrhoeal diseases,2. 15-55 yrs.,,,,,,,,,,,,,
South West,17.4.1,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Diarrhoeal diseases,3. Above 55 yrs.,,,,,,,,,,,,,
South West,17.4.1,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Diarrhoeal diseases,4. Total,,,,,,,,,,,,,
South West,17.4.2,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Tuberculosis,1. 6-14 yrs,,,,,,,,,,,,,
South West,17.4.2,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Tuberculosis,2. 15-55 yrs.,1.0,,1.0,,2.0,,,,2.0,,,,6.0
South West,17.4.2,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Tuberculosis,3. Above 55 yrs.,,,,,,,,,1.0,,,,1.0
South West,17.4.2,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Tuberculosis,4. Total,1.0,,1.0,,2.0,,,,3.0,,,,7.0
South West,17.4.3,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Respiratory diseases including infections,1. 6-14 yrs,,,,,,,,,,,,,
South West,17.4.3,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Respiratory diseases including infections,2. 15-55 yrs.,,1.0,1.0,,1.0,,,,,1.0,,,4.0
South West,17.4.3,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Respiratory diseases including infections,3. Above 55 yrs.,1.0,1.0,1.0,,,,1.0,,,5.0,2.0,3.0,14.0
South West,17.4.3,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Respiratory diseases including infections,4. Total,1.0,2.0,2.0,,1.0,,1.0,,,6.0,2.0,3.0,18.0
South West,17.4.4,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Malaria,1. 6-14 yrs,,,,,,,,,,,,,
South West,17.4.4,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Malaria,2. 15-55 yrs.,,,,,,,,,,,,,
South West,17.4.4,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Malaria,3. Above 55 yrs.,,,,,,,,,,,,,
South West,17.4.4,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Malaria,4. Total,,,,,,,,,,,,,
South West,17.4.5,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being other Fever related,1. 6-14 yrs,,,,,,,,,,,,,
South West,17.4.5,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being other Fever related,2. 15-55 yrs.,,,,,,,,,,1.0,,,1.0
South West,17.4.5,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being other Fever related,3. Above 55 yrs.,1.0,,1.0,,,,,,,1.0,1.0,,4.0
South West,17.4.5,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being other Fever related,4. Total,1.0,,1.0,,,,,,,2.0,1.0,,5.0
South West,17.4.6,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being HIV/AIDS,1. 6-14 yrs,,,,,,,,,,,,,
South West,17.4.6,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being HIV/AIDS,2. 15-55 yrs.,,,,,,,,,,,,,
South West,17.4.6,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being HIV/AIDS,3. Above 55 yrs.,,,,,,,,,,,,,
South West,17.4.6,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being HIV/AIDS,4. Total,,,,,,,,,,,,,
South West,17.4.7,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Heart disease or related to Hypertension,1. 6-14 yrs,,,,,,,,,,,,,
South West,17.4.7,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Heart disease or related to Hypertension,2. 15-55 yrs.,6.0,4.0,,4.0,2.0,2.0,2.0,1.0,1.0,7.0,4.0,6.0,39.0
South West,17.4.7,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Heart disease or related to Hypertension,3. Above 55 yrs.,7.0,10.0,6.0,8.0,11.0,8.0,4.0,9.0,6.0,11.0,8.0,7.0,95.0
South West,17.4.7,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Heart disease or related to Hypertension,4. Total,13.0,14.0,6.0,12.0,13.0,10.0,6.0,10.0,7.0,18.0,12.0,13.0,134.0
South West,17.4.8,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Neurological disease including strokes,1. 6-14 yrs,,,,,,,,,,,,,
South West,17.4.8,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Neurological disease including strokes,2. 15-55 yrs.,,,,1.0,1.0,,,,,,,,2.0
South West,17.4.8,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Neurological disease including strokes,3. Above 55 yrs.,,,,,1.0,1.0,,,,1.0,,,3.0
South West,17.4.8,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Neurological disease including strokes,4. Total,,,,1.0,2.0,1.0,,,,1.0,,,5.0
South West,17.4.9(a),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Abortion,1. 6-14 yrs,,,,,,,,,,,,,
South West,17.4.9(a),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Abortion,2. 15-49 yrs,,,,,,,,,,,,,
South West,17.4.9(a),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Abortion,3. Above 49 yrs.,,,,,,,,,,,,,
South West,17.4.9(a),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Abortion,4. Total,,,,,,,,,,,,,
South West,17.4.9(b),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Obstructed or prolonged labour,1. 6-14 yrs,,,,,,,,,,,,,
South West,17.4.9(b),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Obstructed or prolonged labour,2. 15-49 yrs,,,,,,,,,,,,,
South West,17.4.9(b),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Obstructed or prolonged labour,3. Above 49 yrs.,,,,,,,,,,,,,
South West,17.4.9(b),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Obstructed or prolonged labour,4. Total,,,,,,,,,,,,,
South West,17.4.9(c),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Severe hypertesnion or fits,1. 6-14 yrs,,,,,,,,,,,,,
South West,17.4.9(c),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Severe hypertesnion or fits,2. 15-49 yrs,,,,,,,,,,,,,
South West,17.4.9(c),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Severe hypertesnion or fits,3. Above 49 yrs.,,,,,,,,,,,,,
South West,17.4.9(c),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Severe hypertesnion or fits,4. Total,,,,,,,,,,,,,
South West,17.4.9(d),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Bleeding,1. 6-14 yrs,,,,,,,,,,,,,
South West,17.4.9(d),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Bleeding,2. 15-49 yrs,,,,,,,,,,,,,
South West,17.4.9(d),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Bleeding,3. Above 49 yrs.,,,,,,,,,,,,,
South West,17.4.9(d),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Bleeding,4. Total,,,,,,,,,,,,,
South West,17.4.9(e),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being High Fever,1. 6-14 yrs,,,,,,,,,,,,,
South West,17.4.9(e),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being High Fever,2. 15-49 yrs,,,,,,,,,,,,,
South West,17.4.9(e),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being High Fever,3. Above 49 yrs.,,,,,,,,,,,,,
South West,17.4.9(e),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being High Fever,4. Total,,,,,,,,,,,,,
South West,17.4.9(f),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being other causes (excluding abortion; obstructed or prolonged labour; severe hypertension or fits;,1. 6-14 yrs,,,,,,,,,,,,,
South West,17.4.9(f),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being other causes (excluding abortion; obstructed or prolonged labour; severe hypertension or fits;,2. 15-49 yrs,,,,,,,,,,,,1.0,1.0
South West,17.4.9(f),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being other causes (excluding abortion; obstructed or prolonged labour; severe hypertension or fits;,3. Above 49 yrs.,,,,,,,,,,,,,
South West,17.4.9(f),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being other causes (excluding abortion; obstructed or prolonged labour; severe hypertension or fits;,4. Total,,,,,,,,,,,,1.0,1.0
South West,17.4.10,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Trauma or Accidents or Burn cases,1. 6-14 yrs,,,,,,,,,,,,,
South West,17.4.10,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Trauma or Accidents or Burn cases,2. 15-55 yrs.,3.0,,2.0,1.0,,,,,1.0,2.0,4.0,,13.0
South West,17.4.10,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Trauma or Accidents or Burn cases,3. Above 55 yrs.,3.0,,,1.0,,,,,,,,,4.0
South West,17.4.10,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Trauma or Accidents or Burn cases,4. Total,6.0,,2.0,2.0,,,,,1.0,2.0,4.0,,17.0
South West,17.4.11,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being suicide,1. 6-14 yrs,,,,,,,,,,,,,
South West,17.4.11,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being suicide,2. 15-55 yrs.,1.0,2.0,1.0,,1.0,,,,,1.0,1.0,,7.0
South West,17.4.11,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being suicide,3. Above 55 yrs.,,,,,,,,,,,,,
South West,17.4.11,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being suicide,4. Total,1.0,2.0,1.0,,1.0,,,,,1.0,1.0,,7.0
South West,17.4.12,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Animal bites and stings,1. 6-14 yrs,,,,,,,,,,,,,
South West,17.4.12,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Animal bites and stings,2. 15-55 yrs.,,,,,,,,,,,,,
South West,17.4.12,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Animal bites and stings,3. Above 55 yrs.,,,,,,,,,,,,,
South West,17.4.12,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Animal bites and stings,4. Total,,,,,,,,,,,,,
South West,17.4.13(a),Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Known Acute disease,1. 6-14 yrs,,,,,,,,,,,,,
South West,17.4.13(a),Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Known Acute disease,2. 15-55 yrs.,,,,,,,,,,,,,
South West,17.4.13(a),Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Known Acute disease,3. Above 55 yrs.,1.0,,2.0,1.0,,1.0,,,,1.0,,,6.0
South West,17.4.13(a),Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Known Acute disease,4. Total,1.0,,2.0,1.0,,1.0,,,,1.0,,,6.0
South West,17.4.13(b),Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Known Chronic disease,1. 6-14 yrs,,,,,,,,,,,,,
South West,17.4.13(b),Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Known Chronic disease,2. 15-55 yrs.,3.0,5.0,2.0,2.0,5.0,1.0,,,3.0,1.0,,1.0,23.0
South West,17.4.13(b),Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Known Chronic disease,3. Above 55 yrs.,1.0,4.0,5.0,2.0,2.0,3.0,2.0,2.0,3.0,2.0,,,26.0
South West,17.4.13(b),Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Known Chronic disease,4. Total,4.0,9.0,7.0,4.0,7.0,4.0,2.0,2.0,6.0,3.0,,1.0,49.0
South West,17.4.13(c),Number of cases of Adolescent or Adult deaths (age 6 years & above) where the cause was not known,1. 6-14 yrs,2.0,,,,,,,1.0,,,,,3.0
South West,17.4.13(c),Number of cases of Adolescent or Adult deaths (age 6 years & above) where the cause was not known,2. 15-55 yrs.,5.0,1.0,4.0,6.0,5.0,3.0,4.0,2.0,2.0,4.0,2.0,1.0,39.0
South West,17.4.13(c),Number of cases of Adolescent or Adult deaths (age 6 years & above) where the cause was not known,3. Above 55 yrs.,9.0,12.0,10.0,7.0,17.0,14.0,6.0,4.0,13.0,20.0,7.0,15.0,134.0
South West,17.4.13(c),Number of cases of Adolescent or Adult deaths (age 6 years & above) where the cause was not known,4. Total,16.0,13.0,14.0,13.0,22.0,17.0,10.0,7.0,15.0,24.0,9.0,16.0,176.0
West,1.1,Total number of pregnant women Registered for ANC,TOTAL,10483.0,11248.0,11597.0,11945.0,10957.0,11515.0,9241.0,10108.0,10600.0,12213.0,12764.0,13417.0,136088.0
West,1.1.1,Of which Number registered within first trimester (within 12 weeks),TOTAL,4765.0,5203.0,5668.0,5382.0,4339.0,4501.0,3424.0,4125.0,4591.0,5190.0,5496.0,5535.0,58219.0
West,1.2,Number of Pregnant women registered under JSY,TOTAL,1111.0,884.0,798.0,882.0,813.0,1052.0,487.0,1108.0,971.0,673.0,836.0,974.0,10589.0
West,1.3,Number of pregnant women received 3 ANC check ups during pregnancy,TOTAL,5490.0,6257.0,6716.0,6912.0,7346.0,7438.0,6825.0,7380.0,7781.0,7757.0,7547.0,7773.0,85222.0
West,1.4.1,Number of pregnant women given TT1 during current pregnancy,TOTAL,3691.0,3822.0,3297.0,3768.0,3562.0,4568.0,2960.0,3171.0,2940.0,3117.0,3425.0,4131.0,42452.0
West,1.4.2,Number of pregnant women given TT2 or Booster during current pregnancy,TOTAL,2634.0,3157.0,2686.0,2897.0,2871.0,3316.0,2802.0,2328.0,2622.0,2388.0,2171.0,2821.0,32693.0
West,1.5,Total number of pregnant women given 100 IFA tablets,TOTAL,6345.0,7233.0,7900.0,7909.0,8520.0,8844.0,7626.0,7590.0,8209.0,9387.0,8942.0,8674.0,97179.0
West,1.6.1,Number of new cases of Hypertension (BP>140/90) detected in Pregnant women at the institution,TOTAL,331.0,322.0,254.0,319.0,303.0,402.0,207.0,264.0,214.0,401.0,300.0,280.0,3597.0
West,1.6.2,Number of Eclampsia cases managed during delivery,TOTAL,12.0,11.0,8.0,10.0,13.0,12.0,15.0,18.0,27.0,17.0,15.0,34.0,192.0
West,1.7.1,Number of Pregnant women with anaemia i.e. Hb level<11 (tested cases),TOTAL,3669.0,4897.0,2561.0,2968.0,3069.0,2735.0,2083.0,2249.0,1868.0,2671.0,2855.0,2883.0,34508.0
West,1.7.2,Number of Pregnant women having severe anaemia (Hb<7) treated at institution,TOTAL,295.0,208.0,281.0,273.0,278.0,271.0,182.0,266.0,229.0,290.0,226.0,238.0,3037.0
West,1.8,Number of pregnancy test kits used at SC level,TOTAL,83.0,49.0,14.0,45.0,42.0,48.0,56.0,69.0,150.0,81.0,25.0,48.0,710.0
West,2.1.1.a,Number of deliveries conducted at Home and attended by trained SBA(i.e. Doctor or Nurse or ANM),TOTAL,31.0,27.0,30.0,23.0,41.0,41.0,62.0,31.0,27.0,42.0,30.0,20.0,405.0
West,2.1.1.b,Number of deliveries conducted at Home and attended by non trained SBA (i.e. trained TBA or Relatives etc.),TOTAL,137.0,126.0,105.0,152.0,159.0,186.0,153.0,187.0,147.0,167.0,151.0,128.0,1798.0
West,2.1.1.c,Total number of deliveries conducted at Home and attended by trained or non-trained SBA (i.e. sum of 2.1.1.a and 2.1.1.b),TOTAL,168.0,153.0,135.0,175.0,200.0,227.0,215.0,218.0,174.0,209.0,181.0,148.0,2203.0
West,2.1.2,Number of newborns visited within 24 hours of delivery for deliveries conducted at home,TOTAL,83.0,99.0,82.0,113.0,128.0,138.0,127.0,120.0,112.0,123.0,109.0,85.0,1319.0
West,2.1.3,Number of mothers paid JSY incentive for deliveries conducted at home,TOTAL,2.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,2.0
West,2.2,Deliveries conducted at Public Institutions (Including C-Sections),TOTAL,1614.0,1532.0,1712.0,2037.0,2374.0,2361.0,2241.0,2070.0,2028.0,2154.0,1695.0,1741.0,23559.0
West,2.2.1,"Out of 2.2, Number discharged under 48 hours of delivery",TOTAL,1033.0,979.0,1052.0,1340.0,1210.0,1301.0,1260.0,1191.0,1139.0,1187.0,908.0,874.0,13474.0
West,2.2.2.a,Number of mothers paid JSY Incentive for deliveries conducted at Public Institutions,TOTAL,373.0,384.0,233.0,211.0,207.0,188.0,206.0,195.0,192.0,181.0,203.0,179.0,2752.0
West,2.2.2.b,Number of ASHAs paid JSY Incentive for deliveries conducted at Public Institutions,TOTAL,30.0,53.0,84.0,96.0,41.0,32.0,43.0,32.0,30.0,37.0,4.0,33.0,515.0
West,2.2.2.c,Number of cases of deliveries conducted at Public Institutions where JSY incentive was paid to ANMs or AWWs [only for High Performing States (HPS)],TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
West,2.3,Deliveries conducted at Private Institutions (Including C-Sections),TOTAL,550.0,634.0,733.0,687.0,729.0,907.0,791.0,728.0,665.0,796.0,612.0,597.0,8429.0
West,2.3.1.a,Number of mothers paid JSY Incentive for deliveries conducted at accredited Private Institutions,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
West,2.3.1.b,Number of ASHAs paid JSY Incentive for deliveries conducted at accredited Private Institutions,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
West,2.3.1.c,Number of cases of deliveries conducted at accredited Private Institutions where JSY incentive was paid to ANMs or AWWs [only for High Performing States (HPS)],TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
West,3.1.1,Number of Caesarean (C-Section) deliveries performed at PHCs (Primary Health Centre),TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
West,3.1.2,Number of Caesarean (C-Section) deliveries performed at CHCs (Community Health Centre),TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
West,3.1.3,Number of Caesarean (C-Section) deliveries performed at SDHs (Sub-divisional Hospital) or DHs (District Hospital),TOTAL,438.0,450.0,479.0,530.0,500.0,625.0,568.0,571.0,546.0,579.0,516.0,557.0,6359.0
West,3.1.4,Number of Caesarean (C-Section) deliveries performed at other State owned public institutions,TOTAL,,,,,,,,,,,,,
West,3.1.5,"Total Number of Caesarean (C-Section) deliveries performed at Public facilities i.e. PHC, CHC, SDH, DH and other State owned public institutions (sum of items from 3.1.1 to 3.1.4)",TOTAL,438.0,450.0,479.0,530.0,500.0,625.0,568.0,571.0,546.0,579.0,516.0,557.0,6359.0
West,3.2,No. of C-section deliveries performed at Private facilities,TOTAL,318.0,354.0,350.0,338.0,405.0,566.0,472.0,379.0,380.0,453.0,393.0,355.0,4763.0
West,4.1.1.a,Number of male live births,TOTAL,1237.0,1225.0,1384.0,1591.0,1747.0,1854.0,1669.0,1556.0,1518.0,1738.0,1340.0,1344.0,18203.0
West,4.1.1.b,Number of female live births,TOTAL,1096.0,1075.0,1175.0,1305.0,1545.0,1628.0,1537.0,1438.0,1336.0,1415.0,1129.0,1123.0,15802.0
West,4.1.1.c,Total number of male and female live births (4.1.1.a and 4.1.1.b),TOTAL,2333.0,2300.0,2559.0,2896.0,3292.0,3482.0,3206.0,2994.0,2854.0,3153.0,2469.0,2467.0,34005.0
West,4.1.2,Number of still births,TOTAL,56.0,49.0,55.0,63.0,63.0,46.0,68.0,56.0,45.0,44.0,40.0,51.0,636.0
West,4.1.3,Number of Abortions (spontaneous or induced),TOTAL,406.0,303.0,390.0,820.0,298.0,210.0,264.0,327.0,203.0,379.0,368.0,384.0,4352.0
West,4.2.1,Number of Newborns weighed at birth,TOTAL,2259.0,2123.0,2446.0,2731.0,3074.0,3366.0,3027.0,2762.0,2643.0,1997.0,2307.0,2372.0,31107.0
West,4.2.2,Number of Newborns having weight less than 2.5 kg,TOTAL,483.0,431.0,521.0,707.0,767.0,708.0,680.0,629.0,549.0,651.0,503.0,589.0,7218.0
West,4.3,Number of Newborns breast fed within 1 hour of birth,TOTAL,1488.0,1461.0,1625.0,1949.0,2324.0,2466.0,2247.0,2032.0,1883.0,1931.0,1611.0,1498.0,22515.0
West,5.1.1,Number of cases of pregnant women with Obstetric Complications and attended at PHCs,TOTAL,8.0,6.0,8.0,15.0,27.0,27.0,31.0,23.0,0.0,0.0,0.0,0.0,145.0
West,5.1.2,Number of cases of pregnant women with Obstetric Complications and attended at CHCs,TOTAL,14.0,0.0,15.0,21.0,12.0,20.0,7.0,8.0,15.0,0.0,0.0,0.0,112.0
West,5.1.3,Number of cases of pregnant women with Obstetric Complications and attended at SDHs or DHs,TOTAL,463.0,427.0,479.0,593.0,780.0,587.0,794.0,619.0,542.0,729.0,777.0,890.0,7680.0
West,5.1.4,Number of cases of pregnant women with Obstetric Complications and attended at other State owned public institutions,TOTAL,,,,,,,,,,,,,
West,5.1.5,"Number of cases of pregnant women with Obstetric Complications and attended at Public facilities i.e. PHC, CHC, SDH, DH and other State owned public institutions (sum of items from 5.1.1 to 5.1.4)",TOTAL,485.0,433.0,502.0,629.0,819.0,634.0,832.0,650.0,557.0,729.0,777.0,890.0,7937.0
West,5.2,Number of cases of pregnant women with Obstetric Complications and attended at Private facilities,TOTAL,51.0,77.0,131.0,21.0,41.0,213.0,51.0,32.0,11.0,22.0,14.0,13.0,677.0
West,5.3.1,Number of cases of complicated pregnancies treated with IV antibiotics,TOTAL,398.0,428.0,550.0,466.0,735.0,667.0,743.0,524.0,474.0,547.0,571.0,607.0,6710.0
West,5.3.2,Number of cases of complicated pregnancies treated with IV Antihypertensive/Magsulph injection,TOTAL,131.0,122.0,184.0,134.0,154.0,327.0,140.0,99.0,120.0,22.0,100.0,84.0,1617.0
West,5.3.3,Number of cases of complicated pregnancies treated with IV Oxytocis,TOTAL,226.0,235.0,286.0,247.0,260.0,303.0,283.0,313.0,262.0,310.0,241.0,229.0,3195.0
West,5.3.4,Number of cases of complicated pregnancies treated with Blood Transfusion,TOTAL,249.0,324.0,179.0,293.0,282.0,205.0,233.0,255.0,228.0,222.0,189.0,177.0,2836.0
West,6.1,Women getting post partum check-up within 48 hours after delivery,TOTAL,2084.0,2067.0,2341.0,2726.0,3151.0,3284.0,2912.0,2646.0,2703.0,2766.0,2195.0,2145.0,31020.0
West,6.2,Women getting a post partum check up between 48 hours and 14 days after delivery,TOTAL,2138.0,2266.0,2566.0,2775.0,3236.0,3212.0,2963.0,2683.0,2605.0,2624.0,2462.0,2315.0,31845.0
West,6.3,PNC maternal complications attended,TOTAL,108.0,110.0,122.0,127.0,139.0,127.0,122.0,190.0,178.0,169.0,59.0,120.0,1571.0
West,7.1.1,Number of MTPs conducted at Public Institutions up to 12 weeks of pregnancy,TOTAL,99.0,76.0,93.0,98.0,55.0,60.0,62.0,72.0,94.0,78.0,72.0,76.0,935.0
West,7.1.2,Number of MTPs conducted at Public Institutions for more than 12 weeks of pregnancy,TOTAL,0.0,4.0,7.0,1.0,2.0,7.0,2.0,2.0,0.0,2.0,3.0,6.0,36.0
West,7.1.3,Total number of MTPs conducted at Public Institutions (sum of items 7.1.1 and 7.1.2),TOTAL,99.0,80.0,100.0,99.0,57.0,67.0,64.0,74.0,94.0,80.0,75.0,82.0,971.0
West,7.2,Number of MTPs conducted at Private Facilities,TOTAL,249.0,268.0,294.0,196.0,178.0,159.0,193.0,245.0,239.0,271.0,224.0,224.0,2740.0
West,8.1.a,Number of new cases of RTI/STI in males for which treatment was initiated,TOTAL,388.0,347.0,345.0,485.0,391.0,487.0,343.0,439.0,390.0,370.0,384.0,441.0,4810.0
West,8.1.b,Number of new cases of RTI/STI in females for which treatment was initiated,TOTAL,3152.0,3279.0,3347.0,3307.0,3415.0,3097.0,2900.0,3125.0,3095.0,3183.0,2715.0,3075.0,37690.0
West,8.1.c,Total number of new cases of RTI/STI in males and females for which treatment was initiated (sum of items 8.1.a and 8.1.b),TOTAL,3540.0,3626.0,3692.0,3792.0,3806.0,3584.0,3243.0,3564.0,3485.0,3553.0,3099.0,3516.0,42500.0
West,8.2,Number of suspected RTI/STI cases for whom wet mount test was conducted,TOTAL,230.0,58.0,57.0,88.0,50.0,57.0,47.0,94.0,28.0,142.0,55.0,103.0,1009.0
West,9.1.1.a,Number of NSV (No Scalpel Vasectomy) or Conventional Vasectomy conducted at PHCs,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
West,9.1.1.b,Number of NSV or Conventional Vasectomy conducted at CHCs,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
West,9.1.1.c,Number of NSV or Conventional Vasectomy conducted at SDHs or DHs,TOTAL,8.0,8.0,9.0,31.0,19.0,16.0,17.0,16.0,9.0,6.0,13.0,8.0,160.0
West,9.1.1.d,Number of NSV or Conventional Vasectomy conducted at other State owned public institutions,TOTAL,,,,,,,,,,,,,
West,9.1.1.e,"Total Number of NSV or Conventional Vasectomy conducted at Public facilities i.e. PHC, CHC, SDH, DH and other State owned public institutions (sum of items from 9.1.1.a to 9.1.1.d)",TOTAL,8.0,8.0,9.0,31.0,19.0,16.0,17.0,16.0,9.0,6.0,13.0,8.0,160.0
West,9.1.2,Number of NSV or Conventional Vasectomy conducted at Private facilities,TOTAL,0.0,0.0,1.0,1.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,2.0
West,9.2.1.a,Number of Laparoscopic sterilizations conducted at PHCs,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
West,9.2.1.b,Number of Laparoscopic sterilizations conducted at CHCs,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
West,9.2.1.c,Number of Laparoscopic sterilizations conducted at SDHs or DHs,TOTAL,90.0,100.0,74.0,57.0,55.0,65.0,58.0,104.0,133.0,101.0,116.0,117.0,1070.0
West,9.2.1.d,Number of Laparoscopic sterilizations conducted at other State owned public institutions,TOTAL,,,,,,,,,,,,,
West,9.2.1.e,"Total Number of Laparoscopic sterilizations conducted at Public facilities i.e. PHC, CHC, SDH, DH and other State owned public institutions (sum of items from 9.2.1.a to 9.2.1.d)",TOTAL,90.0,100.0,74.0,57.0,55.0,65.0,58.0,104.0,133.0,101.0,116.0,117.0,1070.0
West,9.2.2,Number of Laparoscopic sterilizations conducted at Private facilities,TOTAL,3.0,7.0,7.0,5.0,2.0,8.0,2.0,2.0,6.0,4.0,5.0,6.0,57.0
West,9.3.1.a,Number of Mini-lap sterilizations conducted at PHCs,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
West,9.3.1.b,Number of Mini-lap sterilizations conducted at CHCs,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
West,9.3.1.c,Number of Mini-lap sterilizations conducted at SDHs or DHs,TOTAL,13.0,3.0,47.0,49.0,31.0,33.0,44.0,1.0,3.0,5.0,64.0,3.0,296.0
West,9.3.1.d,Number of Mini-lap sterilizations conducted at other State owned public institutions,TOTAL,,,,,,,,,,,,,
West,9.3.1.e,"Total Number of Mini-lap sterilizations conducted at Public facilities i.e. PHC, CHC, SDH, DH and other State owned public institutions (sum of items from 9.3.1.a to 9.3.1.d)",TOTAL,13.0,3.0,47.0,49.0,31.0,33.0,44.0,1.0,3.0,5.0,64.0,3.0,296.0
West,9.3.2,Number of Mini-lap sterilizations conducted at Private facilities,TOTAL,5.0,5.0,11.0,8.0,6.0,0.0,2.0,9.0,5.0,7.0,5.0,6.0,69.0
West,9.4.1.a,Number of Post-Partum sterilizations conducted at PHCs,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
West,9.4.1.b,Number of Post-Partum sterilizations conducted at CHCs,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
West,9.4.1.c,Number of Post-Partum sterilizations conducted at SDHs or DHs,TOTAL,70.0,69.0,9.0,32.0,79.0,92.0,37.0,53.0,107.0,57.0,11.0,71.0,687.0
West,9.4.1.d,Number of Post-Partum sterilizations conducted at other State owned public institutions,TOTAL,,,,,,,,,,,,,
West,9.4.1.e,"Total Number of Post-Partum sterilizations conducted at Public facilities i.e. PHC, CHC, SDH, DH and other State owned public institutions (sum of items from 9.4.1.a to 9.4.1.d)",TOTAL,70.0,69.0,9.0,32.0,79.0,92.0,37.0,53.0,107.0,57.0,11.0,71.0,687.0
West,9.4.2,Number of Post-Partum sterilizations conducted at Private facilities,TOTAL,7.0,8.0,9.0,7.0,9.0,6.0,8.0,7.0,8.0,11.0,9.0,8.0,97.0
West,9.5.1.a,Number of IUCD Insertions conducted at SCs,TOTAL,43.0,52.0,51.0,81.0,55.0,34.0,34.0,26.0,61.0,12.0,30.0,33.0,512.0
West,9.5.1.b,Number of IUCD Insertions conducted at PHCs,TOTAL,244.0,247.0,205.0,527.0,343.0,275.0,208.0,261.0,279.0,246.0,292.0,289.0,3416.0
West,9.5.1.c,Number of IUCD Insertions conducted at CHCs,TOTAL,47.0,56.0,44.0,51.0,46.0,53.0,59.0,34.0,45.0,37.0,50.0,63.0,585.0
West,9.5.1.d,Number of IUCD Insertions conducted at SDHs or DHs,TOTAL,347.0,412.0,405.0,433.0,381.0,388.0,296.0,423.0,346.0,302.0,268.0,415.0,4416.0
West,9.5.1.e,Number of IUCD Insertions conducted at other State owned public institutions,TOTAL,,,,,,,,,,,,,
West,9.5.1.f,"Total Number of IUCD Insertions conducted at Public facilities i.e. SC, PHC, CHC, SDH, DH and other State owned public institutions (sum of items from 9.5.1.a to 9.5.1.e)",TOTAL,681.0,767.0,705.0,1092.0,825.0,750.0,597.0,744.0,731.0,597.0,640.0,800.0,8929.0
West,9.5.1A,"Out of above total, Post Partum (within 48 hours of delivery) IUCD insertions",TOTAL,272.0,344.0,355.0,358.0,328.0,321.0,270.0,332.0,290.0,286.0,262.0,260.0,3678.0
West,9.5.2,Number of IUCD Insertions conducted at Private facilities,TOTAL,41.0,34.0,37.0,27.0,27.0,34.0,36.0,50.0,64.0,46.0,50.0,54.0,500.0
West,9.06,Number of IUCD removals,TOTAL,138.0,145.0,138.0,141.0,149.0,137.0,120.0,137.0,182.0,111.0,136.0,151.0,1685.0
West,9.07,Number of Oral Pills cycles distributed,TOTAL,3754.0,2373.0,1709.0,2758.0,2000.0,3793.0,3462.0,2185.0,2170.0,1348.0,1258.0,1357.0,28167.0
West,9.08,Number of Condom pieces distributed,TOTAL,42737.0,43872.0,36372.0,59708.0,44230.0,34714.0,32636.0,31946.0,24207.0,35547.0,41434.0,23828.0,451231.0
West,9.09,Number of Centchroman (weekly) pills given,TOTAL,5.0,8.0,5.0,12.0,5.0,10.0,6.0,4.0,7.0,5.0,5.0,4.0,76.0
West,9.10,Number of Emergency Contraceptive Pills distributed,TOTAL,50.0,38.0,38.0,108.0,79.0,56.0,47.0,115.0,83.0,101.0,42.0,57.0,814.0
West,9.11.1.a,Number of cases of complications following male sterilization,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
West,9.11.1.b,Number of cases of complications following female sterilization,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,1.0,1.0
West,9.11.2.a,Number of failures following male sterilization,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
West,9.11.2.b,Number of failures following female sterilization,TOTAL,2.0,1.0,0.0,1.0,0.0,0.0,1.0,0.0,0.0,1.0,0.0,1.0,7.0
West,9.11.3.a,Number of deaths following male sterilization,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
West,9.11.3.b,Number of deaths following female sterilization,TOTAL,1.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,1.0
West,9.12,Number of Institutions having NSV trained doctors,TOTAL,16.0,13.0,15.0,13.0,12.0,12.0,16.0,8.0,12.0,10.0,13.0,12.0,-1.0
West,10.1.01,Number of Infants (0 to 11 months old)received BCG immunisation,TOTAL,2802.0,2795.0,2806.0,3289.0,3792.0,3835.0,3617.0,3685.0,3488.0,3308.0,2981.0,2908.0,39306.0
West,10.1.02,Number of Infants (0 to 11 months old) received DPT1 immunisation,TOTAL,918.0,769.0,639.0,519.0,551.0,546.0,464.0,443.0,436.0,350.0,331.0,318.0,6284.0
West,10.1.03,Number of Infants (0 to 11 months old) received DPT2 immunisation,TOTAL,1011.0,837.0,634.0,725.0,623.0,646.0,573.0,560.0,540.0,455.0,397.0,406.0,7407.0
West,10.1.04,Number of Infants (0 to 11 months old) received DPT3 immunisation,TOTAL,1065.0,904.0,723.0,796.0,741.0,695.0,557.0,624.0,524.0,522.0,442.0,460.0,8053.0
West,10.1.04A,Number of Infants (0 to 11 months old) received Pentavalent1 immunisation,TOTAL,2508.0,2226.0,1937.0,2652.0,2623.0,2834.0,3641.0,3835.0,3784.0,3337.0,3235.0,3534.0,36146.0
West,10.1.04B,Number of Infants (0 to 11 months old) received Pentavalent2 immunisation,TOTAL,2461.0,2380.0,1904.0,2254.0,2198.0,1943.0,2719.0,3134.0,3593.0,3311.0,2838.0,3510.0,32245.0
West,10.1.04C,Number of Infants (0 to 11 months old) received Pentavalent3 immunisation,TOTAL,2569.0,2358.0,1941.0,2313.0,2135.0,1722.0,2111.0,2374.0,2805.0,3034.0,2767.0,3291.0,29420.0
West,10.1.05,Number of Infants (0 to 11 months old) received OPV 0 (Birth Dose),TOTAL,2067.0,2109.0,2346.0,2579.0,2889.0,3084.0,2883.0,2665.0,2754.0,2697.0,2321.0,2167.0,30561.0
West,10.1.06,Number of Infants (0 to 11 months old) received OPV1 (First Dose),TOTAL,3385.0,3023.0,2615.0,3113.0,3263.0,3400.0,4003.0,4238.0,4227.0,3687.0,3587.0,3890.0,42431.0
West,10.1.07,Number of Infants (0 to 11 months old) received OPV2 (Second Dose),TOTAL,3418.0,3212.0,2561.0,3037.0,2878.0,2586.0,3224.0,3597.0,4163.0,3755.0,3276.0,3916.0,39623.0
West,10.1.08,Number of Infants (0 to 11 months old) received OPV3 (Third Dose),TOTAL,3597.0,3204.0,2686.0,3147.0,2917.0,2423.0,2615.0,2939.0,3330.0,3547.0,3253.0,3776.0,37434.0
West,10.1.09A,Number of Infants (upto 48 hrs of age) received Hepatitis-B0 immunisation,TOTAL,1756.0,1672.0,1971.0,2102.0,2468.0,2585.0,2402.0,2250.0,2141.0,2226.0,1796.0,1937.0,25306.0
West,10.1.09,Number of Infants (0 to 11 months old) received Hepatitis-B1 immunisation,TOTAL,967.0,920.0,800.0,725.0,920.0,756.0,660.0,672.0,609.0,535.0,510.0,480.0,8554.0
West,10.1.10,Number of Infants (0 to 11 months old) received Hepatitis-B2 immunisation,TOTAL,1016.0,865.0,665.0,803.0,765.0,649.0,615.0,633.0,677.0,528.0,484.0,477.0,8177.0
West,10.1.11,Number of Infants (0 to 11 months old) received Hepatitis-B3 immunisation,TOTAL,1026.0,978.0,749.0,849.0,797.0,762.0,576.0,653.0,554.0,534.0,450.0,508.0,8436.0
West,10.1.12,Number of Infants (0 to 11 months old) received Measles immunisation (First Dose),TOTAL,4097.0,3707.0,3961.0,4005.0,3799.0,3321.0,3291.0,3584.0,3134.0,2761.0,2586.0,3154.0,41400.0
West,10.1.12B,Number of Infants (more than 16 months old) received Measles immunisation (Second Dose),TOTAL,13018.0,4075.0,9542.0,2686.0,777.0,168.0,55.0,84.0,60.0,59.0,143.0,521.0,31188.0
West,10.1A,No. of Children aged 9 to 12 months who received JE 1st dose,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
West,10.1.13.a,Total number of male children (9 to 11 months old) fully immunised (BCG+DPT123/Pentavalent123+OPV123+Measles) during the month,TOTAL,1903.0,1995.0,1943.0,1988.0,1995.0,1756.0,1659.0,1858.0,1649.0,1407.0,1366.0,1578.0,21097.0
West,10.1.13.b,Total number of female children (9 to 11 months old) fully immunised (BCG+DPT123/Pentavalent123+OPV123+Measles) during the month,TOTAL,1607.0,1617.0,1679.0,1704.0,1664.0,1541.0,1461.0,1574.0,1395.0,1245.0,1135.0,1421.0,18043.0
West,10.1.13.c,Total number of children (9 to 11 months old) fully immunised (BCG+DPT123/Pentavalent123+OPV123+Measles) during the month (sum of items 10.1.13.a and 10.1.13.b),TOTAL,3510.0,3612.0,3622.0,3692.0,3659.0,3297.0,3120.0,3432.0,3044.0,2652.0,2501.0,2999.0,39140.0
West,10.2.1,Number of Infants (more than 16 months old) received DPT Booster dose,TOTAL,3873.0,3471.0,2482.0,3416.0,3415.0,3051.0,2656.0,2915.0,3155.0,2906.0,3026.0,3913.0,38279.0
West,10.2.2,Number of Infants (more than 16 months old) received OPV Booster dose,TOTAL,3836.0,3455.0,2523.0,3384.0,3414.0,3033.0,2646.0,2874.0,3148.0,2883.0,3021.0,3850.0,38067.0
West,10.2.3,"Number of Infants (more than 16 months old) received Measles, Mumps, Rubella (MMR) Vaccination",TOTAL,222.0,222.0,900.0,410.0,2985.0,4299.0,3721.0,4351.0,4975.0,3313.0,3149.0,3378.0,31925.0
West,10.3.1.a,Total number of male children (12 to 23 months old) fully immunised (BCG+DPT123/Pentavalent123+OPV123+Measles) during the month,TOTAL,1118.0,911.0,1077.0,729.0,770.0,800.0,607.0,647.0,654.0,551.0,551.0,724.0,9139.0
West,10.3.1.b,Total number of female children (12 to 23 months old) fully immunised (BCG+DPT123/Pentavalent123+OPV123+Measles) during the month,TOTAL,945.0,761.0,944.0,581.0,640.0,706.0,587.0,549.0,546.0,484.0,507.0,598.0,7848.0
West,10.3.1.c,Total number of children (12 to 23 months old) fully immunised (BCG+DPT123+OPV123/Pentavalent123+Measles) during the month (sum of items 10.3.1.a and 10.3.1.b),TOTAL,2063.0,1672.0,2021.0,1310.0,1410.0,1506.0,1194.0,1196.0,1200.0,1035.0,1058.0,1322.0,16987.0
West,10.3.2,Number of children (more than 5 years old) given DT5,TOTAL,1693.0,1917.0,2104.0,1499.0,1492.0,1610.0,1559.0,1699.0,1713.0,1729.0,1429.0,2053.0,20497.0
West,10.3.3,Number of children (more than 10 years old) given TT10,TOTAL,371.0,484.0,549.0,382.0,339.0,366.0,337.0,384.0,374.0,393.0,390.0,522.0,4891.0
West,10.3.4,Number of children (more than 16 years old) given TT16,TOTAL,221.0,251.0,240.0,240.0,209.0,204.0,188.0,185.0,202.0,197.0,204.0,216.0,2557.0
West,10.3.5.a,Number of cases of Abscess reported following immunisation [Adverse Event Following Immunisation (AEFI)],TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,1.0,0.0,1.0
West,10.3.5.b,Number of cases of Death reported following immunisation [Adverse Event Following Immunisation (AEFI)],TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
West,10.3.5.c,Number of cases of other complications reported following immunisation [Adverse Event Following Immunisation (AEFI)],TOTAL,3.0,1.0,1.0,0.0,1.0,0.0,0.0,0.0,0.0,1.0,0.0,0.0,7.0
West,10.4.1,Number of Immunisation sessions planned to be held during the month,TOTAL,1373.0,1183.0,1370.0,1174.0,1080.0,1092.0,1123.0,1112.0,1376.0,1337.0,1320.0,1300.0,14840.0
West,10.4.2,Number of Immunisation sessions held during the month,TOTAL,1288.0,1145.0,1328.0,1129.0,1052.0,1047.0,1061.0,1057.0,1343.0,1243.0,1230.0,1252.0,14175.0
West,10.4.3,Number of Immunisation sessions held during the month where ASHAs were present,TOTAL,583.0,627.0,667.0,532.0,516.0,519.0,508.0,524.0,704.0,667.0,710.0,716.0,7273.0
West,10.5.1,Number of children (more than 16 months old) received Japanese Encephalitis (JE) vaccination,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
West,11.1.1,Number of children (9 months to 5 years old) administered 1st dose of Vitamin A (Dose-1),TOTAL,4516.0,3969.0,4078.0,3845.0,3561.0,3216.0,3272.0,3471.0,3088.0,2602.0,1834.0,2071.0,39523.0
West,11.1.2,Number of children (9 months to 5 years old) were administered 5th dose of Vitamin A (Dose-5),TOTAL,4239.0,2935.0,5825.0,2026.0,2188.0,2594.0,2579.0,3001.0,3218.0,2813.0,1409.0,1379.0,34206.0
West,11.1.3,Number of children (9 months to 5 years old) administered 9th dose of Vitamin A (Dose-9),TOTAL,1163.0,1061.0,1581.0,721.0,756.0,894.0,1138.0,1011.0,1114.0,1225.0,595.0,765.0,12024.0
West,12.1,Number of cases of Diptheria reported in children below 5 years of age,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
West,12.2,Number of cases of Pertusis reported in children below 5 years of age,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
West,12.3,Number of cases of Tetanus neonatarum reported in children below 5 years of age,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
West,12.4,Number of cases of Tetanus other than neonatarum reported in children below 5 years of age,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
West,12.5,Number of cases of Polio reported in children below 5 years of age,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
West,12.6,Number of cases of Measles reported in children below 5 years of age,TOTAL,37.0,38.0,13.0,13.0,5.0,1.0,5.0,4.0,2.0,2.0,1.0,11.0,132.0
West,12.7,Number of cases of Diarrhoea and Dehydration reported in children below 5 years of age,TOTAL,2024.0,1767.0,1930.0,2074.0,2144.0,1155.0,762.0,873.0,753.0,491.0,662.0,939.0,15574.0
West,12.8,Number of cases of Malaria reported in children below 5 years of age,TOTAL,3.0,0.0,5.0,12.0,11.0,16.0,8.0,1.0,0.0,0.0,1.0,2.0,59.0
West,12.9,Number of children below 5 years of age admitted with Respiratory Infections,TOTAL,389.0,283.0,220.0,285.0,549.0,1448.0,1637.0,1619.0,981.0,174.0,541.0,315.0,8441.0
West,13.1,Number of Patients operated for cataract,TOTAL,712.0,623.0,522.0,508.0,500.0,700.0,549.0,740.0,825.0,654.0,768.0,891.0,7992.0
West,13.2,Number of Intraocular Lens(IOL) implantations,TOTAL,645.0,548.0,443.0,459.0,473.0,629.0,549.0,677.0,724.0,557.0,686.0,786.0,7176.0
West,13.3,Number of School children detected with Refractive errors,TOTAL,521.0,564.0,809.0,768.0,735.0,635.0,625.0,663.0,1445.0,470.0,518.0,526.0,8279.0
West,13.4,Number of children provided free glasses,TOTAL,192.0,192.0,250.0,147.0,159.0,170.0,371.0,162.0,138.0,146.0,128.0,122.0,2177.0
West,13.5,Number of eyes collected through eye donation,TOTAL,18.0,7.0,9.0,10.0,17.0,31.0,33.0,20.0,36.0,38.0,28.0,28.0,275.0
West,13.6,Number of eyes utilised for corneal transplant,TOTAL,13.0,7.0,7.0,10.0,17.0,25.0,28.0,15.0,31.0,38.0,28.0,28.0,247.0
West,14.01,Number of CHC or SDH or DH functioning as First Referral units (FRUs),TOTAL,4.0,4.0,4.0,4.0,4.0,4.0,4.0,4.0,4.0,4.0,4.0,4.0,-1.0
West,14.02,Number of PHCs functioning 24X7 with atleast 3 Staff Nurses,TOTAL,,,,,,,,,,,,,-1.0
West,14.03,Number of Anganwadi centres reported to have conducted VHNDs,TOTAL,18.0,25.0,18.0,19.0,18.0,21.0,18.0,15.0,11.0,13.0,14.0,13.0,-1.0
West,14.04,Number of facilities having a Rogi Kalyan Samiti (RKS),TOTAL,4.0,4.0,4.0,4.0,4.0,4.0,4.0,4.0,4.0,4.0,4.0,4.0,-1.0
West,14.05,Number of RKS meetings held during the month,TOTAL,0.0,1.0,1.0,1.0,1.0,0.0,0.0,1.0,0.0,0.0,0.0,0.0,5.0
West,14.06,Number of facilities having Ambulance services (Assured Referral Services),TOTAL,18.0,18.0,21.0,18.0,19.0,20.0,20.0,20.0,20.0,17.0,22.0,20.0,-1.0
West,14.07,Total Number of times the Ambulance was used for transporting patients during the month,TOTAL,860.0,670.0,853.0,893.0,1005.0,1054.0,1049.0,899.0,913.0,781.0,935.0,970.0,10882.0
West,14.08,Number of Institutions having Operational Sick New Born and Child Care Units (SNCU),TOTAL,5.0,5.0,5.0,5.0,5.0,5.0,5.0,5.0,5.0,5.0,5.0,5.0,-1.0
West,14.09,Number of functional Laproscopes in CHC/SDH/DH,TOTAL,9.0,9.0,10.0,9.0,9.0,9.0,9.0,9.0,9.0,9.0,9.0,9.0,-1.0
West,14.10.1.a,Number of male patients admitted (Inpatients) during the month,1. Children,2246.0,2501.0,2273.0,2517.0,1773.0,1802.0,1699.0,1569.0,1604.0,1578.0,1700.0,2166.0,23428.0
West,14.10.1.a,Number of male patients admitted (Inpatients) during the month,2. Adults,4941.0,4723.0,6019.0,5609.0,5125.0,6701.0,4722.0,4714.0,4500.0,4338.0,5002.0,10298.0,66692.0
West,14.10.1.b,Number of female patients (Inpatients) admitted during the month,1. Children,2927.0,2942.0,2847.0,2847.0,1451.0,1377.0,1465.0,1254.0,1227.0,1117.0,1309.0,1603.0,22366.0
West,14.10.1.b,Number of female patients (Inpatients) admitted during the month,2. Adults,7131.0,7330.0,8913.0,7907.0,8549.0,10095.0,7709.0,8088.0,7812.0,7580.0,6870.0,13914.0,101898.0
West,14.10.1.c,Total number of patients admitted (Inpatients) during the month (sum of items 14.10.1.a and 14.10.1.b),1. Children,5173.0,5443.0,5120.0,5364.0,3224.0,3179.0,3164.0,2823.0,2831.0,2695.0,3009.0,3769.0,45794.0
West,14.10.1.c,Total number of patients admitted (Inpatients) during the month (sum of items 14.10.1.a and 14.10.1.b),2. Adults,12072.0,12053.0,14932.0,13516.0,13674.0,16796.0,12431.0,12802.0,12312.0,11918.0,11872.0,24212.0,168590.0
West,14.10.2.a,Number of death cases of Inpatient males,TOTAL,178.0,183.0,173.0,192.0,175.0,182.0,160.0,194.0,177.0,244.0,259.0,221.0,2338.0
West,14.10.2.b,Number of death cases of Inpatient females,TOTAL,126.0,105.0,117.0,95.0,116.0,112.0,105.0,125.0,108.0,152.0,161.0,145.0,1467.0
West,14.10.2.c,Number of cases of death of Inpatients (sum of items 14.10.2.a and 14.10.2.b),TOTAL,304.0,288.0,290.0,287.0,291.0,294.0,265.0,319.0,285.0,396.0,420.0,366.0,3805.0
West,14.11,In-Patient Head Count at midnight,TOTAL,33910.0,31882.0,31565.0,36214.0,39269.0,38441.0,36237.0,38012.0,34256.0,34904.0,35803.0,38336.0,428829.0
West,14.12.1,OPD attendance (All),TOTAL,561921.0,576134.0,587740.0,600896.0,640105.0,659451.0,513006.0,574160.0,550276.0,549474.0,606015.0,611560.0,7030738.0
West,14.13.1,Number of major operations carried out using general or spinal anaesthesia,TOTAL,2905.0,3466.0,3736.0,3683.0,3638.0,4183.0,3148.0,3560.0,3499.0,3606.0,3408.0,3673.0,42505.0
West,14.13.1A,"Out of 14.13.1,Gynecology- Hysterectomy surgeries",TOTAL,9.0,52.0,59.0,9.0,11.0,9.0,6.0,10.0,16.0,17.0,35.0,19.0,252.0
West,14.13.2,Number of minor operations carried out without anaesthesia or using local anaesthesia,TOTAL,4751.0,4907.0,8072.0,8993.0,9081.0,5746.0,3681.0,7983.0,9707.0,9287.0,4781.0,6799.0,83788.0
West,14.14.a,Number of patients given AYUSH treatment,TOTAL,16217.0,13922.0,14622.0,15388.0,15310.0,15998.0,15309.0,14506.0,14967.0,13722.0,14885.0,15749.0,180595.0
West,14.14.b,Number of patients on whom Dental Procedure was conducted,TOTAL,5441.0,5911.0,7238.0,5599.0,5490.0,5940.0,4571.0,6508.0,6655.0,4537.0,4839.0,5578.0,68307.0
West,14.14.c,Number of Adolescents counselled,TOTAL,538.0,443.0,492.0,550.0,475.0,489.0,625.0,399.0,373.0,494.0,402.0,555.0,5835.0
West,15.1.1.a,Number of Haemoglobin (Hb) tests conducted,TOTAL,39744.0,42940.0,43694.0,41922.0,39722.0,48516.0,39754.0,39348.0,35983.0,36753.0,37842.0,40367.0,486585.0
West,15.1.1.b,"Out of the total number of Hb tests conducted, number of cases having Hb less than 7gm/dl",TOTAL,3302.0,3349.0,3230.0,3077.0,3356.0,3463.0,2534.0,2328.0,2307.0,2229.0,2386.0,2879.0,34440.0
West,15.1.2.a,Number of HIV tests conducted on males,1. Number tested,2020.0,2060.0,2735.0,2323.0,1720.0,2183.0,1501.0,1837.0,1799.0,1709.0,1858.0,2040.0,23785.0
West,15.1.2.a,Number of HIV tests conducted on males,2. Number Positive,29.0,37.0,42.0,36.0,14.0,23.0,18.0,17.0,42.0,24.0,28.0,24.0,334.0
West,15.1.2.b,Number of HIV tests conducted on Female-Non ANC (i.e. non pregnant females),1. Number tested,2090.0,1891.0,1902.0,1577.0,1421.0,1741.0,1141.0,1696.0,1867.0,1506.0,1619.0,1783.0,20234.0
West,15.1.2.b,Number of HIV tests conducted on Female-Non ANC (i.e. non pregnant females),2. Number Positive,11.0,13.0,14.0,14.0,5.0,4.0,9.0,11.0,15.0,6.0,15.0,12.0,129.0
West,15.1.2.c,Number of HIV tests conducted on Female with ANC (i.e. pregnant females),1. Number tested,2023.0,2228.0,2803.0,2591.0,2368.0,2409.0,1575.0,1796.0,1626.0,1859.0,2097.0,2080.0,25455.0
West,15.1.2.c,Number of HIV tests conducted on Female with ANC (i.e. pregnant females),2. Number Positive,5.0,2.0,3.0,8.0,2.0,2.0,3.0,1.0,4.0,1.0,5.0,5.0,41.0
West,15.1.2.d,Total number of HIV tests conducted (sum of items 15.1.2.a to 15.1.2.c),1. Number tested,6133.0,6179.0,7440.0,6491.0,5509.0,6333.0,4217.0,5329.0,5292.0,5074.0,5574.0,5903.0,69474.0
West,15.1.2.d,Total number of HIV tests conducted (sum of items 15.1.2.a to 15.1.2.c),2. Number Positive,45.0,52.0,59.0,58.0,21.0,29.0,30.0,29.0,61.0,31.0,48.0,41.0,504.0
West,15.2,Number of Widal tests conducted,Number tested,5027.0,7834.0,7444.0,8428.0,6326.0,6437.0,6172.0,4890.0,3068.0,1922.0,2732.0,3971.0,64251.0
West,15.3.a,Number of VDRL tests conducted on males,Number tested,530.0,293.0,378.0,310.0,223.0,240.0,318.0,278.0,315.0,313.0,283.0,268.0,3749.0
West,15.3.b,Number of VDRL tests conducted on Female-Non ANC (i.e. non pregnant females),Number tested,1874.0,981.0,1226.0,1307.0,1083.0,963.0,839.0,1005.0,1024.0,957.0,928.0,1048.0,13235.0
West,15.3.c,Number of VDRL tests conducted on Female with ANC (i.e. pregnant females),Number tested,1954.0,2143.0,1617.0,1743.0,1664.0,1603.0,981.0,1534.0,1298.0,1992.0,1811.0,1662.0,20002.0
West,15.3.d,Total number of VDRL tests conducted (sum of items 15.3.a to 15.3.c),Number tested,4358.0,3417.0,3221.0,3360.0,2970.0,2806.0,2138.0,2817.0,2637.0,3262.0,3022.0,2978.0,36986.0
West,15.4.1,Number of blood smears examined for Malaria,TOTAL,3486.0,3503.0,3661.0,3690.0,3623.0,4694.0,3582.0,3294.0,2940.0,1832.0,2112.0,2218.0,38635.0
West,15.4.2,"Out of blood smears examined for malaria, number of blood smears tested positive for Plasmodium Vivax",TOTAL,8.0,16.0,39.0,43.0,55.0,63.0,38.0,20.0,10.0,3.0,1.0,3.0,299.0
West,15.4.3,"Out of blood smears examined for malaria, number of blood smears tested positive for Plasmodium Falciparum",TOTAL,0.0,0.0,0.0,0.0,1.0,4.0,0.0,2.0,0.0,2.0,0.0,0.0,9.0
West,16.1.1,Stock position of DPT vaccines,1. Balance From Previous Month,3350.0,3050.0,3350.0,4360.0,4220.0,4240.0,2940.0,6270.0,5160.0,4980.0,4130.0,5660.0,51710.0
West,16.1.1,Stock position of DPT vaccines,2. Stocks Received,3500.0,4000.0,4500.0,3000.0,3000.0,2500.0,5500.0,2500.0,2500.0,2000.0,4000.0,3000.0,40000.0
West,16.1.1,Stock position of DPT vaccines,3. Unusable Stock,,,,,,,,,,,,,
West,16.1.1,Stock position of DPT vaccines,4. Stock Distributed,3800.0,3700.0,3490.0,3140.0,2980.0,3800.0,2170.0,3610.0,2680.0,2850.0,2470.0,4070.0,38760.0
West,16.1.1,Stock position of DPT vaccines,5. Total Stock,3050.0,3350.0,4360.0,4220.0,4240.0,2940.0,6270.0,5160.0,4980.0,4130.0,5660.0,4590.0,52950.0
West,16.1.1A,Stock Position of Pentavalent,1. Balance From Previous Month,4230.0,4170.0,3610.0,4510.0,4370.0,5080.0,4460.0,6700.0,5190.0,5840.0,3590.0,5910.0,57660.0
West,16.1.1A,Stock Position of Pentavalent,2. Stocks Received,3500.0,2500.0,3500.0,3000.0,3500.0,3500.0,6000.0,3500.0,4500.0,3000.0,6000.0,5500.0,48000.0
West,16.1.1A,Stock Position of Pentavalent,3. Unusable Stock,,,,,,,,,,,,,
West,16.1.1A,Stock Position of Pentavalent,4. Stock Distributed,3560.0,3060.0,2600.0,3140.0,2790.0,4120.0,3760.0,5010.0,3850.0,5250.0,3680.0,6480.0,47300.0
West,16.1.1A,Stock Position of Pentavalent,5. Total Stock,4170.0,3610.0,4510.0,4370.0,5080.0,4460.0,6700.0,5190.0,5840.0,3590.0,5910.0,4930.0,58360.0
West,16.1.2,Stock position of OPV vaccines,1. Balance From Previous Month,7240.0,6180.0,3760.0,3580.0,4220.0,2180.0,4100.0,7180.0,5740.0,3850.0,1850.0,4630.0,54510.0
West,16.1.2,Stock position of OPV vaccines,2. Stocks Received,7000.0,5000.0,4500.0,7500.0,5000.0,10000.0,9000.0,7000.0,5000.0,5000.0,9500.0,10000.0,84500.0
West,16.1.2,Stock position of OPV vaccines,3. Unusable Stock,,,,,,,,,,,,,
West,16.1.2,Stock position of OPV vaccines,4. Stock Distributed,8060.0,7420.0,4680.0,6860.0,7040.0,8080.0,5920.0,8440.0,6890.0,7000.0,6720.0,11380.0,88490.0
West,16.1.2,Stock position of OPV vaccines,5. Total Stock,6180.0,3760.0,3580.0,4220.0,2180.0,4100.0,7180.0,5740.0,3850.0,1850.0,4630.0,3250.0,50520.0
West,16.1.3,Stock position of TT vaccines,1. Balance From Previous Month,1820.0,2100.0,2420.0,2830.0,2600.0,3000.0,3240.0,4100.0,4630.0,4030.0,3570.0,4300.0,38640.0
West,16.1.3,Stock position of TT vaccines,2. Stocks Received,3000.0,2500.0,3000.0,2500.0,3000.0,3500.0,3000.0,3000.0,1500.0,2000.0,2500.0,3000.0,32500.0
West,16.1.3,Stock position of TT vaccines,3. Unusable Stock,,,,,,,,,,,,,
West,16.1.3,Stock position of TT vaccines,4. Stock Distributed,2720.0,2180.0,2590.0,2730.0,2600.0,3260.0,2140.0,2470.0,2100.0,2460.0,1770.0,3260.0,30280.0
West,16.1.3,Stock position of TT vaccines,5. Total Stock,2100.0,2420.0,2830.0,2600.0,3000.0,3240.0,4100.0,4630.0,4030.0,3570.0,4300.0,4040.0,40860.0
West,16.1.4,Stock position of DT vaccines,1. Balance From Previous Month,,,,,,,,,,,,,
West,16.1.4,Stock position of DT vaccines,2. Stocks Received,,,,,,,,,,,,,
West,16.1.4,Stock position of DT vaccines,3. Unusable Stock,,,,,,,,,,,,,
West,16.1.4,Stock position of DT vaccines,4. Stock Distributed,,,,,,,,,,,,,
West,16.1.4,Stock position of DT vaccines,5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
West,16.1.5,Stock position of BCG vaccines,1. Balance From Previous Month,2770.0,2040.0,1500.0,2390.0,2240.0,1840.0,1480.0,2830.0,1620.0,2130.0,1640.0,2640.0,25120.0
West,16.1.5,Stock position of BCG vaccines,2. Stocks Received,1000.0,1000.0,2000.0,1500.0,1000.0,2000.0,2500.0,1000.0,2000.0,1500.0,2500.0,2000.0,20000.0
West,16.1.5,Stock position of BCG vaccines,3. Unusable Stock,,,,,,,,,,,,,
West,16.1.5,Stock position of BCG vaccines,4. Stock Distributed,1730.0,1540.0,1110.0,1650.0,1400.0,2360.0,1150.0,2210.0,1490.0,1990.0,1500.0,2240.0,20370.0
West,16.1.5,Stock position of BCG vaccines,5. Total Stock,2040.0,1500.0,2390.0,2240.0,1840.0,1480.0,2830.0,1620.0,2130.0,1640.0,2640.0,2400.0,24750.0
West,16.1.6,Stock position of Measles vaccines,1. Balance From Previous Month,2550.0,3465.0,6340.0,5340.0,2295.0,2155.0,1950.0,3295.0,3670.0,3735.0,2680.0,2590.0,40065.0
West,16.1.6,Stock position of Measles vaccines,2. Stocks Received,11000.0,6500.0,38750.0,500.0,1500.0,1500.0,3000.0,3250.0,1750.0,750.0,1500.0,2000.0,72000.0
West,16.1.6,Stock position of Measles vaccines,3. Unusable Stock,,,,,,,,,,,,,
West,16.1.6,Stock position of Measles vaccines,4. Stock Distributed,10085.0,3625.0,39750.0,3545.0,1640.0,1705.0,1655.0,2875.0,1685.0,1805.0,1590.0,2965.0,72925.0
West,16.1.6,Stock position of Measles vaccines,5. Total Stock,3465.0,6340.0,5340.0,2295.0,2155.0,1950.0,3295.0,3670.0,3735.0,2680.0,2590.0,1625.0,39140.0
West,16.1.7,Stock position of JE vaccines,1. Balance From Previous Month,,,,,,,,,,,,,
West,16.1.7,Stock position of JE vaccines,2. Stocks Received,,,,,,,,,,,,,
West,16.1.7,Stock position of JE vaccines,3. Unusable Stock,,,,,,,,,,,,,
West,16.1.7,Stock position of JE vaccines,4. Stock Distributed,,,,,,,,,,,,,
West,16.1.7,Stock position of JE vaccines,5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
West,16.1.8,Stock position of Hepatitis B vaccines,1. Balance From Previous Month,2610.0,2100.0,1460.0,2660.0,2640.0,2390.0,970.0,1730.0,1190.0,1450.0,1000.0,1830.0,22030.0
West,16.1.8,Stock position of Hepatitis B vaccines,2. Stocks Received,1000.0,1000.0,2500.0,1500.0,1100.0,900.0,1500.0,600.0,1200.0,600.0,1500.0,1200.0,14600.0
West,16.1.8,Stock position of Hepatitis B vaccines,3. Unusable Stock,,,,,,,,,,,,,
West,16.1.8,Stock position of Hepatitis B vaccines,4. Stock Distributed,1510.0,1640.0,1300.0,1520.0,1350.0,2320.0,740.0,1140.0,940.0,1050.0,670.0,1150.0,15330.0
West,16.1.8,Stock position of Hepatitis B vaccines,5. Total Stock,2100.0,1460.0,2660.0,2640.0,2390.0,970.0,1730.0,1190.0,1450.0,1000.0,1830.0,1880.0,21300.0
West,16.2.1,Stock Position of IU 380 A (to be used for Family Planning),1. Balance From Previous Month,410.0,480.0,130.0,590.0,110.0,50.0,350.0,140.0,240.0,180.0,195.0,195.0,3070.0
West,16.2.1,Stock Position of IU 380 A (to be used for Family Planning),2. Stocks Received,200.0,,600.0,,,600.0,,100.0,,250.0,450.0,50.0,2250.0
West,16.2.1,Stock Position of IU 380 A (to be used for Family Planning),3. Unusable Stock,,,,,,,,,,,,,
West,16.2.1,Stock Position of IU 380 A (to be used for Family Planning),4. Stock Distributed,130.0,350.0,140.0,480.0,60.0,300.0,210.0,,60.0,235.0,450.0,120.0,2535.0
West,16.2.1,Stock Position of IU 380 A (to be used for Family Planning),5. Total Stock,480.0,130.0,590.0,110.0,50.0,350.0,140.0,240.0,180.0,195.0,195.0,125.0,2785.0
West,16.2.2,Stock Position of Condoms (to be used for Family Planning),1. Balance From Previous Month,12000.0,6000.0,500.0,12500.0,1000.0,,,,,9500.0,500.0,,42000.0
West,16.2.2,Stock Position of Condoms (to be used for Family Planning),2. Stocks Received,18000.0,,12000.0,,,,,,12000.0,6000.0,,6000.0,54000.0
West,16.2.2,Stock Position of Condoms (to be used for Family Planning),3. Unusable Stock,,,,,,,,,,,,,
West,16.2.2,Stock Position of Condoms (to be used for Family Planning),4. Stock Distributed,24000.0,5500.0,,11500.0,1000.0,,,,2500.0,15000.0,500.0,6000.0,66000.0
West,16.2.2,Stock Position of Condoms (to be used for Family Planning),5. Total Stock,6000.0,500.0,12500.0,1000.0,0.0,0.0,0.0,0.0,9500.0,500.0,0.0,0.0,30000.0
West,16.2.3,Stock Position of Oral Contraceptive (to be used for Family Planning),1. Balance From Previous Month,490.0,530.0,120.0,400.0,460.0,590.0,610.0,300.0,455.0,430.0,400.0,560.0,5345.0
West,16.2.3,Stock Position of Oral Contraceptive (to be used for Family Planning),2. Stocks Received,400.0,,600.0,500.0,300.0,200.0,100.0,400.0,200.0,100.0,400.0,300.0,3500.0
West,16.2.3,Stock Position of Oral Contraceptive (to be used for Family Planning),3. Unusable Stock,,,,,,,,,,,,,
West,16.2.3,Stock Position of Oral Contraceptive (to be used for Family Planning),4. Stock Distributed,360.0,410.0,320.0,440.0,170.0,180.0,410.0,245.0,225.0,130.0,240.0,500.0,3630.0
West,16.2.3,Stock Position of Oral Contraceptive (to be used for Family Planning),5. Total Stock,530.0,120.0,400.0,460.0,590.0,610.0,300.0,455.0,430.0,400.0,560.0,360.0,5215.0
West,16.2.4,Stock Position of Emergency Contraceptive (to be used for Family Planning),1. Balance From Previous Month,,,,,,,,,,,,,
West,16.2.4,Stock Position of Emergency Contraceptive (to be used for Family Planning),2. Stocks Received,,,,,,,,,,,,100.0,100.0
West,16.2.4,Stock Position of Emergency Contraceptive (to be used for Family Planning),3. Unusable Stock,,,,,,,,,,,,,
West,16.2.4,Stock Position of Emergency Contraceptive (to be used for Family Planning),4. Stock Distributed,,,,,,,,,,,,100.0,100.0
West,16.2.4,Stock Position of Emergency Contraceptive (to be used for Family Planning),5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
West,16.2.5,Stock Position of Tubal Rings (to be used for Family Planning),1. Balance From Previous Month,,,,100.0,,,,,,,,,100.0
West,16.2.5,Stock Position of Tubal Rings (to be used for Family Planning),2. Stocks Received,,100.0,,,,,,,,,200.0,,300.0
West,16.2.5,Stock Position of Tubal Rings (to be used for Family Planning),3. Unusable Stock,,,,,,,,,,,,,
West,16.2.5,Stock Position of Tubal Rings (to be used for Family Planning),4. Stock Distributed,,100.0,,100.0,,,,,,,200.0,,400.0
West,16.2.5,Stock Position of Tubal Rings (to be used for Family Planning),5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
West,16.3.01,Stock Position of Oxytocin Injection,1. Balance From Previous Month,,,,,,,,,,,,,
West,16.3.01,Stock Position of Oxytocin Injection,2. Stocks Received,,,,,,,,,,,,,
West,16.3.01,Stock Position of Oxytocin Injection,3. Unusable Stock,,,,,,,,,,,,,
West,16.3.01,Stock Position of Oxytocin Injection,4. Stock Distributed,,,,,,,,,,,,,
West,16.3.01,Stock Position of Oxytocin Injection,5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
West,16.3.02,Stock Position of Gloves,1. Balance From Previous Month,,,,,,,,,,,,,
West,16.3.02,Stock Position of Gloves,2. Stocks Received,,,,,,,,,,,,,
West,16.3.02,Stock Position of Gloves,3. Unusable Stock,,,,,,,,,,,,,
West,16.3.02,Stock Position of Gloves,4. Stock Distributed,,,,,,,,,,,,,
West,16.3.02,Stock Position of Gloves,5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
West,16.3.03,Stock Position of MVA Syringes,1. Balance From Previous Month,,,,,,,,,,,,,
West,16.3.03,Stock Position of MVA Syringes,2. Stocks Received,,,,,,,,,,,,,
West,16.3.03,Stock Position of MVA Syringes,3. Unusable Stock,,,,,,,,,,,,,
West,16.3.03,Stock Position of MVA Syringes,4. Stock Distributed,,,,,,,,,,,,,
West,16.3.03,Stock Position of MVA Syringes,5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
West,16.3.04,Stock Position of Fluconazole Tablets,1. Balance From Previous Month,,,,,,,,,,,,,
West,16.3.04,Stock Position of Fluconazole Tablets,2. Stocks Received,,,,,,,,,,,,,
West,16.3.04,Stock Position of Fluconazole Tablets,3. Unusable Stock,,,,,,,,,,,,,
West,16.3.04,Stock Position of Fluconazole Tablets,4. Stock Distributed,,,,,,,,,,,,,
West,16.3.04,Stock Position of Fluconazole Tablets,5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
West,16.3.05,Stock Position of Blood Transfusion Sets,1. Balance From Previous Month,,,,,,,,,,,,,
West,16.3.05,Stock Position of Blood Transfusion Sets,2. Stocks Received,,,,,,,,,,,,,
West,16.3.05,Stock Position of Blood Transfusion Sets,3. Unusable Stock,,,,,,,,,,,,,
West,16.3.05,Stock Position of Blood Transfusion Sets,4. Stock Distributed,,,,,,,,,,,,,
West,16.3.05,Stock Position of Blood Transfusion Sets,5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
West,16.3.06,Stock Position of Gluteraldehyde solution of 2% concentration,1. Balance From Previous Month,,,,,,,,,,,,,
West,16.3.06,Stock Position of Gluteraldehyde solution of 2% concentration,2. Stocks Received,,,,,,,,,,,,,
West,16.3.06,Stock Position of Gluteraldehyde solution of 2% concentration,3. Unusable Stock,,,,,,,,,,,,,
West,16.3.06,Stock Position of Gluteraldehyde solution of 2% concentration,4. Stock Distributed,,,,,,,,,,,,,
West,16.3.06,Stock Position of Gluteraldehyde solution of 2% concentration,5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
West,16.3.07,Stock Position of IFA Tablets,1. Balance From Previous Month,,,,,,,,,,,,,
West,16.3.07,Stock Position of IFA Tablets,2. Stocks Received,,,,,,,,,,,,,
West,16.3.07,Stock Position of IFA Tablets,3. Unusable Stock,,,,,,,,,,,,,
West,16.3.07,Stock Position of IFA Tablets,4. Stock Distributed,,,,,,,,,,,,,
West,16.3.07,Stock Position of IFA Tablets,5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
West,16.3.08,Stock Position of IFA Syrup (Paediatric),1. Balance From Previous Month,,,,,,,,,,,,,
West,16.3.08,Stock Position of IFA Syrup (Paediatric),2. Stocks Received,,,,,,,,,,,,,
West,16.3.08,Stock Position of IFA Syrup (Paediatric),3. Unusable Stock,,,,,,,,,,,,,
West,16.3.08,Stock Position of IFA Syrup (Paediatric),4. Stock Distributed,,,,,,,,,,,,,
West,16.3.08,Stock Position of IFA Syrup (Paediatric),5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
West,16.3.09,Stock Position of Paediatrics Antibiotics (Cotrimaxozole and Injectable Gentamicin),1. Balance From Previous Month,,,,,,,,,,,,,
West,16.3.09,Stock Position of Paediatrics Antibiotics (Cotrimaxozole and Injectable Gentamicin),2. Stocks Received,,,,,,,,,,,,,
West,16.3.09,Stock Position of Paediatrics Antibiotics (Cotrimaxozole and Injectable Gentamicin),3. Unusable Stock,,,,,,,,,,,,,
West,16.3.09,Stock Position of Paediatrics Antibiotics (Cotrimaxozole and Injectable Gentamicin),4. Stock Distributed,,,,,,,,,,,,,
West,16.3.09,Stock Position of Paediatrics Antibiotics (Cotrimaxozole and Injectable Gentamicin),5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
West,16.3.10,Stock Position of Vitamin A solution,1. Balance From Previous Month,103.0,95.0,126.0,288.0,83.0,68.0,47.0,,65.0,28.0,39.0,157.0,1099.0
West,16.3.10,Stock Position of Vitamin A solution,2. Stocks Received,100.0,400.0,600.0,300.0,,,,100.0,,100.0,200.0,100.0,1900.0
West,16.3.10,Stock Position of Vitamin A solution,3. Unusable Stock,,,,,,,,,,,,,
West,16.3.10,Stock Position of Vitamin A solution,4. Stock Distributed,108.0,369.0,438.0,505.0,15.0,21.0,47.0,35.0,37.0,89.0,82.0,165.0,1911.0
West,16.3.10,Stock Position of Vitamin A solution,5. Total Stock,95.0,126.0,288.0,83.0,68.0,47.0,0.0,65.0,28.0,39.0,157.0,92.0,1088.0
West,16.3.11,Stock of ORS (New WHO formulation),1. Balance From Previous Month,,,,,,,,,,,,,
West,16.3.11,Stock of ORS (New WHO formulation),2. Stocks Received,,,,,,,,,,,,,
West,16.3.11,Stock of ORS (New WHO formulation),3. Unusable Stock,,,,,,,,,,,,,
West,16.3.11,Stock of ORS (New WHO formulation),4. Stock Distributed,,,,,,,,,,,,,
West,16.3.11,Stock of ORS (New WHO formulation),5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
West,16.4.1,Stock Position of 0.1 ml Syringes(AD),1. Balance From Previous Month,2264.0,2274.0,1664.0,2224.0,1939.0,999.0,895.0,1945.0,1040.0,880.0,268.0,838.0,17230.0
West,16.4.1,Stock Position of 0.1 ml Syringes(AD),2. Stocks Received,1200.0,600.0,1200.0,600.0,600.0,600.0,2000.0,400.0,800.0,600.0,1800.0,400.0,10800.0
West,16.4.1,Stock Position of 0.1 ml Syringes(AD),3. Unusable Stock,,,,,,,,,,,,,
West,16.4.1,Stock Position of 0.1 ml Syringes(AD),4. Stock Distributed,1190.0,1210.0,640.0,885.0,1540.0,704.0,950.0,1305.0,960.0,1212.0,1230.0,1214.0,13040.0
West,16.4.1,Stock Position of 0.1 ml Syringes(AD),5. Total Stock,2274.0,1664.0,2224.0,1939.0,999.0,895.0,1945.0,1040.0,880.0,268.0,838.0,24.0,14990.0
West,16.4.2,Stock Position of 0.5 ml Syringes(AD),1. Balance From Previous Month,10640.0,12380.0,13700.0,18640.0,19300.0,12630.0,11860.0,16450.0,10930.0,14880.0,14930.0,18030.0,174370.0
West,16.4.2,Stock Position of 0.5 ml Syringes(AD),2. Stocks Received,22000.0,16000.0,48000.0,14000.0,6000.0,16000.0,16000.0,14000.0,18000.0,14000.0,15800.0,14400.0,214200.0
West,16.4.2,Stock Position of 0.5 ml Syringes(AD),3. Unusable Stock,,,,,,,,,,,,,
West,16.4.2,Stock Position of 0.5 ml Syringes(AD),4. Stock Distributed,20260.0,14680.0,43060.0,13340.0,12670.0,16770.0,11410.0,19520.0,14050.0,13950.0,12700.0,22830.0,215240.0
West,16.4.2,Stock Position of 0.5 ml Syringes(AD),5. Total Stock,12380.0,13700.0,18640.0,19300.0,12630.0,11860.0,16450.0,10930.0,14880.0,14930.0,18030.0,9600.0,173330.0
West,16.4.3,Stock Position of 5.0 ml Syringes(Disposable),1. Balance From Previous Month,380.0,230.0,130.0,530.0,400.0,400.0,200.0,600.0,530.0,580.0,520.0,520.0,5020.0
West,16.4.3,Stock Position of 5.0 ml Syringes(Disposable),2. Stocks Received,,,600.0,,200.0,,400.0,200.0,400.0,400.0,,,2200.0
West,16.4.3,Stock Position of 5.0 ml Syringes(Disposable),3. Unusable Stock,,,,,,,,,,,,,
West,16.4.3,Stock Position of 5.0 ml Syringes(Disposable),4. Stock Distributed,150.0,100.0,200.0,130.0,200.0,200.0,,270.0,350.0,460.0,,420.0,2480.0
West,16.4.3,Stock Position of 5.0 ml Syringes(Disposable),5. Total Stock,230.0,130.0,530.0,400.0,400.0,200.0,600.0,530.0,580.0,520.0,520.0,100.0,4740.0
West,17.1,Number of cases of Infant deaths within 24 hrs of birth,TOTAL,1.0,,,,,,,,,,,,1.0
West,17.2.1,Number of cases of Infant deaths 24 hours to 4 weeks of birth with the probable cause being Sepsis,1. Up to 1 Weeks of Birth,2.0,1.0,2.0,1.0,2.0,2.0,2.0,1.0,1.0,4.0,2.0,1.0,21.0
West,17.2.1,Number of cases of Infant deaths 24 hours to 4 weeks of birth with the probable cause being Sepsis,2. Between 1 week & 4 weeks of birth,,,,,1.0,2.0,,,,,,,3.0
West,17.2.1,Number of cases of Infant deaths 24 hours to 4 weeks of birth with the probable cause being Sepsis,3. Total,2.0,1.0,2.0,1.0,3.0,4.0,2.0,1.0,1.0,4.0,2.0,1.0,24.0
West,17.2.2,Number of cases of Infant deaths 24 hours to 4 weeks of birth with the probable cause being Asphyxia,1. Up to 1 Weeks of Birth,1.0,,1.0,1.0,,,1.0,,1.0,,1.0,1.0,7.0
West,17.2.2,Number of cases of Infant deaths 24 hours to 4 weeks of birth with the probable cause being Asphyxia,2. Between 1 week & 4 weeks of birth,,,,,1.0,,,1.0,,,1.0,,3.0
West,17.2.2,Number of cases of Infant deaths 24 hours to 4 weeks of birth with the probable cause being Asphyxia,3. Total,1.0,,1.0,1.0,1.0,,1.0,1.0,1.0,,2.0,1.0,10.0
West,17.2.3,Number of cases of Infant deaths 24 hours to 4 weeks of birth with the probable cause being LBW,1. Up to 1 Weeks of Birth,14.0,20.0,13.0,17.0,11.0,21.0,13.0,6.0,9.0,10.0,14.0,9.0,157.0
West,17.2.3,Number of cases of Infant deaths 24 hours to 4 weeks of birth with the probable cause being LBW,2. Between 1 week & 4 weeks of birth,,,,,3.0,1.0,3.0,,1.0,,,,8.0
West,17.2.3,Number of cases of Infant deaths 24 hours to 4 weeks of birth with the probable cause being LBW,3. Total,14.0,20.0,13.0,17.0,14.0,22.0,16.0,6.0,10.0,10.0,14.0,9.0,165.0
West,17.2.4,"Number of cases of Infant deaths 24 hours to 4 weeks of birth with the probable cause being other than Sepsis, Asphyxia and LBW",1. Up to 1 Weeks of Birth,10.0,12.0,9.0,7.0,4.0,8.0,3.0,8.0,4.0,8.0,6.0,9.0,88.0
West,17.2.4,"Number of cases of Infant deaths 24 hours to 4 weeks of birth with the probable cause being other than Sepsis, Asphyxia and LBW",2. Between 1 week & 4 weeks of birth,,,1.0,,1.0,1.0,2.0,,,,,,5.0
West,17.2.4,"Number of cases of Infant deaths 24 hours to 4 weeks of birth with the probable cause being other than Sepsis, Asphyxia and LBW",3. Total,10.0,12.0,10.0,7.0,5.0,9.0,5.0,8.0,4.0,8.0,6.0,9.0,93.0
West,17.3.1,Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being Pneumonia,1. Between 1 month and 11 months,1.0,4.0,1.0,1.0,2.0,2.0,,,1.0,1.0,2.0,2.0,17.0
West,17.3.1,Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being Pneumonia,2. Between 1 year & 5 years,,,,,,1.0,,,,1.0,2.0,3.0,7.0
West,17.3.1,Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being Pneumonia,3. Total,1.0,4.0,1.0,1.0,2.0,3.0,,,1.0,2.0,4.0,5.0,24.0
West,17.3.2,Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being Diarrhoea,1. Between 1 month and 11 months,,,,,,,,,1.0,,,1.0,2.0
West,17.3.2,Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being Diarrhoea,2. Between 1 year & 5 years,,,,,,,,,,,,,
West,17.3.2,Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being Diarrhoea,3. Total,,,,,,,,,1.0,,,1.0,2.0
West,17.3.3,Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being Fever related,1. Between 1 month and 11 months,1.0,,,1.0,,,,,,,1.0,,3.0
West,17.3.3,Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being Fever related,2. Between 1 year & 5 years,,,,,,,3.0,1.0,,,,,4.0
West,17.3.3,Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being Fever related,3. Total,1.0,,,1.0,,,3.0,1.0,,,1.0,,7.0
West,17.3.4,Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being Measles,1. Between 1 month and 11 months,,,,,,,,,,,,,
West,17.3.4,Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being Measles,2. Between 1 year & 5 years,,,,,,,,,,,,,
West,17.3.4,Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being Measles,3. Total,,,,,,,,,,,,,
West,17.3.5,"Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being other than Pneumonia, Diarrhoea, Fever related and Measles",1. Between 1 month and 11 months,3.0,2.0,3.0,2.0,2.0,,1.0,,2.0,,4.0,3.0,22.0
West,17.3.5,"Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being other than Pneumonia, Diarrhoea, Fever related and Measles",2. Between 1 year & 5 years,1.0,4.0,1.0,3.0,4.0,2.0,5.0,,1.0,4.0,2.0,5.0,32.0
West,17.3.5,"Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being other than Pneumonia, Diarrhoea, Fever related and Measles",3. Total,4.0,6.0,4.0,5.0,6.0,2.0,6.0,,3.0,4.0,6.0,8.0,54.0
West,17.4.1,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Diarrhoeal diseases,1. 6-14 yrs,,,,,,,,,,1.0,,,1.0
West,17.4.1,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Diarrhoeal diseases,2. 15-55 yrs.,,,,1.0,,1.0,,2.0,,,1.0,1.0,6.0
West,17.4.1,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Diarrhoeal diseases,3. Above 55 yrs.,,,1.0,,,,3.0,,1.0,,1.0,,6.0
West,17.4.1,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Diarrhoeal diseases,4. Total,,,1.0,1.0,,1.0,3.0,2.0,1.0,1.0,2.0,1.0,13.0
West,17.4.2,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Tuberculosis,1. 6-14 yrs,,,,,1.0,1.0,,1.0,,,1.0,,4.0
West,17.4.2,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Tuberculosis,2. 15-55 yrs.,9.0,5.0,5.0,13.0,3.0,6.0,8.0,5.0,9.0,10.0,9.0,2.0,84.0
West,17.4.2,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Tuberculosis,3. Above 55 yrs.,1.0,,3.0,7.0,3.0,4.0,7.0,3.0,3.0,5.0,4.0,6.0,46.0
West,17.4.2,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Tuberculosis,4. Total,10.0,5.0,8.0,20.0,7.0,11.0,15.0,9.0,12.0,15.0,14.0,8.0,134.0
West,17.4.3,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Respiratory diseases including infections,1. 6-14 yrs,1.0,1.0,,,1.0,,,,,,2.0,,5.0
West,17.4.3,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Respiratory diseases including infections,2. 15-55 yrs.,8.0,6.0,13.0,14.0,9.0,5.0,13.0,10.0,11.0,11.0,20.0,17.0,137.0
West,17.4.3,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Respiratory diseases including infections,3. Above 55 yrs.,15.0,12.0,22.0,23.0,23.0,19.0,19.0,12.0,19.0,28.0,33.0,30.0,255.0
West,17.4.3,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Respiratory diseases including infections,4. Total,24.0,19.0,35.0,37.0,33.0,24.0,32.0,22.0,30.0,39.0,55.0,47.0,397.0
West,17.4.4,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Malaria,1. 6-14 yrs,,1.0,,,,,,,,,,,1.0
West,17.4.4,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Malaria,2. 15-55 yrs.,,,1.0,1.0,,,,,,,,,2.0
West,17.4.4,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Malaria,3. Above 55 yrs.,,,,,,,,,,,,,
West,17.4.4,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Malaria,4. Total,,1.0,1.0,1.0,,,,,,,,,3.0
West,17.4.5,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being other Fever related,1. 6-14 yrs,,1.0,,,,,,,1.0,,,,2.0
West,17.4.5,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being other Fever related,2. 15-55 yrs.,1.0,4.0,7.0,3.0,8.0,3.0,7.0,4.0,2.0,,3.0,,42.0
West,17.4.5,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being other Fever related,3. Above 55 yrs.,,,2.0,,1.0,2.0,1.0,3.0,,,,1.0,10.0
West,17.4.5,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being other Fever related,4. Total,1.0,5.0,9.0,3.0,9.0,5.0,8.0,7.0,3.0,,3.0,1.0,54.0
West,17.4.6,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being HIV/AIDS,1. 6-14 yrs,,,,,,,,,,,,,
West,17.4.6,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being HIV/AIDS,2. 15-55 yrs.,3.0,,2.0,3.0,5.0,2.0,,1.0,,3.0,2.0,2.0,23.0
West,17.4.6,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being HIV/AIDS,3. Above 55 yrs.,,,1.0,,,,,,,,,,1.0
West,17.4.6,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being HIV/AIDS,4. Total,3.0,,3.0,3.0,5.0,2.0,,1.0,,3.0,2.0,2.0,24.0
West,17.4.7,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Heart disease or related to Hypertension,1. 6-14 yrs,,,,,,,,,,,,,
West,17.4.7,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Heart disease or related to Hypertension,2. 15-55 yrs.,5.0,14.0,14.0,11.0,12.0,17.0,15.0,13.0,19.0,14.0,23.0,16.0,173.0
West,17.4.7,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Heart disease or related to Hypertension,3. Above 55 yrs.,28.0,28.0,32.0,27.0,27.0,22.0,22.0,27.0,41.0,61.0,51.0,35.0,401.0
West,17.4.7,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Heart disease or related to Hypertension,4. Total,33.0,42.0,46.0,38.0,39.0,39.0,37.0,40.0,60.0,75.0,74.0,51.0,574.0
West,17.4.8,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Neurological disease including strokes,1. 6-14 yrs,1.0,,,1.0,1.0,,,,,1.0,1.0,,5.0
West,17.4.8,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Neurological disease including strokes,2. 15-55 yrs.,2.0,4.0,4.0,2.0,1.0,1.0,4.0,2.0,,3.0,2.0,3.0,28.0
West,17.4.8,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Neurological disease including strokes,3. Above 55 yrs.,2.0,2.0,2.0,5.0,4.0,2.0,2.0,6.0,4.0,5.0,3.0,4.0,41.0
West,17.4.8,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Neurological disease including strokes,4. Total,5.0,6.0,6.0,8.0,6.0,3.0,6.0,8.0,4.0,9.0,6.0,7.0,74.0
West,17.4.9(a),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Abortion,1. 6-14 yrs,,,,,,,,,,,,,
West,17.4.9(a),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Abortion,2. 15-49 yrs,,,,,,,,,,,,,
West,17.4.9(a),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Abortion,3. Above 49 yrs.,,,,,,,,,,,,,
West,17.4.9(a),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Abortion,4. Total,,,,,,,,,,,,,
West,17.4.9(b),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Obstructed or prolonged labour,1. 6-14 yrs,,,,,,,,,,,,,
West,17.4.9(b),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Obstructed or prolonged labour,2. 15-49 yrs,,,,,,,,,,,,,
West,17.4.9(b),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Obstructed or prolonged labour,3. Above 49 yrs.,,,,,,,,,,,,,
West,17.4.9(b),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Obstructed or prolonged labour,4. Total,,,,,,,,,,,,,
West,17.4.9(c),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Severe hypertesnion or fits,1. 6-14 yrs,,,,,,,,,,,,,
West,17.4.9(c),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Severe hypertesnion or fits,2. 15-49 yrs,,,,2.0,,,2.0,,,,,,4.0
West,17.4.9(c),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Severe hypertesnion or fits,3. Above 49 yrs.,,,,,,,,,,,,,
West,17.4.9(c),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Severe hypertesnion or fits,4. Total,,,,2.0,,,2.0,,,,,,4.0
West,17.4.9(d),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Bleeding,1. 6-14 yrs,,,,,,,,,,,,,
West,17.4.9(d),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Bleeding,2. 15-49 yrs,,2.0,,,1.0,,,,,,,1.0,4.0
West,17.4.9(d),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Bleeding,3. Above 49 yrs.,,,,,,,,,,,,,
West,17.4.9(d),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Bleeding,4. Total,,2.0,,,1.0,,,,,,,1.0,4.0
West,17.4.9(e),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being High Fever,1. 6-14 yrs,,,,,,,,,,,,,
West,17.4.9(e),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being High Fever,2. 15-49 yrs,,,,,,,,,,1.0,,,1.0
West,17.4.9(e),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being High Fever,3. Above 49 yrs.,,,,,,,,,,,,,
West,17.4.9(e),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being High Fever,4. Total,,,,,,,,,,1.0,,,1.0
West,17.4.9(f),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being other causes (excluding abortion; obstructed or prolonged labour; severe hypertension or fits;,1. 6-14 yrs,,,,,,,,,,,,,
West,17.4.9(f),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being other causes (excluding abortion; obstructed or prolonged labour; severe hypertension or fits;,2. 15-49 yrs,2.0,1.0,2.0,3.0,2.0,4.0,3.0,2.0,4.0,3.0,3.0,1.0,30.0
West,17.4.9(f),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being other causes (excluding abortion; obstructed or prolonged labour; severe hypertension or fits;,3. Above 49 yrs.,,,,,,,,,,,,,
West,17.4.9(f),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being other causes (excluding abortion; obstructed or prolonged labour; severe hypertension or fits;,4. Total,2.0,1.0,2.0,3.0,2.0,4.0,3.0,2.0,4.0,3.0,3.0,1.0,30.0
West,17.4.10,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Trauma or Accidents or Burn cases,1. 6-14 yrs,,,2.0,,2.0,,,1.0,1.0,,,,6.0
West,17.4.10,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Trauma or Accidents or Burn cases,2. 15-55 yrs.,21.0,22.0,10.0,13.0,11.0,6.0,12.0,9.0,3.0,5.0,11.0,14.0,137.0
West,17.4.10,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Trauma or Accidents or Burn cases,3. Above 55 yrs.,7.0,1.0,1.0,2.0,2.0,6.0,1.0,2.0,,1.0,3.0,3.0,29.0
West,17.4.10,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Trauma or Accidents or Burn cases,4. Total,28.0,23.0,13.0,15.0,15.0,12.0,13.0,12.0,4.0,6.0,14.0,17.0,172.0
West,17.4.11,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being suicide,1. 6-14 yrs,,,,,,,,,,,,,
West,17.4.11,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being suicide,2. 15-55 yrs.,,,,,,,,,,1.0,,,1.0
West,17.4.11,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being suicide,3. Above 55 yrs.,,,,,,,,,,,,,
West,17.4.11,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being suicide,4. Total,,,,,,,,,,1.0,,,1.0
West,17.4.12,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Animal bites and stings,1. 6-14 yrs,,,1.0,,,,,,,,,,1.0
West,17.4.12,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Animal bites and stings,2. 15-55 yrs.,,,,,1.0,,1.0,,,,,,2.0
West,17.4.12,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Animal bites and stings,3. Above 55 yrs.,,,1.0,,,,,,,,,,1.0
West,17.4.12,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Animal bites and stings,4. Total,,,2.0,,1.0,,1.0,,,,,,4.0
West,17.4.13(a),Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Known Acute disease,1. 6-14 yrs,,,2.0,,1.0,,,2.0,1.0,,,,6.0
West,17.4.13(a),Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Known Acute disease,2. 15-55 yrs.,10.0,9.0,13.0,22.0,13.0,14.0,17.0,9.0,4.0,11.0,8.0,8.0,138.0
West,17.4.13(a),Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Known Acute disease,3. Above 55 yrs.,7.0,11.0,4.0,17.0,8.0,14.0,9.0,9.0,8.0,12.0,10.0,9.0,118.0
West,17.4.13(a),Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Known Acute disease,4. Total,17.0,20.0,19.0,39.0,22.0,28.0,26.0,20.0,13.0,23.0,18.0,17.0,262.0
West,17.4.13(b),Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Known Chronic disease,1. 6-14 yrs,,1.0,1.0,,,1.0,,3.0,,,,,6.0
West,17.4.13(b),Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Known Chronic disease,2. 15-55 yrs.,12.0,24.0,15.0,15.0,8.0,12.0,23.0,24.0,24.0,27.0,16.0,21.0,221.0
West,17.4.13(b),Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Known Chronic disease,3. Above 55 yrs.,15.0,11.0,13.0,11.0,10.0,15.0,12.0,23.0,28.0,27.0,22.0,27.0,214.0
West,17.4.13(b),Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Known Chronic disease,4. Total,27.0,36.0,29.0,26.0,18.0,28.0,35.0,50.0,52.0,54.0,38.0,48.0,441.0
West,17.4.13(c),Number of cases of Adolescent or Adult deaths (age 6 years & above) where the cause was not known,1. 6-14 yrs,,1.0,,,,,,,,,,,1.0
West,17.4.13(c),Number of cases of Adolescent or Adult deaths (age 6 years & above) where the cause was not known,2. 15-55 yrs.,4.0,10.0,2.0,6.0,11.0,5.0,3.0,8.0,5.0,4.0,9.0,3.0,70.0
West,17.4.13(c),Number of cases of Adolescent or Adult deaths (age 6 years & above) where the cause was not known,3. Above 55 yrs.,1.0,1.0,3.0,1.0,2.0,2.0,,2.0,,1.0,,2.0,15.0
West,17.4.13(c),Number of cases of Adolescent or Adult deaths (age 6 years & above) where the cause was not known,4. Total,5.0,12.0,5.0,7.0,13.0,7.0,3.0,10.0,5.0,5.0,9.0,5.0,86.0
